
<html lang="en"     class="pb-page"  data-request-id="714a7a2b-1f69-456b-b42c-df340c70f77d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-14;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b01689;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?" /></meta><meta name="dc.Creator" content="Sreekanth  Thota" /></meta><meta name="dc.Creator" content="Daniel A.  Rodrigues" /></meta><meta name="dc.Creator" content="Debbie C.  Crans" /></meta><meta name="dc.Creator" content="Eliezer J.  Barreiro" /></meta><meta name="dc.Description" content="Metal based therapeutics are a precious class of drugs in oncology research that include examples of theranostic drugs, which are active in both diagnostic, specifically imaging, and therapeutics a..." /></meta><meta name="Description" content="Metal based therapeutics are a precious class of drugs in oncology research that include examples of theranostic drugs, which are active in both diagnostic, specifically imaging, and therapeutics a..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 15, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01689" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01689" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01689" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01689" /></link>
        
    
    

<title>Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics? | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01689" /></meta><meta property="og:title" content="Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0015.jpeg" /></meta><meta property="og:description" content="Metal based therapeutics are a precious class of drugs in oncology research that include examples of theranostic drugs, which are active in both diagnostic, specifically imaging, and therapeutics applications. Ruthenium compounds have shown selective bioactivity and the ability to overcome the resistance that platinum-based therapeutics face, making them effective oncotherapeutic competitors in rational drug invention approaches. The development of antineoplastic ruthenium therapeutics is of particular interest because ruthenium containing complexes NAMI-A, KP1019, and KP1339 entered clinical trials and DW1/2 is in preclinical levels. The very robust, conformationally rigid organometallic Ru(II) compound DW1/2 is a protein kinase inhibitor and presents new Ru(II) compound designs as anticancer agents. Over the recent years, numerous strategies have been used to encapsulate Ru(II) derived compounds in a nanomaterial system, improving their targeting and delivery into neoplastic cells. A new photodynamic therapy based Ru(II) therapeutic, TLD-1433, has also entered clinical trials. Ru(II)-based compounds can also be photosensitizers for photodynamic therapy, which has proven to be an effective new, alternative, and noninvasive oncotherapy modality." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01689"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01689">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01689&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01689&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01689&amp;href=/doi/10.1021/acs.jmedchem.7b01689" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 5805-5821</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01314" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.7b01788" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Sreekanth Thota</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sreekanth Thota</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Fundação Oswaldo Cruz, Ministério da Saúde, Av. Brazil 4036, Prédio da Expansão, 8° Andar, Sala 814, Manguinhos, 21040-361 Rio de Janeiro, RJ, Brazil</div><div class="loa-info-affiliations-info">Laboratório de Avaliação e Síntese de Substâncias Bioativas (LASSBio), Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), P.O. Box 68023, 21941-902 Rio de Janeiro, RJ, Brazil</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +55-21-38829234. Fax: +55-21-22900494. E-mail: <a href="/cdn-cgi/l/email-protection#4f3c3b3c3d2a2a242e213b273b27203b2e0f28222e2623612c2022"><span class="__cf_email__" data-cfemail="0e7d7a7d7c6b6b656f607a667a66617a6f4e69636f6762206d6163">[email protected]</span></a>, <a href="/cdn-cgi/l/email-protection#7201061a1d061332111606015c141b1d110007085c1000"><span class="__cf_email__" data-cfemail="5724233f382336173433232479313e383425222d793525">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sreekanth++Thota">Sreekanth Thota</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7501-3987" title="Orcid link">http://orcid.org/0000-0002-7501-3987</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel A. Rodrigues</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel A. Rodrigues</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratório de Avaliação e Síntese de Substâncias Bioativas (LASSBio), Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), P.O. Box 68023, 21941-902 Rio de Janeiro, RJ, Brazil</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+A.++Rodrigues">Daniel A. Rodrigues</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Debbie C. Crans</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Debbie C. Crans</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Colorado State University, Fort Collins, Colorado 80523, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Debbie+C.++Crans">Debbie C. Crans</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Eliezer J. Barreiro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eliezer J. Barreiro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratório de Avaliação e Síntese de Substâncias Bioativas (LASSBio), Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), P.O. Box 68023, 21941-902 Rio de Janeiro, RJ, Brazil</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eliezer+J.++Barreiro">Eliezer J. Barreiro</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1759-0038" title="Orcid link">http://orcid.org/0000-0003-1759-0038</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01689&amp;href=/doi/10.1021%2Facs.jmedchem.7b01689" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 5805–5821</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 15, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 November 2017</li><li><span class="item_label"><b>Published</b> online</span>15 February 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 July 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01689" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01689</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5805%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSreekanth%2BThota%252C%2BDaniel%2BA.%2BRodrigues%252C%2BDebbie%2BC.%2BCrans%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D14%26contentID%3Dacs.jmedchem.7b01689%26title%3DRu%2528II%2529%2BCompounds%253A%2BNext-Generation%2BAnticancer%2BMetallotherapeutics%253F%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5821%26publicationDate%3DJuly%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01689"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5217</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">180</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01689" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sreekanth&quot;,&quot;last_name&quot;:&quot;Thota&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;A. Rodrigues&quot;},{&quot;first_name&quot;:&quot;Debbie&quot;,&quot;last_name&quot;:&quot;C. Crans&quot;},{&quot;first_name&quot;:&quot;Eliezer&quot;,&quot;last_name&quot;:&quot;J. Barreiro&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;5805-5821&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01689&quot;},&quot;abstract&quot;:&quot;Metal based therapeutics are a precious class of drugs in oncology research that include examples of theranostic drugs, which are active in both diagnostic, specifically imaging, and therapeutics applications. Ruthenium compounds have shown selective bioactivity and the ability to overcome the resistance that platinum-based therapeutics face, making them effective oncotherapeutic competitors in rational drug invention approaches. The development of antineoplastic ruthenium therapeutics is of particular interest because ruthenium containing complexes NAMI-A, KP1019, and KP1339 entered clinical trials and DW1/2 is in preclinical levels. The very robust, conformationally rigid organometallic Ru(II) compound DW1/2 is a protein kinase inhibitor and presents new Ru(II) compound designs as anticancer agents. Over the recent years, numerous strategies have been used to encapsulate Ru(II) derived compounds in a nanomaterial system, improving their targeting and delivery into neoplastic cells. A new photodynamic therap&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01689&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01689" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01689&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01689" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01689&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01689" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01689&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01689&amp;href=/doi/10.1021/acs.jmedchem.7b01689" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01689" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01689" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01689%26sid%3Dliteratum%253Aachs%26pmid%3D29446940%26genre%3Darticle%26aulast%3DThota%26date%3D2018%26atitle%3DRu%2528II%2529%2BCompounds%253A%2BNext-Generation%2BAnticancer%2BMetallotherapeutics%253F%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D14%26spage%3D5805%26epage%3D5821%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291398" title="Ruthenium">Ruthenium</a>,</li><li><a href="/action/doSearch?ConceptID=292519" title="Cancer therapy">Cancer therapy</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/jmcmar.2018.61.issue-14/20180726/jmcmar.2018.61.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0015.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Metal based therapeutics are a precious class of drugs in oncology research that include examples of theranostic drugs, which are active in both diagnostic, specifically imaging, and therapeutics applications. Ruthenium compounds have shown selective bioactivity and the ability to overcome the resistance that platinum-based therapeutics face, making them effective oncotherapeutic competitors in rational drug invention approaches. The development of antineoplastic ruthenium therapeutics is of particular interest because ruthenium containing complexes <b>NAMI-A</b>, <b>KP1019</b>, and <b>KP1339</b> entered clinical trials and <b>DW1/2</b> is in preclinical levels. The very robust, conformationally rigid organometallic Ru(II) compound <b>DW1/2</b> is a protein kinase inhibitor and presents new Ru(II) compound designs as anticancer agents. Over the recent years, numerous strategies have been used to encapsulate Ru(II) derived compounds in a nanomaterial system, improving their targeting and delivery into neoplastic cells. A new photodynamic therapy based Ru(II) therapeutic, <b>TLD-1433</b>, has also entered clinical trials. Ru(II)-based compounds can also be photosensitizers for photodynamic therapy, which has proven to be an effective new, alternative, and noninvasive oncotherapy modality.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01546" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01546" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tumor is the uncontrolled growth of anomalous cells in the body.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Cancers are among the leading causes of death worldwide, accounting for 8.2 million deaths within 5 years of diagnosis.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> According to a WHO report, it is expected that annual cancer cases will rise from 14 million in 2012 to 26 million within the next 2 decades.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> There is no current oncotherapy that is able to cure most forms of disseminated tumors, so the discovery of novel active chemotherapeutics is predominantly needed.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> There have been tremendous efforts to conquer cancer with current chemotherapy. The next generation of molecularly targeted drugs have potential in personalized medicine because these approaches promise more efficacious and less adverse antitumor therapies in patients who have suffer from resistant cancers.</div><div class="NLM_p">Metallotherapeutics act by preventing cancer cell division and trigger cancer cell apoptosis by inducing DNA damage and disrupting DNA repair process.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6−8)</a> Metal scaffolds currently play an important role in medicinal chemistry and drug development after the serendipitous discovery and development of platinum compounds.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> The platinum-based drug cisplatin (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) is one of the most progressive and commonly used drugs in the clinic in the treatment of numerous forms of human cancers, but its therapeutic value is accompanied by serious side effects, and thus its effectiveness decreases by the increasing observed drug resistance.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> For these reasons, many researchers are actively searching for other alternative transition metal compounds, and new ruthenium compounds have been reported as antitumor metallotherapeutics.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of cisplatin and ruthenium clinical trial, preclinical, and lead compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">2.  Development of Ru(II) Compounds</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01168" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01168" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Ruthenium-based therapeutics are promising candidates that show acceptable biological properties for chemotherapy and have emerged as a favorable adjunctive to the platinum-derived therapeutics.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> For the past few decades ruthenium therapeutics have successfully been used in clinical research and their mechanisms of antitumor action have been reported.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> Several reviews on the anticancer ruthenium compounds have been reported in 2016.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20">(16−20)</a> Ruthenium-based anticancer metallotherapeutics<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> are very appealing alternatives because of their different modes of action, and they were found to have certain merits over platinum-based therapeutics. Ruthenium compounds have desired properties that make these ruthenium scaffolds attractive alternatives for medicinal application. (i) They are active against some cisplatin resistant cell lines. (ii) They have low side effects due to their higher selectivity for cancer cells compared with normal cells. (iii) The higher selectivity of these compounds for their targets may be linked to selective uptake by the tumor compared with healthy tissue.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (iv) Ruthenium can mimic iron in binding to some biological molecules.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Recently Alessio described some myths in the field of ruthenium antitumor therapeutics including discussing ruthenium therapeutics’ low toxicity because ruthenium mimics iron. He suggested that ruthenium therapeutics have inherently low toxicity but that ruthenium’s ability to mimic iron is often confused with toxicity.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Ruthenium belongs to the same group in the periodic table as iron, which is reflected by its high affinity for transferrin and by the its reductive activation in cells.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> Some ruthenium compounds are excellent candidates for clinical development, due the low cytotoxicity and genotoxicity, different ligand exchange kinetics, transport, activation mechanisms, and high biological activity.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.1.  Clinical Trials and Patented Compounds of Ruthenium</h3><div class="NLM_p">There are currently four ruthenium therapeutics in various stages of clinical trials, with one possibly about to obtain marketing approval for use in the clinic. The antineoplastic ruthenium scaffolds that have entered clinical trials include Ru(III) species, imidazolium(imidazole)(dimethylsulfoxide)tetrachlororuthenate(III) (<b>NAMI-A</b>)<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> and indazolium trans-tetrachlorobis(1<i>H</i>-indazole)ruthenate(III)] (<b>KP1019</b>)<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> and <b>KP1339</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) and Ru(II)based therapeutic <b>TLD1433</b>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Ruthenium therapeutic (<b>NAMI-A</b>) was the first ruthenium based complex to reach human clinical investigations. In preclinical investigations in several tumor animal models, ruthenium based therapeutic <b>NAMI-A</b> exhibited inhibition of tumor metastases and appeared to lack cytotoxic actions. It succeeded in phase I clinical studies, but in phase II clinical studies showed only limited efficacy which prevented further clinical development of <b>NAMI-A</b>. Another ruthenium therapeutic <b>KP1019</b> entered phase I clinical trials. Its low solubility limited its further development, but in its place a more soluble sodium salt, <b>KP1339</b>, is currently undergoing clinical trials.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Another interesting Ru(II) therapeutic <b>TLD1433</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) entered phase 1 and phase 2a clinical trials for nonmuscle invasive bladder cancer treatment with photodynamic therapy (PDT).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of Ru(II) clinical trial photodynamic therapy compound.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">From the past decade, some Ru(II) complexes bearing 1,10-phenanthroline and 2,2-bipyridine exerted potent activities against numerous tumor cells<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31−33)</a> whereas other ruthenium complexes were reported as protein kinase inhibitors.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Many medicinal chemists have discovered new Ru(II) scaffolds that are already being investigated in preclinical studies at various stages of development. For example, the ruthenium complex <b>RAPTA-C</b>,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> combination with erlotinib, exhibited efficient anticancer action. In the past few decades several advancements on patents of antineoplastic ruthenium complexes with a range of different scaffolds have been reported.<a onclick="showRef(event, 'ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43">(36−43)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.2.  Ru(II) Lead Compounds (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>)</h3><div class="NLM_p"><b>RAED.</b> Ruthenium compound with diamine scaffolds are of consideration as prospective novel metal-based antitumor therapeutics. <b>RAED</b><a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> compounds are ruthenium-arene compounds bearing 1,2-ethylenediamine ligand. They have the ability of binding to DNA and form adducts with guanine. This ruthenium therapeutic displayed potent cytotoxicity in in vitro neoplastic cells with DNA interaction.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p"><b>RM175.</b> Another ruthenium organometallic lead compound is <b>RM175</b>,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> [(η6-C<sub>6</sub>H<sub>5</sub>C<sub>6</sub>H<sub>5</sub>)RuCl(H<sub>2</sub>NCH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>-N,N′)]<sup>+</sup>PF<sub>6</sub><sup>–</sup>. Test with this ruthenium lead complex the apoptosis was induced through Bax, p53, and loss of clonogenicity.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_p"><b>RDC11.</b> A ruthenium derived lead compound <b>RDC11</b><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> exhibited in vitro cytotoxic activity for numerous tumor cell lines, including those that are sensitive to and those that are resistant to cisplatin. <b>RDC11</b> treatment diminished chronic toxicity compared with cisplatin and hindered the growth of the various xenograft model cancers in mice more efficiently than cisplatin.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_p"><b>DW1/2.</b><b>DW1/2</b><a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> is the first ruthenium antitumor agent targeting a signal transduction pathway. <b>DW1/2</b> binds to a protein and, as such, can be characterized as a glycogen synthase kinase (GSK)-3β inhibitor. It is also a potent activator of p53.</div><div class="NLM_p"><b>KP418.</b> A lead structure was found in the imidazole-containing complex ICR (<b>KP418</b>),<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> imidazolium trans-[tetrachloridobis(1<i>H</i>-imidazole)ruthenate(III)], which proved therapeutic activity against murine P388 leukemia and B16 melanoma.</div><div class="NLM_p"><b>ONCO4417.</b> This ruthenium lead structure more resembles another ruthenium lead compound <b>RM175</b>, whereas insertion of chloride instead of hexafluorophosphate anion (PF<sub>6</sub><sup>–</sup>) in <b>RM175</b> results in another ruthenium lead compound <b>ONCO4417</b>.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> In vitro results concluded that <b>ONCO4417</b> has tantamount efficacy to platinum in many tumor cell lines. This ruthenium lead compound displayed significant efficacy in inhibiting tumor metastasis.</div><div class="NLM_p"><b>RAPTA-C.</b> Ru(II) complexes reported in 2004 bearing phosphoadamantane and arene ligands as a class were named RAPTAs. The [Ru(eta(6)-<i>p</i>-cymene)Cl(2)(pta)], where pta is 1,3,5-triaza-7-phosphaadamantane, was termed <b>RAPTA-C</b><a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and found to induce cell death in Ehrlich ascites carcinoma (EAC) cells via p53-JNK and mitochondrial pathways.</div><div class="NLM_p"><b>RAPTA-T.</b> Another effective ruthenium-containing RAPTA-derivative is the ruthenium(II)-arene drug Ru(η<sup>6</sup>-C<sub>6</sub>H<sub>5</sub>Me)(pta)Cl<sub>2</sub>, abbreviated <b>RAPTA-T</b>.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a><b>RAPTA-T</b> showed anti-invasive and antimetastatic effects against breast cancer cells.</div><div class="NLM_p last"><b>UNICAM-1.</b> A water-soluble ruthenium(II) organometallic compound [Ru(<i>p</i>-cymene)(bis(3,5-dimethylpyrazol-1-yl)methane)Cl]Cl is termed <b>UNICAM-1</b>.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> In A17 triple negative breast cancer cell, this ruthenium lead complex significantly reduces the growth.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">3.  Cellular Uptake and Cytotoxicity of Ru(II) Compounds</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37485" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37485" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The drugs need to permeate the cell membrane to act on the living cells. Cell membranes secure and organize cells, which contain numerous proteins and lipids, and its action is to monitor what substances penetrate the cells. Cellular uptake of small scaffolds can occur via energy-dependent (endocytosis, active transport) and energy-independent (facilitated diffusion, passive diffusion) processes (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> However, the uptake of ruthenium compounds by tumor cells or other cells must be substantial for selective and decisive cancer treatment. Cellular uptake of the ruthenium therapeutics has been analyzed by flow cytometry.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54,55)</a> The complex [Ru(phen)<sub>2</sub>(mitatp)]<sup>2+</sup> exhibited significant antitumor activity against several tumor cells, and flow cytometric experiments and imaging experiments suggested that the ruthenium compound could cross cell membrane and accumulate in the nucleus, leading to induction of G0/G1 cell cycle arrest and apoptosis.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54,55)</a> The ruthenium compound [Ru(DIP)<sub>2</sub>(dppz)]<sup>2+</sup> showed cellular uptake through an energy-independent process.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> For the past decade several reports on cellular uptake of ruthenium compounds has been published.<a onclick="showRef(event, 'ref54 ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56 ref57">(54−57)</a> Schobert et al. reported cellular uptake of Ru(II) compounds as measured by ICP-OES spectrometry. They also discussed the effect of steroids and steroid binding proteins on hormone conjugates of ruthenium.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> One very interesting feature of anticancer Ru(II) therapeutics is the ability to inhibit the efflux pump P-glycoprotein (Pgp).<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Ru(II) compounds bearing natural antitumor naphthoquinone plumbagin exhibited augmented efficacy against resistant tumor cell lines and inhibit the drug efflux pump Pgp.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. General cellular uptake mechanisms of drugs. Reproduced from ref <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (<a href="http://dx.doi.org/10.1039/C7CS00195A" class="extLink">http://dx.doi.org/10.1039/C7CS00195A</a>), Copyright 2017, with permission of The Royal Society of Chemistry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The crucial point in identifying substances is the selectivity index with acceptable biological action and negligible cytotoxicity. During the past 2 decades, several reports have been published on in vitro cytotoxicity of Ru(II) compounds on numerous human cancer cell lines.<a onclick="showRef(event, 'ref61 ref62 ref63 ref64 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref61 ref62 ref63 ref64 ref65 ref66">(61−66)</a> Several analyses have shown that numerous factors such as cell membrane changes and cell adhesion characters, apoptosis through mitochondrial pathway, or inhibition of topoisomerase I and II could at least in part explain the observed cytotoxicity. Bergamo et al. reported the selectivity and cytotoxicity of ruthenium compounds in preclinical and clinical trials. In mammary carcinoma model differentiation of selectivity of the antineoplastic action of <b>KP1019</b>, <b>RM175</b>, <b>RAPTA-T</b>, and <b>NAMI-A</b> is shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Nonselective cytotoxicity was observed when the compound inhibits the primary tumor and lung metastasis growth in a similar way. The in vivo results on a mouse metastasizing tumor demonstrated a moderate inhibition of primary tumor growth for <b>KP1019</b>, <b>RM175</b>, <b>RAPTA-T</b>, and <b>NAMI-A</b>. However, the selectively varies. No selectivity is observed for <b>KP1019</b> in contrast to the other three compounds. More than a 50% reduction of spontaneous lung metastasis formation was observed for <b>RM175</b>, <b>RAPTA-T</b>, and <b>NAMI-A</b>.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In mammary carcinoma model differentiation of the percent inhibition and selectivity of the antineoplastic action of <b>KP1019</b>, <b>RM175</b>, <b>RAPTA-T</b>, and <b>NAMI-A</b>. The right red bar indicates the percent inhibition of lung metastases, and left green bar indicates the percent inhibition of primary tumor growth. Reproduced with permission from   <cite><i>Journal of Inorganic
Biochemistry</i></cite> (<a href="https://www.sciencedirect.com/journal/journal-of-inorganic-biochemistry" class="extLink">https://www.sciencedirect.com/journal/journal-of-inorganic-biochemistry</a>), <span class="NLM_year">2012</span>, Vol. <em>106</em>; <contrib-group><span class="NLM_string-name">Bergamo, A.</span>; <span class="NLM_string-name">Gaiddon, C.</span>; <span class="NLM_string-name">Schellens, J. H.</span>; <span class="NLM_string-name">Beijnen, J. H.</span>; <span class="NLM_string-name">Sava, G.</span></contrib-group> Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates, Pages 90–99,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Copyright 2011, with permission from Elsevier.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">4.  DNA Binding, Protein Binding, and Apoptosis of Ruthenium Compounds</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63400" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63400" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">4.1.  DNA Binding</h3><div class="NLM_p">The nucleus DNA is one of the vital targets for many oncology drugs.<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67,68)</a> DNA is one of the primary pharmacological targets for numerous FDA-approved metallotherapeutics (e.g., cisplatin, carboplatin, oxaliplatin) and organic oncology drugs (doxorubicin, gemcitabine, 5-fluorouracil, etc.).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Significant emphases have been given to the design of compounds with ligand scaffolds that bind to DNA with site selectivity. Interaction of transition complexes with DNA has been a popular subject for researchers in the field of bioinorganic chemistry ever since the discovery of platinum therapeutics as an anticancer agent.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a> Several Ru(II) complexes have shown significant DNA binding affinity.<a onclick="showRef(event, 'ref72 ref73 ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref72 ref73 ref74 ref75">(72−75)</a></div><div class="NLM_p">Past literature studies have indicated that <b>RAED-C</b> forms adducts at guanine bases of oligonucleotide DNA and that <b>RAPTA-C</b> also binds to DNA.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Ru(II) polypyridyl compounds afford favorable platforms for DNA-binding and delivering bioactive drugs to the cell. The compound is activated through the photoirradiation of the photolabile bond that utilizes the metal to ligand charge transfer (MLCT) band, and these compounds have also been assessed as cellular probes. The binding mode of the metallotherapeutics with DNA provides insight into mechanism of action and effectiveness of these therapeutics.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Ruthenium-based oncotherapeutics have displayed differences with respect to their DNA interactions depending on their structure. For example, organometallic piano-stool ruthenium(II) complexes containing biphenyl rings (<b>RM175)</b> interact strongly with DNA binding to guanines.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div><div class="NLM_p last">Oncotherapeutics that target DNA are one of the most effective agents in clinical use and have produced significant improvement in the survival of cancer patients when used in combination with chemotherapeutics that have different mechanisms of action. Therefore, a detailed understanding of the interaction of ruthenium compounds with models of binding sites present in DNA is of paramount significance to unravel the mechanism of action of ruthenium-derived complexes.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> During the past decade, a huge amount of work has been published on the synthesis, cytotoxicity, and DNA-binding ability of Ru(II) compounds.<a onclick="showRef(event, 'ref78 ref79 ref80 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref78 ref79 ref80 ref81 ref82">(78−82)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">4.2.  Protein Binding</h3><div class="NLM_p">Over the past few decades, the analysis of plasma concentrations of oncotherapeutics has demonstrated its value to clinical studies for numerous vital drugs. Although protein binding is a major determinant of drug action, with very few exceptions, it is clearly only one of many factors that influence the disposition of oncology drugs. Normally the protein-binding was analyzed by electronic absorption and fluorescence quenching. High concentration of proteins in plasma and the tendency of various drugs to bind them have led drug discovery groups to identify the significance of plasma protein binding (PPB) in modulating the effective drug concentration at pharmacological target sites. Overall, past studies implied that proteins are biological targets of the Ru(II) polypyridyl scaffolds.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Ru(II) compounds bind to major metal-transporting proteins from human blood such as human serum albumin (HSA) and serum transferrin (Tf). The binding affinity of ruthenium compounds against these two proteins showed that HSA appears to be a more favorable binding partner.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></div><div class="NLM_p last">Intracellular protein binding patterns of the clinical trial ruthenium therapeutics <b>KP1019</b> and <b>KP1339</b> have been reported. <b>KP1019</b> is known to powerfully bind to serum proteins and hamper P-glycoprotein-mediated efflux, making this ruthenium therapeutic attractive for multidrug-resistant tumor therapy.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Preclinical <b>RAPTA-C</b> compound has shown significant binding affinity with two emerging protein targets, thioredoxin reductase and cathepsin B, for demonstrating their antitumor action.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Over the recent years several groups reported significant protein binding affinity of Ru(II) based scaffolds.<a onclick="showRef(event, 'ref83 ref84 ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref83 ref84 ref85 ref86">(83−86)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">4.3.  Apoptosis</h3><div class="NLM_p">Facilitating apoptosis is a very effective approach in the discovery of oncotherapeutics.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> The contribution of apoptosis on tumor size decrease has been extensively investigated since many oncology drugs display their action by promoting apoptosis.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Apoptosis is a process of programmed cell death and controls the development and homeostasis in multicellular organisms and is often characterized by energy-dependent biochemical mechanisms and distinct morphological characteristics. Activation of intrinsic and extrinsic pathways in cells leads to primarily induction of apoptosis. The intrinsic pathway, also known as the mitochondria-mediated pathway, is promoted by DNA damage, oxidative stress, and endoplasmic reticulum (ER) stress.<a onclick="showRef(event, 'ref29 ref89'); return false;" href="javascript:void(0);" class="ref ref29 ref89">(29,89)</a></div><div class="NLM_p">Ruthenium derived clinical trial compound <b>KP1019</b> binds to transferrin, which is more cytotoxic after reduction, and it causes apoptosis via the mitochondrial pathway, also promoting the formation of reactive oxygen species (ROS). Ru(II) compounds have been reported to induce apoptosis via the mitochondrial pathway,<a onclick="showRef(event, 'ref90 ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref90 ref91 ref92">(90−92)</a> autophagy pathway,<a onclick="showRef(event, 'ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref93 ref94">(93,94)</a> and induction of ROS-mediated apoptosis in tumor cells by targeting thioredoxin reductase.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> DNA-intercalating Ru(II) compound [Ru(bpy)(phpy)(dppz)]<sup>+</sup> has been reported as an antitumor agent and was found to be extremely cytotoxic against cancer cell lines. The high affinity for DNA binding of this ruthenium complex damages the transcription factor NF-κB on relevant DNA sequences. Any damage of the transcription factor sequence leads to the inhibition of cellular transcription and irreversible cancer cell apoptosis (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Other reported antitumor actions of ruthenium complexes are through the inhibition of telomerase activity and stabilization of G-quadruplex DNA intermediates.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representation of the antitumor action of the nucleus-targeting complex [Ru(bpy)(phpy)dppz]<sup>+</sup>. Reproduced with permission from ref <a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a>. Copyright 2014, American Chemical Society.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The preclinical ruthenium compound <b>DW1/2</b> inhibits PI3K and GSK3-β, which leads to apoptosis mediated by the mitochondrial and p53 pathways and is the reported mechanism of action of <b>DW1/2</b> as an antitumor drug (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Ru(II) therapeutic <b>DW1/2</b> proposed mechanism of the in vitro cytotoxicity in a model of human melanoma in vitro. Reproduced with permission from   <cite><i>Journal of Inorganic Biochemistry</i></cite> (<a href="https://www.sciencedirect.com/journal/journal-of-inorganic-biochemistry" class="extLink">https://www.sciencedirect.com/journal/journal-of-inorganic-biochemistry</a>), <span class="NLM_year">2012</span>, Vol. <em>106</em>; <contrib-group><span class="NLM_string-name">Bergamo, A.</span>; <span class="NLM_string-name">Gaiddon, C.</span>; <span class="NLM_string-name">Schellens, J. H.</span>; <span class="NLM_string-name">Beijnen, J. H.</span>; <span class="NLM_string-name">Sava, G.</span></contrib-group> Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates, Pages 90–99,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Copyright 2011, with permission from Elsevier.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another complex [Ru(MeIm)(npip)]<sup>2+</sup> (npip <sup>1</sup>/<sub>4</sub> 2-(4-nitrophenyl)imidazo[4,5-<i>f</i>][1,10]phenanthroline) promotes A549 human lung carcinoma cell apoptosis by both damaging mitochondrial homeostasis and death receptor signal pathways. This complex induces apoptosis of BEL-7402 cells through the mitochondrial signal transduction pathway. The apoptotic pathways of several other ruthenium therapeutics have been reported as well.<a onclick="showRef(event, 'ref97 ref98 ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref97 ref98 ref99 ref100">(97−100)</a> Apoptotic and autophagy mechanisms were both induced by the [(η6-<i>p</i>-cymene)Ru(<i>N</i>,<i>N</i>′-hydrazinylthiazolo)Cl]Cl compound in the A2780 human ovarian cancer cell line (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Schematic portrayal of Ru(II)therapeutic inducing the activation of apoptotic and autophagy mechanisms in the A2780 cell line. The red color denotes mRNAs overexpression of specific genes in A2780 human ovarian cancer cells treated with the Ru(II) therapeutic compared with untreated A2780 human ovarian cancer cells. Red intensities are proportional to mRNAs transcripts. Reproduced with permission from ref <a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a>. Copyright 2015, American Chemical Society.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">5.  Ru(II) Compounds as Protein Kinase Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54003" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54003" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The discovery of selective enzyme inhibitors is an important activity at the heart of medicinal chemistry and chemical biology. Protein kinases play a vital role in cell biology, regulate most aspects of cellular processes, and are one of the main oncology targets for drug discovery. Kinase inhibitors are one of the most progressive and competently used inhibitors in the treatment of numerous forms of human cancers. There are more than 518 protein kinases encoded by the human genome, and many of them are associated with human cancers. The design and discovery of compound scaffolds that perturb specific protein functions are of significance for probing biological processes and ultimately for the discovery of potent and safe drugs. Many medicinal chemists are already targeting these kinases and have discovered new compound scaffolds, some of which are already approved by FDA, with others in clinical trials and others still in the developing stage.<a onclick="showRef(event, 'ref101 ref102 ref103'); return false;" href="javascript:void(0);" class="ref ref101 ref102 ref103">(101−103)</a> Some literature results reported that Ru(II) based therapeutics <b>DW1/2</b> and <b>NP309</b> are protein kinase inhibitors, which suggest that these Ru(II) compounds act as inhibitors of the <b>GSK3</b> and <b>Pim1</b> half-sandwich inhibitors.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The first reports of very stable and conformationally rigid ruthenium(II) compounds containing the natural product staurosporine have been reported as protein kinase inhibitors.<a onclick="showRef(event, 'ref104 ref105'); return false;" href="javascript:void(0);" class="ref ref104 ref105">(104,105)</a> The Ru(II) lead compound bearing staurosporine (indocarbazole alkaloid) is reported as a subnanomolar ATP competitive protein kinase inhibitor (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>a).<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> These reports suggested that Ru(II) bearing a staurosporine ligand in a Ru(II) complex binds to the ATP binding site of Pim-1 (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>b). The cocrystallized ruthenium compound bearing staurosporine (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YHS">1YHS</a>) with Pim-1 describes a Ru(II) compound mimicking the binding mode of staurosporine (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>c and <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>d).<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Biersack et al. reported another interesting Ru(II) complex ((arene)Ru(II)compounds) containing the tyrphostin type epidermal growth factor receptor (EGFR) inhibitors.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> These targeted Ru(II) compounds as protein kinase inhibitors represent a major advance in oncotherapy.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Ruthenium(II) therapeutics that are ATP-competitive protein kinase inhibitors. (a) Shape mimicry: structure of lead staurosporine. (b) Cocrystal structure of pseudo-octahedral ruthenium half-sandwich complex with Pim-1 protein kinase (yellow color, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BZI">2BZI</a>). (c) Enlargement of the cocrystal structure of pseudo-octahedral ruthenium half-sandwich complex with Pim-1 protein kinase (yellow color, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BZI">2BZI</a>). (d) The superimposed cocrystal structure of Pim-1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BZI">2BZI</a>) with staurosporine (blue color, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YHS">1YHS</a>) reveals the close match in binding mode between the organometallic compound and the natural product. Reproduced with permission from   <cite><i>Current Opinion in
Chemical Biology</i></cite> (<a href="https://www.sciencedirect.com/journal/current-opinion-in-chemical-biology" class="extLink">https://www.sciencedirect.com/journal/current-opinion-in-chemical-biology</a>) <span class="NLM_year">2007</span>, Vol. <em>11</em>; <contrib-group><span class="NLM_string-name">Meggers, E.</span></contrib-group> Exploring biologically relevant chemical space with metal complexes, Pages 287–292,<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Copyright 2007, with permission from Elsevier.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">6.  Mechanism of Action of Ru(II) Compounds</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46636" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46636" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Many researchers are now seeking to develop new mechanisms of cell death by affecting the general molecular framework by these ruthenium therapeutics.<a onclick="showRef(event, 'ref29 ref107 ref108 ref109 ref110 ref111'); return false;" href="javascript:void(0);" class="ref ref29 ref107 ref108 ref109 ref110 ref111">(29,107−111)</a> The ruthenium therapeutics are most potent when they induce apoptosis by blocking transcription. After the early discovery of ruthenium compounds Clarke has reported a mechanism of the ruthenium compounds by “activation by reduction”. Many research laboratories worldwide were conducting experiments to determine the mechanisms of ruthenium(II) compounds and to elucidate how Ru(II) compounds carry out their antitumor effects. From the literature reports so far, ruthenium compounds exert their anticancer actions by impacting the mitochondrial pathway, autophagy pathway, and ROS mediated apoptosis. Recently Zeng et al. reported common representation of main targets and predicted several mechanisms of action of Ru(II) therapeutics as antitumor candidates (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. General portrayal of the principal targets and projected mechanisms of action of ruthenium complexes as oncotherapeutics. Reproduced from ref <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (<a href="http://dx.doi.org/10.1039/C7CS00195A" class="extLink">http://dx.doi.org/10.1039/C7CS00195A</a>), Copyright 2017, with permission of The Royal Society of Chemistry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">7.  Recent Advances in Nanomaterials</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57052" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57052" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The emergence of bionanomaterials gives scientists a new tool to solve oncotherapy problems.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Nanotechnology has the potential to provide novel, paradigm-shifting solutions to medical emergencies and is currently used as a drug carrier for oncotherapy.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Cancer nanotechnology is being diligently examined and executed in cancer therapy, signifying a major advance in detection, diagnosis, and therapy. Many oncology laboratories are using advanced techniques to discover more precise acting nanotechnology based cancer therapy, which diminishes the adverse effects of the conventional ones. Novel drug delivery system (NDDS) are more and more applied in oncotherapy and diagnosis. In oncotherapy, diagnosis, imaging and drug delivery, nanomaterials including metallic and nonmetallic nanoparticles, polymeric nanoparticles, nanowires, carbon nanotubes, and quantum dots are currently being developed further with appropriate strategies.</div><div class="NLM_p">Nanoparticles can be designed through numerous modifications such as altering their shape, size, and physical and chemical properties to program them for targeting the desired cells. Metal nanoparticles target the neoplastic cells through either active or passive targeting. Previously safe and efficacious functionalized nanomaterials were reported for Ru(II)–selenium nanoparticles,<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Ru(II)–gold nanomaterials,<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Ru(II)–silica composites,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Ru(II)–carbon nanotubes,<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> and organic and biomaterial containing Ru(II) nanomaterials. Over the recent years, numerous strategies have been used to encapsulate Ru(II)-derived compounds in a nanomaterial system and ameliorate their targeting and delivery into neoplastic cells.</div><div class="NLM_p">Ruthenium-encapsulated silica nanoparticles were developed with increased cellular uptake and photoactivation (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A). Development of a Ru(II) photoactive compound to be grafted on the top of the UCNPs to produce <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="3f7b7067126a7c716f7f526c5670">[email protected]</a><sub>2</sub>-Ru has been accomplished (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B). Porous silicon nanoparticles (PSiNPs) to deliver photosensitized ruthenium compounds for photodynamic therapy have been introduced (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C). Another ruthenium nanoparticle system, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="7f2d0a2f302f3f322c310c">[email protected]</a>, induced cancer cell apoptosis by the AKT and MAPK signaling pathways (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>D).</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (A) Mechanized MSNPs graphical portrayal. (B) Schematic representation and <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="3461777a647459675d7b">[email protected]</a><sub>2</sub> nanoparticles TEM image (1) and drug release from <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="084c4750255d4b465848655b6147">[email protected]</a><sub>2</sub>-Ru nanoparticles (2). (C) Synthetic route for pSiNP-Ru-PEG-Man. (D) <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="4e1c3b1e011e0e031d003d">[email protected]</a> construction reaction pathways. Reproduced from ref <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (<a href="http://dx.doi.org/10.1039/C7CS00195A" class="extLink">http://dx.doi.org/10.1039/C7CS00195A</a>), Copyright 2017, with permission of The Royal Society of Chemistry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently reported Ru(II) polypyridyl/thiols protected SeNPs<a onclick="showRef(event, 'ref114 ref115'); return false;" href="javascript:void(0);" class="ref ref114 ref115">(114,115)</a> were found to be extremely sensitive cellular imaging agents and to induce cell death. They are thus referred to as theranostics, that is, carrying out both diagnostic and therapeutic purposes at the same time. Luminescent, multifunctionalized Ru(II) polypyridyl-encapsulated selenium nanoparticles can inhibit bFGF-induced angiogenesis by suppressing the AKT and Erk signaling pathways which induce apoptosis (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Schematic representation of inhibition of bFGF-induced angiogenesis and apoptosis (suppressing the AKT and ERK signaling pathways) by luminescent Ru(II) polypyridyl encapsulated selenium nanoparticles. Reproduced with permission from   <cite><i>Biomaterials</i></cite> (<a href="https://www.sciencedirect.com/journal/biomaterials" class="extLink">https://www.sciencedirect.com/journal/biomaterials</a>), <span class="NLM_year">2013</span>, Vol. <em>34</em>; <contrib-group><span class="NLM_string-name">Sun, D.</span>; <span class="NLM_string-name">Liu, Y.</span>; <span class="NLM_string-name">Yu, Q.</span>; <span class="NLM_string-name">Zhou, Y.</span>; <span class="NLM_string-name">Zhang, R.</span>; <span class="NLM_string-name">Chen, X.</span>; <span class="NLM_string-name">Hong, A.</span>; <span class="NLM_string-name">Liu, J.</span></contrib-group> The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling, Pages 171–180,<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Copyright 2012, with permission from Elsevier.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another ruthenium compound (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="95c7e0b8d8c0d4d5c6f0">[email protected]</a>) exerts multiple functions by having dual-target inhibitors that directly suppress the tumor growth by inducing apoptosis and exerting dependence on ROS generation.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Nanoparticle/Ru(II) polypyridyl complex assembled for NIR-activated release of a DNA covalent-binding agent.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Ru(II)polypyridine compound encapsulated within liposomes reduces the TNBC tumor growth and is a favorable theranostic approach for breast cancer therapy (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). These results indicate that the Ru-liposome system has greater significance on nanooncology.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Ruthenium compounds carrying functionalized multiwalled carbon nanotubes are able to antagonize tumor multidrug resistance and radioresistance.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> A Ru(II) compound deposited on single-walled carbon nanotube composites was used for bimodal photodynamic and photothermal therapy.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Consequently, effective nanoapproaches for oncotherapy in the past few years have witnessed much progress involving nanotechnology strategies.<a onclick="showRef(event, 'ref121 ref122'); return false;" href="javascript:void(0);" class="ref ref121 ref122">(121,122)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Schematic portrayal of ruthenium polypyridyl complex [Ru(phen)<sub>2</sub>dppz](ClO<sub>4</sub>)<sup>2</sup>(Ru) encapsulated within bilayer of liposomes (Lipo-Ru), which reduces the triple-negative breast cancer (TNBC) and is a favorable theranostic approach for cancer therapy. Reproduced with permission from ref <a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a>. Copyright 2017, American Chemical Society.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">8.  Novel Therapeutic Approaches for Ru(II) Compounds</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53423" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53423" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">8.1.  Photodynamic Therapy</h3><div class="NLM_p">Over the recent years, scientists are searching for advanced innovative approaches in cancer treatment. Photodynamic therapy has proven to be a new, impressive, attractive, and noninvasive oncotherapy modality. Photodynamic therapy<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> was developed for the management of neoplastic and nonmalignant diseases and to treat specific types of tumors (i.e., bladder, lung, and urinary tumors). Photodynamic therapy (PDT) has the capability to meet many currently unmet medical emergencies. The working principle of PDT is the light activation of a photosensitizer (PS), which produces ROS that are toxic and thus must be managed appropriately. These ROS then lead to apoptosis, with only minimal damage to normal tissues.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div><div class="NLM_p">Recent literature evidence suggests that many Ru(II) derived compounds act as photosensitizers for both one- and two-photon photodynamic therapy.<a onclick="showRef(event, 'ref125 ref126 ref127 ref128 ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref125 ref126 ref127 ref128 ref129 ref130">(125−130)</a> These metallotherapeutics are potential replacements to the current photosensitizers (PSs). Zhang and her co-workers reported on development of Ru(II) complex-functionalized single-walled carbon nanotubes (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="e1b394a1b2b6a2afb592">[email protected]</a>) as nanotemplates for bimodal two-photon photodynamic therapy (TPPDT) and photothermal therapy (PTT) with irradiation (808 nm), illustrated in <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Upon treatment with light, the Ru(II) compounds are liberated and then produce <sup>1</sup>O<sub>2</sub> upon the two-photon laser irradiation (808 nm). These results suggest that bimodal therapy potentially exerts a greater significant antitumor effect compared with one-modal therapy.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Ru(II) therapeutics for two-photon photodynamic therapy have been reported.<a onclick="showRef(event, 'ref131 ref132'); return false;" href="javascript:void(0);" class="ref ref131 ref132">(131,132)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Schematic portrayal of Ru(II) complex-functionalized single-walled carbon nanotubes (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="beeccbfeede9fdf0eacd">[email protected]</a>) for bimodal two-photon photodynamic therapy (TPPDT) and photothermal therapy (PTT) with irradiation (808 nm). Reproduced with permission from ref <a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a>. Copyright 2017, American Chemical Society.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Ru(II)-based therapeutics are reported as radiosensitizers when used in combination with clinically relevant doses of radiation therapy.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> From the clinical examination, they reported that these ruthenium scaffolds should be equally efficient, with no indication of cross-resistance to platinum therapeutics. These results also suggest impressive radiosensitization with clinically relevant doses of RT compared with p53-mutated or p53-null, higher radiosensitizing activity in p53-wild-type cells and a biological mechanism of action that has been shown to affect increasing the destruction of DNA by these ruthenium scaffolds.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> These significant outcomes highlight the immense potential of ruthenium compounds in PDT.</div></div><div id="sec8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">8.2.  Photoactivated Chemotherapy</h3><div class="NLM_p">Although the PDT strategy has been applied in oncotherapy, the major limitation of this approach is related to the low levels of oxygen (hypoxia), commonly found in solid tumors.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Therefore, for these types of tumors an innovative approach in which light-mediated toxicity is independent of oxygen levels must be developed, and this technique is called photoactivated chemotherapy (PACT). The chemical compounds for this technique exhibit light-activated characteristics and are referred to as photoactivated chemotherapy agents.<a onclick="showRef(event, 'ref127 ref135'); return false;" href="javascript:void(0);" class="ref ref127 ref135">(127,135)</a> The mechanism of action of these agents is based on the ligand exchange to create metal centers able to form DNA adducts or photorelease of a bioactive compound.<a onclick="showRef(event, 'ref135 ref136'); return false;" href="javascript:void(0);" class="ref ref135 ref136">(135,136)</a> Ligand exchange plays a vital part in PACT. Glazer et al. denoted antitumor Ru(II) compounds bearing methylated bipyridyl, pyridylbenzazole ligands and their photochemical and photobiological action.<a onclick="showRef(event, 'ref137 ref138'); return false;" href="javascript:void(0);" class="ref ref137 ref138">(137,138)</a> Very recent work has been reported about interaction between Ru(II) trans-tetrapyridyl ruthenium therapeutic and an oligonucleotide controlled by light irradiation.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></div><div class="NLM_p">The strategy of using Ru(II)-photocaged therapeutics has been denoted in several recent studies in the literature that associate a drug with a complex to the superior restraint of the biological action and release of the drug in selected tissues using light.<a onclick="showRef(event, 'ref140 ref141 ref142'); return false;" href="javascript:void(0);" class="ref ref140 ref141 ref142">(140−142)</a> Abiraterone is an inhibitor of cytochrome P450 17A1 inhibitor (CYP17A1), useful in metastatic prostate cancer therapy. The aid of abiraterone Ru(II)-photocaged complexes led to the selective release of abiraterone after exposure to visible light and potent CYP inhibition.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> These results suggest that the use of this strategy can avert the adverse effects of the parent drugs.</div><div class="NLM_p last">This combined mechanism can also be achieved since after activation by light the ligand is released (drug), which has biological activity. In addition, the resulting complex may still be able to cause damage to the DNA, resulting in a synergistic activity.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> A last approach is to use the combination of mechanisms for developing more efficient Ru(II) therapeutics with dual potential PDT and PACT.<a onclick="showRef(event, 'ref144 ref145'); return false;" href="javascript:void(0);" class="ref ref144 ref145">(144,145)</a></div></div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">9.  Successes, Future Challenges, and Scopes for Drug Discovery</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Many pharmaceutical industries as well as nonprofit government and nongovernment organizations all over the world are eagerly expecting the development of novel oncotherapeutics. However, drug invention and development are proceeding slowly with low success rates, specifically in last steps of the process, the clinical trials. This is augmented by the increasing development of drug resistance, which remains a formidable challenge. Metallotherapeutics are a unique class of drugs in oncology research, also contributing to many possibilities in imaging, cancer therapy, and theranostics at the same time. Currently almost 50% of patients undergoing chemotherapy receive some type of a platinum medication; however, drug resistance to platinum drugs limits its applications and tracing for adjunctive metal therapeutics.</div><div class="NLM_p">During the past 3 decades ruthenium compounds with varying scaffolds have shown tremendous selective bioactivity, as well as the capacity to overcome the resistance of platinum-based therapeutics, making them successful oncotherapeutic competitors in a rational drug invention approach. It is gratifying that four of the ruthenium-derived therapeutics entered human clinical trials, but unfortunately, the results of phase 1 and phase 2 clinical studies did not support the continuation of two of these drugs (<b>NAMI-A</b>, and <b>KP1019</b>) to phase III clinical trials.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Two compounds remain under consideration in clinical trials: <b>KP1339</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and the theranostic compound <b>TLD1433</b>. Some ruthenium based chemotherapeutics have been proven to be mitochondria-targeting oncotherapeutic candidates. Most of the developed Ru(II) scaffolds are lipophilic and carry a positive charge, which expedite their dispersion across the cell membrane. The evidence suggests that Ru(II) therapeutics are significant candidates for future anticancer drug discovery.</div><div class="NLM_p">Comprehensive investigations have been undertaken to alter the structure of Ru(II) compound scaffolds to ameliorate their drug efficacy, while so far minimal effort has been conducted toward determining drug combinations.<a onclick="showRef(event, 'ref35 ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref35 ref146 ref147">(35,146,147)</a> Drug combination treatments in tumor models indicate effective induced apoptosis without added toxicity (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Further development of drug combinations in the future would allow for analysis of their synergistic antineoplastic action in preclinical drug-resistant tumor models, with the objective of ameliorating the therapeutic potential and protracting life expectancy of the patients. These potential outcomes afford valuable, authentic knowledge on ruthenium-derived candidate medicaments and modern insights for future optimized oncotherapy protocols. Novel oncotherapeutics with effective molecular mechanisms of action are imperative in chemotherapy to kill specific tumor types and to conquer toxic adverse effects. The detailed mechanisms of action of some of the ruthenium based therapeutics are still under some investigation and present a big challenge for inorganic medicinal chemists.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Schematic illustration of cellular mechanism involved in the activity of <b>RAPTA-C</b> and erlotinib combinations. In ECRF24 cells, destruction of DNA may lead to failure to progress through G1/S checkpoint, which therefore induces apoptosis. In A2780 and A2780<i>cis</i>R cells, genesis of DNA bridges and micronuclei is by mitotic defection. Due to the genesis of DNA bridges, cytokinesis failure occurs, which leads to senescence. Reproduced with permission from ref <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> (<a href="http://dx.doi.org/10.1038/srep43005" class="extLink">http://dx.doi.org/10.1038/srep43005</a>), licensed under a Creative Commons Attribution 4.0 International License (<a href="https://creativecommons.org/licenses/by/4.0/legalcode" class="extLink">https://creativecommons.org/licenses/by/4.0/legalcode</a>), Nature Publishing Group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a recent investigation, 95% of potential oncotherapeutics entering clinical development failed, correlating with an average of 90% for compounds in all therapeutic areas, which is a great challenge in the oncology drug discovery. We have summarized some of the issues above relating to the complexities of translation. Indeed, in addition to the developmental and mechanistic aspects of drug development, increasing attention to speciation and formulation may also assist this translational aspect of drug development.<a onclick="showRef(event, 'ref148 ref149'); return false;" href="javascript:void(0);" class="ref ref148 ref149">(148,149)</a> Complex clinical trials with an effective targeted translational research constituent enable major advances in the understanding of specific cancer types and directly contribute to defining new tailored standards of patient care.</div><div class="NLM_p last">From all this evidence, it is the hope that Ru(II) derived therapeutics will enter into the market as a supportive to platinum based chemotherapeutics. We present an overview of the comprehensive development of Ru(II) compounds as anticancer metallotherapeutics, which should inspire young budding researchers and senior researchers to enter the interesting field of metallotherapeutics. It is important to conclude that the pharmacokinetic profile of ruthenium-based therapeutics is yet to be ascertained in humans, but emergent results remain positive, keeping our hope alive that designing effective ruthenium-derived compounds to selectively target tumor cells is an achievable goal resulting in a Ru compound that will progress to clinical use.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01689" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40263" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40263" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sreekanth Thota</span> - <span class="hlFld-Affiliation affiliation">National Institute
for Science and Technology on Innovation on Neglected Diseases (INCT/IDN),
Center for Technological Development in Health (CDTS), Fundação
Oswaldo Cruz, Ministério da Saúde, Av. Brazil 4036, Prédio da Expansão, 8° Andar,
Sala 814, Manguinhos, 21040-361 Rio de Janeiro, RJ, Brazil</span>; 
    <span class="hlFld-Affiliation affiliation">Laboratório
de Avaliação e Síntese de Substâncias
Bioativas (LASSBio), Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), P.O. Box 68023, 21941-902 Rio de Janeiro, RJ, Brazil</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7501-3987" title="Orcid link">http://orcid.org/0000-0002-7501-3987</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#99eaedeaebfcfcf2f8f7edf1edf1f6edf8d9fef4f8f0f5b7faf6f4b9eaedf1f6edf8d9fafdedeab7fff0f6faebece3b7fbeb"><span class="__cf_email__" data-cfemail="265552555443434d4748524e524e49524766414b474f4a0845494b">[email protected]</span> <span class="__cf_email__" data-cfemail="196a6d71766d78597a7d6d6a377f70767a6b6c63377b6b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel A. Rodrigues</span> - <span class="hlFld-Affiliation affiliation">Laboratório
de Avaliação e Síntese de Substâncias
Bioativas (LASSBio), Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), P.O. Box 68023, 21941-902 Rio de Janeiro, RJ, Brazil</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Debbie C. Crans</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Colorado State University, Fort Collins, Colorado 80523, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eliezer J. Barreiro</span> - <span class="hlFld-Affiliation affiliation">Laboratório
de Avaliação e Síntese de Substâncias
Bioativas (LASSBio), Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), P.O. Box 68023, 21941-902 Rio de Janeiro, RJ, Brazil</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1759-0038" title="Orcid link">http://orcid.org/0000-0003-1759-0038</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written with contributions from all authors. All authors have given approval to the final manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17812" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17812" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Sreekanth Thota</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=BIO-d7e1583-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Sreekanth Thota</b>, Ph.D., is a Visiting Researcher at the Center for Technological Development in Health, Fiocruz & LASSBio, UFRJ in Rio de Janeiro, Brazil. He studied Pharmaceutical Chemistry at Kakatiya University (India) and Rajiv Gandhi University of Health Sciences (Bangalore, India) and obtained his Ph.D. from Jawaharlal Nehru Technological University Hyderabad (India) in 2011. He then did postdoctoral work at Colorado State University, U.S., under the supervision of Prof. Debbie C. Crans. He received the CAPES-Fiocruz Visiting Researcher Award in 2014. His research interest is focused on synthesis, drug design, drug development, and medicinal chemistry and has published over 40 articles in peer-reviewed journals and book chapters and a book concerning the field of medicinal chemistry. He is the inventor of many bioactive scaffolds.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Daniel A. Rodrigues</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=BIO-d7e1588-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Daniel A. Rodrigues</b> obtained his M.S. degree in Chemistry from Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. Currently, his Ph.D. research is being carried out at Laboratório de Avaliação e Sı́ntese de Substâncias Bioativas (LASSBio) at the Institute of Biomedical Sciences of Federal University of Rio de Janeiro, and is related to the medicinal chemistry field, particularly the design, synthesis, and biological evaluation of multitarget ligands acting as anticancer agents.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Debbie C. Crans</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=BIO-d7e1593-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Debbie C. Crans</b>, Ph.D., is a Professor of Chemistry in Organic, Inorganic Chemistry, Chemical Biology, and Cell and Molecular Biology at Colorado State University. She was an undergraduate at the H. C. Ørsted Institute in Denmark, a graduate student at Harvard University, and a postdoctoral fellow at the University of California, Los Angeles. Crans’s work has systematically explored speciation and solution chemistry of transition metal complexes, polyoxometalates, and their activities in more complex biological systems. She has been recognized with the first Vanadis Award in 2004 and an Arthur Cope Scholar award in 2015 for her fundamental work on vanadium complexes in diabetes. She is currently investigating the structural and functional involvement of menaquinone in the membrane associated electron transfer complex in pathogens.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Eliezer J. Barreiro</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=BIO-d7e1598-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Eliezer J. Barreiro</b>, Ph.D., concluded his scientific education (Docteur-Ès-Sciences d’État) in Medicinal Chemistry at the University of Grenoble, France, in 1978. He spent 4 years as Associate Professor of Organic Chemistry at Federal University of São Carlos, S.P., from 1979 to 1983 before he joined the Federal University of Rio de Janeiro where he got a permanent position. He works in the medicinal chemistry field and founded the Laboratório de Avaliação e Sı́ntese de Substâncias Bioativas (LASSBio) at the Institute of Biomedical Sciences of Federal University of Rio de Janeiro. Professor Barreiro has published over 330 journal articles and book chapters and a book concerning medicinal chemistry, and he is the inventor of 25 patents of bioactive compounds.</p></figure></div><div class="ack" id="ACK-d7e1603-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">S.T, D.A.R, and E.J.B. acknowledge the support of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-BR), Coordenação de Aperfeiçoamento de Pessoal de Nı́vel Superior (CAPES-BR), and Oswaldo Cruz Foundation (Fiocruz-BR). S.T. is thankful to Dr. Carlos M. Morel, Director, CDTS-Fiocruz, for his support for carrying out this research. The author is thankful to Prof. Carlos Alberto Manssour Fraga and Prof. Lı́dia M. Lima for their insights and critical review of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are grateful to the reviewers for their careful comments and precious suggestions. The authors also acknowledge support from the Instituto Nacional de Ciência e Tecnologia de Inovação em Doenças de Populações Negligenciadas (INCT-IDPN).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbrevations Used</td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DNA</td><td class="NLM_def"><p class="first last">deoxyribonucleic acid</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">HAS</td><td class="NLM_def"><p class="first last">human serum albumin</p></td></tr><tr><td class="NLM_term">ICP-OES</td><td class="NLM_def"><p class="first last">inductively coupled plasma optical emission spectrometry</p></td></tr><tr><td class="NLM_term">MLCT</td><td class="NLM_def"><p class="first last">metal to ligand charge transfer</p></td></tr><tr><td class="NLM_term">m-RNA</td><td class="NLM_def"><p class="first last">messenger RNA</p></td></tr><tr><td class="NLM_term">NDDS</td><td class="NLM_def"><p class="first last">novel drug delivery system</p></td></tr><tr><td class="NLM_term">NIR</td><td class="NLM_def"><p class="first last">near-infrared</p></td></tr><tr><td class="NLM_term">NP</td><td class="NLM_def"><p class="first last">nanoparticle</p></td></tr><tr><td class="NLM_term">PACT</td><td class="NLM_def"><p class="first last">photoactivated chemotherapy</p></td></tr><tr><td class="NLM_term">PDT</td><td class="NLM_def"><p class="first last">photodynamic therapy</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">polyethylene glycol</p></td></tr><tr><td class="NLM_term">Pgp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">PS</td><td class="NLM_def"><p class="first last">photosensitizer</p></td></tr><tr><td class="NLM_term">PTT</td><td class="NLM_def"><p class="first last">photothermal therapy</p></td></tr><tr><td class="NLM_term">RDC</td><td class="NLM_def"><p class="first last">ruthenium derived compound</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">RT</td><td class="NLM_def"><p class="first last">radiation therapy</p></td></tr><tr><td class="NLM_term">SeNP</td><td class="NLM_def"><p class="first last">selenium nanoparticle</p></td></tr><tr><td class="NLM_term">TNBC</td><td class="NLM_def"><p class="first last">triple-negative breast cancer</p></td></tr><tr><td class="NLM_term">TPPDT</td><td class="NLM_def"><p class="first last">two-photon photodynmaic therapy</p></td></tr><tr><td class="NLM_term">WHO</td><td class="NLM_def"><p class="first last">World Health Organization</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33623" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33623" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 149 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valastyan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Tumor metastasis: molecular insights and evolving paradigms</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.cell.2011.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=22000009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaksb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2011&pages=275-292&author=S.+Valastyanauthor=R.+A.+Weinberg&title=Tumor+metastasis%3A+molecular+insights+and+evolving+paradigms&doi=10.1016%2Fj.cell.2011.09.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor Metastasis: Molecular Insights and Evolving Paradigms</span></div><div class="casAuthors">Valastyan, Scott; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-292</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Metastases represent the end products of a multistep cell-biol. process termed the invasion-metastasis cascade, which involves dissemination of cancer cells to anatomically distant organ sites and their subsequent adaptation to foreign tissue microenvironments.  Each of these events is driven by the acquisition of genetic and/or epigenetic alterations within tumor cells and the co-option of nonneoplastic stromal cells, which together endow incipient metastatic cells with traits needed to generate macroscopic metastases.  Recent advances provide provocative insights into these cell-biol. and mol. changes, which have implications regarding the steps of the invasion-metastasis cascade that appear amenable to therapeutic targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVqOPVKwPqtbVg90H21EOLACvtfcHk0lgTkPLobt_i6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaksb3N&md5=fa62d15c6b61bf90cfcdc1d51bbe98b9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DValastyan%26aufirst%3DS.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DTumor%2520metastasis%253A%2520molecular%2520insights%2520and%2520evolving%2520paradigms%26jtitle%3DCell%26date%3D2011%26volume%3D147%26spage%3D275%26epage%3D292%26doi%3D10.1016%2Fj.cell.2011.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferlay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soerjomataram, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dikshit, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebelo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkin, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, F.</span></span> <span> </span><span class="NLM_article-title">Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">E359</span>– <span class="NLM_lpage">E386</span>, <span class="refDoi"> DOI: 10.1002/ijc.29210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fijc.29210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=25220842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyktbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2015&pages=E359-E386&author=J.+Ferlayauthor=I.+Soerjomataramauthor=R.+Dikshitauthor=S.+Eserauthor=C.+Mathersauthor=M.+Rebeloauthor=D.+M.+Parkinauthor=D.+Formanauthor=F.+Bray&title=Cancer+incidence+and+mortality+worldwide%3A+sources%2C+methods+and+major+patterns+in+GLOBOCAN+2012&doi=10.1002%2Fijc.29210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012</span></div><div class="casAuthors">Ferlay, Jacques; Soerjomataram, Isabelle; Dikshit, Rajesh; Eser, Sultan; Mathers, Colin; Rebelo, Marise; Parkin, Donald Maxwell; Forman, David; Bray, Freddie</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">E359-E386</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Ests. of the worldwide incidence and mortality from 27 major cancers and for all cancers combined for 2012 are now available in the GLOBOCAN series of the International Agency for Research on Cancer.  We review the sources and methods used in compiling the national cancer incidence and mortality ests., and briefly describe the key results by cancer site and in 20 large "areas" of the world.  Overall, there were 14.1 million new cases and 8.2 million deaths in 2012.  The most commonly diagnosed cancers were lung (1.82 million), breast (1.67 million), and colorectal (1.36 million); the most common causes of cancer death were lung cancer (1.6 million deaths), liver cancer (745,000 deaths), and stomach cancer (723,000 deaths).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOv4ecwK-CfLVg90H21EOLACvtfcHk0lgsgBVr5l4z3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyktbzI&md5=c560896798e5e2b23ff293f6bd805bb6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fijc.29210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.29210%26sid%3Dliteratum%253Aachs%26aulast%3DFerlay%26aufirst%3DJ.%26aulast%3DSoerjomataram%26aufirst%3DI.%26aulast%3DDikshit%26aufirst%3DR.%26aulast%3DEser%26aufirst%3DS.%26aulast%3DMathers%26aufirst%3DC.%26aulast%3DRebelo%26aufirst%3DM.%26aulast%3DParkin%26aufirst%3DD.%2BM.%26aulast%3DForman%26aufirst%3DD.%26aulast%3DBray%26aufirst%3DF.%26atitle%3DCancer%2520incidence%2520and%2520mortality%2520worldwide%253A%2520sources%252C%2520methods%2520and%2520major%2520patterns%2520in%2520GLOBOCAN%25202012%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2015%26volume%3D136%26spage%3DE359%26epage%3DE386%26doi%3D10.1002%2Fijc.29210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thun, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLancey, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Center, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, E. M.</span></span> <span> </span><span class="NLM_article-title">The global burden of cancer: priorities for prevention</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgp263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1093%2Fcarcin%2Fbgp263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=19934210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlCmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=100-110&author=M.+J.+Thunauthor=J.+O.+DeLanceyauthor=M.+M.+Centerauthor=A.+Jemalauthor=E.+M.+Ward&title=The+global+burden+of+cancer%3A+priorities+for+prevention&doi=10.1093%2Fcarcin%2Fbgp263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The global burden of cancer: priorities for prevention</span></div><div class="casAuthors">Thun, Michael J.; De Lancey, John Oliver; Center, Melissa M.; Jemal, Ahmedin; Ward, Elizabeth M.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">100-110</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Despite decreases in the cancer death rates in high-resource countries, such as the USA, the no. of cancer cases and deaths is projected to more than double worldwide over the next 20-40 years.  Cancer is now the third leading cause of death, with >12 million new cases and 7.6 million cancer deaths estd. to have occurred globally in 2007 (1).  By 2030, it is projected that there will be ∼26 million new cancer cases and 17 million cancer deaths per yr.  The projected increase will be driven largely by growth and aging of populations and will be largest in low- and medium-resource countries.  Under current trends, increased longevity in developing countries will nearly triple the no. of people who survive to age 65 by 2050.  This demog. shift is compounded by the entrenchment of modifiable risk factors such as smoking and obesity in many low-and medium-resource countries and by the slower decline in cancers related to chronic infections (esp. stomach, liver and uterine cervix) in economically developing than in industrialized countries.  This paper identifies several preventive measures that offer the most feasible approach to mitigate the anticipated global increase in cancer in countries that can least afford it.  Foremost among these are the need to strengthen efforts in international tobacco control and to increase the availability of vaccines against hepatitis B and human papilloma virus in countries where they are most needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9T-Jh4q4gw7Vg90H21EOLACvtfcHk0lgsgBVr5l4z3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlCmtg%253D%253D&md5=7badfd6b15257e01189cbfc33571c7d6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgp263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgp263%26sid%3Dliteratum%253Aachs%26aulast%3DThun%26aufirst%3DM.%2BJ.%26aulast%3DDeLancey%26aufirst%3DJ.%2BO.%26aulast%3DCenter%26aufirst%3DM.%2BM.%26aulast%3DJemal%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DE.%2BM.%26atitle%3DThe%2520global%2520burden%2520of%2520cancer%253A%2520priorities%2520for%2520prevention%26jtitle%3DCarcinogenesis%26date%3D2010%26volume%3D31%26spage%3D100%26epage%3D110%26doi%3D10.1093%2Fcarcin%2Fbgp263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomasetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span> <span> </span><span class="NLM_article-title">Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">1330</span>– <span class="NLM_lpage">1334</span>, <span class="refDoi"> DOI: 10.1126/science.aaf9011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1126%2Fscience.aaf9011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28336671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksFaksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2017&pages=1330-1334&author=C.+Tomasettiauthor=L.+Liauthor=B.+Vogelstein&title=Stem+cell+divisions%2C+somatic+mutations%2C+cancer+etiology%2C+and+cancer+prevention&doi=10.1126%2Fscience.aaf9011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention</span></div><div class="casAuthors">Tomasetti, Cristian; Li, Lu; Vogelstein, Bert</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">6331</span>),
    <span class="NLM_cas:pages">1330-1334</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cancers are caused by mutations that may be inherited, induced by environmental factors, or result from DNA replication errors (R).  We studied the relationship between the no. of normal stem cell divisions and the risk of 17 cancer types in 69 countries throughout the world.  The data revealed a strong correlation (median = 0.80) between cancer incidence and normal stem cell divisions in all countries, regardless of their environment.  The major role of R mutations in cancer etiol. was supported by an independent approach, based solely on cancer genome sequencing and epidemiol. data, which suggested that R mutations are responsible for two-thirds of the mutations in human cancers.  All of these results are consistent with epidemiol. ests. of the fraction of cancers that can be prevented by changes in the environment.  Moreover, they accentuate the importance of early detection and intervention to reduce deaths from the many cancers arising from unavoidable R mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjgcWECUbyNrVg90H21EOLACvtfcHk0ljXcolJc9eLKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksFaksLY%253D&md5=845d35f2fbb601ffee9ccd60bbdc30cf</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaf9011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaf9011%26sid%3Dliteratum%253Aachs%26aulast%3DTomasetti%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DStem%2520cell%2520divisions%252C%2520somatic%2520mutations%252C%2520cancer%2520etiology%252C%2520and%2520cancer%2520prevention%26jtitle%3DScience%26date%3D2017%26volume%3D355%26spage%3D1330%26epage%3D1334%26doi%3D10.1126%2Fscience.aaf9011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silver, D. P.</span></span> <span> </span><span class="NLM_article-title">Cancer: crossing over to drug resistance</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>451</i></span>,  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1038/4511066a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2F4511066a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=451&publication_year=2008&pages=1066-1067&author=D.+M.+Livingstonauthor=D.+P.+Silver&title=Cancer%3A+crossing+over+to+drug+resistance&doi=10.1038%2F4511066a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F4511066a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F4511066a%26sid%3Dliteratum%253Aachs%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26aulast%3DSilver%26aufirst%3DD.%2BP.%26atitle%3DCancer%253A%2520crossing%2520over%2520to%2520drug%2520resistance%26jtitle%3DNature%26date%3D2008%26volume%3D451%26spage%3D1066%26epage%3D1067%26doi%3D10.1038%2F4511066a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McQuitty, R. J.</span></span> <span> </span><span class="NLM_article-title">Metal-based drugs</span>. <i>Sci. Prog.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.3184/003685014X13898980185076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.3184%2F003685014X13898980185076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=24800466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1aju7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2014&pages=1-19&author=R.+J.+McQuitty&title=Metal-based+drugs&doi=10.3184%2F003685014X13898980185076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Metal-based drugs</span></div><div class="casAuthors">McQuitty, Ruth J.</div><div class="citationInfo"><span class="NLM_cas:title">Science Progress (St. Albans, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-19</span>CODEN:
                <span class="NLM_cas:coden">SCPRAY</span>;
        ISSN:<span class="NLM_cas:issn">0036-8504</span>.
    
            (<span class="NLM_cas:orgname">Science Reviews 2000 Ltd.</span>)
        </div><div class="casAbstract">A review.  Metals have been considered for millennia to have medicinal values.  With the advent of modern medicine, many metal-based drugs have proven to be highly effective in the clinic.  Many different metal ions have shown activity against a range of diseases.  The unique electronic structure of transition metals offers great versatility, not always seen in org. drugs, in terms of the ability to tune the properties of a given mol.  This review gives a brief overview of the most established therapeutic metals, and their more common applications, such as platinum-based anticancer drugs.  New developments within the field of metallodrugs and novel strategies being employed to improve methods of delivery, are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra_0WGihPHsbVg90H21EOLACvtfcHk0ljXcolJc9eLKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1aju7%252FO&md5=60097cc4360b8471f5e6741921d16dcb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3184%2F003685014X13898980185076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3184%252F003685014X13898980185076%26sid%3Dliteratum%253Aachs%26aulast%3DMcQuitty%26aufirst%3DR.%2BJ.%26atitle%3DMetal-based%2520drugs%26jtitle%3DSci.%2520Prog.%26date%3D2014%26volume%3D97%26spage%3D1%26epage%3D19%26doi%3D10.3184%2F003685014X13898980185076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, L. H.</span></span> <span> </span><span class="NLM_article-title">DNA and its associated processes as targets for cancer therapy</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">188</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.1038/nrc749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2Fnrc749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=11990855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1KktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=188-200&author=L.+H.+Hurley&title=DNA+and+its+associated+processes+as+targets+for+cancer+therapy&doi=10.1038%2Fnrc749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">DNA and its associated processes as targets for cancer therapy</span></div><div class="casAuthors">Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">188-200</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  DNA is the mol. target for many of the drugs that are used in cancer therapeutics, and is viewed as a non-specific target of cytotoxic agents.  Although this is true for traditional chemotherapeutics, other agents that were discovered more recently have shown enhanced efficacy.  Furthermore, a new generation of agents that target DNA-assocd. processes are anticipated to be far more specific and effective.  How have these agents evolved, and what are their mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXfymv1PT0YLVg90H21EOLACvtfcHk0ljXcolJc9eLKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1KktL0%253D&md5=e9ca715b3e7374aeb919f340c46cc59d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc749%26sid%3Dliteratum%253Aachs%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DDNA%2520and%2520its%2520associated%2520processes%2520as%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D188%26epage%3D200%26doi%3D10.1038%2Fnrc749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">Bioorganometallic chemistry--from teaching paradigms to medicinal applications</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1039/B707077M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FB707077M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=19169456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVSntLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2009&pages=391-401&author=C.+G.+Hartingerauthor=P.+J.+Dyson&title=Bioorganometallic+chemistry%2D%2Dfrom+teaching+paradigms+to+medicinal+applications&doi=10.1039%2FB707077M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Bioorganometallic chemistry-from teaching paradigms to medicinal applications</span></div><div class="casAuthors">Hartinger, Christian G.; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">391-401</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  In undergraduate level organometallic chem. courses students are usually taught that organometallic compds. are toxic and unstable in air and water.  While this is true of many complexes, some are also non-toxic and stable in air and water.  Indeed, bioorganometallic chem., the study of biomols. or biol. active mols. that contain at least one carbon directly bound to a metal, is a thriving subject, and air and water stability is a general pre-requisite.  This interdisciplinary field is located at the borderline between chem., biochem., biol. and medicine.  In this tutorial review, various aspects of bioorganometallic chem. are introduced, with the main emphasis on medicinal organometallic compds.  Organometallic therapeutics for cancer, HIV and malaria and other medicinal applications are described.  It is also shown how rational ligand design has led to new improved therapies much in the same way that an organometallic chemist working in catalysis will design new ligands for improved activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUlBRnNNFykrVg90H21EOLACvtfcHk0ljXcolJc9eLKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVSntLs%253D&md5=37af5933908fa02d0ee36374a9c1dcad</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1039%2FB707077M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB707077M%26sid%3Dliteratum%253Aachs%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DBioorganometallic%2520chemistry--from%2520teaching%2520paradigms%2520to%2520medicinal%2520applications%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2009%26volume%3D38%26spage%3D391%26epage%3D401%26doi%3D10.1039%2FB707077M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galanski, M.</span></span> <span> </span><span class="NLM_article-title">Recent developments in the field of anticancer platinum complexes</span>. <i>Recent Pat. Anti-Cancer Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.2174/157489206777442287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F157489206777442287" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=285-295&author=M.+Galanski&title=Recent+developments+in+the+field+of+anticancer+platinum+complexes&doi=10.2174%2F157489206777442287"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F157489206777442287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157489206777442287%26sid%3Dliteratum%253Aachs%26aulast%3DGalanski%26aufirst%3DM.%26atitle%3DRecent%2520developments%2520in%2520the%2520field%2520of%2520anticancer%2520platinum%2520complexes%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2006%26volume%3D1%26spage%3D285%26epage%3D295%26doi%3D10.2174%2F157489206777442287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaili, E.</span></span> <span> </span><span class="NLM_article-title">Platinum anticancer drugs and photochemotherapeutic agents: recent advances and future developments</span>. <i>Sci. Prog.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.3184/003685014X13904811808460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.3184%2F003685014X13904811808460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=24800467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1aju7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2014&pages=20-40&author=E.+Shaili&title=Platinum+anticancer+drugs+and+photochemotherapeutic+agents%3A+recent+advances+and+future+developments&doi=10.3184%2F003685014X13904811808460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Platinum anticancer drugs and photochemotherapeutic agents: recent advances and future developments</span></div><div class="casAuthors">Shaili, Evyenia</div><div class="citationInfo"><span class="NLM_cas:title">Science Progress (St. Albans, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-40</span>CODEN:
                <span class="NLM_cas:coden">SCPRAY</span>;
        ISSN:<span class="NLM_cas:issn">0036-8504</span>.
    
            (<span class="NLM_cas:orgname">Science Reviews 2000 Ltd.</span>)
        </div><div class="casAbstract">A review.  Platinum-based chemotherapeutic drugs such as cisplatin, carboplatin and oxaliplatin are widely applied for the treatment of various types of tumors.  Over the last few decades, a large variety of Pt(II) and Pt(IV) complexes have been developed to improve the applicability in a wider spectrum of cancers, increase their therapeutic window and reduce the dose-limiting side effects.  Photodynamic therapy (PDT), which is the administration of a photosensitizer followed by visible light activation, is a promising route to avoid damage to healthy cells and the surrounding tissue.  Transition metal complexes as photochemotherapeutic agents are an attractive option for further development in the field of photoactivated chemotherapy (PACT).  These complexes exhibit different nos. and types of excited states which are easily accessible upon light irradn., subsequently giving rise to the formation of various photoproducts that can enable a distinct mode of action.  Platinum-diazido complexes are promising candidates for PACT due to the low cytotoxicity when irradiated with visible light.  This review summarises the mode of action of current platinum anticancer drugs with cisplatin as a lead example and the development of non-conventional Pt(II) complexes.  Background information regarding PDT, the photophys. and photochem. properties of metal complexes is provided, as well as notable examples of photoactivated metal complexes with biol. activity.  Particular emphasis is placed on recent developments on platinum photoactivated drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo54vAhqySDubVg90H21EOLACvtfcHk0lgX3WpSs5lEVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1aju7%252FP&md5=f17ed8cde8ac00973e300e8619bd2ece</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3184%2F003685014X13904811808460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3184%252F003685014X13904811808460%26sid%3Dliteratum%253Aachs%26aulast%3DShaili%26aufirst%3DE.%26atitle%3DPlatinum%2520anticancer%2520drugs%2520and%2520photochemotherapeutic%2520agents%253A%2520recent%2520advances%2520and%2520future%2520developments%26jtitle%3DSci.%2520Prog.%26date%3D2014%26volume%3D97%26spage%3D20%26epage%3D40%26doi%3D10.3184%2F003685014X13904811808460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohmichi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayakawa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, Y.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of platinum drug resistance</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2005.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.tips.2005.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=15749154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVeisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=113-116&author=M.+Ohmichiauthor=J.+Hayakawaauthor=K.+Tasakaauthor=H.+Kurachiauthor=Y.+Murata&title=Mechanisms+of+platinum+drug+resistance&doi=10.1016%2Fj.tips.2005.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of platinum drug resistance</span></div><div class="casAuthors">Ohmichi, Masahide; Hayakawa, Jun; Tasaka, Keiichi; Kurachi, Hirohisa; Murata, Yuji</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">113-116</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Platinum-based drugs are among the most active anticancer agents available and are used widely for the treatment of a variety of human solid tumors.  Although patients show high response rates to Pt drugs, most patients develop resistance to these drugs during treatment.  Because the acquisition of resistance is a major obstacle to the clin. use of Pt drugs, the processes by which cells develop such resistance are of great interest and efforts were made to overcome this problem.  Both mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) cascades are involved in resistance to these drugs, and clin. trials of some small-mol. inhibitors of the MAPK and PI3K-Akt cascades to overcome resistance to Pt drugs are ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMhWjQ2uCNdrVg90H21EOLACvtfcHk0lgX3WpSs5lEVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVeisLw%253D&md5=d78b82e31b6891980e9b14fa3ae611e7</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2005.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2005.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DOhmichi%26aufirst%3DM.%26aulast%3DHayakawa%26aufirst%3DJ.%26aulast%3DTasaka%26aufirst%3DK.%26aulast%3DKurachi%26aufirst%3DH.%26aulast%3DMurata%26aufirst%3DY.%26atitle%3DMechanisms%2520of%2520platinum%2520drug%2520resistance%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D113%26epage%3D116%26doi%3D10.1016%2Fj.tips.2005.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaiddon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schellens, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beijnen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sava, G.</span></span> <span> </span><span class="NLM_article-title">Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2011.09.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jinorgbio.2011.09.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=22112845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOgtbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2012&pages=90-99&author=A.+Bergamoauthor=C.+Gaiddonauthor=J.+H.+Schellensauthor=J.+H.+Beijnenauthor=G.+Sava&title=Approaching+tumour+therapy+beyond+platinum+drugs%3A+status+of+the+art+and+perspectives+of+ruthenium+drug+candidates&doi=10.1016%2Fj.jinorgbio.2011.09.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Approaching tumour therapy beyond platinum drugs: Status of the art and perspectives of ruthenium drug candidates</span></div><div class="casAuthors">Bergamo, A.; Gaiddon, C.; Schellens, J. H. M.; Beijnen, J. H.; Sava, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-99</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The study of metal complexes for the treatment of cancer diseases has resulted in the identification of some unique properties of ruthenium-based compds.  Among these inorg.-based agents, 2 of them, namely the ruthenium(III) drugs NAMI-A and KP1019 have undertaken with some success the clin. evaluations of phase I and preliminary phase II trials in patients.  Here we highlight the strategies that have led to the discovery of metal-based (NAMI-A and KP1019) and of organometallic (RM175, RAPTA-T, RDC11, and DW1/2) ruthenium-based complexes, and we report their main biol./pharmacol. characteristics and expectations for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7cdFNtCDy-bVg90H21EOLACvtfcHk0lgX3WpSs5lEVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOgtbfN&md5=f4b107159ed35bfdda947dc9fdc2593f</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2011.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2011.09.030%26sid%3Dliteratum%253Aachs%26aulast%3DBergamo%26aufirst%3DA.%26aulast%3DGaiddon%26aufirst%3DC.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26aulast%3DSava%26aufirst%3DG.%26atitle%3DApproaching%2520tumour%2520therapy%2520beyond%2520platinum%2520drugs%253A%2520status%2520of%2520the%2520art%2520and%2520perspectives%2520of%2520ruthenium%2520drug%2520candidates%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2012%26volume%3D106%26spage%3D90%26epage%3D99%26doi%3D10.1016%2Fj.jinorgbio.2011.09.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alessio, E.</span></span> <span> </span><span class="NLM_article-title">Thirty years of the drug candidate NAMI-A and the myths in the field of ruthenium anticancer compounds: A personal perspective</span>. <i>Eur. J. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1549</span>– <span class="NLM_lpage">1560</span>, <span class="refDoi"> DOI: 10.1002/ejic.201600986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fejic.201600986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKru7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1549-1560&author=E.+Alessio&title=Thirty+years+of+the+drug+candidate+NAMI-A+and+the+myths+in+the+field+of+ruthenium+anticancer+compounds%3A+A+personal+perspective&doi=10.1002%2Fejic.201600986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective</span></div><div class="casAuthors">Alessio, Enzo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1549-1560</span>CODEN:
                <span class="NLM_cas:coden">EJICFO</span>;
        ISSN:<span class="NLM_cas:issn">1434-1948</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">As anticipated in the title, this contribution is basically divided into two, strictly connected, parts.  The first is a personal overview of the ruthenium drug candidate NAMI-A, almost 30 years after its synthesis and the discovery of its unprecedented antimetastatic properties in animal models at nontoxic dosages.  The sections relating to the chem. and biol. behavior of the complex, and the hypotheses on its mechanism(s) of action, are kept to a min., whereas more space is devoted to discussion of the results of the clin. investigations.  The second part deals in detail with a no. of undemonstrated misconceptions (or myths) that, over the years, have thrived around NAMI-A and other ruthenium drug candidates, thus neg. affecting the whole field of Ru anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbjex9sRUkCbVg90H21EOLACvtfcHk0liJsRvcojzLZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKru7bK&md5=ca48413b7dd02a63edf5049a9a5c7377</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fejic.201600986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejic.201600986%26sid%3Dliteratum%253Aachs%26aulast%3DAlessio%26aufirst%3DE.%26atitle%3DThirty%2520years%2520of%2520the%2520drug%2520candidate%2520NAMI-A%2520and%2520the%2520myths%2520in%2520the%2520field%2520of%2520ruthenium%2520anticancer%2520compounds%253A%2520A%2520personal%2520perspective%26jtitle%3DEur.%2520J.%2520Inorg.%2520Chem.%26date%3D2017%26volume%3D2017%26spage%3D1549%26epage%3D1560%26doi%3D10.1002%2Fejic.201600986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kostova, I.</span></span> <span> </span><span class="NLM_article-title">Ruthenium complexes as anticancer agents</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1085</span>– <span class="NLM_lpage">1107</span>, <span class="refDoi"> DOI: 10.2174/092986706776360941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F092986706776360941" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=16611086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslKqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1085-1107&author=I.+Kostova&title=Ruthenium+complexes+as+anticancer+agents&doi=10.2174%2F092986706776360941"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium complexes as anticancer agents</span></div><div class="casAuthors">Kostova, Irena</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1085-1107</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cancer is one of the major cases of death in the world.  Current treatment of cancer is limited to surgery, radiotherapy, and the use of cytotoxic agents, despite their well known side effects and problems assocd. with the development of resistance.  For most forms of disseminated cancer, however, no curative therapy is available, and the discovery and development of novel active chemotherapeutic agents is largely needed.  Since the development of cisplatin, an inorg. platinum complex, numerous platinum and non-platinum metal complexes were synthesized and tested for anticancer activity.  Very few match the clin. efficacy of cisplatin.  Ruthenium complexes were prepd. to ameliorate cisplatin activity, particularly on resistant tumors, or to reduce host toxicity at active doses.  Since many years a lot of scientific groups have actively worked in the field of inorg. antitumor drugs and have developed a no. of Ru(II) and Ru(III) complexes, which were shown to possess good antitumor and, above all, antimetastatic properties against animal models.  Ruthenium complexes are presently an object of great attention in the field of medicinal chem., as antitumor agents with selective antimetastatic properties and low systemic toxicity.  Ruthenium compds. appear to penetrate reasonably well the tumor cells and bind effectively to DNA.  In this review, the achievements in the field of medicinal chem., DNA binding modes, and the development status of Ru(II) and Ru(III) complexes as anticancer agents are discussed.  The aim of this review is therefore that of critically examg. the past and the actual work on ruthenium compds. with emphasis on their proposed role in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJekZc9T8z-bVg90H21EOLACvtfcHk0liJsRvcojzLZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslKqtbs%253D&md5=42ca40ec180cea41e301a176472acc8c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F092986706776360941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706776360941%26sid%3Dliteratum%253Aachs%26aulast%3DKostova%26aufirst%3DI.%26atitle%3DRuthenium%2520complexes%2520as%2520anticancer%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D1085%26epage%3D1107%26doi%3D10.2174%2F092986706776360941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtkamp, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier-Menches, S. M.</span></span> <span> </span><span class="NLM_article-title">Characterizing activation mechanisms and binding preferences of ruthenium metallo-prodrugs by a competitive binding assay</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">322</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2017.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jinorgbio.2017.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28739166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1WrtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2017&pages=322-327&author=C.+Artnerauthor=H.+U.+Holtkampauthor=C.+G.+Hartingerauthor=S.+M.+Meier-Menches&title=Characterizing+activation+mechanisms+and+binding+preferences+of+ruthenium+metallo-prodrugs+by+a+competitive+binding+assay&doi=10.1016%2Fj.jinorgbio.2017.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Characterizing activation mechanisms and binding preferences of ruthenium metallo-prodrugs by a competitive binding assay</span></div><div class="casAuthors">Artner, Christian; Holtkamp, Hannah U.; Hartinger, Christian G.; Meier-Menches, Samuel M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">322-327</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The activation mechanisms and reactivity of ruthenium metallo-prodrug lead structures were investigated in detail using capillary zone electrophoresis mass spectrometry (CZE-MS) in a time-dependent manner and by exposing to a protein/oligonucleotide mixt.  The competitive assays were performed with sodium trans-[RuCl4(HInd)2] where Hind = indazole (NKP-1339), [(η6-p-cymene)RuCl2(pta)], where pta = 1,3,5-triaza-7-phosphaadamantane (RAPTA-C) and [(η6-biphenyl)RuCl(1,2-ethylenediamine)]PF6 (RM175).  Mol. and quant. information on binding preferences was obtained by coupling CZE to electrospray ionization MS (ESI-MS) and inductively coupled plasma MS (ICP-MS), resp.  A score system is presented that ranks the binding preferences of Ru complexes with nucleotides and demonstrated the following trend of decreasing selectivity after 24 h: RM175 (0.89) > RAPTA-C (0.78) > NKP-1339 (0.40).  As expected, the organometallic drug candidates RM175 and RAPTA-C underwent a halido/aqua ligand exchange reaction at the metal center and showed distinct reactivity towards the biomols.  In particular, the protein/DNA binding sites of RAPTA-C in a mixt. of protein (ubiquitin) and oligonucleotide (5'-dATTGGCAC-3') were located at single-amino acid and single-nucleotide resoln., resp.  Activated RAPTA-C bound selectively to Met1, adenine and cytosine in this setting, which contrasts with the selectivity of RM175 for guanine.  Finally, activation products of NKP-1339 were detected corresponding to RuII(Hind)2 fragments coordinated to the oligonucleotide, which represents one of the few examples of a directly obsd. RuII adduct.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKOfkLtsucrrVg90H21EOLACvtfcHk0liJsRvcojzLZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1WrtbnF&md5=c10713ed529e1e79d7b90e8a80d74e02</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2017.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2017.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DArtner%26aufirst%3DC.%26aulast%3DHoltkamp%26aufirst%3DH.%2BU.%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DMeier-Menches%26aufirst%3DS.%2BM.%26atitle%3DCharacterizing%2520activation%2520mechanisms%2520and%2520binding%2520preferences%2520of%2520ruthenium%2520metallo-prodrugs%2520by%2520a%2520competitive%2520binding%2520assay%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2017%26volume%3D177%26spage%3D322%26epage%3D327%26doi%3D10.1016%2Fj.jinorgbio.2017.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span></span> <span> </span><span class="NLM_article-title">Editorial: Anticancer ruthenium complexes in drug discovery and medicinal chemistry</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">771</span>, <span class="refDoi"> DOI: 10.2174/138955751610160503003405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F138955751610160503003405" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=771&author=S.+Thota&title=Editorial%3A+Anticancer+ruthenium+complexes+in+drug+discovery+and+medicinal+chemistry&doi=10.2174%2F138955751610160503003405"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F138955751610160503003405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955751610160503003405%26sid%3Dliteratum%253Aachs%26aulast%3DThota%26aufirst%3DS.%26atitle%3DEditorial%253A%2520Anticancer%2520ruthenium%2520complexes%2520in%2520drug%2520discovery%2520and%2520medicinal%2520chemistry%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D771%26doi%3D10.2174%2F138955751610160503003405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biersack, B.</span></span> <span> </span><span class="NLM_article-title">Anticancer Activity and modes of action of (arene) ruthenium(II) complexes coordinated to C-, N-, and O-ligands</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">804</span>– <span class="NLM_lpage">814</span>, <span class="refDoi"> DOI: 10.2174/138955751610160503004623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F138955751610160503004623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=27161009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFagsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=804-814&author=B.+Biersack&title=Anticancer+Activity+and+modes+of+action+of+%28arene%29+ruthenium%28II%29+complexes+coordinated+to+C-%2C+N-%2C+and+O-ligands&doi=10.2174%2F138955751610160503004623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligands</span></div><div class="casAuthors">Biersack, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">804-814</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">An overview of anticancer active (arene)ruthenium(II) complexes coordinated to period 2 element-based ligand systems, i.e., carbon-, nitrogen-, and oxygen-coordinated ligands, is provided in this mini-review.  A bridge is forged from the large group of anticancer active ruthenium compds. with monodentate and chelating nitrogen ligands via complexes of O,O-chelating ligands to organometallic ruthenium derivs. coordinated to carbon.  (Arene)ruthenium(II) complexes with reduced side-effects and enhanced efficacy against cancer are highlighted.  Pertinent literature is covered up to 2014.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomRvHgdNwAzLVg90H21EOLACvtfcHk0lhpvGEA39uOWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFagsLo%253D&md5=3818a9fcda577f76fe6d2c0d7524eccb</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F138955751610160503004623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955751610160503004623%26sid%3Dliteratum%253Aachs%26aulast%3DBiersack%26aufirst%3DB.%26atitle%3DAnticancer%2520Activity%2520and%2520modes%2520of%2520action%2520of%2520%2528arene%2529%2520ruthenium%2528II%2529%2520complexes%2520coordinated%2520to%2520C-%252C%2520N-%252C%2520and%2520O-ligands%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D804%26epage%3D814%26doi%3D10.2174%2F138955751610160503004623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span> <span> </span><span class="NLM_article-title">Development of arene ruthenium antitumor complexes</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.2174/138955751610160503003937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F138955751610160503003937" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=787-795&author=W.+Suauthor=Z.+Tangauthor=P.+Li&title=Development+of+arene+ruthenium+antitumor+complexes&doi=10.2174%2F138955751610160503003937"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F138955751610160503003937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955751610160503003937%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DP.%26atitle%3DDevelopment%2520of%2520arene%2520ruthenium%2520antitumor%2520complexes%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D787%26epage%3D795%26doi%3D10.2174%2F138955751610160503003937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamsi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azam, A.</span></span> <span> </span><span class="NLM_article-title">Ruthenium complexes: An emerging ground to the development of metallopharmaceuticals for cancer therapy</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">772</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.2174/1389557515666151001142012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F1389557515666151001142012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=772-786&author=M.+Abidauthor=F.+Shamsiauthor=A.+Azam&title=Ruthenium+complexes%3A+An+emerging+ground+to+the+development+of+metallopharmaceuticals+for+cancer+therapy&doi=10.2174%2F1389557515666151001142012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F1389557515666151001142012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557515666151001142012%26sid%3Dliteratum%253Aachs%26aulast%3DAbid%26aufirst%3DM.%26aulast%3DShamsi%26aufirst%3DF.%26aulast%3DAzam%26aufirst%3DA.%26atitle%3DRuthenium%2520complexes%253A%2520An%2520emerging%2520ground%2520to%2520the%2520development%2520of%2520metallopharmaceuticals%2520for%2520cancer%2520therapy%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D772%26epage%3D786%26doi%3D10.2174%2F1389557515666151001142012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, W.</span></span> <span> </span><span class="NLM_article-title">Arene ruthenium(II) complexes: The promising chemotherapeutic agent in inhibiting the proliferation, migration and invasion</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">796</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.2174/1389557515666151001142159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F1389557515666151001142159" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=796-803&author=K.+Zhengauthor=Q.+Wuauthor=Y.+Dingauthor=W.+Mei&title=Arene+ruthenium%28II%29+complexes%3A+The+promising+chemotherapeutic+agent+in+inhibiting+the+proliferation%2C+migration+and+invasion&doi=10.2174%2F1389557515666151001142159"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F1389557515666151001142159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557515666151001142159%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DMei%26aufirst%3DW.%26atitle%3DArene%2520ruthenium%2528II%2529%2520complexes%253A%2520The%2520promising%2520chemotherapeutic%2520agent%2520in%2520inhibiting%2520the%2520proliferation%252C%2520migration%2520and%2520invasion%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D796%26epage%3D803%26doi%3D10.2174%2F1389557515666151001142159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poynton, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bright, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunnlaugsson, T.</span></span> <span> </span><span class="NLM_article-title">The development of ruthenium(ii) polypyridyl complexes and conjugates for <i>in vitro</i> cellular and <i>in vivo</i> applications</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">7706</span>– <span class="NLM_lpage">7756</span>, <span class="refDoi"> DOI: 10.1039/C7CS00680B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC7CS00680B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=29177281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVKgtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=7706-7756&author=F.+E.+Poyntonauthor=S.+A.+Brightauthor=S.+Blascoauthor=D.+C.+Williamsauthor=J.+M.+Kellyauthor=T.+Gunnlaugsson&title=The+development+of+ruthenium%28ii%29+polypyridyl+complexes+and+conjugates+for+in+vitro+cellular+and+in+vivo+applications&doi=10.1039%2FC7CS00680B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The development of ruthenium(II) polypyridyl complexes and conjugates for in vitro cellular and in vivo applications</span></div><div class="casAuthors">Poynton, Fergus E.; Bright, Sandra A.; Blasco, Salvador; Williams, D. Clive; Kelly, John M.; Gunnlaugsson, Thorfinnur</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7706-7756</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Ruthenium(II) [Ru(II)] polypyridyl complexes have been the focus of intense investigations since work began exploring their supramol. interactions with DNA.  In recent years, there have been considerable efforts to translate this soln.-based research into a biol. environment with the intention of developing new classes of probes, luminescent imaging agents, therapeutics and theranostics.  In only 10 years the field has expanded with diverse applications for these complexes as imaging agents and promising candidates for therapeutics.  In light of these efforts this review exclusively focuses on the developments of these complexes in biol. systems, both in cells and in vivo, and hopes to communicate to readers the diversity of applications within which these complexes have found use, as well as new insights gained along the way and challenges that researchers in this field still face.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0yZtydmk55bVg90H21EOLACvtfcHk0lhpvGEA39uOWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVKgtL%252FF&md5=b692e8e2d18dd88e6d48b745f070e2d4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1039%2FC7CS00680B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CS00680B%26sid%3Dliteratum%253Aachs%26aulast%3DPoynton%26aufirst%3DF.%2BE.%26aulast%3DBright%26aufirst%3DS.%2BA.%26aulast%3DBlasco%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DD.%2BC.%26aulast%3DKelly%26aufirst%3DJ.%2BM.%26aulast%3DGunnlaugsson%26aufirst%3DT.%26atitle%3DThe%2520development%2520of%2520ruthenium%2528ii%2529%2520polypyridyl%2520complexes%2520and%2520conjugates%2520for%2520in%2520vitro%2520cellular%2520and%2520in%2520vivo%2520applications%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2017%26volume%3D46%26spage%3D7706%26epage%3D7756%26doi%3D10.1039%2FC7CS00680B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Notaro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">7317</span>– <span class="NLM_lpage">7337</span>, <span class="refDoi"> DOI: 10.1039/C7CS00356K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC7CS00356K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=29027562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1CrtLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=7317-7337&author=A.+Notaroauthor=G.+Gasser&title=Monomeric+and+dimeric+coordinatively+saturated+and+substitutionally+inert+Ru%28ii%29+polypyridyl+complexes+as+anticancer+drug+candidates&doi=10.1039%2FC7CS00356K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(II) polypyridyl complexes as anticancer drug candidates</span></div><div class="casAuthors">Notaro, Anna; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7317-7337</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Due to the increasing impact of cancer on worldwide mortality, more and more attention is being devoted to the investigation of novel anticancer strategies.  Among these, chemotherapy plays a key role in fighting cancer.  This explains the increasing engagement of both the pharmaceutical industry and academia towards the discovery of new chemotherapeutic agents.  In recent years, metal-based drugs have attracted much attention due to their atypical physico-chem. properties compared to org. mols.  After the approval of cisplatin as a chemotherapeutic agent in 1978, several types of metal-based drugs have been explored.  Among them, Ru-based anticancer drug candidates have become a central subject in this research field.  However, most of the Ru-based compds. investigated over the last two decades express their cytotoxicity with a mechanism of action involving, among others, a ligand-exchange mechanism.  In this Review, we give a complete overview of a specific class of antiproliferative ruthenium complexes, namely coordinatively satd. and substitutionally inert Ru(II) polypyridyl complexes.  This implies that the cytotoxicity obsd. comes from the entire complex and not from ligand-exchange.  In this Review, we present monomeric and dimeric Ru(II) polypyridyl complexes, which have been found to be toxic to cancer cells.  More specifically, monomeric Ru(II) polypyridyl complexes are analyzed considering their direct interaction or not with DNA as the cause of cell death, while dimeric Ru(II) polypyridyl complexes are classified according to their biol. targets.  Very importantly, the cellular targets of these complexes are discussed in detail.  Indeed, several targets were identified and different mechanisms of action were suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC29dn6JqWwLVg90H21EOLACvtfcHk0lidKx1zMSw7oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1CrtLrI&md5=7e75dd00ef156901717f18db3f67d304</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2FC7CS00356K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CS00356K%26sid%3Dliteratum%253Aachs%26aulast%3DNotaro%26aufirst%3DA.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DMonomeric%2520and%2520dimeric%2520coordinatively%2520saturated%2520and%2520substitutionally%2520inert%2520Ru%2528ii%2529%2520polypyridyl%2520complexes%2520as%2520anticancer%2520drug%2520candidates%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2017%26volume%3D46%26spage%3D7317%26epage%3D7337%26doi%3D10.1039%2FC7CS00356K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allardyce, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">Ruthenium in medicine: Current clinical uses and future prospects</span>. <i>Platinum Met. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVOgsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=62-69&author=C.+S.+Allardyceauthor=P.+J.+Dyson&title=Ruthenium+in+medicine%3A+Current+clinical+uses+and+future+prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium in medicine: Current clinical uses and future prospects</span></div><div class="casAuthors">Allardyce, Claire S.; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Platinum Metals Review</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">62-69</span>CODEN:
                <span class="NLM_cas:coden">PTMRA3</span>;
        ISSN:<span class="NLM_cas:issn">0032-1400</span>.
    
            (<span class="NLM_cas:orgname">Johnson Matthey Public Ltd. Co.</span>)
        </div><div class="casAbstract">A review.  There is no doubt about the success of precious metals in the clinic, with, for example, platinum compds. being widely used in the treatment of cancer, silver compds. being useful antimicrobial agents and gold compds. used routinely in the treatment of rheumatoid arthritis.  The medicinal properties of the other platinum group metals are now being recognized and of these a ruthenium anticancer agent has recently entered the clinic, showing promising activity on otherwise resistant tumors.  Like all metal drugs, the activity of the ruthenium compds. depends on both the oxidn. state and the ligands.  By manipulating these features ruthenium-centered antimalarial, antibiotic and immunosuppressive drugs have been made.  In addn., ruthenium has unique properties which make it particularly useful in drug design.  In this review we discuss ruthenium from a clin. stance and outline the medicinal uses of ruthenium-based compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppc8V-Mj8EArVg90H21EOLACvtfcHk0lidKx1zMSw7oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVOgsLs%253D&md5=778378be61f6e9a4629abe1c585cf87a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllardyce%26aufirst%3DC.%2BS.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DRuthenium%2520in%2520medicine%253A%2520Current%2520clinical%2520uses%2520and%2520future%2520prospects%26jtitle%3DPlatinum%2520Met.%2520Rev.%26date%3D2001%26volume%3D45%26spage%3D62%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frasca, D. R.</span></span> <span> </span><span class="NLM_article-title">Non-platinum chemotherapeutic metallopharmaceuticals</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">2511</span>– <span class="NLM_lpage">2534</span>, <span class="refDoi"> DOI: 10.1021/cr9804238</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr9804238" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADyaK1MXkslChtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=2511-2534&author=M.+J.+Clarkeauthor=F.+Zhuauthor=D.+R.+Frasca&title=Non-platinum+chemotherapeutic+metallopharmaceuticals&doi=10.1021%2Fcr9804238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Non-Platinum Chemotherapeutic Metallopharmaceuticals</span></div><div class="casAuthors">Clarke, Michael J.; Zhu, Fuchun; Frasca, Dominic R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2511-2533</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 404 refs. on possible mechanistic approaches to chemotherapeutic anticancer drugs involving non-platinum metal ion complexes exclusive of metalloproteins or metal-activated antibiotics.  There is particular emphasis on those that can interact with nucleic acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBaHVfLpgm9LVg90H21EOLACvtfcHk0lidKx1zMSw7oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkslChtLc%253D&md5=760d59b6d6c55c74efb6c1deb3806870</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fcr9804238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9804238%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DM.%2BJ.%26aulast%3DZhu%26aufirst%3DF.%26aulast%3DFrasca%26aufirst%3DD.%2BR.%26atitle%3DNon-platinum%2520chemotherapeutic%2520metallopharmaceuticals%26jtitle%3DChem.%2520Rev.%26date%3D1999%26volume%3D99%26spage%3D2511%26epage%3D2534%26doi%3D10.1021%2Fcr9804238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messori, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccioli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocchietto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sava, G.</span></span> <span> </span><span class="NLM_article-title">Biological role of adduct formation of the ruthenium(III) complex NAMI-A with serum albumin and serum transferrin</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">411</span>, <span class="refDoi"> DOI: 10.1023/A:1026243000320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1023%2FA%3A1026243000320" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=401-411&author=A.+Bergamoauthor=L.+Messoriauthor=F.+Piccioliauthor=M.+Cocchiettoauthor=G.+Sava&title=Biological+role+of+adduct+formation+of+the+ruthenium%28III%29+complex+NAMI-A+with+serum+albumin+and+serum+transferrin&doi=10.1023%2FA%3A1026243000320"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1023%2FA%3A1026243000320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1026243000320%26sid%3Dliteratum%253Aachs%26aulast%3DBergamo%26aufirst%3DA.%26aulast%3DMessori%26aufirst%3DL.%26aulast%3DPiccioli%26aufirst%3DF.%26aulast%3DCocchietto%26aufirst%3DM.%26aulast%3DSava%26aufirst%3DG.%26atitle%3DBiological%2520role%2520of%2520adduct%2520formation%2520of%2520the%2520ruthenium%2528III%2529%2520complex%2520NAMI-A%2520with%2520serum%2520albumin%2520and%2520serum%2520transferrin%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2003%26volume%3D21%26spage%3D401%26epage%3D411%26doi%3D10.1023%2FA%3A1026243000320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alessio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mestroni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sava, G.</span></span> <span> </span><span class="NLM_article-title">Ruthenium antimetastatic agents</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1525</span>– <span class="NLM_lpage">1535</span>, <span class="refDoi"> DOI: 10.2174/1568026043387421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F1568026043387421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=15579094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKmsbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=1525-1535&author=E.+Alessioauthor=G.+Mestroniauthor=A.+Bergamoauthor=G.+Sava&title=Ruthenium+antimetastatic+agents&doi=10.2174%2F1568026043387421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium antimetastatic agents</span></div><div class="casAuthors">Alessio, Enzo; Mestroni, Giovanni; Bergamo, Alberta; Sava, Gianni</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1525-1535</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  NAMI-A, i.e. (imH)[trans-RuCl4(dmso-S)(i.m.)] (i.m. = imidazole, dmso = dimethylsulfoxide), is a Ru(III) complex that, after extensive preclin. investigations that evidenced its remarkable and specific activity against metastases, has recently and successfully completed a Phase I trial (first ruthenium complex ever to reach clin. testing).  This review article, after a brief summary of the main chem. and pharmacol. aspects of NAMI-A, focuses on the development of new classes of ruthenium complexes originated from the NAMI-A frame.  In particular, the chem. and biol. features of the following classes of compds. will be treated: (i) NAMI-A-type complexes, derived from NAMI-A by changing the nature of the N-ligand, (ii) dinuclear NAMI-A-type compds. contg. heterocyclic bridging N-N ligands, (iii) new Ru-dmso nitrosyls broadly derived from NAMI-A-type complexes.  Several of these new compds. were found to have antimetastatic activity comparable to, or even better than, NAMI-A; however, the nature of the target(s) responsible for the antimetastatic activity remains unclear.  Common to any type of NAMI-A-type compd., both monomeric and dimeric, cell cytotoxicity (which is generally very low) is not sufficient to explain their potent and peculiar antitumor activity.  All active NAMI-A-type compds. share the capacity to modify important parameters of metastasis such as tumor invasion, matrix metallo proteinases activity and cell cycle progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvZfbwhzvZVLVg90H21EOLACvtfcHk0liVQOtBq_w9LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKmsbrP&md5=0771fa8fc0097989bb6f83cc72d98386</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F1568026043387421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026043387421%26sid%3Dliteratum%253Aachs%26aulast%3DAlessio%26aufirst%3DE.%26aulast%3DMestroni%26aufirst%3DG.%26aulast%3DBergamo%26aufirst%3DA.%26aulast%3DSava%26aufirst%3DG.%26atitle%3DRuthenium%2520antimetastatic%2520agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D1525%26epage%3D1535%26doi%3D10.2174%2F1568026043387421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorbas-Seifried, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorbas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">KP1019, a new redox-active anticancer agent preclinical development and results of a clinical phase I study in tumor patients</span>. <i>Chem. Biodiversity</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2140</span>– <span class="NLM_lpage">2155</span>, <span class="refDoi"> DOI: 10.1002/cbdv.200890195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fcbdv.200890195" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=2140-2155&author=C.+G.+Hartingerauthor=M.+A.+Jakupecauthor=S.+Zorbas-Seifriedauthor=M.+Groesslauthor=A.+Eggerauthor=W.+Bergerauthor=H.+Zorbasauthor=P.+J.+Dysonauthor=B.+K.+Keppler&title=KP1019%2C+a+new+redox-active+anticancer+agent+preclinical+development+and+results+of+a+clinical+phase+I+study+in+tumor+patients&doi=10.1002%2Fcbdv.200890195"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200890195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200890195%26sid%3Dliteratum%253Aachs%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DZorbas-Seifried%26aufirst%3DS.%26aulast%3DGroessl%26aufirst%3DM.%26aulast%3DEgger%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DZorbas%26aufirst%3DH.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DKP1019%252C%2520a%2520new%2520redox-active%2520anticancer%2520agent%2520preclinical%2520development%2520and%2520results%2520of%2520a%2520clinical%2520phase%2520I%2520study%2520in%2520tumor%2520patients%26jtitle%3DChem.%2520Biodiversity%26date%3D2008%26volume%3D5%26spage%3D2140%26epage%3D2155%26doi%3D10.1002%2Fcbdv.200890195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorbas-Seifried, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kynast, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorbas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">From bench to bedside-preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1<i>H</i>-indazole)ruthenate(III)] (KP1019 or FFC14A)</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">891</span>– <span class="NLM_lpage">904</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2006.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jinorgbio.2006.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=16603249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVCluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2006&pages=891-904&author=C.+G.+Hartingerauthor=S.+Zorbas-Seifriedauthor=M.+A.+Jakupecauthor=B.+Kynastauthor=H.+Zorbasauthor=B.+K.+Keppler&title=From+bench+to+bedside-preclinical+and+early+clinical+development+of+the+anticancer+agent+indazolium+trans-%5Btetrachlorobis%281H-indazole%29ruthenate%28III%29%5D+%28KP1019+or+FFC14A%29&doi=10.1016%2Fj.jinorgbio.2006.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">From bench to bedside - preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)</span></div><div class="casAuthors">Hartinger, Christian G.; Zorbas-Seifried, Stefanie; Jakupec, Michael A.; Kynast, Bernd; Zorbas, Haralabos; Keppler, Bernhard K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">891-904</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A) is just the second ruthenium-based anticancer agent after NAMI-A which was developed to the stage of clin. trials.  Important steps in the mode of action of KP1019 are thought to be the binding to the serum protein transferrin and the transport into the cell via the transferrin pathway.  Addnl., the selective activation by redn. in the tumor might contribute to the low side effects obsd. in in vivo studies.  Apoptosis is induced at non-toxic levels via the mitochondrial pathway.  These features distinguish it from the established platinum anticancer drugs and suggest that different types of cancer might be treatable with this drug.  Indeed, promising activity against certain types of tumors, which are not successfully treatable with cisplatin, and only a very low incidence of acquired resistance has been obsd. in in vitro and in vivo studies.  Recently, a clin. phase I trial was finished in which none of the treated patients experienced serious side effects, while disease stabilization in five of six evaluable patients was achieved.  In this review, the preclin. and early clin. development of KP1019 - from bench to bedside - is recapitulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQXGOcIpo0P7Vg90H21EOLACvtfcHk0liVQOtBq_w9LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVCluro%253D&md5=8fe177baac72fa807e2eb96ecce7e07a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2006.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2006.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DZorbas-Seifried%26aufirst%3DS.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DKynast%26aufirst%3DB.%26aulast%3DZorbas%26aufirst%3DH.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DFrom%2520bench%2520to%2520bedside-preclinical%2520and%2520early%2520clinical%2520development%2520of%2520the%2520anticancer%2520agent%2520indazolium%2520trans-%255Btetrachlorobis%25281H-indazole%2529ruthenate%2528III%2529%255D%2520%2528KP1019%2520or%2520FFC14A%2529%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2006%26volume%3D100%26spage%3D891%26epage%3D904%26doi%3D10.1016%2Fj.jinorgbio.2006.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. S.</span></span> <span> </span><span class="NLM_article-title">The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">5771</span>– <span class="NLM_lpage">5804</span>, <span class="refDoi"> DOI: 10.1039/C7CS00195A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC7CS00195A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28654103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKnsLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=5771-5804&author=L.+Zengauthor=P.+Guptaauthor=Y.+Chenauthor=E.+Wangauthor=L.+Jiauthor=H.+Chaoauthor=Z.+S.+Chen&title=The+development+of+anticancer+ruthenium%28II%29+complexes%3A+from+single+molecule+compounds+to+nanomaterials&doi=10.1039%2FC7CS00195A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials</span></div><div class="casAuthors">Zeng, Leli; Gupta, Pranav; Chen, Yanglu; Wang, Enju; Ji, Liangnian; Chao, Hui; Chen, Zhe-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5771-5804</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cancer is rapidly becoming the top killer in the world.  Most of the FDA approved anticancer drugs are org. mols., while metallodrugs are very scarce.  The advent of the first metal based therapeutic agent, cisplatin, launched a new era in the application of transition metal complexes for therapeutic design.  Due to their unique and versatile biochem. properties, ruthenium-based compds. have emerged as promising anti-cancer agents that serve as alternatives to cisplatin and its derivertives.  Ruthenium(III) complexes have successfully been used in clin. research and their mechanisms of anticancer action have been reported in large vols. over the past few decades.  Ruthenium(II) complexes have also attracted significant attention as anticancer candidates; however, only a few of them have been reported comprehensively.  In this review, we discuss the development of ruthenium(II) complexes as anticancer candidates and biocatalysts, including arene ruthenium complexes, polypyridyl ruthenium complexes, and ruthenium nanomaterial complexes.  This review focuses on the likely mechanisms of action of ruthenium(II)-based anticancer drugs and the relationship between their chem. structures and biol. properties.  This review also highlights the catalytic activity and the photoinduced activation of ruthenium(II) complexes, their targeted delivery, and their activity in nanomaterial systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx59we0hNm3rVg90H21EOLACvtfcHk0liVQOtBq_w9LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKnsLbO&md5=cf049fe11e91a1ea45a72174a32e0100</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC7CS00195A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CS00195A%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DGupta%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%2BS.%26atitle%3DThe%2520development%2520of%2520anticancer%2520ruthenium%2528II%2529%2520complexes%253A%2520from%2520single%2520molecule%2520compounds%2520to%2520nanomaterials%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2017%26volume%3D46%26spage%3D5771%26epage%3D5804%26doi%3D10.1039%2FC7CS00195A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smithen, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beh, M. H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hetu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and photobiological activity of Ru(II) dyads derived from pyrrole-2-carboxylate thionoesters</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4121</span>– <span class="NLM_lpage">4132</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.7b00072</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.7b00072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktlSrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=4121-4132&author=D.+A.+Smithenauthor=H.+Yinauthor=M.+H.+R.+Behauthor=M.+Hetuauthor=T.+S.+Cameronauthor=S.+A.+McFarlandauthor=A.+Thompson&title=Synthesis+and+photobiological+activity+of+Ru%28II%29+dyads+derived+from+pyrrole-2-carboxylate+thionoesters&doi=10.1021%2Facs.inorgchem.7b00072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Photobiological Activity of Ru(II) Dyads Derived from Pyrrole-2-carboxylate Thionoesters</span></div><div class="casAuthors">Smithen, Deborah A.; Yin, Huimin; Beh, Michael H. R.; Hetu, Marc; Cameron, T. Stanley; McFarland, Sherri A.; Thompson, Alison</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4121-4132</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and characterization of a series of heteroleptic ruthenium(II) dyads derived from pyrrole-2-carboxylate thionoesters are reported.  Ligands bearing a conjugated thiocarbonyl group were found to be more reactive toward Ru(II) complexation compared to analogous all-oxygen pyrrole-2-carboxylate esters, and salient features of the resulting complexes were detd. using X-ray crystallog., electronic absorption, and NMR spectroscopy.  Selected complexes were evaluated for their potential in photobiol. applications, whereupon all compds. demonstrated in vitro photodynamic therapy effects in HL-60 and SK-MEL-28 cells, with low nanomolar activities obsd., and exhibited some of the largest photocytotoxicity indexes to date (>2000).  Importantly, the Ru(II) dyads could be activated by relatively soft doses of visible (100 J cm-2, 29 mW cm-2) or red light (100 J cm-2, 34 mW cm-2), which is compatible with therapeutic applications.  Some compds. even demonstrated up to five-fold selectivity for malignant cells over noncancerous cells.  These complexes were also shown to photocleave, and in some cases unwind, DNA in cell-free expts.  Thus, this new class of Ru(II) dyads has the capacity to interact with and damage biol. macromols. in the cell, making them attractive agents for photodynamic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrOFJOOcOh37Vg90H21EOLACvtfcHk0ljIzhKBUokN8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktlSrtr0%253D&md5=fd9e243cb8b28e7345c86a59738f5218</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.7b00072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.7b00072%26sid%3Dliteratum%253Aachs%26aulast%3DSmithen%26aufirst%3DD.%2BA.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DBeh%26aufirst%3DM.%2BH.%2BR.%26aulast%3DHetu%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DT.%2BS.%26aulast%3DMcFarland%26aufirst%3DS.%2BA.%26aulast%3DThompson%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520photobiological%2520activity%2520of%2520Ru%2528II%2529%2520dyads%2520derived%2520from%2520pyrrole-2-carboxylate%2520thionoesters%26jtitle%3DInorg.%2520Chem.%26date%3D2017%26volume%3D56%26spage%3D4121%26epage%3D4132%26doi%3D10.1021%2Facs.inorgchem.7b00072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span> <span> </span><span class="NLM_article-title">Ruthenium(II) complexes with 2-phenylimidazo[4,5-f][1,10]phenanthroline derivatives that strongly combat cisplatin-resistant tumor cells</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">19449</span>, <span class="refDoi"> DOI: 10.1038/srep19449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2Fsrep19449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=26763798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos1KjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=19449&author=L.+Zengauthor=Y.+Chenauthor=J.+Liuauthor=H.+Huangauthor=R.+Guanauthor=L.+Jiauthor=H.+Chao&title=Ruthenium%28II%29+complexes+with+2-phenylimidazo%5B4%2C5-f%5D%5B1%2C10%5Dphenanthroline+derivatives+that+strongly+combat+cisplatin-resistant+tumor+cells&doi=10.1038%2Fsrep19449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells</span></div><div class="casAuthors">Zeng, Leli; Chen, Yu; Liu, Jiangping; Huang, Huaiyi; Guan, Ruilin; Ji, Liangnian; Chao, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19449</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cisplatin was the first metal-based therapeutic agent approved for the treatment of human cancers, but its clin. activity is greatly limited by tumor drug resistance.  This work utilized the parent complex [Ru(phen)2(PIP)]2+ (1) to develop three Ru(II) complexes (2-4) with different positional modifications.  These compds. exhibited similar or superior cytotoxicities compared to cisplatin in HeLa, A549 and multidrug-resistant (A549R) tumor cell lines.  Complex 4, the most potent member of the series, was highly active against A549R cancer cells (IC50 = 0.8 μM).  This complex exhibited 178-fold better activity than cisplatin (IC50 = 142.5 μM) in A549R cells. 3D multicellular A549R tumor spheroids were also used to confirm the high proliferative and cytotoxic activity of complex 4.  Complex 4 had the greatest cellular uptake and had a tendency to accumulate in the mitochondria of A549R cells.  Further mechanistic studies showed that complex 4 induced A549R cell apoptosis via inhibition of thioredoxin reductase (TrxR), elevated intracellular ROS levels, mitochondrial dysfunction and cell cycle arrest, making it an outstanding candidate for overcoming cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0cJQ9w19R5rVg90H21EOLACvtfcHk0ljIzhKBUokN8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos1KjtA%253D%253D&md5=c0c5b682ec6408dfaf3a8dd630e858d9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fsrep19449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep19449%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DGuan%26aufirst%3DR.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26atitle%3DRuthenium%2528II%2529%2520complexes%2520with%25202-phenylimidazo%255B4%252C5-f%255D%255B1%252C10%255Dphenanthroline%2520derivatives%2520that%2520strongly%2520combat%2520cisplatin-resistant%2520tumor%2520cells%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D19449%26doi%3D10.1038%2Fsrep19449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karki, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darj, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span> <span> </span><span class="NLM_article-title">Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6632</span>– <span class="NLM_lpage">6641</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.bmc.2007.08.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=6632-6641&author=S.+S.+Karkiauthor=S.+Thotaauthor=S.+Y.+Darjauthor=J.+Balzariniauthor=E.+De+Clercq&title=Synthesis%2C+anticancer%2C+and+cytotoxic+activities+of+some+mononuclear+Ru%28II%29+compounds&doi=10.1016%2Fj.bmc.2007.08.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DKarki%26aufirst%3DS.%2BS.%26aulast%3DThota%26aufirst%3DS.%26aulast%3DDarj%26aufirst%3DS.%2BY.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DSynthesis%252C%2520anticancer%252C%2520and%2520cytotoxic%2520activities%2520of%2520some%2520mononuclear%2520Ru%2528II%2529%2520compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D6632%26epage%3D6641%26doi%3D10.1016%2Fj.bmc.2007.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clavel, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paunescu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak-Sliwinska, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffioen, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scopelliti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">Modulating the anticancer activity of ruthenium(II)-arene complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3356</span>– <span class="NLM_lpage">3365</span>, <span class="refDoi"> DOI: 10.1021/jm501655t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501655t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVGlt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3356-3365&author=C.+M.+Clavelauthor=E.+Paunescuauthor=P.+Nowak-Sliwinskaauthor=A.+W.+Griffioenauthor=R.+Scopellitiauthor=P.+J.+Dyson&title=Modulating+the+anticancer+activity+of+ruthenium%28II%29-arene+complexes&doi=10.1021%2Fjm501655t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating the Anticancer Activity of Ruthenium(II)-Arene Complexes</span></div><div class="casAuthors">Clavel, Catherine M.; Paunescu, Emilia; Nowak-Sliwinska, Patrycja; Griffioen, Arjan W.; Scopelliti, Rosario; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3356-3365</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Following the identification of [Ru(η6-p-cymene)Cl2(1H,1H,2H,2H-perfluorodecyl-3-(pyridin-3-yl)propanoate)], a ruthenium(II)-arene complex with a perfluoroalkyl-modified ligand that displays remarkable in vitro cancer cell selectivity, a series of structurally related compds. were designed.  In the new derivs., the p-cymene ring and/or the chloride ligands are substituted by other ligands to modulate the steric bulk or aquation kinetics.  The new compds. were evaluated in both in vitro (cytotoxicity and migration assays) and in vivo (chicken chorioallantoic membrane) models and were found to exhibit potent antivascular effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopQSD3OVYw87Vg90H21EOLACvtfcHk0ljIzhKBUokN8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVGlt70%253D&md5=11855e1f34a759a94a4d6ce6b4bf20e2</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm501655t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501655t%26sid%3Dliteratum%253Aachs%26aulast%3DClavel%26aufirst%3DC.%2BM.%26aulast%3DPaunescu%26aufirst%3DE.%26aulast%3DNowak-Sliwinska%26aufirst%3DP.%26aulast%3DGriffioen%26aufirst%3DA.%2BW.%26aulast%3DScopelliti%26aufirst%3DR.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DModulating%2520the%2520anticancer%2520activity%2520of%2520ruthenium%2528II%2529-arene%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3356%26epage%3D3365%26doi%3D10.1021%2Fjm501655t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggers, E.</span></span> <span> </span><span class="NLM_article-title">Ruthenium complexes as protein kinase inhibitors</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">523</span>, <span class="refDoi"> DOI: 10.1021/ol036283s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol036283s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=521-523&author=L.+Zhangauthor=P.+Carrollauthor=E.+Meggers&title=Ruthenium+complexes+as+protein+kinase+inhibitors&doi=10.1021%2Fol036283s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fol036283s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol036283s%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DCarroll%26aufirst%3DP.%26aulast%3DMeggers%26aufirst%3DE.%26atitle%3DRuthenium%2520complexes%2520as%2520protein%2520kinase%2520inhibitors%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D521%26epage%3D523%26doi%3D10.1021%2Fol036283s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berndsen, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdul, U. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meraldi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffioen, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak-Sliwinska, P.</span></span> <span> </span><span class="NLM_article-title">Combination of ruthenium(II)-arene complex [Ru(η<sup>6</sup>-p-cymene)Cl<sub>2</sub>(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">43005</span>, <span class="refDoi"> DOI: 10.1038/srep43005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2Fsrep43005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28223694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtlymsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=43005&author=R.+H.+Berndsenauthor=A.+Weissauthor=U.+K.+Abdulauthor=T.+J.+Wongauthor=P.+Meraldiauthor=A.+W.+Griffioenauthor=P.+J.+Dysonauthor=P.+Nowak-Sliwinska&title=Combination+of+ruthenium%28II%29-arene+complex+%5BRu%28%CE%B76-p-cymene%29Cl2%28pta%29%5D+%28RAPTA-C%29+and+the+epidermal+growth+factor+receptor+inhibitor+erlotinib+results+in+efficient+angiostatic+and+antitumor+activity&doi=10.1038%2Fsrep43005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity</span></div><div class="casAuthors">Berndsen, Robert H.; Weiss, Andrea; Abdul, U. Kulsoom; Wong, Tse J.; Meraldi, Patrick; Griffioen, Arjan W.; Dyson, Paul J.; Nowak-Sliwinska, Patrycja</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">43005</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ruthenium-based compds. show strong potential as anti-cancer drugs and are being investigated as alternatives to other well-established metal-based chemotherapeutics.  The organometallic compd. [Ru(η6-p-cymene)Cl2(pta)], where pta = 1,3,5-triaza-7-phosphaadamantane (RAPTA-C) exhibits broad acting anti-tumor efficacy with intrinsic angiostatic activity.  In the search for an optimal anti-angiogenesis drug combination, we identified synergistic potential between RAPTA-C and the epidermal growth factor receptor (EGFR) inhibitor, erlotinib.  This drug combination results in strong synergistic inhibition of cell viability in human endothelial (ECRF24 and HUVEC) and human ovarian carcinoma (A2780 and A2780cisR) cells.  Addnl., erlotinib significantly enhances the cellular uptake of RAPTA-C relative to treatment with RAPTA-C alone in human ovarian carcinoma cells, but not endothelial cells.  Drug combinations induce the formation of chromosome bridges that persist after mitotic exit and delay abscission in A2780 and A2780cisR, therefore suggesting initiation of cellular senescence.  The therapeutic potential of these compds. and their combination is further validated in vivo on A2780 tumors grown on the chicken chorioallantoic membrane (CAM) model, and in a preclin. model in nude mice.  Immunohistochem. anal. confirms effective anti-angiogenic and anti-proliferative activity in vivo, based on a significant redn. of microvascular d. and a decrease in proliferating cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsjQY3MJOumrVg90H21EOLACvtfcHk0lhLzXhDB__b_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtlymsL0%253D&md5=084b991abae2f10059deead249e3e6d9</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fsrep43005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep43005%26sid%3Dliteratum%253Aachs%26aulast%3DBerndsen%26aufirst%3DR.%2BH.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DAbdul%26aufirst%3DU.%2BK.%26aulast%3DWong%26aufirst%3DT.%2BJ.%26aulast%3DMeraldi%26aufirst%3DP.%26aulast%3DGriffioen%26aufirst%3DA.%2BW.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DNowak-Sliwinska%26aufirst%3DP.%26atitle%3DCombination%2520of%2520ruthenium%2528II%2529-arene%2520complex%2520%255BRu%2528%25CE%25B76-p-cymene%2529Cl2%2528pta%2529%255D%2520%2528RAPTA-C%2529%2520and%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitor%2520erlotinib%2520results%2520in%2520efficient%2520angiostatic%2520and%2520antitumor%2520activity%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D43005%26doi%3D10.1038%2Fsrep43005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span>; <span class="NLM_string-name">Lainez, R. F.</span>; <span class="NLM_string-name">Abraba, H.</span>; <span class="NLM_string-name">Michael, M.</span>; <span class="NLM_string-name">Duncan, J. M.</span></span> <span> </span><span class="NLM_article-title">Ruthenium Anticancer Complexes</span>. U.S. Patent <span class="NLM_patent">20060058270A1</span>, Mar 16, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=P.+J.+Sadler&author=R.+F.+Lainez&author=H.+Abraba&author=M.+Michael&author=J.+M.+Duncan&title=Ruthenium+Anticancer+Complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DRuthenium%2520Anticancer%2520Complexes%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wenjie, M.</span></span> <span> </span><span class="NLM_article-title">Chair Ruthenium Complexes and Their Use as Anticancer Agents</span>. U.S. Patent <span class="NLM_patent">8357678B2</span>, Jan 22, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+Wenjie&title=Chair+Ruthenium+Complexes+and+Their+Use+as+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWenjie%26aufirst%3DM.%26atitle%3DChair%2520Ruthenium%2520Complexes%2520and%2520Their%2520Use%2520as%2520Anticancer%2520Agents%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mestroni, G.</span>; <span class="NLM_string-name">Alessio, E.</span>; <span class="NLM_string-name">Sava, G.</span></span> <span> </span><span class="NLM_article-title">New Salts of Anionic Complexes of Ru(III) as Antimetastatic and Antineoplastic Agents</span>. WO Patent <span class="NLM_patent">1998000431A1</span>, Jan 8, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=G.+Mestroni&author=E.+Alessio&author=G.+Sava&title=New+Salts+of+Anionic+Complexes+of+Ru%28III%29+as+Antimetastatic+and+Antineoplastic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMestroni%26aufirst%3DG.%26atitle%3DNew%2520Salts%2520of%2520Anionic%2520Complexes%2520of%2520Ru%2528III%2529%2520as%2520Antimetastatic%2520and%2520Antineoplastic%2520Agents%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gamble, A. J.</span>; <span class="NLM_string-name">Lynam, J. M.</span>; <span class="NLM_string-name">Walton, P. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Anticancer activity of Ruthenium(II) <i>cis</i>-<i>cis</i>-1,3,5-Triaminocyclohexane Complexes</span>. WO Patent <span class="NLM_patent">2013038134A1</span>, Mar 21, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+J.+Gamble&author=J.+M.+Lynam&author=P.+H.+Walton&title=Synthesis+and+Anticancer+activity+of+Ruthenium%28II%29+cis-cis-1%2C3%2C5-Triaminocyclohexane+Complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGamble%26aufirst%3DA.%2BJ.%26atitle%3DSynthesis%2520and%2520Anticancer%2520activity%2520of%2520Ruthenium%2528II%2529%2520cis-cis-1%252C3%252C5-Triaminocyclohexane%2520Complexes%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. E.</span>; <span class="NLM_string-name">Sadler, P. J.</span>; <span class="NLM_string-name">Chen, H.</span>; <span class="NLM_string-name">Jodrell, D.</span></span> <span> </span><span class="NLM_article-title">Half-Sandwich Ruthenium(II) Compounds Comprising Nitrogen Containing Ligands for Treatment of Cancer</span>. U.S. Patent <span class="NLM_patent">20050239765A1</span>, Dec 27, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+E.+Morris&author=P.+J.+Sadler&author=H.+Chen&author=D.+Jodrell&title=Half-Sandwich+Ruthenium%28II%29+Compounds+Comprising+Nitrogen+Containing+Ligands+for+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DR.%2BE.%26atitle%3DHalf-Sandwich%2520Ruthenium%2528II%2529%2520Compounds%2520Comprising%2520Nitrogen%2520Containing%2520Ligands%2520for%2520Treatment%2520of%2520Cancer%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. E.</span>; <span class="NLM_string-name">Sadler, P. J.</span>; <span class="NLM_string-name">Jodrell, D.</span>; <span class="NLM_string-name">Chen, H.</span></span> <span> </span><span class="NLM_article-title">Ruthenium(II) Compounds for Use in the Therapy of Cancer</span>. U.S. Patent <span class="NLM_patent">6936634B2</span>, Aug 30, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+E.+Morris&author=P.+J.+Sadler&author=D.+Jodrell&author=H.+Chen&title=Ruthenium%28II%29+Compounds+for+Use+in+the+Therapy+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DR.%2BE.%26atitle%3DRuthenium%2528II%2529%2520Compounds%2520for%2520Use%2520in%2520the%2520Therapy%2520of%2520Cancer%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">Medicament Preparations Containing Tumour-Inhibiting Ruthenium(III) Complexes</span>. WO Patent <span class="NLM_patent">1997036595A3</span>, Nov 6, <span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=B.+K.+Keppler&title=Medicament+Preparations+Containing+Tumour-Inhibiting+Ruthenium%28III%29+Complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DMedicament%2520Preparations%2520Containing%2520Tumour-Inhibiting%2520Ruthenium%2528III%2529%2520Complexes%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mestroni, G.</span>; <span class="NLM_string-name">Alessio, E.</span>; <span class="NLM_string-name">Sava, G.</span>; <span class="NLM_string-name">Lengo, E.</span>; <span class="NLM_string-name">Zorzet, S.</span>; <span class="NLM_string-name">Bergamo, A.</span></span> <span> </span><span class="NLM_article-title">Ruthenium Dimeric Compounds Suitable as Antimetastatic and Antineoplastic Agents</span>. U.S. Patent <span class="NLM_patent">US6921824B1</span>, Jul 26, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=G.+Mestroni&author=E.+Alessio&author=G.+Sava&author=E.+Lengo&author=S.+Zorzet&author=A.+Bergamo&title=Ruthenium+Dimeric+Compounds+Suitable+as+Antimetastatic+and+Antineoplastic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMestroni%26aufirst%3DG.%26atitle%3DRuthenium%2520Dimeric%2520Compounds%2520Suitable%2520as%2520Antimetastatic%2520and%2520Antineoplastic%2520Agents%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aird, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Socorro Murdoch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jodrell, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cancer cell growth by ruthenium(II) arene complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3616</span>– <span class="NLM_lpage">3621</span>, <span class="refDoi"> DOI: 10.1021/jm010051m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010051m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntF2hsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3616-3621&author=R.+E.+Morrisauthor=R.+E.+Airdauthor=P.+del+Socorro+Murdochauthor=H.+Chenauthor=J.+Cummingsauthor=N.+D.+Hughesauthor=S.+Parsonsauthor=A.+Parkinauthor=G.+Boydauthor=D.+I.+Jodrellauthor=P.+J.+Sadler&title=Inhibition+of+cancer+cell+growth+by+ruthenium%28II%29+arene+complexes&doi=10.1021%2Fjm010051m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Cancer Cell Growth by Ruthenium(II) Arene Complexes</span></div><div class="casAuthors">Morris, Robert E.; Aird, Rhona E.; Murdoch, Piedad del Socorro; Chen, Haimei; Cummings, Jeff; Hughes, Nathan D.; Parsons, Simon; Parkin, Andrew; Boyd, Gary; Jodrell, Duncan I.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3616-3621</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of the growth of the human ovarian cancer cell line A2780 by organometallic ruthenium(II) complexes of the type [(η6-arene)Ru(X)(Y)(Z)], where arene is benzene or substituted benzene, X, Y, and Z are halide, acetonitrile, or isonicotinamide, or X,Y is ethylenediamine (en) or N-ethylethylenediamine, has been investigated.  The x-ray crystal structures of the complexes [(η6-p-cymene)Ru(en)Cl]PF6 (I), [(η6-p-cymene)RuCl2(isonicotinamide)], and [(η6-biphenyl)Ru(en)Cl]PF6 are reported.  They have "piano stool" geometries with η6 coordination of the arene ligand.  Complexes with X,Y as a chelated en ligand and Z as a monofunctional leaving group had the highest activity.  Some complexes were as active as carboplatin.  Hydrolysis of the reactive Ru-Cl bond in I was detected by HPLC but was suppressed by the addn. of chloride ions.  I binds strongly and selectively to G bases on DNA oligonucleotides to form monofunctional adducts.  No inhibition of topoisomerase I or II by complex I was detected.  These chelated Ru(II) arene complexes have potential as novel metal-based anticancer agents with a mechanism of action different from that of the Ru(III) complex currently on clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL0wRcF1CDQrVg90H21EOLACvtfcHk0lgpDbjdjHEotg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntF2hsrw%253D&md5=339b3602c2dea640f0e27ee8126d14fc</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm010051m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010051m%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DR.%2BE.%26aulast%3DAird%26aufirst%3DR.%2BE.%26aulast%3Ddel%2BSocorro%2BMurdoch%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DCummings%26aufirst%3DJ.%26aulast%3DHughes%26aufirst%3DN.%2BD.%26aulast%3DParsons%26aufirst%3DS.%26aulast%3DParkin%26aufirst%3DA.%26aulast%3DBoyd%26aufirst%3DG.%26aulast%3DJodrell%26aufirst%3DD.%2BI.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DInhibition%2520of%2520cancer%2520cell%2520growth%2520by%2520ruthenium%2528II%2529%2520arene%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3616%26epage%3D3621%26doi%3D10.1021%2Fjm010051m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adhireksan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campomanes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clavel, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nazarov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Droge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothlisberger, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, C. A.</span></span> <span> </span><span class="NLM_article-title">Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3462</span>, <span class="refDoi"> DOI: 10.1038/ncomms4462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2Fncomms4462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=24637564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A280%3ADC%252BC2crks1Siug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=3462&author=Z.+Adhireksanauthor=G.+E.+Daveyauthor=P.+Campomanesauthor=M.+Groesslauthor=C.+M.+Clavelauthor=H.+Yuauthor=A.+A.+Nazarovauthor=C.+H.+Yeoauthor=W.+H.+Angauthor=P.+Drogeauthor=U.+Rothlisbergerauthor=P.+J.+Dysonauthor=C.+A.+Davey&title=Ligand+substitutions+between+ruthenium-cymene+compounds+can+control+protein+versus+DNA+targeting+and+anticancer+activity&doi=10.1038%2Fncomms4462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity</span></div><div class="casAuthors">Adhireksan Zenita; Davey Gabriela E; Campomanes Pablo; Groessl Michael; Clavel Catherine M; Rothlisberger Ursula; Dyson Paul J; Yu Haojie; Droge Peter; Nazarov Alexey A; Yeo Charmian Hui Fang; Ang Wee Han; Davey Curt A</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3462</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ruthenium compounds have become promising alternatives to platinum drugs by displaying specific activities against different cancers and favourable toxicity and clearance properties.  Nonetheless, their molecular targeting and mechanism of action are poorly understood.  Here we study two prototypical ruthenium-arene agents-the cytotoxic antiprimary tumour compound [(η(6)-p-cymene)Ru(ethylene-diamine)Cl]PF6 and the relatively non-cytotoxic antimetastasis compound [(η(6)-p-cymene)Ru(1,3,5-triaza-7-phosphaadamantane)Cl2]-and discover that the former targets the DNA of chromatin, while the latter preferentially forms adducts on the histone proteins.  Using a novel 'atom-to-cell' approach, we establish the basis for the surprisingly site-selective adduct formation behaviour and distinct cellular impact of these two chemically similar anticancer agents, which suggests that the cytotoxic effects arise largely from DNA lesions, whereas the protein adducts may be linked to the other therapeutic activities.  Our study shows promise for developing new ruthenium drugs, via ligand-based modulation of DNA versus protein binding and thus cytotoxic potential, to target distinguishing epigenetic features of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTZqBhtNtqH3iA3UY9EwTNrfW6udTcc2ebyRlLcGjhz57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crks1Siug%253D%253D&md5=1503acd1c2fee807c904004015956975</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fncomms4462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4462%26sid%3Dliteratum%253Aachs%26aulast%3DAdhireksan%26aufirst%3DZ.%26aulast%3DDavey%26aufirst%3DG.%2BE.%26aulast%3DCampomanes%26aufirst%3DP.%26aulast%3DGroessl%26aufirst%3DM.%26aulast%3DClavel%26aufirst%3DC.%2BM.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DNazarov%26aufirst%3DA.%2BA.%26aulast%3DYeo%26aufirst%3DC.%2BH.%26aulast%3DAng%26aufirst%3DW.%2BH.%26aulast%3DDroge%26aufirst%3DP.%26aulast%3DRothlisberger%26aufirst%3DU.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DDavey%26aufirst%3DC.%2BA.%26atitle%3DLigand%2520substitutions%2520between%2520ruthenium-cymene%2520compounds%2520can%2520control%2520protein%2520versus%2520DNA%2520targeting%2520and%2520anticancer%2520activity%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D3462%26doi%3D10.1038%2Fncomms4462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schornagel, Q. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tente, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macpherson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aird, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jodrell, D. I.</span></span> <span> </span><span class="NLM_article-title">Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">577</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1007/s00280-004-0932-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1007%2Fs00280-004-0932-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=15726367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslOmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=577-583&author=R.+L.+Haywardauthor=Q.+C.+Schornagelauthor=R.+Tenteauthor=J.+S.+Macphersonauthor=R.+E.+Airdauthor=S.+Guichardauthor=A.+Habtemariamauthor=P.+Sadlerauthor=D.+I.+Jodrell&title=Investigation+of+the+role+of+Bax%2C+p21%2FWaf1+and+p53+as+determinants+of+cellular+responses+in+HCT116+colorectal+cancer+cells+exposed+to+the+novel+cytotoxic+ruthenium%28II%29+organometallic+agent%2C+RM175&doi=10.1007%2Fs00280-004-0932-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175</span></div><div class="casAuthors">Hayward, R. L.; Schornagel, Q. C.; Tente, R.; Macpherson, J. S.; Aird, R. E.; Guichard, S.; Habtemariam, A.; Sadler, P.; Jodrell, D. I.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">577-583</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Ruthenium(II) organometallic complexes form monofunctional adducts with guanine in DNA in vitro and have a cytotoxic anticancer activity spectrum in preclin. models suggesting lack of cross-resistance with cisplatin.  The primary cytotoxic lesion remains to be identified but the downstream mechanism of action is nevertheless of interest.  Using isogenic derivs. of the HCT116 colorectal cancer cell line, we investigated the role of p53, p21/WAF1 and Bax in the cellular response to the novel ruthenium(II) organometallic complex RM175, [(η6-C6H5C6H5)RuCl (H2NCH2CH2NH2-N,N')]+ PF-6.  Western blotting demonstrated dose-dependent accumulation of p53, Bax and p21/WAF1 within 48 h of the start of RM175 treatment in wild-type HCT116 cells.  HCT116 wild-type and Bax-null cells arrested in the G1 and G2 phases of the cell cycle.  This pattern of cell cycle arrest was not obsd. in p53-null or in p21/WAF1-null cells.  Following RM175 treatment, HCT116 wild-type and p21/WAF1 null cells underwent a dose-dependent induction of apoptosis (Annexin-V and sub-G1 apoptosis assays).  This apoptotic response was not obsd. in p53-null or Bax-null cells.  In short-term sulforhodamine B assays, the IC50 for RM175 was 16 μM for p53-null HCT116, and 8 μM for wild-type cells (P<0.05).  However, the sensitivity to RM175 in clonogenic assays at 16 days was independent of p53 status.  These results identify determinants of the short-term in vitro response to RM175 demonstrating a role for p53 and p21/WAF1 in the growth arrest and for p53 and Bax in the apoptotic response.  The mechanism of p53-independent suppression of long-term clonogenicity remains to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkxwFbHtVeAbVg90H21EOLACvtfcHk0liWjzaHJq9FFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslOmt7k%253D&md5=9f6b5b0f96393a1bf903b5ef058fa010</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fs00280-004-0932-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-004-0932-9%26sid%3Dliteratum%253Aachs%26aulast%3DHayward%26aufirst%3DR.%2BL.%26aulast%3DSchornagel%26aufirst%3DQ.%2BC.%26aulast%3DTente%26aufirst%3DR.%26aulast%3DMacpherson%26aufirst%3DJ.%2BS.%26aulast%3DAird%26aufirst%3DR.%2BE.%26aulast%3DGuichard%26aufirst%3DS.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DSadler%26aufirst%3DP.%26aulast%3DJodrell%26aufirst%3DD.%2BI.%26atitle%3DInvestigation%2520of%2520the%2520role%2520of%2520Bax%252C%2520p21%252FWaf1%2520and%2520p53%2520as%2520determinants%2520of%2520cellular%2520responses%2520in%2520HCT116%2520colorectal%2520cancer%2520cells%2520exposed%2520to%2520the%2520novel%2520cytotoxic%2520ruthenium%2528II%2529%2520organometallic%2520agent%252C%2520RM175%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2005%26volume%3D55%26spage%3D577%26epage%3D583%26doi%3D10.1007%2Fs00280-004-0932-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyva, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenny, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benosman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fricker, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harlepp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hébraud, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wlosik, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirlin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeffer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeffler, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaiddon, C.</span></span> <span> </span><span class="NLM_article-title">A ruthenium-containing organometallic compound reduces tumor growth through induction of the endoplasmic reticulum stress gene CHOP</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">5458</span>– <span class="NLM_lpage">5466</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-4408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1158%2F0008-5472.CAN-08-4408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=19549908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvFajsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=5458-5466&author=X.+Mengauthor=M.+L.+Leyvaauthor=M.+Jennyauthor=I.+Grossauthor=S.+Benosmanauthor=B.+Frickerauthor=S.+Harleppauthor=P.+H%C3%A9braudauthor=A.+Boosauthor=P.+Wlosikauthor=P.+Bischoffauthor=C.+Sirlinauthor=M.+Pfefferauthor=J.+P.+Loefflerauthor=C.+Gaiddon&title=A+ruthenium-containing+organometallic+compound+reduces+tumor+growth+through+induction+of+the+endoplasmic+reticulum+stress+gene+CHOP&doi=10.1158%2F0008-5472.CAN-08-4408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A Ruthenium-Containing Organometallic Compound Reduces Tumor Growth through Induction of the Endoplasmic Reticulum Stress Gene CHOP</span></div><div class="casAuthors">Meng, Xiangjun; Leyva, Mili L.; Jenny, Marjorie; Gross, Isabelle; Benosman, Samir; Fricker, Bastien; Harlepp, Sebastien; Hebraud, Pascal; Boos, Anne; Wlosik, Pauline; Bischoff, Pierre; Sirlin, Claude; Pfeffer, Michel; Loeffler, Jean-Philippe; Gaiddon, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5458-5466</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cisplatin-derived anticancer therapy has been used for three decades despite its side effects.  Other types of organometallic complexes, namely, some ruthenium-derived compds. (RDC), which would display cytotoxicity through different modes of action, might represent alternative therapeutic agents.  We have studied both in vitro and in vivo the biol. properties of RDC11, one of the most active compds. of a new class of RDCs that contain a covalent bond between the ruthenium atom and a carbon.  We showed that RDC11 inhibited the growth of various tumors implanted in mice more efficiently than cisplatin.  Importantly, in striking contrast with cisplatin, RDC11 did not cause severe side effects on the liver, kidneys, or the neuronal sensory system.  We analyzed the mode of action of RDC11 and showed that RDC11 interacted poorly with DNA and induced only limited DNA damages compared with cisplatin, suggesting alternative transduction pathways.  Indeed, we found that target genes of the endoplasmic reticulum stress pathway, such as Bip, XBP1, PDI, and CHOP, were activated in RDC11-treated cells.  Induction of the transcription factor CHOP, a crucial mediator of endoplasmic reticulum stress apoptosis, was also confirmed in tumors treated with RDC11.  Activation of CHOP led to the expression of several of its target genes, including proapoptotic genes.  In addn., the silencing of CHOP by RNA interference significantly reduced the cytotoxicity of RDC11.  Altogether, our results led us to conclude that RDC11 acts by an atypical pathway involving CHOP and endoplasmic reticulum stress, and thus might provide an interesting alternative for anticancer therapy. [Cancer Res 2009;69(13):5458-66].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnASKwXHM3ubVg90H21EOLACvtfcHk0liWjzaHJq9FFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvFajsrY%253D&md5=f71d72505b4312140eced6453ac59b1d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-4408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-4408%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DLeyva%26aufirst%3DM.%2BL.%26aulast%3DJenny%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DI.%26aulast%3DBenosman%26aufirst%3DS.%26aulast%3DFricker%26aufirst%3DB.%26aulast%3DHarlepp%26aufirst%3DS.%26aulast%3DH%25C3%25A9braud%26aufirst%3DP.%26aulast%3DBoos%26aufirst%3DA.%26aulast%3DWlosik%26aufirst%3DP.%26aulast%3DBischoff%26aufirst%3DP.%26aulast%3DSirlin%26aufirst%3DC.%26aulast%3DPfeffer%26aufirst%3DM.%26aulast%3DLoeffler%26aufirst%3DJ.%2BP.%26aulast%3DGaiddon%26aufirst%3DC.%26atitle%3DA%2520ruthenium-containing%2520organometallic%2520compound%2520reduces%2520tumor%2520growth%2520through%2520induction%2520of%2520the%2520endoplasmic%2520reticulum%2520stress%2520gene%2520CHOP%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D5458%26epage%3D5466%26doi%3D10.1158%2F0008-5472.CAN-08-4408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Debreczeni, J. É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atilla, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggers, E.</span></span> <span> </span><span class="NLM_article-title">Ruthenium half-sandwich complexes bound to protein kinase pim-1</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1580</span>– <span class="NLM_lpage">1585</span>, <span class="refDoi"> DOI: 10.1002/anie.200503468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fanie.200503468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD28XisVahsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=1580-1585&author=J.+%C3%89.+Debreczeniauthor=A.+N.+Bullockauthor=G.+E.+Atillaauthor=D.+S.+Williamsauthor=H.+Bregmanauthor=S.+Knappauthor=E.+Meggers&title=Ruthenium+half-sandwich+complexes+bound+to+protein+kinase+pim-1&doi=10.1002%2Fanie.200503468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium half-sandwich complexes bound to protein kinase pim-1</span></div><div class="casAuthors">Debreczeni, Judit E.; Bullock, Alex N.; Atilla, G. Ekin; Williams, Douglas S.; Bregman, Howard; Knapp, Stefan; Meggers, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1580-1585</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Keeping in shape with half a sandwich: The structure of a picomolar organoruthenium inhibitor bound to the ATP-binding site of the protein kinase Pim-1 demonstrates that the ruthenium center has solely a structural role in organizing the org. ligands in the three-dimensional receptor space, thus yielding a structure that is complementary in shape and functional group presentation to the active site of Pim-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9GY4rvd-xobVg90H21EOLACvtfcHk0liWjzaHJq9FFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisVahsLc%253D&md5=9916f0a06f3248b417f2b1ea622e31e5</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fanie.200503468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200503468%26sid%3Dliteratum%253Aachs%26aulast%3DDebreczeni%26aufirst%3DJ.%2B%25C3%2589.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DAtilla%26aufirst%3DG.%2BE.%26aulast%3DWilliams%26aufirst%3DD.%2BS.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeggers%26aufirst%3DE.%26atitle%3DRuthenium%2520half-sandwich%2520complexes%2520bound%2520to%2520protein%2520kinase%2520pim-1%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D1580%26epage%3D1585%26doi%3D10.1002%2Fanie.200503468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trondl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffeter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowol, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2925</span>– <span class="NLM_lpage">2932</span>, <span class="refDoi"> DOI: 10.1039/C3SC53243G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC3SC53243G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOiurbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=2925-2932&author=R.+Trondlauthor=P.+Heffeterauthor=C.+R.+Kowolauthor=M.+A.+Jakupecauthor=W.+Bergerauthor=B.+K.+Keppler&title=NKP-1339%2C+the+first+ruthenium-based+anticancer+drug+on+the+edge+to+clinical+application&doi=10.1039%2FC3SC53243G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application</span></div><div class="casAuthors">Trondl, Robert; Heffeter, Petra; Kowol, Christian R.; Jakupec, Michael A.; Berger, Walter; Keppler, Bernhard K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2925-2932</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">NKP-1339 is the first-in-class ruthenium-based anticancer drug in clin. development against solid cancer and has recently been studied successfully in a phase I clin. trial.  Ruthenium compds. such as KP1019 (indazolium trans-[tetrachloridobis(1H-indazole)ruthenate(III)]) and NKP-1339 (the sodium salt analog of KP1019, sodium trans-[tetrachloridobis(1H-indazole)ruthenate(III)]) have a high tumor targeting potential based (1) on their strong binding to serum proteins such as albumin and transferrin as well as (2) on their activation in the reductive tumor milieu.  The redox activity of ruthenium compds. is believed to represent one major mode of action leading to disturbance of the cellular redox balance and, consequently, induction of G2/M cell cycle arrest, blockage of DNA synthesis, and induction of apoptosis via the mitochondrial pathway.  Moreover, potent synergistic activities of NKP-1339 with the clin. approved tyrosine kinase inhibitor sorafenib were recently reported in vitro and in vivo.  Taken together, KP1019 and NKP-1339 are promising drug candidates, and esp. the very limited side effects obsd. so far in clin. phase I trials seem to be a major advantage of this class of ruthenium drugs as compared to other chemotherapeutics and targeted anticancer compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEg6EqdpG67rVg90H21EOLACvtfcHk0lhMWoIxXpOTSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOiurbM&md5=6f64a036fee96d03f0f0803b80ff1da7</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1039%2FC3SC53243G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3SC53243G%26sid%3Dliteratum%253Aachs%26aulast%3DTrondl%26aufirst%3DR.%26aulast%3DHeffeter%26aufirst%3DP.%26aulast%3DKowol%26aufirst%3DC.%2BR.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DNKP-1339%252C%2520the%2520first%2520ruthenium-based%2520anticancer%2520drug%2520on%2520the%2520edge%2520to%2520clinical%2520application%26jtitle%3DChem.%2520Sci.%26date%3D2014%26volume%3D5%26spage%3D2925%26epage%3D2932%26doi%3D10.1039%2FC3SC53243G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antonarakis, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emadi, A.</span></span> <span> </span><span class="NLM_article-title">Ruthenium-based chemotherapeutics: are they ready for prime time?</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1007/s00280-010-1293-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1007%2Fs00280-010-1293-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=20213076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkslalt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=1-9&author=E.+S.+Antonarakisauthor=A.+Emadi&title=Ruthenium-based+chemotherapeutics%3A+are+they+ready+for+prime+time%3F&doi=10.1007%2Fs00280-010-1293-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium-based chemotherapeutics: are they ready for prime time?</span></div><div class="casAuthors">Antonarakis, Emmanuel S.; Emadi, Ashkan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Since the discovery of cis-platinum, many transition metal complexes have been synthesized and assayed for antineoplastic activity.  In recent years, ruthenium-based mols. have emerged as promising antitumor and antimetastatic agents with potential uses in platinum-resistant tumors or as alternatives to platinum.  Ruthenium compds. theor. possess unique biochem. features allowing them to accumulate preferentially in neoplastic tissues and to convert to their active state only after entering tumor cells.  Intriguingly, some ruthenium agents show significant activity against cancer metastases but have minimal effects on primary tumors.  Two ruthenium-based drugs, NAMI-A and KP1019, have reached human clin. testing.  This review will highlight the chem. properties, mechanism of action, preclin. data, and early phase clin. results of these two lead ruthenium compds.  Other promising ruthenium agents will also be reviewed with emphasis on the novel ruthenium compd. ONCO4417, and DW1/2 that has demonstrated Pim-1 kinase inhibition in preclin. systems.  Further development of these and other ruthenium agents may rely on novel approaches including rational combination strategies as well as identification of potential pharmacodynamic biomarkers of drug activity aiding early phase clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAaeL0zbqnFLVg90H21EOLACvtfcHk0lhMWoIxXpOTSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkslalt7Y%253D&md5=cb705a7e874eeb25d755a8096e6b2a4e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs00280-010-1293-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-010-1293-1%26sid%3Dliteratum%253Aachs%26aulast%3DAntonarakis%26aufirst%3DE.%2BS.%26aulast%3DEmadi%26aufirst%3DA.%26atitle%3DRuthenium-based%2520chemotherapeutics%253A%2520are%2520they%2520ready%2520for%2520prime%2520time%253F%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2010%26volume%3D66%26spage%3D1%26epage%3D9%26doi%3D10.1007%2Fs00280-010-1293-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharyya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1155</span>, <span class="refDoi"> DOI: 10.1007/s00775-008-0400-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1007%2Fs00775-008-0400-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=18597125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOqsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=1149-1155&author=S.+Chatterjeeauthor=S.+Kunduauthor=A.+Bhattacharyyaauthor=C.+G.+Hartingerauthor=P.+J.+Dyson&title=The+ruthenium%28II%29-arene+compound+RAPTA-C+induces+apoptosis+in+EAC+cells+through+mitochondrial+and+p53-JNK+pathways&doi=10.1007%2Fs00775-008-0400-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways</span></div><div class="casAuthors">Chatterjee, Soumya; Kundu, Subhadip; Bhattacharyya, Arindam; Hartinger, Christian G.; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1149-1155</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">An investigation of the mol. mechanism of the anticancer activity demonstrated by the ruthenium(II)-arene compd. [Ru(η6-p-cymene)Cl2(pta)] (pta is 1,3,5-triaza-7-phosphaadamantane), termed "RAPTA-C", in Ehrlich ascites carcinoma (EAC) bearing mice is described.  RAPTA-C exhibits effective cell growth inhibition by triggering G2/M phase arrest and apoptosis in cancer cells.  Cell cycle arrest is assocd. with increased levels of p21 and reduced amts. of cyclin E. RAPTA-C treatment also enhances the levels of p53, and its treatment triggers the mitochondrial apoptotic pathway, as shown by the change in Bax to Bcl-2 ratios, resulting in cytochrome c release and caspase-9 activation. c-Jun NH2-terminal kinase (JNK) is a crit. mediator in RAPTA-C-induced cell growth inhibition.  Activation of JNK by RAPTA-C increases significantly during apoptosis.  Overall, these results suggest a crit. role for JNK and p53 in RAPTA-C-induced G2/M arrest and apoptosis of EAC-bearing mice.  Consequently, RAPTA-C treatment results in a significant inhibition in the progression of cancer in an animal model, which emulates the human disease, and does so with remarkably low general toxicity; hence, RAPTA-C has potential for clin. application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlcpDD8dE6LrVg90H21EOLACvtfcHk0lhMWoIxXpOTSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOqsLrE&md5=d8b5160a2ee5392e721372ed97aea709</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2Fs00775-008-0400-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-008-0400-9%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DKundu%26aufirst%3DS.%26aulast%3DBhattacharyya%26aufirst%3DA.%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520ruthenium%2528II%2529-arene%2520compound%2520RAPTA-C%2520induces%2520apoptosis%2520in%2520EAC%2520cells%2520through%2520mitochondrial%2520and%2520p53-JNK%2520pathways%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2008%26volume%3D13%26spage%3D1149%26epage%3D1155%26doi%3D10.1007%2Fs00775-008-0400-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escrig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maclachlan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knott, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meibom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sava, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">The differential distribution of RAPTA-T in non-invasive and invasive breast cancer cells correlates with its anti-invasive and anti-metastatic effects</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1869</span>, <span class="refDoi"> DOI: 10.3390/ijms18091869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.3390%2Fijms18091869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVOls77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=1869&author=R.+F.+S.+Leeauthor=S.+Escrigauthor=C.+Maclachlanauthor=G.+W.+Knottauthor=A.+Meibomauthor=G.+Savaauthor=P.+J.+Dyson&title=The+differential+distribution+of+RAPTA-T+in+non-invasive+and+invasive+breast+cancer+cells+correlates+with+its+anti-invasive+and+anti-metastatic+effects&doi=10.3390%2Fijms18091869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The differential distribution of rapta-t in non-invasive and invasive breast cancer cells correlates with its anti-invasive and anti-metastatic effects</span></div><div class="casAuthors">Lee, Ronald F. S.; Escrig, Stephane; Maclachlan, Catherine; Knott, Graham W.; Meibom, Anders; Sava, Gianni; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1869/1-1869/8</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Nanoscale secondary ion mass spectrometry (NanoSIMS) combined with transmission electron microscopy (TEM) can be a powerful approach to visualize the exact distribution of drugs at the sub-cellular level.  In this work, we exploit this approach to identify the distribution and localisation of the organometallic ruthenium(II)-arene drug Ru(η6-C6H5Me)(pta)Cl2, termed RAPTA-T, in MDA-MB-231 and MCF-7 human breast cancer cells.  These cell lines have been chosen because the former cell lines are highly invasive and resistant to most chemotherapeutic agents and the latter ones are very sensitive to hormonal-based therapies.  In the MDA-MB-231 cells, RAPTA-T was found to predominantly localise on the cell membrane and to a lesser extent in the nucleolus.  These findings are consistent with the previously reported anti-metastatic properties of RAPTA-T and the observation that once internalized RAPTA-T is assocd. with chromatin.  RAPTA-T shows a lack of membrane accumulation on the non-invasive MCF-7 cells, which correlates well with its selective anti-metastatic properties on invasive cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonW4I_gAONpLVg90H21EOLACvtfcHk0liLmtZGRc1ljQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVOls77E&md5=fd0c6922f8844261181121c9d422f26b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.3390%2Fijms18091869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18091869%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DR.%2BF.%2BS.%26aulast%3DEscrig%26aufirst%3DS.%26aulast%3DMaclachlan%26aufirst%3DC.%26aulast%3DKnott%26aufirst%3DG.%2BW.%26aulast%3DMeibom%26aufirst%3DA.%26aulast%3DSava%26aufirst%3DG.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520differential%2520distribution%2520of%2520RAPTA-T%2520in%2520non-invasive%2520and%2520invasive%2520breast%2520cancer%2520cells%2520correlates%2520with%2520its%2520anti-invasive%2520and%2520anti-metastatic%2520effects%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D1869%26doi%3D10.3390%2Fijms18091869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazmay, G. V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hysi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupidi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettinari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gambini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettinari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iezzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amici, A.</span></span> <span> </span><span class="NLM_article-title">The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5-dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2016.03.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.phrs.2016.03.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=27038531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsF2gsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2016&pages=282-290&author=M.+Montaniauthor=G.+V.+B.+Pazmayauthor=A.+Hysiauthor=G.+Lupidiauthor=R.+Pettinariauthor=V.+Gambiniauthor=M.+Tilioauthor=F.+Marchettiauthor=C.+Pettinariauthor=S.+Ferraroauthor=M.+Iezziauthor=C.+Marchiniauthor=A.+Amici&title=The+water+soluble+ruthenium%28II%29+organometallic+compound+%5BRu%28p-cymene%29%28bis%283%2C5-dimethylpyrazol-1-yl%29methane%29Cl%5DCl+suppresses+triple+negative+breast+cancer+growth+by+inhibiting+tumor+infiltration+of+regulatory+T+cells&doi=10.1016%2Fj.phrs.2016.03.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells</span></div><div class="casAuthors">Montani, Maura; Pazmay, Gretta V. Badillo; Hysi, Albana; Lupidi, Giulio; Pettinari, Riccardo; Gambini, Valentina; Tilio, Martina; Marchetti, Fabio; Pettinari, Claudio; Ferraro, Stefano; Iezzi, Manuela; Marchini, Cristina; Amici, Augusto</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">282-290</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ruthenium compds. have become promising alternatives to platinum drugs by displaying specific activities against different cancers and favorable toxicity and clearance properties.  Here, we show that the ruthenium(II) complex [Ru(p-cymene)(bis(3,5-dimethylpyrazol-1-yl)methane)Cl]Cl (UNICAM-1) exhibits potent in vivo antitumor effects.  When administered as four-dose course, by repeating a single dose (52.4 mg kg-1) every three days, UNICAM-1 significantly reduces the growth of A17 triple neg. breast cancer cells transplanted into FVB syngeneic mice.  Pharmacokinetic studies indicate that UNICAM-1 is rapidly eliminated from kidney, liver and bloodstream thanks to its high hydrosoly., exerting excellent therapeutic activity with minimal side effects.  Immunohistol. anal. revealed that the efficacy of UNICAM-1, mainly relies on its capacity to reverse tumor-assocd. immune suppression by significantly reducing the no. of tumor-infiltrating regulatory T cells.  Therefore, UNICAM-1 appears very promising for the treatment of TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8X8zRDhLxmLVg90H21EOLACvtfcHk0liLmtZGRc1ljQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsF2gsLw%253D&md5=db0df4808aebe14384d1f6454fe103c7</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2016.03.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2016.03.032%26sid%3Dliteratum%253Aachs%26aulast%3DMontani%26aufirst%3DM.%26aulast%3DPazmay%26aufirst%3DG.%2BV.%2BB.%26aulast%3DHysi%26aufirst%3DA.%26aulast%3DLupidi%26aufirst%3DG.%26aulast%3DPettinari%26aufirst%3DR.%26aulast%3DGambini%26aufirst%3DV.%26aulast%3DTilio%26aufirst%3DM.%26aulast%3DMarchetti%26aufirst%3DF.%26aulast%3DPettinari%26aufirst%3DC.%26aulast%3DFerraro%26aufirst%3DS.%26aulast%3DIezzi%26aufirst%3DM.%26aulast%3DMarchini%26aufirst%3DC.%26aulast%3DAmici%26aufirst%3DA.%26atitle%3DThe%2520water%2520soluble%2520ruthenium%2528II%2529%2520organometallic%2520compound%2520%255BRu%2528p-cymene%2529%2528bis%25283%252C5-dimethylpyrazol-1-yl%2529methane%2529Cl%255DCl%2520suppresses%2520triple%2520negative%2520breast%2520cancer%2520growth%2520by%2520inhibiting%2520tumor%2520infiltration%2520of%2520regulatory%2520T%2520cells%26jtitle%3DPharmacol.%2520Res.%26date%3D2016%26volume%3D107%26spage%3D282%26epage%3D290%26doi%3D10.1016%2Fj.phrs.2016.03.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis, visible light photocleavage, antiproliferative and cellular uptake properties of ruthenium complex [Ru(phen)<sub>2</sub> mitatp)]<sup>2+</sup></span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ejmech.2012.07.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=146-154&author=H.+J.+Yuauthor=Y.+Chenauthor=L.+Yuauthor=Z.+F.+Haoauthor=L.+H.+Zhou&title=Synthesis%2C+visible+light+photocleavage%2C+antiproliferative+and+cellular+uptake+properties+of+ruthenium+complex+%5BRu%28phen%292+mitatp%29%5D2%2B&doi=10.1016%2Fj.ejmech.2012.07.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%2BJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DHao%26aufirst%3DZ.%2BF.%26aulast%3DZhou%26aufirst%3DL.%2BH.%26atitle%3DSynthesis%252C%2520visible%2520light%2520photocleavage%252C%2520antiproliferative%2520and%2520cellular%2520uptake%2520properties%2520of%2520ruthenium%2520complex%2520%255BRu%2528phen%25292%2520mitatp%2529%255D2%252B%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D146%26epage%3D154%26doi%3D10.1016%2Fj.ejmech.2012.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puckett, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, J. K.</span></span> <span> </span><span class="NLM_article-title">Methods to explore cellular uptake of ruthenium complexes</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1021/ja0677564</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0677564" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlansbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=46-47&author=C.+A.+Puckettauthor=J.+K.+Barton&title=Methods+to+explore+cellular+uptake+of+ruthenium+complexes&doi=10.1021%2Fja0677564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Methods to Explore Cellular Uptake of Ruthenium Complexes</span></div><div class="casAuthors">Puckett, Cindy A.; Barton, Jacqueline K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-47</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cellular uptake of a series of dipyridophenazine (dppz) complexes of Ru(II) was examd. by flow cytometry.  The complexes, owing to their facile synthesis, stability, and luminescence, provide a route to compare and contrast systematically factors governing cellular entry.  Substituting the ancillary ligands in the dppz complexes of Ru(II) permits variation in the overall complex charge, size, and hydrophobicity.  In HeLa cells, cellular uptake appears to be facilitated by the lipophilic 4,7-diphenyl-1,10-phenanthroline (DIP) ligand.  Despite the large size of Ru(DIP)2dppz2+ (20 Å diam.), this complex is readily transported inside the cell compared to smaller and more hydrophilic complexes, such as Ru(bpy)2dppz2+.  Accumulation in the cellular interior is confirmed by confocal microscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXOSgxuK6E1rVg90H21EOLACvtfcHk0liLmtZGRc1ljQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlansbnK&md5=1d9f94460484aae4080f0eeeb715383c</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fja0677564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0677564%26sid%3Dliteratum%253Aachs%26aulast%3DPuckett%26aufirst%3DC.%2BA.%26aulast%3DBarton%26aufirst%3DJ.%2BK.%26atitle%3DMethods%2520to%2520explore%2520cellular%2520uptake%2520of%2520ruthenium%2520complexes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D46%26epage%3D47%26doi%3D10.1021%2Fja0677564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gill, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. A.</span></span> <span> </span><span class="NLM_article-title">Ruthenium(II) polypyridyl complexes and DNA-from structural probes to cellular imaging and therapeutics</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">3179</span>– <span class="NLM_lpage">3192</span>, <span class="refDoi"> DOI: 10.1039/c2cs15299a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2Fc2cs15299a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=22314926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVOhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2012&pages=3179-3192&author=M.+R.+Gillauthor=J.+A.+Thomas&title=Ruthenium%28II%29+polypyridyl+complexes+and+DNA-from+structural+probes+to+cellular+imaging+and+therapeutics&doi=10.1039%2Fc2cs15299a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium(II) polypyridyl complexes and DNA-from structural probes to cellular imaging and therapeutics</span></div><div class="casAuthors">Gill, Martin R.; Thomas, Jim A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3179-3192</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  In the last few decades, coordination complexes based on d6 metal centers and polypyridyl ligand architectures been developed as structure- and site-specific reversible DNA binding agents.  Due to their attractive photophys. properties, much of this research has focused on complexes based on ruthenium(II) centers and, more recently, attention has turned to the use of these complexes in biol. contexts.  As the rules that govern the cellular uptake and cellular localization of such systems are detd. they are finding numerous applications ranging from imaging to therapeutics.  This review illustrates how the interdisciplinary nature of this research-which takes in synthetic chem., biophys. and in cellulo studies-makes this an exciting area in which an array of further applications are likely to emerge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbQQDjT_D7vrVg90H21EOLACvtfcHk0lhSNAAfnnlWng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVOhtbY%253D&md5=0e99085c63eadb273a7532616e85b8d2</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2Fc2cs15299a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2cs15299a%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DM.%2BR.%26aulast%3DThomas%26aufirst%3DJ.%2BA.%26atitle%3DRuthenium%2528II%2529%2520polypyridyl%2520complexes%2520and%2520DNA-from%2520structural%2520probes%2520to%2520cellular%2520imaging%2520and%2520therapeutics%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2012%26volume%3D41%26spage%3D3179%26epage%3D3192%26doi%3D10.1039%2Fc2cs15299a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puckett, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, J. K.</span></span> <span> </span><span class="NLM_article-title">Mechanism of cellular uptake of a ruthenium polypyridyl complex</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">11711</span>– <span class="NLM_lpage">11716</span>, <span class="refDoi"> DOI: 10.1021/bi800856t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi800856t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CltbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=11711-11716&author=C.+A.+Puckettauthor=J.+K.+Barton&title=Mechanism+of+cellular+uptake+of+a+ruthenium+polypyridyl+complex&doi=10.1021%2Fbi800856t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Cellular Uptake of a Ruthenium Polypyridyl Complex</span></div><div class="casAuthors">Puckett, Cindy A.; Barton, Jacqueline K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">11711-11716</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Transition metal complexes provide a promising avenue for the design of therapeutic and diagnostic agents, but the limited understanding of their cellular uptake is a roadblock to their effective application.  Here, we examine the mechanism of cellular entry of a luminescent ruthenium(II) polypyridyl complex, Ru(DIP)2dppz2+ (where DIP = 4,7-diphenyl-1,10-phenanthroline and dppz = dipyridophenazine), into HeLa cells, with the extent of uptake measured by flow cytometry.  No diminution of cellular uptake is obsd. under metabolic inhibition with deoxyglucose and oligomycin, indicating an energy-independent mode of entry.  The presence of org. cation transporter inhibitors also does not significantly alter uptake.  However, the cellular internalization of Ru(DIP)2dppz2+ is sensitive to the membrane potential.  Uptake decreases when cells are depolarized with high potassium buffer and increases when cells are hyperpolarized with valinomycin.  These results support passive diffusion of Ru(DIP)2dppz2+ into the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobvqylMc3ir7Vg90H21EOLACvtfcHk0lhSNAAfnnlWng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CltbvM&md5=660c5806a6809d5f99da2765c379bbeb</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fbi800856t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi800856t%26sid%3Dliteratum%253Aachs%26aulast%3DPuckett%26aufirst%3DC.%2BA.%26aulast%3DBarton%26aufirst%3DJ.%2BK.%26atitle%3DMechanism%2520of%2520cellular%2520uptake%2520of%2520a%2520ruthenium%2520polypyridyl%2520complex%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D11711%26epage%3D11716%26doi%3D10.1021%2Fbi800856t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schobert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Effenberger-Neidnicht, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underhill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biersack, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, G. L.</span></span> <span> </span><span class="NLM_article-title">(Arene)Cl<sub>2</sub>Ru(II) complexes with N-coordinated estrogen and androgen isonicotinates: interaction with sex hormone binding globulin and anticancer activity</span>. <i>Steroids</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1016/j.steroids.2010.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.steroids.2010.12.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=393-399&author=R.+Schobertauthor=S.+Seibtauthor=K.+Effenberger-Neidnichtauthor=C.+Underhillauthor=B.+Biersackauthor=G.+L.+Hammond&title=%28Arene%29Cl2Ru%28II%29+complexes+with+N-coordinated+estrogen+and+androgen+isonicotinates%3A+interaction+with+sex+hormone+binding+globulin+and+anticancer+activity&doi=10.1016%2Fj.steroids.2010.12.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2010.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2010.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DSchobert%26aufirst%3DR.%26aulast%3DSeibt%26aufirst%3DS.%26aulast%3DEffenberger-Neidnicht%26aufirst%3DK.%26aulast%3DUnderhill%26aufirst%3DC.%26aulast%3DBiersack%26aufirst%3DB.%26aulast%3DHammond%26aufirst%3DG.%2BL.%26atitle%3D%2528Arene%2529Cl2Ru%2528II%2529%2520complexes%2520with%2520N-coordinated%2520estrogen%2520and%2520androgen%2520isonicotinates%253A%2520interaction%2520with%2520sex%2520hormone%2520binding%2520globulin%2520and%2520anticancer%2520activity%26jtitle%3DSteroids%26date%3D2011%26volume%3D76%26spage%3D393%26epage%3D399%26doi%3D10.1016%2Fj.steroids.2010.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vock, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scolaro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagopoulos, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juillerat-Jeanneret, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sava, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scopelliti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2166</span>– <span class="NLM_lpage">2175</span>, <span class="refDoi"> DOI: 10.1021/jm070039f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070039f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFCht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2166-2175&author=C.+A.+Vockauthor=W.+H.+Angauthor=C.+Scolaroauthor=A.+D.+Phillipsauthor=L.+Lagopoulosauthor=L.+Juillerat-Jeanneretauthor=G.+Savaauthor=R.+Scopellitiauthor=P.+J.+Dyson&title=Development+of+ruthenium+antitumor+drugs+that+overcome+multidrug+resistance+mechanisms&doi=10.1021%2Fjm070039f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Ruthenium Antitumor Drugs that Overcome Multidrug Resistance Mechanisms</span></div><div class="casAuthors">Vock, Carsten A.; Ang, Wee Han; Scolaro, Claudine; Phillips, Andrew D.; Lagopoulos, Lucienne; Juillerat-Jeanneret, Lucienne; Sava, Gianni; Scopelliti, Rosario; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2166-2175</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Organometallic ruthenium(II) complexes of the general formula [Ru(η6-p-cymene)Cl2(L)] and [Ru(η6-p-cymene)Cl(L)2][BPh4] with modified phenoxazine- and anthracene-based multidrug resistance (MDR) modulator ligands (L) have been synthesized, spectroscopically characterized, and evaluated in vitro for their cytotoxic and MDR reverting properties in comparison with the free ligands.  For an anthracene-based ligand, coordination to a ruthenium(II) arene fragment led to significant improvement of cytotoxicity as well as Pgp inhibition activity.  A similar, but weaker effect was also obsd. when using a benzimidazole-phenoxazine deriv. as Pgp inhibitor.  The most active compd. in terms of both Pgp inhibition and cytotoxicity is [Ru(η6-p-cymene)Cl2(L)] (I), where L is an anthracene-based ligand.  Studies show that it induces cell death via inhibition of DNA synthesis.  Moreover, because the complex is fluorescent, its uptake in cells was studied, and relative to the free anthracene-based ligand, uptake of the complex is accelerated and accumulation of the complex in the cell nucleus is obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonj2cQeVrAErVg90H21EOLACvtfcHk0lhSNAAfnnlWng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFCht78%253D&md5=11320bb404222e0545d307f773b98ea8</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm070039f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070039f%26sid%3Dliteratum%253Aachs%26aulast%3DVock%26aufirst%3DC.%2BA.%26aulast%3DAng%26aufirst%3DW.%2BH.%26aulast%3DScolaro%26aufirst%3DC.%26aulast%3DPhillips%26aufirst%3DA.%2BD.%26aulast%3DLagopoulos%26aufirst%3DL.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DSava%26aufirst%3DG.%26aulast%3DScopelliti%26aufirst%3DR.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DDevelopment%2520of%2520ruthenium%2520antitumor%2520drugs%2520that%2520overcome%2520multidrug%2520resistance%2520mechanisms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2166%26epage%3D2175%26doi%3D10.1021%2Fjm070039f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spoerlein-Guettler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schobert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biersack, B.</span></span> <span> </span><span class="NLM_article-title">Ferrocene and (arene) ruthenium(II) complexes of the natural anticancer naphthoquinone plumbagin with enhanced efficacy against resistant cancer cells and a genuine mode of action</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2014.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jinorgbio.2014.04.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2014&pages=64-72&author=C.+Spoerlein-Guettlerauthor=K.+Mahalauthor=R.+Schobertauthor=B.+Biersack&title=Ferrocene+and+%28arene%29+ruthenium%28II%29+complexes+of+the+natural+anticancer+naphthoquinone+plumbagin+with+enhanced+efficacy+against+resistant+cancer+cells+and+a+genuine+mode+of+action&doi=10.1016%2Fj.jinorgbio.2014.04.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2014.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2014.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DSpoerlein-Guettler%26aufirst%3DC.%26aulast%3DMahal%26aufirst%3DK.%26aulast%3DSchobert%26aufirst%3DR.%26aulast%3DBiersack%26aufirst%3DB.%26atitle%3DFerrocene%2520and%2520%2528arene%2529%2520ruthenium%2528II%2529%2520complexes%2520of%2520the%2520natural%2520anticancer%2520naphthoquinone%2520plumbagin%2520with%2520enhanced%2520efficacy%2520against%2520resistant%2520cancer%2520cells%2520and%2520a%2520genuine%2520mode%2520of%2520action%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2014%26volume%3D138%26spage%3D64%26epage%3D72%26doi%3D10.1016%2Fj.jinorgbio.2014.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yerra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghavendra, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, E. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, DNA binding, DNA cleavage, protein binding and cytotoxic activities of Ru(II) complexes</span>. <i>Int. J. Biol. Macromol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">670</span>, <span class="refDoi"> DOI: 10.1016/j.ijbiomac.2015.09.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ijbiomac.2015.09.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=26424207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2ht7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2016&pages=663-670&author=S.+Thotaauthor=S.+Vallalaauthor=R.+Yerraauthor=D.+A.+Rodriguesauthor=N.+M.+Raghavendraauthor=E.+J.+Barreiro&title=Synthesis%2C+characterization%2C+DNA+binding%2C+DNA+cleavage%2C+protein+binding+and+cytotoxic+activities+of+Ru%28II%29+complexes&doi=10.1016%2Fj.ijbiomac.2015.09.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization, DNA binding, DNA cleavage, protein binding and cytotoxic activities of Ru(II) complexes</span></div><div class="casAuthors">Thota, Sreekanth; Vallala, Srujana; Yerra, Rajeshwar; Rodrigues, Daniel Alencar; Raghavendra, Nulgumnalli Manjunathaiah; Barreiro, Eliezer J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Macromolecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">663-670</span>CODEN:
                <span class="NLM_cas:coden">IJBMDR</span>;
        ISSN:<span class="NLM_cas:issn">0141-8130</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The authors report on the synthesis of novel Ru(II) compds. (Ru-1 to Ru-8: I, II) bearing R-pdc, 4-Cl-pbinh ligands (R = 4-CF3, 4-F, 4-OH pdc = 3-phenyl-5-(1H-pyrrol-2-yl)-4,5-dihydro-1H-pyrazole-1-carbothioamide, pbinh = phenoxybenzylidene isonicotinyl hydrazides) and their in vitro antitumor activity toward the cell lines murine leukemia L1210, human lymphocyte CEM, human epithelial cervical carcinoma HeLa, BEL-<7402≥ and Molt4/C8.  Some of the complexes exhibited more potent antiproliferative activity against cell lines than the std. drug cisplatin.  Ruthenium complex Ru-2 displayed potent cytotoxicity with than that of cisplatin.  DNA-binding, DNA cleavage and protein binding properties of ruthenium complexes with these ligands are reported.  Interactions of these ruthenium complexes with DNA revealed an intercalative mode of binding between them.  Synchronous fluorescence spectra proved that the interaction of ruthenium complexes with bovine serum albumin (BSA) resulted in a conformational change of the latter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4jpirhumv-LVg90H21EOLACvtfcHk0liBl21PEcoXDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2ht7bP&md5=7c78d96612732bde09268868c6d9310a</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.ijbiomac.2015.09.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijbiomac.2015.09.045%26sid%3Dliteratum%253Aachs%26aulast%3DThota%26aufirst%3DS.%26aulast%3DVallala%26aufirst%3DS.%26aulast%3DYerra%26aufirst%3DR.%26aulast%3DRodrigues%26aufirst%3DD.%2BA.%26aulast%3DRaghavendra%26aufirst%3DN.%2BM.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26atitle%3DSynthesis%252C%2520characterization%252C%2520DNA%2520binding%252C%2520DNA%2520cleavage%252C%2520protein%2520binding%2520and%2520cytotoxic%2520activities%2520of%2520Ru%2528II%2529%2520complexes%26jtitle%3DInt.%2520J.%2520Biol.%2520Macromol.%26date%3D2016%26volume%3D82%26spage%3D663%26epage%3D670%26doi%3D10.1016%2Fj.ijbiomac.2015.09.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novakova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vojtiskova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. relationship to cytotoxicity</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2004.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.chembiol.2004.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=15664521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=121-129&author=O.+Novakovaauthor=J.+Kasparkovaauthor=V.+Bursovaauthor=C.+Hofrauthor=M.+Vojtiskovaauthor=H.+Chenauthor=P.+J.+Sadlerauthor=V.+Brabec&title=Conformation+of+DNA+modified+by+monofunctional+Ru%28II%29+arene+complexes%3A+recognition+by+DNA+binding+proteins+and+repair.+relationship+to+cytotoxicity&doi=10.1016%2Fj.chembiol.2004.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Conformation of DNA Modified by Monofunctional Ru(II) Arene Complexes: Recognition by DNA Binding Proteins and Repair. Relationship to Cytotoxicity</span></div><div class="casAuthors">Novakova, Olga; Kasparkova, Jana; Bursova, Vendula; Hofr, Ctirad; Vojtiskova, Marie; Chen, Haimei; Sadler, Peter J.; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-129</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We analyzed DNA duplexes modified at central guanine residues by monofunctional Ru(II) arene complexes [(η6-arene)Ru(II)(en)(Cl)]+ (arene = tetrahydroanthracene or p-cymene, Ru-THA or Ru-CYM, resp.).  These two complexes were chosen as representatives of two different classes of Ru(II) arene compds. for which initial studies revealed different binding modes: one that may involve DNA intercalation (tricyclic-ring Ru-THA) and the other (mono-ring Ru-CYM) that may not.  Ru-THA is ∼20 times more toxic to cancer cells than Ru-CYM.  The adducts of Ru-THA and Ru-CYM have contrasting effects on the conformation, thermodn. stability, and polymn. of DNA in vitro.  In addn., the adducts of Ru-CYM are removed from DNA more efficiently than those of Ru-THA.  Interestingly, the mammalian nucleotide excision repair system has low efficiency for excision of ruthenium adducts compared to cisplatin intra-strand crosslinks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX-yZpZy2brbVg90H21EOLACvtfcHk0liBl21PEcoXDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtlKlsQ%253D%253D&md5=76b8086e0528b503379e2ade2e8d08bb</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DNovakova%26aufirst%3DO.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBursova%26aufirst%3DV.%26aulast%3DHofr%26aufirst%3DC.%26aulast%3DVojtiskova%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DConformation%2520of%2520DNA%2520modified%2520by%2520monofunctional%2520Ru%2528II%2529%2520arene%2520complexes%253A%2520recognition%2520by%2520DNA%2520binding%2520proteins%2520and%2520repair.%2520relationship%2520to%2520cytotoxicity%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D121%26epage%3D129%26doi%3D10.1016%2Fj.chembiol.2004.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ratanaphan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nhukeaw, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hongthong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">Differential cytotoxicity, cellular uptake, apoptosis and inhibition of BRCA1 expression of BRCA1-defective and sporadic breast cancer cells induced by an anticancer ruthenium(II)-arene compound, RAPTA-EA1</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.2174/1871520616666160404110953</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F1871520616666160404110953" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=212-220&author=A.+Ratanaphanauthor=T.+Nhukeawauthor=K.+Hongthongauthor=P.+J.+Dyson&title=Differential+cytotoxicity%2C+cellular+uptake%2C+apoptosis+and+inhibition+of+BRCA1+expression+of+BRCA1-defective+and+sporadic+breast+cancer+cells+induced+by+an+anticancer+ruthenium%28II%29-arene+compound%2C+RAPTA-EA1&doi=10.2174%2F1871520616666160404110953"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2174%2F1871520616666160404110953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871520616666160404110953%26sid%3Dliteratum%253Aachs%26aulast%3DRatanaphan%26aufirst%3DA.%26aulast%3DNhukeaw%26aufirst%3DT.%26aulast%3DHongthong%26aufirst%3DK.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DDifferential%2520cytotoxicity%252C%2520cellular%2520uptake%252C%2520apoptosis%2520and%2520inhibition%2520of%2520BRCA1%2520expression%2520of%2520BRCA1-defective%2520and%2520sporadic%2520breast%2520cancer%2520cells%2520induced%2520by%2520an%2520anticancer%2520ruthenium%2528II%2529-arene%2520compound%252C%2520RAPTA-EA1%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2017%26volume%3D17%26spage%3D212%26epage%3D220%26doi%3D10.2174%2F1871520616666160404110953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Popolin, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J. P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becceneri, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graminha, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corrêa, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colina-Vegas, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellena, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cominetti, M. R.</span></span> <span> </span><span class="NLM_article-title">Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0183275</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0183275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1371%2Fjournal.pone.0183275" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0183275&author=C.+P.+Popolinauthor=J.+P.+B.+Reisauthor=A.+B.+Becceneriauthor=A.+E.+Graminhaauthor=M.+A.+P.+Almeidaauthor=R.+S.+Corr%C3%AAaauthor=L.+A.+Colina-Vegasauthor=J.+Ellenaauthor=A.+A.+Batistaauthor=M.+R.+Cominetti&title=Cytotoxicity+and+anti-tumor+effects+of+new+ruthenium+complexes+on+triple+negative+breast+cancer+cells&doi=10.1371%2Fjournal.pone.0183275"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0183275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0183275%26sid%3Dliteratum%253Aachs%26aulast%3DPopolin%26aufirst%3DC.%2BP.%26aulast%3DReis%26aufirst%3DJ.%2BP.%2BB.%26aulast%3DBecceneri%26aufirst%3DA.%2BB.%26aulast%3DGraminha%26aufirst%3DA.%2BE.%26aulast%3DAlmeida%26aufirst%3DM.%2BA.%2BP.%26aulast%3DCorr%25C3%25AAa%26aufirst%3DR.%2BS.%26aulast%3DColina-Vegas%26aufirst%3DL.%2BA.%26aulast%3DEllena%26aufirst%3DJ.%26aulast%3DBatista%26aufirst%3DA.%2BA.%26aulast%3DCominetti%26aufirst%3DM.%2BR.%26atitle%3DCytotoxicity%2520and%2520anti-tumor%2520effects%2520of%2520new%2520ruthenium%2520complexes%2520on%2520triple%2520negative%2520breast%2520cancer%2520cells%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0183275%26doi%3D10.1371%2Fjournal.pone.0183275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grozav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balacescu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balacescu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheminel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berindan-Neagoe, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, B.</span></span> <span> </span><span class="NLM_article-title">Synthesis, anticancer activity, and genome profiling of thiazolo arene ruthenium complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8475</span>– <span class="NLM_lpage">8490</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00855</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00855" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8475-8490&author=A.+Grozavauthor=O.+Balacescuauthor=L.+Balacescuauthor=T.+Cheminelauthor=I.+Berindan-Neagoeauthor=B.+Therrien&title=Synthesis%2C+anticancer+activity%2C+and+genome+profiling+of+thiazolo+arene+ruthenium+complexes&doi=10.1021%2Facs.jmedchem.5b00855"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00855%26sid%3Dliteratum%253Aachs%26aulast%3DGrozav%26aufirst%3DA.%26aulast%3DBalacescu%26aufirst%3DO.%26aulast%3DBalacescu%26aufirst%3DL.%26aulast%3DCheminel%26aufirst%3DT.%26aulast%3DBerindan-Neagoe%26aufirst%3DI.%26aulast%3DTherrien%26aufirst%3DB.%26atitle%3DSynthesis%252C%2520anticancer%2520activity%252C%2520and%2520genome%2520profiling%2520of%2520thiazolo%2520arene%2520ruthenium%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8475%26epage%3D8490%26doi%3D10.1021%2Facs.jmedchem.5b00855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaveera, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span> <span> </span><span class="NLM_article-title">Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexes</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.3109/14756360903357577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.3109%2F14756360903357577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=20128638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotlSmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=513-519&author=S.+Thotaauthor=S.+S.+Karkiauthor=K.+N.+Jayaveeraauthor=J.+Balzariniauthor=E.+De+Clercq&title=Synthesis%2C+antineoplastic+and+cytotoxic+activities+of+some+mononuclear+Ru%28II%29+complexes&doi=10.3109%2F14756360903357577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexes</span></div><div class="casAuthors">Thota, Sreekanth; Karki, Subhas S.; Jayaveera, K. N.; Balzarini, Jan; De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">513-519</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A series of mononuclear Ru(II) complexes of the type [Ru(S)2(K)]2+, where S = 1,10-phenanthroline/2,2'-bipyridine and K = 4-OH-btsz, 4-CH3-btsz, 3,4-di-OCH3-btsz, 4-OH-binh, 4-CH3-binh, 3,4-di-OCH3-binh (btsz/binh = benzaldehyde thiosemicarbazone/isonicotinyl hydrazone), were prepd. and characterized by elemental anal., FTIR, 1H-NMR, and mass spectroscopy.  The complexes displayed metal-ligand charge transfer (MLCT) transitions in the visible region.  These ligands formed bidentate octahedral ruthenium complexes.  The title complexes were evaluated for their in vivo anticancer activity against a transplantable murine tumor cell line, Ehrlich's ascites carcinoma (EAC), and in vitro cytotoxic activity against human cancer cell lines Molt 4/C8 and CEM and murine tumor cell line L1210.  The ruthenium complexes showed promising biol. activity esp. in decreasing tumor vol. and viable ascites cell counts.  Treatment with these complexes prolonged the life span of mice bearing EAC tumors by 10-52%.  In vitro evaluation of these ruthenium complexes revealed cytotoxic activity from 0.21 to 24 μM against Molt 4/C8, 0.16 to 19 μM against CEM, and 0.75 to 32 μM against L1210.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfjIM2peX8cLVg90H21EOLACvtfcHk0ljkyf6lbdeeBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotlSmsbk%253D&md5=ec0a391d97808f590d089d4b7d7535d2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.3109%2F14756360903357577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756360903357577%26sid%3Dliteratum%253Aachs%26aulast%3DThota%26aufirst%3DS.%26aulast%3DKarki%26aufirst%3DS.%2BS.%26aulast%3DJayaveera%26aufirst%3DK.%2BN.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DSynthesis%252C%2520antineoplastic%2520and%2520cytotoxic%2520activities%2520of%2520some%2520mononuclear%2520Ru%2528II%2529%2520complexes%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2010%26volume%3D25%26spage%3D513%26epage%3D519%26doi%3D10.3109%2F14756360903357577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1038/nrd3428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2Fnrd3428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=21455236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=261-275&author=S.+Balasubramanianauthor=L.+H.+Hurleyauthor=S.+Neidle&title=Targeting+G-quadruplexes+in+gene+promoters%3A+a+novel+anticancer+strategy%3F&doi=10.1038%2Fnrd3428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?</span></div><div class="casAuthors">Balasubramanian, Shankar; Hurley, Laurence H.; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">261-275</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  G-quadruplexes are four-stranded DNA structures that are over-represented in gene promoter regions and are viewed as emerging therapeutic targets in oncol., as transcriptional repression of oncogenes through stabilization of these structures could be a novel anticancer strategy.  Many gene promoter G-quadruplexes have physicochem. properties and structural characteristics that might make them druggable, and their structural diversity suggests that a high degree of selectivity might be possible.  Here, we describe the evidence for G-quadruplexes in gene promoters and discuss their potential as therapeutic targets, as well as progress in the development of strategies to harness this potential through intervention with small-mol. ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk0ePjfQEBk7Vg90H21EOLACvtfcHk0ljkyf6lbdeeBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmtbw%253D&md5=b3ea27635da9d1ff72d60228f1ef6d76</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1038%2Fnrd3428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3428%26sid%3Dliteratum%253Aachs%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DTargeting%2520G-quadruplexes%2520in%2520gene%2520promoters%253A%2520a%2520novel%2520anticancer%2520strategy%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D261%26epage%3D275%26doi%3D10.1038%2Fnrd3428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagawa, K.</span></span> <span> </span><span class="NLM_article-title">Targeting DNA damage response in cancer therapy</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">370</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1111/cas.12366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1111%2Fcas.12366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=24484288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvFWitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2014&pages=370-388&author=N.+Hosoyaauthor=K.+Miyagawa&title=Targeting+DNA+damage+response+in+cancer+therapy&doi=10.1111%2Fcas.12366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting DNA damage response in cancer therapy</span></div><div class="casAuthors">Hosoya, Noriko; Miyagawa, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">370-388</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Cancer chemotherapy and radiotherapy are designed to kill cancer cells mostly by inducing DNA damage.  DNA damage is normally recognized and repaired by the intrinsic DNA damage response machinery.  If the damaged lesions are successfully repaired, the cells will survive.  In order to specifically and effectively kill cancer cells by therapies that induce DNA damage, it is important to take advantage of specific abnormalities in the DNA damage response machinery that are present in cancer cells but not in normal cells.  Such properties of cancer cells can provide biomarkers or targets for sensitization.  For example, defects or upregulation of the specific pathways that recognize or repair specific types of DNA damage can serve as biomarkers of favorable or poor response to therapies that induce such types of DNA damage.  Inhibition of a DNA damage response pathway may enhance the therapeutic effects in combination with the DNA-damaging agents.  Moreover, it may also be useful as a monotherapy when it achieves synthetic lethality, in which inhibition of a complementary DNA damage response pathway selectively kills cancer cells that have a defect in a particular DNA repair pathway.  The most striking application of this strategy is the treatment of cancers deficient in homologous recombination by poly(ADP-ribose) polymerase inhibitors.  In this review, we describe the impact of targeting the cancer-specific aberrations in the DNA damage response by explaining how these treatment strategies are currently being evaluated in preclin. or clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNrms7_IuKabVg90H21EOLACvtfcHk0ljkyf6lbdeeBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvFWitb0%253D&md5=e5484fa4a619052a621c999349ec9b83</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1111%2Fcas.12366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.12366%26sid%3Dliteratum%253Aachs%26aulast%3DHosoya%26aufirst%3DN.%26aulast%3DMiyagawa%26aufirst%3DK.%26atitle%3DTargeting%2520DNA%2520damage%2520response%2520in%2520cancer%2520therapy%26jtitle%3DCancer%2520Sci.%26date%3D2014%26volume%3D105%26spage%3D370%26epage%3D388%26doi%3D10.1111%2Fcas.12366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patra, A. K.</span></span> <span> </span><span class="NLM_article-title">Ruthenium(II) complexes of saccharin with dipyridoquinoxaline and dipyridophenazine: Structures, biological interactions and photoinduced DNA damage activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ejmech.2017.04.076" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=52-62&author=P.+Kumarauthor=S.+Dasariauthor=A.+K.+Patra&title=Ruthenium%28II%29+complexes+of+saccharin+with+dipyridoquinoxaline+and+dipyridophenazine%3A+Structures%2C+biological+interactions+and+photoinduced+DNA+damage+activity&doi=10.1016%2Fj.ejmech.2017.04.076"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.076%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DDasari%26aufirst%3DS.%26aulast%3DPatra%26aufirst%3DA.%2BK.%26atitle%3DRuthenium%2528II%2529%2520complexes%2520of%2520saccharin%2520with%2520dipyridoquinoxaline%2520and%2520dipyridophenazine%253A%2520Structures%252C%2520biological%2520interactions%2520and%2520photoinduced%2520DNA%2520damage%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D136%26spage%3D52%26epage%3D62%26doi%3D10.1016%2Fj.ejmech.2017.04.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sathyaraj, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weyhermüller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, B. U.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization and DNA binding studies of new ruthenium(II)bisterpyridine complexes</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2009.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ejmech.2009.10.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=284-291&author=G.+Sathyarajauthor=T.+Weyherm%C3%BCllerauthor=B.+U.+Nair&title=Synthesis%2C+characterization+and+DNA+binding+studies+of+new+ruthenium%28II%29bisterpyridine+complexes&doi=10.1016%2Fj.ejmech.2009.10.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DSathyaraj%26aufirst%3DG.%26aulast%3DWeyherm%25C3%25BCller%26aufirst%3DT.%26aulast%3DNair%26aufirst%3DB.%2BU.%26atitle%3DSynthesis%252C%2520characterization%2520and%2520DNA%2520binding%2520studies%2520of%2520new%2520ruthenium%2528II%2529bisterpyridine%2520complexes%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D284%26epage%3D291%26doi%3D10.1016%2Fj.ejmech.2009.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arockiasamy, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radhika, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parthasarathi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, B. U.</span></span> <span> </span><span class="NLM_article-title">Synthesis and DNA-binding studies of two ruthenium(II) complexes of an intercalating ligand</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">2044</span>– <span class="NLM_lpage">2051</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2008.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ejmech.2008.10.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=2044-2051&author=D.+L.+Arockiasamyauthor=S.+Radhikaauthor=R.+Parthasarathiauthor=B.+U.+Nair&title=Synthesis+and+DNA-binding+studies+of+two+ruthenium%28II%29+complexes+of+an+intercalating+ligand&doi=10.1016%2Fj.ejmech.2008.10.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2008.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2008.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DArockiasamy%26aufirst%3DD.%2BL.%26aulast%3DRadhika%26aufirst%3DS.%26aulast%3DParthasarathi%26aufirst%3DR.%26aulast%3DNair%26aufirst%3DB.%2BU.%26atitle%3DSynthesis%2520and%2520DNA-binding%2520studies%2520of%2520two%2520ruthenium%2528II%2529%2520complexes%2520of%2520an%2520intercalating%2520ligand%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D2044%26epage%3D2051%26doi%3D10.1016%2Fj.ejmech.2008.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, and anticancer activity of a series of ketone-N(4)-substituted thiosemicarbazones and their ruthenium(II) arene complexes</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">12440</span>– <span class="NLM_lpage">12449</span>, <span class="refDoi"> DOI: 10.1021/ic401362s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic401362s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=12440-12449&author=W.+Suauthor=Q.+Qianauthor=P.+Liauthor=X.+Leiauthor=Q.+Xiaoauthor=S.+Huangauthor=C.+Huangauthor=J.+Cui&title=Synthesis%2C+characterization%2C+and+anticancer+activity+of+a+series+of+ketone-N%284%29-substituted+thiosemicarbazones+and+their+ruthenium%28II%29+arene+complexes&doi=10.1021%2Fic401362s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fic401362s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic401362s%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DW.%26aulast%3DQian%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DCui%26aufirst%3DJ.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520anticancer%2520activity%2520of%2520a%2520series%2520of%2520ketone-N%25284%2529-substituted%2520thiosemicarbazones%2520and%2520their%2520ruthenium%2528II%2529%2520arene%2520complexes%26jtitle%3DInorg.%2520Chem.%26date%3D2013%26volume%3D52%26spage%3D12440%26epage%3D12449%26doi%3D10.1021%2Fic401362s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamatchi, T.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitrapriya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fronczek, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natarajan, K.</span></span> <span> </span><span class="NLM_article-title">Influence of carboxylic acid functionalities in ruthenium (II) polypyridyl complexes on DNA binding, cytotoxicity and antioxidant activity: synthesis, structure and <i>in vitro</i> anticancer activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.11.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ejmech.2012.11.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2013&pages=253-264&author=T.%0AS.+Kamatchiauthor=N.+Chitrapriyaauthor=S.+K.+Kimauthor=F.+R.+Fronczekauthor=K.+Natarajan&title=Influence+of+carboxylic+acid+functionalities+in+ruthenium+%28II%29+polypyridyl+complexes+on+DNA+binding%2C+cytotoxicity+and+antioxidant+activity%3A+synthesis%2C+structure+and+in+vitro+anticancer+activity&doi=10.1016%2Fj.ejmech.2012.11.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.11.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.11.024%26sid%3Dliteratum%253Aachs%26aulast%3DKamatchi%26aufirst%3DT.%2BS.%26aulast%3DChitrapriya%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DFronczek%26aufirst%3DF.%2BR.%26aulast%3DNatarajan%26aufirst%3DK.%26atitle%3DInfluence%2520of%2520carboxylic%2520acid%2520functionalities%2520in%2520ruthenium%2520%2528II%2529%2520polypyridyl%2520complexes%2520on%2520DNA%2520binding%252C%2520cytotoxicity%2520and%2520antioxidant%2520activity%253A%2520synthesis%252C%2520structure%2520and%2520in%2520vitro%2520anticancer%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D59%26spage%3D253%26epage%3D264%26doi%3D10.1016%2Fj.ejmech.2012.11.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Busto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valladolid, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alonso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozano, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalon, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzano, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrion, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biver, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García, B.</span></span> <span> </span><span class="NLM_article-title">Anticancer activity and DNA binding of a bifunctional Ru(II) arene aqua-complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">9962</span>– <span class="NLM_lpage">9974</span>, <span class="refDoi"> DOI: 10.1021/ic401197a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic401197a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=9962-9974&author=N.+Bustoauthor=J.+Valladolidauthor=M.+Martinez-Alonsoauthor=H.+J.+Lozanoauthor=F.+A.+Jalonauthor=B.+R.+Manzanoauthor=A.+M.+Rodriguezauthor=M.+C.+Carrionauthor=T.+Biverauthor=J.+M.+Lealauthor=G.+Espinoauthor=B.+Garc%C3%ADa&title=Anticancer+activity+and+DNA+binding+of+a+bifunctional+Ru%28II%29+arene+aqua-complex+with+the+2%2C4-diamino-6-%282-pyridyl%29-1%2C3%2C5-triazine+ligand&doi=10.1021%2Fic401197a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fic401197a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic401197a%26sid%3Dliteratum%253Aachs%26aulast%3DBusto%26aufirst%3DN.%26aulast%3DValladolid%26aufirst%3DJ.%26aulast%3DMartinez-Alonso%26aufirst%3DM.%26aulast%3DLozano%26aufirst%3DH.%2BJ.%26aulast%3DJalon%26aufirst%3DF.%2BA.%26aulast%3DManzano%26aufirst%3DB.%2BR.%26aulast%3DRodriguez%26aufirst%3DA.%2BM.%26aulast%3DCarrion%26aufirst%3DM.%2BC.%26aulast%3DBiver%26aufirst%3DT.%26aulast%3DLeal%26aufirst%3DJ.%2BM.%26aulast%3DEspino%26aufirst%3DG.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DB.%26atitle%3DAnticancer%2520activity%2520and%2520DNA%2520binding%2520of%2520a%2520bifunctional%2520Ru%2528II%2529%2520arene%2520aqua-complex%2520with%2520the%25202%252C4-diamino-6-%25282-pyridyl%2529-1%252C3%252C5-triazine%2520ligand%26jtitle%3DInorg.%2520Chem.%26date%3D2013%26volume%3D52%26spage%3D9962%26epage%3D9974%26doi%3D10.1021%2Fic401197a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lincoln, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordén, B.</span></span> <span> </span><span class="NLM_article-title">DNA binding geometries of ruthenium(II) complexes with 1,10-phenanthroline and 2,2′-bipyridine ligands studied with linear dichroism spectroscopy. Borderline cases of intercalation</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">9583</span>– <span class="NLM_lpage">9594</span>, <span class="refDoi"> DOI: 10.1021/jp9824914</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp9824914" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=9583-9594&author=P.+Lincolnauthor=B.+Nord%C3%A9n&title=DNA+binding+geometries+of+ruthenium%28II%29+complexes+with+1%2C10-phenanthroline+and+2%2C2%E2%80%B2-bipyridine+ligands+studied+with+linear+dichroism+spectroscopy.+Borderline+cases+of+intercalation&doi=10.1021%2Fjp9824914"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjp9824914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp9824914%26sid%3Dliteratum%253Aachs%26aulast%3DLincoln%26aufirst%3DP.%26aulast%3DNord%25C3%25A9n%26aufirst%3DB.%26atitle%3DDNA%2520binding%2520geometries%2520of%2520ruthenium%2528II%2529%2520complexes%2520with%25201%252C10-phenanthroline%2520and%25202%252C2%25E2%2580%25B2-bipyridine%2520ligands%2520studied%2520with%2520linear%2520dichroism%2520spectroscopy.%2520Borderline%2520cases%2520of%2520intercalation%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D1998%26volume%3D102%26spage%3D9583%26epage%3D9594%26doi%3D10.1021%2Fjp9824914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1021/ja027719m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja027719m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFCnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=173-186&author=H.+Chenauthor=J.+A.+Parkinsonauthor=R.+E.+Morrisauthor=P.+J.+Sadler&title=Highly+selective+binding+of+organometallic+ruthenium+ethylenediamine+complexes+to+nucleic+acids%3A+novel+recognition+mechanisms&doi=10.1021%2Fja027719m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Selective Binding of Organometallic Ruthenium Ethylenediamine Complexes to Nucleic Acids: Novel Recognition Mechanisms</span></div><div class="casAuthors">Chen, Haimei; Parkinson, John A.; Morris, Robert E.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">173-186</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recognition of nucleic acid derivs. by organometallic ruthenium(II) arene anticancer complexes of the type [(η6-arene)Ru(II)(en)X] (en = ethylenediamine, arene = biphenyl (Bip), tetrahydroanthracene (THA), dihydroanthracene (DHA), p-cymene (Cym) or benzene (Ben), X = Cl- or H2O) was studied using 1H, 31P and 15N (15N-en) NMR spectroscopy.  For mononucleosides, [(η6-Bip)Ru(en)]2+ binds only to N7 of guanosine, to N7 and N1 of inosine, and to N3 of thymidine.  Binding to N3 of cytidine was weak, and almost no binding to adenosine was obsd.  The reactivity of the various binding sites of nucleobases toward Ru at neutral pH decreased in the order G(N7) > I(N7) > I(N1), T(N3) > C(N3) > A(N7), A(N1).  Therefore, pseudo-octahedral diamino Ru(II) arene complexes are much more highly discriminatory between G and A bases than square-planar Pt(II) complexes.  Such site-selectivity appears to be controlled by the en NH2 groups, which H-bond with exocyclic oxygens but are nonbonding and repulsive toward exocyclic amino groups of the nucleobases.  For reactions with mononucleotides, the same pattern of site selectivity was obsd., but, in addn., significant amts. of the 5'-phosphate-bound species (40-60%) were present at equil. for 5'-TMP, 5'-CMP and 5'-AMP.  In contrast, no binding to the phosphodiester groups of 3', 5'-cyclic-GMP (cGMP) or cAMP was detected.  Reactions with nucleotides proceeded via aquation of [(η6-arene)Ru(en)Cl]+, followed by rapid binding to the 5'-phosphate, and then rearrangement to give N7, N1, or N3-bound products.  Small amts. of the dinuclear species, e.g., Ru-O(PO3)GMPN7-Ru, Ru-O(PO3)IMPN1-Ru, Ru-O(PO3)TMPN3-Ru, Ru-N7IMPN1-Ru, and Ru-N7InoN1-Ru were also detected.  In competitive binding expts. for [(η6-Bip)Ru(en)Cl]+ with 5'-GMP vs. 5'-AMP or 5'-CMP or 5'-TMP, the only final adduct was [(η6-Bip)Ru(en)(N7-GMP)]. Ru-H2O species were more reactive than Ru-OH species.  The presence of Cl- or phosphate in neutral soln. significantly decreased the rates of Ru-N7 binding through competitive coordination to Ru.  In kinetic studies (pH 7.0, 298 K, 100 mM NaClO4), the rates of reaction of cGMP with {(η6-arene)Ru(II)(en)X}n+ (X = Cl- or H2O) decreased in the order: THA > Bip > DHA >> Cym > Ben, suggesting that N7-binding is promoted by favorable arene-purine hydrophobic interactions in the associative transition state.  These findings have revealed that the diamine NH2 groups, the hydrophobic arene, and the chloride leaving group have important roles in the novel mechanism of recognition of nucleic acids by Ru arene complexes, and will aid the design of more effective anticancer complexes, as well as new site-specific DNA reagents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrarvfTzPmCsLVg90H21EOLACvtfcHk0liO4LzA9BtNHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFCnsLg%253D&md5=0eeb6544ba9d89d997369cbfebc7a3cd</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fja027719m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja027719m%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DParkinson%26aufirst%3DJ.%2BA.%26aulast%3DMorris%26aufirst%3DR.%2BE.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DHighly%2520selective%2520binding%2520of%2520organometallic%2520ruthenium%2520ethylenediamine%2520complexes%2520to%2520nucleic%2520acids%253A%2520novel%2520recognition%2520mechanisms%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D173%26epage%3D186%26doi%3D10.1021%2Fja027719m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bešker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coletti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Re, N.</span></span> <span> </span><span class="NLM_article-title">Binding of antitumor ruthenium complexes to DNA and proteins: A theoretical approach</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">9955</span>– <span class="NLM_lpage">9964</span>, <span class="refDoi"> DOI: 10.1021/jp072182q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp072182q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2007&pages=9955-9964&author=N.+Be%C5%A1kerauthor=C.+Colettiauthor=A.+Marroneauthor=N.+Re&title=Binding+of+antitumor+ruthenium+complexes+to+DNA+and+proteins%3A+A+theoretical+approach&doi=10.1021%2Fjp072182q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjp072182q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp072182q%26sid%3Dliteratum%253Aachs%26aulast%3DBe%25C5%25A1ker%26aufirst%3DN.%26aulast%3DColetti%26aufirst%3DC.%26aulast%3DMarrone%26aufirst%3DA.%26aulast%3DRe%26aufirst%3DN.%26atitle%3DBinding%2520of%2520antitumor%2520ruthenium%2520complexes%2520to%2520DNA%2520and%2520proteins%253A%2520A%2520theoretical%2520approach%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2007%26volume%3D111%26spage%3D9955%26epage%3D9964%26doi%3D10.1021%2Fjp072182q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caruso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gariboldi, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettinari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettinari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, and antitumor activity of water-soluble (arene)ruthenium(II) derivatives of 1,3-dimethyl-4-acylpyrazolon-5-ato ligands. First example of Ru(arene)(ligand) antitumor species involving simultaneous Ru-N7(guanine) bonding and ligand intercalation to DNA</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3668</span>– <span class="NLM_lpage">3677</span>, <span class="refDoi"> DOI: 10.1021/ic403170y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic403170y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=3668-3677&author=F.+Carusoauthor=E.+Montiauthor=J.+Matthewsauthor=M.+Rossiauthor=M.+B.+Gariboldiauthor=C.+Pettinariauthor=R.+Pettinariauthor=F.+Marchetti&title=Synthesis%2C+characterization%2C+and+antitumor+activity+of+water-soluble+%28arene%29ruthenium%28II%29+derivatives+of+1%2C3-dimethyl-4-acylpyrazolon-5-ato+ligands.+First+example+of+Ru%28arene%29%28ligand%29+antitumor+species+involving+simultaneous+Ru-N7%28guanine%29+bonding+and+ligand+intercalation+to+DNA&doi=10.1021%2Fic403170y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fic403170y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic403170y%26sid%3Dliteratum%253Aachs%26aulast%3DCaruso%26aufirst%3DF.%26aulast%3DMonti%26aufirst%3DE.%26aulast%3DMatthews%26aufirst%3DJ.%26aulast%3DRossi%26aufirst%3DM.%26aulast%3DGariboldi%26aufirst%3DM.%2BB.%26aulast%3DPettinari%26aufirst%3DC.%26aulast%3DPettinari%26aufirst%3DR.%26aulast%3DMarchetti%26aufirst%3DF.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520antitumor%2520activity%2520of%2520water-soluble%2520%2528arene%2529ruthenium%2528II%2529%2520derivatives%2520of%25201%252C3-dimethyl-4-acylpyrazolon-5-ato%2520ligands.%2520First%2520example%2520of%2520Ru%2528arene%2529%2528ligand%2529%2520antitumor%2520species%2520involving%2520simultaneous%2520Ru-N7%2528guanine%2529%2520bonding%2520and%2520ligand%2520intercalation%2520to%2520DNA%26jtitle%3DInorg.%2520Chem.%26date%3D2014%26volume%3D53%26spage%3D3668%26epage%3D3677%26doi%3D10.1021%2Fic403170y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foxon, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wragg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, A. J. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, and DNA binding properties of ruthenium(II) complexes containing the redox active ligand benzo[<i>i</i>]dipyrido[3,2-<i>a</i>:2′,3′-<i>c</i>]phenazine-11,16-quinone</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.1021/ic201914h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic201914h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=463-471&author=S.+P.+Foxonauthor=C.+Greenauthor=M.+G.+Walkerauthor=A.+Wraggauthor=H.+Adamsauthor=J.+A.+Weinsteinauthor=S.+C.+Parkerauthor=A.+J.+H.+M.+Meijerauthor=J.+A.+Thomas&title=Synthesis%2C+characterization%2C+and+DNA+binding+properties+of+ruthenium%28II%29+complexes+containing+the+redox+active+ligand+benzo%5Bi%5Ddipyrido%5B3%2C2-a%3A2%E2%80%B2%2C3%E2%80%B2-c%5Dphenazine-11%2C16-quinone&doi=10.1021%2Fic201914h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fic201914h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic201914h%26sid%3Dliteratum%253Aachs%26aulast%3DFoxon%26aufirst%3DS.%2BP.%26aulast%3DGreen%26aufirst%3DC.%26aulast%3DWalker%26aufirst%3DM.%2BG.%26aulast%3DWragg%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DH.%26aulast%3DWeinstein%26aufirst%3DJ.%2BA.%26aulast%3DParker%26aufirst%3DS.%2BC.%26aulast%3DMeijer%26aufirst%3DA.%2BJ.%2BH.%2BM.%26aulast%3DThomas%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520DNA%2520binding%2520properties%2520of%2520ruthenium%2528II%2529%2520complexes%2520containing%2520the%2520redox%2520active%2520ligand%2520benzo%255Bi%255Ddipyrido%255B3%252C2-a%253A2%25E2%2580%25B2%252C3%25E2%2580%25B2-c%255Dphenazine-11%252C16-quinone%26jtitle%3DInorg.%2520Chem.%26date%3D2012%26volume%3D51%26spage%3D463%26epage%3D471%26doi%3D10.1021%2Fic201914h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elie, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalo, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez
de Mingo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Delgado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadhukha, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contel, M.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo evaluation of water-soluble iminophosphorane ruthenium(II) compounds. A potential chemotherapeutic agent for triple negative breast cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9995</span>– <span class="NLM_lpage">10012</span>, <span class="refDoi"> DOI: 10.1021/jm5012337</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012337" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKqur3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9995-10012&author=M.+Frikauthor=A.+Martinezauthor=B.+T.+Elieauthor=O.+Gonzaloauthor=D.+Ramirez%0Ade+Mingoauthor=M.+Sanauauthor=R.+Sanchez-Delgadoauthor=T.+Sadhukhaauthor=S.+Prabhaauthor=J.+W.+Ramosauthor=I.+Marzoauthor=M.+Contel&title=In+vitro+and+in+vivo+evaluation+of+water-soluble+iminophosphorane+ruthenium%28II%29+compounds.+A+potential+chemotherapeutic+agent+for+triple+negative+breast+cancer&doi=10.1021%2Fjm5012337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Breast Cancer</span></div><div class="casAuthors">Frik, Malgorzata; Martinez, Alberto; Elie, Benelita T.; Gonzalo, Oscar; Ramirez de Mingo, Daniel; Sanau, Mercedes; Sanchez-Delgado, Roberto; Sadhukha, Tanmoy; Prabha, Swayam; Ramos, Joe W.; Marzo, Isabel; Contel, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9995-10012</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of organometallic ruthenium(II) complexes contg. iminophosphorane ligands have been synthesized and characterized.  Cationic compds. with chloride as counterion are sol. in water (70-100 mg/mL).  Most compds. (esp. highly water-sol. I) are more cytotoxic to a no. of human cancer cell lines than cisplatin.  Initial mechanistic studies indicate that the cell death type for these compds. is mainly through canonical or caspase-dependent apoptosis, nondependent on p53, and that the compds. do not interact with DNA or inhibit protease cathepsin B.  In vivo expts. of I on MDA-MB-231 xenografts in NOD.CB17-Prkdc SCID/J mice showed an impressive tumor redn. (shrinkage) of 56% after 28 days of treatment (14 doses of 5 mg/kg every other day) with low systemic toxicity.  Pharmacokinetic studies showed a quick absorption of I in plasma with preferential accumulation in the breast tumor tissues when compared to kidney and liver, which may explain its high efficacy in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsRq4axNxQnbVg90H21EOLACvtfcHk0liO4LzA9BtNHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKqur3M&md5=6f5f53172aeae72fe6f7c73646c3b878</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm5012337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012337%26sid%3Dliteratum%253Aachs%26aulast%3DFrik%26aufirst%3DM.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DElie%26aufirst%3DB.%2BT.%26aulast%3DGonzalo%26aufirst%3DO.%26aulast%3DRamirez%2Bde%2BMingo%26aufirst%3DD.%26aulast%3DSanau%26aufirst%3DM.%26aulast%3DSanchez-Delgado%26aufirst%3DR.%26aulast%3DSadhukha%26aufirst%3DT.%26aulast%3DPrabha%26aufirst%3DS.%26aulast%3DRamos%26aufirst%3DJ.%2BW.%26aulast%3DMarzo%26aufirst%3DI.%26aulast%3DContel%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520evaluation%2520of%2520water-soluble%2520iminophosphorane%2520ruthenium%2528II%2529%2520compounds.%2520A%2520potential%2520chemotherapeutic%2520agent%2520for%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9995%26epage%3D10012%26doi%3D10.1021%2Fjm5012337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, X. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L. N.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, DNA-binding and DNA-photocleavage studies of [Ru(bpy)<sub>2</sub>(pmip)]<sup>2+</sup> and [Ru(phen)<sub>2</sub>(pmip)]<sup>2+</sup> (pmip = 2-(2′-pyrimidyl)imidazo[4,5-<i>f</i> ][1,10]phenanthroline</span>. <i>Polyhedron</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">1361</span>, <span class="refDoi"> DOI: 10.1016/j.poly.2009.02.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.poly.2009.02.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=1355-1361&author=S.+Shiauthor=T.+Xieauthor=T.+M.+Yaoauthor=C.+R.+Wangauthor=X.+T.+Gengauthor=D.+J.+Yangauthor=L.+J.+Hanauthor=L.+N.+Ji&title=Synthesis%2C+characterization%2C+DNA-binding+and+DNA-photocleavage+studies+of+%5BRu%28bpy%292%28pmip%29%5D2%2B+and+%5BRu%28phen%292%28pmip%29%5D2%2B+%28pmip+%3D+2-%282%E2%80%B2-pyrimidyl%29imidazo%5B4%2C5-f+%5D%5B1%2C10%5Dphenanthroline&doi=10.1016%2Fj.poly.2009.02.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.poly.2009.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.poly.2009.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DT.%26aulast%3DYao%26aufirst%3DT.%2BM.%26aulast%3DWang%26aufirst%3DC.%2BR.%26aulast%3DGeng%26aufirst%3DX.%2BT.%26aulast%3DYang%26aufirst%3DD.%2BJ.%26aulast%3DHan%26aufirst%3DL.%2BJ.%26aulast%3DJi%26aufirst%3DL.%2BN.%26atitle%3DSynthesis%252C%2520characterization%252C%2520DNA-binding%2520and%2520DNA-photocleavage%2520studies%2520of%2520%255BRu%2528bpy%25292%2528pmip%2529%255D2%252B%2520and%2520%255BRu%2528phen%25292%2528pmip%2529%255D2%252B%2520%2528pmip%2520%253D%25202-%25282%25E2%2580%25B2-pyrimidyl%2529imidazo%255B4%252C5-f%2520%255D%255B1%252C10%255Dphenanthroline%26jtitle%3DPolyhedron%26date%3D2009%26volume%3D28%26spage%3D1355%26epage%3D1361%26doi%3D10.1016%2Fj.poly.2009.02.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span> <span> </span><span class="NLM_article-title">Targeting nucleus DNA with a cyclometalated dipyridophenazine ruthenium(II) complex</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8971</span>– <span class="NLM_lpage">8983</span>, <span class="refDoi"> DOI: 10.1021/jm501095r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501095r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8971-8983&author=H.+Huangauthor=P.+Zhangauthor=B.+Yuauthor=Y.+Chenauthor=J.+Wangauthor=L.+Jiauthor=H.+Chao&title=Targeting+nucleus+DNA+with+a+cyclometalated+dipyridophenazine+ruthenium%28II%29+complex&doi=10.1021%2Fjm501095r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm501095r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501095r%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26atitle%3DTargeting%2520nucleus%2520DNA%2520with%2520a%2520cyclometalated%2520dipyridophenazine%2520ruthenium%2528II%2529%2520complex%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8971%26epage%3D8983%26doi%3D10.1021%2Fjm501095r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. J.</span></span> <span> </span><span class="NLM_article-title">Protein binding and anticancer activity studies of ruthenium(II) polypyridyl complexes toward BEL-7402 cells</span>. <i>J. Photochem. Photobiol., B</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2016.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jphotobiol.2016.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=26945645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1yhu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2016&pages=39-48&author=S.+H.+Laiauthor=W.+Liauthor=J.+H.+Yaoauthor=B.+J.+Hanauthor=G.+B.+Jiangauthor=C.+Zhangauthor=C.+C.+Zengauthor=Y.+J.+Liu&title=Protein+binding+and+anticancer+activity+studies+of+ruthenium%28II%29+polypyridyl+complexes+toward+BEL-7402+cells&doi=10.1016%2Fj.jphotobiol.2016.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Protein binding and anticancer activity studies of ruthenium(II) polypyridyl complexes toward BEL-7402 cells</span></div><div class="casAuthors">Lai, Shang-Hai; Li, Wei; Yao, Jun-Hua; Han, Bing-Jie; Jiang, Guang-Bin; Zhang, Cheng; Zeng, Chuan-Chuan; Liu, Yun-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39-48</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Four new ruthenium(II) polypyridyl complexes [Ru(dmb)2(dqtbt)](ClO4)2 (1) (dqtbt = 12-(2,3-diphenyl-quinoxalin-6-yl)-4,5,10,13-tetraazabenzo[b]triphenylene, dmb = 4,4'-dimethyl-2,2'-bipyridine), [Ru(bpy)2(dqtbt)](ClO4)2 (2) (bpy = 2,2'-bipyridine), [Ru(phen)2(dqtbt)](ClO4)2 (3) (phen = 1,10-phenanthroline) and [Ru(dmp)2(dqtbt)](ClO4)2 (4) (dmp = 2,9-dimethyl-1,10-phenanthroline) were synthesized and characterized.  The cytotoxicity in vitro of the complexes was evaluated against human BEL-7402, A549, HeLa, HepG-2 and MG-63 cancer cell lines.  These complexes are sensitive to BEL-7402 cells, the IC50 values are 4.9 ± 0.5, 4.6 ± 0.4, 7.7 ± 1.8 and 1.9 ± 0.3 μM toward BEL-7402 cells.  The complexes can increase the levels of reactive oxygen species and induce the decrease of mitochondrial membrane potential.  Morphol. and comet assay studies show that the complexes can effectively induce apoptosis in BEL-7402 cells.  Complexes 1-4 inhibit the cell growth at G0/G1 phase in BEL-7402 cell line.  The complexes can downregulate the expression of Bcl-2 and Bcl-x proteins and upregulate the levels of Bid protein in BEL-7402 cells.  The results show that the complexes induce BEL-7402 cell apoptosis through a ROS-mediated mitochondrial dysfunction pathway.  In addn., the complexes show strong protein-binding affinities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTeunpIXY6O7Vg90H21EOLACvtfcHk0lhAoYlRNiBeHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1yhu7o%253D&md5=16ee8ad22ec41491a82f3c9b606b5866</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2016.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2016.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DS.%2BH.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DYao%26aufirst%3DJ.%2BH.%26aulast%3DHan%26aufirst%3DB.%2BJ.%26aulast%3DJiang%26aufirst%3DG.%2BB.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZeng%26aufirst%3DC.%2BC.%26aulast%3DLiu%26aufirst%3DY.%2BJ.%26atitle%3DProtein%2520binding%2520and%2520anticancer%2520activity%2520studies%2520of%2520ruthenium%2528II%2529%2520polypyridyl%2520complexes%2520toward%2520BEL-7402%2520cells%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%252C%2520B%26date%3D2016%26volume%3D158%26spage%3D39%26epage%3D48%26doi%3D10.1016%2Fj.jphotobiol.2016.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Čanović, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simović, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radisavljević, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bratsos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demitri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitrović, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bugarčić, Z. D.</span></span> <span> </span><span class="NLM_article-title">Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1007</span>– <span class="NLM_lpage">1028</span>, <span class="refDoi"> DOI: 10.1007/s00775-017-1479-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1007%2Fs00775-017-1479-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28695374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFCrt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1007-1028&author=P.+%C4%8Canovi%C4%87author=A.+R.+Simovi%C4%87author=S.+Radisavljevi%C4%87author=I.+Bratsosauthor=N.+Demitriauthor=M.+Mitrovi%C4%87author=I.+Zelenauthor=Z.+D.+Bugar%C4%8Di%C4%87&title=Impact+of+aromaticity+on+anticancer+activity+of+polypyridyl+ruthenium%28II%29+complexes%3A+synthesis%2C+structure%2C+DNA%2Fprotein+binding%2C+lipophilicity+and+anticancer+activity&doi=10.1007%2Fs00775-017-1479-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity</span></div><div class="casAuthors">Canovic, Petar; Simovic, Ana Rilak; Radisavljevic, Snezana; Bratsos, Ioannis; Demitri, Nicola; Mitrovic, Marina; Zelen, Ivanka; Bugarcic, Zivadin D.</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1028</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Abstr.: With the aim of assessing how the aromaticity of the inert chelating ligand can influence the activity of ruthenium(II) polypyridyl complexes, two new monofunctional ruthenium(II) complexes, [Ru(Cl-Ph-tpy)(phen)Cl]Cl (1) and [Ru(Cl-Ph-tpy)(o-bqdi)Cl]Cl (2) (where Cl-Ph-tpy = 4'-(4-chlorophenyl)-2,2':6',2''-terpyridine, phen = 1,10-phenanthroline, o-bqdi = o-benzoquinonediimine), were synthesized.  All complexes were fully characterized by elemental anal. and spectroscopic techniques (IR, UV-Vis, 1D and 2D NMR, XRD).  Their chem. behavior in aq. soln. was studied by UV-Vis and NMR spectroscopy showing that both compds. are relatively labile leading to the formation of the corresponding aqua species 1a and 2a. 1H NMR spectroscopy studies performed on complexes 1 and 2 demonstrated that after the hydrolysis of the Cl ligand, they are capable to interact with guanine derivs. (i.e., 9-methylguanine (9MeG) and 5'-GMP) through the N7, forming monofunctional adduct.  The kinetics and the mechanism of the reaction of complexes 1 and 2 with the biol. more relevant 5'-GMP ligand were studied by UV-Vis spectroscopy.  DNA/protein interactions of the complexes have been examd. by photophys. studies, which demonstrated a bifunctional binding mode of the complexes with DNA and the complexes strongly quench the fluorescence intensity of bovine serum albumin (BSA) through the mechanism of both static and dynamic quenching.  Complexes 1 and 2 strongly induced apoptosis of treated cancer cells with high percentages of apoptotic cells and negligible percentage of necrotic cells.  In addn., both ruthenium complexes decreased Bcl-2/Bax ratio causing cytochrome c mitochondrial release, the activation of caspase-3 and induction of apoptosis.  Graphical Abstr.: [Figure not available: see fulltext.].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLs52nvOspf7Vg90H21EOLACvtfcHk0lhAoYlRNiBeHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFCrt77J&md5=0744e0901c1da0af41f8a8c9804cf32c</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs00775-017-1479-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-017-1479-7%26sid%3Dliteratum%253Aachs%26aulast%3D%25C4%258Canovi%25C4%2587%26aufirst%3DP.%26aulast%3DSimovi%25C4%2587%26aufirst%3DA.%2BR.%26aulast%3DRadisavljevi%25C4%2587%26aufirst%3DS.%26aulast%3DBratsos%26aufirst%3DI.%26aulast%3DDemitri%26aufirst%3DN.%26aulast%3DMitrovi%25C4%2587%26aufirst%3DM.%26aulast%3DZelen%26aufirst%3DI.%26aulast%3DBugar%25C4%258Di%25C4%2587%26aufirst%3DZ.%2BD.%26atitle%3DImpact%2520of%2520aromaticity%2520on%2520anticancer%2520activity%2520of%2520polypyridyl%2520ruthenium%2528II%2529%2520complexes%253A%2520synthesis%252C%2520structure%252C%2520DNA%252Fprotein%2520binding%252C%2520lipophilicity%2520and%2520anticancer%2520activity%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2017%26volume%3D22%26spage%3D1007%26epage%3D1028%26doi%3D10.1007%2Fs00775-017-1479-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heffeter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atil, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reza Hoda, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Körner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jungwirth, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micksche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koellensperger, G.</span></span> <span> </span><span class="NLM_article-title">Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1007/s00775-010-0642-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1007%2Fs00775-010-0642-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=20221888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVWrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=737-748&author=P.+Heffeterauthor=K.+B%C3%B6ckauthor=B.+Atilauthor=M.+A.+Reza+Hodaauthor=W.+K%C3%B6rnerauthor=C.+Bartelauthor=U.+Jungwirthauthor=B.+K.+Kepplerauthor=M.+Mickscheauthor=W.+Bergerauthor=G.+Koellensperger&title=Intracellular+protein+binding+patterns+of+the+anticancer+ruthenium+drugs+KP1019+and+KP1339&doi=10.1007%2Fs00775-010-0642-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339</span></div><div class="casAuthors">Heffeter, Petra; Boeck, Katharina; Atil, Bihter; Hoda, Mir Ali Reza; Koerner, Wilfried; Bartel, Caroline; Jungwirth, Ute; Keppler, Bernhard K.; Micksche, Michael; Berger, Walter; Koellensperger, Gunda</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">737-748</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The ruthenium compd. KP1019 has demonstrated promising anticancer activity in a pilot clin. trial.  This study aims to evaluate the intracellular uptake/binding patterns of KP1019 and its sodium salt KP1339, which is currently in a phase I-IIa study.  Although KP1339 tended to be moderately less cytotoxic than KP1019, IC50 values in several cancer cell models revealed significant correlation of the cytotoxicity profiles, suggesting similar targets for the two drugs.  Accordingly, both drugs activated apoptosis, indicated by caspase activation via comparable pathways.  Drug uptake detd. by inductively coupled plasma mass spectrometry (ICP-MS) was completed after 1 h, corresponding to full cytotoxicity as early as after 3 h of drug exposure.  Surprisingly, the total cellular drug uptake did not correlate with cytotoxicity.  However, distinct differences in intracellular distribution patterns suggested that the major targets for the two ruthenium drugs are cytosolic rather than nuclear.  Consequently, drug-protein binding in cytosolic fractions of drug-treated cells was analyzed by native size-exclusion chromatog. (SEC) coupled online with ICP-MS.  Ruthenium-protein binding of KP1019- and KP1339-treated cells distinctly differed from the platinum binding pattern obsd. after cisplatin treatment.  An adapted SEC-SEC-ICP-MS system identified large protein complexes/aggregates above 700 kDa as initial major binding partners in the cytosol, followed by ruthenium redistribution to the sol. protein wt. fraction below 40 kDa.  Taken together, our data indicate that KP1019 and KP1339 rapidly enter tumor cells, followed by binding to larger protein complexes/organelles.  The different protein binding patterns as compared with those for cisplatin suggest specific protein targets and consequently a unique mode of action for the ruthenium drugs investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEoJ1NMqGFDbVg90H21EOLACvtfcHk0lip78a6-fmuQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVWrtr4%253D&md5=7ac9cd4c320cb6a888eedccfabd2bbc2</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1007%2Fs00775-010-0642-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-010-0642-1%26sid%3Dliteratum%253Aachs%26aulast%3DHeffeter%26aufirst%3DP.%26aulast%3DB%25C3%25B6ck%26aufirst%3DK.%26aulast%3DAtil%26aufirst%3DB.%26aulast%3DReza%2BHoda%26aufirst%3DM.%2BA.%26aulast%3DK%25C3%25B6rner%26aufirst%3DW.%26aulast%3DBartel%26aufirst%3DC.%26aulast%3DJungwirth%26aufirst%3DU.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26aulast%3DMicksche%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DKoellensperger%26aufirst%3DG.%26atitle%3DIntracellular%2520protein%2520binding%2520patterns%2520of%2520the%2520anticancer%2520ruthenium%2520drugs%2520KP1019%2520and%2520KP1339%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2010%26volume%3D15%26spage%3D737%26epage%3D748%26doi%3D10.1007%2Fs00775-010-0642-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabbiani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorrentino, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigobello, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bindoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geldbach, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Re, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messori, L.</span></span> <span> </span><span class="NLM_article-title">Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">6773</span>– <span class="NLM_lpage">6781</span>, <span class="refDoi"> DOI: 10.1021/jm8006678</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8006678" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SjtrnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6773-6781&author=A.+Casiniauthor=C.+Gabbianiauthor=F.+Sorrentinoauthor=M.+P.+Rigobelloauthor=A.+Bindoliauthor=T.+J.+Geldbachauthor=A.+Marroneauthor=N.+Reauthor=C.+G.+Hartingerauthor=P.+J.+Dysonauthor=L.+Messori&title=Emerging+protein+targets+for+anticancer+metallodrugs%3A+inhibition+of+thioredoxin+reductase+and+cathepsin+B+by+antitumor+ruthenium%28II%29-arene+compounds&doi=10.1021%2Fjm8006678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging Protein Targets for Anticancer Metallodrugs: Inhibition of Thioredoxin Reductase and Cathepsin B by Antitumor Ruthenium(II)-Arene Compounds</span></div><div class="casAuthors">Casini, Angela; Gabbiani, Chiara; Sorrentino, Francesca; Rigobello, Maria Pia; Bindoli, Alberto; Geldbach, Tilmann J.; Marrone, Alessandro; Re, Nazzareno; Hartinger, Christian G.; Dyson, Paul J.; Messori, Luigi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6773-6781</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of ruthenium(II)-arene (RAPTA) compds. were evaluated for their ability to inhibit thioredoxin reductase (either cytosolic or mitochondrial) and cathepsin B, two possible targets for anticancer metallodrugs.  In general, inhibition of the thioredoxin reductases was lower than that of cathepsin B, although selected compds. were excellent inhibitors of both classes of enzymes in comparison to other metal-based drugs.  Some initial structure-activity relationships could be established.  On the basis of the obtained data, different mechanisms of binding/inhibition appear to be operative; remarkably the selectivity of the ruthenium compds. toward solid metastatic tumors also correlates to the obsd. trends.  Notably, docking studies of the interactions of representative RAPTA compds. with cathepsin B were performed that provided realistic structures for the resulting protein-metallodrug adducts.  Good agreement was generally found between the inhibiting potency of the RAPTA compds. and the computed stability of the corresponding cat B/RAPTA adducts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp31mwpgTGSJrVg90H21EOLACvtfcHk0lip78a6-fmuQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SjtrnP&md5=b0476c1489528084f704025bd416dbc3</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm8006678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8006678%26sid%3Dliteratum%253Aachs%26aulast%3DCasini%26aufirst%3DA.%26aulast%3DGabbiani%26aufirst%3DC.%26aulast%3DSorrentino%26aufirst%3DF.%26aulast%3DRigobello%26aufirst%3DM.%2BP.%26aulast%3DBindoli%26aufirst%3DA.%26aulast%3DGeldbach%26aufirst%3DT.%2BJ.%26aulast%3DMarrone%26aufirst%3DA.%26aulast%3DRe%26aufirst%3DN.%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DMessori%26aufirst%3DL.%26atitle%3DEmerging%2520protein%2520targets%2520for%2520anticancer%2520metallodrugs%253A%2520inhibition%2520of%2520thioredoxin%2520reductase%2520and%2520cathepsin%2520B%2520by%2520antitumor%2520ruthenium%2528II%2529-arene%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6773%26epage%3D6781%26doi%3D10.1021%2Fjm8006678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghobrial, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witzig, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adjei, A. A.</span></span> <span> </span><span class="NLM_article-title">Targeting apoptosis pathways in cancer therapy</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">178</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.3322/canjclin.55.3.178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.3322%2Fcanjclin.55.3.178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=15890640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A280%3ADC%252BD2M3ltFSrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=178-194&author=I.+M.+Ghobrialauthor=T.+E.+Witzigauthor=A.+A.+Adjei&title=Targeting+apoptosis+pathways+in+cancer+therapy&doi=10.3322%2Fcanjclin.55.3.178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting apoptosis pathways in cancer therapy</span></div><div class="casAuthors">Ghobrial Irene M; Witzig Thomas E; Adjei Alex A</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">178-94</span>
        ISSN:<span class="NLM_cas:issn">0007-9235</span>.
    </div><div class="casAbstract">Apoptosis, or programmed cell death, is a mechanism by which cells undergo death to control cell proliferation or in response to DNA damage.  The understanding of apoptosis has provided the basis for novel targeted therapies that can induce death in cancer cells or sensitize them to established cytotoxic agents and radiation therapy.  These novel agents include those targeting the extrinsic pathway such as tumor necrosis factor-related apoptosis-inducing ligand receptor 1, and those targeting the intrinsic Bcl-2 family pathway such as antisense bcl-2 oligonucleotides.  Many pathways and proteins control the apoptosis machinery.  Examples include p53, the nuclear factor kappa B, the phosphatidylinositol 3 kinase pathway, and the ubiquitin/proteosome pathway.  These can be targeted by specific modulators such as bortezomib, and mammalian target of rapamycin inhibitors such as CCI-779 and RAD 001.  Because these pathways may be preferentially altered in tumor cells, there is potential for a selective effect in tumors sparing normal tissue.  This article reviews the current understanding of the apoptotic pathways, including the extrinsic (cytoplasmic) and intrinsic (mitochondrial) pathways, and the agents being developed to target these pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLw6UbhfjAnfcsfMJQC1ZdfW6udTcc2eb1NNiG43ao-bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M3ltFSrsw%253D%253D&md5=4d3abeedf409e92fdd2c39ba33c79252</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.3322%2Fcanjclin.55.3.178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcanjclin.55.3.178%26sid%3Dliteratum%253Aachs%26aulast%3DGhobrial%26aufirst%3DI.%2BM.%26aulast%3DWitzig%26aufirst%3DT.%2BE.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26atitle%3DTargeting%2520apoptosis%2520pathways%2520in%2520cancer%2520therapy%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2005%26volume%3D55%26spage%3D178%26epage%3D194%26doi%3D10.3322%2Fcanjclin.55.3.178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S.</span></span> <span> </span><span class="NLM_article-title">Apoptosis: A review of programmed cell death</span>. <i>Toxicol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1080/01926230701320337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1080%2F01926230701320337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=17562483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtlWmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=495-516&author=S.+Elmore&title=Apoptosis%3A+A+review+of+programmed+cell+death&doi=10.1080%2F01926230701320337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis: A Review of Programmed Cell Death</span></div><div class="casAuthors">Elmore, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">495-516</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The process of programmed cell death, or apoptosis, is generally characterized by distinct morphol. characteristics and energy-dependent biochem. mechanisms.  Apoptosis is considered a vital component of various processes including normal cell turnover, proper development and functioning of the immune system, hormone-dependent atrophy, embryonic development and chem.-induced cell death.  Inappropriate apoptosis (either too little or too much) is a factor in many human conditions including neurodegenerative diseases, ischemic damage, autoimmune disorders and many types of cancer.  The ability to modulate the life or death of a cell is recognized for its immense therapeutic potential.  Therefore, research continues to focus on the elucidation and anal. of the cell cycle machinery and signaling pathways that control cell cycle arrest and apoptosis.  To that end, the field of apoptosis research has been moving forward at an alarmingly rapid rate.  Although many of the key apoptotic proteins have been identified, the mol. mechanisms of action or inaction of these proteins remain to be elucidated.  The goal of this review is to provide a general overview of current knowledge on the process of apoptosis including morphol., biochem., the role of apoptosis in health and disease, detection methods, as well as a discussion of potential alternative forms of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOnYsGFlMYFbVg90H21EOLACvtfcHk0ljq3fgqNwd1cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtlWmtb4%253D&md5=0f5e4a0a17cbfae1c7b3246eb1245e52</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1080%2F01926230701320337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F01926230701320337%26sid%3Dliteratum%253Aachs%26aulast%3DElmore%26aufirst%3DS.%26atitle%3DApoptosis%253A%2520A%2520review%2520of%2520programmed%2520cell%2520death%26jtitle%3DToxicol.%2520Pathol.%26date%3D2007%26volume%3D35%26spage%3D495%26epage%3D516%26doi%3D10.1080%2F01926230701320337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, W.</span></span> <span> </span><span class="NLM_article-title">Ruthenium(II) complexes as potential apoptosis inducers in chemotherapy</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.2174/1871520616666160622085441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F1871520616666160622085441" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=29-39&author=K.+Zhengauthor=Q.+Wuauthor=C.+Wangauthor=W.+Tanauthor=W.+Mei&title=Ruthenium%28II%29+complexes+as+potential+apoptosis+inducers+in+chemotherapy&doi=10.2174%2F1871520616666160622085441"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.2174%2F1871520616666160622085441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871520616666160622085441%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DMei%26aufirst%3DW.%26atitle%3DRuthenium%2528II%2529%2520complexes%2520as%2520potential%2520apoptosis%2520inducers%2520in%2520chemotherapy%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2017%26volume%3D17%26spage%3D29%26epage%3D39%26doi%3D10.2174%2F1871520616666160622085441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and anticancer properties of ruthenium (II) complexes as potent apoptosis inducers through mitochondrial disruption</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.07.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ejmech.2017.07.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28800456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSls7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=180-190&author=D.+Wanauthor=B.+Tangauthor=Y.+J.+Wangauthor=B.+H.+Guoauthor=H.+Yinauthor=Q.+Y.+Yiauthor=Y.+J.+Liu&title=Synthesis+and+anticancer+properties+of+ruthenium+%28II%29+complexes+as+potent+apoptosis+inducers+through+mitochondrial+disruption&doi=10.1016%2Fj.ejmech.2017.07.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anticancer properties of ruthenium (II) complexes as potent apoptosis inducers through mitochondrial disruption</span></div><div class="casAuthors">Wan, Dan; Tang, Bing; Wang, Yang-Jie; Guo, Bo-Hong; Yin, Hui; Yi, Qiao-Yan; Liu, Yun-Jun</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">180-190</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A new ligand MHPIP (MHPIP = 2-(1-methyl-1H-pyrazol-4-yl)-1H-imidazo[4,5-f][1,10]phenanthroline) and its three ruthenium (II) complexes [Ru(N-N)2(MHPIP)](ClO4)2 (N-N = phen: 1,10-phenanthroline 1; dmp = 2,9-dimethyl-1,10-phenanthroline 2; ttbpy = 4,4'-ditertiarybutyl-2,2'-bipyridine 3) were synthesized and characterized.  The cytotoxic activity in vitro was studied by MTT method.  The complexes 1-3 show moderate cytotoxic effects on the cell growth in HepG2 cells with an IC50 value of 25.5 ± 3.5, 35.6 ± 1.9 and 27.4 ± 2.3 μM, resp.  The apoptosis was investigated with AO/EB and Annex V/PI staining methods and comet assay.  The reactive oxygen species, mitochondrial membrane potential were investigated under a fluorescent microscope.  Autophagy assay shows that the complexes can cause autophagy and up-regulate the expression of Beclin-1 protein.  Addnl., the complexes inhibit the cell growth in HepG2 cells at G0/G1 phase, and the complexes can regulate the expression of caspase-3 and Bcl-2 family proteins.  The complexes induce apoptosis in HepG2 cells through DNA damage and ROS-mediated mitochondrial dysfunction pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBFjnmKY3YzrVg90H21EOLACvtfcHk0ljq3fgqNwd1cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSls7fK&md5=4480f3a3257d2e3b6b6333ea35990724</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.07.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.07.066%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%2BJ.%26aulast%3DGuo%26aufirst%3DB.%2BH.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DYi%26aufirst%3DQ.%2BY.%26aulast%3DLiu%26aufirst%3DY.%2BJ.%26atitle%3DSynthesis%2520and%2520anticancer%2520properties%2520of%2520ruthenium%2520%2528II%2529%2520complexes%2520as%2520potent%2520apoptosis%2520inducers%2520through%2520mitochondrial%2520disruption%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D139%26spage%3D180%26epage%3D190%26doi%3D10.1016%2Fj.ejmech.2017.07.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. S.</span></span> <span> </span><span class="NLM_article-title">Ruthenium polypyridyl complexes that induce mitochondria-mediated apoptosis in cancer cells</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6366</span>– <span class="NLM_lpage">6368</span>, <span class="refDoi"> DOI: 10.1021/ic100277w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic100277w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFyqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6366-6368&author=T.+Chenauthor=Y.+Liuauthor=W.+J.+Zhengauthor=J.+Liuauthor=Y.+S.+Wong&title=Ruthenium+polypyridyl+complexes+that+induce+mitochondria-mediated+apoptosis+in+cancer+cells&doi=10.1021%2Fic100277w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium Polypyridyl Complexes That Induce Mitochondria-Mediated Apoptosis in Cancer Cells</span></div><div class="casAuthors">Chen, Tianfeng; Liu, Yanan; Zheng, Wen-Jie; Liu, Jie; Wong, Yum-Shing</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6366-6368</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The limitations of cisplatin-based chemotherapy, including high toxicity, undesirable side effects, and drug resistance, have motivated extensive investigations into alternative metal-based cancer therapies.  Ruthenium (Ru) possesses several favorable properties suited to rational anticancer drug design and biol. applications.  In the present study, we synthesized a series of ruthenium polypyridyl complexes contg. N,N-chelating ligands, examd. their anticancer activities, and elucidated the mol. mechanisms through which they caused the cancer cell death.  The results demonstrated that [Ru(phen)2-p-MOPIP](PF6)2·2H2O (RuPOP), a complex with potent antiproliferative activity, is able to induce mitochondria-mediated and caspase-dependent apoptosis in human cancer cells.  On the basis of these results, we suggest that RuPOP may be a candidate for further evaluation as a chemopreventive and chemotherapeutic agent for human cancers, esp. for melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK3CCg7D3hOLVg90H21EOLACvtfcHk0ljq3fgqNwd1cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFyqsL8%253D&md5=5b73dac8b2f844d4c31d6bd081a7f5f0</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fic100277w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic100277w%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DW.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DY.%2BS.%26atitle%3DRuthenium%2520polypyridyl%2520complexes%2520that%2520induce%2520mitochondria-mediated%2520apoptosis%2520in%2520cancer%2520cells%26jtitle%3DInorg.%2520Chem.%26date%3D2010%26volume%3D49%26spage%3D6366%26epage%3D6368%26doi%3D10.1021%2Fic100277w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. J.</span></span> <span> </span><span class="NLM_article-title">Ruthenium(II) complexes: DNA-binding, cytotoxicity, apoptosis, cellular localization, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential and western blot analysis</span>. <i>J. Photochem. Photobiol., B</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2014.07.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jphotobiol.2014.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=25108205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Kqsr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2014&pages=94-104&author=W.+Liauthor=G.+W.+Jiangauthor=J.+H.+Yaoauthor=X.+Z.+Wangauthor=J.+Wangauthor=B.+J.+Hanauthor=Y.+Y.+Xieauthor=G.+J.+Linauthor=H.+L.+Huangauthor=Y.+J.+Liu&title=Ruthenium%28II%29+complexes%3A+DNA-binding%2C+cytotoxicity%2C+apoptosis%2C+cellular+localization%2C+cell+cycle+arrest%2C+reactive+oxygen+species%2C+mitochondrial+membrane+potential+and+western+blot+analysis&doi=10.1016%2Fj.jphotobiol.2014.07.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium(II) complexes: DNA-binding, cytotoxicity, apoptosis, cellular localization, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential and western blot analysis</span></div><div class="casAuthors">Li, Wei; Jiang, Guang-Bin; Yao, Jun-Hua; Wang, Xiu-Zhen; Wang, Ji; Han, Bing-Jie; Xie, Yang-Yin; Lin, Gan-Jian; Huang, Hong-Liang; Liu, Yun-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">94-104</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The aim of our study was to investigate DNA-binding and cytotoxic activity of the four new Ru(II) polypyridyl complexes [Ru(dmb)2(HMHPIP)](ClO4)2 (1), [Ru(bpy)2(HMHPIP)](ClO4)2 (2), [Ru(phen)2(HMHPIP)](ClO4)2 (3) and [Ru(dmp)2(HMHPIP)](ClO4)2 (4).  The complexes interact with DNA through intercalative mode and show relatively high cytotoxic activity against A549 cells, no cytotoxicity toward MG-63 cells.  Complexes 1-4 can enhance the levels of ROS in A549 cells and induce the decrease of the mitochondrial membrane potential.  These complexes inhibit the cell growth in A549 cells at G0/G1 or S phase.  Complex 3 activated caspase 7, and down-regulated the expression of the anti-apoptotic protein Bcl-2.  Complexes 1-4 induce apoptosis in A549 cells through ROS-mediated mitochondrial dysfunction pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmiX4GYtV-pbVg90H21EOLACvtfcHk0lifH-Qydi4gJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Kqsr7J&md5=de43b46ff2feae8af918450a6ba09287</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2014.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2014.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DG.%2BW.%26aulast%3DYao%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DX.%2BZ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DB.%2BJ.%26aulast%3DXie%26aufirst%3DY.%2BY.%26aulast%3DLin%26aufirst%3DG.%2BJ.%26aulast%3DHuang%26aufirst%3DH.%2BL.%26aulast%3DLiu%26aufirst%3DY.%2BJ.%26atitle%3DRuthenium%2528II%2529%2520complexes%253A%2520DNA-binding%252C%2520cytotoxicity%252C%2520apoptosis%252C%2520cellular%2520localization%252C%2520cell%2520cycle%2520arrest%252C%2520reactive%2520oxygen%2520species%252C%2520mitochondrial%2520membrane%2520potential%2520and%2520western%2520blot%2520analysis%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%252C%2520B%26date%3D2014%26volume%3D140%26spage%3D94%26epage%3D104%26doi%3D10.1016%2Fj.jphotobiol.2014.07.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castonguay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doucet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juhas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maysinger, D.</span></span> <span> </span><span class="NLM_article-title">New ruthenium(II)–letrozole complexes as anticancer therapeutics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8799</span>– <span class="NLM_lpage">8806</span>, <span class="refDoi"> DOI: 10.1021/jm301103y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301103y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8799-8806&author=A.+Castonguayauthor=C.+Doucetauthor=M.+Juhasauthor=D.+Maysinger&title=New+ruthenium%28II%29%E2%80%93letrozole+complexes+as+anticancer+therapeutics&doi=10.1021%2Fjm301103y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fjm301103y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301103y%26sid%3Dliteratum%253Aachs%26aulast%3DCastonguay%26aufirst%3DA.%26aulast%3DDoucet%26aufirst%3DC.%26aulast%3DJuhas%26aufirst%3DM.%26aulast%3DMaysinger%26aufirst%3DD.%26atitle%3DNew%2520ruthenium%2528II%2529%25E2%2580%2593letrozole%2520complexes%2520as%2520anticancer%2520therapeutics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8799%26epage%3D8806%26doi%3D10.1021%2Fjm301103y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span> <span> </span><span class="NLM_article-title">Nuclear permeable ruthenium(II) β-carboline complexes induce autophagy to antagonize mitochondrial-mediated apoptosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7613</span>– <span class="NLM_lpage">7624</span>, <span class="refDoi"> DOI: 10.1021/jm1009296</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1009296" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSntbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7613-7624&author=C.+Tanauthor=S.+Laiauthor=S.+Wuauthor=S.+Huauthor=L.+Zhouauthor=Y.+Chenauthor=M.+Wangauthor=Y.+Zhuauthor=W.+Lianauthor=W.+Pengauthor=L.+Jiauthor=A.+Xu&title=Nuclear+permeable+ruthenium%28II%29+%CE%B2-carboline+complexes+induce+autophagy+to+antagonize+mitochondrial-mediated+apoptosis&doi=10.1021%2Fjm1009296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear Permeable Ruthenium(II) β-Carboline Complexes Induce Autophagy To Antagonize Mitochondrial-Mediated Apoptosis</span></div><div class="casAuthors">Tan, Caiping; Lai, Sensen; Wu, Shouhai; Hu, Sheng; Zhou, Lingjun; Chen, Yu; Wang, Minxu; Zhu, Yiping; Lian, Wu; Peng, Wenlie; Ji, Liangnian; Xu, Anlong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7613-7624</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The role of autophagy in cancer development and response to cancer therapy has been a subject of debate.  Here we demonstrate that a series of ruthenium(II) complexes contg. a β-carboline alkaloid as ligand can simultaneously induce autophagy and apoptosis in tumor cells.  These Ru(II) complexes are nuclear permeable and highly active against a panel of human cancer cell lines, with complex 3 displaying activities greater than those of cisplatin.  The antiproliferative potentialities of 1-3 are in accordance with their relative lipophilicities, cell membrane penetration abilities, and in vitro DNA binding affinities.  Complexes 1-3 trigger release of reactive oxygen species (ROS) and attenuation of ROS by scavengers reduced the sub-G1 population, suggesting ROS-dependent apoptosis.  Inhibition of ROS generation also reduces autophagy, indicating that ROS triggers autophagy.  Further studies show that suppression of autophagy using pharmacol. inhibitors (3-methyladenine and chloroquine) enhances apoptotic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfI94bSBZCQLVg90H21EOLACvtfcHk0lifH-Qydi4gJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSntbjN&md5=8c2e1e1037d4a28e485e4776ddef930c</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjm1009296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1009296%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DC.%26aulast%3DLai%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLian%26aufirst%3DW.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DA.%26atitle%3DNuclear%2520permeable%2520ruthenium%2528II%2529%2520%25CE%25B2-carboline%2520complexes%2520induce%2520autophagy%2520to%2520antagonize%2520mitochondrial-mediated%2520apoptosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7613%26epage%3D7624%26doi%3D10.1021%2Fjm1009296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngai, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1480</span>– <span class="NLM_lpage">1490</span>, <span class="refDoi"> DOI: 10.1039/C4MT00044G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC4MT00044G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=24823440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtF2rsrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1480-1490&author=Z.+Luoauthor=L.+Yuauthor=F.+Yangauthor=Z.+Zhaoauthor=B.+Yuauthor=H.+Laiauthor=K.+H.+Wongauthor=S.+M.+Ngaiauthor=W.+Zhengauthor=T.+Chen&title=Ruthenium+polypyridyl+complexes+as+inducer+of+ROS-mediated+apoptosis+in+cancer+cells+by+targeting+thioredoxin+reductase&doi=10.1039%2FC4MT00044G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase</span></div><div class="casAuthors">Luo, Zuandi; Yu, Lianling; Yang, Fang; Zhao, Zhennan; Yu, Bo; Lai, Haoqiang; Wong, Ka-Hing; Ngai, Sai-Ming; Zheng, Wenjie; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1480-1490</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">TrxR is an NADPH-dependent selenoenzyme upregulated in a no. of cancers.  It plays a pivotal role in cancer progression and represents an increasingly attractive target for anticancer drugs.  The limitations of cisplatin in cancer treatment have motivated the extensive investigation to other metal complexes, esp. ruthenium (Ru) complexes.  In this study, we present the in vitro biol. evaluation of four Ru(II) polypridyl complexes with diimine ligands, namely, [Ru(bpy)3]2+ (1), [Ru(phen)3]2+ (2), [Ru(i.p.)3]2+ (3), [Ru(pip)3]2+ (4) (bpy = 2,2'-bipyridine, phen = 1,10-phenanthroline, i.p. = imidazole[4,5-f][1,10]phenanthroline, pip = 2-phenylimidazo[4,5-f][1,10]phenanthroline), and demonstrate that they exhibit antiproliferative activities against A375 human melanoma cells through inhibition of TrxR.  As the planarity of the structure increases, their TrxR-inhibitory effects and in vitro anticancer activities were enhanced.  Among them, complex 4 exhibited higher antiproliferative activity than cisplatin, and the TrxR-inhibitory potency of 4 was more effective than auranofin, a pos. TrxR inhibitor.  Complex 4 suppressed the cancer cell growth through induction of apoptosis as evidenced by accumulation of sub-G1 cell population, DNA fragmentation and nuclear condensation.  Moreover, complex 4 was able to localize in mitochondria and therein induced ROS-dependent apoptosis by inhibition of TrxR activity.  Activation of MAPKs, AKT, DNA damage-mediated p53 phosphorylation and inhibition of VEGFR signaling were also triggered in cells exposed to complex 4.  On the basis of this evidence, we suggest that Ru polypyridyl complexes could be developed as TrxR-targeted agents that demonstrate application potentials for treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeZZCCQveR-rVg90H21EOLACvtfcHk0lhx6iyWkgRh6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtF2rsrrK&md5=9e74cca7a8be3d1fbbc36a986d333e2e</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1039%2FC4MT00044G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MT00044G%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DLai%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DK.%2BH.%26aulast%3DNgai%26aufirst%3DS.%2BM.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DRuthenium%2520polypyridyl%2520complexes%2520as%2520inducer%2520of%2520ROS-mediated%2520apoptosis%2520in%2520cancer%2520cells%2520by%2520targeting%2520thioredoxin%2520reductase%26jtitle%3DMetallomics%26date%3D2014%26volume%3D6%26spage%3D1480%26epage%3D1490%26doi%3D10.1039%2FC4MT00044G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Q. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span> <span> </span><span class="NLM_article-title">Water-soluble ruthenium(II) complexes with chiral 4-(2,3-dihydroxypropyl)-formamide oxoaporphine (FOA): In vitro and in vivo anticancer activity by stabilization of G-quadruplex DNA, inhibition of telomerase activity, and induction of tumor cell apoptosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4771</span>– <span class="NLM_lpage">4789</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00444</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00444" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFaktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4771-4789&author=Z.+F.+Chenauthor=Q.+P.+Qinauthor=J.+L.+Qinauthor=J.+Zhouauthor=Y.+L.+Liauthor=N.+Liauthor=Y.+C.+Liuauthor=H.+Liang&title=Water-soluble+ruthenium%28II%29+complexes+with+chiral+4-%282%2C3-dihydroxypropyl%29-formamide+oxoaporphine+%28FOA%29%3A+In+vitro+and+in+vivo+anticancer+activity+by+stabilization+of+G-quadruplex+DNA%2C+inhibition+of+telomerase+activity%2C+and+induction+of+tumor+cell+apoptosis&doi=10.1021%2Facs.jmedchem.5b00444"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Water-Soluble Ruthenium(II) Complexes with Chiral 4-(2,3-Dihydroxypropyl)-formamide Oxoaporphine (FOA): In Vitro and in Vivo Anticancer Activity by Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity, and Induction of Tumor Cell Apoptosis</span></div><div class="casAuthors">Chen, Zhen-Feng; Qin, Qi-Pin; Qin, Jiao-Lan; Zhou, Jie; Li, Yu-Lan; Li, Nan; Liu, Yan-Cheng; Liang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4771-4789</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Three water-sol. ruthenium(II) complexes with chiral 4-(2,3-dihydroxypropyl)-formamide oxoaporphine (FOA) were synthesized and characterized.  It was found that these ruthenium(II) complexes exhibited considerable in vitro anticancer activities and that they were the effective stabilizers of telomeric and G-quadruplex-DNA (G4-DNA) in promoter of c-myc, which acted as a telomerase inhibitor targeting G4-DNA and induced cell senescence and apoptosis.  Interestingly, the in vitro anticancer activity of 6 (LC-003) was higher than those of 4 (LC-001) and 5 (LC-002), more selective for BEL-7404 cells than for normal HL-7702 cells, and preferred to activate caspases-3/9.  The different biol. behaviors of the ruthenium complexes could be correlated with the chiral nature of 4-(2,3-dihydroxypropyl)-formamide oxoaporphine.  More significantly, 6 exhibited effective inhibitory on tumor growth in BEL-7402 xenograft mouse model and higher in vivo safety than cisplatin.  These mechanistic insights indicate that 6 displays low toxicity and can be a novel anticancer drug candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJKydKSiDEKLVg90H21EOLACvtfcHk0lhx6iyWkgRh6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFaktb0%253D&md5=3cd16ac3e5f3ad27f46be1ccea91be60</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00444%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%2BF.%26aulast%3DQin%26aufirst%3DQ.%2BP.%26aulast%3DQin%26aufirst%3DJ.%2BL.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DY.%2BC.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3DWater-soluble%2520ruthenium%2528II%2529%2520complexes%2520with%2520chiral%25204-%25282%252C3-dihydroxypropyl%2529-formamide%2520oxoaporphine%2520%2528FOA%2529%253A%2520In%2520vitro%2520and%2520in%2520vivo%2520anticancer%2520activity%2520by%2520stabilization%2520of%2520G-quadruplex%2520DNA%252C%2520inhibition%2520of%2520telomerase%2520activity%252C%2520and%2520induction%2520of%2520tumor%2520cell%2520apoptosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4771%26epage%3D4789%26doi%3D10.1021%2Facs.jmedchem.5b00444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettinari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettinari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skelton, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonfili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuccioloni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozzicafreddo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecarini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeletti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eleuteri, A. M.</span></span> <span> </span><span class="NLM_article-title">Arene-ruthenium(II) acylpyrazolonato complexes: apoptosis-promoting effects on human cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4532</span>– <span class="NLM_lpage">4542</span>, <span class="refDoi"> DOI: 10.1021/jm500458c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500458c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntlKns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4532-4542&author=R.+Pettinariauthor=C.+Pettinariauthor=F.+Marchettiauthor=B.+W.+Skeltonauthor=A.+H.+Whiteauthor=L.+Bonfiliauthor=M.+Cuccioloniauthor=M.+Mozzicafreddoauthor=V.+Cecariniauthor=M.+Angelettiauthor=M.+Nabissiauthor=A.+M.+Eleuteri&title=Arene-ruthenium%28II%29+acylpyrazolonato+complexes%3A+apoptosis-promoting+effects+on+human+cancer+cells&doi=10.1021%2Fjm500458c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Arene-Ruthenium(II) Acylpyrazolonato Complexes: Apoptosis-Promoting Effects on Human Cancer Cells</span></div><div class="casAuthors">Pettinari, Riccardo; Pettinari, Claudio; Marchetti, Fabio; Skelton, Brian W.; White, Allan H.; Bonfili, Laura; Cuccioloni, Massimiliano; Mozzicafreddo, Matteo; Cecarini, Valentina; Angeletti, Mauro; Nabissi, Massimo; Eleuteri, Anna Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4532-4542</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of ruthenium(II) arene complexes with the 4-(biphenyl-4-carbonyl)-3-methyl-1-phenyl-5-pyrazolonate ligand, and related 1,3,5-triaza-7-phosphaadamantane (PTA) derivs., has been synthesized.  The compds. have been characterized by NMR and IR spectroscopy, ESI mass spectrometry, elemental anal., and X-ray crystallog.  Antiproliferative activity in four human cancer cell lines was detd. by MTT assay, yielding dose- and cancer cell line-dependent IC50 values of 9-34 μM for three hexamethylbenzene-ruthenium complexes, whereas the other metal complexes were much less active.  Apoptosis was the mechanism involved in the anticancer activity of such compds.  In fact, the hexamethylbenzene-ruthenium complexes activated caspase activity, with consequent DNA fragmentation, accumulation of pro-apoptotic proteins (p27, p53, p89 PARP fragments), and the concomitant down-regulation of antiapoptotic protein Bcl-2.  Biosensor-based binding studies indicated that the ancillary ligands were crit. in detg. the DNA binding affinities, and competition binding expts. further characterized the nature of the interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFYkJ_DKvP4LVg90H21EOLACvtfcHk0lhx6iyWkgRh6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntlKns7c%253D&md5=7b7494a51759b407387713df02331c9a</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fjm500458c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500458c%26sid%3Dliteratum%253Aachs%26aulast%3DPettinari%26aufirst%3DR.%26aulast%3DPettinari%26aufirst%3DC.%26aulast%3DMarchetti%26aufirst%3DF.%26aulast%3DSkelton%26aufirst%3DB.%2BW.%26aulast%3DWhite%26aufirst%3DA.%2BH.%26aulast%3DBonfili%26aufirst%3DL.%26aulast%3DCuccioloni%26aufirst%3DM.%26aulast%3DMozzicafreddo%26aufirst%3DM.%26aulast%3DCecarini%26aufirst%3DV.%26aulast%3DAngeletti%26aufirst%3DM.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DEleuteri%26aufirst%3DA.%2BM.%26atitle%3DArene-ruthenium%2528II%2529%2520acylpyrazolonato%2520complexes%253A%2520apoptosis-promoting%2520effects%2520on%2520human%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4532%26epage%3D4542%26doi%3D10.1021%2Fjm500458c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yerra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, E. J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, characterization, cytotoxic and structure activity relationships of novel Ru(II) complexes</span>. <i>Chin. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">721</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1016/j.cclet.2015.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.cclet.2015.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltlKgsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=721-726&author=S.+Thotaauthor=S.+Vallalaauthor=R.+Yerraauthor=E.+J.+Barreiro&title=Design%2C+synthesis%2C+characterization%2C+cytotoxic+and+structure+activity+relationships+of+novel+Ru%28II%29+complexes&doi=10.1016%2Fj.cclet.2015.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, characterization, cytotoxic and structure activity relationships of novel Ru(II) complexes</span></div><div class="casAuthors">Thota, Sreekanth; Vallala, Srujana; Yerra, Rajeshwar; Barreiro, Eliezer J.</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Chemical Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">721-726</span>CODEN:
                <span class="NLM_cas:coden">CCLEE7</span>;
        ISSN:<span class="NLM_cas:issn">1001-8417</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Platinum contg. compds. showed antineoplastic potential, but their clin. applications have been limited by high toxicity.  Ruthenium contg. complexes have long been known to be well suited for biol. applications, and have long been used as replacements to popular platinum based-drugs.  Here, the authors report a novel series of ruthenium(II) arene compds. ([Ru(N-N)2L] where N-N = 1,10-phenanthroline or 2,2'-bipyridine and L = thiosemicarbazone or isonicotinylhydrazone ligands) bearing thiosemicarbazone and isonicotinylhydrazone ligands with potent anticancer activity their structure activity relations and apoptosis was studied.  The cytotoxic activity of the new ruthenium(II) arene compds. has been evaluated in several cell lines (Molt 4/C8, L1210, CEM, HL60 and BEL7402).  Among them, ten complexes are excellent in vitro growth inhibitory activity against various cell lines with IC50 in the sub-micromolar range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAymQ-dzQlj7Vg90H21EOLACvtfcHk0lhUWsQexQj9fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltlKgsr4%253D&md5=f431961ac7548e424c007a2d49ca530a</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.cclet.2015.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cclet.2015.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DThota%26aufirst%3DS.%26aulast%3DVallala%26aufirst%3DS.%26aulast%3DYerra%26aufirst%3DR.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520characterization%252C%2520cytotoxic%2520and%2520structure%2520activity%2520relationships%2520of%2520novel%2520Ru%2528II%2529%2520complexes%26jtitle%3DChin.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D26%26spage%3D721%26epage%3D726%26doi%3D10.1016%2Fj.cclet.2015.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cloonan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmes, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bright, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poynton, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunnlaugsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. C.</span></span> <span> </span><span class="NLM_article-title">Detailed biological profiling of a photoactivated and apoptosis inducing pdppz ruthenium(II) polypyridyl complex in cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4494</span>– <span class="NLM_lpage">4505</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00451</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00451" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXot1SqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4494-4505&author=S.+M.+Cloonanauthor=R.+B.+Elmesauthor=M.+Erbyauthor=S.+A.+Brightauthor=F.+E.+Poyntonauthor=D.+E.+Nolanauthor=S.+J.+Quinnauthor=T.+Gunnlaugssonauthor=D.+C.+Williams&title=Detailed+biological+profiling+of+a+photoactivated+and+apoptosis+inducing+pdppz+ruthenium%28II%29+polypyridyl+complex+in+cancer+cells&doi=10.1021%2Facs.jmedchem.5b00451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Detailed Biological Profiling of a Photoactivated and Apoptosis Inducing pdppz Ruthenium(II) Polypyridyl Complex in Cancer Cells</span></div><div class="casAuthors">Cloonan, Suzanne M.; Elmes, Robert B. P.; Erby, MariaLuisa; Bright, Sandra A.; Poynton, Fergus E.; Nolan, Derek E.; Quinn, Susan J.; Gunnlaugsson, Thorfinnur; Williams, D. Clive</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4494-4505</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ruthenium polypyridyl complexes show great promise as new photodynamic therapy (PDT) agents.  However, a lack of detailed understanding of their mode of action in cells poses a challenge to their development.  We have designed a new Ru(II) PDT candidate that efficiently enters cells by incorporation of the lipophilic arom. pdppz ([2,3-h]dipyrido[3,2-a:2',3'-c]phenazine) ligand and exhibits photoactivity through incorporation of 1,4,5,8-tetraazaphenanthrene ancillary ligands.  Its photoreactivity toward biomols. was studied in vitro, where light activation caused DNA cleavage.  Cellular internalization occurred via an energy dependent mechanism.  Confocal and transmission electron microscopy revealed that the complex localizes in various organelles, including the mitochondria.  The complex is nontoxic in the dark, with cellular clearance within 96 h; however, upon visible light activation it induces caspase-dependent and reactive-oxygen-species-dependent apoptosis, with low micromolar IC50 values.  This investigation greatly increases our understanding of such systems in cellulo, aiding development and realization of their application in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou-7ftJg3jLLVg90H21EOLACvtfcHk0lhUWsQexQj9fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXot1SqsLk%253D&md5=973d63ff055f258aaf2a7af8cf975468</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00451%26sid%3Dliteratum%253Aachs%26aulast%3DCloonan%26aufirst%3DS.%2BM.%26aulast%3DElmes%26aufirst%3DR.%2BB.%26aulast%3DErby%26aufirst%3DM.%26aulast%3DBright%26aufirst%3DS.%2BA.%26aulast%3DPoynton%26aufirst%3DF.%2BE.%26aulast%3DNolan%26aufirst%3DD.%2BE.%26aulast%3DQuinn%26aufirst%3DS.%2BJ.%26aulast%3DGunnlaugsson%26aufirst%3DT.%26aulast%3DWilliams%26aufirst%3DD.%2BC.%26atitle%3DDetailed%2520biological%2520profiling%2520of%2520a%2520photoactivated%2520and%2520apoptosis%2520inducing%2520pdppz%2520ruthenium%2528II%2529%2520polypyridyl%2520complex%2520in%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4494%26epage%3D4505%26doi%3D10.1021%2Facs.jmedchem.5b00451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liany, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corrêa, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deflon, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cominetti, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista, A. A.</span></span> <span> </span><span class="NLM_article-title">Selective Ru(II)/lawsone complexes inhibiting tumor cell growth by apoptosis</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2017.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jinorgbio.2017.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28865744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOjtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2017&pages=66-76&author=K.+M.+Oliveiraauthor=L.+D.+Lianyauthor=R.+S.+Corr%C3%AAaauthor=V.+M.+Deflonauthor=M.+R.+Cominettiauthor=A.+A.+Batista&title=Selective+Ru%28II%29%2Flawsone+complexes+inhibiting+tumor+cell+growth+by+apoptosis&doi=10.1016%2Fj.jinorgbio.2017.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Ru(II)/lawsone complexes inhibiting tumor cell growth by apoptosis</span></div><div class="casAuthors">Oliveira, Katia M.; Liany, Luna-Dulcey; Correa, Rodrigo S.; Deflon, Victor M.; Cominetti, Marcia R.; Batista, Alzir A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">66-76</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">New Ru(II) complexes with lawsone (law) characterized as trans-[Ru(law)(PPh3)2(N-N)]PF6, where PPh3 means triphenylphosphine and N-N is 2,2'-bipyridine (1), 4,4'-dimethyl-2,2'-bipyridine (2), 4,4'-dimethoxy-2,2'-bipyridine (3), 1,10-phenanthroline (4) or 4,7-diphenyl-1,10-phenanthroline (5), induce apoptosis in tumor cells.  Cytotoxicity of the complexes against the tumor cell lines DU-145 (prostate cancer cells), MCF-7 (breast cancer cells), A549 (lung cancer cells) and lung non-tumor cell line MRC-5 demonstrated promising IC50 values, lower than those found for the cisplatin, a drug used as a ref.  Due to the high cytotoxic activity and selectivity against A549 cells line, complex was selected for detailed assays.  The complex inhibits cells migration in concns. in a nanomolar range, inducing tumor cell death by apoptosis, as confirmed by flow cytometry expts.  Furthermore, the antiproliferative activity of complex on A549 tumor cells is attributed to a cell cycle arrest at the Sub G1 phase, followed by a decrease in the no. of cells at the S phase.  In addn., the interaction of the complexes (1-5) with CT-DNA was evaluated by CD, in which no changes in the secondary structure of DNA were obsd., suggesting a weak interaction of the complexes with the biomol.  Complexes (1-5) showed a higher interaction with human serum albumin (HSA) by non-covalent van der Waals forces and hydrogen bonding, resulting in static quenching.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWVjOT08uTD7Vg90H21EOLACvtfcHk0lgjU4fUoBFXiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOjtr3J&md5=5d1be17905dc0bcfb5e7caa42d5faa06</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2017.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2017.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DOliveira%26aufirst%3DK.%2BM.%26aulast%3DLiany%26aufirst%3DL.%2BD.%26aulast%3DCorr%25C3%25AAa%26aufirst%3DR.%2BS.%26aulast%3DDeflon%26aufirst%3DV.%2BM.%26aulast%3DCominetti%26aufirst%3DM.%2BR.%26aulast%3DBatista%26aufirst%3DA.%2BA.%26atitle%3DSelective%2520Ru%2528II%2529%252Flawsone%2520complexes%2520inhibiting%2520tumor%2520cell%2520growth%2520by%2520apoptosis%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2017%26volume%3D176%26spage%3D66%26epage%3D76%26doi%3D10.1016%2Fj.jinorgbio.2017.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span> <span> </span><span class="NLM_article-title">Protein kinase biochemistry and drug discovery</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2011.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.bioorg.2011.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=21872901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GqsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=192-210&author=P.+A.+Schwartzauthor=B.+W.+Murray&title=Protein+kinase+biochemistry+and+drug+discovery&doi=10.1016%2Fj.bioorg.2011.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase biochemistry and drug discovery</span></div><div class="casAuthors">Schwartz, Phillip A.; Murray, Brion W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">192-210</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein kinases are fascinating biol. catalysts with a rapidly expanding knowledge base, a growing appreciation in cell regulatory control, and an ascendant role in successful therapeutic intervention.  To better understand protein kinases, the mol. underpinnings of phosphoryl group transfer, protein phosphorylation, and inhibitor interactions are examd.  This anal. begins with a survey of phosphate group and phosphoprotein properties which provide context to the evolutionary selection of phosphorylation as a central mechanism for biol. regulation of most cellular processes.  Next, the kinetic and catalytic mechanisms of protein kinases are examd. with respect to model aq. systems to define the elements of catalysis.  A brief structural biol. overview further delves into the mol. basis of catalysis and regulation of catalytic activity.  Concomitant with a prominent role in normal physiol., protein kinases have important roles in the disease state.  To facilitate effective kinase drug discovery, classic and emerging approaches for characterizing kinase inhibitors are evaluated including biochem. assay design, inhibitor mechanism of action anal., and proper kinetic treatment of irreversible inhibitors.  As the resulting protein kinase inhibitors can modulate intended and unintended targets, profiling methods are discussed which can illuminate a more complete range of an inhibitor's biol. activities to enable more meaningful cellular studies and more effective clin. studies.  Taken as a whole, a wealth of protein kinase biochem. knowledge is available, yet it is clear that a substantial extent of our understanding in this field remains to be discovered which should yield many new opportunities for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx9JNgQhbDT7Vg90H21EOLACvtfcHk0lgjU4fUoBFXiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GqsrfE&md5=3c85386861ef6effbd7ef95d638df0a2</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2011.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2011.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DP.%2BA.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26atitle%3DProtein%2520kinase%2520biochemistry%2520and%2520drug%2520discovery%26jtitle%3DBioorg.%2520Chem.%26date%3D2011%26volume%3D39%26spage%3D192%26epage%3D210%26doi%3D10.1016%2Fj.bioorg.2011.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Organometallic compounds: an opportunity for chemical biology?</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1232</span>– <span class="NLM_lpage">1252</span>, <span class="refDoi"> DOI: 10.1002/cbic.201200159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fcbic.201200159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=22619182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Kktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=1232-1252&author=M.+Patraauthor=G.+Gasser&title=Organometallic+compounds%3A+an+opportunity+for+chemical+biology%3F&doi=10.1002%2Fcbic.201200159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic Compounds: An Opportunity for Chemical Biology?</span></div><div class="casAuthors">Patra, Malay; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1232-1252</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Organometallic compds. are renowned for their remarkable applications in the field of catalysis, but much less is known about their potential in chem. biol.  Indeed, such compds. have long been considered to be either unstable under physiol. conditions or cytotoxic.  As a consequence, little attention has been paid to their possible utilization for biol. purposes.  Because of their outstanding physicochem. properties, which include chem. stability, structural diversity and unique photo- and electrochem. properties, however, organometallic compds. have the ability to play a leading role in the field of chem. biol.  Indeed, remarkable examples of the use of such compds.-notably as enzyme inhibitors and as luminescent agents-have recently been reported.  Here we summarise recent advances in the use of organometallic compds. for chem. biol. purposes, an area that we define as "organometallic chem. biol.".  We also demonstrate that these recent discoveries are only a beginning and that many other organometallic complexes are likely to be found useful in this field of research in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPNf0UB7MS87Vg90H21EOLACvtfcHk0lgjU4fUoBFXiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Kktrw%253D&md5=45260dcd1168ae3b7311dad351669eda</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201200159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201200159%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DM.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DOrganometallic%2520compounds%253A%2520an%2520opportunity%2520for%2520chemical%2520biology%253F%26jtitle%3DChemBioChem%26date%3D2012%26volume%3D13%26spage%3D1232%26epage%3D1252%26doi%3D10.1002%2Fcbic.201200159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meggers, E.</span></span> <span> </span><span class="NLM_article-title">Exploring biologically relevant chemical space with metal complexes</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2007.05.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.cbpa.2007.05.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=17548234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvVOnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=287-292&author=E.+Meggers&title=Exploring+biologically+relevant+chemical+space+with+metal+complexes&doi=10.1016%2Fj.cbpa.2007.05.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring biologically relevant chemical space with metal complexes</span></div><div class="casAuthors">Meggers, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">287-292</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Altering biol. processes with small synthetic mols. is a general approach for the design of drugs and mol. probes.  Medicinal chem. and chem. biol. are focused predominately on the design of org. mols., whereas inorg. compds. find applications mainly for their reactivity (e.g. cisplatin as a DNA-reactive therapeutic) or imaging properties (e.g. gadolinium complexes as MRI diagnostics).  In such inorg. pharmaceuticals or probes, coordination chem. in the biol. environment or at the target site lies at the heart of their modes of action.  However, past and very recent results suggest that it is also worth exploring a different aspect of metal complexes: their ability to form structures with unique and defined shapes for the design of org.-like' small-mol. probes and drugs.  In such metal-org. compds., the metal has the main purpose to organize the org. ligands in three-dimensional space.  It is likely that such an approach will complement the mol. diversity of org. chem. in the quest for the discovery of compds. with superior biol. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY2uFY9Nc-ybVg90H21EOLACvtfcHk0lgKLctiLl5Hxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvVOnsr8%253D&md5=e6966e955608408cc652f3433c9c600a</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2007.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2007.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DMeggers%26aufirst%3DE.%26atitle%3DExploring%2520biologically%2520relevant%2520chemical%2520space%2520with%2520metal%2520complexes%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D11%26spage%3D287%26epage%3D292%26doi%3D10.1016%2Fj.cbpa.2007.05.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggers, E.</span></span> <span> </span><span class="NLM_article-title">Rapid access to unexplored chemical space by ligand scanning around a ruthenium center: discovery of potent and selective protein kinase inhibitors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">884</span>, <span class="refDoi"> DOI: 10.1021/ja055523r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja055523r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=877-884&author=H.+Bregmanauthor=P.+J.+Carrollauthor=E.+Meggers&title=Rapid+access+to+unexplored+chemical+space+by+ligand+scanning+around+a+ruthenium+center%3A+discovery+of+potent+and+selective+protein+kinase+inhibitors&doi=10.1021%2Fja055523r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1021%2Fja055523r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja055523r%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DCarroll%26aufirst%3DP.%2BJ.%26aulast%3DMeggers%26aufirst%3DE.%26atitle%3DRapid%2520access%2520to%2520unexplored%2520chemical%2520space%2520by%2520ligand%2520scanning%2520around%2520a%2520ruthenium%2520center%253A%2520discovery%2520of%2520potent%2520and%2520selective%2520protein%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D877%26epage%3D884%26doi%3D10.1021%2Fja055523r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maksimoska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kissil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marmorstein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggers, E.</span></span> <span> </span><span class="NLM_article-title">Targeting large kinase active site with rigid, bulky octahedral ruthenium complexes</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">15764</span>– <span class="NLM_lpage">15765</span>, <span class="refDoi"> DOI: 10.1021/ja805555a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja805555a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=15764-15765&author=J.+Maksimoskaauthor=L.+Fengauthor=K.+Harmsauthor=C.+Yiauthor=J.+Kissilauthor=R.+Marmorsteinauthor=E.+Meggers&title=Targeting+large+kinase+active+site+with+rigid%2C+bulky+octahedral+ruthenium+complexes&doi=10.1021%2Fja805555a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fja805555a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja805555a%26sid%3Dliteratum%253Aachs%26aulast%3DMaksimoska%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DHarms%26aufirst%3DK.%26aulast%3DYi%26aufirst%3DC.%26aulast%3DKissil%26aufirst%3DJ.%26aulast%3DMarmorstein%26aufirst%3DR.%26aulast%3DMeggers%26aufirst%3DE.%26atitle%3DTargeting%2520large%2520kinase%2520active%2520site%2520with%2520rigid%252C%2520bulky%2520octahedral%2520ruthenium%2520complexes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D15764%26epage%3D15765%26doi%3D10.1021%2Fja805555a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biersack, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoldakova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Effenberger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schobert, R.</span></span> <span> </span><span class="NLM_article-title">Arene)Ru(II) complexes of epidermal growth factor receptor inhibiting tyrphostins with enhanced selectivity and cytotoxicity in cancer cells</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1972</span>– <span class="NLM_lpage">1975</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2010.01.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ejmech.2010.01.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=1972-1975&author=B.+Biersackauthor=M.+Zoldakovaauthor=K.+Effenbergerauthor=R.+Schobert&title=Arene%29Ru%28II%29+complexes+of+epidermal+growth+factor+receptor+inhibiting+tyrphostins+with+enhanced+selectivity+and+cytotoxicity+in+cancer+cells&doi=10.1016%2Fj.ejmech.2010.01.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.01.040%26sid%3Dliteratum%253Aachs%26aulast%3DBiersack%26aufirst%3DB.%26aulast%3DZoldakova%26aufirst%3DM.%26aulast%3DEffenberger%26aufirst%3DK.%26aulast%3DSchobert%26aufirst%3DR.%26atitle%3DArene%2529Ru%2528II%2529%2520complexes%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520inhibiting%2520tyrphostins%2520with%2520enhanced%2520selectivity%2520and%2520cytotoxicity%2520in%2520cancer%2520cells%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D1972%26epage%3D1975%26doi%3D10.1016%2Fj.ejmech.2010.01.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seršen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kljun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kryeziu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panchuk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Körner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffeter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turel, I.</span></span> <span> </span><span class="NLM_article-title">Structure-related mode-of-action differences of anticancer organoruthenium complexes with β–Diketonates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3984</span>– <span class="NLM_lpage">3996</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00288</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00288" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3984-3996&author=S.+Ser%C5%A1enauthor=J.+Kljunauthor=K.+Kryeziuauthor=R.+Panchukauthor=B.+Alteauthor=W.+K%C3%B6rnerauthor=P.+Heffeterauthor=W.+Bergerauthor=I.+Turel&title=Structure-related+mode-of-action+differences+of+anticancer+organoruthenium+complexes+with+%CE%B2%E2%80%93Diketonates&doi=10.1021%2Facs.jmedchem.5b00288"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00288%26sid%3Dliteratum%253Aachs%26aulast%3DSer%25C5%25A1en%26aufirst%3DS.%26aulast%3DKljun%26aufirst%3DJ.%26aulast%3DKryeziu%26aufirst%3DK.%26aulast%3DPanchuk%26aufirst%3DR.%26aulast%3DAlte%26aufirst%3DB.%26aulast%3DK%25C3%25B6rner%26aufirst%3DW.%26aulast%3DHeffeter%26aufirst%3DP.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DTurel%26aufirst%3DI.%26atitle%3DStructure-related%2520mode-of-action%2520differences%2520of%2520anticancer%2520organoruthenium%2520complexes%2520with%2520%25CE%25B2%25E2%2580%2593Diketonates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3984%26epage%3D3996%26doi%3D10.1021%2Facs.jmedchem.5b00288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mello-Andrade, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Costa, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pires, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lino-Junior, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irusta, V. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carneiro, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Melo-Reis, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silveira-Lacerda, E. P.</span></span> <span> </span><span class="NLM_article-title">Antitumor effectiveness and mechanism of action of Ru(II)/amino acid/diphosphine complexes in the peritoneal carcinomatosis progression</span>. <i>Tumor Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1177/1010428317695933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1177%2F1010428317695933" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2017&pages=1-18&author=F.+Mello-Andradeauthor=W.+L.+da+Costaauthor=W.+C.+Piresauthor=F.+C.+Pereiraauthor=C.+G.+Cardosoauthor=R.+S.+Lino-Juniorauthor=V.+R.+C.+Irustaauthor=C.+C.+Carneiroauthor=P.+R.+de+Melo-Reisauthor=C.+H.+Castroauthor=M.+A.+P.+Almeidaauthor=A.+A.+Batistaauthor=E.+P.+Silveira-Lacerda&title=Antitumor+effectiveness+and+mechanism+of+action+of+Ru%28II%29%2Famino+acid%2Fdiphosphine+complexes+in+the+peritoneal+carcinomatosis+progression&doi=10.1177%2F1010428317695933"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1177%2F1010428317695933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1010428317695933%26sid%3Dliteratum%253Aachs%26aulast%3DMello-Andrade%26aufirst%3DF.%26aulast%3Dda%2BCosta%26aufirst%3DW.%2BL.%26aulast%3DPires%26aufirst%3DW.%2BC.%26aulast%3DPereira%26aufirst%3DF.%2BC.%26aulast%3DCardoso%26aufirst%3DC.%2BG.%26aulast%3DLino-Junior%26aufirst%3DR.%2BS.%26aulast%3DIrusta%26aufirst%3DV.%2BR.%2BC.%26aulast%3DCarneiro%26aufirst%3DC.%2BC.%26aulast%3Dde%2BMelo-Reis%26aufirst%3DP.%2BR.%26aulast%3DCastro%26aufirst%3DC.%2BH.%26aulast%3DAlmeida%26aufirst%3DM.%2BA.%2BP.%26aulast%3DBatista%26aufirst%3DA.%2BA.%26aulast%3DSilveira-Lacerda%26aufirst%3DE.%2BP.%26atitle%3DAntitumor%2520effectiveness%2520and%2520mechanism%2520of%2520action%2520of%2520Ru%2528II%2529%252Famino%2520acid%252Fdiphosphine%2520complexes%2520in%2520the%2520peritoneal%2520carcinomatosis%2520progression%26jtitle%3DTumor%2520Biol.%26date%3D2017%26volume%3D39%26spage%3D1%26epage%3D18%26doi%3D10.1177%2F1010428317695933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Süss-Fink, G.</span></span> <span> </span><span class="NLM_article-title">Arene ruthenium complexes as anticancer agents</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1673</span>– <span class="NLM_lpage">1688</span>, <span class="refDoi"> DOI: 10.1039/B916860P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FB916860P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=20449402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=1673-1688&author=G.+S%C3%BCss-Fink&title=Arene+ruthenium+complexes+as+anticancer+agents&doi=10.1039%2FB916860P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Arene ruthenium complexes as anticancer agents</span></div><div class="casAuthors">Suess-Fink, Georg</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1673-1688</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Neutral or cationic arene ruthenium complexes providing both hydrophilic as well as hydrophobic properties due to the robustness of the ruthenium-arene unit hold a high potential for the development of metal-based anticancer drugs.  Mononuclear arene ruthenium complexes contg. P- or N-donor ligands or N,N-, N,O- or O,O-chelating ligands, dinuclear arene ruthenium systems with adjustable org. linkers, trinuclear arene ruthenium clusters contg. an oxo cap, tetranuclear arene ruthenium porphyrin derivs. that are photoactive, as well as hexanuclear ruthenium cages that are either empty or filled with other mols. have been shown to be active against a variety of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1IE2hoGlyPrVg90H21EOLACvtfcHk0lhnGcLtW1w5Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqtr4%253D&md5=2758ad6804f77d33612401411fe7c116</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1039%2FB916860P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB916860P%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25BCss-Fink%26aufirst%3DG.%26atitle%3DArene%2520ruthenium%2520complexes%2520as%2520anticancer%2520agents%26jtitle%3DDalton%2520Trans.%26date%3D2010%26volume%3D39%26spage%3D1673%26epage%3D1688%26doi%3D10.1039%2FB916860P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lima, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mello, F. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pires, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delella, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felisbino, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Paula
Silveira-Lacerda, E.</span></span> <span> </span><span class="NLM_article-title">Cytoxicity and apoptotic mechanism of ruthenium(II) amino acid complexes in sarcoma-180 tumor cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e105865</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0105865</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1371%2Fjournal.pone.0105865" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e105865&author=A.+P.+Limaauthor=F.+C.+Pereiraauthor=M.+A.+P.+Almeidaauthor=F.+M.+S.+Melloauthor=W.+C.+Piresauthor=T.+M.+Pintoauthor=F.+K.+Delellaauthor=S.+L.+Felisbinoauthor=V.+Morenoauthor=A.+A.+Batistaauthor=E.+de+Paula%0ASilveira-Lacerda&title=Cytoxicity+and+apoptotic+mechanism+of+ruthenium%28II%29+amino+acid+complexes+in+sarcoma-180+tumor+cells&doi=10.1371%2Fjournal.pone.0105865"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0105865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0105865%26sid%3Dliteratum%253Aachs%26aulast%3DLima%26aufirst%3DA.%2BP.%26aulast%3DPereira%26aufirst%3DF.%2BC.%26aulast%3DAlmeida%26aufirst%3DM.%2BA.%2BP.%26aulast%3DMello%26aufirst%3DF.%2BM.%2BS.%26aulast%3DPires%26aufirst%3DW.%2BC.%26aulast%3DPinto%26aufirst%3DT.%2BM.%26aulast%3DDelella%26aufirst%3DF.%2BK.%26aulast%3DFelisbino%26aufirst%3DS.%2BL.%26aulast%3DMoreno%26aufirst%3DV.%26aulast%3DBatista%26aufirst%3DA.%2BA.%26aulast%3Dde%2BPaula%2BSilveira-Lacerda%26aufirst%3DE.%26atitle%3DCytoxicity%2520and%2520apoptotic%2520mechanism%2520of%2520ruthenium%2528II%2529%2520amino%2520acid%2520complexes%2520in%2520sarcoma-180%2520tumor%2520cells%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De105865%26doi%3D10.1371%2Fjournal.pone.0105865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Irace, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuozzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccolo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caraglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paduano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montesarchio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santamaria, R.</span></span> <span> </span><span class="NLM_article-title">Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer <i>in vitro</i>: insights into their mode of action</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">45236</span>, <span class="refDoi"> DOI: 10.1038/srep45236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2Fsrep45236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28349991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1KisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=45236&author=C.+Iraceauthor=G.+Missoauthor=A.+Capuozzoauthor=M.+Piccoloauthor=C.+Riccardiauthor=A.+Luchiniauthor=M.+Caragliaauthor=L.+Paduanoauthor=D.+Montesarchioauthor=R.+Santamaria&title=Antiproliferative+effects+of+ruthenium-based+nucleolipidic+nanoaggregates+in+human+models+of+breast+cancer+in+vitro%3A+insights+into+their+mode+of+action&doi=10.1038%2Fsrep45236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action</span></div><div class="casAuthors">Irace, Carlo; Misso, Gabriella; Capuozzo, Antonella; Piccolo, Marialuisa; Riccardi, Claudia; Luchini, Alessandra; Caraglia, Michele; Paduano, Luigi; Montesarchio, Daniela; Santamaria, Rita</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45236</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Looking for new metal-based anticancer treatments, in recent years many ruthenium complexes have been proposed as effective and safe potential drugs.  In this context we have recently developed a novel approach for the in vivo delivery of Ru(III) complexes, prepg. stable ruthenium-based nucleolipidic nanoaggregates endowed with significant antiproliferative activity.  Herein we describe the cellular response to our ruthenium-contg. formulations in selected models of human breast cancer.  By in vitro bioscreens in the context of preclin. studies, we have focused on their ability to inhibit breast cancer cell proliferation by the activation of the intrinsic apoptotic pathway, possibly via mitochondrial perturbations involving Bcl-2 family members and predisposing to programmed cell death.  In addn., the most efficient ruthenium-contg. cationic nanoaggregates we have hitherto developed are able to elicit both extrinsic and intrinsic apoptosis, as well as autophagy.  To limit chemoresistance and counteract uncontrolled proliferation, multiple cell death pathways activation by metal-based chemotherapeutics is a challenging, yet very promising strategy for targeted therapy development in aggressive cancer diseases, such as triple-neg. breast cancer with limited treatment options.  These outcomes provide valuable, original knowledge on ruthenium-based candidate drugs and new insights for future optimized cancer treatment protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXTcZAcU_G8rVg90H21EOLACvtfcHk0lhnGcLtW1w5Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1KisLs%253D&md5=2171f837866f8ddcb74bd3ea0fa871f2</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1038%2Fsrep45236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep45236%26sid%3Dliteratum%253Aachs%26aulast%3DIrace%26aufirst%3DC.%26aulast%3DMisso%26aufirst%3DG.%26aulast%3DCapuozzo%26aufirst%3DA.%26aulast%3DPiccolo%26aufirst%3DM.%26aulast%3DRiccardi%26aufirst%3DC.%26aulast%3DLuchini%26aufirst%3DA.%26aulast%3DCaraglia%26aufirst%3DM.%26aulast%3DPaduano%26aufirst%3DL.%26aulast%3DMontesarchio%26aufirst%3DD.%26aulast%3DSantamaria%26aufirst%3DR.%26atitle%3DAntiproliferative%2520effects%2520of%2520ruthenium-based%2520nucleolipidic%2520nanoaggregates%2520in%2520human%2520models%2520of%2520breast%2520cancer%2520in%2520vitro%253A%2520insights%2520into%2520their%2520mode%2520of%2520action%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D45236%26doi%3D10.1038%2Fsrep45236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span>; <span class="NLM_string-name">Crans, D.
C.</span></span> <i>Metal Nanoparticles: Synthesis and Applications in Pharmaceutical Sciences</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span>, <span class="NLM_string-name">Crans, D.
C.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Germany</span>, <span class="NLM_year">2018</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">312</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2F9783527807093" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=1-312&author=S.+Thota&author=D.%0AC.+Cransauthor=S.+Thota&author=D.%0AC.+Crans&title=Metal+Nanoparticles%3A+Synthesis+and+Applications+in+Pharmaceutical+Sciences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1002%2F9783527807093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527807093%26sid%3Dliteratum%253Aachs%26aulast%3DThota%26aufirst%3DS.%26btitle%3DMetal%2520Nanoparticles%253A%2520Synthesis%2520and%2520Applications%2520in%2520Pharmaceutical%2520Sciences%26aulast%3DThota%26aufirst%3DS.%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2018%26spage%3D1%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astruc, D.</span></span> <span> </span><span class="NLM_article-title">Docetaxel nanotechnology in anticancer therapy</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">952</span>– <span class="NLM_lpage">972</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fcmdc.201200052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=952-972&author=P.+Zhaoauthor=D.+Astruc&title=Docetaxel+nanotechnology+in+anticancer+therapy&doi=10.1002%2Fcmdc.201200052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200052%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DAstruc%26aufirst%3DD.%26atitle%3DDocetaxel%2520nanotechnology%2520in%2520anticancer%2520therapy%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D952%26epage%3D972%26doi%3D10.1002%2Fcmdc.201200052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of tumor growth and vasculature and fluorescence imaging using functionalized ruthenium-thiol protected selenium nanoparticles</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1572</span>– <span class="NLM_lpage">1583</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2013.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.biomaterials.2013.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=24268198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVShu7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=1572-1583&author=D.+Sunauthor=Y.+Liuauthor=Q.+Yuauthor=X.+Qinauthor=L.+Yangauthor=Y.+Zhouauthor=L.+Chenauthor=J.+Liu&title=Inhibition+of+tumor+growth+and+vasculature+and+fluorescence+imaging+using+functionalized+ruthenium-thiol+protected+selenium+nanoparticles&doi=10.1016%2Fj.biomaterials.2013.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tumor growth and vasculature and fluorescence imaging using functionalized ruthenium-thiol protected selenium nanoparticles</span></div><div class="casAuthors">Sun, Dongdong; Liu, Yanan; Yu, Qianqian; Qin, Xiuying; Yang, Licong; Zhou, Yanhui; Chen, Lanmei; Liu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1572-1583</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Here we reported the high tumor targeting efficacy of luminescent Ru(II)-thiols protected selenium nanoparticles (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="d98bacf4948c98998abc">[email protected]</a>).  We have shown that a dual-target inhibitor <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="ebb99ec6a6beaaabb88e">[email protected]</a> directly suppress the tumor growth but also block blood-vessel growth.  We also detd. that the nanoparticles entered the cells via clathrin-mediated endocytosis pathway.  In a xenograft HepG2 tumor model, we found that <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="d785a2fa9a82969784b2">[email protected]</a> effectively inhibited tumor angiogenesis and suppressed tumor growth with low side effects using metronomic chemotherapy with <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="4a183f67071f0b0a192f64">[email protected]</a>  In vivo investigation of nanoparticles on nude mice bearing HepG2 cancer xenografts confirmed that <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="4c1e396101190d0c1f29">[email protected]</a> nanoparticles possessed high tumor-targeted fluorescence imaging, exhibited enhanced antitumor efficacy and decreased systemic toxicity.  Moreover, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="14466139594155544771">[email protected]</a> not only significantly induced dose-dependent disruption of mitochondrial membrane potential in HepG2 cells after 24 h treatment, but it also enhanced reactive oxygen species (ROS) generation.  Our results suggest that the potential application of these <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="44163169091105041721">[email protected]</a> nanoparticles in targeting cancer imaging and chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp87jzmAWwlCrVg90H21EOLACvtfcHk0lhnGcLtW1w5Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVShu7vP&md5=251af033e93a1d0ebf4ce86fe690b9f1</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2013.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2013.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520tumor%2520growth%2520and%2520vasculature%2520and%2520fluorescence%2520imaging%2520using%2520functionalized%2520ruthenium-thiol%2520protected%2520selenium%2520nanoparticles%26jtitle%3DBiomaterials%26date%3D2014%26volume%3D35%26spage%3D1572%26epage%3D1583%26doi%3D10.1016%2Fj.biomaterials.2013.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2012.09.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.biomaterials.2012.09.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=23059005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVOgt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=171-180&author=D.+Sunauthor=Y.+Liuauthor=Q.+Yuauthor=Y.+Zhouauthor=R.+Zhangauthor=X.+Chenauthor=A.+Hongauthor=J.+Liu&title=The+effects+of+luminescent+ruthenium%28II%29+polypyridyl+functionalized+selenium+nanoparticles+on+bFGF-induced+angiogenesis+and+AKT%2FERK+signaling&doi=10.1016%2Fj.biomaterials.2012.09.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling</span></div><div class="casAuthors">Sun, Dongdong; Liu, Yanan; Yu, Qianqian; Zhou, Yanhui; Zhang, Rong; Chen, Xiaojia; Hong, An; Liu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">171-180</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Anti-angiogenesis is an effective strategy for cancer treatment because uncontrolled tumor growth depends on tumor angiogenesis and sufficient blood supply.  Thus, blocking angiogenesis could be a strategy to arrest tumor growth.  The function and mechanism of luminescent ruthenium-modified selenium nanoparticles (Ru-SeNPs) in angiogenesis have not been elucidated to date.  Here, we found that Ru-SeNPs significantly inhibited human umbilical vascular endothelial cell (HUVEC) proliferation, migration and tube formation.  Ru-SeNPs was also tested in vivo in the chicken chorioallantoic membrane (CAM) assay and found to inhibit bFGF-treated CAMs development like suramin.  Moreover, we showed that Ru-SeNPs inhibited the activations of FGFR1 and its downstream protein kinases, such ErK and AKT.  Furthermore, by using fluorescence confocal microscopy and TEM imaging studies, we have demonstrated their cellular uptake and localization within the cytoplasm of HepG2 and HUVEC cells.  These findings indicate that Ru-SeNPs inhibits angiogenesis and may be a viable drug candidate in anti-angiogenesis and anticancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxnG8kCEmuBLVg90H21EOLACvtfcHk0lho6UzYF09jow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVOgt7zJ&md5=f1ac1941e25fc3089b9cca828f86e02b</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2012.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2012.09.031%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHong%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DThe%2520effects%2520of%2520luminescent%2520ruthenium%2528II%2529%2520polypyridyl%2520functionalized%2520selenium%2520nanoparticles%2520on%2520bFGF-induced%2520angiogenesis%2520and%2520AKT%252FERK%2520signaling%26jtitle%3DBiomaterials%26date%3D2013%26volume%3D34%26spage%3D171%26epage%3D180%26doi%3D10.1016%2Fj.biomaterials.2012.09.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Rational design of cancer-targeted selenium nanoparticles to antagonize multidrug resistance in cancer cells</span>. <i>Nanomedicine</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">947</span>– <span class="NLM_lpage">958</span>, <span class="refDoi"> DOI: 10.1016/j.nano.2015.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.nano.2015.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=25680543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisl2ru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=947-958&author=T.+Liuauthor=L.+Zengauthor=W.+Jiangauthor=Y.+Fuauthor=W.+Zhengauthor=T.+Chen&title=Rational+design+of+cancer-targeted+selenium+nanoparticles+to+antagonize+multidrug+resistance+in+cancer+cells&doi=10.1016%2Fj.nano.2015.01.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of cancer-targeted selenium nanoparticles to antagonize multidrug resistance in cancer cells</span></div><div class="casAuthors">Liu, Ting; Zeng, Lilan; Jiang, Wenting; Fu, Yuanting; Zheng, Wenjie; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">947-958</span>CODEN:
                <span class="NLM_cas:coden">NANOBF</span>;
        ISSN:<span class="NLM_cas:issn">1549-9634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Multidrug resistance is one of the greatest challenges in cancer therapy.  Herein we described the synthesis of folate (FA)-conjugated selenium nanoparticles (SeNPs) as cancer-targeted nano-drug delivery system for ruthenium polypyridyl (RuPOP) exhibits strong fluorescence, which allows the direct imaging of the cellular trafficking of the nanosystem.  This nanosystem could effectively antagonize against multidrug resistance in liver cancer.  FA surface conjugation significantly enhanced the cellular uptake of SeNPs by FA receptor-mediated endocytosis through nystain-dependent lipid raft-mediated and clathrin-mediated pathways.  The nanomaterials overcame the multidrug resistance in R-HepG2 cells through inhibition of ABC family proteins expression.  Internalized nanoparticles triggered ROS overprodn. and induced apoptosis by activating p53 and MAPKs pathways.  Moreover, FA-SeNPs exhibited low in vivo acute toxicity, which verified the safety and application potential of FA-SeNPs as nanodrugs.  This study provides an effective strategy for the design of cancer-targeted nanodrugs against multidrug resistant cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4SBRYhbZLXbVg90H21EOLACvtfcHk0lho6UzYF09jow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisl2ru7w%253D&md5=e28985eb3878313d3b214ecaec3994fd</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.nano.2015.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nano.2015.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DRational%2520design%2520of%2520cancer-targeted%2520selenium%2520nanoparticles%2520to%2520antagonize%2520multidrug%2520resistance%2520in%2520cancer%2520cells%26jtitle%3DNanomedicine%26date%3D2015%26volume%3D11%26spage%3D947%26epage%3D958%26doi%3D10.1016%2Fj.nano.2015.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">An upconversion nanoparticle/Ru(II) polypyridyl complex assembly for NIR-activated release of a DNA covalent-binding agent</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">23804</span>– <span class="NLM_lpage">23808</span>, <span class="refDoi"> DOI: 10.1039/C6RA03396B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC6RA03396B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFCrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=23804-23808&author=Y.+Chenauthor=G.+Jiangauthor=Q.+Zhouauthor=Y.+Zhangauthor=K.+Liauthor=Y.+Zhengauthor=B.+Zhangauthor=X.+Wang&title=An+upconversion+nanoparticle%2FRu%28II%29+polypyridyl+complex+assembly+for+NIR-activated+release+of+a+DNA+covalent-binding+agent&doi=10.1039%2FC6RA03396B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">An upconversion nanoparticle/Ru(II) polypyridyl complex assembly for NIR-activated release of a DNA covalent-binding agent</span></div><div class="casAuthors">Chen, Yumeng; Jiang, Guoyu; Zhou, Qianxiong; Zhang, Yangyang; Li, Ke; Zheng, Yue; Zhang, Baowen; Wang, Xuesong</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">23804-23808</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Photoactivated anticancer chemotherapy distinguishes itself by its high selectivity by virtue of the spatiotemporal control of irradn.  However, short photoactivation wavelengths limit its application.  Herein, an amphiphilic Ru(II) complex, cis-[Ru(bpy)2(C18H37CN)2]2+ (bpy = 2,2'-bipyridine), was embedded along with a poly(ethylene glycol, PEG)-modified lipid onto the surfaces of oleate-capped lanthanide-doped upconversion nanoparticles (UCNPs).  The resultant core-shell hybrid system is water-dispersible, stable in the dark, and releases a DNA covalent-binding agent of [Ru(bpy)2(H2O)2]2+ upon 980 nm laser irradn., providing guidelines for developing near-IR (NIR) light triggered chemotherapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTU2opfKYcirVg90H21EOLACvtfcHk0lho6UzYF09jow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFCrsrk%253D&md5=b1ce76f4cc5336695bdf8257070dd67d</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1039%2FC6RA03396B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6RA03396B%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DAn%2520upconversion%2520nanoparticle%252FRu%2528II%2529%2520polypyridyl%2520complex%2520assembly%2520for%2520NIR-activated%2520release%2520of%2520a%2520DNA%2520covalent-binding%2520agent%26jtitle%3DRSC%2520Adv.%26date%3D2016%26volume%3D6%26spage%3D23804%26epage%3D23808%26doi%3D10.1039%2FC6RA03396B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfram, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guevara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span> <span> </span><span class="NLM_article-title">A liposome encapsulated ruthenium polypyridine complex as a theranostic platform for triple-negative breast cancer</span>. <i>Nano Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2913</span>– <span class="NLM_lpage">2920</span>, <span class="refDoi"> DOI: 10.1021/acs.nanolett.7b00132</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.nanolett.7b00132" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmt12lsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=2913-2920&author=J.+Shenauthor=H.+C.+Kimauthor=J.+Wolframauthor=C.+Muauthor=W.+Zhangauthor=H.+Liuauthor=Y.+Xieauthor=J.+Maiauthor=H.+Zhangauthor=Z.+Liauthor=M.+Guevaraauthor=Z.+W.+Maoauthor=H.+Shen&title=A+liposome+encapsulated+ruthenium+polypyridine+complex+as+a+theranostic+platform+for+triple-negative+breast+cancer&doi=10.1021%2Facs.nanolett.7b00132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer</span></div><div class="casAuthors">Shen, Jianliang; Kim, Han-Cheon; Wolfram, Joy; Mu, Chaofeng; Zhang, Wei; Liu, Haoran; Xie, Yan; Mai, Junhua; Zhang, Hang; Li, Zhi; Guevara, Maria; Mao, Zong-Wan; Shen, Haifa</div><div class="citationInfo"><span class="NLM_cas:title">Nano Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2913-2920</span>CODEN:
                <span class="NLM_cas:coden">NALEFD</span>;
        ISSN:<span class="NLM_cas:issn">1530-6984</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ruthenium coordination complexes have the potential to serve as novel theranostic agents for cancer.  However, a major limitation in their clin. implementation is effective tumor accumulation.  In this study, the authors have developed a liposome-based theranostic nanodelivery system for [Ru(phen)2dppz](ClO4)2 (Lipo-Ru).  This ruthenium polypyridine complex emits a strong fluorescent signal when incorporated in the hydrophobic lipid bilayer of the delivery vehicle or in the DNA helix, enabling visualization of the therapeutic agent in tumor tissues.  Incubation of MDA-MB-231 breast cancer cells with Lipo-Ru induced double-strand DNA breaks and triggers apoptosis.  In a mouse model of triple-neg. breast cancer, treatment with Lipo-Ru dramatically reduced tumor growth.  Biodistribution studies of Lipo-Ru revealed that more than 20% of the injected dose accumulated in the tumor.  These results suggest that Lipo-Ru could serve as a promising theranostic platform for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2FW6TrBmR1bVg90H21EOLACvtfcHk0lj2X3FF8GOeCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmt12lsbg%253D&md5=4c3097a926d8fc33d2f07cfb002453b9</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Facs.nanolett.7b00132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.nanolett.7b00132%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%2BC.%26aulast%3DWolfram%26aufirst%3DJ.%26aulast%3DMu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DMai%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGuevara%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DZ.%2BW.%26aulast%3DShen%26aufirst%3DH.%26atitle%3DA%2520liposome%2520encapsulated%2520ruthenium%2520polypyridine%2520complex%2520as%2520a%2520theranostic%2520platform%2520for%2520triple-negative%2520breast%2520cancer%26jtitle%3DNano%2520Lett.%26date%3D2017%26volume%3D17%26spage%3D2913%26epage%3D2920%26doi%3D10.1021%2Facs.nanolett.7b00132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Functionalized multiwalled carbon nanotubes as carriers of ruthenium complexes to antagonize cancer multidrug resistance and radioresistance</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">14933</span>– <span class="NLM_lpage">14945</span>, <span class="refDoi"> DOI: 10.1021/acsami.5b03739</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.5b03739" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKit7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=14933-14945&author=N.+Wangauthor=Y.+Fengauthor=L.+Zengauthor=Z.+Zhaoauthor=T.+Chen&title=Functionalized+multiwalled+carbon+nanotubes+as+carriers+of+ruthenium+complexes+to+antagonize+cancer+multidrug+resistance+and+radioresistance&doi=10.1021%2Facsami.5b03739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Functionalized Multiwalled Carbon Nanotubes as Carriers of Ruthenium Complexes to Antagonize Cancer Multidrug Resistance and Radioresistance</span></div><div class="casAuthors">Wang, Ni; Feng, Yanxian; Zeng, Lilan; Zhao, Zhennan; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">14933-14945</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multidrug resistance and radioresistance are major obstacles for successful cancer therapy.  Due to the unique characteristics of high surface area, improved cellular uptake, and the possibility to be easily bound with therapeutics, carbon nanotubes (CNTs) have attracted increasing attention as potential nanodrug delivery systems.  In this study, a CNT-based radiosensitive nanodrug delivery system was rationally designed to antagonize the multidrug resistance in hepatocellular carcinoma.  The nanosystem was loaded with a potent anticancer ruthenium polypyridyl complex (RuPOP) via π-π interaction and formation of a hydrogen bond.  The functionalized nanosystem (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="94c6e1c4dbc4d4d9c3d7dac0e7">[email protected]</a>) enhanced the cellular uptake of RuPOP in liver cancer cells, esp. drug-resistant R-HepG2 cells, through endocytosis.  Consistently, the selective cellular uptake endowed the nanosystem amplified anticancer efficacy against R-HepG2 cells but not in normal cells.  Interestingly, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="dc8ea98c938c9c918b9f9288af">[email protected]</a> significantly enhanced the anticancer efficacy of clin. used X-ray against R-HepG2 cells through induction of apoptosis and G0/G1 cell cycle arrest, with the involvement of ROS overprodn., which activated several downstream signaling pathways, including DNA damage-mediated p53 phosphorylation, activation of p38, and inactivation of AKT and ERK.  Moreover, the nanosystem also effectively reduces the toxic side effects of loaded drugs and prolongs the blood circulation in vivo.  Taken together, the results demonstrate the rational design of functionalized carbon nanotubes and their application as effective nanomedicine to overcome cancer multidrug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8cjbcIKuLxLVg90H21EOLACvtfcHk0lj2X3FF8GOeCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKit7fI&md5=992f09a410b8776359a0a0f87994ae8b</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Facsami.5b03739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.5b03739%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DN.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DFunctionalized%2520multiwalled%2520carbon%2520nanotubes%2520as%2520carriers%2520of%2520ruthenium%2520complexes%2520to%2520antagonize%2520cancer%2520multidrug%2520resistance%2520and%2520radioresistance%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2015%26volume%3D7%26spage%3D14933%26epage%3D14945%26doi%3D10.1021%2Facsami.5b03739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span> <span> </span><span class="NLM_article-title">Noncovalent ruthenium(II) complexes-single-walled carbon nanotube composites for bimodal photothermal and photodynamic therapy with near-infrared irradiation</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">23278</span>– <span class="NLM_lpage">23290</span>, <span class="refDoi"> DOI: 10.1021/acsami.5b07510</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.5b07510" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1SisLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=23278-23290&author=P.+Zhangauthor=H.+Huangauthor=J.+Huangauthor=H.+Chenauthor=J.+Wangauthor=K.+Qiuauthor=D.+Zhaoauthor=L.+Jiauthor=H.+Chao&title=Noncovalent+ruthenium%28II%29+complexes-single-walled+carbon+nanotube+composites+for+bimodal+photothermal+and+photodynamic+therapy+with+near-infrared+irradiation&doi=10.1021%2Facsami.5b07510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Noncovalent Ruthenium(II) Complexes-Single-Walled Carbon Nanotube Composites for Bimodal Photothermal and Photodynamic Therapy with Near-Infrared Irradiation</span></div><div class="casAuthors">Zhang, Pingyu; Huang, Huaiyi; Huang, Juanjuan; Chen, Hongmin; Wang, Jinquan; Qiu, Kangqiang; Zhao, Donglei; Ji, Liangnian; Chao, Hui</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">23278-23290</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To enhance the efficacy and optimize the treatment of cancers, the integration of multimodal treatment strategies leading to synergistic effects is a promising approach.  The coassembly of multifunctional agents for systematic therapies has received considerable interest in cancer treatment.  Herein, Ru(II) complex-functionalized single-walled carbon nanotubes (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="9dcfe8ddcecaded3c9ee">[email protected]</a>) are developed as nanotemplates for bimodal photothermal and two-photon photodynamic therapy (PTT-TPPDT).  SWCNTs have the ability to load a great amt. of Ru(II) complexes (Ru1 or Ru2) via noncovalent π-π interactions.  The loaded Ru(II) complexes are efficiently released by the photothermal effect of irradn. from an 808 nm diode laser (0.25 W/cm2).  The released Ru(II) complexes produce singlet oxygen species (1O2) upon two-photon laser irradn. (808 nm, 0.25 W/cm2) and can be used as a two-photon photodynamic therapy (TPPDT) agent.  Based on the combination of photothermal therapy and two-photon photodynamic therapy, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="a0f2d5e0f3f7e3eef4d3">[email protected]</a> have greater anticancer efficacies than either PDT using Ru(II) complexes or PTT using SWCNTs in two-dimensional (2D) cancer cell and three-dimensional (3D) multicellular tumor spheroid (MCTS) models.  Furthermore, in vivo tumor ablation is achieved with excellent treatment efficacy under a diode laser (808 nm) irradn. at the power d. of 0.25 W/cm2 for 5 min.  This study examines an efficacious bimodal PTT and TPPDT nanoplatform for the development of cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq83C2yDWwiqrVg90H21EOLACvtfcHk0lj2X3FF8GOeCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1SisLbP&md5=cd55dec6607f67ce7e1743c74fdb5e82</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Facsami.5b07510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.5b07510%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26atitle%3DNoncovalent%2520ruthenium%2528II%2529%2520complexes-single-walled%2520carbon%2520nanotube%2520composites%2520for%2520bimodal%2520photothermal%2520and%2520photodynamic%2520therapy%2520with%2520near-infrared%2520irradiation%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2015%26volume%3D7%26spage%3D23278%26epage%3D23290%26doi%3D10.1021%2Facsami.5b07510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farabi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zikeli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Styles, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodges, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikramenou, Z.</span></span> <span> </span><span class="NLM_article-title">High coating of Ru(II) complexes on gold nanoparticles for single particle luminescence imaging in cells</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1039/C3CC47606E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC3CC47606E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=24281162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2rt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=617-619&author=N.+J.+Rogersauthor=S.+Claireauthor=R.+M.+Harrisauthor=S.+Farabiauthor=G.+Zikeliauthor=I.+B.+Stylesauthor=N.+J.+Hodgesauthor=Z.+Pikramenou&title=High+coating+of+Ru%28II%29+complexes+on+gold+nanoparticles+for+single+particle+luminescence+imaging+in+cells&doi=10.1039%2FC3CC47606E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">High coating of Ru(II) complexes on gold nanoparticles for single particle luminescence imaging in cells</span></div><div class="casAuthors">Rogers, Nicola J.; Claire, Sunil; Harris, Robert M.; Farabi, Shiva; Zikeli, Gerald; Styles, Iain B.; Hodges, Nikolas J.; Pikramenou, Zoe</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">617-619</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Gold nanoparticles are efficiently labeled with a luminescent ruthenium complex, producing 13 and 100 nm diam., monodisperse red-emissive imaging probes with luminescence lifetimes prolonged over the mol. unit.  Single, 100 nm particles are obsd. in whole cell luminescence imaging which reveals their biomol. assocn. with chromatin in the nucleus of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZHNUWV-v2YLVg90H21EOLACvtfcHk0lipcljvMYZhNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2rt7%252FK&md5=96ac312118bcd5b7729be4ad9f984742</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1039%2FC3CC47606E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CC47606E%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DN.%2BJ.%26aulast%3DClaire%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DR.%2BM.%26aulast%3DFarabi%26aufirst%3DS.%26aulast%3DZikeli%26aufirst%3DG.%26aulast%3DStyles%26aufirst%3DI.%2BB.%26aulast%3DHodges%26aufirst%3DN.%2BJ.%26aulast%3DPikramenou%26aufirst%3DZ.%26atitle%3DHigh%2520coating%2520of%2520Ru%2528II%2529%2520complexes%2520on%2520gold%2520nanoparticles%2520for%2520single%2520particle%2520luminescence%2520imaging%2520in%2520cells%26jtitle%3DChem.%2520Commun.%26date%3D2014%26volume%3D50%26spage%3D617%26epage%3D619%26doi%3D10.1039%2FC3CC47606E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">Effective PDT/PTT dual-modal phototherapeutic killing of pathogenic bacteria by using ruthenium nanoparticles</span>. <i>J. Mater. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">6258</span>– <span class="NLM_lpage">6270</span>, <span class="refDoi"> DOI: 10.1039/C6TB01122E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC6TB01122E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=32263638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKru73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=6258-6270&author=X.+Huangauthor=G.+Chenauthor=J.+Panauthor=X.+Chenauthor=N.+Huangauthor=X.+Wangauthor=J.+Liu&title=Effective+PDT%2FPTT+dual-modal+phototherapeutic+killing+of+pathogenic+bacteria+by+using+ruthenium+nanoparticles&doi=10.1039%2FC6TB01122E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Effective PDT/PTT dual-modal phototherapeutic killing of pathogenic bacteria by using ruthenium nanoparticles</span></div><div class="casAuthors">Huang, Xiaoquan; Chen, Gengjia; Pan, Jiali; Chen, Xu; Huang, Na; Wang, Xin; Liu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry B: Materials for Biology and Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">6258-6270</span>CODEN:
                <span class="NLM_cas:coden">JMCBDV</span>;
        ISSN:<span class="NLM_cas:issn">2050-7518</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A s.c. abscess is a local infection caused by pathogenic bacteria.  Due to the emergence of multidrug-resistant (MDR) pathogenic bacteria, there is an urgent need for the development of new approaches to treat s.c. abscesses.  In recent studies, we detd. that ruthenium nanoparticles have high photothermal conversion efficiency and can transfer energy to surrounding oxygen mols. to generate cytotoxic singlet oxygen (ROS).  Acetylcholine (Ach) was modified and added to the surface of the ruthenium nanoparticles to form composite nanoparticles (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="39785a51796b4c77694a">[email protected]</a>).  Acetylcholine played a role in targeting the nanoparticles on bacteria, and promoting their entry into the bacterial cells as detd. by bacterial plate assays.  Expts. using a mouse s.c. abscess model also showed that <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="d998bab1998bac9789aa">[email protected]</a> were targeted on bacteria.  Upon irradn. with an 808 nm laser, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="efae8c87afbd9aa1bf9c">[email protected]</a> could function as both a photodynamic therapeutic (PDT) and a photothermal therapeutic (PTT) agent to kill pathogenic bacteria, and repair infected wounds without leaving residual implanted materials.  The use of <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="6223010a2230172c3211">[email protected]</a> represents an attractive potential treatment approach for s.c. abscesses due to their high efficacy and minimal invasiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTUM0HmAW9abVg90H21EOLACvtfcHk0lipcljvMYZhNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKru73J&md5=8978e64a1b5be47ce64f9d88905a96ab</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1039%2FC6TB01122E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6TB01122E%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DEffective%2520PDT%252FPTT%2520dual-modal%2520phototherapeutic%2520killing%2520of%2520pathogenic%2520bacteria%2520by%2520using%2520ruthenium%2520nanoparticles%26jtitle%3DJ.%2520Mater.%2520Chem.%2520B%26date%3D2016%26volume%3D4%26spage%3D6258%26epage%3D6270%26doi%3D10.1039%2FC6TB01122E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jori, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korbelik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Q.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">889</span>– <span class="NLM_lpage">905</span>, <span class="refDoi"> DOI: 10.1093/jnci/90.12.889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1093%2Fjnci%2F90.12.889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=9637138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADyaK1cXktFOqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1998&pages=889-905&author=T.+J.+Doughertyauthor=C.+J.+Gomerauthor=B.+W.+Hendersonauthor=G.+Joriauthor=D.+Kesselauthor=M.+Korbelikauthor=J.+Moanauthor=Q.+Peng&title=Photodynamic+therapy&doi=10.1093%2Fjnci%2F90.12.889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy</span></div><div class="casAuthors">Dougherty, Thomas J.; Gomer, Charles J.; Henderson, Barbara W.; Jori, Giulio; Kessel, David; Korbelik, Mladen; Moan, Johan; Peng, Qian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">889-905</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 221 refs.  Photodynamic therapy involves administration of a tumor-localizing photosensitizing agent, which may require metabolic synthesis (i.e., a prodrug), followed by activation of the agent by light of a specific wavelength.  This therapy results in a sequence of photochem. and photobiol. processes that cause irreversible photodamage to tumor tissues.  Results from preclin. and clin. studies conducted world-wide over a 25-yr period have established photodynamic therapy as a useful treatment approach for some cancers.  Since 1993, regulatory approval for photodynamic therapy involving use of a partially purified, com. available hematoporphyrin deriv. compd. (Photofrin) in patients with early and advanced stage cancer of the lung, digestive tract, and genitourinary tract has been obtained in Canada, The Netherlands, France, Germany, Japan, and the United States.  We have attempted to conduct and present a comprehensive review of this rapidly expanding field.  Mechanisms of subcellular and tumor localization of photosensitizing agents, as well as of mol., cellular, and tumor responses assocd. with photodynamic therapy, are discussed.  Tech. issues regarding light dosimetry are also considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCG5-ldyzkdbVg90H21EOLACvtfcHk0lipcljvMYZhNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktFOqsLY%253D&md5=f78d7eece516f3e15cee527ffe97779e</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F90.12.889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F90.12.889%26sid%3Dliteratum%253Aachs%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26aulast%3DGomer%26aufirst%3DC.%2BJ.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DJori%26aufirst%3DG.%26aulast%3DKessel%26aufirst%3DD.%26aulast%3DKorbelik%26aufirst%3DM.%26aulast%3DMoan%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DQ.%26atitle%3DPhotodynamic%2520therapy%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1998%26volume%3D90%26spage%3D889%26epage%3D905%26doi%3D10.1093%2Fjnci%2F90.12.889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubbiani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubafard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacque, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anstaett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felgentrager, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maisch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiccia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, and biological evaluation of new Ru(II) polypyridyl photosensitizers for photodynamic therapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7280</span>– <span class="NLM_lpage">7292</span>, <span class="refDoi"> DOI: 10.1021/jm500566f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500566f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKlu73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7280-7292&author=A.+Freiauthor=R.+Rubbianiauthor=S.+Tubafardauthor=O.+Blacqueauthor=P.+Anstaettauthor=A.+Felgentragerauthor=T.+Maischauthor=L.+Spicciaauthor=G.+Gasser&title=Synthesis%2C+characterization%2C+and+biological+evaluation+of+new+Ru%28II%29+polypyridyl+photosensitizers+for+photodynamic+therapy&doi=10.1021%2Fjm500566f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Characterization, and Biological Evaluation of New Ru(II) Polypyridyl Photosensitizers for Photodynamic Therapy</span></div><div class="casAuthors">Frei, Angelo; Rubbiani, Riccardo; Tubafard, Solmaz; Blacque, Olivier; Anstaett, Philipp; Felgentrager, Ariane; Maisch, Tim; Spiccia, Leone; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7280-7292</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two Ru(II) polypyridyl complexes, Ru(DIP)2(bdt) (1) and [Ru(dqpCO2Me)(ptpy)]2+ (2) (DIP = 4,7-diphenyl-1,10-phenanthroline, bdt = 1,2-benzenedithiolate, dqpCO2Me = 4-methylcarboxy-2,6-di(quinolin-8-yl)pyridine), ptpy = 4'-phenyl-2,2':6',2''-terpyridine) have been investigated as photosensitizers (PSs) for photodynamic therapy (PDT).  In our exptl. settings, the phototoxicity and phototoxic index (PI) of 2 (IC50(light): 25.3 μM, 420 nm, 6.95 J/cm2; PI >4) and particularly of 1 (IC50(light): 0.62 μM, 420 nm, 6.95 J/cm2; PI: 80) are considerably superior compared to the two clin. approved PSs porfimer sodium and 5-aminolevulinic acid.  Cellular uptake and distribution of these complexes was investigated by confocal microscopy (1) and by inductively coupled plasma mass spectrometry (1 and 2).  Their phototoxicity was also detd. against the Gram-(+) Staphylococcus aureus and Gram-(-) Escherichia coli for potential antimicrobial PDT (aPDT) applications.  Both complexes showed significant aPDT activity (420 nm, 8 J/cm2) against Gram-(+) (S. aureus; >6 log10 CFU redn.) and, for 2, also against Gram-(-) E. coli (>4 log10 CFU redn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1QENinj0EILVg90H21EOLACvtfcHk0lhn6IETgnPYnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKlu73M&md5=95f232e052cf5ad756557e861e9086e5</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjm500566f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500566f%26sid%3Dliteratum%253Aachs%26aulast%3DFrei%26aufirst%3DA.%26aulast%3DRubbiani%26aufirst%3DR.%26aulast%3DTubafard%26aufirst%3DS.%26aulast%3DBlacque%26aufirst%3DO.%26aulast%3DAnstaett%26aufirst%3DP.%26aulast%3DFelgentrager%26aufirst%3DA.%26aulast%3DMaisch%26aufirst%3DT.%26aulast%3DSpiccia%26aufirst%3DL.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520biological%2520evaluation%2520of%2520new%2520Ru%2528II%2529%2520polypyridyl%2520photosensitizers%2520for%2520photodynamic%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7280%26epage%3D7292%26doi%3D10.1021%2Fjm500566f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hess, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierroz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacque, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the medicinal potential of two ruthenium(II) polypyridine complexes as one- and two-photon photodynamic therapy photosensitizers</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">9888</span>– <span class="NLM_lpage">9896</span>, <span class="refDoi"> DOI: 10.1002/chem.201701392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fchem.201701392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28509422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2gs77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=9888-9896&author=J.+Hessauthor=H.+Huangauthor=A.+Kaiserauthor=V.+Pierrozauthor=O.+Blacqueauthor=H.+Chaoauthor=G.+Gasser&title=Evaluation+of+the+medicinal+potential+of+two+ruthenium%28II%29+polypyridine+complexes+as+one-+and+two-photon+photodynamic+therapy+photosensitizers&doi=10.1002%2Fchem.201701392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers</span></div><div class="casAuthors">Hess, Jeannine; Huang, Huaiyi; Kaiser, Adrian; Pierroz, Vanessa; Blacque, Olivier; Chao, Hui; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">9888-9896</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Two [Ru(phen)2dppz]2+ derivs. (phen=1,10-phenantroline, dppz=dipyrido[3,2-a:2',3'-c]phenazine) with different functional groups on the dppz ligand [dppz-7,8-(OMe)2 (1), dppz-7,8-(OH)2 (2)] have been synthesized, characterized and investigated as photosensitizers (PSs) for photodynamic therapy (PDT) against cancer.  Both complexes showed intense red phosphorescence and promising singlet oxygen (1O2) quantum yields of 75 % (1) and 54 % (2) in acetonitrile.  Complex 1 (logPo/w=-0.52, 2.4 nmol Ru per mg protein) was found to be more lipophilic, having also a higher cellular uptake efficiency compared to 2 (logPo/w=-0.20, 0.9 nmol Ru per mg protein).  Complex 1 localized evenly in HeLa cells whereas 2, was mainly visualized in the cell membrane by confocal microscopy.  In the dark, complex 1 (IC50=36.5 μm) was found to be more toxic than complex 2 (IC50 >100 μm) on a HeLa cells monolayer.  Importantly, in view of PDT applications, both complexes were found to be non-toxic in the dark towards multicellular HeLa spheroids (IC50>100 μM).  Upon one-photon irradn. (420 nm, 9.27 J cm-2), 1 exhibited higher phototoxicity (IC50=3.1 μm) than 2 (IC50=16.7 μm) on HeLa cell monolayers.  When two-photon irradn. (800 nm, 9.90 J cm-2) was applied, only 1 (IC50=9.5 μm) was found to be active toward HeLa spheroids.  This study demonstrates that the functional group on the intercalative ligand has a strong influence on the cellular localization and anticancer activity of RuII polypyridyl complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpALsMHxl67W7Vg90H21EOLACvtfcHk0lhn6IETgnPYnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2gs77K&md5=5f4b0fb8ecd4d2cd980344015aaec947</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1002%2Fchem.201701392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201701392%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DPierroz%26aufirst%3DV.%26aulast%3DBlacque%26aufirst%3DO.%26aulast%3DChao%26aufirst%3DH.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DEvaluation%2520of%2520the%2520medicinal%2520potential%2520of%2520two%2520ruthenium%2528II%2529%2520polypyridine%2520complexes%2520as%2520one-%2520and%2520two-photon%2520photodynamic%2520therapy%2520photosensitizers%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D9888%26epage%3D9896%26doi%3D10.1002%2Fchem.201701392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heinemann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karges, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Critical Overview of the Use of Ru(II) Polypyridyl complexes as photosensitizers in one-photon and two-photon photodynamic therapy</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2727</span>– <span class="NLM_lpage">2736</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.7b00180</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.7b00180" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yqs7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2017&pages=2727-2736&author=F.+Heinemannauthor=J.+Kargesauthor=G.+Gasser&title=Critical+Overview+of+the+Use+of+Ru%28II%29+Polypyridyl+complexes+as+photosensitizers+in+one-photon+and+two-photon+photodynamic+therapy&doi=10.1021%2Facs.accounts.7b00180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy</span></div><div class="casAuthors">Heinemann, Franz; Karges, Johannes; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2727-2736</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photodynamic Therapy (PDT) is an emerging technique to treat certain types of cancer, bacterial, fungal, and viral infections, and skin diseases.  In past years, different research groups developed new ruthenium-contg. photosensitizers (PSs) with tuned photophys. and biol. properties to better fit the requirements of PDT.  In this Account, we report and discuss the latest results in this research area, emphasizing particularly our own research.  For example, inspired by the DNA intercalating complex [Ru(bpy)2(dppz)]2+ bpy = 2,2'-bipyridine; dppz = (dipyrido[3,2-a:2',3'-c]phenazine), a series of ruthenium complexes bearing differently functionalized dppz ligands were synthesized to target DNA.  The introduction of the substituents on the dppz ligand did not reduce much the affinity of the complexes to DNA but highly affected their cellular uptake.  The most effective complex in this series, [Ru(bpy)2(dppz-7-OMe)]2+, showed IC50 values in the low micromolar range against several types of cancer cells upon light irradn. and, importantly, a high phototoxic index (PI) of >150.  This value is comparable to or even better than several PSs used in clinics under comparable exptl. conditions.  This compd. was found to localize in the nucleus and to induce DNA damage in HeLa cells upon light irradn.  Interestingly, cells in the mitotic phase were found to be more affected and to have a different mechanism of cell death (apoptosis) upon light irradn. than those in the interphase (paraptosis).  To take advantage of that, the PS was combined with a cell cycle inhibitor to synchronize cells in the mitotic phase, further improving the phototoxicity by a factor of 3.6.  In addn., our group recently demonstrated that [Ru(bphen)2(benzene-1,2-dislufinate)] (bphen = 4,7-diphenyl-1,10-phenanthroline) localizes in mitochondria and has an IC50 value of 0.62 μM with a PI of over 80 in HeLa cells upon light irradn. at 420 nm.  Interestingly, this complex was also found to efficiently kill Gram-pos. Staphylococcus aureus under light irradn.  Antimicrobial PDT (aPDT) is another field of research where Ru(II) polypyridyl complexes can play an interesting role to fight antibiotics resistance. [Ru(dqpCO2Me)(ptpy)]2+ (dqpCO2Me = 4-methylcarboxy-2,6-di(quinolin-8-yl)pyridine), ptpy = 4'-phenyl-2,2':6',2''-terpyridine is addnl. efficient against Gram-neg. Escherichia coli.  The efficacy of pos. charged Ru(II) PSs is related to their affinity to the neg. charged membrane of Gram-neg. bacteria.A drawback of many Ru(II) polypyridyl PSs is their low absorption in the biol. optical window (600-900 nm) where light penetration depth into tissue is the highest.  The lowest energy transition in the UV/Vis spectra of Ru(II) polypyridyl complexes is usually a metal-to-ligand charge-transfer band.  To shift the absorption into this range, tuning of the ligand system, for example, by extending π-systems, has been described in the literature.  Another approach to make excitation in the optical biol. window possible is Two-Photon Absorption (2PA).  High photon d. is needed and usually confocal laser beams are used for excitation.  In collaboration with the Chao group, a series of homoleptic Ru(II) complexes bearing tertiary alkyl ammonium substituted bipyridine ligands with two photon cross sections between 185 and 250 GM at around 800 nm was tested in vitro.  They showed IC50 values in the micromolar range and PIs between 103 and 313.  The highly pos.-charged complexes were found to enter the cell via endocytosis and to target lysosomes.  Studies on 3D tumor cell spheroids, a model closer to real tumors than commonly used 2D cell monolayers, were also performed.  It could be demonstrated that 2P-PDT treatment with 800 nm laser irradn. was significantly more effective than that with 450 nm laser irradn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcr8TypCe_ALVg90H21EOLACvtfcHk0lhn6IETgnPYnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yqs7zL&md5=d14969ed7afc004cd5bf16c208ddfcd2</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.7b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.7b00180%26sid%3Dliteratum%253Aachs%26aulast%3DHeinemann%26aufirst%3DF.%26aulast%3DKarges%26aufirst%3DJ.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DCritical%2520Overview%2520of%2520the%2520Use%2520of%2520Ru%2528II%2529%2520Polypyridyl%2520complexes%2520as%2520photosensitizers%2520in%2520one-photon%2520and%2520two-photon%2520photodynamic%2520therapy%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2017%26volume%3D50%26spage%3D2727%26epage%3D2736%26doi%3D10.1021%2Facs.accounts.7b00180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierroz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Combination of Ru(ii) complexes and light: new frontiers in cancer therapy</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2660</span>– <span class="NLM_lpage">2686</span>, <span class="refDoi"> DOI: 10.1039/C4SC03759F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC4SC03759F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=29308166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVGqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=2660-2686&author=C.+Mariauthor=V.+Pierrozauthor=S.+Ferrariauthor=G.+Gasser&title=Combination+of+Ru%28ii%29+complexes+and+light%3A+new+frontiers+in+cancer+therapy&doi=10.1039%2FC4SC03759F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of Ru(II) complexes and light: new frontiers in cancer therapy</span></div><div class="casAuthors">Mari, Cristina; Pierroz, Vanessa; Ferrari, Stefano; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2660-2686</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The synergistic action of light, oxygen and a photosensitizer (PS) has found applications for decades in medicine under the name of photodynamic therapy (PDT) for the treatment of skin diseases and, more recently, for the treatment of cancer.  However, of the thirteen PSs currently approved for the treatment of cancer over more than 10 countries, only two contain a metal ion.  This fact is rather surprising considering that nowadays around 50% of conventional chemotherapies involve the use of cisplatin and other platinum-contg. drugs.  In this perspective article, we review the opportunities brought by the use of Ru(II) complexes as PSs in PDT.  In addn., we also present the recent achievements in the application of Ru(II) complexes in photoactivated chemotherapy (PACT).  In this strategy, the presence of oxygen is not required to achieve cell toxicity.  This is of significance since tumors are generally hypoxic.  Importantly, this perspective article focuses particularly on the Ru(II) complexes for which an in vitro biol. evaluation has been performed and the mechanism of action (partially) unveiled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_bEsxUQdijbVg90H21EOLACvtfcHk0lgpztOQvjTXcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVGqsA%253D%253D&md5=6df3d5f614a2cd6f951189a3340a2590</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1039%2FC4SC03759F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4SC03759F%26sid%3Dliteratum%253Aachs%26aulast%3DMari%26aufirst%3DC.%26aulast%3DPierroz%26aufirst%3DV.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DCombination%2520of%2520Ru%2528ii%2529%2520complexes%2520and%2520light%253A%2520new%2520frontiers%2520in%2520cancer%2520therapy%26jtitle%3DChem.%2520Sci.%26date%3D2015%26volume%3D6%26spage%3D2660%26epage%3D2686%26doi%3D10.1039%2FC4SC03759F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span> <span> </span><span class="NLM_article-title">Highly charged ruthenium(II) polypyridyl complexes as lysosome-localized photosensitizers for two-photon photodynamic therapy</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">14049</span>– <span class="NLM_lpage">14052</span>, <span class="refDoi"> DOI: 10.1002/anie.201507800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fanie.201507800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1elsL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=14049-14052&author=H.+Huangauthor=B.+Yuauthor=P.+Zhangauthor=J.+Huangauthor=Y.+Chenauthor=G.+Gasserauthor=L.+Jiauthor=H.+Chao&title=Highly+charged+ruthenium%28II%29+polypyridyl+complexes+as+lysosome-localized+photosensitizers+for+two-photon+photodynamic+therapy&doi=10.1002%2Fanie.201507800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Charged Ruthenium(II) Polypyridyl Complexes as Lysosome-Localized Photosensitizers for Two-Photon Photodynamic Therapy</span></div><div class="casAuthors">Huang, Huaiyi; Yu, Bole; Zhang, Pingyu; Huang, Juanjuan; Chen, Yu; Gasser, Gilles; Ji, Liangnian; Chao, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">14049-14052</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is a noninvasive medical technique that has received increasing attention over the last years and been applied for the treatment of certain types of cancer.  However, the currently clin. used PDT agents have several limitations, such as low water soly., poor photostability, and limited selectivity towards cancer cells, aside from having very low two-photon cross-sections around 800 nm, which limits their potential use in TP-PDT.  To tackle these drawbacks, three highly pos. charged ruthenium(II) polypyridyl complexes were synthesized.  These complexes selectively localize in the lysosomes, an ideal localization for PDT purposes.  One of these complexes showed an impressive phototoxicity index upon irradn. at 800 nm in 3D HeLa multicellular tumor spheroids and thus holds great promise for applications in two-photon photodynamic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcb9izqx5Zk7Vg90H21EOLACvtfcHk0lgpztOQvjTXcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1elsL%252FN&md5=fad2f74f12a45ffcc49ac2e56fb287ae</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1002%2Fanie.201507800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201507800%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGasser%26aufirst%3DG.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26atitle%3DHighly%2520charged%2520ruthenium%2528II%2529%2520polypyridyl%2520complexes%2520as%2520lysosome-localized%2520photosensitizers%2520for%2520two-photon%2520photodynamic%2520therapy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D14049%26epage%3D14052%26doi%3D10.1002%2Fanie.201507800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span> <span> </span><span class="NLM_article-title">Direct imaging of biological sulfur dioxide derivatives in vivo using a two-photon phosphorescent probe</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2015.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.biomaterials.2015.06.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2015&pages=128-136&author=G.+Liauthor=Y.+Chenauthor=J.+Wangauthor=J.+Wuauthor=G.+Gasserauthor=L.+Jiauthor=H.+Chao&title=Direct+imaging+of+biological+sulfur+dioxide+derivatives+in+vivo+using+a+two-photon+phosphorescent+probe&doi=10.1016%2Fj.biomaterials.2015.06.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2015.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2015.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DGasser%26aufirst%3DG.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26atitle%3DDirect%2520imaging%2520of%2520biological%2520sulfur%2520dioxide%2520derivatives%2520in%2520vivo%2520using%2520a%2520two-photon%2520phosphorescent%2520probe%26jtitle%3DBiomaterials%26date%3D2015%26volume%3D63%26spage%3D128%26epage%3D136%26doi%3D10.1016%2Fj.biomaterials.2015.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennigar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colpitts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasimova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeCoste, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamberlain, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, S. A.</span></span> <span> </span><span class="NLM_article-title">Ru(II) dyads derived from α-oligothiophenes: A new class of potent and versatile photosensitizers for PDT</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>282–283</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2014.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ccr.2014.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Gns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282%E2%80%93283&publication_year=2015&pages=127-138&author=G.+Shiauthor=S.+Monroauthor=R.+Hennigarauthor=J.+Colpittsauthor=J.+Fongauthor=K.+Kasimovaauthor=H.+Yinauthor=R.+DeCosteauthor=C.+Spencerauthor=L.+Chamberlainauthor=A.+Mandelauthor=L.+Lilgeauthor=S.+A.+McFarland&title=Ru%28II%29+dyads+derived+from+%CE%B1-oligothiophenes%3A+A+new+class+of+potent+and+versatile+photosensitizers+for+PDT&doi=10.1016%2Fj.ccr.2014.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Ru(II) dyads derived from α-oligothiophenes: A new class of potent and versatile photosensitizers for PDT</span></div><div class="casAuthors">Shi, Ge; Monro, Susan; Hennigar, Robie; Colpitts, Julie; Fong, Jamie; Kasimova, Kamola; Yin, Huimin; DeCoste, Ryan; Spencer, Colin; Chamberlain, Lance; Mandel, Arkady; Lilge, Lothar; McFarland, Sherri A.</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">282-283</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-138</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Ru(II) dyads derived from org. units that impart low-lying 3IL excited states combine the most attractive features of org. photosensitizers with those of coordination complexes.  The result is a bichromophoric system with excited-state lifetimes that are significantly longer than those assocd. with traditional 3MLCT states.  Incorporation of α-oligothiophenes as the org. chromophore leads to systems that act as dual Type I/II photosensitizers, opening up the possibility of treating hypoxic tumors with photodynamic therapy (PDT) and overcoming problems with in vivo dosimetry.  These photosensitizers, particularly those that consist of three thiophene units and higher, are remarkable DNA binders and photocleavers when exposed to light, exhibiting no interference with DNA structural integrity in the absence of a light-trigger.  Such light-responsive agents localize in the nuclei of cells without the need for a carrier and produce a potent PDT response with minimal dark toxicity.  This phototherapeutic effect translates directly to animals and is superior to the clin. agent Photofrin in this model.  These Ru(II) dyads can be activated with light in the PDT window, despite very low molar absorptivities in this region, and this phenomenon can be attributed to the efficiency with which these agents operate.  The ability to activate these prodrugs with UV to near-IR light marks an unprecedented versatility that can be exploited to match treatment depth to tumor invasion depth without compromising potency, giving rise to photosensitizers for multiwavelength PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNfTsxLAyC7rVg90H21EOLACvtfcHk0lgpztOQvjTXcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Gns78%253D&md5=148232f59b51e383d97a9d94d5e576cc</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DG.%26aulast%3DMonro%26aufirst%3DS.%26aulast%3DHennigar%26aufirst%3DR.%26aulast%3DColpitts%26aufirst%3DJ.%26aulast%3DFong%26aufirst%3DJ.%26aulast%3DKasimova%26aufirst%3DK.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DDeCoste%26aufirst%3DR.%26aulast%3DSpencer%26aufirst%3DC.%26aulast%3DChamberlain%26aufirst%3DL.%26aulast%3DMandel%26aufirst%3DA.%26aulast%3DLilge%26aufirst%3DL.%26aulast%3DMcFarland%26aufirst%3DS.%2BA.%26atitle%3DRu%2528II%2529%2520dyads%2520derived%2520from%2520%25CE%25B1-oligothiophenes%253A%2520A%2520new%2520class%2520of%2520potent%2520and%2520versatile%2520photosensitizers%2520for%2520PDT%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2015%26volume%3D282%25E2%2580%2593283%26spage%3D127%26epage%3D138%26doi%3D10.1016%2Fj.ccr.2014.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boca, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Four, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Sanden, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astilean, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldeck, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemercier, G.</span></span> <span> </span><span class="NLM_article-title">An ethylene-glycol decorated ruthenium(II) complex for two-photon photodynamic therapy</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_fpage">4590</span>– <span class="NLM_lpage">4592</span>, <span class="refDoi"> DOI: 10.1039/b907143a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2Fb907143a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=19617993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD1MXoslClsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=4590-4592&author=S.+C.+Bocaauthor=M.+Fourauthor=A.+Bonneauthor=B.+van+der%0ASandenauthor=S.+Astileanauthor=P.+L.+Baldeckauthor=G.+Lemercier&title=An+ethylene-glycol+decorated+ruthenium%28II%29+complex+for+two-photon+photodynamic+therapy&doi=10.1039%2Fb907143a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">An ethylene-glycol decorated ruthenium(II) complex for two-photon photodynamic therapy</span></div><div class="casAuthors">Boca, Sanda C.; Four, Mickael; Bonne, Adeline; van der Sanden, Boudewijn; Astilean, Simion; Baldeck, Patrice L.; Lemercier, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">4590-4592</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel water-sol. ethylene-glycol decorated terpyridine Ru(II) complex was prepd., which represents a promising new class of selective two-photon sensitizers for use in photodynamic therapy within a confined space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwj5EPJCOgiLVg90H21EOLACvtfcHk0lhCe8mN9lb2wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXoslClsr8%253D&md5=3bdf65a4e3b748f1c29be0a444316724</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1039%2Fb907143a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb907143a%26sid%3Dliteratum%253Aachs%26aulast%3DBoca%26aufirst%3DS.%2BC.%26aulast%3DFour%26aufirst%3DM.%26aulast%3DBonne%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BSanden%26aufirst%3DB.%26aulast%3DAstilean%26aufirst%3DS.%26aulast%3DBaldeck%26aufirst%3DP.%2BL.%26aulast%3DLemercier%26aufirst%3DG.%26atitle%3DAn%2520ethylene-glycol%2520decorated%2520ruthenium%2528II%2529%2520complex%2520for%2520two-photon%2520photodynamic%2520therapy%26jtitle%3DChem.%2520Commun.%26date%3D2009%26spage%3D4590%26epage%3D4592%26doi%3D10.1039%2Fb907143a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemercier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Four, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson-Daku, L. M.</span></span> <span> </span><span class="NLM_article-title"><sup>3</sup>MLCT excited states in Ru(II) complexes: Reactivity and related two-photon absorption applications in the near-infrared spectral range</span>. <i>C. R. Chim.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">709</span>– <span class="NLM_lpage">715</span>, <span class="refDoi"> DOI: 10.1016/j.crci.2007.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.crci.2007.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1yktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=709-715&author=G.+Lemercierauthor=A.+Bonneauthor=M.+Fourauthor=L.+M.+Lawson-Daku&title=3MLCT+excited+states+in+Ru%28II%29+complexes%3A+Reactivity+and+related+two-photon+absorption+applications+in+the+near-infrared+spectral+range&doi=10.1016%2Fj.crci.2007.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">3MLCT excited states in Ru(II) complexes: Reactivity and related two-photon absorption applications in the near-infrared spectral range</span></div><div class="casAuthors">Lemercier, Gilles; Bonne, Adeline; Four, Mickael; Lawson-Daku, Latevi M.</div><div class="citationInfo"><span class="NLM_cas:title">Comptes Rendus Chimie</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">709-715</span>CODEN:
                <span class="NLM_cas:coden">CRCOCR</span>;
        ISSN:<span class="NLM_cas:issn">1631-0748</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">This short review provides a concise summary of the current state of research on the population by two-photon absorption of the triplet metal-to-ligand 3MLCT excited state of ruthenium(II) complexes.  Several effective and potential applications of this nonlinear optics phenomenon (optical power limiting in the near IR, biol. imagery and photodynamic therapy, PDT) and related linear effects will also be presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBULVF_PgSJbVg90H21EOLACvtfcHk0lhCe8mN9lb2wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1yktro%253D&md5=92668f550849c632960a6a429f2f68cf</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2Fj.crci.2007.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.crci.2007.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DLemercier%26aufirst%3DG.%26aulast%3DBonne%26aufirst%3DA.%26aulast%3DFour%26aufirst%3DM.%26aulast%3DLawson-Daku%26aufirst%3DL.%2BM.%26atitle%3D3MLCT%2520excited%2520states%2520in%2520Ru%2528II%2529%2520complexes%253A%2520Reactivity%2520and%2520related%2520two-photon%2520absorption%2520applications%2520in%2520the%2520near-infrared%2520spectral%2520range%26jtitle%3DC.%2520R.%2520Chim.%26date%3D2008%26volume%3D11%26spage%3D709%26epage%3D715%26doi%3D10.1016%2Fj.crci.2007.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westhorpe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallevo, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bark, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menezes, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. A.</span></span> <span> </span><span class="NLM_article-title">Radiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">20596</span>, <span class="refDoi"> DOI: 10.1038/srep20596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2Fsrep20596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=26867983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFSksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=20596&author=R.+Carterauthor=A.+Westhorpeauthor=M.+J.+Romeroauthor=A.+Habtemariamauthor=C.+R.+Gallevoauthor=Y.+Barkauthor=N.+Menezesauthor=P.+J.+Sadlerauthor=R.+A.+Sharma&title=Radiosensitisation+of+human+colorectal+cancer+cells+by+ruthenium%28II%29+arene+anticancer+complexes&doi=10.1038%2Fsrep20596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes</span></div><div class="casAuthors">Carter, R.; Westhorpe, A.; Romero, Mj; Habtemariam, A.; Gallevo, Cr; Bark, Y.; Menezes, N.; Sadler, Pj; Sharma, Ra</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">20596</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Some of the largest improvements in clin. outcomes for patients with solid cancers obsd. over the past 3 decades have been from concurrent treatment with chemotherapy and radiotherapy (RT).  The lethal effects of RT on cancer cells arise primarily from damage to DNA.  Ruthenium (Ru) is a transition metal of the platinum group, with potentially less toxicity than platinum drugs.  We postulated that ruthenium-arene complexes are radiosensitizers when used in combination with RT.  We screened 14 ruthenium-arene complexes and identified AH54 and AH63 as supra-additive radiosensitizers by clonogenic survival assays and isobologram analyses.  Both complexes displayed facial chirality.  At clin. relevant doses of RT, radiosensitization of cancer cells by AH54 and AH63 was p53-dependent.  Radiation enhancement ratios for 5-10 micromolar drug concns. ranged from 1.19 to 1.82.  In p53-wildtype cells, both drugs induced significant G2 cell cycle arrest and apoptosis.  Colorectal cancer cells deficient in DNA damage repair proteins, EME1 and MUS81, were significantly more sensitive to both agents.  Both drugs were active in cancer cell lines displaying acquired resistance to oxaliplatin or cisplatin.  Our findings broaden the potential scope for these drugs for use in cancer therapy, including combination with radiotherapy to treat colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVMH20t7IG0rVg90H21EOLACvtfcHk0lhCe8mN9lb2wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFSksbw%253D&md5=0e95ec3f1b55cdad044af8d17fcb4217</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1038%2Fsrep20596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep20596%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DR.%26aulast%3DWesthorpe%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DM.%2BJ.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DGallevo%26aufirst%3DC.%2BR.%26aulast%3DBark%26aufirst%3DY.%26aulast%3DMenezes%26aufirst%3DN.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26aulast%3DSharma%26aufirst%3DR.%2BA.%26atitle%3DRadiosensitisation%2520of%2520human%2520colorectal%2520cancer%2520cells%2520by%2520ruthenium%2528II%2529%2520arene%2520anticancer%2520complexes%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D20596%26doi%3D10.1038%2Fsrep20596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span> <span> </span><span class="NLM_article-title">Hypoxia--a key regulatory factor in tumour growth</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1038/nrc704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2Fnrc704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=11902584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=38-47&author=A.+L.+Harris&title=Hypoxia%2D%2Da+key+regulatory+factor+in+tumour+growth&doi=10.1038%2Fnrc704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia - a key regulatory factor in tumor growth</span></div><div class="casAuthors">Harris, Adrian L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-47</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cells undergo a variety of biol. responses when placed in hypoxic conditions, including activation of signaling pathways that regulate proliferation, angiogenesis and death.  Cancer cells have adapted these pathways, allowing tumors to survive and even grow under hypoxic conditions, and tumor hypoxia is assocd. with poor prognosis and resistance to radiation therapy.  Many elements of the hypoxia-response pathway are therefore good candidates for therapeutic targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO3m4smDSP37Vg90H21EOLACvtfcHk0lgAC_hjQZwPgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL4%253D&md5=e3f65ce80422e4743d49905e1796fe5c</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1038%2Fnrc704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc704%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DHypoxia--a%2520key%2520regulatory%2520factor%2520in%2520tumour%2520growth%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D38%26epage%3D47%26doi%3D10.1038%2Fnrc704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Lightening up ruthenium complexes to fight cancer?</span>. <i>Chimia</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.2533/chimia.2015.176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2533%2Fchimia.2015.176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=26668934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXoslyntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2015&pages=176-181&author=C.+Mariauthor=G.+Gasser&title=Lightening+up+ruthenium+complexes+to+fight+cancer%3F&doi=10.2533%2Fchimia.2015.176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Lightening up ruthenium complexes to fight cancer?</span></div><div class="casAuthors">Mari, Cristina; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chimia</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">176-181</span>CODEN:
                <span class="NLM_cas:coden">CHIMAD</span>;
        ISSN:<span class="NLM_cas:issn">0009-4293</span>.
    
            (<span class="NLM_cas:orgname">Swiss Chemical Society</span>)
        </div><div class="casAbstract">A review.  In medicine, light is used in a medical treatment called photodynamic therapy (PDT) to treat some types of cancer and skin diseases.  This technique generally allows for reduced side effects compared to traditional chemotherapy.  However, PDT is not fully effective on hypoxic tumors (i.e. lacking oxygen).  To overcome this important drawback, photoactivated chemotherapy (PACT) agents have been designed to obtain light-mediated cancer cell death via an oxygen-independent mechanism.  Ruthenium complexes have already been and are currently deeply explored as traditional anticancer agents.  However, as reported in this short review article, such compds. can also bring novel opportunities in the field of light-mediated cancer treatment.  Herein, we report on our findings in the optimization of Ru(ii) polypyridyl complexes as PDT and PACT agents for the potential treatment of cancer and, interestingly, also of bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLTvt-SxlhXbVg90H21EOLACvtfcHk0lgAC_hjQZwPgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXoslyntLY%253D&md5=54b50c6f699710bb9afbefd7dbde6599</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.2533%2Fchimia.2015.176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2533%252Fchimia.2015.176%26sid%3Dliteratum%253Aachs%26aulast%3DMari%26aufirst%3DC.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DLightening%2520up%2520ruthenium%2520complexes%2520to%2520fight%2520cancer%253F%26jtitle%3DChimia%26date%3D2015%26volume%3D69%26spage%3D176%26epage%3D181%26doi%3D10.2533%2Fchimia.2015.176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farrer, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salassa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine</span>. <i>Dalton trans.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>0</i></span>,  <span class="NLM_fpage">10690</span>– <span class="NLM_lpage">10701</span>, <span class="refDoi"> DOI: 10.1039/b917753a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2Fb917753a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFSgt7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=0&publication_year=2009&pages=10690-10701&author=N.+J.+Farrerauthor=L.+Salassaauthor=P.+J.+Sadler&title=Photoactivated+chemotherapy+%28PACT%29%3A+the+potential+of+excited-state+d-block+metals+in+medicine&doi=10.1039%2Fb917753a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine</span></div><div class="casAuthors">Farrer, Nicola J.; Salassa, Luca; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">10690-10701</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The fields of phototherapy and of inorg. chemotherapy both have long histories.  Inorg. photoactivated chemotherapy (PACT) offers both temporal and spatial control over drug activation and has remarkable potential for the treatment of cancer.  Following photoexcitation, a no. of different decay pathways (both photophys. and photochem.) are available to a metal complex.  These pathways can result in radiative energy release, loss of ligands or transfer of energy to another species, such as triplet oxygen.  We discuss the features which need to be considered when developing a metal-based anticancer drug, and the common mechanisms by which the current complexes are believed to operate.  We then provide a comprehensive overview of PACT developments for complexes of the different d-block metals for the treatment of cancer, detailing the more established areas concerning Ti, V, Cr, Mn, Re, Fe, Ru, Os, Co, Rh, Pt, and Cu and also highlighting areas where there is potential for greater exploration.  Nanoparticles (Ag, Au) and quantum dots (Cd) are also discussed for their photothermal destructive potential.  We also discuss the potential held in particular by mixed-metal systems and Ru complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaW_paG_wgTrVg90H21EOLACvtfcHk0lgAC_hjQZwPgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFSgt7%252FP&md5=c505a936782c60488c0809227baf711a</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1039%2Fb917753a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb917753a%26sid%3Dliteratum%253Aachs%26aulast%3DFarrer%26aufirst%3DN.%2BJ.%26aulast%3DSalassa%26aufirst%3DL.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DPhotoactivated%2520chemotherapy%2520%2528PACT%2529%253A%2520the%2520potential%2520of%2520excited-state%2520d-block%2520metals%2520in%2520medicine%26jtitle%3DDalton%2520trans.%26date%3D2009%26volume%3D0%26spage%3D10690%26epage%3D10701%26doi%3D10.1039%2Fb917753a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kohler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nease, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garofolo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidary, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thummel, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glazer, E. C.</span></span> <span> </span><span class="NLM_article-title">Photochemical and photobiological activity of ru(II) homoleptic and heteroleptic complexes containing methylated bipyridyl-type ligands</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">12214</span>– <span class="NLM_lpage">12223</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.7b01642</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.7b01642" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGjsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=12214-12223&author=L.+Kohlerauthor=L.+Neaseauthor=P.+Voauthor=J.+Garofoloauthor=D.+K.+Heidaryauthor=R.+P.+Thummelauthor=E.+C.+Glazer&title=Photochemical+and+photobiological+activity+of+ru%28II%29+homoleptic+and+heteroleptic+complexes+containing+methylated+bipyridyl-type+ligands&doi=10.1021%2Facs.inorgchem.7b01642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Photochemical and photobiological activity of Ru(II) homoleptic and heteroleptic complexes containing methylated bipyridyl-type ligands</span></div><div class="casAuthors">Kohler, Lars; Nease, Leona; Vo, Pascal; Garofolo, Jenna; Heidary, David K.; Thummel, Randolph P.; Glazer, Edith C.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">12214-12223</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Light-activated compds. are powerful tools and potential agents for medical applications, as biol. effects can be controlled in space and time.  Ruthenium polypyridyl complexes can induce cytotoxic effects through multiple mechanisms, including acting as photosensitizers for singlet oxygen (1O2) prodn., generating other reactive oxygen species (ROS), releasing biol. active ligands, and creating reactive intermediates that form covalent bonds to biol. mols.  A structure-activity relationship (SAR) study was performed on a series of Ru(II) complexes contg. isomeric tetramethyl-substituted bipyridyl-type ligands.  Three of the ligand systems studied contained strain-inducing Me groups and created photolabile metal complexes, which can form covalent bonds to biomols. upon light activation, while the fourth was unstrained and resulted in photostable complexes, which can generate 1O2.  The compds. studied included both bis-heteroleptic complexes contg. two bipyridine ligands and a third, substituted ligand and tris-homoleptic complexes contg. only the substituted ligand.  The photophysics, electrochem., photochem., and photobiol. were assessed.  Strained heteroleptic complexes were found to be more photoactive and cytotoxic then tris-homoleptic complexes, and bipyridine ligands were superior to bipyrimidine.  However, the homoleptic complexes exhibited an enhanced ability to inhibit protein prodn. in live cells.  Specific methylation patterns were assocd. with improved activation with red light, and photolabile complexes were generally more potent cytotoxic agents than the photostable 1O2-generating compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMF1WUOUEWnbVg90H21EOLACvtfcHk0lis0Ei5B3EhZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGjsLrL&md5=d0fd85043d710c2a1e56d1d9b82be06e</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.7b01642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.7b01642%26sid%3Dliteratum%253Aachs%26aulast%3DKohler%26aufirst%3DL.%26aulast%3DNease%26aufirst%3DL.%26aulast%3DVo%26aufirst%3DP.%26aulast%3DGarofolo%26aufirst%3DJ.%26aulast%3DHeidary%26aufirst%3DD.%2BK.%26aulast%3DThummel%26aufirst%3DR.%2BP.%26aulast%3DGlazer%26aufirst%3DE.%2BC.%26atitle%3DPhotochemical%2520and%2520photobiological%2520activity%2520of%2520ru%2528II%2529%2520homoleptic%2520and%2520heteroleptic%2520complexes%2520containing%2520methylated%2520bipyridyl-type%2520ligands%26jtitle%3DInorg.%2520Chem.%26date%3D2017%26volume%3D56%26spage%3D12214%26epage%3D12223%26doi%3D10.1021%2Facs.inorgchem.7b01642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Havrylyuk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidary, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nease, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glazer, E. C.</span></span> <span> </span><span class="NLM_article-title">Photochemical properties and structure-activity relationships of Ru(II) complexes with pyridylbenzazole ligands as promising anticancer agents</span>. <i>Eur. J. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1687</span>– <span class="NLM_lpage">1694</span>, <span class="refDoi"> DOI: 10.1002/ejic.201601450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fejic.201601450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=29200939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislOit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1687-1694&author=D.+Havrylyukauthor=D.+K.+Heidaryauthor=L.+Neaseauthor=S.+Parkinauthor=E.+C.+Glazer&title=Photochemical+properties+and+structure-activity+relationships+of+Ru%28II%29+complexes+with+pyridylbenzazole+ligands+as+promising+anticancer+agents&doi=10.1002%2Fejic.201601450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Photochemical Properties and Structure-Activity Relationships of RuII Complexes with Pyridylbenzazole Ligands as Promising Anticancer Agents</span></div><div class="casAuthors">Havrylyuk, Dmytro; Heidary, David K.; Nease, Leona; Parkin, Sean; Glazer, Edith C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1687-1694</span>CODEN:
                <span class="NLM_cas:coden">EJICFO</span>;
        ISSN:<span class="NLM_cas:issn">1434-1948</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Ruthenium complexes capable of light-triggered cytotoxicity are appealing potential prodrugs for photodynamic therapy (PDT) and photoactivated chemotherapy (PACT).  Two groups of (polypyridyl)RuII complexes with 2-(2-pyridyl)benzazole ligands were synthesized and investigated for their photochem. properties and anticancer activity to compare strained and unstrained systems that are likely to have different biol. mechanisms of action.  The structure-activity relationship was focused on the benzazole-core bioisosterism and replacement of coligands in RuII complexes.  Strained compds. rapidly ejected the 2-(2-pyridyl)benzazole ligand after light irradn., and possessed strong toxicity in the HL-60 cell line both under dark and light conditions.  In contrast, unstrained RuII complexes were nontoxic in the absence of light, induced cytotoxicity at nanomolar concns. after light irradn., and were capable of light-induced DNA damage.  The 90-220-fold difference in light and dark IC50 values provides a large potential therapeutic window to allow for selective targeting of cells by exposure to light.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh2vmg-ypKLbVg90H21EOLACvtfcHk0lis0Ei5B3EhZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislOit7o%253D&md5=6ea0044d8943685afa5e60daf66b47d4</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1002%2Fejic.201601450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejic.201601450%26sid%3Dliteratum%253Aachs%26aulast%3DHavrylyuk%26aufirst%3DD.%26aulast%3DHeidary%26aufirst%3DD.%2BK.%26aulast%3DNease%26aufirst%3DL.%26aulast%3DParkin%26aufirst%3DS.%26aulast%3DGlazer%26aufirst%3DE.%2BC.%26atitle%3DPhotochemical%2520properties%2520and%2520structure-activity%2520relationships%2520of%2520Ru%2528II%2529%2520complexes%2520with%2520pyridylbenzazole%2520ligands%2520as%2520promising%2520anticancer%2520agents%26jtitle%3DEur.%2520J.%2520Inorg.%2520Chem.%26date%3D2017%26volume%3D2017%26spage%3D1687%26epage%3D1694%26doi%3D10.1002%2Fejic.201601450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Rixel, V. H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moolenaar, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegler, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messori, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, S.</span></span> <span> </span><span class="NLM_article-title">Controlling with light the interaction between trans-tetrapyridyl ruthenium complexes and an oligonucleotide</span>. <i>Dalton trans.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1039/C7DT03613B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC7DT03613B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=29230469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVGmt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=507-516&author=V.+H.+S.+Van+Rixelauthor=G.+F.+Moolenaarauthor=M.+A.+Sieglerauthor=L.+Messoriauthor=S.+Bonnet&title=Controlling+with+light+the+interaction+between+trans-tetrapyridyl+ruthenium+complexes+and+an+oligonucleotide&doi=10.1039%2FC7DT03613B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Controlling with light the interaction between trans-tetrapyridyl ruthenium complexes and an oligonucleotide</span></div><div class="casAuthors">van Rixel, Vincent H. S.; Moolenaar, Geri F.; Siegler, Maxime A.; Messori, Luigi; Bonnet, Sylvestre</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">507-516</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Three new trans-Ru(II) complexes coordinated to tetrapyridyl ligands, [Ru(bapbpy)(DMSO)Cl]Cl ([2]Cl), [Ru(bapbpy)(Hmte)2](PF6)2 ([3](PF6)2), and [Ru(biqbpy)(Hmte)2](PF6)2 ([4](PF6)2), (biqbpy = 6,6'-bis[N-(isoquinolyl)-1-amino]-2,2'-bipyridine, bapbpy = 6,6'-bis[N-(pyridyl)-1-amino]-2,2'-bipyridine, Hmte = 2-(Methylthio)ethanol) were prepd. as analogs of [Ru(biqbpy)(DMSO)Cl]Cl ([1]Cl), a recently described photoactivated chemotherapy agent.  The new complexes were characterized, and their crystal structures showed the distorted coordination octahedron typical of this family of complexes.  Their photoreactivity in soln. was analyzed by spectrophotometry and mass spectrometry, which showed that the S ligand was substituted upon blue light irradn.  The binding of the Ru complexes to a ref. single-stranded oligonucleotide (s(5'CTACGGTTTCAC3')) was explored both in the dark and under light irradn. by gel electrophoresis and high-resoln. mass spectrometry.  While adduct formation in the dark was negligible for the four complexes, light irradn. gave adducts with one or two Ru centers per oligonucleotide.  The absence of interactions in the dark and the presence of complex-oligonucleotide adducts demonstrate that visible light controls the interaction of these Ru complexes with nucleic acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGBFMW6lG1d7Vg90H21EOLACvtfcHk0lis0Ei5B3EhZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVGmt77L&md5=60dda0e64c593ecea874acf8f9d61469</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1039%2FC7DT03613B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7DT03613B%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BRixel%26aufirst%3DV.%2BH.%2BS.%26aulast%3DMoolenaar%26aufirst%3DG.%2BF.%26aulast%3DSiegler%26aufirst%3DM.%2BA.%26aulast%3DMessori%26aufirst%3DL.%26aulast%3DBonnet%26aufirst%3DS.%26atitle%3DControlling%2520with%2520light%2520the%2520interaction%2520between%2520trans-tetrapyridyl%2520ruthenium%2520complexes%2520and%2520an%2520oligonucleotide%26jtitle%3DDalton%2520trans.%26date%3D2018%26volume%3D47%26spage%3D507%26epage%3D516%26doi%3D10.1039%2FC7DT03613B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lameijer, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Askes, S. H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Devedec, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, S.</span></span> <span> </span><span class="NLM_article-title">A red-light-activated ruthenium-caged NAMPT inhibitor remains phototoxic in hypoxic cancer cells</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">11549</span>– <span class="NLM_lpage">11553</span>, <span class="refDoi"> DOI: 10.1002/anie.201703890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fanie.201703890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSmu77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=11549-11553&author=L.+N.+Lameijerauthor=D.+Ernstauthor=S.+L.+Hopkinsauthor=M.+S.+Meijerauthor=S.+H.+C.+Askesauthor=S.+E.+Le+Devedecauthor=S.+Bonnet&title=A+red-light-activated+ruthenium-caged+NAMPT+inhibitor+remains+phototoxic+in+hypoxic+cancer+cells&doi=10.1002%2Fanie.201703890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">A Red-Light-Activated Ruthenium-Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells</span></div><div class="casAuthors">Lameijer, Lucien N.; Ernst, Daniel; Hopkins, Samantha L.; Meijer, Michael S.; Askes, Sven H. C.; Le Devedec, Sylvia E.; Bonnet, Sylvestre</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">11549-11553</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We describe two water-sol. ruthenium complexes, [1]Cl2 and [2]Cl2, that photodissociate to release a cytotoxic nicotinamide phosphoribosyltransferase (NAMPT) inhibitor with a low dose (21 J cm-2) of red light in an oxygen-independent manner.  Using a specific NAMPT activity assay, up to an 18-fold increase in inhibition potency was measured upon red-light activation of [2]Cl2, while [1]Cl2 was thermally unstable.  For the first time, the dark and red-light-induced cytotoxicity of these photocaged compds. could be tested under hypoxia (1 % O2).  In skin (A431) and lung (A549) cancer cells, a 3- to 4-fold increase in cytotoxicity was found upon red-light irradn. for [2]Cl2, whether the cells were cultured and irradiated with 1 % or 21 % O2.  These results demonstrate the potential of photoactivated chemotherapy for hypoxic cancer cells, in which classical photodynamic therapy, which relies on oxygen activation, is poorly efficient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPvyLLGQboPLVg90H21EOLACvtfcHk0lis0Ei5B3EhZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSmu77L&md5=b5ab704916712872f33ed4d67838e380</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1002%2Fanie.201703890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201703890%26sid%3Dliteratum%253Aachs%26aulast%3DLameijer%26aufirst%3DL.%2BN.%26aulast%3DErnst%26aufirst%3DD.%26aulast%3DHopkins%26aufirst%3DS.%2BL.%26aulast%3DMeijer%26aufirst%3DM.%2BS.%26aulast%3DAskes%26aufirst%3DS.%2BH.%2BC.%26aulast%3DLe%2BDevedec%26aufirst%3DS.%2BE.%26aulast%3DBonnet%26aufirst%3DS.%26atitle%3DA%2520red-light-activated%2520ruthenium-caged%2520NAMPT%2520inhibitor%2520remains%2520phototoxic%2520in%2520hypoxic%2520cancer%2520cells%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D11549%26epage%3D11553%26doi%3D10.1002%2Fanie.201703890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herroon, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podgorski, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodanko, J. J.</span></span> <span> </span><span class="NLM_article-title">Illuminating cytochrome P450 binding: Ru(ii)-caged inhibitors of CYP17A1</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3673</span>– <span class="NLM_lpage">3676</span>, <span class="refDoi"> DOI: 10.1039/C7CC01459G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC7CC01459G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28304025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktVShu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=3673-3676&author=A.+Liauthor=R.+Yadavauthor=J.+K.+Whiteauthor=M.+K.+Herroonauthor=B.+P.+Callahanauthor=I.+Podgorskiauthor=C.+Turroauthor=E.+E.+Scottauthor=J.+J.+Kodanko&title=Illuminating+cytochrome+P450+binding%3A+Ru%28ii%29-caged+inhibitors+of+CYP17A1&doi=10.1039%2FC7CC01459G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Illuminating cytochrome P450 binding: Ru(II)-caged inhibitors of CYP17A1</span></div><div class="casAuthors">Li, Ao; Yadav, Rahul; White, Jessica K.; Herroon, Mackenzie K.; Callahan, Brian P.; Podgorski, Izabela; Turro, Claudia; Scott, Emily E.; Kodanko, Jeremy J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">3673-3676</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">New Ru(II)-caged abiraterone (ABI) complexes were synthesized that exhibit strong absorption in the visible region and release the steroidal CYP17A1 inhibitor abiraterone upon exposure to low energy visible light in buffer and prostate cancer cells.  Photoinduced release results in abiraterone binding to its CYP17A1 target in an inhibitory mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraOhsrARVNiLVg90H21EOLACvtfcHk0lhOcIbSWLlgmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktVShu7k%253D&md5=042870f352c3f09a7352d072edfe54c2</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1039%2FC7CC01459G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC01459G%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DA.%26aulast%3DYadav%26aufirst%3DR.%26aulast%3DWhite%26aufirst%3DJ.%2BK.%26aulast%3DHerroon%26aufirst%3DM.%2BK.%26aulast%3DCallahan%26aufirst%3DB.%2BP.%26aulast%3DPodgorski%26aufirst%3DI.%26aulast%3DTurro%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DE.%2BE.%26aulast%3DKodanko%26aufirst%3DJ.%2BJ.%26atitle%3DIlluminating%2520cytochrome%2520P450%2520binding%253A%2520Ru%2528ii%2529-caged%2520inhibitors%2520of%2520CYP17A1%26jtitle%3DChem.%2520Commun.%26date%3D2017%26volume%3D53%26spage%3D3673%26epage%3D3676%26doi%3D10.1039%2FC7CC01459G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renfrew, A. K.</span></span> <span> </span><span class="NLM_article-title">Photolabile ruthenium complexes to cage and release a highly cytotoxic anticancer agent</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>179</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2017.11.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jinorgbio.2017.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=29180165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOiu7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2018&pages=146-153&author=J.+Weiauthor=A.+K.+Renfrew&title=Photolabile+ruthenium+complexes+to+cage+and+release+a+highly+cytotoxic+anticancer+agent&doi=10.1016%2Fj.jinorgbio.2017.11.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Photolabile ruthenium complexes to cage and release a highly cytotoxic anticancer agent</span></div><div class="casAuthors">Wei, Jianhua; Renfrew, Anna K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">146-153</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">CHS-828 (N-(6-(4-chlorophenoxy)hexyl)-N'-cyano-N''-4-pyridyl guanidine) is an anticancer agent with low bioavailability and high systemic toxicity.  Here the authors present an approach to improve the therapeutic profile of the drug using photolabile ruthenium complexes to generate light-activated prodrugs of CHS-828.  Both prodrug complexes are stable in the dark but release CHS-828 when irradiated with visible light.  The complexes are water-sol. and accumulate in tumor cells in very high concns., predominantly in the mitochondria.  Both prodrug complexes are significantly less cytotoxic than free CHS-828 in the dark but their toxicity increases up to 10-fold in combination with visible light.  The cellular responses to light treatment are consistent with release of the cytotoxic CHS-828 ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4QFiFHaHZbrVg90H21EOLACvtfcHk0lhOcIbSWLlgmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOiu7bO&md5=bbbd0b7a2197150e2665a8fd2afe677e</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2017.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2017.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DRenfrew%26aufirst%3DA.%2BK.%26atitle%3DPhotolabile%2520ruthenium%2520complexes%2520to%2520cage%2520and%2520release%2520a%2520highly%2520cytotoxic%2520anticancer%2520agent%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2018%26volume%3D179%26spage%3D146%26epage%3D153%26doi%3D10.1016%2Fj.jinorgbio.2017.11.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zamora, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denning, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidary, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wachter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nease, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glazer, E. C.</span></span> <span> </span><span class="NLM_article-title">Ruthenium-containing P450 inhibitors for dual enzyme inhibition and DNA damage</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2165</span>– <span class="NLM_lpage">2173</span>, <span class="refDoi"> DOI: 10.1039/C6DT04405K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC6DT04405K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28121322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=2165-2173&author=A.+Zamoraauthor=C.+A.+Denningauthor=D.+K.+Heidaryauthor=E.+Wachterauthor=L.+A.+Neaseauthor=J.+Ruizauthor=E.+C.+Glazer&title=Ruthenium-containing+P450+inhibitors+for+dual+enzyme+inhibition+and+DNA+damage&doi=10.1039%2FC6DT04405K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium-containing P450 inhibitors for dual enzyme inhibition and DNA damage</span></div><div class="casAuthors">Zamora, Ana; Denning, Catherine A.; Heidary, David K.; Wachter, Erin; Nease, Leona A.; Ruiz, Jose; Glazer, Edith C.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2165-2173</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cytochrome P450s are key players in drug metab., and overexpression in tumors is assocd. with significant resistance to many medicinal agents.  Consequently, inhibition of P450s could serve as a strategy to restore drug efficacy.  However, the widespread expression of P450s throughout the human body and the crit. roles they play in various biosynthetic pathways motivates the development of P 450 inhibitors capable of controlled local administration.  Ruthenium complexes contg. P 450 inhibitors as ligands were synthesized in order to develop pro-drugs that can be triggered to release the inhibitors in a spatially and temporally controlled fashion.  Upon light activation the compds. release ligands that directly bind and inhibit P 450 enzymes, while the ruthenium center is able to directly damage DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoThP9A_DHfxrVg90H21EOLACvtfcHk0lhOcIbSWLlgmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCrsLc%253D&md5=181eacdc16d10e3af5f3d539cd98147c</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1039%2FC6DT04405K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6DT04405K%26sid%3Dliteratum%253Aachs%26aulast%3DZamora%26aufirst%3DA.%26aulast%3DDenning%26aufirst%3DC.%2BA.%26aulast%3DHeidary%26aufirst%3DD.%2BK.%26aulast%3DWachter%26aufirst%3DE.%26aulast%3DNease%26aufirst%3DL.%2BA.%26aulast%3DRuiz%26aufirst%3DJ.%26aulast%3DGlazer%26aufirst%3DE.%2BC.%26atitle%3DRuthenium-containing%2520P450%2520inhibitors%2520for%2520dual%2520enzyme%2520inhibition%2520and%2520DNA%2520damage%26jtitle%3DDalton%2520Trans.%26date%3D2017%26volume%3D46%26spage%3D2165%26epage%3D2173%26doi%3D10.1039%2FC6DT04405K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pracharova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepankova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span> <span> </span><span class="NLM_article-title">Photo-induced DNA cleavage and cytotoxicity of a ruthenium(II) arene anticancer complex</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2015.12.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jinorgbio.2015.12.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2016&pages=149-155&author=V.+Brabecauthor=J.+Pracharovaauthor=J.+Stepankovaauthor=P.+J.+Sadlerauthor=J.+Kasparkova&title=Photo-induced+DNA+cleavage+and+cytotoxicity+of+a+ruthenium%28II%29+arene+anticancer+complex&doi=10.1016%2Fj.jinorgbio.2015.12.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2015.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2015.12.029%26sid%3Dliteratum%253Aachs%26aulast%3DBrabec%26aufirst%3DV.%26aulast%3DPracharova%26aufirst%3DJ.%26aulast%3DStepankova%26aufirst%3DJ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26aulast%3DKasparkova%26aufirst%3DJ.%26atitle%3DPhoto-induced%2520DNA%2520cleavage%2520and%2520cytotoxicity%2520of%2520a%2520ruthenium%2528II%2529%2520arene%2520anticancer%2520complex%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2016%26volume%3D160%26spage%3D149%26epage%3D155%26doi%3D10.1016%2Fj.jinorgbio.2015.12.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Fusion of photodynamic therapy and photoactivated chemotherapy: a novel Ru(II) arene complex with dual activities of photo binding and photocleavage toward DNA</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">15375</span>– <span class="NLM_lpage">15384</span>, <span class="refDoi"> DOI: 10.1039/C4DT01755B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC4DT01755B" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=15375-15384&author=Y.+Chenauthor=W.+Leiauthor=G.+Jiangauthor=Y.+Houauthor=C.+Liauthor=B.+Zhangauthor=Q.+Zhouauthor=X.+Wang&title=Fusion+of+photodynamic+therapy+and+photoactivated+chemotherapy%3A+a+novel+Ru%28II%29+arene+complex+with+dual+activities+of+photo+binding+and+photocleavage+toward+DNA&doi=10.1039%2FC4DT01755B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1039%2FC4DT01755B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4DT01755B%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLei%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DFusion%2520of%2520photodynamic%2520therapy%2520and%2520photoactivated%2520chemotherapy%253A%2520a%2520novel%2520Ru%2528II%2529%2520arene%2520complex%2520with%2520dual%2520activities%2520of%2520photo%2520binding%2520and%2520photocleavage%2520toward%2520DNA%26jtitle%3DDalton%2520Trans.%26date%3D2014%26volume%3D43%26spage%3D15375%26epage%3D15384%26doi%3D10.1039%2FC4DT01755B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leijen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgers, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pluim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tibben, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Werkhoven, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sava, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beijnen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schellens, J. H.</span></span> <span> </span><span class="NLM_article-title">Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1007/s10637-014-0179-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1007%2Fs10637-014-0179-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=25344453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFShsLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=201-214&author=S.+Leijenauthor=S.+A.+Burgersauthor=P.+Baasauthor=D.+Pluimauthor=M.+Tibbenauthor=E.+van+Werkhovenauthor=E.+Alessioauthor=G.+Savaauthor=J.+H.+Beijnenauthor=J.+H.+Schellens&title=Phase+I%2FII+study+with+ruthenium+compound+NAMI-A+and+gemcitabine+in+patients+with+non-small+cell+lung+cancer+after+first+line+therapy&doi=10.1007%2Fs10637-014-0179-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy</span></div><div class="casAuthors">Leijen, Suzanne; Burgers, Sjaak A.; Baas, Paul; Pluim, Dick; Tibben, Matthijs; van Werkhoven, Erik; Alessio, Enzo; Sava, Gianni; Beijnen, Jos H.; Schellens, Jan H. M.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">201-214</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">This phase I/II study detd. the maximal tolerable dose, dose limiting toxicities, antitumor activity, the pharmacokinetics and pharmacodynamics of ruthenium compd. NAMI-A in combination with gemcitabine in Non-Small Cell Lung Cancer patients after first line treatment.  Initial dose escalation of NAMI-A was performed in a 28 day cycle: NAMI-A as a 3 h infusion through a port-a-cath at a starting dose of 300 mg/m2 at day 1, 8 and 15, in combination with gemcitabine 1,000 mg/m2 at days 2, 9 and 16.  Subsequently, dose escalation of NAMI-A in a 21 day schedule was explored.  At the maximal tolerable dose level of this schedule an expansion group was enrolled of which 15 patients were evaluable for response.  Due to frequent neutropenic dose interruptions in the third week, the 28 day schedule was amended into a 21 day schedule.  The maximal tolerable dose was 300 and 450 mg/m2 of NAMI-A (21 day schedule).  Main adverse events consisted of neutropenia, anemia, elevated liver enzymes, transient creatinine elevation, nausea, vomiting, constipation, diarrhea, fatigue, and renal toxicity.  NAMI-A administered in combination with gemcitabine is only moderately tolerated and less active in NSCLC patients after first line treatment than gemcitabine alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcT3vG0pRk3LVg90H21EOLACvtfcHk0lih6mPLYY2z-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFShsLvI&md5=7e39b259bf03bd8990fdcfde165c5412</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1007%2Fs10637-014-0179-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-014-0179-1%26sid%3Dliteratum%253Aachs%26aulast%3DLeijen%26aufirst%3DS.%26aulast%3DBurgers%26aufirst%3DS.%2BA.%26aulast%3DBaas%26aufirst%3DP.%26aulast%3DPluim%26aufirst%3DD.%26aulast%3DTibben%26aufirst%3DM.%26aulast%3Dvan%2BWerkhoven%26aufirst%3DE.%26aulast%3DAlessio%26aufirst%3DE.%26aulast%3DSava%26aufirst%3DG.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%26atitle%3DPhase%2520I%252FII%2520study%2520with%2520ruthenium%2520compound%2520NAMI-A%2520and%2520gemcitabine%2520in%2520patients%2520with%2520non-small%2520cell%2520lung%2520cancer%2520after%2520first%2520line%2520therapy%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2015%26volume%3D33%26spage%3D201%26epage%3D214%26doi%3D10.1007%2Fs10637-014-0179-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heffeter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atil, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kryeziu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groza, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koellensperger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Körner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jungwirth, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, W.</span></span> <span> </span><span class="NLM_article-title">The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3366</span>– <span class="NLM_lpage">3375</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2013.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ejca.2013.05.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=3366-3375&author=P.+Heffeterauthor=B.+Atilauthor=K.+Kryeziuauthor=D.+Grozaauthor=G.+Koellenspergerauthor=W.+K%C3%B6rnerauthor=U.+Jungwirthauthor=T.+Mohrauthor=B.+K.+Kepplerauthor=W.+Berger&title=The+ruthenium+compound+KP1339+potentiates+the+anticancer+activity+of+sorafenib+in+vitro+and+in+vivo&doi=10.1016%2Fj.ejca.2013.05.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2013.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2013.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DHeffeter%26aufirst%3DP.%26aulast%3DAtil%26aufirst%3DB.%26aulast%3DKryeziu%26aufirst%3DK.%26aulast%3DGroza%26aufirst%3DD.%26aulast%3DKoellensperger%26aufirst%3DG.%26aulast%3DK%25C3%25B6rner%26aufirst%3DW.%26aulast%3DJungwirth%26aufirst%3DU.%26aulast%3DMohr%26aufirst%3DT.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26aulast%3DBerger%26aufirst%3DW.%26atitle%3DThe%2520ruthenium%2520compound%2520KP1339%2520potentiates%2520the%2520anticancer%2520activity%2520of%2520sorafenib%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2013%26volume%3D49%26spage%3D3366%26epage%3D3375%26doi%3D10.1016%2Fj.ejca.2013.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crans, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lay, P. A.</span></span> <span> </span><span class="NLM_article-title">Speciation of metal drugs, supplements and toxins in media and bodily fluids controls <i>in vitro</i> activities</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">498</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2017.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ccr.2017.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlGgtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2017&pages=473-498&author=A.+Levinaauthor=D.+C.+Cransauthor=P.+A.+Lay&title=Speciation+of+metal+drugs%2C+supplements+and+toxins+in+media+and+bodily+fluids+controls+in+vitro+activities&doi=10.1016%2Fj.ccr.2017.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Speciation of metal drugs, supplements and toxins in media and bodily fluids controls in vitro activities</span></div><div class="casAuthors">Levina, Aviva; Crans, Debbie C.; Lay, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">473-498</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Studies of metal uptake, metab. and excretion by single bacterial, yeast, plant and animal cells is a widespread area of research, yet little is known about the reactivity and speciation of metal ions in the corresponding cell culture media, which dictates in vitro activities.  This review discusses: (i) compn. requirements for the culture of different types of cells; (ii) the main anal. techniques used in metal speciation studies, including sepn. techniques, spectroscopies (electronic, magnetic resonance and X-ray absorption), biol. assays and computational techniques; (iii) speciation of essential or toxic metal ions added to the media as inorg. salts; (iv) speciation of typical metal-based drugs in mammalian cell test systems; (v) factors such as the time-dependence of speciation, which will differ depending on whether or not the species was pre-incubated in the medium; and (vi) whether assays where performed in media that are in contact with other extracellular components that were more reminiscent of the in vivo extracellular environment than std. assays.  Reactions with cell culture media often lead to complete changes in metal speciation and to alterations of biol. activities that may often differ significantly from in vivo activities, or between different in vitro assays, often leading to conflicting evidence of activities.  In particular, the main cellular uptake pathways of metal compds., including passive diffusion, active uptake through transport channels and endocytosis-mediated uptake, provide a link between chem. forms of the metal species in the medium and their biol. activities.  Particular care is required for the complexes with strong chelating ligands, such as 1,10-phenanthroline and its derivs.  The release of such ligands and their binding to essential trace elements in the media may elicit strong biol. effects of their own through the interference with both extracellular and intracellular essential metal metab. that may have nothing to do with the parent drug.  The role of serum proteins, in particular albumin and transferrin, in the speciation and reactivity of metal complexes in cell culture media is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnpw2zoRSm-bVg90H21EOLACvtfcHk0lih6mPLYY2z-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlGgtb0%253D&md5=4e7b34c5a269dfa959fb08fb77309791</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2017.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2017.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DLevina%26aufirst%3DA.%26aulast%3DCrans%26aufirst%3DD.%2BC.%26aulast%3DLay%26aufirst%3DP.%2BA.%26atitle%3DSpeciation%2520of%2520metal%2520drugs%252C%2520supplements%2520and%2520toxins%2520in%2520media%2520and%2520bodily%2520fluids%2520controls%2520in%2520vitro%2520activities%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2017%26volume%3D352%26spage%3D473%26epage%3D498%26doi%3D10.1016%2Fj.ccr.2017.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doucette, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassell, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crans, D. C.</span></span> <span> </span><span class="NLM_article-title">Selective speciation improves efficacy and lowers toxicity of platinum anticancer and vanadium antidiabetic drugs</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2016.09.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jinorgbio.2016.09.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=27751591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslSiu7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2016&pages=56-70&author=K.+A.+Doucetteauthor=K.+N.+Hassellauthor=D.+C.+Crans&title=Selective+speciation+improves+efficacy+and+lowers+toxicity+of+platinum+anticancer+and+vanadium+antidiabetic+drugs&doi=10.1016%2Fj.jinorgbio.2016.09.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Selective speciation improves efficacy and lowers toxicity of platinum anticancer and vanadium antidiabetic drugs</span></div><div class="casAuthors">Doucette, Kaitlin A.; Hassell, Kelly N.; Crans, Debbie C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">56-70</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Improving efficacy and lowering resistance to metal-based drugs can be addressed by consideration of the coordination complex speciation and key reactions important to vanadium antidiabetic drugs or platinum anticancer drugs under biol. conditions.  The methods of analyses vary depending on the specific metal ion chem.  The vanadium compds. interconvert readily, whereas the reactions of the platinum compds. are much slower and thus much easier to study.  However, the vanadium species are readily differentiated due to vanadium complexes differing in color.  For both vanadium and platinum systems, understanding the processes as the compds., Lipoplatin and Satraplatin, enter cells is needed to better combat the disease; there are many cellular metabolites, which may affect processing and thus the efficacy of the drugs.  Examples of two formulations of platinum compds. illustrate how changing the chem. of the platinum will result in less toxic and better tolerated drugs.  The consequence of the much lower toxicity of the drug, can be readily realized because cisplatin administration requires hospital stay whereas Lipoplatin can be done in an outpatient manner.  Similarly, the properties of Satraplatin allow for development of an oral drug.  These forms of platinum demonstrate that the direct consequence of more selective speciation is lower side effects and cheaper administration of the anticancer agent.  Therefore we urge that as the community goes forward in development of new drugs, control of speciation chem. will be considered as one of the key strategies in the future development of anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbmUDjquH_lLVg90H21EOLACvtfcHk0liT5lZKFybbcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslSiu7jO&md5=e44a3b89c54e51d203396d402a62f95d</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2016.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2016.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DDoucette%26aufirst%3DK.%2BA.%26aulast%3DHassell%26aufirst%3DK.%2BN.%26aulast%3DCrans%26aufirst%3DD.%2BC.%26atitle%3DSelective%2520speciation%2520improves%2520efficacy%2520and%2520lowers%2520toxicity%2520of%2520platinum%2520anticancer%2520and%2520vanadium%2520antidiabetic%2520drugs%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2016%26volume%3D165%26spage%3D56%26epage%3D70%26doi%3D10.1016%2Fj.jinorgbio.2016.09.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 180 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Heiko Geisler, Julia Westermayr, Klaudia Cseh, Dominik Wenisch, Valentin Fuchs, Sophia Harringer, Sarah Plutzar, Natalie Gajic, Michaela Hejl, Michael A. Jakupec, Philipp Marquetand, <span class="NLM_string-name hlFld-ContribAuthor">Wolfgang Kandioller</span>. </span><span class="cited-content_cbyCitation_article-title">Tridentate 3-Substituted Naphthoquinone Ruthenium Arene Complexes: Synthesis, Characterization, Aqueous Behavior, and Theoretical and Biological Studies. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2021,</strong> <em>60 </em>
                                    (13)
                                     , 9805-9819. <a href="https://doi.org/10.1021/acs.inorgchem.1c01083" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.1c01083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.1c01083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.1c01083%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DTridentate%252B3-Substituted%252BNaphthoquinone%252BRuthenium%252BArene%252BComplexes%25253A%252BSynthesis%25252C%252BCharacterization%25252C%252BAqueous%252BBehavior%25252C%252Band%252BTheoretical%252Band%252BBiological%252BStudies%26aulast%3DGeisler%26aufirst%3DHeiko%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08042021%26date%3D11062021%26volume%3D60%26issue%3D13%26spage%3D9805%26epage%3D9819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Laia Rafols, Dana Josa, David Aguilà, Leoní A. Barrios, Olivier Roubeau, Jordi Cirera, Vanessa Soto-Cerrato, Ricardo Pérez-Tomás, Manuel Martínez, Arnald Grabulosa, <span class="NLM_string-name hlFld-ContribAuthor">Patrick Gamez</span>. </span><span class="cited-content_cbyCitation_article-title">Piano-Stool Ruthenium(II) Complexes with Delayed Cytotoxic Activity: Origin of the Lag Time. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2021,</strong> <em>60 </em>
                                    (11)
                                     , 7974-7990. <a href="https://doi.org/10.1021/acs.inorgchem.1c00507" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.1c00507</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.1c00507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.1c00507%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DPiano-Stool%252BRuthenium%252528II%252529%252BComplexes%252Bwith%252BDelayed%252BCytotoxic%252BActivity%25253A%252BOrigin%252Bof%252Bthe%252BLag%252BTime%26aulast%3DRafols%26aufirst%3DLaia%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19022021%26date%3D12052021%26volume%3D60%26issue%3D11%26spage%3D7974%26epage%3D7990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xue-Quan Zhou, Imma Carbo-Bague, Maxime A. Siegler, Jonathan Hilgendorf, Uttara Basu, Ingo Ott, Rongfang Liu, Liyan Zhang, Vadde Ramu, Adriaan P. IJzerman, <span class="NLM_string-name hlFld-ContribAuthor">Sylvestre Bonnet</span>. </span><span class="cited-content_cbyCitation_article-title">Rollover Cyclometalation vs Nitrogen Coordination in Tetrapyridyl Anticancer Gold(III) Complexes: Effect on Protein Interaction and Toxicity. </span><span class="cited-content_cbyCitation_journal-name">JACS Au</span><span> <strong>2021,</strong> <em>1 </em>
                                    (4)
                                     , 380-395. <a href="https://doi.org/10.1021/jacsau.0c00104" title="DOI URL">https://doi.org/10.1021/jacsau.0c00104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacsau.0c00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacsau.0c00104%26sid%3Dliteratum%253Aachs%26jtitle%3DJACS%2520Au%26atitle%3DRollover%252BCyclometalation%252Bvs%252BNitrogen%252BCoordination%252Bin%252BTetrapyridyl%252BAnticancer%252BGold%252528III%252529%252BComplexes%25253A%252BEffect%252Bon%252BProtein%252BInteraction%252Band%252BToxicity%26aulast%3DZhou%26aufirst%3DXue-Quan%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D09122020%26date%3D16032021%26volume%3D1%26issue%3D4%26spage%3D380%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Moumita Maji, Sourav Acharya, Indira Bhattacharya, Arnab Gupta, <span class="NLM_string-name hlFld-ContribAuthor">Arindam Mukherjee</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of an Imidazole-Containing Schiff Base of an Aromatic Sulfonamide on the Cytotoxic Efficacy of N,N-Coordinated Half-Sandwich Ruthenium(II) p-Cymene Complexes. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2021,</strong> <em>60 </em>
                                    (7)
                                     , 4744-4754. <a href="https://doi.org/10.1021/acs.inorgchem.0c03706" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.0c03706</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.0c03706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.0c03706%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DEffect%252Bof%252Ban%252BImidazole-Containing%252BSchiff%252BBase%252Bof%252Ban%252BAromatic%252BSulfonamide%252Bon%252Bthe%252BCytotoxic%252BEfficacy%252Bof%252BN%25252CN-Coordinated%252BHalf-Sandwich%252BRuthenium%252528II%252529%252Bp-Cymene%252BComplexes%26aulast%3DMaji%26aufirst%3DMoumita%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D18122020%26date%3D24032021%26volume%3D60%26issue%3D7%26spage%3D4744%26epage%3D4754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jit Karmakar, Promita Nandy, Saurabh Das, Debalina Bhattacharya, Parimal Karmakar, <span class="NLM_string-name hlFld-ContribAuthor">Samaresh Bhattacharya</span>. </span><span class="cited-content_cbyCitation_article-title">Utilization of Guanidine-Based Ancillary Ligands in Arene–Ruthenium Complexes for Selective Cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (12)
                                     , 8226-8238. <a href="https://doi.org/10.1021/acsomega.0c06265" title="DOI URL">https://doi.org/10.1021/acsomega.0c06265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c06265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c06265%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DUtilization%252Bof%252BGuanidine-Based%252BAncillary%252BLigands%252Bin%252BArene%2525E2%252580%252593Ruthenium%252BComplexes%252Bfor%252BSelective%252BCytotoxicity%26aulast%3DKarmakar%26aufirst%3DJit%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D24122020%26date%3D11032021%26date%3D19032021%26volume%3D6%26issue%3D12%26spage%3D8226%26epage%3D8238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sourav Acharya, Moumita Maji, Manas Pratim Chakraborty, Indira Bhattacharya, Rahul Das, Arnab Gupta, <span class="NLM_string-name hlFld-ContribAuthor">Arindam Mukherjee</span>. </span><span class="cited-content_cbyCitation_article-title">Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic N,O-Coordinated Pt(II) and Ru(II) Complexes of Trimethoxy Aniline-Based Schiff Bases. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2021,</strong> <em>60 </em>
                                    (5)
                                     , 3418-3430. <a href="https://doi.org/10.1021/acs.inorgchem.0c03820" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.0c03820</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.0c03820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.0c03820%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DDisruption%252Bof%252Bthe%252BMicrotubule%252BNetwork%252Band%252BInhibition%252Bof%252BVEGFR2%252BPhosphorylation%252Bby%252BCytotoxic%252BN%25252CO-Coordinated%252BPt%252528II%252529%252Band%252BRu%252528II%252529%252BComplexes%252Bof%252BTrimethoxy%252BAniline-Based%252BSchiff%252BBases%26aulast%3DAcharya%26aufirst%3DSourav%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D30122020%26date%3D08022021%26volume%3D60%26issue%3D5%26spage%3D3418%26epage%3D3430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fengrui Qu, Robert W. Lamb, Colin G. Cameron, Seungjo Park, Olaitan Oladipupo, Jessica L. Gray, Yifei Xu, Houston D. Cole, Marco Bonizzoni, Yonghyun Kim, Sherri A. McFarland, Charles Edwin Webster, <span class="NLM_string-name hlFld-ContribAuthor">Elizabeth T. Papish</span>. </span><span class="cited-content_cbyCitation_article-title">Singlet Oxygen Formation vs Photodissociation for Light-Responsive Protic Ruthenium Anticancer Compounds: The Oxygenated Substituent Determines Which Pathway Dominates. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2021,</strong> <em>60 </em>
                                    (4)
                                     , 2138-2148. <a href="https://doi.org/10.1021/acs.inorgchem.0c02027" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.0c02027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.0c02027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.0c02027%26sid%3Dliteratum%253Aachs%26jtitle%3DInorg.%2520Chem.%26date%3D2017%26issue%3D56%26spage%3D7519%26jtitle%3DDalton%2520Trans%26date%3D2018%26issue%3D47%26spage%3D15685%26jtitle%3DInorganic%2520Chemistry%26atitle%3DSinglet%252BOxygen%252BFormation%252Bvs%252BPhotodissociation%252Bfor%252BLight-Responsive%252BProtic%252BRuthenium%252BAnticancer%252BCompounds%25253A%252BThe%252BOxygenated%252BSubstituent%252BDetermines%252BWhich%252BPathway%252BDominates%26aulast%3DQu%26aufirst%3DFengrui%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D08072020%26date%3D03022021%26volume%3D60%26issue%3D4%26spage%3D2138%26epage%3D2148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chunqiu Yu, Zhibin Wang, Zeren Sun, Lei Zhang, Wanwan Zhang, Yungen Xu, <span class="NLM_string-name hlFld-ContribAuthor">Jing-Jing Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Platinum-Based Combination Therapy: Molecular Rationale, Current Clinical Uses, and Future Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13397-13412. <a href="https://doi.org/10.1021/acs.jmedchem.0c00950" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00950</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00950%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPlatinum-Based%252BCombination%252BTherapy%25253A%252BMolecular%252BRationale%25252C%252BCurrent%252BClinical%252BUses%25252C%252Band%252BFuture%252BPerspectives%26aulast%3DYu%26aufirst%3DChunqiu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03062020%26date%3D09092020%26date%3D19082020%26volume%3D63%26issue%3D22%26spage%3D13397%26epage%3D13412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gabriel H. Ribeiro, Adriana P. M. Guedes, Tamires D. de Oliveira, Camila R. S. T. b. de Correia, Legna Colina-Vegas, Mauro A. Lima, Joaquim A. Nóbrega, Márcia R. Cominetti, Fillipe V. Rocha, Antônio G. Ferreira, Eduardo E. Castellano, Felipe R. Teixeira, <span class="NLM_string-name hlFld-ContribAuthor">Alzir A. Batista</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2020,</strong> <em>59 </em>
                                    (20)
                                     , 15004-15018. <a href="https://doi.org/10.1021/acs.inorgchem.0c01835" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.0c01835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.0c01835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.0c01835%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DRuthenium%252528II%252529%252BPhosphine%25252FMercapto%252BComplexes%25253A%252BTheir%252Bin%252BVitro%252BCytotoxicity%252BEvaluation%252Band%252BActions%252Bas%252BInhibitors%252Bof%252BTopoisomerase%252Band%252BProteasome%252BActing%252Bas%252BPossible%252BTriggers%252Bof%252BCell%252BDeath%252BInduction%26aulast%3DRibeiro%26aufirst%3DGabriel%2BH.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D23062020%26date%3D30092020%26volume%3D59%26issue%3D20%26spage%3D15004%26epage%3D15018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Robert B. P. Elmes, Gary J. Ryan, Maria Luisa Erby, Daniel O. Frimannsson, Jonathan A. Kitchen, Mark Lawler, D. Clive Williams, Susan J. Quinn, <span class="NLM_string-name hlFld-ContribAuthor">Thorfinnur Gunnlaugsson</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Characterization, and Biological Profiling of Ruthenium(II)-Based 4-Nitro- and 4-Amino-1,8-naphthalimide Conjugates. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2020,</strong> <em>59 </em>
                                    (15)
                                     , 10874-10893. <a href="https://doi.org/10.1021/acs.inorgchem.0c01395" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.0c01395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.0c01395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.0c01395%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252BCharacterization%25252C%252Band%252BBiological%252BProfiling%252Bof%252BRuthenium%252528II%252529-Based%252B4-Nitro-%252Band%252B4-Amino-1%25252C8-naphthalimide%252BConjugates%26aulast%3DElmes%26aufirst%3DRobert%2BB.%2BP.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12052020%26date%3D16072020%26volume%3D59%26issue%3D15%26spage%3D10874%26epage%3D10893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sanaz Malali, Jan Chyba, Michal Knor, Michal Horní, Marek Nečas, Jan Novotný, <span class="NLM_string-name hlFld-ContribAuthor">Radek Marek</span>. </span><span class="cited-content_cbyCitation_article-title">Zwitterionic Ru(III) Complexes: Stability of Metal–Ligand Bond and Host–Guest Binding with Cucurbit[7]uril. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2020,</strong> <em>59 </em>
                                    (14)
                                     , 10185-10196. <a href="https://doi.org/10.1021/acs.inorgchem.0c01328" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.0c01328</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.0c01328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.0c01328%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DZwitterionic%252BRu%252528III%252529%252BComplexes%25253A%252BStability%252Bof%252BMetal%2525E2%252580%252593Ligand%252BBond%252Band%252BHost%2525E2%252580%252593Guest%252BBinding%252Bwith%252BCucurbit%25255B7%25255Duril%26aulast%3DMalali%26aufirst%3DSanaz%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05052020%26date%3D07072020%26volume%3D59%26issue%3D14%26spage%3D10185%26epage%3D10196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chanchal Sonkar, Novina Malviya, Rishi Ranjan, Srimanta Pakhira, <span class="NLM_string-name hlFld-ContribAuthor">Suman Mukhopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic Insight for Targeting Biomolecules by Ruthenium(II) NSAID Complexes. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Bio Materials</span><span> <strong>2020,</strong> <em>3 </em>
                                    (7)
                                     , 4600-4612. <a href="https://doi.org/10.1021/acsabm.0c00501" title="DOI URL">https://doi.org/10.1021/acsabm.0c00501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsabm.0c00501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsabm.0c00501%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Bio%2520Materials%26atitle%3DMechanistic%252BInsight%252Bfor%252BTargeting%252BBiomolecules%252Bby%252BRuthenium%252528II%252529%252BNSAID%252BComplexes%26aulast%3DSonkar%26aufirst%3DChanchal%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01052020%26date%3D22062020%26date%3D07072020%26date%3D22062020%26volume%3D3%26issue%3D7%26spage%3D4600%26epage%3D4612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Raphael T. Ryan, Kimberly C. Stevens, Rosemary Calabro, Sean Parkin, Jumanah Mahmoud, Doo Young Kim, David K. Heidary, Edith C. Glazer, <span class="NLM_string-name hlFld-ContribAuthor">John P. Selegue</span>. </span><span class="cited-content_cbyCitation_article-title">Bis-tridentate N-Heterocyclic Carbene Ru(II) Complexes are Promising New Agents for Photodynamic Therapy. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2020,</strong> <em>59 </em>
                                    (13)
                                     , 8882-8892. <a href="https://doi.org/10.1021/acs.inorgchem.0c00686" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.0c00686</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.0c00686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.0c00686%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DBis-tridentate%252BN-Heterocyclic%252BCarbene%252BRu%252528II%252529%252BComplexes%252Bare%252BPromising%252BNew%252BAgents%252Bfor%252BPhotodynamic%252BTherapy%26aulast%3DRyan%26aufirst%3DRaphael%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06032020%26date%3D12062020%26volume%3D59%26issue%3D13%26spage%3D8882%26epage%3D8892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anna Notaro, Angelo Frei, Riccardo Rubbiani, Marta Jakubaszek, Uttara Basu, Severin Koch, Cristina Mari, Mazzarine Dotou, Olivier Blacque, Jérémie Gouyon, Fethi Bedioui, Nils Rotthowe, Rainer F. Winter, Bruno Goud, Stefano Ferrari, Mickaël Tharaud, Martina Řezáčová, Jana Humajová, Pavel Tomšík, <span class="NLM_string-name hlFld-ContribAuthor">Gilles Gasser</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium(II) Complex Containing a Redox-Active Semiquinonate Ligand as a Potential Chemotherapeutic Agent: From Synthesis to In Vivo Studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (10)
                                     , 5568-5584. <a href="https://doi.org/10.1021/acs.jmedchem.0c00431" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00431</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00431%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRuthenium%252528II%252529%252BComplex%252BContaining%252Ba%252BRedox-Active%252BSemiquinonate%252BLigand%252Bas%252Ba%252BPotential%252BChemotherapeutic%252BAgent%25253A%252BFrom%252BSynthesis%252Bto%252BIn%252BVivo%252BStudies%26aulast%3DNotaro%26aufirst%3DAnna%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19032020%26date%3D07052020%26date%3D22042020%26volume%3D63%26issue%3D10%26spage%3D5568%26epage%3D5584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Arpan Mukherjee, Sourav Acharya, Kallol Purkait, Kaustav Chakraborty, Ashima Bhattacharjee, <span class="NLM_string-name hlFld-ContribAuthor">Arindam Mukherjee</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of N,N Coordination and RuII Halide Bond in Enhancing Selective Toxicity of a Tyramine-Based RuII (p-Cymene) Complex. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2020,</strong> <em>59 </em>
                                    (9)
                                     , 6581-6594. <a href="https://doi.org/10.1021/acs.inorgchem.0c00694" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.0c00694</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.0c00694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.0c00694%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DEffect%252Bof%252BN%25252CN%252BCoordination%252Band%252BRuII%252BHalide%252BBond%252Bin%252BEnhancing%252BSelective%252BToxicity%252Bof%252Ba%252BTyramine-Based%252BRuII%252B%252528p-Cymene%252529%252BComplex%26aulast%3DMukherjee%26aufirst%3DArpan%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06032020%26date%3D15042020%26volume%3D59%26issue%3D9%26spage%3D6581%26epage%3D6594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sundarraman Balaji, Mohamed Kasim Mohamed Subarkhan, Rengan Ramesh, Hangxiang Wang, <span class="NLM_string-name hlFld-ContribAuthor">David Semeril</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure of Arene Ru(II) N∧O-Chelating Complexes: In Vitro Cytotoxicity and Cancer Cell Death Mechanism. </span><span class="cited-content_cbyCitation_journal-name">Organometallics</span><span> <strong>2020,</strong> <em>39 </em>
                                    (8)
                                     , 1366-1375. <a href="https://doi.org/10.1021/acs.organomet.0c00092" title="DOI URL">https://doi.org/10.1021/acs.organomet.0c00092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.organomet.0c00092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.organomet.0c00092%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganometallics%26atitle%3DSynthesis%252Band%252BStructure%252Bof%252BArene%252BRu%252528II%252529%252BN%2525E2%252588%2525A7O-Chelating%252BComplexes%25253A%252BIn%252BVitro%252BCytotoxicity%252Band%252BCancer%252BCell%252BDeath%252BMechanism%26aulast%3DBalaji%26aufirst%3DSundarraman%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11022020%26date%3D08042020%26volume%3D39%26issue%3D8%26spage%3D1366%26epage%3D1375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Diogo E. L. Carvalho, Katia M. Oliveira, Larissa M. Bomfim, Milena B. P. Soares, Daniel P. Bezerra, Alzir A. Batista, <span class="NLM_string-name hlFld-ContribAuthor">Rodrigo S. Correa</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleobase Derivatives as Building Blocks to Form Ru(II)-Based Complexes with High Cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (1)
                                     , 122-130. <a href="https://doi.org/10.1021/acsomega.9b01921" title="DOI URL">https://doi.org/10.1021/acsomega.9b01921</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b01921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b01921%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DNucleobase%252BDerivatives%252Bas%252BBuilding%252BBlocks%252Bto%252BForm%252BRu%252528II%252529-Based%252BComplexes%252Bwith%252BHigh%252BCytotoxicity%26aulast%3DCarvalho%26aufirst%3DDiogo%2BE.%2BL.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D26062019%26date%3D17122019%26date%3D03012020%26volume%3D5%26issue%3D1%26spage%3D122%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kallol Purkait, Ruturaj, Arindam Mukherjee, <span class="NLM_string-name hlFld-ContribAuthor">Arnab Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">ATP7B Binds Ruthenium(II) p-Cymene Half-Sandwich Complexes: Role of Steric Hindrance and Ru–I Coordination in Rescuing the Sequestration. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (22)
                                     , 15659-15670. <a href="https://doi.org/10.1021/acs.inorgchem.9b02780" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.9b02780</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.9b02780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.9b02780%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DATP7B%252BBinds%252BRuthenium%252528II%252529%252Bp-Cymene%252BHalf-Sandwich%252BComplexes%25253A%252BRole%252Bof%252BSteric%252BHindrance%252Band%252BRu%2525E2%252580%252593I%252BCoordination%252Bin%252BRescuing%252Bthe%252BSequestration%26aulast%3DPurkait%26aufirst%3DKallol%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D18092019%26date%3D28102019%26volume%3D58%26issue%3D22%26spage%3D15659%26epage%3D15670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Luca Mascheroni, Maria Vittoria Dozzi, Elisabetta Ranucci, Paolo Ferruti, Valentina Francia, Anna Salvati, <span class="NLM_string-name hlFld-ContribAuthor">Daniela Maggioni</span>. </span><span class="cited-content_cbyCitation_article-title">Tuning Polyamidoamine Design To Increase Uptake and Efficacy of Ruthenium Complexes for Photodynamic Therapy. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (21)
                                     , 14586-14599. <a href="https://doi.org/10.1021/acs.inorgchem.9b02245" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.9b02245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.9b02245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.9b02245%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DTuning%252BPolyamidoamine%252BDesign%252BTo%252BIncrease%252BUptake%252Band%252BEfficacy%252Bof%252BRuthenium%252BComplexes%252Bfor%252BPhotodynamic%252BTherapy%26aulast%3DMascheroni%26aufirst%3DLuca%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D25072019%26date%3D16102019%26volume%3D58%26issue%3D21%26spage%3D14586%26epage%3D14599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Veronica Corrales Sánchez, Cristina Nieto-Jiménez, José Antonio Castro-Osma, Fernando de Andrés, Pedro J. Pacheco-Liñán, Iván Bravo, Nuria Rodríguez Fariñas, Enrique Niza, Elena Domínguez-Jurado, Agustín Lara-Sánchez, Ángel Ríos, Mónica Gómez Juárez, Juan Carlos Montero, Atanasio Pandiella, Alexandr Shafir, Carlos Alonso-Moreno, <span class="NLM_string-name hlFld-ContribAuthor">Alberto Ocaña</span>. </span><span class="cited-content_cbyCitation_article-title">Screening and Preliminary Biochemical and Biological Studies of [RuCl(p-cymene)(N,N-bis(diphenylphosphino)-isopropylamine)][BF4] in Breast Cancer Models. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (8)
                                     , 13005-13014. <a href="https://doi.org/10.1021/acsomega.9b00296" title="DOI URL">https://doi.org/10.1021/acsomega.9b00296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b00296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b00296%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DScreening%252Band%252BPreliminary%252BBiochemical%252Band%252BBiological%252BStudies%252Bof%252B%25255BRuCl%252528p-cymene%252529%252528N%25252CN-bis%252528diphenylphosphino%252529-isopropylamine%252529%25255D%25255BBF4%25255D%252Bin%252BBreast%252BCancer%252BModels%26aulast%3DCorrales%2BS%25C3%25A1nchez%26aufirst%3DVeronica%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D01022019%26date%3D26062019%26date%3D01082019%26volume%3D4%26issue%3D8%26spage%3D13005%26epage%3D13014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Martin Sojka, Michaela Fojtu, Jindriska Fialova, Michal Masarik, Marek Necas, <span class="NLM_string-name hlFld-ContribAuthor">Radek Marek</span>. </span><span class="cited-content_cbyCitation_article-title">Locked and Loaded: Ruthenium(II)-Capped Cucurbit[n]uril-Based Rotaxanes with Antimetastatic Properties. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (16)
                                     , 10861-10870. <a href="https://doi.org/10.1021/acs.inorgchem.9b01203" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.9b01203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.9b01203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.9b01203%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DLocked%252Band%252BLoaded%25253A%252BRuthenium%252528II%252529-Capped%252BCucurbit%25255Bn%25255Duril-Based%252BRotaxanes%252Bwith%252BAntimetastatic%252BProperties%26aulast%3DSojka%26aufirst%3DMartin%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24042019%26date%3D29072019%26volume%3D58%26issue%3D16%26spage%3D10861%26epage%3D10870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sourav Acharya, Moumita Maji, Ruturaj, Kallol Purkait, Arnab Gupta, <span class="NLM_string-name hlFld-ContribAuthor">Arindam Mukherjee</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Structure, Stability, and Inhibition of Tubulin Polymerization by RuII–p-Cymene Complexes of Trimethoxyaniline-Based Schiff Bases. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (14)
                                     , 9213-9224. <a href="https://doi.org/10.1021/acs.inorgchem.9b00853" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.9b00853</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.9b00853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.9b00853%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252BStructure%25252C%252BStability%25252C%252Band%252BInhibition%252Bof%252BTubulin%252BPolymerization%252Bby%252BRuII%2525E2%252580%252593p-Cymene%252BComplexes%252Bof%252BTrimethoxyaniline-Based%252BSchiff%252BBases%26aulast%3DAcharya%26aufirst%3DSourav%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D25032019%26date%3D26062019%26volume%3D58%26issue%3D14%26spage%3D9213%26epage%3D9224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kateryna Ohui, Maria V. Babak, Denisa Darvasiova, Alexander Roller, Daniel Vegh, Peter Rapta, Grace Rui Shi Guan, Yi Hsuan Ou, Giorgia Pastorin, <span class="NLM_string-name hlFld-ContribAuthor">Vladimir B. Arion</span>. </span><span class="cited-content_cbyCitation_article-title">Redox-Active Organoruthenium(II)– and Organoosmium(II)–Copper(II) Complexes, with an Amidrazone–Morpholine Hybrid and [CuICl2]− as Counteranion and Their Antiproliferative Activity. </span><span class="cited-content_cbyCitation_journal-name">Organometallics</span><span> <strong>2019,</strong> <em>38 </em>
                                    (10)
                                     , 2307-2318. <a href="https://doi.org/10.1021/acs.organomet.9b00229" title="DOI URL">https://doi.org/10.1021/acs.organomet.9b00229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.organomet.9b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.organomet.9b00229%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganometallics%26atitle%3DRedox-Active%252BOrganoruthenium%252528II%252529%2525E2%252580%252593%252Band%252BOrganoosmium%252528II%252529%2525E2%252580%252593Copper%252528II%252529%252BComplexes%25252C%252Bwith%252Ban%252BAmidrazone%2525E2%252580%252593Morpholine%252BHybrid%252Band%252B%25255BCuICl2%25255D%2525E2%252588%252592%252Bas%252BCounteranion%252Band%252BTheir%252BAntiproliferative%252BActivity%26aulast%3DOhui%26aufirst%3DKateryna%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07042019%26date%3D06052019%26volume%3D38%26issue%3D10%26spage%3D2307%26epage%3D2318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Srividya Swaminathan, Jebiti Haribabu, Naveen Kumar Kalagatur, Ramaiah Konakanchi, Nithya Balakrishnan, Nattamai Bhuvanesh, <span class="NLM_string-name hlFld-ContribAuthor">Ramasamy Karvembu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anticancer Activity of [RuCl2(η6-arene)(aroylthiourea)] Complexes—High Activity against the Human Neuroblastoma (IMR-32) Cancer Cell Line. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (4)
                                     , 6245-6256. <a href="https://doi.org/10.1021/acsomega.9b00349" title="DOI URL">https://doi.org/10.1021/acsomega.9b00349</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b00349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b00349%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DSynthesis%252Band%252BAnticancer%252BActivity%252Bof%252B%25255BRuCl2%252528%2525CE%2525B76-arene%252529%252528aroylthiourea%252529%25255D%252BComplexes%2525E2%252580%252594High%252BActivity%252Bagainst%252Bthe%252BHuman%252BNeuroblastoma%252B%252528IMR-32%252529%252BCancer%252BCell%252BLine%26aulast%3DSwaminathan%26aufirst%3DSrividya%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06022019%26date%3D22032019%26volume%3D4%26issue%3D4%26spage%3D6245%26epage%3D6256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jian-Jun Cao, Yue Zheng, Xiao-Wen Wu, Cai-Ping Tan, Mu-He Chen, Na Wu, Liang-Nian Ji, <span class="NLM_string-name hlFld-ContribAuthor">Zong-Wan Mao</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer Cyclometalated Iridium(III) Complexes with Planar Ligands: Mitochondrial DNA Damage and Metabolism Disturbance. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3311-3322. <a href="https://doi.org/10.1021/acs.jmedchem.8b01704" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01704%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAnticancer%252BCyclometalated%252BIridium%252528III%252529%252BComplexes%252Bwith%252BPlanar%252BLigands%25253A%252BMitochondrial%252BDNA%252BDamage%252Band%252BMetabolism%252BDisturbance%26aulast%3DCao%26aufirst%3DJian-Jun%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D01112018%26date%3D12032019%26date%3D28022019%26volume%3D62%26issue%3D7%26spage%3D3311%26epage%3D3322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hua-Hong Zou, Ting Meng, Qi Chen, Yi-Quan Zhang, Hai-Ling Wang, Bo Li, Kai Wang, Zi-Lu Chen, <span class="NLM_string-name hlFld-ContribAuthor">Fupei Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional Mononuclear Dysprosium Complexes: Single-Ion Magnet Behaviors and Antitumor Activities. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (4)
                                     , 2286-2298. <a href="https://doi.org/10.1021/acs.inorgchem.8b02250" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.8b02250</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.8b02250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.8b02250%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DBifunctional%252BMononuclear%252BDysprosium%252BComplexes%25253A%252BSingle-Ion%252BMagnet%252BBehaviors%252Band%252BAntitumor%252BActivities%26aulast%3DZou%26aufirst%3DHua-Hong%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D08082018%26date%3D30012019%26volume%3D58%26issue%3D4%26spage%3D2286%26epage%3D2298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Justin Shum, Peter Kam-Keung Leung, <span class="NLM_string-name hlFld-ContribAuthor">Kenneth Kam-Wing Lo</span>. </span><span class="cited-content_cbyCitation_article-title">Luminescent Ruthenium(II) Polypyridine Complexes for a Wide Variety of Biomolecular and Cellular Applications. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (4)
                                     , 2231-2247. <a href="https://doi.org/10.1021/acs.inorgchem.8b02979" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.8b02979</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.8b02979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.8b02979%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DLuminescent%252BRuthenium%252528II%252529%252BPolypyridine%252BComplexes%252Bfor%252Ba%252BWide%252BVariety%252Bof%252BBiomolecular%252Band%252BCellular%252BApplications%26aulast%3DShum%26aufirst%3DJustin%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D20102018%26date%3D29012019%26volume%3D58%26issue%3D4%26spage%3D2231%26epage%3D2247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bernhard Englinger, Christine Pirker, Petra Heffeter, Alessio Terenzi, Christian R. Kowol, Bernhard K. Keppler, <span class="NLM_string-name hlFld-ContribAuthor">Walter Berger</span>. </span><span class="cited-content_cbyCitation_article-title">Metal Drugs and the Anticancer Immune Response. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (2)
                                     , 1519-1624. <a href="https://doi.org/10.1021/acs.chemrev.8b00396" title="DOI URL">https://doi.org/10.1021/acs.chemrev.8b00396</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.8b00396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.8b00396%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DMetal%252BDrugs%252Band%252Bthe%252BAnticancer%252BImmune%252BResponse%26aulast%3DEnglinger%26aufirst%3DBernhard%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D22062018%26date%3D29112018%26volume%3D119%26issue%3D2%26spage%3D1519%26epage%3D1624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhenzhen Tian, Juanjuan Li, Shumiao Zhang, Zhishan Xu, Yuliang Yang, Deliang Kong, Hairong Zhang, Xingxing Ge, Junming Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Zhe Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Lysosome-Targeted Chemotherapeutics: Half-Sandwich Ruthenium(II) Complexes That Are Selectively Toxic to Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2018,</strong> <em>57 </em>
                                    (17)
                                     , 10498-10502. <a href="https://doi.org/10.1021/acs.inorgchem.8b01944" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.8b01944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.8b01944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.8b01944%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DLysosome-Targeted%252BChemotherapeutics%25253A%252BHalf-Sandwich%252BRuthenium%252528II%252529%252BComplexes%252BThat%252BAre%252BSelectively%252BToxic%252Bto%252BCancer%252BCells%26aulast%3DTian%26aufirst%3DZhenzhen%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12072018%26date%3D17082018%26volume%3D57%26issue%3D17%26spage%3D10498%26epage%3D10502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sanam Movassaghi, Sukhjit Singh, Aewan Mansur, Kelvin K. H. Tong, Muhammad Hanif, Hannah U. Holtkamp, Tilo Söhnel, Stephen M. F. Jamieson, <span class="NLM_string-name hlFld-ContribAuthor">Christian G. Hartinger</span>. </span><span class="cited-content_cbyCitation_article-title">(Pyridin-2-yl)-NHC Organoruthenium Complexes: Antiproliferative Properties and Reactivity toward Biomolecules. </span><span class="cited-content_cbyCitation_journal-name">Organometallics</span><span> <strong>2018,</strong> <em>37 </em>
                                    (10)
                                     , 1575-1584. <a href="https://doi.org/10.1021/acs.organomet.8b00153" title="DOI URL">https://doi.org/10.1021/acs.organomet.8b00153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.organomet.8b00153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.organomet.8b00153%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganometallics%26atitle%3D%252528Pyridin-2-yl%252529-NHC%252BOrganoruthenium%252BComplexes%25253A%252BAntiproliferative%252BProperties%252Band%252BReactivity%252Btoward%252BBiomolecules%26aulast%3DMovassaghi%26aufirst%3DSanam%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12032018%26date%3D09052018%26volume%3D37%26issue%3D10%26spage%3D1575%26epage%3D1584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuka Kobayashi, Masaru Hoshino, Tomoshi Kameda, Kazuya Kobayashi, Kenichi Akaji, Shinsuke Inuki, Hiroaki Ohno, <span class="NLM_string-name hlFld-ContribAuthor">Shinya Oishi</span>. </span><span class="cited-content_cbyCitation_article-title">Use of a Compact Tripodal Tris(bipyridine) Ligand to Stabilize a Single-Metal-Centered Chirality: Stereoselective Coordination of Iron(II) and Ruthenium(II) on a Semirigid Hexapeptide Macrocycle. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2018,</strong> <em>57 </em>
                                    (9)
                                     , 5475-5485. <a href="https://doi.org/10.1021/acs.inorgchem.8b00416" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.8b00416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.8b00416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.8b00416%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DUse%252Bof%252Ba%252BCompact%252BTripodal%252BTris%252528bipyridine%252529%252BLigand%252Bto%252BStabilize%252Ba%252BSingle-Metal-Centered%252BChirality%25253A%252BStereoselective%252BCoordination%252Bof%252BIron%252528II%252529%252Band%252BRuthenium%252528II%252529%252Bon%252Ba%252BSemirigid%252BHexapeptide%252BMacrocycle%26aulast%3DKobayashi%26aufirst%3DYuka%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D20022018%26date%3D10042018%26volume%3D57%26issue%3D9%26spage%3D5475%26epage%3D5485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emilia  Păunescu</span>, <span class="hlFld-ContribAuthor ">Ghalia  Boubaker</span>, <span class="hlFld-ContribAuthor ">Oksana  Desiatkina</span>, <span class="hlFld-ContribAuthor ">Nicoleta  Anghel</span>, <span class="hlFld-ContribAuthor ">Yosra  Amdouni</span>, <span class="hlFld-ContribAuthor ">Andrew  Hemphill</span>, <span class="hlFld-ContribAuthor ">Julien  Furrer</span>. </span><span class="cited-content_cbyCitation_article-title">The quest of the best – A SAR study of trithiolato-bridged dinuclear Ruthenium(II)-Arene compounds presenting antiparasitic properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113610. <a href="https://doi.org/10.1016/j.ejmech.2021.113610" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113610%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bquest%252Bof%252Bthe%252Bbest%252B%2525E2%252580%252593%252BA%252BSAR%252Bstudy%252Bof%252Btrithiolato-bridged%252Bdinuclear%252BRuthenium%252528II%252529-Arene%252Bcompounds%252Bpresenting%252Bantiparasitic%252Bproperties%26aulast%3DP%25C4%2583unescu%26aufirst%3DEmilia%26date%3D2021%26volume%3D222%26spage%3D113610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Imtiyaz  Yousuf</span>, <span class="hlFld-ContribAuthor ">Masrat  Bashir</span>, <span class="hlFld-ContribAuthor ">Farukh  Arjmand</span>, <span class="hlFld-ContribAuthor ">Sartaj  Tabassum</span>. </span><span class="cited-content_cbyCitation_article-title">Advancement of metal compounds as therapeutic and diagnostic metallodrugs: Current frontiers and future perspectives. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2021,</strong> <em>445 </em>, 214104. <a href="https://doi.org/10.1016/j.ccr.2021.214104" title="DOI URL">https://doi.org/10.1016/j.ccr.2021.214104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2021.214104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2021.214104%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DAdvancement%252Bof%252Bmetal%252Bcompounds%252Bas%252Btherapeutic%252Band%252Bdiagnostic%252Bmetallodrugs%25253A%252BCurrent%252Bfrontiers%252Band%252Bfuture%252Bperspectives%26aulast%3DYousuf%26aufirst%3DImtiyaz%26date%3D2021%26volume%3D445%26spage%3D214104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shadia A.  Elsayed</span>, <span class="hlFld-ContribAuthor ">Hagar E.  Badr</span>, <span class="hlFld-ContribAuthor ">Armando  di Biase</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  El-Hendawy</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization of ruthenium(II), nickel(II), palladium(II), and platinum(II) triphenylphosphine-based complexes bearing an ONS-donor chelating agent: Interaction with biomolecules, antioxidant, in vitro cytotoxic, apoptotic activity and cell cycle analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2021,</strong> <em>223 </em>, 111549. <a href="https://doi.org/10.1016/j.jinorgbio.2021.111549" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2021.111549</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2021.111549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2021.111549%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DSynthesis%25252C%252Bcharacterization%252Bof%252Bruthenium%252528II%252529%25252C%252Bnickel%252528II%252529%25252C%252Bpalladium%252528II%252529%25252C%252Band%252Bplatinum%252528II%252529%252Btriphenylphosphine-based%252Bcomplexes%252Bbearing%252Ban%252BONS-donor%252Bchelating%252Bagent%25253A%252BInteraction%252Bwith%252Bbiomolecules%25252C%252Bantioxidant%25252C%252Bin%252Bvitro%252Bcytotoxic%25252C%252Bapoptotic%252Bactivity%252Band%252Bcell%252Bcycle%252Banalysis%26aulast%3DElsayed%26aufirst%3DShadia%2BA.%26date%3D2021%26volume%3D223%26spage%3D111549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Gou</span>, <span class="hlFld-ContribAuthor ">GuoJin  Huang</span>, <span class="hlFld-ContribAuthor ">Jinlong  Li</span>, <span class="hlFld-ContribAuthor ">Feng  Yang</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Versatile delivery systems for non-platinum metal-based anticancer therapeutic agents. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2021,</strong> <em>441 </em>, 213975. <a href="https://doi.org/10.1016/j.ccr.2021.213975" title="DOI URL">https://doi.org/10.1016/j.ccr.2021.213975</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2021.213975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2021.213975%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DVersatile%252Bdelivery%252Bsystems%252Bfor%252Bnon-platinum%252Bmetal-based%252Banticancer%252Btherapeutic%252Bagents%26aulast%3DGou%26aufirst%3DYi%26date%3D2021%26volume%3D441%26spage%3D213975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Sun</span>, <span class="hlFld-ContribAuthor ">Yingsi  Li</span>, <span class="hlFld-ContribAuthor ">Hongdong  Shi</span>, <span class="hlFld-ContribAuthor ">Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Jitian  Zhang</span>, <span class="hlFld-ContribAuthor ">Qianling  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium Complexes as Promising Candidates against Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (15)
                                     , 4389. <a href="https://doi.org/10.3390/molecules26154389" title="DOI URL">https://doi.org/10.3390/molecules26154389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26154389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26154389%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRuthenium%252BComplexes%252Bas%252BPromising%252BCandidates%252Bagainst%252BLung%252BCancer%26aulast%3DSun%26aufirst%3DQi%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D15%26spage%3D4389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chanchal  Sonkar</span>, <span class="hlFld-ContribAuthor ">Novina  Malviya</span>, <span class="hlFld-ContribAuthor ">Nilima  Sinha</span>, <span class="hlFld-ContribAuthor ">Attreyee  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Srimanta  Pakhira</span>, <span class="hlFld-ContribAuthor ">Suman  Mukhopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Selective anticancer activities of ruthenium(II)-tetrazole complexes and their mechanistic insights. </span><span class="cited-content_cbyCitation_journal-name">BioMetals</span><span> <strong>2021,</strong> <em>34 </em>
                                    (4)
                                     , 795-812. <a href="https://doi.org/10.1007/s10534-021-00308-x" title="DOI URL">https://doi.org/10.1007/s10534-021-00308-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10534-021-00308-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10534-021-00308-x%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMetals%26atitle%3DSelective%252Banticancer%252Bactivities%252Bof%252Bruthenium%252528II%252529-tetrazole%252Bcomplexes%252Band%252Btheir%252Bmechanistic%252Binsights%26aulast%3DSonkar%26aufirst%3DChanchal%26date%3D2021%26date%3D2021%26volume%3D34%26issue%3D4%26spage%3D795%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maomao  He</span>, <span class="hlFld-ContribAuthor ">Fangman  Chen</span>, <span class="hlFld-ContribAuthor ">Dan  Shao</span>, <span class="hlFld-ContribAuthor ">Philipp  Weis</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Wei</span>, <span class="hlFld-ContribAuthor ">Wen  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Photoresponsive metallopolymer nanoparticles for cancer theranostics. </span><span class="cited-content_cbyCitation_journal-name">Biomaterials</span><span> <strong>2021,</strong> <em>275 </em>, 120915. <a href="https://doi.org/10.1016/j.biomaterials.2021.120915" title="DOI URL">https://doi.org/10.1016/j.biomaterials.2021.120915</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biomaterials.2021.120915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biomaterials.2021.120915%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomaterials%26atitle%3DPhotoresponsive%252Bmetallopolymer%252Bnanoparticles%252Bfor%252Bcancer%252Btheranostics%26aulast%3DHe%26aufirst%3DMaomao%26date%3D2021%26volume%3D275%26spage%3D120915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanam  Maikoo</span>, <span class="hlFld-ContribAuthor ">Abir  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Nyeleti  Vukea</span>, <span class="hlFld-ContribAuthor ">Laura Margaret Kirkpatrick  Dingle</span>, <span class="hlFld-ContribAuthor ">William John  Samson</span>, <span class="hlFld-ContribAuthor ">Jo-Anne  de la Mare</span>, <span class="hlFld-ContribAuthor ">Adrienne Lesley  Edkins</span>, <span class="hlFld-ContribAuthor ">Irvin Noel  Booysen</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium complexes with
              mono-
              or
              bis
              -heterocyclic chelates: DNA/BSA binding, antioxidant and anticancer studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (11)
                                     , 4077-4088. <a href="https://doi.org/10.1080/07391102.2020.1775126" title="DOI URL">https://doi.org/10.1080/07391102.2020.1775126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1775126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1775126%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DRuthenium%252Bcomplexes%252Bwith%252Bmono-%252Bor%252Bbis%252B-heterocyclic%252Bchelates%25253A%252BDNA%25252FBSA%252Bbinding%25252C%252Bantioxidant%252Band%252Banticancer%252Bstudies%26aulast%3DMaikoo%26aufirst%3DSanam%26date%3D2021%26date%3D2020%26volume%3D39%26issue%3D11%26spage%3D4077%26epage%3D4088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adnan  Zahirović</span>, <span class="hlFld-ContribAuthor ">Sunčica  Roca</span>, <span class="hlFld-ContribAuthor ">Emira  Kahrović</span>, <span class="hlFld-ContribAuthor ">Aleksandar  Višnjevac</span>. </span><span class="cited-content_cbyCitation_article-title">Low DNA and high BSA binding affinity of cationic ruthenium(II) organometallic featuring pyridine and 2’-hydroxychalcone ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1236 </em>, 130326. <a href="https://doi.org/10.1016/j.molstruc.2021.130326" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.130326</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.130326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.130326%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DLow%252BDNA%252Band%252Bhigh%252BBSA%252Bbinding%252Baffinity%252Bof%252Bcationic%252Bruthenium%252528II%252529%252Borganometallic%252Bfeaturing%252Bpyridine%252Band%252B2%2525E2%252580%252599-hydroxychalcone%252Bligands%26aulast%3DZahirovi%25C4%2587%26aufirst%3DAdnan%26date%3D2021%26volume%3D1236%26spage%3D130326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priyanka  Khanvilkar</span>, <span class="hlFld-ContribAuthor ">Soumya R.  Dash</span>, <span class="hlFld-ContribAuthor ">Devjani  Banerjee</span>, <span class="hlFld-ContribAuthor ">Aliasgar  Vohra</span>, <span class="hlFld-ContribAuthor ">Ranjitsinh  Devkar</span>, <span class="hlFld-ContribAuthor ">Debjani  Chakraborty</span>. </span><span class="cited-content_cbyCitation_article-title">Organoruthenium (II) complexes featuring pyrazole‐linked thiosemicarbazone ligands: Synthesis, DNA/BSA interactions, molecular docking, and cytotoxicity studies. </span><span class="cited-content_cbyCitation_journal-name">Applied Organometallic Chemistry</span><span> <strong>2021,</strong> <em>15 </em><a href="https://doi.org/10.1002/aoc.6343" title="DOI URL">https://doi.org/10.1002/aoc.6343</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/aoc.6343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Faoc.6343%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Organometallic%2520Chemistry%26atitle%3DOrganoruthenium%252B%252528II%252529%252Bcomplexes%252Bfeaturing%252Bpyrazole%2525E2%252580%252590linked%252Bthiosemicarbazone%252Bligands%25253A%252BSynthesis%25252C%252BDNA%25252FBSA%252Binteractions%25252C%252Bmolecular%252Bdocking%25252C%252Band%252Bcytotoxicity%252Bstudies%26aulast%3DKhanvilkar%26aufirst%3DPriyanka%26date%3D2021%26date%3D2021%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priyaranjan  Kumar</span>, <span class="hlFld-ContribAuthor ">Prerana  Singh</span>, <span class="hlFld-ContribAuthor ">Sanjoy  Saren</span>, <span class="hlFld-ContribAuthor ">Sandip  Pakira</span>, <span class="hlFld-ContribAuthor ">Sri  Sivakumar</span>, <span class="hlFld-ContribAuthor ">Ashis K.  Patra</span>. </span><span class="cited-content_cbyCitation_article-title">Kinetically labile ruthenium(
              ii
              ) complexes of terpyridines and saccharin: effect of substituents on photoactivity, solvation kinetics, and photocytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2021,</strong> <em>50 </em>
                                    (23)
                                     , 8196-8217. <a href="https://doi.org/10.1039/D1DT00246E" title="DOI URL">https://doi.org/10.1039/D1DT00246E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1DT00246E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1DT00246E%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DKinetically%252Blabile%252Bruthenium%252528%252Bii%252B%252529%252Bcomplexes%252Bof%252Bterpyridines%252Band%252Bsaccharin%25253A%252Beffect%252Bof%252Bsubstituents%252Bon%252Bphotoactivity%25252C%252Bsolvation%252Bkinetics%25252C%252Band%252Bphotocytotoxicity%26aulast%3DKumar%26aufirst%3DPriyaranjan%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D23%26spage%3D8196%26epage%3D8217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joanna  Skiba</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Kowalczyk</span>, <span class="hlFld-ContribAuthor ">Damian  Trzybiński</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Woźniak</span>, <span class="hlFld-ContribAuthor ">Valerije  Vrček</span>, <span class="hlFld-ContribAuthor ">Magdalena  Gapińska</span>, <span class="hlFld-ContribAuthor ">Konrad  Kowalski</span>. </span><span class="cited-content_cbyCitation_article-title">Stereo‐Defined Ferrocenyl Glycol Nucleic Acid (Fc‐GNA) Constituents: Synthesis, Electrochemistry, Mechanism of Formation, and Anticancer Activity Studies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Inorganic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (22)
                                     , 2171-2181. <a href="https://doi.org/10.1002/ejic.202100193" title="DOI URL">https://doi.org/10.1002/ejic.202100193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejic.202100193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejic.202100193%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Inorganic%2520Chemistry%26atitle%3DStereo%2525E2%252580%252590Defined%252BFerrocenyl%252BGlycol%252BNucleic%252BAcid%252B%252528Fc%2525E2%252580%252590GNA%252529%252BConstituents%25253A%252BSynthesis%25252C%252BElectrochemistry%25252C%252BMechanism%252Bof%252BFormation%25252C%252Band%252BAnticancer%252BActivity%252BStudies%26aulast%3DSkiba%26aufirst%3DJoanna%26date%3D2021%26date%3D2021%26volume%3D2021%26issue%3D22%26spage%3D2171%26epage%3D2181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vivianne S.  Velozo-Sa</span>, <span class="hlFld-ContribAuthor ">Regina M.M.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Celisnolia M.  Leite</span>, <span class="hlFld-ContribAuthor ">Marcia R.  Cominetti</span>, <span class="hlFld-ContribAuthor ">Isabely M.M.  Barbosa</span>, <span class="hlFld-ContribAuthor ">Fabrício L.S.  Silva</span>, <span class="hlFld-ContribAuthor ">Natália  Martins Feitosa</span>, <span class="hlFld-ContribAuthor ">Mario S.  Schultz</span>, <span class="hlFld-ContribAuthor ">Alzir A.  Batista</span>. </span><span class="cited-content_cbyCitation_article-title">Scavenging capacity and cytotoxicity of new Ru(II)-diphosphine/α-amino acid complexes. </span><span class="cited-content_cbyCitation_journal-name">Polyhedron</span><span> <strong>2021,</strong> <em>201 </em>, 115169. <a href="https://doi.org/10.1016/j.poly.2021.115169" title="DOI URL">https://doi.org/10.1016/j.poly.2021.115169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.poly.2021.115169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.poly.2021.115169%26sid%3Dliteratum%253Aachs%26jtitle%3DPolyhedron%26atitle%3DScavenging%252Bcapacity%252Band%252Bcytotoxicity%252Bof%252Bnew%252BRu%252528II%252529-diphosphine%25252F%2525CE%2525B1-amino%252Bacid%252Bcomplexes%26aulast%3DVelozo-Sa%26aufirst%3DVivianne%2BS.%26date%3D2021%26volume%3D201%26spage%3D115169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Júlia Scaff Moreira  Dias</span>, <span class="hlFld-ContribAuthor ">Felipe Terra  Martins</span>, <span class="hlFld-ContribAuthor ">João Honorato  de Araújo Neto</span>, <span class="hlFld-ContribAuthor ">Eduardo Ernesto  Castellano</span>, <span class="hlFld-ContribAuthor ">Rommel Bezerra  Viana</span>, <span class="hlFld-ContribAuthor ">Jéssica da Silva  Teixeira</span>, <span class="hlFld-ContribAuthor ">Elisalva Teixeira  Guimarães</span>, <span class="hlFld-ContribAuthor ">Milena Botelho Pereira  Soares</span>, <span class="hlFld-ContribAuthor ">Marília Imaculada  Frazão Barbosa</span>, <span class="hlFld-ContribAuthor ">Antônio Carlos  Doriguetto</span>. </span><span class="cited-content_cbyCitation_article-title">Novel ruthenium(
              iii
              ) complexes with hydroxybenzophenones: experimental and theoretical characterization and
              in vitro
              leishmanicidal activity comparing complexes and ligands. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2021,</strong> <em>45 </em>
                                    (17)
                                     , 7501-7515. <a href="https://doi.org/10.1039/D0NJ06159J" title="DOI URL">https://doi.org/10.1039/D0NJ06159J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ06159J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ06159J%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DNovel%252Bruthenium%252528%252Biii%252B%252529%252Bcomplexes%252Bwith%252Bhydroxybenzophenones%25253A%252Bexperimental%252Band%252Btheoretical%252Bcharacterization%252Band%252Bin%252Bvitro%252Bleishmanicidal%252Bactivity%252Bcomparing%252Bcomplexes%252Band%252Bligands%26aulast%3DDias%26aufirst%3DJ%25C3%25BAlia%2BScaff%2BMoreira%26date%3D2021%26date%3D2021%26volume%3D45%26issue%3D17%26spage%3D7501%26epage%3D7515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luna  Song</span>, <span class="hlFld-ContribAuthor ">Hehe  Bai</span>, <span class="hlFld-ContribAuthor ">Chenyang  Liu</span>, <span class="hlFld-ContribAuthor ">Wenjun  Gong</span>, <span class="hlFld-ContribAuthor ">Ai  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Zhao</span>, <span class="hlFld-ContribAuthor ">Xuan  Zhao</span>, <span class="hlFld-ContribAuthor ">Hongfei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Biomacromolecular Interactions, Photodynamic NO Releasing and Cellular Imaging of Two [RuCl(qn)(Lbpy)(NO)]X Complexes. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (9)
                                     , 2545. <a href="https://doi.org/10.3390/molecules26092545" title="DOI URL">https://doi.org/10.3390/molecules26092545</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26092545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26092545%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%25252C%252BBiomacromolecular%252BInteractions%25252C%252BPhotodynamic%252BNO%252BReleasing%252Band%252BCellular%252BImaging%252Bof%252BTwo%252B%25255BRuCl%252528qn%252529%252528Lbpy%252529%252528NO%252529%25255DX%252BComplexes%26aulast%3DSong%26aufirst%3DLuna%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D9%26spage%3D2545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Konrad  Kowalski</span>. </span><span class="cited-content_cbyCitation_article-title">Organometallic nucleosides—Synthesis, transformations, and applications. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2021,</strong> <em>432 </em>, 213705. <a href="https://doi.org/10.1016/j.ccr.2020.213705" title="DOI URL">https://doi.org/10.1016/j.ccr.2020.213705</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2020.213705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2020.213705%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DOrganometallic%252Bnucleosides%2525E2%252580%252594Synthesis%25252C%252Btransformations%25252C%252Band%252Bapplications%26aulast%3DKowalski%26aufirst%3DKonrad%26date%3D2021%26volume%3D432%26spage%3D213705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yusuf Oloruntoyin  Ayipo</span>, <span class="hlFld-ContribAuthor ">Wahab Adesina  Osunniran</span>, <span class="hlFld-ContribAuthor ">Mohd Nizam  Mordi</span>. </span><span class="cited-content_cbyCitation_article-title">Metal complexes of β-carboline: Advances in anticancer therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2021,</strong> <em>432 </em>, 213746. <a href="https://doi.org/10.1016/j.ccr.2020.213746" title="DOI URL">https://doi.org/10.1016/j.ccr.2020.213746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2020.213746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2020.213746%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DMetal%252Bcomplexes%252Bof%252B%2525CE%2525B2-carboline%25253A%252BAdvances%252Bin%252Banticancer%252Btherapeutics%26aulast%3DAyipo%26aufirst%3DYusuf%2BOloruntoyin%26date%3D2021%26volume%3D432%26spage%3D213746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minja  Mladenović</span>, <span class="hlFld-ContribAuthor ">Ibrahim  Morgan</span>, <span class="hlFld-ContribAuthor ">Nebojša  Ilić</span>, <span class="hlFld-ContribAuthor ">Mohamad  Saoud</span>, <span class="hlFld-ContribAuthor ">Marija V.  Pergal</span>, <span class="hlFld-ContribAuthor ">Goran N.  Kaluđerović</span>, <span class="hlFld-ContribAuthor ">Nikola Ž.  Knežević</span>. </span><span class="cited-content_cbyCitation_article-title">pH-Responsive Release of Ruthenium Metallotherapeutics from Mesoporous Silica-Based Nanocarriers. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 460. <a href="https://doi.org/10.3390/pharmaceutics13040460" title="DOI URL">https://doi.org/10.3390/pharmaceutics13040460</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics13040460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics13040460%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DpH-Responsive%252BRelease%252Bof%252BRuthenium%252BMetallotherapeutics%252Bfrom%252BMesoporous%252BSilica-Based%252BNanocarriers%26aulast%3DMladenovi%25C4%2587%26aufirst%3DMinja%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4%26spage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanam  Maikoo</span>, <span class="hlFld-ContribAuthor ">Daniel  Makayane</span>, <span class="hlFld-ContribAuthor ">Irvin Noel  Booysen</span>, <span class="hlFld-ContribAuthor ">Phikelelani  Ngubane</span>, <span class="hlFld-ContribAuthor ">Andile  Khathi</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium compounds as potential therapeutic agents for type 2 diabetes mellitus. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113064. <a href="https://doi.org/10.1016/j.ejmech.2020.113064" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113064%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRuthenium%252Bcompounds%252Bas%252Bpotential%252Btherapeutic%252Bagents%252Bfor%252Btype%252B2%252Bdiabetes%252Bmellitus%26aulast%3DMaikoo%26aufirst%3DSanam%26date%3D2021%26volume%3D213%26spage%3D113064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Azza A.  Hassoon</span>, <span class="hlFld-ContribAuthor ">Attila  Szorcsik</span>, <span class="hlFld-ContribAuthor ">Ferenc  Bogár</span>, <span class="hlFld-ContribAuthor ">Ibolya Zita  Papp</span>, <span class="hlFld-ContribAuthor ">Lívia  Fülöp</span>, <span class="hlFld-ContribAuthor ">Zoltán  Kele</span>, <span class="hlFld-ContribAuthor ">Tamás  Gajda</span>. </span><span class="cited-content_cbyCitation_article-title">The interaction of half-sandwich (η5-Cp*)Rh(III) cation with histidine containing peptides and their ternary species with (N,N) bidentate ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2021,</strong> <em>216 </em>, 111330. <a href="https://doi.org/10.1016/j.jinorgbio.2020.111330" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2020.111330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2020.111330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2020.111330%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DThe%252Binteraction%252Bof%252Bhalf-sandwich%252B%252528%2525CE%2525B75-Cp%252A%252529Rh%252528III%252529%252Bcation%252Bwith%252Bhistidine%252Bcontaining%252Bpeptides%252Band%252Btheir%252Bternary%252Bspecies%252Bwith%252B%252528N%25252CN%252529%252Bbidentate%252Bligands%26aulast%3DHassoon%26aufirst%3DAzza%2BA.%26date%3D2021%26volume%3D216%26spage%3D111330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ricardo  Cerón-Camacho</span>, <span class="hlFld-ContribAuthor ">Manuel A.  Roque-Ramires</span>, <span class="hlFld-ContribAuthor ">Alexander D.  Ryabov</span>, <span class="hlFld-ContribAuthor ">Ronan  Le Lagadec</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclometalated Osmium Compounds and beyond: Synthesis, Properties, Applications. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (6)
                                     , 1563. <a href="https://doi.org/10.3390/molecules26061563" title="DOI URL">https://doi.org/10.3390/molecules26061563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26061563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26061563%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DCyclometalated%252BOsmium%252BCompounds%252Band%252Bbeyond%25253A%252BSynthesis%25252C%252BProperties%25252C%252BApplications%26aulast%3DCer%25C3%25B3n-Camacho%26aufirst%3DRicardo%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D6%26spage%3D1563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marwa E.  El‐Afify</span>, <span class="hlFld-ContribAuthor ">Shadia A.  Elsayed</span>, <span class="hlFld-ContribAuthor ">Thanaa I.  Shalaby</span>, <span class="hlFld-ContribAuthor ">Elshahat A.  Toson</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  El‐Hendawy</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization, DNA binding/cleavage, cytotoxic, apoptotic, and antibacterial activities of V(IV), Mo(VI), and Ru(II) complexes containing a bioactive ONS‐donor chelating agent. </span><span class="cited-content_cbyCitation_journal-name">Applied Organometallic Chemistry</span><span> <strong>2021,</strong> <em>35 </em>
                                    (2)
                                     <a href="https://doi.org/10.1002/aoc.6082" title="DOI URL">https://doi.org/10.1002/aoc.6082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/aoc.6082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Faoc.6082%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Organometallic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcharacterization%25252C%252BDNA%252Bbinding%25252Fcleavage%25252C%252Bcytotoxic%25252C%252Bapoptotic%25252C%252Band%252Bantibacterial%252Bactivities%252Bof%252BV%252528IV%252529%25252C%252BMo%252528VI%252529%25252C%252Band%252BRu%252528II%252529%252Bcomplexes%252Bcontaining%252Ba%252Bbioactive%252BONS%2525E2%252580%252590donor%252Bchelating%252Bagent%26aulast%3DEl%25E2%2580%2590Afify%26aufirst%3DMarwa%2BE.%26date%3D2021%26date%3D2020%26volume%3D35%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Imtiyaz  Yousuf</span>, <span class="hlFld-ContribAuthor ">Masrat  Bashir</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, structural investigations, and cytotoxic evaluation of a half‐sandwich Ru(II)‐arene complex. </span><span class="cited-content_cbyCitation_journal-name">Applied Organometallic Chemistry</span><span> <strong>2021,</strong> <em>35 </em>
                                    (2)
                                     <a href="https://doi.org/10.1002/aoc.6090" title="DOI URL">https://doi.org/10.1002/aoc.6090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/aoc.6090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Faoc.6090%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Organometallic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bstructural%252Binvestigations%25252C%252Band%252Bcytotoxic%252Bevaluation%252Bof%252Ba%252Bhalf%2525E2%252580%252590sandwich%252BRu%252528II%252529%2525E2%252580%252590arene%252Bcomplex%26aulast%3DYousuf%26aufirst%3DImtiyaz%26date%3D2021%26date%3D2020%26volume%3D35%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa  Santi</span>, <span class="hlFld-ContribAuthor ">Ana Katrina  Mapanao</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Biancalana</span>, <span class="hlFld-ContribAuthor ">Fabio  Marchetti</span>, <span class="hlFld-ContribAuthor ">Valerio  Voliani</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium arene complexes in the treatment of 3D models of head and neck squamous cell carcinomas. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113143. <a href="https://doi.org/10.1016/j.ejmech.2020.113143" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113143%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRuthenium%252Barene%252Bcomplexes%252Bin%252Bthe%252Btreatment%252Bof%252B3D%252Bmodels%252Bof%252Bhead%252Band%252Bneck%252Bsquamous%252Bcell%252Bcarcinomas%26aulast%3DSanti%26aufirst%3DMelissa%26date%3D2021%26volume%3D212%26spage%3D113143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bobo  Feng</span>, <span class="hlFld-ContribAuthor ">Elin  Sundin</span>, <span class="hlFld-ContribAuthor ">Per  Lincoln</span>, <span class="hlFld-ContribAuthor ">Anna K. F.  Mårtensson</span>. </span><span class="cited-content_cbyCitation_article-title">DNA threading intercalation of enantiopure [Ru(phen)
              2
              bidppz]
              2+
              induced by hydrophobic catalysis. </span><span class="cited-content_cbyCitation_journal-name">Physical Chemistry Chemical Physics</span><span> <strong>2021,</strong> <em>23 </em>
                                    (3)
                                     , 2238-2244. <a href="https://doi.org/10.1039/D0CP00845A" title="DOI URL">https://doi.org/10.1039/D0CP00845A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CP00845A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CP00845A%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Chemistry%2520Chemical%2520Physics%26atitle%3DDNA%252Bthreading%252Bintercalation%252Bof%252Benantiopure%252B%25255BRu%252528phen%252529%252B2%252Bbidppz%25255D%252B2%25252B%252Binduced%252Bby%252Bhydrophobic%252Bcatalysis%26aulast%3DFeng%26aufirst%3DBobo%26date%3D2021%26date%3D2021%26volume%3D23%26issue%3D3%26spage%3D2238%26epage%3D2244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashaparna  Mondal</span>, <span class="hlFld-ContribAuthor ">Utsav  Sen</span>, <span class="hlFld-ContribAuthor ">Nilmadhab  Roy</span>, <span class="hlFld-ContribAuthor ">Venkatesan  Muthukumar</span>, <span class="hlFld-ContribAuthor ">Suban Kumar  Sahoo</span>, <span class="hlFld-ContribAuthor ">Bipasha  Bose</span>, <span class="hlFld-ContribAuthor ">Priyankar  Paira</span>. </span><span class="cited-content_cbyCitation_article-title">DNA targeting half sandwich Ru(
              ii
              )-
              p
              -cymene-N^N complexes as cancer cell imaging and terminating agents: influence of regioisomers in cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2021,</strong> <em>50 </em>
                                    (3)
                                     , 979-997. <a href="https://doi.org/10.1039/D0DT03107K" title="DOI URL">https://doi.org/10.1039/D0DT03107K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0DT03107K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0DT03107K%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DDNA%252Btargeting%252Bhalf%252Bsandwich%252BRu%252528%252Bii%252B%252529-%252Bp%252B-cymene-N%25255EN%252Bcomplexes%252Bas%252Bcancer%252Bcell%252Bimaging%252Band%252Bterminating%252Bagents%25253A%252Binfluence%252Bof%252Bregioisomers%252Bin%252Bcytotoxicity%26aulast%3DMondal%26aufirst%3DAshaparna%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D3%26spage%3D979%26epage%3D997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruotong  Liu</span>, <span class="hlFld-ContribAuthor ">Chanling  Yuan</span>, <span class="hlFld-ContribAuthor ">Yin  Feng</span>, <span class="hlFld-ContribAuthor ">Jiayi  Qian</span>, <span class="hlFld-ContribAuthor ">Xiaoting  Huang</span>, <span class="hlFld-ContribAuthor ">Qiutong  Chen</span>, <span class="hlFld-ContribAuthor ">Shuyuan  Zhou</span>, <span class="hlFld-ContribAuthor ">Yin  Ding</span>, <span class="hlFld-ContribAuthor ">Bingbing  Zhai</span>, <span class="hlFld-ContribAuthor ">Wenjie  Mei</span>, <span class="hlFld-ContribAuthor ">Liangzhong  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted synthesis of ruthenium(
              ii
              ) complexes containing levofloxacin-induced G2/M phase arrest by triggering DNA damage. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (8)
                                     , 4444-4453. <a href="https://doi.org/10.1039/D0RA09418H" title="DOI URL">https://doi.org/10.1039/D0RA09418H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA09418H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA09418H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DMicrowave-assisted%252Bsynthesis%252Bof%252Bruthenium%252528%252Bii%252B%252529%252Bcomplexes%252Bcontaining%252Blevofloxacin-induced%252BG2%25252FM%252Bphase%252Barrest%252Bby%252Btriggering%252BDNA%252Bdamage%26aulast%3DLiu%26aufirst%3DRuotong%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D8%26spage%3D4444%26epage%3D4453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Syed Raza  Shah</span>, <span class="hlFld-ContribAuthor ">Zarbad  Shah</span>, <span class="hlFld-ContribAuthor ">Ajmal  Khan</span>, <span class="hlFld-ContribAuthor ">Ayaz  Ahmed</span>, <span class="hlFld-ContribAuthor ">Shariqa  Khwaja</span>, <span class="hlFld-ContribAuthor ">Rene  Csuk</span>, <span class="hlFld-ContribAuthor ">Muhammad U.  Anwar</span>, <span class="hlFld-ContribAuthor ">Ahmed  Al-Harrasi</span>. </span><span class="cited-content_cbyCitation_article-title">Alkali complexes of non-steroidal anti-inflammatory drugs inhibit lung and oral cancers
              in vitro. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2021,</strong> <em>45 </em>
                                    (1)
                                     , 45-52. <a href="https://doi.org/10.1039/D0NJ04585C" title="DOI URL">https://doi.org/10.1039/D0NJ04585C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ04585C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ04585C%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DAlkali%252Bcomplexes%252Bof%252Bnon-steroidal%252Banti-inflammatory%252Bdrugs%252Binhibit%252Blung%252Band%252Boral%252Bcancers%252Bin%252Bvitro%26aulast%3DShah%26aufirst%3DSyed%2BRaza%26date%3D2021%26date%3D2021%26volume%3D45%26issue%3D1%26spage%3D45%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siva Prasad  Y.</span>, <span class="hlFld-ContribAuthor ">Lalitha  Krishnamoorthy</span>, <span class="hlFld-ContribAuthor ">Aenugu Sravya  Chowdary</span>, <span class="hlFld-ContribAuthor ">Jugun Prakash  Chinta</span>, <span class="hlFld-ContribAuthor ">Nagarajan  Subbiah</span>. </span><span class="cited-content_cbyCitation_article-title">Metals and Metal Complexes for Medicinal Applications. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 83-117. <a href="https://doi.org/10.1007/978-3-030-56413-1_3" title="DOI URL">https://doi.org/10.1007/978-3-030-56413-1_3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-56413-1_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-56413-1_3%26sid%3Dliteratum%253Aachs%26atitle%3DMetals%252Band%252BMetal%252BComplexes%252Bfor%252BMedicinal%252BApplications%26aulast%3DY.%26aufirst%3DSiva%2BPrasad%26date%3D2021%26date%3D2021%26spage%3D83%26epage%3D117%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DMetal%25252C%252BMetal%252BOxides%252Band%252BMetal%252BSulphides%252Bfor%252BBiomedical%252BApplications%26aulast%3DRajendran%26aufirst%3DSaravanan%26date%3D2021%26volume%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tahir  Farooq</span>. </span><span class="cited-content_cbyCitation_article-title">Triazoles in Coordination Complexes. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 201-221. <a href="https://doi.org/10.1016/B978-0-12-817113-4.00001-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-817113-4.00001-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-817113-4.00001-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-817113-4.00001-9%26sid%3Dliteratum%253Aachs%26atitle%3DTriazoles%252Bin%252BCoordination%252BComplexes%26aulast%3DFarooq%26aufirst%3DTahir%26date%3D2021%26spage%3D201%26epage%3D221%26pub%3DElsevier%26atitle%3DAdvances%252Bin%252BTriazole%252BChemistry%26date%3D2021%26volume%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katia M.  Oliveira</span>, <span class="hlFld-ContribAuthor ">João  Honorato</span>, <span class="hlFld-ContribAuthor ">Felipe C.  Demidoff</span>, <span class="hlFld-ContribAuthor ">Mario S.  Schultz</span>, <span class="hlFld-ContribAuthor ">Chaquip D.  Netto</span>, <span class="hlFld-ContribAuthor ">Marcia R.  Cominetti</span>, <span class="hlFld-ContribAuthor ">Rodrigo S.  Correa</span>, <span class="hlFld-ContribAuthor ">Alzir A.  Batista</span>. </span><span class="cited-content_cbyCitation_article-title">Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2021,</strong> <em>214 </em>, 111289. <a href="https://doi.org/10.1016/j.jinorgbio.2020.111289" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2020.111289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2020.111289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2020.111289%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DLapachol%252Bin%252Bthe%252BDesign%252Bof%252Ba%252BNew%252BRuthenium%252528II%252529-Diphosphine%252BComplex%252Bas%252Ba%252BPromising%252BAnticancer%252BMetallodrug%26aulast%3DOliveira%26aufirst%3DKatia%2BM.%26date%3D2021%26volume%3D214%26spage%3D111289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohd.  Muddassir</span>, <span class="hlFld-ContribAuthor ">Abdullah  Alarifi</span>, <span class="hlFld-ContribAuthor ">Mohd.  Afzal</span>. </span><span class="cited-content_cbyCitation_article-title">A New Piano-Stool Ruthenium(II) P-Cymene-Based Complex: Crystallographic, Hirshfeld Surface, DFT, and Luminescent Studies. </span><span class="cited-content_cbyCitation_journal-name">Crystals</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     , 13. <a href="https://doi.org/10.3390/cryst11010013" title="DOI URL">https://doi.org/10.3390/cryst11010013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cryst11010013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcryst11010013%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystals%26atitle%3DA%252BNew%252BPiano-Stool%252BRuthenium%252528II%252529%252BP-Cymene-Based%252BComplex%25253A%252BCrystallographic%25252C%252BHirshfeld%252BSurface%25252C%252BDFT%25252C%252Band%252BLuminescent%252BStudies%26aulast%3DMuddassir%26aufirst%3DMohd.%26date%3D2021%26date%3D2020%26volume%3D11%26issue%3D1%26spage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Utpal  Das</span>, <span class="hlFld-ContribAuthor ">Binoy  Kar</span>, <span class="hlFld-ContribAuthor ">Sudhindra  Pete</span>, <span class="hlFld-ContribAuthor ">Priyankar  Paira</span>. </span><span class="cited-content_cbyCitation_article-title">Ru(
              ii
              ), Ir(
              iii
              ), Re(
              i
              ) and Rh(
              iii
              ) based complexes as next generation anticancer metallopharmaceuticals. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2021,</strong> <em>204 </em><a href="https://doi.org/10.1039/D1DT01326B" title="DOI URL">https://doi.org/10.1039/D1DT01326B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1DT01326B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1DT01326B%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DRu%252528%252Bii%252B%252529%25252C%252BIr%252528%252Biii%252B%252529%25252C%252BRe%252528%252Bi%252B%252529%252Band%252BRh%252528%252Biii%252B%252529%252Bbased%252Bcomplexes%252Bas%252Bnext%252Bgeneration%252Banticancer%252Bmetallopharmaceuticals%26aulast%3DDas%26aufirst%3DUtpal%26date%3D2021%26date%3D2021%26volume%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P  Sudhindra</span>, <span class="hlFld-ContribAuthor ">S  Ajay Sharma</span>, <span class="hlFld-ContribAuthor ">Nilmadhab  Roy</span>, <span class="hlFld-ContribAuthor ">Prithvi  Moharana</span>, <span class="hlFld-ContribAuthor ">Priyankar  Paira</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in cytotoxicity, cellular uptake and mechanism of action of ruthenium metallodrugs: A review. </span><span class="cited-content_cbyCitation_journal-name">Polyhedron</span><span> <strong>2020,</strong> <em>192 </em>, 114827. <a href="https://doi.org/10.1016/j.poly.2020.114827" title="DOI URL">https://doi.org/10.1016/j.poly.2020.114827</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.poly.2020.114827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.poly.2020.114827%26sid%3Dliteratum%253Aachs%26jtitle%3DPolyhedron%26atitle%3DRecent%252Badvances%252Bin%252Bcytotoxicity%25252C%252Bcellular%252Buptake%252Band%252Bmechanism%252Bof%252Baction%252Bof%252Bruthenium%252Bmetallodrugs%25253A%252BA%252Breview%26aulast%3DSudhindra%26aufirst%3DP%26date%3D2020%26volume%3D192%26spage%3D114827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">RanjithKumar  Jakku</span>, <span class="hlFld-ContribAuthor ">Rami Reddy  Eda</span>, <span class="hlFld-ContribAuthor ">Nedaossadat  Mirzadeh</span>, <span class="hlFld-ContribAuthor ">Srinivasa Reddy  Telukutla</span>, <span class="hlFld-ContribAuthor ">Anil Kumar  Vardhaman</span>, <span class="hlFld-ContribAuthor ">Giribabu  Lingamallu</span>, <span class="hlFld-ContribAuthor ">Sridhar  Balasubramanian</span>, <span class="hlFld-ContribAuthor ">Pooja  Deep</span>, <span class="hlFld-ContribAuthor ">Ramakrisna  Sistla</span>, <span class="hlFld-ContribAuthor ">Suresh  Bhargava</span>, <span class="hlFld-ContribAuthor ">Rajiv  Trivedi</span>. </span><span class="cited-content_cbyCitation_article-title">(η6-Arene) ruthenium(II) complexes with ferrocene-tethered salicylaldimine ligands: Synthesis, characterization and anti-cancer properties. </span><span class="cited-content_cbyCitation_journal-name">Polyhedron</span><span> <strong>2020,</strong> <em>192 </em>, 114829. <a href="https://doi.org/10.1016/j.poly.2020.114829" title="DOI URL">https://doi.org/10.1016/j.poly.2020.114829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.poly.2020.114829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.poly.2020.114829%26sid%3Dliteratum%253Aachs%26jtitle%3DPolyhedron%26atitle%3D%252528%2525CE%2525B76-Arene%252529%252Bruthenium%252528II%252529%252Bcomplexes%252Bwith%252Bferrocene-tethered%252Bsalicylaldimine%252Bligands%25253A%252BSynthesis%25252C%252Bcharacterization%252Band%252Banti-cancer%252Bproperties%26aulast%3DJakku%26aufirst%3DRanjithKumar%26date%3D2020%26volume%3D192%26spage%3D114829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bandar A.  Babgi</span>, <span class="hlFld-ContribAuthor ">Khlood H.  Mashat</span>, <span class="hlFld-ContribAuthor ">Magda H.  Abdellattif</span>, <span class="hlFld-ContribAuthor ">Muhammed N.  Arshad</span>, <span class="hlFld-ContribAuthor ">Khaled A.  Alzahrani</span>, <span class="hlFld-ContribAuthor ">Abdullah M.  Asiri</span>, <span class="hlFld-ContribAuthor ">Jun  Du</span>, <span class="hlFld-ContribAuthor ">Mark G.  Humphrey</span>, <span class="hlFld-ContribAuthor ">Mostafa A.  Hussien</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, structures, DNA-binding, cytotoxicity and molecular docking of CuBr(PPh3)(diimine). </span><span class="cited-content_cbyCitation_journal-name">Polyhedron</span><span> <strong>2020,</strong> <em>192 </em>, 114847. <a href="https://doi.org/10.1016/j.poly.2020.114847" title="DOI URL">https://doi.org/10.1016/j.poly.2020.114847</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.poly.2020.114847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.poly.2020.114847%26sid%3Dliteratum%253Aachs%26jtitle%3DPolyhedron%26atitle%3DSynthesis%25252C%252Bstructures%25252C%252BDNA-binding%25252C%252Bcytotoxicity%252Band%252Bmolecular%252Bdocking%252Bof%252BCuBr%252528PPh3%252529%252528diimine%252529%26aulast%3DBabgi%26aufirst%3DBandar%2BA.%26date%3D2020%26volume%3D192%26spage%3D114847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentin  Studer</span>, <span class="hlFld-ContribAuthor ">Nicoleta  Anghel</span>, <span class="hlFld-ContribAuthor ">Oksana  Desiatkina</span>, <span class="hlFld-ContribAuthor ">Timo  Felder</span>, <span class="hlFld-ContribAuthor ">Ghalia  Boubaker</span>, <span class="hlFld-ContribAuthor ">Yosra  Amdouni</span>, <span class="hlFld-ContribAuthor ">Jessica  Ramseier</span>, <span class="hlFld-ContribAuthor ">Martin  Hungerbühler</span>, <span class="hlFld-ContribAuthor ">Christoph  Kempf</span>, <span class="hlFld-ContribAuthor ">Johannes Thomas  Heverhagen</span>, <span class="hlFld-ContribAuthor ">Andrew  Hemphill</span>, <span class="hlFld-ContribAuthor ">Nico  Ruprecht</span>, <span class="hlFld-ContribAuthor ">Julien  Furrer</span>, <span class="hlFld-ContribAuthor ">Emilia  Păunescu</span>. </span><span class="cited-content_cbyCitation_article-title">Conjugates Containing Two and Three Trithiolato-Bridged Dinuclear Ruthenium(II)-Arene Units as In Vitro Antiparasitic and Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (12)
                                     , 471. <a href="https://doi.org/10.3390/ph13120471" title="DOI URL">https://doi.org/10.3390/ph13120471</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13120471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13120471%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DConjugates%252BContaining%252BTwo%252Band%252BThree%252BTrithiolato-Bridged%252BDinuclear%252BRuthenium%252528II%252529-Arene%252BUnits%252Bas%252BIn%252BVitro%252BAntiparasitic%252Band%252BAnticancer%252BAgents%26aulast%3DStuder%26aufirst%3DValentin%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D12%26spage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raquel Santos  Faria</span>, <span class="hlFld-ContribAuthor ">Hugo Delleon  Silva</span>, <span class="hlFld-ContribAuthor ">Francyelli  Mello-Andrade</span>, <span class="hlFld-ContribAuthor ">Wanessa Carvalho  Pires</span>, <span class="hlFld-ContribAuthor ">Flávia  de Castro Pereira</span>, <span class="hlFld-ContribAuthor ">Aliny Pereira  de Lima</span>, <span class="hlFld-ContribAuthor ">Sônia  de Fátima Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Thallita Monteiro  Teixeira</span>, <span class="hlFld-ContribAuthor ">Paula Francinete Faustino  da Silva</span>, <span class="hlFld-ContribAuthor ">Plínio Lázaro Faleiro  Naves</span>, <span class="hlFld-ContribAuthor ">Alzir Azevedo  Batista</span>, <span class="hlFld-ContribAuthor ">Renato José  da Silva Oliveira</span>, <span class="hlFld-ContribAuthor ">Rui Manuel  Reis</span>, <span class="hlFld-ContribAuthor ">Elisângela  de Paula Silveira-Lacerda</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium(II)/Benzonitrile Complex Induces Cytotoxic Effect in Sarcoma-180 Cells by Caspase-Mediated and Tp53/p21-Mediated Apoptosis, with Moderate Brine Shrimp Toxicity. </span><span class="cited-content_cbyCitation_journal-name">Biological Trace Element Research</span><span> <strong>2020,</strong> <em>198 </em>
                                    (2)
                                     , 669-680. <a href="https://doi.org/10.1007/s12011-020-02098-8" title="DOI URL">https://doi.org/10.1007/s12011-020-02098-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12011-020-02098-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12011-020-02098-8%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Trace%2520Element%2520Research%26atitle%3DRuthenium%252528II%252529%25252FBenzonitrile%252BComplex%252BInduces%252BCytotoxic%252BEffect%252Bin%252BSarcoma-180%252BCells%252Bby%252BCaspase-Mediated%252Band%252BTp53%25252Fp21-Mediated%252BApoptosis%25252C%252Bwith%252BModerate%252BBrine%252BShrimp%252BToxicity%26aulast%3DFaria%26aufirst%3DRaquel%2BSantos%26date%3D2020%26date%3D2020%26volume%3D198%26issue%3D2%26spage%3D669%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Celine  Eidenschenk</span>, <span class="hlFld-ContribAuthor ">Lionel  Cheruzel</span>. </span><span class="cited-content_cbyCitation_article-title">Ru(II)-diimine complexes and cytochrome P450 working hand-in-hand. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2020,</strong> <em>213 </em>, 111254. <a href="https://doi.org/10.1016/j.jinorgbio.2020.111254" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2020.111254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2020.111254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2020.111254%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DRu%252528II%252529-diimine%252Bcomplexes%252Band%252Bcytochrome%252BP450%252Bworking%252Bhand-in-hand%26aulast%3DEidenschenk%26aufirst%3DCeline%26date%3D2020%26volume%3D213%26spage%3D111254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuchen  Wang</span>, <span class="hlFld-ContribAuthor ">Jiahui  Jin</span>, <span class="hlFld-ContribAuthor ">Liwei  Shu</span>, <span class="hlFld-ContribAuthor ">Tongyu  Li</span>, <span class="hlFld-ContribAuthor ">Siming  Lu</span>, <span class="hlFld-ContribAuthor ">Mohamed Kasim Mohamed  Subarkhan</span>, <span class="hlFld-ContribAuthor ">Chao  Chen</span>, <span class="hlFld-ContribAuthor ">Hangxiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">New Organometallic Ruthenium(II) Compounds Synergistically Show Cytotoxic, Antimetastatic and Antiangiogenic Activities for the Treatment of Metastatic Cancer. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (66)
                                     , 15170-15182. <a href="https://doi.org/10.1002/chem.202002970" title="DOI URL">https://doi.org/10.1002/chem.202002970</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202002970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202002970%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DNew%252BOrganometallic%252BRuthenium%252528II%252529%252BCompounds%252BSynergistically%252BShow%252BCytotoxic%25252C%252BAntimetastatic%252Band%252BAntiangiogenic%252BActivities%252Bfor%252Bthe%252BTreatment%252Bof%252BMetastatic%252BCancer%26aulast%3DWang%26aufirst%3DYuchen%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D66%26spage%3D15170%26epage%3D15182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katia M.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Erica J.  Peterson</span>, <span class="hlFld-ContribAuthor ">Murilo C.  Carroccia</span>, <span class="hlFld-ContribAuthor ">Marcia R.  Cominetti</span>, <span class="hlFld-ContribAuthor ">Victor M.  Deflon</span>, <span class="hlFld-ContribAuthor ">Nicholas P.  Farrell</span>, <span class="hlFld-ContribAuthor ">Alzir A.  Batista</span>, <span class="hlFld-ContribAuthor ">Rodrigo S.  Correa</span>. </span><span class="cited-content_cbyCitation_article-title">Ru(
              ii
              )-Naphthoquinone complexes with high selectivity for triple-negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2020,</strong> <em>49 </em>
                                    (45)
                                     , 16193-16203. <a href="https://doi.org/10.1039/D0DT01091J" title="DOI URL">https://doi.org/10.1039/D0DT01091J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0DT01091J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0DT01091J%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DRu%252528%252Bii%252B%252529-Naphthoquinone%252Bcomplexes%252Bwith%252Bhigh%252Bselectivity%252Bfor%252Btriple-negative%252Bbreast%252Bcancer%26aulast%3DOliveira%26aufirst%3DKatia%2BM.%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D45%26spage%3D16193%26epage%3D16203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan E.  Wise</span>, <span class="hlFld-ContribAuthor ">Aimee J.  Gamble</span>, <span class="hlFld-ContribAuthor ">Sham W.  Arkawazi</span>, <span class="hlFld-ContribAuthor ">Paul H.  Walton</span>, <span class="hlFld-ContribAuthor ">M. Carmen  Galan</span>, <span class="hlFld-ContribAuthor ">Michael P.  O'Hagan</span>, <span class="hlFld-ContribAuthor ">Karen G.  Hogg</span>, <span class="hlFld-ContribAuthor ">Joanne L.  Marrison</span>, <span class="hlFld-ContribAuthor ">Peter J.  O'Toole</span>, <span class="hlFld-ContribAuthor ">Hazel A.  Sparkes</span>, <span class="hlFld-ContribAuthor ">Jason M.  Lynam</span>, <span class="hlFld-ContribAuthor ">Paul G.  Pringle</span>. </span><span class="cited-content_cbyCitation_article-title">Cytotoxic (
              cis
              ,
              cis
              -1,3,5-triaminocyclohexane)ruthenium(
              ii
              )-diphosphine complexes; evidence for covalent binding
              and
              intercalation with DNA. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2020,</strong> <em>49 </em>
                                    (43)
                                     , 15219-15230. <a href="https://doi.org/10.1039/D0DT02612C" title="DOI URL">https://doi.org/10.1039/D0DT02612C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0DT02612C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0DT02612C%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DCytotoxic%252B%252528%252Bcis%252B%25252C%252Bcis%252B-1%25252C3%25252C5-triaminocyclohexane%252529ruthenium%252528%252Bii%252B%252529-diphosphine%252Bcomplexes%25253B%252Bevidence%252Bfor%252Bcovalent%252Bbinding%252Band%252Bintercalation%252Bwith%252BDNA%26aulast%3DWise%26aufirst%3DDan%2BE.%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D43%26spage%3D15219%26epage%3D15230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Binoy  Kar</span>, <span class="hlFld-ContribAuthor ">Nilmadhab  Roy</span>, <span class="hlFld-ContribAuthor ">Sudhindra  Pete</span>, <span class="hlFld-ContribAuthor ">Prithvi  Moharana</span>, <span class="hlFld-ContribAuthor ">Priyankar  Paira</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium and iridium based mononuclear and multinuclear complexes: A Breakthrough of Next-Generation anticancer metallopharmaceuticals. </span><span class="cited-content_cbyCitation_journal-name">Inorganica Chimica Acta</span><span> <strong>2020,</strong> <em>512 </em>, 119858. <a href="https://doi.org/10.1016/j.ica.2020.119858" title="DOI URL">https://doi.org/10.1016/j.ica.2020.119858</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ica.2020.119858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ica.2020.119858%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganica%2520Chimica%2520Acta%26atitle%3DRuthenium%252Band%252Biridium%252Bbased%252Bmononuclear%252Band%252Bmultinuclear%252Bcomplexes%25253A%252BA%252BBreakthrough%252Bof%252BNext-Generation%252Banticancer%252Bmetallopharmaceuticals%26aulast%3DKar%26aufirst%3DBinoy%26date%3D2020%26volume%3D512%26spage%3D119858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mziyanda  Mbaba</span>, <span class="hlFld-ContribAuthor ">Taryn M.  Golding</span>, <span class="hlFld-ContribAuthor ">Gregory S.  Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Biological Investigation of Organometallic Platinum-Group Metal (Ir, Ru, Rh, Os, Pd, Pt) Complexes as Antimalarial Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (22)
                                     , 5276. <a href="https://doi.org/10.3390/molecules25225276" title="DOI URL">https://doi.org/10.3390/molecules25225276</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25225276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25225276%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BBiological%252BInvestigation%252Bof%252BOrganometallic%252BPlatinum-Group%252BMetal%252B%252528Ir%25252C%252BRu%25252C%252BRh%25252C%252BOs%25252C%252BPd%25252C%252BPt%252529%252BComplexes%252Bas%252BAntimalarial%252BAgents%26aulast%3DMbaba%26aufirst%3DMziyanda%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D22%26spage%3D5276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Chen</span>, <span class="hlFld-ContribAuthor ">Chang  Xu</span>, <span class="hlFld-ContribAuthor ">Tongyu  Li</span>, <span class="hlFld-ContribAuthor ">Siming  Lu</span>, <span class="hlFld-ContribAuthor ">Fangzhou  Luo</span>, <span class="hlFld-ContribAuthor ">Hangxiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel NHC-coordinated ruthenium(II) arene complexes achieve synergistic efficacy as safe and effective anticancer therapeutics. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>203 </em>, 112605. <a href="https://doi.org/10.1016/j.ejmech.2020.112605" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112605</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112605%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BNHC-coordinated%252Bruthenium%252528II%252529%252Barene%252Bcomplexes%252Bachieve%252Bsynergistic%252Befficacy%252Bas%252Bsafe%252Band%252Beffective%252Banticancer%252Btherapeutics%26aulast%3DChen%26aufirst%3DChao%26date%3D2020%26volume%3D203%26spage%3D112605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atrayee  Banaspati</span>, <span class="hlFld-ContribAuthor ">Md Kausar  Raza</span>, <span class="hlFld-ContribAuthor ">Tridib K.  Goswami</span>. </span><span class="cited-content_cbyCitation_article-title">Ni(II) curcumin complexes for cellular imaging and photo-triggered in vitro anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112632. <a href="https://doi.org/10.1016/j.ejmech.2020.112632" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112632</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112632%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNi%252528II%252529%252Bcurcumin%252Bcomplexes%252Bfor%252Bcellular%252Bimaging%252Band%252Bphoto-triggered%252Bin%2525C2%2525A0vitro%252Banticancer%252Bactivity%26aulast%3DBanaspati%26aufirst%3DAtrayee%26date%3D2020%26volume%3D204%26spage%3D112632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rong  Wang</span>, <span class="hlFld-ContribAuthor ">Bi-Qun  Zou</span>, <span class="hlFld-ContribAuthor ">Qi-Pin  Qin</span>, <span class="hlFld-ContribAuthor ">Zhen-Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Ming-Xiong  Tan</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization and the anticancer activity of six lanthanides(III) complexes with 5,7-dihalogenated-8-quinolinol and 2,2’-bipyridine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Transition Metal Chemistry</span><span> <strong>2020,</strong> <em>45 </em>
                                    (7)
                                     , 477-483. <a href="https://doi.org/10.1007/s11243-020-00399-4" title="DOI URL">https://doi.org/10.1007/s11243-020-00399-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11243-020-00399-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11243-020-00399-4%26sid%3Dliteratum%253Aachs%26jtitle%3DTransition%2520Metal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcharacterization%252Band%252Bthe%252Banticancer%252Bactivity%252Bof%252Bsix%252Blanthanides%252528III%252529%252Bcomplexes%252Bwith%252B5%25252C7-dihalogenated-8-quinolinol%252Band%252B2%25252C2%2525E2%252580%252599-bipyridine%252Bderivatives%26aulast%3DWang%26aufirst%3DRong%26date%3D2020%26date%3D2020%26volume%3D45%26issue%3D7%26spage%3D477%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oksana  Desiatkina</span>, <span class="hlFld-ContribAuthor ">Emilia  Păunescu</span>, <span class="hlFld-ContribAuthor ">Martin  Mösching</span>, <span class="hlFld-ContribAuthor ">Nicoleta  Anghel</span>, <span class="hlFld-ContribAuthor ">Ghalia  Boubaker</span>, <span class="hlFld-ContribAuthor ">Yosra  Amdouni</span>, <span class="hlFld-ContribAuthor ">Andrew  Hemphill</span>, <span class="hlFld-ContribAuthor ">Julien  Furrer</span>. </span><span class="cited-content_cbyCitation_article-title">Coumarin‐Tagged Dinuclear Trithiolato‐Bridged Ruthenium(II)⋅Arene Complexes: Photophysical Properties and Antiparasitic Activity. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2020,</strong> <em>21 </em>
                                    (19)
                                     , 2818-2835. <a href="https://doi.org/10.1002/cbic.202000174" title="DOI URL">https://doi.org/10.1002/cbic.202000174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.202000174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.202000174%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DCoumarin%2525E2%252580%252590Tagged%252BDinuclear%252BTrithiolato%2525E2%252580%252590Bridged%252BRuthenium%252528II%252529%2525E2%25258B%252585Arene%252BComplexes%25253A%252BPhotophysical%252BProperties%252Band%252BAntiparasitic%252BActivity%26aulast%3DDesiatkina%26aufirst%3DOksana%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D19%26spage%3D2818%26epage%3D2835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta Erminia  Alberto</span>, <span class="hlFld-ContribAuthor ">Gloria  Mazzone</span>, <span class="hlFld-ContribAuthor ">Claudia  Regina</span>, <span class="hlFld-ContribAuthor ">Nino  Russo</span>, <span class="hlFld-ContribAuthor ">Emilia  Sicilia</span>. </span><span class="cited-content_cbyCitation_article-title">Theoretical exploration of the photophysical properties of two-component Ru
              II
              –porphyrin dyes as promising assemblies for a combined antitumor effect. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2020,</strong> <em>49 </em>
                                    (36)
                                     , 12653-12661. <a href="https://doi.org/10.1039/D0DT02197K" title="DOI URL">https://doi.org/10.1039/D0DT02197K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0DT02197K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0DT02197K%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DTheoretical%252Bexploration%252Bof%252Bthe%252Bphotophysical%252Bproperties%252Bof%252Btwo-component%252BRu%252BII%252B%2525E2%252580%252593porphyrin%252Bdyes%252Bas%252Bpromising%252Bassemblies%252Bfor%252Ba%252Bcombined%252Bantitumor%252Beffect%26aulast%3DAlberto%26aufirst%3DMarta%2BErminia%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D36%26spage%3D12653%26epage%3D12661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raphael T.  Ryan</span>, <span class="hlFld-ContribAuthor ">Dmytro  Havrylyuk</span>, <span class="hlFld-ContribAuthor ">Kimberly C.  Stevens</span>, <span class="hlFld-ContribAuthor ">L. Henry  Moore</span>, <span class="hlFld-ContribAuthor ">Doo Young  Kim</span>, <span class="hlFld-ContribAuthor ">Jessica S.  Blackburn</span>, <span class="hlFld-ContribAuthor ">David K.  Heidary</span>, <span class="hlFld-ContribAuthor ">John P.  Selegue</span>, <span class="hlFld-ContribAuthor ">Edith C.  Glazer</span>. </span><span class="cited-content_cbyCitation_article-title">Avobenzone incorporation in a diverse range of Ru(
              ii
              ) scaffolds produces potent potential antineoplastic agents. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2020,</strong> <em>49 </em>
                                    (35)
                                     , 12161-12167. <a href="https://doi.org/10.1039/D0DT02016H" title="DOI URL">https://doi.org/10.1039/D0DT02016H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0DT02016H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0DT02016H%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DAvobenzone%252Bincorporation%252Bin%252Ba%252Bdiverse%252Brange%252Bof%252BRu%252528%252Bii%252B%252529%252Bscaffolds%252Bproduces%252Bpotent%252Bpotential%252Bantineoplastic%252Bagents%26aulast%3DRyan%26aufirst%3DRaphael%2BT.%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D35%26spage%3D12161%26epage%3D12167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aliny Pereira  de Lima</span>, <span class="hlFld-ContribAuthor ">Marcio Aurélio Pinheiro  Almeida</span>, <span class="hlFld-ContribAuthor ">Francyelli  Mello-Andrade</span>, <span class="hlFld-ContribAuthor ">Flávia  de Castro Pereira</span>, <span class="hlFld-ContribAuthor ">Wanessa Carvalho  Pires</span>, <span class="hlFld-ContribAuthor ">Davi Carvalho  Abreu</span>, <span class="hlFld-ContribAuthor ">Vivianne  de Souza Velozo-Sá</span>, <span class="hlFld-ContribAuthor ">Alzir Azevedo  Batista</span>, <span class="hlFld-ContribAuthor ">Elisângela  de Paula Silveira-Lacerda</span>. </span><span class="cited-content_cbyCitation_article-title">Ru(II)-Based Amino Acid Complexes Show Promise for Leukemia Treatment: Cytotoxicity and Some Light on their Mechanism of Action. </span><span class="cited-content_cbyCitation_journal-name">Biological Trace Element Research</span><span> <strong>2020,</strong> <em>197 </em>
                                    (1)
                                     , 123-131. <a href="https://doi.org/10.1007/s12011-019-01976-0" title="DOI URL">https://doi.org/10.1007/s12011-019-01976-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12011-019-01976-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12011-019-01976-0%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Trace%2520Element%2520Research%26atitle%3DRu%252528II%252529-Based%252BAmino%252BAcid%252BComplexes%252BShow%252BPromise%252Bfor%252BLeukemia%252BTreatment%25253A%252BCytotoxicity%252Band%252BSome%252BLight%252Bon%252Btheir%252BMechanism%252Bof%252BAction%26aulast%3Dde%2BLima%26aufirst%3DAliny%2BPereira%26date%3D2020%26date%3D2019%26volume%3D197%26issue%3D1%26spage%3D123%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jebiti  Haribabu</span>, <span class="hlFld-ContribAuthor ">Swaminathan  Srividya</span>, <span class="hlFld-ContribAuthor ">Reddicherla  Umapathi</span>, <span class="hlFld-ContribAuthor ">Dasararaju  Gayathri</span>, <span class="hlFld-ContribAuthor ">Pannuru  Venkatesu</span>, <span class="hlFld-ContribAuthor ">Nattamai  Bhuvanesh</span>, <span class="hlFld-ContribAuthor ">Ramasamy  Karvembu</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced anticancer activity of half-sandwich Ru(II)-p-cymene complex bearing heterocyclic hydrazone ligand. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry Communications</span><span> <strong>2020,</strong> <em>119 </em>, 108054. <a href="https://doi.org/10.1016/j.inoche.2020.108054" title="DOI URL">https://doi.org/10.1016/j.inoche.2020.108054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.inoche.2020.108054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.inoche.2020.108054%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%2520Communications%26atitle%3DEnhanced%252Banticancer%252Bactivity%252Bof%252Bhalf-sandwich%252BRu%252528II%252529-p-cymene%252Bcomplex%252Bbearing%252Bheterocyclic%252Bhydrazone%252Bligand%26aulast%3DHaribabu%26aufirst%3DJebiti%26date%3D2020%26volume%3D119%26spage%3D108054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Chen</span>, <span class="hlFld-ContribAuthor ">Qin  Tao</span>, <span class="hlFld-ContribAuthor ">Jian  Wu</span>, <span class="hlFld-ContribAuthor ">Mengmeng  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi  Su</span>, <span class="hlFld-ContribAuthor ">Yong  Qian</span>, <span class="hlFld-ContribAuthor ">Tao  Yu</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Xuling  Xue</span>, <span class="hlFld-ContribAuthor ">Hong-Ke  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2020,</strong> <em>210 </em>, 111132. <a href="https://doi.org/10.1016/j.jinorgbio.2020.111132" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2020.111132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2020.111132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2020.111132%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DA%252Blysosome-targeted%252Bruthenium%252528II%252529%252Bpolypyridyl%252Bcomplex%252Bas%252Bphotodynamic%252Banticancer%252Bagent%26aulast%3DChen%26aufirst%3DJun%26date%3D2020%26volume%3D210%26spage%3D111132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thangavel  Sathiya Kamatchi</span>, <span class="hlFld-ContribAuthor ">Mohamed Kasim  Mohamed Subarkhan</span>, <span class="hlFld-ContribAuthor ">Rengan  Ramesh</span>, <span class="hlFld-ContribAuthor ">Hangxiang  Wang</span>, <span class="hlFld-ContribAuthor ">Jan Grzegorz  Małecki</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(
              ii
              ) carbazole-based hydrazone complexes. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2020,</strong> <em>49 </em>
                                    (32)
                                     , 11385-11395. <a href="https://doi.org/10.1039/D0DT01476A" title="DOI URL">https://doi.org/10.1039/D0DT01476A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0DT01476A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0DT01476A%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DInvestigation%252Binto%252Bantiproliferative%252Bactivity%252Band%252Bapoptosis%252Bmechanism%252Bof%252Bnew%252Barene%252BRu%252528%252Bii%252B%252529%252Bcarbazole-based%252Bhydrazone%252Bcomplexes%26aulast%3DSathiya%2BKamatchi%26aufirst%3DThangavel%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D32%26spage%3D11385%26epage%3D11395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric M.  Lewandowski</span>, <span class="hlFld-ContribAuthor ">Łukasz  Szczupak</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Kowalczyk</span>, <span class="hlFld-ContribAuthor ">Gracia  Mendoza</span>, <span class="hlFld-ContribAuthor ">Manuel  Arruebo</span>, <span class="hlFld-ContribAuthor ">Lian M. C.  Jacobs</span>, <span class="hlFld-ContribAuthor ">Paweł  Stączek</span>, <span class="hlFld-ContribAuthor ">Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Konrad  Kowalski</span>. </span><span class="cited-content_cbyCitation_article-title">Metallocenyl 7‐ACA Conjugates: Antibacterial Activity Studies and Atomic‐Resolution X‐ray Crystal Structure with CTX‐M β‐Lactamase. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2020,</strong> <em>21 </em>
                                    (15)
                                     , 2187-2195. <a href="https://doi.org/10.1002/cbic.202000054" title="DOI URL">https://doi.org/10.1002/cbic.202000054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.202000054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.202000054%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DMetallocenyl%252B7%2525E2%252580%252590ACA%252BConjugates%25253A%252BAntibacterial%252BActivity%252BStudies%252Band%252BAtomic%2525E2%252580%252590Resolution%252BX%2525E2%252580%252590ray%252BCrystal%252BStructure%252Bwith%252BCTX%2525E2%252580%252590M%252B%2525CE%2525B2%2525E2%252580%252590Lactamase%26aulast%3DLewandowski%26aufirst%3DEric%2BM.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D15%26spage%3D2187%26epage%3D2195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia  Sanz del Olmo</span>, <span class="hlFld-ContribAuthor ">Ana M.  Bajo</span>, <span class="hlFld-ContribAuthor ">Maksim  Ionov</span>, <span class="hlFld-ContribAuthor ">Sandra  García-Gallego</span>, <span class="hlFld-ContribAuthor ">Maria  Bryszewska</span>, <span class="hlFld-ContribAuthor ">Rafael  Gómez</span>, <span class="hlFld-ContribAuthor ">Paula  Ortega</span>, <span class="hlFld-ContribAuthor ">F. Javier  de la Mata</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>199 </em>, 112414. <a href="https://doi.org/10.1016/j.ejmech.2020.112414" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112414%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCyclopentadienyl%252Bruthenium%252528II%252529%252Bcarbosilane%252Bmetallodendrimers%252Bas%252Ba%252Bpromising%252Btreatment%252Bagainst%252Badvanced%252Bprostate%252Bcancer%26aulast%3DSanz%2Bdel%2BOlmo%26aufirst%3DNatalia%26date%3D2020%26volume%3D199%26spage%3D112414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Romana  Masnikosa</span>, <span class="hlFld-ContribAuthor ">Milan M.  Milutinović</span>, <span class="hlFld-ContribAuthor ">Ivo  Crnolatac</span>, <span class="hlFld-ContribAuthor ">Aleksandar  Tot</span>, <span class="hlFld-ContribAuthor ">Suzana  Veličković</span>, <span class="hlFld-ContribAuthor ">Žanka  Bojić-Trbojević</span>, <span class="hlFld-ContribAuthor ">Ana  Rilak-Simović</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-adhesive action of novel ruthenium(II) chlorophenyl terpyridine complexes with a high affinity for double-stranded DNA: in vitro and in silico. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2020,</strong> <em>208 </em>, 111090. <a href="https://doi.org/10.1016/j.jinorgbio.2020.111090" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2020.111090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2020.111090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2020.111090%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DAnti-adhesive%252Baction%252Bof%252Bnovel%252Bruthenium%252528II%252529%252Bchlorophenyl%252Bterpyridine%252Bcomplexes%252Bwith%252Ba%252Bhigh%252Baffinity%252Bfor%252Bdouble-stranded%252BDNA%25253A%252Bin%252Bvitro%252Band%252Bin%252Bsilico%26aulast%3DMasnikosa%26aufirst%3DRomana%26date%3D2020%26volume%3D208%26spage%3D111090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anuja  P.K.</span>, <span class="hlFld-ContribAuthor ">Priyankar  Paira</span>. </span><span class="cited-content_cbyCitation_article-title">Luminescent anticancer Ru(II)-arenebipyridine and phenanthroline complexes: Synthesis, characterization, DFT studies, biological interactions and cellular imaging application. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2020,</strong> <em>208 </em>, 111099. <a href="https://doi.org/10.1016/j.jinorgbio.2020.111099" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2020.111099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2020.111099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2020.111099%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DLuminescent%252Banticancer%252BRu%252528II%252529-arenebipyridine%252Band%252Bphenanthroline%252Bcomplexes%25253A%252BSynthesis%25252C%252Bcharacterization%25252C%252BDFT%252Bstudies%25252C%252Bbiological%252Binteractions%252Band%252Bcellular%252Bimaging%252Bapplication%26aulast%3DP.K.%26aufirst%3DAnuja%26date%3D2020%26volume%3D208%26spage%3D111099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Burkhon  Elmuradov</span>, <span class="hlFld-ContribAuthor ">Gerald  Dräger</span>, <span class="hlFld-ContribAuthor ">Holger  Butenschön</span>. </span><span class="cited-content_cbyCitation_article-title">Novel π‐Extended Quinazoline‐Ferrocene Conjugates: Synthesis, Structure, and Redox Behavior. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (23)
                                     , 3430-3440. <a href="https://doi.org/10.1002/ejoc.202000414" title="DOI URL">https://doi.org/10.1002/ejoc.202000414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202000414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202000414%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DNovel%252B%2525CF%252580%2525E2%252580%252590Extended%252BQuinazoline%2525E2%252580%252590Ferrocene%252BConjugates%25253A%252BSynthesis%25252C%252BStructure%25252C%252Band%252BRedox%252BBehavior%26aulast%3DElmuradov%26aufirst%3DBurkhon%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D23%26spage%3D3430%26epage%3D3440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">János P.  Mészáros</span>, <span class="hlFld-ContribAuthor ">Jelena M.  Poljarević</span>, <span class="hlFld-ContribAuthor ">István  Szatmári</span>, <span class="hlFld-ContribAuthor ">Oszkár  Csuvik</span>, <span class="hlFld-ContribAuthor ">Ferenc  Fülöp</span>, <span class="hlFld-ContribAuthor ">Norbert  Szoboszlai</span>, <span class="hlFld-ContribAuthor ">Gabriella  Spengler</span>, <span class="hlFld-ContribAuthor ">Éva A.  Enyedy</span>. </span><span class="cited-content_cbyCitation_article-title">An 8-hydroxyquinoline–proline hybrid with multidrug resistance reversal activity and the solution chemistry of its half-sandwich organometallic Ru and Rh complexes. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2020,</strong> <em>49 </em>
                                    (23)
                                     , 7977-7992. <a href="https://doi.org/10.1039/D0DT01256D" title="DOI URL">https://doi.org/10.1039/D0DT01256D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0DT01256D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0DT01256D%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DAn%252B8-hydroxyquinoline%2525E2%252580%252593proline%252Bhybrid%252Bwith%252Bmultidrug%252Bresistance%252Breversal%252Bactivity%252Band%252Bthe%252Bsolution%252Bchemistry%252Bof%252Bits%252Bhalf-sandwich%252Borganometallic%252BRu%252Band%252BRh%252Bcomplexes%26aulast%3DM%25C3%25A9sz%25C3%25A1ros%26aufirst%3DJ%25C3%25A1nos%2BP.%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D23%26spage%3D7977%26epage%3D7992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hernán  Villota</span>, <span class="hlFld-ContribAuthor ">Sebastian  Pizarro</span>, <span class="hlFld-ContribAuthor ">Francisco  Gajardo</span>, <span class="hlFld-ContribAuthor ">Álvaro  Delgadillo</span>, <span class="hlFld-ContribAuthor ">Fabián  Cortés-Mancera</span>, <span class="hlFld-ContribAuthor ">Giuliano  Bernal</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium Complex Induce Cell Death in G-415 Gallbladder Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Gastrointestinal Cancer</span><span> <strong>2020,</strong> <em>51 </em>
                                    (2)
                                     , 571-578. <a href="https://doi.org/10.1007/s12029-019-00278-x" title="DOI URL">https://doi.org/10.1007/s12029-019-00278-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12029-019-00278-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12029-019-00278-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Gastrointestinal%2520Cancer%26atitle%3DRuthenium%252BComplex%252BInduce%252BCell%252BDeath%252Bin%252BG-415%252BGallbladder%252BCancer%252BCells%26aulast%3DVillota%26aufirst%3DHern%25C3%25A1n%26date%3D2020%26date%3D2019%26volume%3D51%26issue%3D2%26spage%3D571%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Poulami  Mandal</span>, <span class="hlFld-ContribAuthor ">Chanchal  Sonkar</span>, <span class="hlFld-ContribAuthor ">Sandeep Singh  Dhankhar</span>, <span class="hlFld-ContribAuthor ">C.M.  Nagaraja</span>, <span class="hlFld-ContribAuthor ">Suman  Mukhopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium(II)-arene complexes containing ferrocenamide ligands: Synthesis, characterisation and antiproliferative activity against cancer cell lines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Organometallic Chemistry</span><span> <strong>2020,</strong> <em>916 </em>, 121247. <a href="https://doi.org/10.1016/j.jorganchem.2020.121247" title="DOI URL">https://doi.org/10.1016/j.jorganchem.2020.121247</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jorganchem.2020.121247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jorganchem.2020.121247%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Organometallic%2520Chemistry%26atitle%3DRuthenium%252528II%252529-arene%252Bcomplexes%252Bcontaining%252Bferrocenamide%252Bligands%25253A%252BSynthesis%25252C%252Bcharacterisation%252Band%252Bantiproliferative%252Bactivity%252Bagainst%252Bcancer%252Bcell%252Blines%26aulast%3DMandal%26aufirst%3DPoulami%26date%3D2020%26volume%3D916%26spage%3D121247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Grazia  Ferraro</span>, <span class="hlFld-ContribAuthor ">Marialuisa  Piccolo</span>, <span class="hlFld-ContribAuthor ">Gabriella  Misso</span>, <span class="hlFld-ContribAuthor ">Francesco  Maione</span>, <span class="hlFld-ContribAuthor ">Daniela  Montesarchio</span>, <span class="hlFld-ContribAuthor ">Michele  Caraglia</span>, <span class="hlFld-ContribAuthor ">Luigi  Paduano</span>, <span class="hlFld-ContribAuthor ">Rita  Santamaria</span>, <span class="hlFld-ContribAuthor ">Carlo  Irace</span>. </span><span class="cited-content_cbyCitation_article-title">Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (6)
                                     , 1412. <a href="https://doi.org/10.3390/cells9061412" title="DOI URL">https://doi.org/10.3390/cells9061412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9061412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9061412%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DBreast%252BCancer%252BChemotherapeutic%252BOptions%25253A%252BA%252BGeneral%252BOverview%252Bon%252Bthe%252BPreclinical%252BValidation%252Bof%252Ba%252BMulti-Target%252BRuthenium%252528III%252529%252BComplex%252BLodged%252Bin%252BNucleolipid%252BNanosystems%26aulast%3DFerraro%26aufirst%3DMaria%2BGrazia%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D6%26spage%3D1412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruirong  Ye</span>, <span class="hlFld-ContribAuthor ">Caiping  Tan</span>, <span class="hlFld-ContribAuthor ">Bichun  Chen</span>, <span class="hlFld-ContribAuthor ">Rongtao  Li</span>, <span class="hlFld-ContribAuthor ">Zongwan  Mao</span>. </span><span class="cited-content_cbyCitation_article-title">Zinc-Containing Metalloenzymes: Inhibition by Metal-Based Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.3389/fchem.2020.00402" title="DOI URL">https://doi.org/10.3389/fchem.2020.00402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2020.00402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2020.00402%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DZinc-Containing%252BMetalloenzymes%25253A%252BInhibition%252Bby%252BMetal-Based%252BAnticancer%252BAgents%26aulast%3DYe%26aufirst%3DRuirong%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Qin  Qin</span>, <span class="hlFld-ContribAuthor ">Bi-Qun  Zou</span>, <span class="hlFld-ContribAuthor ">Qi-Pin  Qin</span>, <span class="hlFld-ContribAuthor ">Zhen-Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Lin  Yang</span>, <span class="hlFld-ContribAuthor ">Ming-Xiong  Tan</span>, <span class="hlFld-ContribAuthor ">Chun-Jie  Liang</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Highly cytotoxic, cyclometalated iridium(
              iii
              )-5-fluoro-8-quinolinol complexes as cancer cell mitochondriotropic agents. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (19)
                                     , 7832-7837. <a href="https://doi.org/10.1039/D0NJ00465K" title="DOI URL">https://doi.org/10.1039/D0NJ00465K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ00465K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ00465K%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DHighly%252Bcytotoxic%25252C%252Bcyclometalated%252Biridium%252528%252Biii%252B%252529-5-fluoro-8-quinolinol%252Bcomplexes%252Bas%252Bcancer%252Bcell%252Bmitochondriotropic%252Bagents%26aulast%3DQin%26aufirst%3DLi-Qin%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D19%26spage%3D7832%26epage%3D7837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luana M.  Sousa</span>, <span class="hlFld-ContribAuthor ">Diesley M. S.  Araújo</span>, <span class="hlFld-ContribAuthor ">Katia M.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Letícia P.  De Oliveira</span>, <span class="hlFld-ContribAuthor ">Pedro I. S.  Maia</span>, <span class="hlFld-ContribAuthor ">Victor M.  Deflon</span>, <span class="hlFld-ContribAuthor ">Alzir A.  Batista</span>, <span class="hlFld-ContribAuthor ">Antônio E. H.  Machado</span>, <span class="hlFld-ContribAuthor ">Wendell  Guerra</span>, <span class="hlFld-ContribAuthor ">Gustavo  Von Poelhsitz</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, spectroscopic characterization and computational study of Ru(II)/DMSO complexes with monocoordinated carbazate ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Coordination Chemistry</span><span> <strong>2020,</strong> <em>73 </em>
                                    (10)
                                     , 1605-1618. <a href="https://doi.org/10.1080/00958972.2020.1777286" title="DOI URL">https://doi.org/10.1080/00958972.2020.1777286</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00958972.2020.1777286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00958972.2020.1777286%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Coordination%2520Chemistry%26atitle%3DSynthesis%25252C%252Bspectroscopic%252Bcharacterization%252Band%252Bcomputational%252Bstudy%252Bof%252BRu%252528II%252529%25252FDMSO%252Bcomplexes%252Bwith%252Bmonocoordinated%252Bcarbazate%252Bligands%26aulast%3DSousa%26aufirst%3DLuana%2BM.%26date%3D2020%26date%3D2020%26volume%3D73%26issue%3D10%26spage%3D1605%26epage%3D1618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donát  Gelle</span>, <span class="hlFld-ContribAuthor ">Martin  Lamač</span>, <span class="hlFld-ContribAuthor ">Karel  Mach</span>, <span class="hlFld-ContribAuthor ">Ludmila  Šimková</span>, <span class="hlFld-ContribAuthor ">Róbert  Gyepes</span>, <span class="hlFld-ContribAuthor ">Lucia  Sommerová</span>, <span class="hlFld-ContribAuthor ">Andrea  Martišová</span>, <span class="hlFld-ContribAuthor ">Martin  Bartošík</span>, <span class="hlFld-ContribAuthor ">Tomáš  Vaculovič</span>, <span class="hlFld-ContribAuthor ">Viktor  Kanický</span>, <span class="hlFld-ContribAuthor ">Roman  Hrstka</span>, <span class="hlFld-ContribAuthor ">Jiří  Pinkas</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced Intracellular Accumulation and Cytotoxicity of Ferrocene‐Ruthenium Arene Conjugates. </span><span class="cited-content_cbyCitation_journal-name">ChemPlusChem</span><span> <strong>2020,</strong> <em>85 </em>
                                    (5)
                                     , 1034-1043. <a href="https://doi.org/10.1002/cplu.202000022" title="DOI URL">https://doi.org/10.1002/cplu.202000022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cplu.202000022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcplu.202000022%26sid%3Dliteratum%253Aachs%26jtitle%3DChemPlusChem%26atitle%3DEnhanced%252BIntracellular%252BAccumulation%252Band%252BCytotoxicity%252Bof%252BFerrocene%2525E2%252580%252590Ruthenium%252BArene%252BConjugates%26aulast%3DGelle%26aufirst%3DDon%25C3%25A1t%26date%3D2020%26date%3D2020%26volume%3D85%26issue%3D5%26spage%3D1034%26epage%3D1043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youchao  Wang</span>, <span class="hlFld-ContribAuthor ">Na  Tian</span>, <span class="hlFld-ContribAuthor ">Weize  Sun</span>, <span class="hlFld-ContribAuthor ">Boerhan  Rena</span>, <span class="hlFld-ContribAuthor ">Xusheng  Guo</span>, <span class="hlFld-ContribAuthor ">Yang  Feng</span>, <span class="hlFld-ContribAuthor ">Chao  Li</span>, <span class="hlFld-ContribAuthor ">Xuesong  Wang</span>, <span class="hlFld-ContribAuthor ">Qianxiong  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">A Ru(II)‐Based Nanoassembly Exhibiting Theranostic PACT Activity in NIR Region. </span><span class="cited-content_cbyCitation_journal-name">Particle & Particle Systems Characterization</span><span> <strong>2020,</strong> <em>37 </em>
                                    (5)
                                     , 2000045. <a href="https://doi.org/10.1002/ppsc.202000045" title="DOI URL">https://doi.org/10.1002/ppsc.202000045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ppsc.202000045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fppsc.202000045%26sid%3Dliteratum%253Aachs%26jtitle%3DParticle%2520%2526%2520Particle%2520Systems%2520Characterization%26atitle%3DA%252BRu%252528II%252529%2525E2%252580%252590Based%252BNanoassembly%252BExhibiting%252BTheranostic%252BPACT%252BActivity%252Bin%252BNIR%252BRegion%26aulast%3DWang%26aufirst%3DYouchao%26date%3D2020%26date%3D2020%26volume%3D37%26issue%3D5%26spage%3D2000045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angelica E.  Graminha</span>, <span class="hlFld-ContribAuthor ">João  Honorato</span>, <span class="hlFld-ContribAuthor ">Liany Luna  Dulcey</span>, <span class="hlFld-ContribAuthor ">Luani Rezende  Godoy</span>, <span class="hlFld-ContribAuthor ">Marília F.  Barbosa</span>, <span class="hlFld-ContribAuthor ">Marcia R.  Cominetti</span>, <span class="hlFld-ContribAuthor ">Antonio C.  Menezes</span>, <span class="hlFld-ContribAuthor ">Alzir A.  Batista</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2020,</strong> <em>206 </em>, 111021. <a href="https://doi.org/10.1016/j.jinorgbio.2020.111021" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2020.111021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2020.111021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2020.111021%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DEvaluation%252Bof%252Bthe%252Bbiological%252Bpotential%252Bof%252Bruthenium%252528II%252529%252Bcomplexes%252Bwith%252Bcinnamic%252Bacid%26aulast%3DGraminha%26aufirst%3DAngelica%2BE.%26date%3D2020%26volume%3D206%26spage%3D111021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Facs.jmedchem.7b01689&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01689%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=180&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0015.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of cisplatin and ruthenium clinical trial, preclinical, and lead compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of Ru(II) clinical trial photodynamic therapy compound.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. General cellular uptake mechanisms of drugs. Reproduced from ref <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (<a href="http://dx.doi.org/10.1039/C7CS00195A" class="extLink">http://dx.doi.org/10.1039/C7CS00195A</a>), Copyright 2017, with permission of The Royal Society of Chemistry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In mammary carcinoma model differentiation of the percent inhibition and selectivity of the antineoplastic action of <b>KP1019</b>, <b>RM175</b>, <b>RAPTA-T</b>, and <b>NAMI-A</b>. The right red bar indicates the percent inhibition of lung metastases, and left green bar indicates the percent inhibition of primary tumor growth. Reproduced with permission from   <cite><i>Journal of Inorganic
Biochemistry</i></cite> (<a href="https://www.sciencedirect.com/journal/journal-of-inorganic-biochemistry" class="extLink">https://www.sciencedirect.com/journal/journal-of-inorganic-biochemistry</a>), <span class="NLM_year">2012</span>, Vol. <em>106</em>; <contrib-group><span class="NLM_string-name">Bergamo, A.</span>; <span class="NLM_string-name">Gaiddon, C.</span>; <span class="NLM_string-name">Schellens, J. H.</span>; <span class="NLM_string-name">Beijnen, J. H.</span>; <span class="NLM_string-name">Sava, G.</span></contrib-group> Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates, Pages 90–99,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Copyright 2011, with permission from Elsevier.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representation of the antitumor action of the nucleus-targeting complex [Ru(bpy)(phpy)dppz]<sup>+</sup>. Reproduced with permission from ref <a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a>. Copyright 2014, American Chemical Society.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Ru(II) therapeutic <b>DW1/2</b> proposed mechanism of the in vitro cytotoxicity in a model of human melanoma in vitro. Reproduced with permission from   <cite><i>Journal of Inorganic Biochemistry</i></cite> (<a href="https://www.sciencedirect.com/journal/journal-of-inorganic-biochemistry" class="extLink">https://www.sciencedirect.com/journal/journal-of-inorganic-biochemistry</a>), <span class="NLM_year">2012</span>, Vol. <em>106</em>; <contrib-group><span class="NLM_string-name">Bergamo, A.</span>; <span class="NLM_string-name">Gaiddon, C.</span>; <span class="NLM_string-name">Schellens, J. H.</span>; <span class="NLM_string-name">Beijnen, J. H.</span>; <span class="NLM_string-name">Sava, G.</span></contrib-group> Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates, Pages 90–99,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Copyright 2011, with permission from Elsevier.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Schematic portrayal of Ru(II)therapeutic inducing the activation of apoptotic and autophagy mechanisms in the A2780 cell line. The red color denotes mRNAs overexpression of specific genes in A2780 human ovarian cancer cells treated with the Ru(II) therapeutic compared with untreated A2780 human ovarian cancer cells. Red intensities are proportional to mRNAs transcripts. Reproduced with permission from ref <a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a>. Copyright 2015, American Chemical Society.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Ruthenium(II) therapeutics that are ATP-competitive protein kinase inhibitors. (a) Shape mimicry: structure of lead staurosporine. (b) Cocrystal structure of pseudo-octahedral ruthenium half-sandwich complex with Pim-1 protein kinase (yellow color, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BZI">2BZI</a>). (c) Enlargement of the cocrystal structure of pseudo-octahedral ruthenium half-sandwich complex with Pim-1 protein kinase (yellow color, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BZI">2BZI</a>). (d) The superimposed cocrystal structure of Pim-1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BZI">2BZI</a>) with staurosporine (blue color, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YHS">1YHS</a>) reveals the close match in binding mode between the organometallic compound and the natural product. Reproduced with permission from   <cite><i>Current Opinion in
Chemical Biology</i></cite> (<a href="https://www.sciencedirect.com/journal/current-opinion-in-chemical-biology" class="extLink">https://www.sciencedirect.com/journal/current-opinion-in-chemical-biology</a>) <span class="NLM_year">2007</span>, Vol. <em>11</em>; <contrib-group><span class="NLM_string-name">Meggers, E.</span></contrib-group> Exploring biologically relevant chemical space with metal complexes, Pages 287–292,<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Copyright 2007, with permission from Elsevier.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. General portrayal of the principal targets and projected mechanisms of action of ruthenium complexes as oncotherapeutics. Reproduced from ref <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (<a href="http://dx.doi.org/10.1039/C7CS00195A" class="extLink">http://dx.doi.org/10.1039/C7CS00195A</a>), Copyright 2017, with permission of The Royal Society of Chemistry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (A) Mechanized MSNPs graphical portrayal. (B) Schematic representation and <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="cd988e839d8da09ea482">[email protected]</a><sub>2</sub> nanoparticles TEM image (1) and drug release from <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="3e7a7166136b7d706e7e536d5771">[email protected]</a><sub>2</sub>-Ru nanoparticles (2). (C) Synthetic route for pSiNP-Ru-PEG-Man. (D) <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="702205203f20303d233e03">[email protected]</a> construction reaction pathways. Reproduced from ref <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (<a href="http://dx.doi.org/10.1039/C7CS00195A" class="extLink">http://dx.doi.org/10.1039/C7CS00195A</a>), Copyright 2017, with permission of The Royal Society of Chemistry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Schematic representation of inhibition of bFGF-induced angiogenesis and apoptosis (suppressing the AKT and ERK signaling pathways) by luminescent Ru(II) polypyridyl encapsulated selenium nanoparticles. Reproduced with permission from   <cite><i>Biomaterials</i></cite> (<a href="https://www.sciencedirect.com/journal/biomaterials" class="extLink">https://www.sciencedirect.com/journal/biomaterials</a>), <span class="NLM_year">2013</span>, Vol. <em>34</em>; <contrib-group><span class="NLM_string-name">Sun, D.</span>; <span class="NLM_string-name">Liu, Y.</span>; <span class="NLM_string-name">Yu, Q.</span>; <span class="NLM_string-name">Zhou, Y.</span>; <span class="NLM_string-name">Zhang, R.</span>; <span class="NLM_string-name">Chen, X.</span>; <span class="NLM_string-name">Hong, A.</span>; <span class="NLM_string-name">Liu, J.</span></contrib-group> The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling, Pages 171–180,<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Copyright 2012, with permission from Elsevier.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Schematic portrayal of ruthenium polypyridyl complex [Ru(phen)<sub>2</sub>dppz](ClO<sub>4</sub>)<sup>2</sup>(Ru) encapsulated within bilayer of liposomes (Lipo-Ru), which reduces the triple-negative breast cancer (TNBC) and is a favorable theranostic approach for cancer therapy. Reproduced with permission from ref <a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a>. Copyright 2017, American Chemical Society.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Schematic portrayal of Ru(II) complex-functionalized single-walled carbon nanotubes (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="3f6d4a7f6c687c716b4c">[email protected]</a>) for bimodal two-photon photodynamic therapy (TPPDT) and photothermal therapy (PTT) with irradiation (808 nm). Reproduced with permission from ref <a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a>. Copyright 2017, American Chemical Society.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/medium/jm-2017-01689k_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Schematic illustration of cellular mechanism involved in the activity of <b>RAPTA-C</b> and erlotinib combinations. In ECRF24 cells, destruction of DNA may lead to failure to progress through G1/S checkpoint, which therefore induces apoptosis. In A2780 and A2780<i>cis</i>R cells, genesis of DNA bridges and micronuclei is by mitotic defection. Due to the genesis of DNA bridges, cytokinesis failure occurs, which leads to senescence. Reproduced with permission from ref <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> (<a href="http://dx.doi.org/10.1038/srep43005" class="extLink">http://dx.doi.org/10.1038/srep43005</a>), licensed under a Creative Commons Attribution 4.0 International License (<a href="https://creativecommons.org/licenses/by/4.0/legalcode" class="extLink">https://creativecommons.org/licenses/by/4.0/legalcode</a>), Nature Publishing Group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01689/20180719/images/large/jm-2017-01689k_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01689&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i26">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63408" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63408" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 149 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valastyan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Tumor metastasis: molecular insights and evolving paradigms</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.cell.2011.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=22000009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaksb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2011&pages=275-292&author=S.+Valastyanauthor=R.+A.+Weinberg&title=Tumor+metastasis%3A+molecular+insights+and+evolving+paradigms&doi=10.1016%2Fj.cell.2011.09.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor Metastasis: Molecular Insights and Evolving Paradigms</span></div><div class="casAuthors">Valastyan, Scott; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-292</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Metastases represent the end products of a multistep cell-biol. process termed the invasion-metastasis cascade, which involves dissemination of cancer cells to anatomically distant organ sites and their subsequent adaptation to foreign tissue microenvironments.  Each of these events is driven by the acquisition of genetic and/or epigenetic alterations within tumor cells and the co-option of nonneoplastic stromal cells, which together endow incipient metastatic cells with traits needed to generate macroscopic metastases.  Recent advances provide provocative insights into these cell-biol. and mol. changes, which have implications regarding the steps of the invasion-metastasis cascade that appear amenable to therapeutic targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVqOPVKwPqtbVg90H21EOLACvtfcHk0ljv6ezh-iIsMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaksb3N&md5=fa62d15c6b61bf90cfcdc1d51bbe98b9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DValastyan%26aufirst%3DS.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DTumor%2520metastasis%253A%2520molecular%2520insights%2520and%2520evolving%2520paradigms%26jtitle%3DCell%26date%3D2011%26volume%3D147%26spage%3D275%26epage%3D292%26doi%3D10.1016%2Fj.cell.2011.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferlay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soerjomataram, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dikshit, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebelo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkin, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, F.</span></span> <span> </span><span class="NLM_article-title">Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">E359</span>– <span class="NLM_lpage">E386</span>, <span class="refDoi"> DOI: 10.1002/ijc.29210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fijc.29210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=25220842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyktbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2015&pages=E359-E386&author=J.+Ferlayauthor=I.+Soerjomataramauthor=R.+Dikshitauthor=S.+Eserauthor=C.+Mathersauthor=M.+Rebeloauthor=D.+M.+Parkinauthor=D.+Formanauthor=F.+Bray&title=Cancer+incidence+and+mortality+worldwide%3A+sources%2C+methods+and+major+patterns+in+GLOBOCAN+2012&doi=10.1002%2Fijc.29210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012</span></div><div class="casAuthors">Ferlay, Jacques; Soerjomataram, Isabelle; Dikshit, Rajesh; Eser, Sultan; Mathers, Colin; Rebelo, Marise; Parkin, Donald Maxwell; Forman, David; Bray, Freddie</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">E359-E386</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Ests. of the worldwide incidence and mortality from 27 major cancers and for all cancers combined for 2012 are now available in the GLOBOCAN series of the International Agency for Research on Cancer.  We review the sources and methods used in compiling the national cancer incidence and mortality ests., and briefly describe the key results by cancer site and in 20 large "areas" of the world.  Overall, there were 14.1 million new cases and 8.2 million deaths in 2012.  The most commonly diagnosed cancers were lung (1.82 million), breast (1.67 million), and colorectal (1.36 million); the most common causes of cancer death were lung cancer (1.6 million deaths), liver cancer (745,000 deaths), and stomach cancer (723,000 deaths).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOv4ecwK-CfLVg90H21EOLACvtfcHk0ljk3HswEuJrLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyktbzI&md5=c560896798e5e2b23ff293f6bd805bb6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fijc.29210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.29210%26sid%3Dliteratum%253Aachs%26aulast%3DFerlay%26aufirst%3DJ.%26aulast%3DSoerjomataram%26aufirst%3DI.%26aulast%3DDikshit%26aufirst%3DR.%26aulast%3DEser%26aufirst%3DS.%26aulast%3DMathers%26aufirst%3DC.%26aulast%3DRebelo%26aufirst%3DM.%26aulast%3DParkin%26aufirst%3DD.%2BM.%26aulast%3DForman%26aufirst%3DD.%26aulast%3DBray%26aufirst%3DF.%26atitle%3DCancer%2520incidence%2520and%2520mortality%2520worldwide%253A%2520sources%252C%2520methods%2520and%2520major%2520patterns%2520in%2520GLOBOCAN%25202012%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2015%26volume%3D136%26spage%3DE359%26epage%3DE386%26doi%3D10.1002%2Fijc.29210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thun, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLancey, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Center, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, E. M.</span></span> <span> </span><span class="NLM_article-title">The global burden of cancer: priorities for prevention</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1093/carcin/bgp263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1093%2Fcarcin%2Fbgp263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=19934210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlCmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=100-110&author=M.+J.+Thunauthor=J.+O.+DeLanceyauthor=M.+M.+Centerauthor=A.+Jemalauthor=E.+M.+Ward&title=The+global+burden+of+cancer%3A+priorities+for+prevention&doi=10.1093%2Fcarcin%2Fbgp263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The global burden of cancer: priorities for prevention</span></div><div class="casAuthors">Thun, Michael J.; De Lancey, John Oliver; Center, Melissa M.; Jemal, Ahmedin; Ward, Elizabeth M.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">100-110</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Despite decreases in the cancer death rates in high-resource countries, such as the USA, the no. of cancer cases and deaths is projected to more than double worldwide over the next 20-40 years.  Cancer is now the third leading cause of death, with >12 million new cases and 7.6 million cancer deaths estd. to have occurred globally in 2007 (1).  By 2030, it is projected that there will be ∼26 million new cancer cases and 17 million cancer deaths per yr.  The projected increase will be driven largely by growth and aging of populations and will be largest in low- and medium-resource countries.  Under current trends, increased longevity in developing countries will nearly triple the no. of people who survive to age 65 by 2050.  This demog. shift is compounded by the entrenchment of modifiable risk factors such as smoking and obesity in many low-and medium-resource countries and by the slower decline in cancers related to chronic infections (esp. stomach, liver and uterine cervix) in economically developing than in industrialized countries.  This paper identifies several preventive measures that offer the most feasible approach to mitigate the anticipated global increase in cancer in countries that can least afford it.  Foremost among these are the need to strengthen efforts in international tobacco control and to increase the availability of vaccines against hepatitis B and human papilloma virus in countries where they are most needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9T-Jh4q4gw7Vg90H21EOLACvtfcHk0ljk3HswEuJrLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlCmtg%253D%253D&md5=7badfd6b15257e01189cbfc33571c7d6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgp263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgp263%26sid%3Dliteratum%253Aachs%26aulast%3DThun%26aufirst%3DM.%2BJ.%26aulast%3DDeLancey%26aufirst%3DJ.%2BO.%26aulast%3DCenter%26aufirst%3DM.%2BM.%26aulast%3DJemal%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DE.%2BM.%26atitle%3DThe%2520global%2520burden%2520of%2520cancer%253A%2520priorities%2520for%2520prevention%26jtitle%3DCarcinogenesis%26date%3D2010%26volume%3D31%26spage%3D100%26epage%3D110%26doi%3D10.1093%2Fcarcin%2Fbgp263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomasetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span> <span> </span><span class="NLM_article-title">Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">1330</span>– <span class="NLM_lpage">1334</span>, <span class="refDoi"> DOI: 10.1126/science.aaf9011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1126%2Fscience.aaf9011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28336671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksFaksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2017&pages=1330-1334&author=C.+Tomasettiauthor=L.+Liauthor=B.+Vogelstein&title=Stem+cell+divisions%2C+somatic+mutations%2C+cancer+etiology%2C+and+cancer+prevention&doi=10.1126%2Fscience.aaf9011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention</span></div><div class="casAuthors">Tomasetti, Cristian; Li, Lu; Vogelstein, Bert</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">6331</span>),
    <span class="NLM_cas:pages">1330-1334</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cancers are caused by mutations that may be inherited, induced by environmental factors, or result from DNA replication errors (R).  We studied the relationship between the no. of normal stem cell divisions and the risk of 17 cancer types in 69 countries throughout the world.  The data revealed a strong correlation (median = 0.80) between cancer incidence and normal stem cell divisions in all countries, regardless of their environment.  The major role of R mutations in cancer etiol. was supported by an independent approach, based solely on cancer genome sequencing and epidemiol. data, which suggested that R mutations are responsible for two-thirds of the mutations in human cancers.  All of these results are consistent with epidemiol. ests. of the fraction of cancers that can be prevented by changes in the environment.  Moreover, they accentuate the importance of early detection and intervention to reduce deaths from the many cancers arising from unavoidable R mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjgcWECUbyNrVg90H21EOLACvtfcHk0liMSQMUeThcgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksFaksLY%253D&md5=845d35f2fbb601ffee9ccd60bbdc30cf</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaf9011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaf9011%26sid%3Dliteratum%253Aachs%26aulast%3DTomasetti%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DStem%2520cell%2520divisions%252C%2520somatic%2520mutations%252C%2520cancer%2520etiology%252C%2520and%2520cancer%2520prevention%26jtitle%3DScience%26date%3D2017%26volume%3D355%26spage%3D1330%26epage%3D1334%26doi%3D10.1126%2Fscience.aaf9011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silver, D. P.</span></span> <span> </span><span class="NLM_article-title">Cancer: crossing over to drug resistance</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>451</i></span>,  <span class="NLM_fpage">1066</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1038/4511066a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2F4511066a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=451&publication_year=2008&pages=1066-1067&author=D.+M.+Livingstonauthor=D.+P.+Silver&title=Cancer%3A+crossing+over+to+drug+resistance&doi=10.1038%2F4511066a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F4511066a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F4511066a%26sid%3Dliteratum%253Aachs%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26aulast%3DSilver%26aufirst%3DD.%2BP.%26atitle%3DCancer%253A%2520crossing%2520over%2520to%2520drug%2520resistance%26jtitle%3DNature%26date%3D2008%26volume%3D451%26spage%3D1066%26epage%3D1067%26doi%3D10.1038%2F4511066a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McQuitty, R. J.</span></span> <span> </span><span class="NLM_article-title">Metal-based drugs</span>. <i>Sci. Prog.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.3184/003685014X13898980185076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.3184%2F003685014X13898980185076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=24800466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1aju7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2014&pages=1-19&author=R.+J.+McQuitty&title=Metal-based+drugs&doi=10.3184%2F003685014X13898980185076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Metal-based drugs</span></div><div class="casAuthors">McQuitty, Ruth J.</div><div class="citationInfo"><span class="NLM_cas:title">Science Progress (St. Albans, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-19</span>CODEN:
                <span class="NLM_cas:coden">SCPRAY</span>;
        ISSN:<span class="NLM_cas:issn">0036-8504</span>.
    
            (<span class="NLM_cas:orgname">Science Reviews 2000 Ltd.</span>)
        </div><div class="casAbstract">A review.  Metals have been considered for millennia to have medicinal values.  With the advent of modern medicine, many metal-based drugs have proven to be highly effective in the clinic.  Many different metal ions have shown activity against a range of diseases.  The unique electronic structure of transition metals offers great versatility, not always seen in org. drugs, in terms of the ability to tune the properties of a given mol.  This review gives a brief overview of the most established therapeutic metals, and their more common applications, such as platinum-based anticancer drugs.  New developments within the field of metallodrugs and novel strategies being employed to improve methods of delivery, are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra_0WGihPHsbVg90H21EOLACvtfcHk0liMSQMUeThcgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1aju7%252FO&md5=60097cc4360b8471f5e6741921d16dcb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3184%2F003685014X13898980185076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3184%252F003685014X13898980185076%26sid%3Dliteratum%253Aachs%26aulast%3DMcQuitty%26aufirst%3DR.%2BJ.%26atitle%3DMetal-based%2520drugs%26jtitle%3DSci.%2520Prog.%26date%3D2014%26volume%3D97%26spage%3D1%26epage%3D19%26doi%3D10.3184%2F003685014X13898980185076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, L. H.</span></span> <span> </span><span class="NLM_article-title">DNA and its associated processes as targets for cancer therapy</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">188</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.1038/nrc749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2Fnrc749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=11990855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1KktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=188-200&author=L.+H.+Hurley&title=DNA+and+its+associated+processes+as+targets+for+cancer+therapy&doi=10.1038%2Fnrc749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">DNA and its associated processes as targets for cancer therapy</span></div><div class="casAuthors">Hurley, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">188-200</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  DNA is the mol. target for many of the drugs that are used in cancer therapeutics, and is viewed as a non-specific target of cytotoxic agents.  Although this is true for traditional chemotherapeutics, other agents that were discovered more recently have shown enhanced efficacy.  Furthermore, a new generation of agents that target DNA-assocd. processes are anticipated to be far more specific and effective.  How have these agents evolved, and what are their mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXfymv1PT0YLVg90H21EOLACvtfcHk0liMSQMUeThcgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1KktL0%253D&md5=e9ca715b3e7374aeb919f340c46cc59d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc749%26sid%3Dliteratum%253Aachs%26aulast%3DHurley%26aufirst%3DL.%2BH.%26atitle%3DDNA%2520and%2520its%2520associated%2520processes%2520as%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D188%26epage%3D200%26doi%3D10.1038%2Fnrc749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">Bioorganometallic chemistry--from teaching paradigms to medicinal applications</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1039/B707077M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FB707077M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=19169456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVSntLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2009&pages=391-401&author=C.+G.+Hartingerauthor=P.+J.+Dyson&title=Bioorganometallic+chemistry%2D%2Dfrom+teaching+paradigms+to+medicinal+applications&doi=10.1039%2FB707077M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Bioorganometallic chemistry-from teaching paradigms to medicinal applications</span></div><div class="casAuthors">Hartinger, Christian G.; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">391-401</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  In undergraduate level organometallic chem. courses students are usually taught that organometallic compds. are toxic and unstable in air and water.  While this is true of many complexes, some are also non-toxic and stable in air and water.  Indeed, bioorganometallic chem., the study of biomols. or biol. active mols. that contain at least one carbon directly bound to a metal, is a thriving subject, and air and water stability is a general pre-requisite.  This interdisciplinary field is located at the borderline between chem., biochem., biol. and medicine.  In this tutorial review, various aspects of bioorganometallic chem. are introduced, with the main emphasis on medicinal organometallic compds.  Organometallic therapeutics for cancer, HIV and malaria and other medicinal applications are described.  It is also shown how rational ligand design has led to new improved therapies much in the same way that an organometallic chemist working in catalysis will design new ligands for improved activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUlBRnNNFykrVg90H21EOLACvtfcHk0lgZsk8S4A4XZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVSntLs%253D&md5=37af5933908fa02d0ee36374a9c1dcad</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1039%2FB707077M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB707077M%26sid%3Dliteratum%253Aachs%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DBioorganometallic%2520chemistry--from%2520teaching%2520paradigms%2520to%2520medicinal%2520applications%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2009%26volume%3D38%26spage%3D391%26epage%3D401%26doi%3D10.1039%2FB707077M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galanski, M.</span></span> <span> </span><span class="NLM_article-title">Recent developments in the field of anticancer platinum complexes</span>. <i>Recent Pat. Anti-Cancer Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.2174/157489206777442287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F157489206777442287" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=285-295&author=M.+Galanski&title=Recent+developments+in+the+field+of+anticancer+platinum+complexes&doi=10.2174%2F157489206777442287"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F157489206777442287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157489206777442287%26sid%3Dliteratum%253Aachs%26aulast%3DGalanski%26aufirst%3DM.%26atitle%3DRecent%2520developments%2520in%2520the%2520field%2520of%2520anticancer%2520platinum%2520complexes%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2006%26volume%3D1%26spage%3D285%26epage%3D295%26doi%3D10.2174%2F157489206777442287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaili, E.</span></span> <span> </span><span class="NLM_article-title">Platinum anticancer drugs and photochemotherapeutic agents: recent advances and future developments</span>. <i>Sci. Prog.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.3184/003685014X13904811808460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.3184%2F003685014X13904811808460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=24800467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1aju7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2014&pages=20-40&author=E.+Shaili&title=Platinum+anticancer+drugs+and+photochemotherapeutic+agents%3A+recent+advances+and+future+developments&doi=10.3184%2F003685014X13904811808460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Platinum anticancer drugs and photochemotherapeutic agents: recent advances and future developments</span></div><div class="casAuthors">Shaili, Evyenia</div><div class="citationInfo"><span class="NLM_cas:title">Science Progress (St. Albans, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-40</span>CODEN:
                <span class="NLM_cas:coden">SCPRAY</span>;
        ISSN:<span class="NLM_cas:issn">0036-8504</span>.
    
            (<span class="NLM_cas:orgname">Science Reviews 2000 Ltd.</span>)
        </div><div class="casAbstract">A review.  Platinum-based chemotherapeutic drugs such as cisplatin, carboplatin and oxaliplatin are widely applied for the treatment of various types of tumors.  Over the last few decades, a large variety of Pt(II) and Pt(IV) complexes have been developed to improve the applicability in a wider spectrum of cancers, increase their therapeutic window and reduce the dose-limiting side effects.  Photodynamic therapy (PDT), which is the administration of a photosensitizer followed by visible light activation, is a promising route to avoid damage to healthy cells and the surrounding tissue.  Transition metal complexes as photochemotherapeutic agents are an attractive option for further development in the field of photoactivated chemotherapy (PACT).  These complexes exhibit different nos. and types of excited states which are easily accessible upon light irradn., subsequently giving rise to the formation of various photoproducts that can enable a distinct mode of action.  Platinum-diazido complexes are promising candidates for PACT due to the low cytotoxicity when irradiated with visible light.  This review summarises the mode of action of current platinum anticancer drugs with cisplatin as a lead example and the development of non-conventional Pt(II) complexes.  Background information regarding PDT, the photophys. and photochem. properties of metal complexes is provided, as well as notable examples of photoactivated metal complexes with biol. activity.  Particular emphasis is placed on recent developments on platinum photoactivated drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo54vAhqySDubVg90H21EOLACvtfcHk0lgZsk8S4A4XZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1aju7%252FP&md5=f17ed8cde8ac00973e300e8619bd2ece</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3184%2F003685014X13904811808460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3184%252F003685014X13904811808460%26sid%3Dliteratum%253Aachs%26aulast%3DShaili%26aufirst%3DE.%26atitle%3DPlatinum%2520anticancer%2520drugs%2520and%2520photochemotherapeutic%2520agents%253A%2520recent%2520advances%2520and%2520future%2520developments%26jtitle%3DSci.%2520Prog.%26date%3D2014%26volume%3D97%26spage%3D20%26epage%3D40%26doi%3D10.3184%2F003685014X13904811808460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohmichi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayakawa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, Y.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of platinum drug resistance</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2005.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.tips.2005.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=15749154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVeisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=113-116&author=M.+Ohmichiauthor=J.+Hayakawaauthor=K.+Tasakaauthor=H.+Kurachiauthor=Y.+Murata&title=Mechanisms+of+platinum+drug+resistance&doi=10.1016%2Fj.tips.2005.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of platinum drug resistance</span></div><div class="casAuthors">Ohmichi, Masahide; Hayakawa, Jun; Tasaka, Keiichi; Kurachi, Hirohisa; Murata, Yuji</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">113-116</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Platinum-based drugs are among the most active anticancer agents available and are used widely for the treatment of a variety of human solid tumors.  Although patients show high response rates to Pt drugs, most patients develop resistance to these drugs during treatment.  Because the acquisition of resistance is a major obstacle to the clin. use of Pt drugs, the processes by which cells develop such resistance are of great interest and efforts were made to overcome this problem.  Both mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) cascades are involved in resistance to these drugs, and clin. trials of some small-mol. inhibitors of the MAPK and PI3K-Akt cascades to overcome resistance to Pt drugs are ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMhWjQ2uCNdrVg90H21EOLACvtfcHk0liQOu8iEjFQOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVeisLw%253D&md5=d78b82e31b6891980e9b14fa3ae611e7</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2005.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2005.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DOhmichi%26aufirst%3DM.%26aulast%3DHayakawa%26aufirst%3DJ.%26aulast%3DTasaka%26aufirst%3DK.%26aulast%3DKurachi%26aufirst%3DH.%26aulast%3DMurata%26aufirst%3DY.%26atitle%3DMechanisms%2520of%2520platinum%2520drug%2520resistance%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D113%26epage%3D116%26doi%3D10.1016%2Fj.tips.2005.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaiddon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schellens, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beijnen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sava, G.</span></span> <span> </span><span class="NLM_article-title">Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2011.09.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jinorgbio.2011.09.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=22112845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOgtbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2012&pages=90-99&author=A.+Bergamoauthor=C.+Gaiddonauthor=J.+H.+Schellensauthor=J.+H.+Beijnenauthor=G.+Sava&title=Approaching+tumour+therapy+beyond+platinum+drugs%3A+status+of+the+art+and+perspectives+of+ruthenium+drug+candidates&doi=10.1016%2Fj.jinorgbio.2011.09.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Approaching tumour therapy beyond platinum drugs: Status of the art and perspectives of ruthenium drug candidates</span></div><div class="casAuthors">Bergamo, A.; Gaiddon, C.; Schellens, J. H. M.; Beijnen, J. H.; Sava, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-99</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The study of metal complexes for the treatment of cancer diseases has resulted in the identification of some unique properties of ruthenium-based compds.  Among these inorg.-based agents, 2 of them, namely the ruthenium(III) drugs NAMI-A and KP1019 have undertaken with some success the clin. evaluations of phase I and preliminary phase II trials in patients.  Here we highlight the strategies that have led to the discovery of metal-based (NAMI-A and KP1019) and of organometallic (RM175, RAPTA-T, RDC11, and DW1/2) ruthenium-based complexes, and we report their main biol./pharmacol. characteristics and expectations for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7cdFNtCDy-bVg90H21EOLACvtfcHk0liQOu8iEjFQOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOgtbfN&md5=f4b107159ed35bfdda947dc9fdc2593f</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2011.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2011.09.030%26sid%3Dliteratum%253Aachs%26aulast%3DBergamo%26aufirst%3DA.%26aulast%3DGaiddon%26aufirst%3DC.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26aulast%3DSava%26aufirst%3DG.%26atitle%3DApproaching%2520tumour%2520therapy%2520beyond%2520platinum%2520drugs%253A%2520status%2520of%2520the%2520art%2520and%2520perspectives%2520of%2520ruthenium%2520drug%2520candidates%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2012%26volume%3D106%26spage%3D90%26epage%3D99%26doi%3D10.1016%2Fj.jinorgbio.2011.09.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alessio, E.</span></span> <span> </span><span class="NLM_article-title">Thirty years of the drug candidate NAMI-A and the myths in the field of ruthenium anticancer compounds: A personal perspective</span>. <i>Eur. J. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1549</span>– <span class="NLM_lpage">1560</span>, <span class="refDoi"> DOI: 10.1002/ejic.201600986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fejic.201600986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKru7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1549-1560&author=E.+Alessio&title=Thirty+years+of+the+drug+candidate+NAMI-A+and+the+myths+in+the+field+of+ruthenium+anticancer+compounds%3A+A+personal+perspective&doi=10.1002%2Fejic.201600986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective</span></div><div class="casAuthors">Alessio, Enzo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1549-1560</span>CODEN:
                <span class="NLM_cas:coden">EJICFO</span>;
        ISSN:<span class="NLM_cas:issn">1434-1948</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">As anticipated in the title, this contribution is basically divided into two, strictly connected, parts.  The first is a personal overview of the ruthenium drug candidate NAMI-A, almost 30 years after its synthesis and the discovery of its unprecedented antimetastatic properties in animal models at nontoxic dosages.  The sections relating to the chem. and biol. behavior of the complex, and the hypotheses on its mechanism(s) of action, are kept to a min., whereas more space is devoted to discussion of the results of the clin. investigations.  The second part deals in detail with a no. of undemonstrated misconceptions (or myths) that, over the years, have thrived around NAMI-A and other ruthenium drug candidates, thus neg. affecting the whole field of Ru anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbjex9sRUkCbVg90H21EOLACvtfcHk0liQOu8iEjFQOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKru7bK&md5=ca48413b7dd02a63edf5049a9a5c7377</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fejic.201600986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejic.201600986%26sid%3Dliteratum%253Aachs%26aulast%3DAlessio%26aufirst%3DE.%26atitle%3DThirty%2520years%2520of%2520the%2520drug%2520candidate%2520NAMI-A%2520and%2520the%2520myths%2520in%2520the%2520field%2520of%2520ruthenium%2520anticancer%2520compounds%253A%2520A%2520personal%2520perspective%26jtitle%3DEur.%2520J.%2520Inorg.%2520Chem.%26date%3D2017%26volume%3D2017%26spage%3D1549%26epage%3D1560%26doi%3D10.1002%2Fejic.201600986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kostova, I.</span></span> <span> </span><span class="NLM_article-title">Ruthenium complexes as anticancer agents</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1085</span>– <span class="NLM_lpage">1107</span>, <span class="refDoi"> DOI: 10.2174/092986706776360941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F092986706776360941" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=16611086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslKqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1085-1107&author=I.+Kostova&title=Ruthenium+complexes+as+anticancer+agents&doi=10.2174%2F092986706776360941"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium complexes as anticancer agents</span></div><div class="casAuthors">Kostova, Irena</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1085-1107</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cancer is one of the major cases of death in the world.  Current treatment of cancer is limited to surgery, radiotherapy, and the use of cytotoxic agents, despite their well known side effects and problems assocd. with the development of resistance.  For most forms of disseminated cancer, however, no curative therapy is available, and the discovery and development of novel active chemotherapeutic agents is largely needed.  Since the development of cisplatin, an inorg. platinum complex, numerous platinum and non-platinum metal complexes were synthesized and tested for anticancer activity.  Very few match the clin. efficacy of cisplatin.  Ruthenium complexes were prepd. to ameliorate cisplatin activity, particularly on resistant tumors, or to reduce host toxicity at active doses.  Since many years a lot of scientific groups have actively worked in the field of inorg. antitumor drugs and have developed a no. of Ru(II) and Ru(III) complexes, which were shown to possess good antitumor and, above all, antimetastatic properties against animal models.  Ruthenium complexes are presently an object of great attention in the field of medicinal chem., as antitumor agents with selective antimetastatic properties and low systemic toxicity.  Ruthenium compds. appear to penetrate reasonably well the tumor cells and bind effectively to DNA.  In this review, the achievements in the field of medicinal chem., DNA binding modes, and the development status of Ru(II) and Ru(III) complexes as anticancer agents are discussed.  The aim of this review is therefore that of critically examg. the past and the actual work on ruthenium compds. with emphasis on their proposed role in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJekZc9T8z-bVg90H21EOLACvtfcHk0lhIyfY4W0h_UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslKqtbs%253D&md5=42ca40ec180cea41e301a176472acc8c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F092986706776360941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706776360941%26sid%3Dliteratum%253Aachs%26aulast%3DKostova%26aufirst%3DI.%26atitle%3DRuthenium%2520complexes%2520as%2520anticancer%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D1085%26epage%3D1107%26doi%3D10.2174%2F092986706776360941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtkamp, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier-Menches, S. M.</span></span> <span> </span><span class="NLM_article-title">Characterizing activation mechanisms and binding preferences of ruthenium metallo-prodrugs by a competitive binding assay</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">322</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2017.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jinorgbio.2017.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28739166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1WrtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2017&pages=322-327&author=C.+Artnerauthor=H.+U.+Holtkampauthor=C.+G.+Hartingerauthor=S.+M.+Meier-Menches&title=Characterizing+activation+mechanisms+and+binding+preferences+of+ruthenium+metallo-prodrugs+by+a+competitive+binding+assay&doi=10.1016%2Fj.jinorgbio.2017.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Characterizing activation mechanisms and binding preferences of ruthenium metallo-prodrugs by a competitive binding assay</span></div><div class="casAuthors">Artner, Christian; Holtkamp, Hannah U.; Hartinger, Christian G.; Meier-Menches, Samuel M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">322-327</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The activation mechanisms and reactivity of ruthenium metallo-prodrug lead structures were investigated in detail using capillary zone electrophoresis mass spectrometry (CZE-MS) in a time-dependent manner and by exposing to a protein/oligonucleotide mixt.  The competitive assays were performed with sodium trans-[RuCl4(HInd)2] where Hind = indazole (NKP-1339), [(η6-p-cymene)RuCl2(pta)], where pta = 1,3,5-triaza-7-phosphaadamantane (RAPTA-C) and [(η6-biphenyl)RuCl(1,2-ethylenediamine)]PF6 (RM175).  Mol. and quant. information on binding preferences was obtained by coupling CZE to electrospray ionization MS (ESI-MS) and inductively coupled plasma MS (ICP-MS), resp.  A score system is presented that ranks the binding preferences of Ru complexes with nucleotides and demonstrated the following trend of decreasing selectivity after 24 h: RM175 (0.89) > RAPTA-C (0.78) > NKP-1339 (0.40).  As expected, the organometallic drug candidates RM175 and RAPTA-C underwent a halido/aqua ligand exchange reaction at the metal center and showed distinct reactivity towards the biomols.  In particular, the protein/DNA binding sites of RAPTA-C in a mixt. of protein (ubiquitin) and oligonucleotide (5'-dATTGGCAC-3') were located at single-amino acid and single-nucleotide resoln., resp.  Activated RAPTA-C bound selectively to Met1, adenine and cytosine in this setting, which contrasts with the selectivity of RM175 for guanine.  Finally, activation products of NKP-1339 were detected corresponding to RuII(Hind)2 fragments coordinated to the oligonucleotide, which represents one of the few examples of a directly obsd. RuII adduct.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKOfkLtsucrrVg90H21EOLACvtfcHk0lhIyfY4W0h_UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1WrtbnF&md5=c10713ed529e1e79d7b90e8a80d74e02</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2017.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2017.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DArtner%26aufirst%3DC.%26aulast%3DHoltkamp%26aufirst%3DH.%2BU.%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DMeier-Menches%26aufirst%3DS.%2BM.%26atitle%3DCharacterizing%2520activation%2520mechanisms%2520and%2520binding%2520preferences%2520of%2520ruthenium%2520metallo-prodrugs%2520by%2520a%2520competitive%2520binding%2520assay%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2017%26volume%3D177%26spage%3D322%26epage%3D327%26doi%3D10.1016%2Fj.jinorgbio.2017.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span></span> <span> </span><span class="NLM_article-title">Editorial: Anticancer ruthenium complexes in drug discovery and medicinal chemistry</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">771</span>, <span class="refDoi"> DOI: 10.2174/138955751610160503003405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F138955751610160503003405" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=771&author=S.+Thota&title=Editorial%3A+Anticancer+ruthenium+complexes+in+drug+discovery+and+medicinal+chemistry&doi=10.2174%2F138955751610160503003405"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F138955751610160503003405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955751610160503003405%26sid%3Dliteratum%253Aachs%26aulast%3DThota%26aufirst%3DS.%26atitle%3DEditorial%253A%2520Anticancer%2520ruthenium%2520complexes%2520in%2520drug%2520discovery%2520and%2520medicinal%2520chemistry%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D771%26doi%3D10.2174%2F138955751610160503003405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biersack, B.</span></span> <span> </span><span class="NLM_article-title">Anticancer Activity and modes of action of (arene) ruthenium(II) complexes coordinated to C-, N-, and O-ligands</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">804</span>– <span class="NLM_lpage">814</span>, <span class="refDoi"> DOI: 10.2174/138955751610160503004623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F138955751610160503004623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=27161009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFagsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=804-814&author=B.+Biersack&title=Anticancer+Activity+and+modes+of+action+of+%28arene%29+ruthenium%28II%29+complexes+coordinated+to+C-%2C+N-%2C+and+O-ligands&doi=10.2174%2F138955751610160503004623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligands</span></div><div class="casAuthors">Biersack, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">804-814</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">An overview of anticancer active (arene)ruthenium(II) complexes coordinated to period 2 element-based ligand systems, i.e., carbon-, nitrogen-, and oxygen-coordinated ligands, is provided in this mini-review.  A bridge is forged from the large group of anticancer active ruthenium compds. with monodentate and chelating nitrogen ligands via complexes of O,O-chelating ligands to organometallic ruthenium derivs. coordinated to carbon.  (Arene)ruthenium(II) complexes with reduced side-effects and enhanced efficacy against cancer are highlighted.  Pertinent literature is covered up to 2014.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomRvHgdNwAzLVg90H21EOLACvtfcHk0liItN18TFDZTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFagsLo%253D&md5=3818a9fcda577f76fe6d2c0d7524eccb</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F138955751610160503004623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955751610160503004623%26sid%3Dliteratum%253Aachs%26aulast%3DBiersack%26aufirst%3DB.%26atitle%3DAnticancer%2520Activity%2520and%2520modes%2520of%2520action%2520of%2520%2528arene%2529%2520ruthenium%2528II%2529%2520complexes%2520coordinated%2520to%2520C-%252C%2520N-%252C%2520and%2520O-ligands%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D804%26epage%3D814%26doi%3D10.2174%2F138955751610160503004623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span> <span> </span><span class="NLM_article-title">Development of arene ruthenium antitumor complexes</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.2174/138955751610160503003937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F138955751610160503003937" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=787-795&author=W.+Suauthor=Z.+Tangauthor=P.+Li&title=Development+of+arene+ruthenium+antitumor+complexes&doi=10.2174%2F138955751610160503003937"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F138955751610160503003937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955751610160503003937%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DP.%26atitle%3DDevelopment%2520of%2520arene%2520ruthenium%2520antitumor%2520complexes%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D787%26epage%3D795%26doi%3D10.2174%2F138955751610160503003937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamsi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azam, A.</span></span> <span> </span><span class="NLM_article-title">Ruthenium complexes: An emerging ground to the development of metallopharmaceuticals for cancer therapy</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">772</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.2174/1389557515666151001142012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F1389557515666151001142012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=772-786&author=M.+Abidauthor=F.+Shamsiauthor=A.+Azam&title=Ruthenium+complexes%3A+An+emerging+ground+to+the+development+of+metallopharmaceuticals+for+cancer+therapy&doi=10.2174%2F1389557515666151001142012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F1389557515666151001142012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557515666151001142012%26sid%3Dliteratum%253Aachs%26aulast%3DAbid%26aufirst%3DM.%26aulast%3DShamsi%26aufirst%3DF.%26aulast%3DAzam%26aufirst%3DA.%26atitle%3DRuthenium%2520complexes%253A%2520An%2520emerging%2520ground%2520to%2520the%2520development%2520of%2520metallopharmaceuticals%2520for%2520cancer%2520therapy%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D772%26epage%3D786%26doi%3D10.2174%2F1389557515666151001142012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, W.</span></span> <span> </span><span class="NLM_article-title">Arene ruthenium(II) complexes: The promising chemotherapeutic agent in inhibiting the proliferation, migration and invasion</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">796</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.2174/1389557515666151001142159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F1389557515666151001142159" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=796-803&author=K.+Zhengauthor=Q.+Wuauthor=Y.+Dingauthor=W.+Mei&title=Arene+ruthenium%28II%29+complexes%3A+The+promising+chemotherapeutic+agent+in+inhibiting+the+proliferation%2C+migration+and+invasion&doi=10.2174%2F1389557515666151001142159"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F1389557515666151001142159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557515666151001142159%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DMei%26aufirst%3DW.%26atitle%3DArene%2520ruthenium%2528II%2529%2520complexes%253A%2520The%2520promising%2520chemotherapeutic%2520agent%2520in%2520inhibiting%2520the%2520proliferation%252C%2520migration%2520and%2520invasion%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D796%26epage%3D803%26doi%3D10.2174%2F1389557515666151001142159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poynton, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bright, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunnlaugsson, T.</span></span> <span> </span><span class="NLM_article-title">The development of ruthenium(ii) polypyridyl complexes and conjugates for <i>in vitro</i> cellular and <i>in vivo</i> applications</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">7706</span>– <span class="NLM_lpage">7756</span>, <span class="refDoi"> DOI: 10.1039/C7CS00680B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC7CS00680B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=29177281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVKgtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=7706-7756&author=F.+E.+Poyntonauthor=S.+A.+Brightauthor=S.+Blascoauthor=D.+C.+Williamsauthor=J.+M.+Kellyauthor=T.+Gunnlaugsson&title=The+development+of+ruthenium%28ii%29+polypyridyl+complexes+and+conjugates+for+in+vitro+cellular+and+in+vivo+applications&doi=10.1039%2FC7CS00680B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The development of ruthenium(II) polypyridyl complexes and conjugates for in vitro cellular and in vivo applications</span></div><div class="casAuthors">Poynton, Fergus E.; Bright, Sandra A.; Blasco, Salvador; Williams, D. Clive; Kelly, John M.; Gunnlaugsson, Thorfinnur</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7706-7756</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Ruthenium(II) [Ru(II)] polypyridyl complexes have been the focus of intense investigations since work began exploring their supramol. interactions with DNA.  In recent years, there have been considerable efforts to translate this soln.-based research into a biol. environment with the intention of developing new classes of probes, luminescent imaging agents, therapeutics and theranostics.  In only 10 years the field has expanded with diverse applications for these complexes as imaging agents and promising candidates for therapeutics.  In light of these efforts this review exclusively focuses on the developments of these complexes in biol. systems, both in cells and in vivo, and hopes to communicate to readers the diversity of applications within which these complexes have found use, as well as new insights gained along the way and challenges that researchers in this field still face.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0yZtydmk55bVg90H21EOLACvtfcHk0lgpfm9xmZhnUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVKgtL%252FF&md5=b692e8e2d18dd88e6d48b745f070e2d4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1039%2FC7CS00680B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CS00680B%26sid%3Dliteratum%253Aachs%26aulast%3DPoynton%26aufirst%3DF.%2BE.%26aulast%3DBright%26aufirst%3DS.%2BA.%26aulast%3DBlasco%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DD.%2BC.%26aulast%3DKelly%26aufirst%3DJ.%2BM.%26aulast%3DGunnlaugsson%26aufirst%3DT.%26atitle%3DThe%2520development%2520of%2520ruthenium%2528ii%2529%2520polypyridyl%2520complexes%2520and%2520conjugates%2520for%2520in%2520vitro%2520cellular%2520and%2520in%2520vivo%2520applications%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2017%26volume%3D46%26spage%3D7706%26epage%3D7756%26doi%3D10.1039%2FC7CS00680B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Notaro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">7317</span>– <span class="NLM_lpage">7337</span>, <span class="refDoi"> DOI: 10.1039/C7CS00356K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC7CS00356K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=29027562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1CrtLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=7317-7337&author=A.+Notaroauthor=G.+Gasser&title=Monomeric+and+dimeric+coordinatively+saturated+and+substitutionally+inert+Ru%28ii%29+polypyridyl+complexes+as+anticancer+drug+candidates&doi=10.1039%2FC7CS00356K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(II) polypyridyl complexes as anticancer drug candidates</span></div><div class="casAuthors">Notaro, Anna; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7317-7337</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Due to the increasing impact of cancer on worldwide mortality, more and more attention is being devoted to the investigation of novel anticancer strategies.  Among these, chemotherapy plays a key role in fighting cancer.  This explains the increasing engagement of both the pharmaceutical industry and academia towards the discovery of new chemotherapeutic agents.  In recent years, metal-based drugs have attracted much attention due to their atypical physico-chem. properties compared to org. mols.  After the approval of cisplatin as a chemotherapeutic agent in 1978, several types of metal-based drugs have been explored.  Among them, Ru-based anticancer drug candidates have become a central subject in this research field.  However, most of the Ru-based compds. investigated over the last two decades express their cytotoxicity with a mechanism of action involving, among others, a ligand-exchange mechanism.  In this Review, we give a complete overview of a specific class of antiproliferative ruthenium complexes, namely coordinatively satd. and substitutionally inert Ru(II) polypyridyl complexes.  This implies that the cytotoxicity obsd. comes from the entire complex and not from ligand-exchange.  In this Review, we present monomeric and dimeric Ru(II) polypyridyl complexes, which have been found to be toxic to cancer cells.  More specifically, monomeric Ru(II) polypyridyl complexes are analyzed considering their direct interaction or not with DNA as the cause of cell death, while dimeric Ru(II) polypyridyl complexes are classified according to their biol. targets.  Very importantly, the cellular targets of these complexes are discussed in detail.  Indeed, several targets were identified and different mechanisms of action were suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC29dn6JqWwLVg90H21EOLACvtfcHk0lgpfm9xmZhnUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1CrtLrI&md5=7e75dd00ef156901717f18db3f67d304</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2FC7CS00356K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CS00356K%26sid%3Dliteratum%253Aachs%26aulast%3DNotaro%26aufirst%3DA.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DMonomeric%2520and%2520dimeric%2520coordinatively%2520saturated%2520and%2520substitutionally%2520inert%2520Ru%2528ii%2529%2520polypyridyl%2520complexes%2520as%2520anticancer%2520drug%2520candidates%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2017%26volume%3D46%26spage%3D7317%26epage%3D7337%26doi%3D10.1039%2FC7CS00356K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allardyce, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">Ruthenium in medicine: Current clinical uses and future prospects</span>. <i>Platinum Met. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVOgsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=62-69&author=C.+S.+Allardyceauthor=P.+J.+Dyson&title=Ruthenium+in+medicine%3A+Current+clinical+uses+and+future+prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium in medicine: Current clinical uses and future prospects</span></div><div class="casAuthors">Allardyce, Claire S.; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Platinum Metals Review</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">62-69</span>CODEN:
                <span class="NLM_cas:coden">PTMRA3</span>;
        ISSN:<span class="NLM_cas:issn">0032-1400</span>.
    
            (<span class="NLM_cas:orgname">Johnson Matthey Public Ltd. Co.</span>)
        </div><div class="casAbstract">A review.  There is no doubt about the success of precious metals in the clinic, with, for example, platinum compds. being widely used in the treatment of cancer, silver compds. being useful antimicrobial agents and gold compds. used routinely in the treatment of rheumatoid arthritis.  The medicinal properties of the other platinum group metals are now being recognized and of these a ruthenium anticancer agent has recently entered the clinic, showing promising activity on otherwise resistant tumors.  Like all metal drugs, the activity of the ruthenium compds. depends on both the oxidn. state and the ligands.  By manipulating these features ruthenium-centered antimalarial, antibiotic and immunosuppressive drugs have been made.  In addn., ruthenium has unique properties which make it particularly useful in drug design.  In this review we discuss ruthenium from a clin. stance and outline the medicinal uses of ruthenium-based compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppc8V-Mj8EArVg90H21EOLACvtfcHk0ljk2vjbp2bYdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVOgsLs%253D&md5=778378be61f6e9a4629abe1c585cf87a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllardyce%26aufirst%3DC.%2BS.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DRuthenium%2520in%2520medicine%253A%2520Current%2520clinical%2520uses%2520and%2520future%2520prospects%26jtitle%3DPlatinum%2520Met.%2520Rev.%26date%3D2001%26volume%3D45%26spage%3D62%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frasca, D. R.</span></span> <span> </span><span class="NLM_article-title">Non-platinum chemotherapeutic metallopharmaceuticals</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">2511</span>– <span class="NLM_lpage">2534</span>, <span class="refDoi"> DOI: 10.1021/cr9804238</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr9804238" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADyaK1MXkslChtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=2511-2534&author=M.+J.+Clarkeauthor=F.+Zhuauthor=D.+R.+Frasca&title=Non-platinum+chemotherapeutic+metallopharmaceuticals&doi=10.1021%2Fcr9804238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Non-Platinum Chemotherapeutic Metallopharmaceuticals</span></div><div class="casAuthors">Clarke, Michael J.; Zhu, Fuchun; Frasca, Dominic R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2511-2533</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 404 refs. on possible mechanistic approaches to chemotherapeutic anticancer drugs involving non-platinum metal ion complexes exclusive of metalloproteins or metal-activated antibiotics.  There is particular emphasis on those that can interact with nucleic acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBaHVfLpgm9LVg90H21EOLACvtfcHk0ljk2vjbp2bYdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkslChtLc%253D&md5=760d59b6d6c55c74efb6c1deb3806870</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fcr9804238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9804238%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DM.%2BJ.%26aulast%3DZhu%26aufirst%3DF.%26aulast%3DFrasca%26aufirst%3DD.%2BR.%26atitle%3DNon-platinum%2520chemotherapeutic%2520metallopharmaceuticals%26jtitle%3DChem.%2520Rev.%26date%3D1999%26volume%3D99%26spage%3D2511%26epage%3D2534%26doi%3D10.1021%2Fcr9804238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messori, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccioli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocchietto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sava, G.</span></span> <span> </span><span class="NLM_article-title">Biological role of adduct formation of the ruthenium(III) complex NAMI-A with serum albumin and serum transferrin</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">411</span>, <span class="refDoi"> DOI: 10.1023/A:1026243000320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1023%2FA%3A1026243000320" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=401-411&author=A.+Bergamoauthor=L.+Messoriauthor=F.+Piccioliauthor=M.+Cocchiettoauthor=G.+Sava&title=Biological+role+of+adduct+formation+of+the+ruthenium%28III%29+complex+NAMI-A+with+serum+albumin+and+serum+transferrin&doi=10.1023%2FA%3A1026243000320"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1023%2FA%3A1026243000320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1026243000320%26sid%3Dliteratum%253Aachs%26aulast%3DBergamo%26aufirst%3DA.%26aulast%3DMessori%26aufirst%3DL.%26aulast%3DPiccioli%26aufirst%3DF.%26aulast%3DCocchietto%26aufirst%3DM.%26aulast%3DSava%26aufirst%3DG.%26atitle%3DBiological%2520role%2520of%2520adduct%2520formation%2520of%2520the%2520ruthenium%2528III%2529%2520complex%2520NAMI-A%2520with%2520serum%2520albumin%2520and%2520serum%2520transferrin%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2003%26volume%3D21%26spage%3D401%26epage%3D411%26doi%3D10.1023%2FA%3A1026243000320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alessio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mestroni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sava, G.</span></span> <span> </span><span class="NLM_article-title">Ruthenium antimetastatic agents</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1525</span>– <span class="NLM_lpage">1535</span>, <span class="refDoi"> DOI: 10.2174/1568026043387421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F1568026043387421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=15579094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKmsbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=1525-1535&author=E.+Alessioauthor=G.+Mestroniauthor=A.+Bergamoauthor=G.+Sava&title=Ruthenium+antimetastatic+agents&doi=10.2174%2F1568026043387421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium antimetastatic agents</span></div><div class="casAuthors">Alessio, Enzo; Mestroni, Giovanni; Bergamo, Alberta; Sava, Gianni</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1525-1535</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  NAMI-A, i.e. (imH)[trans-RuCl4(dmso-S)(i.m.)] (i.m. = imidazole, dmso = dimethylsulfoxide), is a Ru(III) complex that, after extensive preclin. investigations that evidenced its remarkable and specific activity against metastases, has recently and successfully completed a Phase I trial (first ruthenium complex ever to reach clin. testing).  This review article, after a brief summary of the main chem. and pharmacol. aspects of NAMI-A, focuses on the development of new classes of ruthenium complexes originated from the NAMI-A frame.  In particular, the chem. and biol. features of the following classes of compds. will be treated: (i) NAMI-A-type complexes, derived from NAMI-A by changing the nature of the N-ligand, (ii) dinuclear NAMI-A-type compds. contg. heterocyclic bridging N-N ligands, (iii) new Ru-dmso nitrosyls broadly derived from NAMI-A-type complexes.  Several of these new compds. were found to have antimetastatic activity comparable to, or even better than, NAMI-A; however, the nature of the target(s) responsible for the antimetastatic activity remains unclear.  Common to any type of NAMI-A-type compd., both monomeric and dimeric, cell cytotoxicity (which is generally very low) is not sufficient to explain their potent and peculiar antitumor activity.  All active NAMI-A-type compds. share the capacity to modify important parameters of metastasis such as tumor invasion, matrix metallo proteinases activity and cell cycle progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvZfbwhzvZVLVg90H21EOLACvtfcHk0ljk2vjbp2bYdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKmsbrP&md5=0771fa8fc0097989bb6f83cc72d98386</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F1568026043387421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026043387421%26sid%3Dliteratum%253Aachs%26aulast%3DAlessio%26aufirst%3DE.%26aulast%3DMestroni%26aufirst%3DG.%26aulast%3DBergamo%26aufirst%3DA.%26aulast%3DSava%26aufirst%3DG.%26atitle%3DRuthenium%2520antimetastatic%2520agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D1525%26epage%3D1535%26doi%3D10.2174%2F1568026043387421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorbas-Seifried, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorbas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">KP1019, a new redox-active anticancer agent preclinical development and results of a clinical phase I study in tumor patients</span>. <i>Chem. Biodiversity</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2140</span>– <span class="NLM_lpage">2155</span>, <span class="refDoi"> DOI: 10.1002/cbdv.200890195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fcbdv.200890195" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=2140-2155&author=C.+G.+Hartingerauthor=M.+A.+Jakupecauthor=S.+Zorbas-Seifriedauthor=M.+Groesslauthor=A.+Eggerauthor=W.+Bergerauthor=H.+Zorbasauthor=P.+J.+Dysonauthor=B.+K.+Keppler&title=KP1019%2C+a+new+redox-active+anticancer+agent+preclinical+development+and+results+of+a+clinical+phase+I+study+in+tumor+patients&doi=10.1002%2Fcbdv.200890195"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200890195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200890195%26sid%3Dliteratum%253Aachs%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DZorbas-Seifried%26aufirst%3DS.%26aulast%3DGroessl%26aufirst%3DM.%26aulast%3DEgger%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DZorbas%26aufirst%3DH.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DKP1019%252C%2520a%2520new%2520redox-active%2520anticancer%2520agent%2520preclinical%2520development%2520and%2520results%2520of%2520a%2520clinical%2520phase%2520I%2520study%2520in%2520tumor%2520patients%26jtitle%3DChem.%2520Biodiversity%26date%3D2008%26volume%3D5%26spage%3D2140%26epage%3D2155%26doi%3D10.1002%2Fcbdv.200890195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorbas-Seifried, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kynast, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorbas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">From bench to bedside-preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1<i>H</i>-indazole)ruthenate(III)] (KP1019 or FFC14A)</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">891</span>– <span class="NLM_lpage">904</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2006.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jinorgbio.2006.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=16603249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVCluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2006&pages=891-904&author=C.+G.+Hartingerauthor=S.+Zorbas-Seifriedauthor=M.+A.+Jakupecauthor=B.+Kynastauthor=H.+Zorbasauthor=B.+K.+Keppler&title=From+bench+to+bedside-preclinical+and+early+clinical+development+of+the+anticancer+agent+indazolium+trans-%5Btetrachlorobis%281H-indazole%29ruthenate%28III%29%5D+%28KP1019+or+FFC14A%29&doi=10.1016%2Fj.jinorgbio.2006.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">From bench to bedside - preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)</span></div><div class="casAuthors">Hartinger, Christian G.; Zorbas-Seifried, Stefanie; Jakupec, Michael A.; Kynast, Bernd; Zorbas, Haralabos; Keppler, Bernhard K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">891-904</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A) is just the second ruthenium-based anticancer agent after NAMI-A which was developed to the stage of clin. trials.  Important steps in the mode of action of KP1019 are thought to be the binding to the serum protein transferrin and the transport into the cell via the transferrin pathway.  Addnl., the selective activation by redn. in the tumor might contribute to the low side effects obsd. in in vivo studies.  Apoptosis is induced at non-toxic levels via the mitochondrial pathway.  These features distinguish it from the established platinum anticancer drugs and suggest that different types of cancer might be treatable with this drug.  Indeed, promising activity against certain types of tumors, which are not successfully treatable with cisplatin, and only a very low incidence of acquired resistance has been obsd. in in vitro and in vivo studies.  Recently, a clin. phase I trial was finished in which none of the treated patients experienced serious side effects, while disease stabilization in five of six evaluable patients was achieved.  In this review, the preclin. and early clin. development of KP1019 - from bench to bedside - is recapitulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQXGOcIpo0P7Vg90H21EOLACvtfcHk0lgjhtvk7y7VYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVCluro%253D&md5=8fe177baac72fa807e2eb96ecce7e07a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2006.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2006.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DZorbas-Seifried%26aufirst%3DS.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DKynast%26aufirst%3DB.%26aulast%3DZorbas%26aufirst%3DH.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DFrom%2520bench%2520to%2520bedside-preclinical%2520and%2520early%2520clinical%2520development%2520of%2520the%2520anticancer%2520agent%2520indazolium%2520trans-%255Btetrachlorobis%25281H-indazole%2529ruthenate%2528III%2529%255D%2520%2528KP1019%2520or%2520FFC14A%2529%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2006%26volume%3D100%26spage%3D891%26epage%3D904%26doi%3D10.1016%2Fj.jinorgbio.2006.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. S.</span></span> <span> </span><span class="NLM_article-title">The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">5771</span>– <span class="NLM_lpage">5804</span>, <span class="refDoi"> DOI: 10.1039/C7CS00195A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC7CS00195A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28654103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKnsLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=5771-5804&author=L.+Zengauthor=P.+Guptaauthor=Y.+Chenauthor=E.+Wangauthor=L.+Jiauthor=H.+Chaoauthor=Z.+S.+Chen&title=The+development+of+anticancer+ruthenium%28II%29+complexes%3A+from+single+molecule+compounds+to+nanomaterials&doi=10.1039%2FC7CS00195A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials</span></div><div class="casAuthors">Zeng, Leli; Gupta, Pranav; Chen, Yanglu; Wang, Enju; Ji, Liangnian; Chao, Hui; Chen, Zhe-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5771-5804</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cancer is rapidly becoming the top killer in the world.  Most of the FDA approved anticancer drugs are org. mols., while metallodrugs are very scarce.  The advent of the first metal based therapeutic agent, cisplatin, launched a new era in the application of transition metal complexes for therapeutic design.  Due to their unique and versatile biochem. properties, ruthenium-based compds. have emerged as promising anti-cancer agents that serve as alternatives to cisplatin and its derivertives.  Ruthenium(III) complexes have successfully been used in clin. research and their mechanisms of anticancer action have been reported in large vols. over the past few decades.  Ruthenium(II) complexes have also attracted significant attention as anticancer candidates; however, only a few of them have been reported comprehensively.  In this review, we discuss the development of ruthenium(II) complexes as anticancer candidates and biocatalysts, including arene ruthenium complexes, polypyridyl ruthenium complexes, and ruthenium nanomaterial complexes.  This review focuses on the likely mechanisms of action of ruthenium(II)-based anticancer drugs and the relationship between their chem. structures and biol. properties.  This review also highlights the catalytic activity and the photoinduced activation of ruthenium(II) complexes, their targeted delivery, and their activity in nanomaterial systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx59we0hNm3rVg90H21EOLACvtfcHk0lixDdaUShcpvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKnsLbO&md5=cf049fe11e91a1ea45a72174a32e0100</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC7CS00195A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CS00195A%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DGupta%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%2BS.%26atitle%3DThe%2520development%2520of%2520anticancer%2520ruthenium%2528II%2529%2520complexes%253A%2520from%2520single%2520molecule%2520compounds%2520to%2520nanomaterials%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2017%26volume%3D46%26spage%3D5771%26epage%3D5804%26doi%3D10.1039%2FC7CS00195A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smithen, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beh, M. H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hetu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and photobiological activity of Ru(II) dyads derived from pyrrole-2-carboxylate thionoesters</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4121</span>– <span class="NLM_lpage">4132</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.7b00072</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.7b00072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktlSrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=4121-4132&author=D.+A.+Smithenauthor=H.+Yinauthor=M.+H.+R.+Behauthor=M.+Hetuauthor=T.+S.+Cameronauthor=S.+A.+McFarlandauthor=A.+Thompson&title=Synthesis+and+photobiological+activity+of+Ru%28II%29+dyads+derived+from+pyrrole-2-carboxylate+thionoesters&doi=10.1021%2Facs.inorgchem.7b00072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Photobiological Activity of Ru(II) Dyads Derived from Pyrrole-2-carboxylate Thionoesters</span></div><div class="casAuthors">Smithen, Deborah A.; Yin, Huimin; Beh, Michael H. R.; Hetu, Marc; Cameron, T. Stanley; McFarland, Sherri A.; Thompson, Alison</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4121-4132</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and characterization of a series of heteroleptic ruthenium(II) dyads derived from pyrrole-2-carboxylate thionoesters are reported.  Ligands bearing a conjugated thiocarbonyl group were found to be more reactive toward Ru(II) complexation compared to analogous all-oxygen pyrrole-2-carboxylate esters, and salient features of the resulting complexes were detd. using X-ray crystallog., electronic absorption, and NMR spectroscopy.  Selected complexes were evaluated for their potential in photobiol. applications, whereupon all compds. demonstrated in vitro photodynamic therapy effects in HL-60 and SK-MEL-28 cells, with low nanomolar activities obsd., and exhibited some of the largest photocytotoxicity indexes to date (>2000).  Importantly, the Ru(II) dyads could be activated by relatively soft doses of visible (100 J cm-2, 29 mW cm-2) or red light (100 J cm-2, 34 mW cm-2), which is compatible with therapeutic applications.  Some compds. even demonstrated up to five-fold selectivity for malignant cells over noncancerous cells.  These complexes were also shown to photocleave, and in some cases unwind, DNA in cell-free expts.  Thus, this new class of Ru(II) dyads has the capacity to interact with and damage biol. macromols. in the cell, making them attractive agents for photodynamic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrOFJOOcOh37Vg90H21EOLACvtfcHk0lixDdaUShcpvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktlSrtr0%253D&md5=fd9e243cb8b28e7345c86a59738f5218</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.7b00072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.7b00072%26sid%3Dliteratum%253Aachs%26aulast%3DSmithen%26aufirst%3DD.%2BA.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DBeh%26aufirst%3DM.%2BH.%2BR.%26aulast%3DHetu%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DT.%2BS.%26aulast%3DMcFarland%26aufirst%3DS.%2BA.%26aulast%3DThompson%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520photobiological%2520activity%2520of%2520Ru%2528II%2529%2520dyads%2520derived%2520from%2520pyrrole-2-carboxylate%2520thionoesters%26jtitle%3DInorg.%2520Chem.%26date%3D2017%26volume%3D56%26spage%3D4121%26epage%3D4132%26doi%3D10.1021%2Facs.inorgchem.7b00072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span> <span> </span><span class="NLM_article-title">Ruthenium(II) complexes with 2-phenylimidazo[4,5-f][1,10]phenanthroline derivatives that strongly combat cisplatin-resistant tumor cells</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">19449</span>, <span class="refDoi"> DOI: 10.1038/srep19449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2Fsrep19449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=26763798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos1KjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=19449&author=L.+Zengauthor=Y.+Chenauthor=J.+Liuauthor=H.+Huangauthor=R.+Guanauthor=L.+Jiauthor=H.+Chao&title=Ruthenium%28II%29+complexes+with+2-phenylimidazo%5B4%2C5-f%5D%5B1%2C10%5Dphenanthroline+derivatives+that+strongly+combat+cisplatin-resistant+tumor+cells&doi=10.1038%2Fsrep19449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells</span></div><div class="casAuthors">Zeng, Leli; Chen, Yu; Liu, Jiangping; Huang, Huaiyi; Guan, Ruilin; Ji, Liangnian; Chao, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19449</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cisplatin was the first metal-based therapeutic agent approved for the treatment of human cancers, but its clin. activity is greatly limited by tumor drug resistance.  This work utilized the parent complex [Ru(phen)2(PIP)]2+ (1) to develop three Ru(II) complexes (2-4) with different positional modifications.  These compds. exhibited similar or superior cytotoxicities compared to cisplatin in HeLa, A549 and multidrug-resistant (A549R) tumor cell lines.  Complex 4, the most potent member of the series, was highly active against A549R cancer cells (IC50 = 0.8 μM).  This complex exhibited 178-fold better activity than cisplatin (IC50 = 142.5 μM) in A549R cells. 3D multicellular A549R tumor spheroids were also used to confirm the high proliferative and cytotoxic activity of complex 4.  Complex 4 had the greatest cellular uptake and had a tendency to accumulate in the mitochondria of A549R cells.  Further mechanistic studies showed that complex 4 induced A549R cell apoptosis via inhibition of thioredoxin reductase (TrxR), elevated intracellular ROS levels, mitochondrial dysfunction and cell cycle arrest, making it an outstanding candidate for overcoming cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0cJQ9w19R5rVg90H21EOLACvtfcHk0lixDdaUShcpvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos1KjtA%253D%253D&md5=c0c5b682ec6408dfaf3a8dd630e858d9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fsrep19449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep19449%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DGuan%26aufirst%3DR.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26atitle%3DRuthenium%2528II%2529%2520complexes%2520with%25202-phenylimidazo%255B4%252C5-f%255D%255B1%252C10%255Dphenanthroline%2520derivatives%2520that%2520strongly%2520combat%2520cisplatin-resistant%2520tumor%2520cells%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D19449%26doi%3D10.1038%2Fsrep19449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karki, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darj, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span> <span> </span><span class="NLM_article-title">Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6632</span>– <span class="NLM_lpage">6641</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.bmc.2007.08.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=6632-6641&author=S.+S.+Karkiauthor=S.+Thotaauthor=S.+Y.+Darjauthor=J.+Balzariniauthor=E.+De+Clercq&title=Synthesis%2C+anticancer%2C+and+cytotoxic+activities+of+some+mononuclear+Ru%28II%29+compounds&doi=10.1016%2Fj.bmc.2007.08.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DKarki%26aufirst%3DS.%2BS.%26aulast%3DThota%26aufirst%3DS.%26aulast%3DDarj%26aufirst%3DS.%2BY.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DSynthesis%252C%2520anticancer%252C%2520and%2520cytotoxic%2520activities%2520of%2520some%2520mononuclear%2520Ru%2528II%2529%2520compounds%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D6632%26epage%3D6641%26doi%3D10.1016%2Fj.bmc.2007.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clavel, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paunescu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak-Sliwinska, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffioen, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scopelliti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">Modulating the anticancer activity of ruthenium(II)-arene complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3356</span>– <span class="NLM_lpage">3365</span>, <span class="refDoi"> DOI: 10.1021/jm501655t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501655t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVGlt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3356-3365&author=C.+M.+Clavelauthor=E.+Paunescuauthor=P.+Nowak-Sliwinskaauthor=A.+W.+Griffioenauthor=R.+Scopellitiauthor=P.+J.+Dyson&title=Modulating+the+anticancer+activity+of+ruthenium%28II%29-arene+complexes&doi=10.1021%2Fjm501655t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating the Anticancer Activity of Ruthenium(II)-Arene Complexes</span></div><div class="casAuthors">Clavel, Catherine M.; Paunescu, Emilia; Nowak-Sliwinska, Patrycja; Griffioen, Arjan W.; Scopelliti, Rosario; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3356-3365</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Following the identification of [Ru(η6-p-cymene)Cl2(1H,1H,2H,2H-perfluorodecyl-3-(pyridin-3-yl)propanoate)], a ruthenium(II)-arene complex with a perfluoroalkyl-modified ligand that displays remarkable in vitro cancer cell selectivity, a series of structurally related compds. were designed.  In the new derivs., the p-cymene ring and/or the chloride ligands are substituted by other ligands to modulate the steric bulk or aquation kinetics.  The new compds. were evaluated in both in vitro (cytotoxicity and migration assays) and in vivo (chicken chorioallantoic membrane) models and were found to exhibit potent antivascular effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopQSD3OVYw87Vg90H21EOLACvtfcHk0liqGvXwNhBe1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVGlt70%253D&md5=11855e1f34a759a94a4d6ce6b4bf20e2</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm501655t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501655t%26sid%3Dliteratum%253Aachs%26aulast%3DClavel%26aufirst%3DC.%2BM.%26aulast%3DPaunescu%26aufirst%3DE.%26aulast%3DNowak-Sliwinska%26aufirst%3DP.%26aulast%3DGriffioen%26aufirst%3DA.%2BW.%26aulast%3DScopelliti%26aufirst%3DR.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DModulating%2520the%2520anticancer%2520activity%2520of%2520ruthenium%2528II%2529-arene%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3356%26epage%3D3365%26doi%3D10.1021%2Fjm501655t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggers, E.</span></span> <span> </span><span class="NLM_article-title">Ruthenium complexes as protein kinase inhibitors</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">523</span>, <span class="refDoi"> DOI: 10.1021/ol036283s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol036283s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=521-523&author=L.+Zhangauthor=P.+Carrollauthor=E.+Meggers&title=Ruthenium+complexes+as+protein+kinase+inhibitors&doi=10.1021%2Fol036283s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fol036283s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol036283s%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DCarroll%26aufirst%3DP.%26aulast%3DMeggers%26aufirst%3DE.%26atitle%3DRuthenium%2520complexes%2520as%2520protein%2520kinase%2520inhibitors%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D521%26epage%3D523%26doi%3D10.1021%2Fol036283s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berndsen, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdul, U. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meraldi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffioen, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak-Sliwinska, P.</span></span> <span> </span><span class="NLM_article-title">Combination of ruthenium(II)-arene complex [Ru(η<sup>6</sup>-p-cymene)Cl<sub>2</sub>(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">43005</span>, <span class="refDoi"> DOI: 10.1038/srep43005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2Fsrep43005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28223694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtlymsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=43005&author=R.+H.+Berndsenauthor=A.+Weissauthor=U.+K.+Abdulauthor=T.+J.+Wongauthor=P.+Meraldiauthor=A.+W.+Griffioenauthor=P.+J.+Dysonauthor=P.+Nowak-Sliwinska&title=Combination+of+ruthenium%28II%29-arene+complex+%5BRu%28%CE%B76-p-cymene%29Cl2%28pta%29%5D+%28RAPTA-C%29+and+the+epidermal+growth+factor+receptor+inhibitor+erlotinib+results+in+efficient+angiostatic+and+antitumor+activity&doi=10.1038%2Fsrep43005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity</span></div><div class="casAuthors">Berndsen, Robert H.; Weiss, Andrea; Abdul, U. Kulsoom; Wong, Tse J.; Meraldi, Patrick; Griffioen, Arjan W.; Dyson, Paul J.; Nowak-Sliwinska, Patrycja</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">43005</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ruthenium-based compds. show strong potential as anti-cancer drugs and are being investigated as alternatives to other well-established metal-based chemotherapeutics.  The organometallic compd. [Ru(η6-p-cymene)Cl2(pta)], where pta = 1,3,5-triaza-7-phosphaadamantane (RAPTA-C) exhibits broad acting anti-tumor efficacy with intrinsic angiostatic activity.  In the search for an optimal anti-angiogenesis drug combination, we identified synergistic potential between RAPTA-C and the epidermal growth factor receptor (EGFR) inhibitor, erlotinib.  This drug combination results in strong synergistic inhibition of cell viability in human endothelial (ECRF24 and HUVEC) and human ovarian carcinoma (A2780 and A2780cisR) cells.  Addnl., erlotinib significantly enhances the cellular uptake of RAPTA-C relative to treatment with RAPTA-C alone in human ovarian carcinoma cells, but not endothelial cells.  Drug combinations induce the formation of chromosome bridges that persist after mitotic exit and delay abscission in A2780 and A2780cisR, therefore suggesting initiation of cellular senescence.  The therapeutic potential of these compds. and their combination is further validated in vivo on A2780 tumors grown on the chicken chorioallantoic membrane (CAM) model, and in a preclin. model in nude mice.  Immunohistochem. anal. confirms effective anti-angiogenic and anti-proliferative activity in vivo, based on a significant redn. of microvascular d. and a decrease in proliferating cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsjQY3MJOumrVg90H21EOLACvtfcHk0liqGvXwNhBe1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtlymsL0%253D&md5=084b991abae2f10059deead249e3e6d9</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fsrep43005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep43005%26sid%3Dliteratum%253Aachs%26aulast%3DBerndsen%26aufirst%3DR.%2BH.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DAbdul%26aufirst%3DU.%2BK.%26aulast%3DWong%26aufirst%3DT.%2BJ.%26aulast%3DMeraldi%26aufirst%3DP.%26aulast%3DGriffioen%26aufirst%3DA.%2BW.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DNowak-Sliwinska%26aufirst%3DP.%26atitle%3DCombination%2520of%2520ruthenium%2528II%2529-arene%2520complex%2520%255BRu%2528%25CE%25B76-p-cymene%2529Cl2%2528pta%2529%255D%2520%2528RAPTA-C%2529%2520and%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitor%2520erlotinib%2520results%2520in%2520efficient%2520angiostatic%2520and%2520antitumor%2520activity%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D43005%26doi%3D10.1038%2Fsrep43005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span>; <span class="NLM_string-name">Lainez, R. F.</span>; <span class="NLM_string-name">Abraba, H.</span>; <span class="NLM_string-name">Michael, M.</span>; <span class="NLM_string-name">Duncan, J. M.</span></span> <span> </span><span class="NLM_article-title">Ruthenium Anticancer Complexes</span>. U.S. Patent <span class="NLM_patent">20060058270A1</span>, Mar 16, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=P.+J.+Sadler&author=R.+F.+Lainez&author=H.+Abraba&author=M.+Michael&author=J.+M.+Duncan&title=Ruthenium+Anticancer+Complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DRuthenium%2520Anticancer%2520Complexes%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wenjie, M.</span></span> <span> </span><span class="NLM_article-title">Chair Ruthenium Complexes and Their Use as Anticancer Agents</span>. U.S. Patent <span class="NLM_patent">8357678B2</span>, Jan 22, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+Wenjie&title=Chair+Ruthenium+Complexes+and+Their+Use+as+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWenjie%26aufirst%3DM.%26atitle%3DChair%2520Ruthenium%2520Complexes%2520and%2520Their%2520Use%2520as%2520Anticancer%2520Agents%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mestroni, G.</span>; <span class="NLM_string-name">Alessio, E.</span>; <span class="NLM_string-name">Sava, G.</span></span> <span> </span><span class="NLM_article-title">New Salts of Anionic Complexes of Ru(III) as Antimetastatic and Antineoplastic Agents</span>. WO Patent <span class="NLM_patent">1998000431A1</span>, Jan 8, <span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=G.+Mestroni&author=E.+Alessio&author=G.+Sava&title=New+Salts+of+Anionic+Complexes+of+Ru%28III%29+as+Antimetastatic+and+Antineoplastic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMestroni%26aufirst%3DG.%26atitle%3DNew%2520Salts%2520of%2520Anionic%2520Complexes%2520of%2520Ru%2528III%2529%2520as%2520Antimetastatic%2520and%2520Antineoplastic%2520Agents%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gamble, A. J.</span>; <span class="NLM_string-name">Lynam, J. M.</span>; <span class="NLM_string-name">Walton, P. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Anticancer activity of Ruthenium(II) <i>cis</i>-<i>cis</i>-1,3,5-Triaminocyclohexane Complexes</span>. WO Patent <span class="NLM_patent">2013038134A1</span>, Mar 21, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+J.+Gamble&author=J.+M.+Lynam&author=P.+H.+Walton&title=Synthesis+and+Anticancer+activity+of+Ruthenium%28II%29+cis-cis-1%2C3%2C5-Triaminocyclohexane+Complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGamble%26aufirst%3DA.%2BJ.%26atitle%3DSynthesis%2520and%2520Anticancer%2520activity%2520of%2520Ruthenium%2528II%2529%2520cis-cis-1%252C3%252C5-Triaminocyclohexane%2520Complexes%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. E.</span>; <span class="NLM_string-name">Sadler, P. J.</span>; <span class="NLM_string-name">Chen, H.</span>; <span class="NLM_string-name">Jodrell, D.</span></span> <span> </span><span class="NLM_article-title">Half-Sandwich Ruthenium(II) Compounds Comprising Nitrogen Containing Ligands for Treatment of Cancer</span>. U.S. Patent <span class="NLM_patent">20050239765A1</span>, Dec 27, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+E.+Morris&author=P.+J.+Sadler&author=H.+Chen&author=D.+Jodrell&title=Half-Sandwich+Ruthenium%28II%29+Compounds+Comprising+Nitrogen+Containing+Ligands+for+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DR.%2BE.%26atitle%3DHalf-Sandwich%2520Ruthenium%2528II%2529%2520Compounds%2520Comprising%2520Nitrogen%2520Containing%2520Ligands%2520for%2520Treatment%2520of%2520Cancer%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. E.</span>; <span class="NLM_string-name">Sadler, P. J.</span>; <span class="NLM_string-name">Jodrell, D.</span>; <span class="NLM_string-name">Chen, H.</span></span> <span> </span><span class="NLM_article-title">Ruthenium(II) Compounds for Use in the Therapy of Cancer</span>. U.S. Patent <span class="NLM_patent">6936634B2</span>, Aug 30, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+E.+Morris&author=P.+J.+Sadler&author=D.+Jodrell&author=H.+Chen&title=Ruthenium%28II%29+Compounds+for+Use+in+the+Therapy+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DR.%2BE.%26atitle%3DRuthenium%2528II%2529%2520Compounds%2520for%2520Use%2520in%2520the%2520Therapy%2520of%2520Cancer%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">Medicament Preparations Containing Tumour-Inhibiting Ruthenium(III) Complexes</span>. WO Patent <span class="NLM_patent">1997036595A3</span>, Nov 6, <span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=B.+K.+Keppler&title=Medicament+Preparations+Containing+Tumour-Inhibiting+Ruthenium%28III%29+Complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DMedicament%2520Preparations%2520Containing%2520Tumour-Inhibiting%2520Ruthenium%2528III%2529%2520Complexes%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mestroni, G.</span>; <span class="NLM_string-name">Alessio, E.</span>; <span class="NLM_string-name">Sava, G.</span>; <span class="NLM_string-name">Lengo, E.</span>; <span class="NLM_string-name">Zorzet, S.</span>; <span class="NLM_string-name">Bergamo, A.</span></span> <span> </span><span class="NLM_article-title">Ruthenium Dimeric Compounds Suitable as Antimetastatic and Antineoplastic Agents</span>. U.S. Patent <span class="NLM_patent">US6921824B1</span>, Jul 26, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=G.+Mestroni&author=E.+Alessio&author=G.+Sava&author=E.+Lengo&author=S.+Zorzet&author=A.+Bergamo&title=Ruthenium+Dimeric+Compounds+Suitable+as+Antimetastatic+and+Antineoplastic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMestroni%26aufirst%3DG.%26atitle%3DRuthenium%2520Dimeric%2520Compounds%2520Suitable%2520as%2520Antimetastatic%2520and%2520Antineoplastic%2520Agents%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aird, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Socorro Murdoch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jodrell, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of cancer cell growth by ruthenium(II) arene complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3616</span>– <span class="NLM_lpage">3621</span>, <span class="refDoi"> DOI: 10.1021/jm010051m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010051m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntF2hsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3616-3621&author=R.+E.+Morrisauthor=R.+E.+Airdauthor=P.+del+Socorro+Murdochauthor=H.+Chenauthor=J.+Cummingsauthor=N.+D.+Hughesauthor=S.+Parsonsauthor=A.+Parkinauthor=G.+Boydauthor=D.+I.+Jodrellauthor=P.+J.+Sadler&title=Inhibition+of+cancer+cell+growth+by+ruthenium%28II%29+arene+complexes&doi=10.1021%2Fjm010051m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Cancer Cell Growth by Ruthenium(II) Arene Complexes</span></div><div class="casAuthors">Morris, Robert E.; Aird, Rhona E.; Murdoch, Piedad del Socorro; Chen, Haimei; Cummings, Jeff; Hughes, Nathan D.; Parsons, Simon; Parkin, Andrew; Boyd, Gary; Jodrell, Duncan I.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3616-3621</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of the growth of the human ovarian cancer cell line A2780 by organometallic ruthenium(II) complexes of the type [(η6-arene)Ru(X)(Y)(Z)], where arene is benzene or substituted benzene, X, Y, and Z are halide, acetonitrile, or isonicotinamide, or X,Y is ethylenediamine (en) or N-ethylethylenediamine, has been investigated.  The x-ray crystal structures of the complexes [(η6-p-cymene)Ru(en)Cl]PF6 (I), [(η6-p-cymene)RuCl2(isonicotinamide)], and [(η6-biphenyl)Ru(en)Cl]PF6 are reported.  They have "piano stool" geometries with η6 coordination of the arene ligand.  Complexes with X,Y as a chelated en ligand and Z as a monofunctional leaving group had the highest activity.  Some complexes were as active as carboplatin.  Hydrolysis of the reactive Ru-Cl bond in I was detected by HPLC but was suppressed by the addn. of chloride ions.  I binds strongly and selectively to G bases on DNA oligonucleotides to form monofunctional adducts.  No inhibition of topoisomerase I or II by complex I was detected.  These chelated Ru(II) arene complexes have potential as novel metal-based anticancer agents with a mechanism of action different from that of the Ru(III) complex currently on clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL0wRcF1CDQrVg90H21EOLACvtfcHk0liULGMNOM3bCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntF2hsrw%253D&md5=339b3602c2dea640f0e27ee8126d14fc</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm010051m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010051m%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DR.%2BE.%26aulast%3DAird%26aufirst%3DR.%2BE.%26aulast%3Ddel%2BSocorro%2BMurdoch%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DCummings%26aufirst%3DJ.%26aulast%3DHughes%26aufirst%3DN.%2BD.%26aulast%3DParsons%26aufirst%3DS.%26aulast%3DParkin%26aufirst%3DA.%26aulast%3DBoyd%26aufirst%3DG.%26aulast%3DJodrell%26aufirst%3DD.%2BI.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DInhibition%2520of%2520cancer%2520cell%2520growth%2520by%2520ruthenium%2528II%2529%2520arene%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3616%26epage%3D3621%26doi%3D10.1021%2Fjm010051m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adhireksan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campomanes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clavel, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nazarov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Droge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothlisberger, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, C. A.</span></span> <span> </span><span class="NLM_article-title">Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3462</span>, <span class="refDoi"> DOI: 10.1038/ncomms4462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2Fncomms4462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=24637564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A280%3ADC%252BC2crks1Siug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=3462&author=Z.+Adhireksanauthor=G.+E.+Daveyauthor=P.+Campomanesauthor=M.+Groesslauthor=C.+M.+Clavelauthor=H.+Yuauthor=A.+A.+Nazarovauthor=C.+H.+Yeoauthor=W.+H.+Angauthor=P.+Drogeauthor=U.+Rothlisbergerauthor=P.+J.+Dysonauthor=C.+A.+Davey&title=Ligand+substitutions+between+ruthenium-cymene+compounds+can+control+protein+versus+DNA+targeting+and+anticancer+activity&doi=10.1038%2Fncomms4462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity</span></div><div class="casAuthors">Adhireksan Zenita; Davey Gabriela E; Campomanes Pablo; Groessl Michael; Clavel Catherine M; Rothlisberger Ursula; Dyson Paul J; Yu Haojie; Droge Peter; Nazarov Alexey A; Yeo Charmian Hui Fang; Ang Wee Han; Davey Curt A</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3462</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ruthenium compounds have become promising alternatives to platinum drugs by displaying specific activities against different cancers and favourable toxicity and clearance properties.  Nonetheless, their molecular targeting and mechanism of action are poorly understood.  Here we study two prototypical ruthenium-arene agents-the cytotoxic antiprimary tumour compound [(η(6)-p-cymene)Ru(ethylene-diamine)Cl]PF6 and the relatively non-cytotoxic antimetastasis compound [(η(6)-p-cymene)Ru(1,3,5-triaza-7-phosphaadamantane)Cl2]-and discover that the former targets the DNA of chromatin, while the latter preferentially forms adducts on the histone proteins.  Using a novel 'atom-to-cell' approach, we establish the basis for the surprisingly site-selective adduct formation behaviour and distinct cellular impact of these two chemically similar anticancer agents, which suggests that the cytotoxic effects arise largely from DNA lesions, whereas the protein adducts may be linked to the other therapeutic activities.  Our study shows promise for developing new ruthenium drugs, via ligand-based modulation of DNA versus protein binding and thus cytotoxic potential, to target distinguishing epigenetic features of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTZqBhtNtqH3iA3UY9EwTNrfW6udTcc2eYnI0iwOujDvrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crks1Siug%253D%253D&md5=1503acd1c2fee807c904004015956975</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fncomms4462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4462%26sid%3Dliteratum%253Aachs%26aulast%3DAdhireksan%26aufirst%3DZ.%26aulast%3DDavey%26aufirst%3DG.%2BE.%26aulast%3DCampomanes%26aufirst%3DP.%26aulast%3DGroessl%26aufirst%3DM.%26aulast%3DClavel%26aufirst%3DC.%2BM.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DNazarov%26aufirst%3DA.%2BA.%26aulast%3DYeo%26aufirst%3DC.%2BH.%26aulast%3DAng%26aufirst%3DW.%2BH.%26aulast%3DDroge%26aufirst%3DP.%26aulast%3DRothlisberger%26aufirst%3DU.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DDavey%26aufirst%3DC.%2BA.%26atitle%3DLigand%2520substitutions%2520between%2520ruthenium-cymene%2520compounds%2520can%2520control%2520protein%2520versus%2520DNA%2520targeting%2520and%2520anticancer%2520activity%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D3462%26doi%3D10.1038%2Fncomms4462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schornagel, Q. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tente, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macpherson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aird, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jodrell, D. I.</span></span> <span> </span><span class="NLM_article-title">Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">577</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1007/s00280-004-0932-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1007%2Fs00280-004-0932-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=15726367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslOmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=577-583&author=R.+L.+Haywardauthor=Q.+C.+Schornagelauthor=R.+Tenteauthor=J.+S.+Macphersonauthor=R.+E.+Airdauthor=S.+Guichardauthor=A.+Habtemariamauthor=P.+Sadlerauthor=D.+I.+Jodrell&title=Investigation+of+the+role+of+Bax%2C+p21%2FWaf1+and+p53+as+determinants+of+cellular+responses+in+HCT116+colorectal+cancer+cells+exposed+to+the+novel+cytotoxic+ruthenium%28II%29+organometallic+agent%2C+RM175&doi=10.1007%2Fs00280-004-0932-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175</span></div><div class="casAuthors">Hayward, R. L.; Schornagel, Q. C.; Tente, R.; Macpherson, J. S.; Aird, R. E.; Guichard, S.; Habtemariam, A.; Sadler, P.; Jodrell, D. I.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">577-583</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Ruthenium(II) organometallic complexes form monofunctional adducts with guanine in DNA in vitro and have a cytotoxic anticancer activity spectrum in preclin. models suggesting lack of cross-resistance with cisplatin.  The primary cytotoxic lesion remains to be identified but the downstream mechanism of action is nevertheless of interest.  Using isogenic derivs. of the HCT116 colorectal cancer cell line, we investigated the role of p53, p21/WAF1 and Bax in the cellular response to the novel ruthenium(II) organometallic complex RM175, [(η6-C6H5C6H5)RuCl (H2NCH2CH2NH2-N,N')]+ PF-6.  Western blotting demonstrated dose-dependent accumulation of p53, Bax and p21/WAF1 within 48 h of the start of RM175 treatment in wild-type HCT116 cells.  HCT116 wild-type and Bax-null cells arrested in the G1 and G2 phases of the cell cycle.  This pattern of cell cycle arrest was not obsd. in p53-null or in p21/WAF1-null cells.  Following RM175 treatment, HCT116 wild-type and p21/WAF1 null cells underwent a dose-dependent induction of apoptosis (Annexin-V and sub-G1 apoptosis assays).  This apoptotic response was not obsd. in p53-null or Bax-null cells.  In short-term sulforhodamine B assays, the IC50 for RM175 was 16 μM for p53-null HCT116, and 8 μM for wild-type cells (P<0.05).  However, the sensitivity to RM175 in clonogenic assays at 16 days was independent of p53 status.  These results identify determinants of the short-term in vitro response to RM175 demonstrating a role for p53 and p21/WAF1 in the growth arrest and for p53 and Bax in the apoptotic response.  The mechanism of p53-independent suppression of long-term clonogenicity remains to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkxwFbHtVeAbVg90H21EOLACvtfcHk0ljMugMS8dzdYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslOmt7k%253D&md5=9f6b5b0f96393a1bf903b5ef058fa010</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fs00280-004-0932-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-004-0932-9%26sid%3Dliteratum%253Aachs%26aulast%3DHayward%26aufirst%3DR.%2BL.%26aulast%3DSchornagel%26aufirst%3DQ.%2BC.%26aulast%3DTente%26aufirst%3DR.%26aulast%3DMacpherson%26aufirst%3DJ.%2BS.%26aulast%3DAird%26aufirst%3DR.%2BE.%26aulast%3DGuichard%26aufirst%3DS.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DSadler%26aufirst%3DP.%26aulast%3DJodrell%26aufirst%3DD.%2BI.%26atitle%3DInvestigation%2520of%2520the%2520role%2520of%2520Bax%252C%2520p21%252FWaf1%2520and%2520p53%2520as%2520determinants%2520of%2520cellular%2520responses%2520in%2520HCT116%2520colorectal%2520cancer%2520cells%2520exposed%2520to%2520the%2520novel%2520cytotoxic%2520ruthenium%2528II%2529%2520organometallic%2520agent%252C%2520RM175%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2005%26volume%3D55%26spage%3D577%26epage%3D583%26doi%3D10.1007%2Fs00280-004-0932-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyva, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenny, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benosman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fricker, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harlepp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hébraud, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wlosik, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirlin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeffer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeffler, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaiddon, C.</span></span> <span> </span><span class="NLM_article-title">A ruthenium-containing organometallic compound reduces tumor growth through induction of the endoplasmic reticulum stress gene CHOP</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">5458</span>– <span class="NLM_lpage">5466</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-4408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1158%2F0008-5472.CAN-08-4408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=19549908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvFajsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=5458-5466&author=X.+Mengauthor=M.+L.+Leyvaauthor=M.+Jennyauthor=I.+Grossauthor=S.+Benosmanauthor=B.+Frickerauthor=S.+Harleppauthor=P.+H%C3%A9braudauthor=A.+Boosauthor=P.+Wlosikauthor=P.+Bischoffauthor=C.+Sirlinauthor=M.+Pfefferauthor=J.+P.+Loefflerauthor=C.+Gaiddon&title=A+ruthenium-containing+organometallic+compound+reduces+tumor+growth+through+induction+of+the+endoplasmic+reticulum+stress+gene+CHOP&doi=10.1158%2F0008-5472.CAN-08-4408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A Ruthenium-Containing Organometallic Compound Reduces Tumor Growth through Induction of the Endoplasmic Reticulum Stress Gene CHOP</span></div><div class="casAuthors">Meng, Xiangjun; Leyva, Mili L.; Jenny, Marjorie; Gross, Isabelle; Benosman, Samir; Fricker, Bastien; Harlepp, Sebastien; Hebraud, Pascal; Boos, Anne; Wlosik, Pauline; Bischoff, Pierre; Sirlin, Claude; Pfeffer, Michel; Loeffler, Jean-Philippe; Gaiddon, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5458-5466</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cisplatin-derived anticancer therapy has been used for three decades despite its side effects.  Other types of organometallic complexes, namely, some ruthenium-derived compds. (RDC), which would display cytotoxicity through different modes of action, might represent alternative therapeutic agents.  We have studied both in vitro and in vivo the biol. properties of RDC11, one of the most active compds. of a new class of RDCs that contain a covalent bond between the ruthenium atom and a carbon.  We showed that RDC11 inhibited the growth of various tumors implanted in mice more efficiently than cisplatin.  Importantly, in striking contrast with cisplatin, RDC11 did not cause severe side effects on the liver, kidneys, or the neuronal sensory system.  We analyzed the mode of action of RDC11 and showed that RDC11 interacted poorly with DNA and induced only limited DNA damages compared with cisplatin, suggesting alternative transduction pathways.  Indeed, we found that target genes of the endoplasmic reticulum stress pathway, such as Bip, XBP1, PDI, and CHOP, were activated in RDC11-treated cells.  Induction of the transcription factor CHOP, a crucial mediator of endoplasmic reticulum stress apoptosis, was also confirmed in tumors treated with RDC11.  Activation of CHOP led to the expression of several of its target genes, including proapoptotic genes.  In addn., the silencing of CHOP by RNA interference significantly reduced the cytotoxicity of RDC11.  Altogether, our results led us to conclude that RDC11 acts by an atypical pathway involving CHOP and endoplasmic reticulum stress, and thus might provide an interesting alternative for anticancer therapy. [Cancer Res 2009;69(13):5458-66].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnASKwXHM3ubVg90H21EOLACvtfcHk0ljMugMS8dzdYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvFajsrY%253D&md5=f71d72505b4312140eced6453ac59b1d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-4408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-4408%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DLeyva%26aufirst%3DM.%2BL.%26aulast%3DJenny%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DI.%26aulast%3DBenosman%26aufirst%3DS.%26aulast%3DFricker%26aufirst%3DB.%26aulast%3DHarlepp%26aufirst%3DS.%26aulast%3DH%25C3%25A9braud%26aufirst%3DP.%26aulast%3DBoos%26aufirst%3DA.%26aulast%3DWlosik%26aufirst%3DP.%26aulast%3DBischoff%26aufirst%3DP.%26aulast%3DSirlin%26aufirst%3DC.%26aulast%3DPfeffer%26aufirst%3DM.%26aulast%3DLoeffler%26aufirst%3DJ.%2BP.%26aulast%3DGaiddon%26aufirst%3DC.%26atitle%3DA%2520ruthenium-containing%2520organometallic%2520compound%2520reduces%2520tumor%2520growth%2520through%2520induction%2520of%2520the%2520endoplasmic%2520reticulum%2520stress%2520gene%2520CHOP%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D5458%26epage%3D5466%26doi%3D10.1158%2F0008-5472.CAN-08-4408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Debreczeni, J. É.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atilla, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggers, E.</span></span> <span> </span><span class="NLM_article-title">Ruthenium half-sandwich complexes bound to protein kinase pim-1</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1580</span>– <span class="NLM_lpage">1585</span>, <span class="refDoi"> DOI: 10.1002/anie.200503468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fanie.200503468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD28XisVahsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=1580-1585&author=J.+%C3%89.+Debreczeniauthor=A.+N.+Bullockauthor=G.+E.+Atillaauthor=D.+S.+Williamsauthor=H.+Bregmanauthor=S.+Knappauthor=E.+Meggers&title=Ruthenium+half-sandwich+complexes+bound+to+protein+kinase+pim-1&doi=10.1002%2Fanie.200503468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium half-sandwich complexes bound to protein kinase pim-1</span></div><div class="casAuthors">Debreczeni, Judit E.; Bullock, Alex N.; Atilla, G. Ekin; Williams, Douglas S.; Bregman, Howard; Knapp, Stefan; Meggers, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1580-1585</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Keeping in shape with half a sandwich: The structure of a picomolar organoruthenium inhibitor bound to the ATP-binding site of the protein kinase Pim-1 demonstrates that the ruthenium center has solely a structural role in organizing the org. ligands in the three-dimensional receptor space, thus yielding a structure that is complementary in shape and functional group presentation to the active site of Pim-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9GY4rvd-xobVg90H21EOLACvtfcHk0ljMugMS8dzdYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisVahsLc%253D&md5=9916f0a06f3248b417f2b1ea622e31e5</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fanie.200503468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200503468%26sid%3Dliteratum%253Aachs%26aulast%3DDebreczeni%26aufirst%3DJ.%2B%25C3%2589.%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DAtilla%26aufirst%3DG.%2BE.%26aulast%3DWilliams%26aufirst%3DD.%2BS.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeggers%26aufirst%3DE.%26atitle%3DRuthenium%2520half-sandwich%2520complexes%2520bound%2520to%2520protein%2520kinase%2520pim-1%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D1580%26epage%3D1585%26doi%3D10.1002%2Fanie.200503468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trondl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffeter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowol, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2925</span>– <span class="NLM_lpage">2932</span>, <span class="refDoi"> DOI: 10.1039/C3SC53243G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC3SC53243G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOiurbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=2925-2932&author=R.+Trondlauthor=P.+Heffeterauthor=C.+R.+Kowolauthor=M.+A.+Jakupecauthor=W.+Bergerauthor=B.+K.+Keppler&title=NKP-1339%2C+the+first+ruthenium-based+anticancer+drug+on+the+edge+to+clinical+application&doi=10.1039%2FC3SC53243G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application</span></div><div class="casAuthors">Trondl, Robert; Heffeter, Petra; Kowol, Christian R.; Jakupec, Michael A.; Berger, Walter; Keppler, Bernhard K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2925-2932</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">NKP-1339 is the first-in-class ruthenium-based anticancer drug in clin. development against solid cancer and has recently been studied successfully in a phase I clin. trial.  Ruthenium compds. such as KP1019 (indazolium trans-[tetrachloridobis(1H-indazole)ruthenate(III)]) and NKP-1339 (the sodium salt analog of KP1019, sodium trans-[tetrachloridobis(1H-indazole)ruthenate(III)]) have a high tumor targeting potential based (1) on their strong binding to serum proteins such as albumin and transferrin as well as (2) on their activation in the reductive tumor milieu.  The redox activity of ruthenium compds. is believed to represent one major mode of action leading to disturbance of the cellular redox balance and, consequently, induction of G2/M cell cycle arrest, blockage of DNA synthesis, and induction of apoptosis via the mitochondrial pathway.  Moreover, potent synergistic activities of NKP-1339 with the clin. approved tyrosine kinase inhibitor sorafenib were recently reported in vitro and in vivo.  Taken together, KP1019 and NKP-1339 are promising drug candidates, and esp. the very limited side effects obsd. so far in clin. phase I trials seem to be a major advantage of this class of ruthenium drugs as compared to other chemotherapeutics and targeted anticancer compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEg6EqdpG67rVg90H21EOLACvtfcHk0ljo7bXJfr7-tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOiurbM&md5=6f64a036fee96d03f0f0803b80ff1da7</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1039%2FC3SC53243G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3SC53243G%26sid%3Dliteratum%253Aachs%26aulast%3DTrondl%26aufirst%3DR.%26aulast%3DHeffeter%26aufirst%3DP.%26aulast%3DKowol%26aufirst%3DC.%2BR.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DNKP-1339%252C%2520the%2520first%2520ruthenium-based%2520anticancer%2520drug%2520on%2520the%2520edge%2520to%2520clinical%2520application%26jtitle%3DChem.%2520Sci.%26date%3D2014%26volume%3D5%26spage%3D2925%26epage%3D2932%26doi%3D10.1039%2FC3SC53243G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antonarakis, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emadi, A.</span></span> <span> </span><span class="NLM_article-title">Ruthenium-based chemotherapeutics: are they ready for prime time?</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1007/s00280-010-1293-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1007%2Fs00280-010-1293-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=20213076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkslalt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=1-9&author=E.+S.+Antonarakisauthor=A.+Emadi&title=Ruthenium-based+chemotherapeutics%3A+are+they+ready+for+prime+time%3F&doi=10.1007%2Fs00280-010-1293-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium-based chemotherapeutics: are they ready for prime time?</span></div><div class="casAuthors">Antonarakis, Emmanuel S.; Emadi, Ashkan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Since the discovery of cis-platinum, many transition metal complexes have been synthesized and assayed for antineoplastic activity.  In recent years, ruthenium-based mols. have emerged as promising antitumor and antimetastatic agents with potential uses in platinum-resistant tumors or as alternatives to platinum.  Ruthenium compds. theor. possess unique biochem. features allowing them to accumulate preferentially in neoplastic tissues and to convert to their active state only after entering tumor cells.  Intriguingly, some ruthenium agents show significant activity against cancer metastases but have minimal effects on primary tumors.  Two ruthenium-based drugs, NAMI-A and KP1019, have reached human clin. testing.  This review will highlight the chem. properties, mechanism of action, preclin. data, and early phase clin. results of these two lead ruthenium compds.  Other promising ruthenium agents will also be reviewed with emphasis on the novel ruthenium compd. ONCO4417, and DW1/2 that has demonstrated Pim-1 kinase inhibition in preclin. systems.  Further development of these and other ruthenium agents may rely on novel approaches including rational combination strategies as well as identification of potential pharmacodynamic biomarkers of drug activity aiding early phase clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAaeL0zbqnFLVg90H21EOLACvtfcHk0ljo7bXJfr7-tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkslalt7Y%253D&md5=cb705a7e874eeb25d755a8096e6b2a4e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs00280-010-1293-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-010-1293-1%26sid%3Dliteratum%253Aachs%26aulast%3DAntonarakis%26aufirst%3DE.%2BS.%26aulast%3DEmadi%26aufirst%3DA.%26atitle%3DRuthenium-based%2520chemotherapeutics%253A%2520are%2520they%2520ready%2520for%2520prime%2520time%253F%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2010%26volume%3D66%26spage%3D1%26epage%3D9%26doi%3D10.1007%2Fs00280-010-1293-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharyya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1155</span>, <span class="refDoi"> DOI: 10.1007/s00775-008-0400-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1007%2Fs00775-008-0400-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=18597125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOqsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=1149-1155&author=S.+Chatterjeeauthor=S.+Kunduauthor=A.+Bhattacharyyaauthor=C.+G.+Hartingerauthor=P.+J.+Dyson&title=The+ruthenium%28II%29-arene+compound+RAPTA-C+induces+apoptosis+in+EAC+cells+through+mitochondrial+and+p53-JNK+pathways&doi=10.1007%2Fs00775-008-0400-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways</span></div><div class="casAuthors">Chatterjee, Soumya; Kundu, Subhadip; Bhattacharyya, Arindam; Hartinger, Christian G.; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1149-1155</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">An investigation of the mol. mechanism of the anticancer activity demonstrated by the ruthenium(II)-arene compd. [Ru(η6-p-cymene)Cl2(pta)] (pta is 1,3,5-triaza-7-phosphaadamantane), termed "RAPTA-C", in Ehrlich ascites carcinoma (EAC) bearing mice is described.  RAPTA-C exhibits effective cell growth inhibition by triggering G2/M phase arrest and apoptosis in cancer cells.  Cell cycle arrest is assocd. with increased levels of p21 and reduced amts. of cyclin E. RAPTA-C treatment also enhances the levels of p53, and its treatment triggers the mitochondrial apoptotic pathway, as shown by the change in Bax to Bcl-2 ratios, resulting in cytochrome c release and caspase-9 activation. c-Jun NH2-terminal kinase (JNK) is a crit. mediator in RAPTA-C-induced cell growth inhibition.  Activation of JNK by RAPTA-C increases significantly during apoptosis.  Overall, these results suggest a crit. role for JNK and p53 in RAPTA-C-induced G2/M arrest and apoptosis of EAC-bearing mice.  Consequently, RAPTA-C treatment results in a significant inhibition in the progression of cancer in an animal model, which emulates the human disease, and does so with remarkably low general toxicity; hence, RAPTA-C has potential for clin. application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlcpDD8dE6LrVg90H21EOLACvtfcHk0ljo7bXJfr7-tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOqsLrE&md5=d8b5160a2ee5392e721372ed97aea709</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2Fs00775-008-0400-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-008-0400-9%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DKundu%26aufirst%3DS.%26aulast%3DBhattacharyya%26aufirst%3DA.%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520ruthenium%2528II%2529-arene%2520compound%2520RAPTA-C%2520induces%2520apoptosis%2520in%2520EAC%2520cells%2520through%2520mitochondrial%2520and%2520p53-JNK%2520pathways%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2008%26volume%3D13%26spage%3D1149%26epage%3D1155%26doi%3D10.1007%2Fs00775-008-0400-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escrig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maclachlan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knott, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meibom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sava, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">The differential distribution of RAPTA-T in non-invasive and invasive breast cancer cells correlates with its anti-invasive and anti-metastatic effects</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1869</span>, <span class="refDoi"> DOI: 10.3390/ijms18091869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.3390%2Fijms18091869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVOls77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=1869&author=R.+F.+S.+Leeauthor=S.+Escrigauthor=C.+Maclachlanauthor=G.+W.+Knottauthor=A.+Meibomauthor=G.+Savaauthor=P.+J.+Dyson&title=The+differential+distribution+of+RAPTA-T+in+non-invasive+and+invasive+breast+cancer+cells+correlates+with+its+anti-invasive+and+anti-metastatic+effects&doi=10.3390%2Fijms18091869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The differential distribution of rapta-t in non-invasive and invasive breast cancer cells correlates with its anti-invasive and anti-metastatic effects</span></div><div class="casAuthors">Lee, Ronald F. S.; Escrig, Stephane; Maclachlan, Catherine; Knott, Graham W.; Meibom, Anders; Sava, Gianni; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1869/1-1869/8</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Nanoscale secondary ion mass spectrometry (NanoSIMS) combined with transmission electron microscopy (TEM) can be a powerful approach to visualize the exact distribution of drugs at the sub-cellular level.  In this work, we exploit this approach to identify the distribution and localisation of the organometallic ruthenium(II)-arene drug Ru(η6-C6H5Me)(pta)Cl2, termed RAPTA-T, in MDA-MB-231 and MCF-7 human breast cancer cells.  These cell lines have been chosen because the former cell lines are highly invasive and resistant to most chemotherapeutic agents and the latter ones are very sensitive to hormonal-based therapies.  In the MDA-MB-231 cells, RAPTA-T was found to predominantly localise on the cell membrane and to a lesser extent in the nucleolus.  These findings are consistent with the previously reported anti-metastatic properties of RAPTA-T and the observation that once internalized RAPTA-T is assocd. with chromatin.  RAPTA-T shows a lack of membrane accumulation on the non-invasive MCF-7 cells, which correlates well with its selective anti-metastatic properties on invasive cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonW4I_gAONpLVg90H21EOLACvtfcHk0lg4WUUvZ0svRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVOls77E&md5=fd0c6922f8844261181121c9d422f26b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.3390%2Fijms18091869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18091869%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DR.%2BF.%2BS.%26aulast%3DEscrig%26aufirst%3DS.%26aulast%3DMaclachlan%26aufirst%3DC.%26aulast%3DKnott%26aufirst%3DG.%2BW.%26aulast%3DMeibom%26aufirst%3DA.%26aulast%3DSava%26aufirst%3DG.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520differential%2520distribution%2520of%2520RAPTA-T%2520in%2520non-invasive%2520and%2520invasive%2520breast%2520cancer%2520cells%2520correlates%2520with%2520its%2520anti-invasive%2520and%2520anti-metastatic%2520effects%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D1869%26doi%3D10.3390%2Fijms18091869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazmay, G. V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hysi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupidi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettinari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gambini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettinari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iezzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amici, A.</span></span> <span> </span><span class="NLM_article-title">The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5-dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2016.03.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.phrs.2016.03.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=27038531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsF2gsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2016&pages=282-290&author=M.+Montaniauthor=G.+V.+B.+Pazmayauthor=A.+Hysiauthor=G.+Lupidiauthor=R.+Pettinariauthor=V.+Gambiniauthor=M.+Tilioauthor=F.+Marchettiauthor=C.+Pettinariauthor=S.+Ferraroauthor=M.+Iezziauthor=C.+Marchiniauthor=A.+Amici&title=The+water+soluble+ruthenium%28II%29+organometallic+compound+%5BRu%28p-cymene%29%28bis%283%2C5-dimethylpyrazol-1-yl%29methane%29Cl%5DCl+suppresses+triple+negative+breast+cancer+growth+by+inhibiting+tumor+infiltration+of+regulatory+T+cells&doi=10.1016%2Fj.phrs.2016.03.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells</span></div><div class="casAuthors">Montani, Maura; Pazmay, Gretta V. Badillo; Hysi, Albana; Lupidi, Giulio; Pettinari, Riccardo; Gambini, Valentina; Tilio, Martina; Marchetti, Fabio; Pettinari, Claudio; Ferraro, Stefano; Iezzi, Manuela; Marchini, Cristina; Amici, Augusto</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">282-290</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ruthenium compds. have become promising alternatives to platinum drugs by displaying specific activities against different cancers and favorable toxicity and clearance properties.  Here, we show that the ruthenium(II) complex [Ru(p-cymene)(bis(3,5-dimethylpyrazol-1-yl)methane)Cl]Cl (UNICAM-1) exhibits potent in vivo antitumor effects.  When administered as four-dose course, by repeating a single dose (52.4 mg kg-1) every three days, UNICAM-1 significantly reduces the growth of A17 triple neg. breast cancer cells transplanted into FVB syngeneic mice.  Pharmacokinetic studies indicate that UNICAM-1 is rapidly eliminated from kidney, liver and bloodstream thanks to its high hydrosoly., exerting excellent therapeutic activity with minimal side effects.  Immunohistol. anal. revealed that the efficacy of UNICAM-1, mainly relies on its capacity to reverse tumor-assocd. immune suppression by significantly reducing the no. of tumor-infiltrating regulatory T cells.  Therefore, UNICAM-1 appears very promising for the treatment of TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8X8zRDhLxmLVg90H21EOLACvtfcHk0lg4WUUvZ0svRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsF2gsLw%253D&md5=db0df4808aebe14384d1f6454fe103c7</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2016.03.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2016.03.032%26sid%3Dliteratum%253Aachs%26aulast%3DMontani%26aufirst%3DM.%26aulast%3DPazmay%26aufirst%3DG.%2BV.%2BB.%26aulast%3DHysi%26aufirst%3DA.%26aulast%3DLupidi%26aufirst%3DG.%26aulast%3DPettinari%26aufirst%3DR.%26aulast%3DGambini%26aufirst%3DV.%26aulast%3DTilio%26aufirst%3DM.%26aulast%3DMarchetti%26aufirst%3DF.%26aulast%3DPettinari%26aufirst%3DC.%26aulast%3DFerraro%26aufirst%3DS.%26aulast%3DIezzi%26aufirst%3DM.%26aulast%3DMarchini%26aufirst%3DC.%26aulast%3DAmici%26aufirst%3DA.%26atitle%3DThe%2520water%2520soluble%2520ruthenium%2528II%2529%2520organometallic%2520compound%2520%255BRu%2528p-cymene%2529%2528bis%25283%252C5-dimethylpyrazol-1-yl%2529methane%2529Cl%255DCl%2520suppresses%2520triple%2520negative%2520breast%2520cancer%2520growth%2520by%2520inhibiting%2520tumor%2520infiltration%2520of%2520regulatory%2520T%2520cells%26jtitle%3DPharmacol.%2520Res.%26date%3D2016%26volume%3D107%26spage%3D282%26epage%3D290%26doi%3D10.1016%2Fj.phrs.2016.03.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis, visible light photocleavage, antiproliferative and cellular uptake properties of ruthenium complex [Ru(phen)<sub>2</sub> mitatp)]<sup>2+</sup></span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ejmech.2012.07.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=146-154&author=H.+J.+Yuauthor=Y.+Chenauthor=L.+Yuauthor=Z.+F.+Haoauthor=L.+H.+Zhou&title=Synthesis%2C+visible+light+photocleavage%2C+antiproliferative+and+cellular+uptake+properties+of+ruthenium+complex+%5BRu%28phen%292+mitatp%29%5D2%2B&doi=10.1016%2Fj.ejmech.2012.07.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%2BJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DHao%26aufirst%3DZ.%2BF.%26aulast%3DZhou%26aufirst%3DL.%2BH.%26atitle%3DSynthesis%252C%2520visible%2520light%2520photocleavage%252C%2520antiproliferative%2520and%2520cellular%2520uptake%2520properties%2520of%2520ruthenium%2520complex%2520%255BRu%2528phen%25292%2520mitatp%2529%255D2%252B%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D146%26epage%3D154%26doi%3D10.1016%2Fj.ejmech.2012.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puckett, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, J. K.</span></span> <span> </span><span class="NLM_article-title">Methods to explore cellular uptake of ruthenium complexes</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1021/ja0677564</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0677564" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlansbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=46-47&author=C.+A.+Puckettauthor=J.+K.+Barton&title=Methods+to+explore+cellular+uptake+of+ruthenium+complexes&doi=10.1021%2Fja0677564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Methods to Explore Cellular Uptake of Ruthenium Complexes</span></div><div class="casAuthors">Puckett, Cindy A.; Barton, Jacqueline K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-47</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cellular uptake of a series of dipyridophenazine (dppz) complexes of Ru(II) was examd. by flow cytometry.  The complexes, owing to their facile synthesis, stability, and luminescence, provide a route to compare and contrast systematically factors governing cellular entry.  Substituting the ancillary ligands in the dppz complexes of Ru(II) permits variation in the overall complex charge, size, and hydrophobicity.  In HeLa cells, cellular uptake appears to be facilitated by the lipophilic 4,7-diphenyl-1,10-phenanthroline (DIP) ligand.  Despite the large size of Ru(DIP)2dppz2+ (20 Å diam.), this complex is readily transported inside the cell compared to smaller and more hydrophilic complexes, such as Ru(bpy)2dppz2+.  Accumulation in the cellular interior is confirmed by confocal microscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXOSgxuK6E1rVg90H21EOLACvtfcHk0lg4WUUvZ0svRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlansbnK&md5=1d9f94460484aae4080f0eeeb715383c</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fja0677564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0677564%26sid%3Dliteratum%253Aachs%26aulast%3DPuckett%26aufirst%3DC.%2BA.%26aulast%3DBarton%26aufirst%3DJ.%2BK.%26atitle%3DMethods%2520to%2520explore%2520cellular%2520uptake%2520of%2520ruthenium%2520complexes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D46%26epage%3D47%26doi%3D10.1021%2Fja0677564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gill, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. A.</span></span> <span> </span><span class="NLM_article-title">Ruthenium(II) polypyridyl complexes and DNA-from structural probes to cellular imaging and therapeutics</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">3179</span>– <span class="NLM_lpage">3192</span>, <span class="refDoi"> DOI: 10.1039/c2cs15299a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2Fc2cs15299a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=22314926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVOhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2012&pages=3179-3192&author=M.+R.+Gillauthor=J.+A.+Thomas&title=Ruthenium%28II%29+polypyridyl+complexes+and+DNA-from+structural+probes+to+cellular+imaging+and+therapeutics&doi=10.1039%2Fc2cs15299a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium(II) polypyridyl complexes and DNA-from structural probes to cellular imaging and therapeutics</span></div><div class="casAuthors">Gill, Martin R.; Thomas, Jim A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3179-3192</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  In the last few decades, coordination complexes based on d6 metal centers and polypyridyl ligand architectures been developed as structure- and site-specific reversible DNA binding agents.  Due to their attractive photophys. properties, much of this research has focused on complexes based on ruthenium(II) centers and, more recently, attention has turned to the use of these complexes in biol. contexts.  As the rules that govern the cellular uptake and cellular localization of such systems are detd. they are finding numerous applications ranging from imaging to therapeutics.  This review illustrates how the interdisciplinary nature of this research-which takes in synthetic chem., biophys. and in cellulo studies-makes this an exciting area in which an array of further applications are likely to emerge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbQQDjT_D7vrVg90H21EOLACvtfcHk0liYe5KfT-P1vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVOhtbY%253D&md5=0e99085c63eadb273a7532616e85b8d2</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2Fc2cs15299a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2cs15299a%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DM.%2BR.%26aulast%3DThomas%26aufirst%3DJ.%2BA.%26atitle%3DRuthenium%2528II%2529%2520polypyridyl%2520complexes%2520and%2520DNA-from%2520structural%2520probes%2520to%2520cellular%2520imaging%2520and%2520therapeutics%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2012%26volume%3D41%26spage%3D3179%26epage%3D3192%26doi%3D10.1039%2Fc2cs15299a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puckett, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, J. K.</span></span> <span> </span><span class="NLM_article-title">Mechanism of cellular uptake of a ruthenium polypyridyl complex</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">11711</span>– <span class="NLM_lpage">11716</span>, <span class="refDoi"> DOI: 10.1021/bi800856t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi800856t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CltbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=11711-11716&author=C.+A.+Puckettauthor=J.+K.+Barton&title=Mechanism+of+cellular+uptake+of+a+ruthenium+polypyridyl+complex&doi=10.1021%2Fbi800856t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Cellular Uptake of a Ruthenium Polypyridyl Complex</span></div><div class="casAuthors">Puckett, Cindy A.; Barton, Jacqueline K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">11711-11716</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Transition metal complexes provide a promising avenue for the design of therapeutic and diagnostic agents, but the limited understanding of their cellular uptake is a roadblock to their effective application.  Here, we examine the mechanism of cellular entry of a luminescent ruthenium(II) polypyridyl complex, Ru(DIP)2dppz2+ (where DIP = 4,7-diphenyl-1,10-phenanthroline and dppz = dipyridophenazine), into HeLa cells, with the extent of uptake measured by flow cytometry.  No diminution of cellular uptake is obsd. under metabolic inhibition with deoxyglucose and oligomycin, indicating an energy-independent mode of entry.  The presence of org. cation transporter inhibitors also does not significantly alter uptake.  However, the cellular internalization of Ru(DIP)2dppz2+ is sensitive to the membrane potential.  Uptake decreases when cells are depolarized with high potassium buffer and increases when cells are hyperpolarized with valinomycin.  These results support passive diffusion of Ru(DIP)2dppz2+ into the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobvqylMc3ir7Vg90H21EOLACvtfcHk0liYe5KfT-P1vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CltbvM&md5=660c5806a6809d5f99da2765c379bbeb</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fbi800856t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi800856t%26sid%3Dliteratum%253Aachs%26aulast%3DPuckett%26aufirst%3DC.%2BA.%26aulast%3DBarton%26aufirst%3DJ.%2BK.%26atitle%3DMechanism%2520of%2520cellular%2520uptake%2520of%2520a%2520ruthenium%2520polypyridyl%2520complex%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D11711%26epage%3D11716%26doi%3D10.1021%2Fbi800856t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schobert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Effenberger-Neidnicht, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underhill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biersack, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, G. L.</span></span> <span> </span><span class="NLM_article-title">(Arene)Cl<sub>2</sub>Ru(II) complexes with N-coordinated estrogen and androgen isonicotinates: interaction with sex hormone binding globulin and anticancer activity</span>. <i>Steroids</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1016/j.steroids.2010.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.steroids.2010.12.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=393-399&author=R.+Schobertauthor=S.+Seibtauthor=K.+Effenberger-Neidnichtauthor=C.+Underhillauthor=B.+Biersackauthor=G.+L.+Hammond&title=%28Arene%29Cl2Ru%28II%29+complexes+with+N-coordinated+estrogen+and+androgen+isonicotinates%3A+interaction+with+sex+hormone+binding+globulin+and+anticancer+activity&doi=10.1016%2Fj.steroids.2010.12.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2010.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2010.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DSchobert%26aufirst%3DR.%26aulast%3DSeibt%26aufirst%3DS.%26aulast%3DEffenberger-Neidnicht%26aufirst%3DK.%26aulast%3DUnderhill%26aufirst%3DC.%26aulast%3DBiersack%26aufirst%3DB.%26aulast%3DHammond%26aufirst%3DG.%2BL.%26atitle%3D%2528Arene%2529Cl2Ru%2528II%2529%2520complexes%2520with%2520N-coordinated%2520estrogen%2520and%2520androgen%2520isonicotinates%253A%2520interaction%2520with%2520sex%2520hormone%2520binding%2520globulin%2520and%2520anticancer%2520activity%26jtitle%3DSteroids%26date%3D2011%26volume%3D76%26spage%3D393%26epage%3D399%26doi%3D10.1016%2Fj.steroids.2010.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vock, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scolaro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagopoulos, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juillerat-Jeanneret, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sava, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scopelliti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2166</span>– <span class="NLM_lpage">2175</span>, <span class="refDoi"> DOI: 10.1021/jm070039f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070039f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFCht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2166-2175&author=C.+A.+Vockauthor=W.+H.+Angauthor=C.+Scolaroauthor=A.+D.+Phillipsauthor=L.+Lagopoulosauthor=L.+Juillerat-Jeanneretauthor=G.+Savaauthor=R.+Scopellitiauthor=P.+J.+Dyson&title=Development+of+ruthenium+antitumor+drugs+that+overcome+multidrug+resistance+mechanisms&doi=10.1021%2Fjm070039f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Ruthenium Antitumor Drugs that Overcome Multidrug Resistance Mechanisms</span></div><div class="casAuthors">Vock, Carsten A.; Ang, Wee Han; Scolaro, Claudine; Phillips, Andrew D.; Lagopoulos, Lucienne; Juillerat-Jeanneret, Lucienne; Sava, Gianni; Scopelliti, Rosario; Dyson, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2166-2175</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Organometallic ruthenium(II) complexes of the general formula [Ru(η6-p-cymene)Cl2(L)] and [Ru(η6-p-cymene)Cl(L)2][BPh4] with modified phenoxazine- and anthracene-based multidrug resistance (MDR) modulator ligands (L) have been synthesized, spectroscopically characterized, and evaluated in vitro for their cytotoxic and MDR reverting properties in comparison with the free ligands.  For an anthracene-based ligand, coordination to a ruthenium(II) arene fragment led to significant improvement of cytotoxicity as well as Pgp inhibition activity.  A similar, but weaker effect was also obsd. when using a benzimidazole-phenoxazine deriv. as Pgp inhibitor.  The most active compd. in terms of both Pgp inhibition and cytotoxicity is [Ru(η6-p-cymene)Cl2(L)] (I), where L is an anthracene-based ligand.  Studies show that it induces cell death via inhibition of DNA synthesis.  Moreover, because the complex is fluorescent, its uptake in cells was studied, and relative to the free anthracene-based ligand, uptake of the complex is accelerated and accumulation of the complex in the cell nucleus is obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonj2cQeVrAErVg90H21EOLACvtfcHk0liYe5KfT-P1vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFCht78%253D&md5=11320bb404222e0545d307f773b98ea8</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm070039f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070039f%26sid%3Dliteratum%253Aachs%26aulast%3DVock%26aufirst%3DC.%2BA.%26aulast%3DAng%26aufirst%3DW.%2BH.%26aulast%3DScolaro%26aufirst%3DC.%26aulast%3DPhillips%26aufirst%3DA.%2BD.%26aulast%3DLagopoulos%26aufirst%3DL.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DSava%26aufirst%3DG.%26aulast%3DScopelliti%26aufirst%3DR.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DDevelopment%2520of%2520ruthenium%2520antitumor%2520drugs%2520that%2520overcome%2520multidrug%2520resistance%2520mechanisms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2166%26epage%3D2175%26doi%3D10.1021%2Fjm070039f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spoerlein-Guettler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schobert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biersack, B.</span></span> <span> </span><span class="NLM_article-title">Ferrocene and (arene) ruthenium(II) complexes of the natural anticancer naphthoquinone plumbagin with enhanced efficacy against resistant cancer cells and a genuine mode of action</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2014.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jinorgbio.2014.04.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2014&pages=64-72&author=C.+Spoerlein-Guettlerauthor=K.+Mahalauthor=R.+Schobertauthor=B.+Biersack&title=Ferrocene+and+%28arene%29+ruthenium%28II%29+complexes+of+the+natural+anticancer+naphthoquinone+plumbagin+with+enhanced+efficacy+against+resistant+cancer+cells+and+a+genuine+mode+of+action&doi=10.1016%2Fj.jinorgbio.2014.04.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2014.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2014.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DSpoerlein-Guettler%26aufirst%3DC.%26aulast%3DMahal%26aufirst%3DK.%26aulast%3DSchobert%26aufirst%3DR.%26aulast%3DBiersack%26aufirst%3DB.%26atitle%3DFerrocene%2520and%2520%2528arene%2529%2520ruthenium%2528II%2529%2520complexes%2520of%2520the%2520natural%2520anticancer%2520naphthoquinone%2520plumbagin%2520with%2520enhanced%2520efficacy%2520against%2520resistant%2520cancer%2520cells%2520and%2520a%2520genuine%2520mode%2520of%2520action%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2014%26volume%3D138%26spage%3D64%26epage%3D72%26doi%3D10.1016%2Fj.jinorgbio.2014.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yerra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghavendra, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, E. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, DNA binding, DNA cleavage, protein binding and cytotoxic activities of Ru(II) complexes</span>. <i>Int. J. Biol. Macromol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">670</span>, <span class="refDoi"> DOI: 10.1016/j.ijbiomac.2015.09.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ijbiomac.2015.09.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=26424207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2ht7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2016&pages=663-670&author=S.+Thotaauthor=S.+Vallalaauthor=R.+Yerraauthor=D.+A.+Rodriguesauthor=N.+M.+Raghavendraauthor=E.+J.+Barreiro&title=Synthesis%2C+characterization%2C+DNA+binding%2C+DNA+cleavage%2C+protein+binding+and+cytotoxic+activities+of+Ru%28II%29+complexes&doi=10.1016%2Fj.ijbiomac.2015.09.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization, DNA binding, DNA cleavage, protein binding and cytotoxic activities of Ru(II) complexes</span></div><div class="casAuthors">Thota, Sreekanth; Vallala, Srujana; Yerra, Rajeshwar; Rodrigues, Daniel Alencar; Raghavendra, Nulgumnalli Manjunathaiah; Barreiro, Eliezer J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Macromolecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">663-670</span>CODEN:
                <span class="NLM_cas:coden">IJBMDR</span>;
        ISSN:<span class="NLM_cas:issn">0141-8130</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The authors report on the synthesis of novel Ru(II) compds. (Ru-1 to Ru-8: I, II) bearing R-pdc, 4-Cl-pbinh ligands (R = 4-CF3, 4-F, 4-OH pdc = 3-phenyl-5-(1H-pyrrol-2-yl)-4,5-dihydro-1H-pyrazole-1-carbothioamide, pbinh = phenoxybenzylidene isonicotinyl hydrazides) and their in vitro antitumor activity toward the cell lines murine leukemia L1210, human lymphocyte CEM, human epithelial cervical carcinoma HeLa, BEL-<7402≥ and Molt4/C8.  Some of the complexes exhibited more potent antiproliferative activity against cell lines than the std. drug cisplatin.  Ruthenium complex Ru-2 displayed potent cytotoxicity with than that of cisplatin.  DNA-binding, DNA cleavage and protein binding properties of ruthenium complexes with these ligands are reported.  Interactions of these ruthenium complexes with DNA revealed an intercalative mode of binding between them.  Synchronous fluorescence spectra proved that the interaction of ruthenium complexes with bovine serum albumin (BSA) resulted in a conformational change of the latter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4jpirhumv-LVg90H21EOLACvtfcHk0liDgr-RwiTRxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2ht7bP&md5=7c78d96612732bde09268868c6d9310a</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.ijbiomac.2015.09.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijbiomac.2015.09.045%26sid%3Dliteratum%253Aachs%26aulast%3DThota%26aufirst%3DS.%26aulast%3DVallala%26aufirst%3DS.%26aulast%3DYerra%26aufirst%3DR.%26aulast%3DRodrigues%26aufirst%3DD.%2BA.%26aulast%3DRaghavendra%26aufirst%3DN.%2BM.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26atitle%3DSynthesis%252C%2520characterization%252C%2520DNA%2520binding%252C%2520DNA%2520cleavage%252C%2520protein%2520binding%2520and%2520cytotoxic%2520activities%2520of%2520Ru%2528II%2529%2520complexes%26jtitle%3DInt.%2520J.%2520Biol.%2520Macromol.%26date%3D2016%26volume%3D82%26spage%3D663%26epage%3D670%26doi%3D10.1016%2Fj.ijbiomac.2015.09.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novakova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vojtiskova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. relationship to cytotoxicity</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2004.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.chembiol.2004.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=15664521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=121-129&author=O.+Novakovaauthor=J.+Kasparkovaauthor=V.+Bursovaauthor=C.+Hofrauthor=M.+Vojtiskovaauthor=H.+Chenauthor=P.+J.+Sadlerauthor=V.+Brabec&title=Conformation+of+DNA+modified+by+monofunctional+Ru%28II%29+arene+complexes%3A+recognition+by+DNA+binding+proteins+and+repair.+relationship+to+cytotoxicity&doi=10.1016%2Fj.chembiol.2004.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Conformation of DNA Modified by Monofunctional Ru(II) Arene Complexes: Recognition by DNA Binding Proteins and Repair. Relationship to Cytotoxicity</span></div><div class="casAuthors">Novakova, Olga; Kasparkova, Jana; Bursova, Vendula; Hofr, Ctirad; Vojtiskova, Marie; Chen, Haimei; Sadler, Peter J.; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-129</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We analyzed DNA duplexes modified at central guanine residues by monofunctional Ru(II) arene complexes [(η6-arene)Ru(II)(en)(Cl)]+ (arene = tetrahydroanthracene or p-cymene, Ru-THA or Ru-CYM, resp.).  These two complexes were chosen as representatives of two different classes of Ru(II) arene compds. for which initial studies revealed different binding modes: one that may involve DNA intercalation (tricyclic-ring Ru-THA) and the other (mono-ring Ru-CYM) that may not.  Ru-THA is ∼20 times more toxic to cancer cells than Ru-CYM.  The adducts of Ru-THA and Ru-CYM have contrasting effects on the conformation, thermodn. stability, and polymn. of DNA in vitro.  In addn., the adducts of Ru-CYM are removed from DNA more efficiently than those of Ru-THA.  Interestingly, the mammalian nucleotide excision repair system has low efficiency for excision of ruthenium adducts compared to cisplatin intra-strand crosslinks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX-yZpZy2brbVg90H21EOLACvtfcHk0liDgr-RwiTRxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtlKlsQ%253D%253D&md5=76b8086e0528b503379e2ade2e8d08bb</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DNovakova%26aufirst%3DO.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBursova%26aufirst%3DV.%26aulast%3DHofr%26aufirst%3DC.%26aulast%3DVojtiskova%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DConformation%2520of%2520DNA%2520modified%2520by%2520monofunctional%2520Ru%2528II%2529%2520arene%2520complexes%253A%2520recognition%2520by%2520DNA%2520binding%2520proteins%2520and%2520repair.%2520relationship%2520to%2520cytotoxicity%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D121%26epage%3D129%26doi%3D10.1016%2Fj.chembiol.2004.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ratanaphan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nhukeaw, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hongthong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span> <span> </span><span class="NLM_article-title">Differential cytotoxicity, cellular uptake, apoptosis and inhibition of BRCA1 expression of BRCA1-defective and sporadic breast cancer cells induced by an anticancer ruthenium(II)-arene compound, RAPTA-EA1</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.2174/1871520616666160404110953</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F1871520616666160404110953" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=212-220&author=A.+Ratanaphanauthor=T.+Nhukeawauthor=K.+Hongthongauthor=P.+J.+Dyson&title=Differential+cytotoxicity%2C+cellular+uptake%2C+apoptosis+and+inhibition+of+BRCA1+expression+of+BRCA1-defective+and+sporadic+breast+cancer+cells+induced+by+an+anticancer+ruthenium%28II%29-arene+compound%2C+RAPTA-EA1&doi=10.2174%2F1871520616666160404110953"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2174%2F1871520616666160404110953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871520616666160404110953%26sid%3Dliteratum%253Aachs%26aulast%3DRatanaphan%26aufirst%3DA.%26aulast%3DNhukeaw%26aufirst%3DT.%26aulast%3DHongthong%26aufirst%3DK.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26atitle%3DDifferential%2520cytotoxicity%252C%2520cellular%2520uptake%252C%2520apoptosis%2520and%2520inhibition%2520of%2520BRCA1%2520expression%2520of%2520BRCA1-defective%2520and%2520sporadic%2520breast%2520cancer%2520cells%2520induced%2520by%2520an%2520anticancer%2520ruthenium%2528II%2529-arene%2520compound%252C%2520RAPTA-EA1%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2017%26volume%3D17%26spage%3D212%26epage%3D220%26doi%3D10.2174%2F1871520616666160404110953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Popolin, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J. P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becceneri, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graminha, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corrêa, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colina-Vegas, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellena, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cominetti, M. R.</span></span> <span> </span><span class="NLM_article-title">Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0183275</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0183275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1371%2Fjournal.pone.0183275" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0183275&author=C.+P.+Popolinauthor=J.+P.+B.+Reisauthor=A.+B.+Becceneriauthor=A.+E.+Graminhaauthor=M.+A.+P.+Almeidaauthor=R.+S.+Corr%C3%AAaauthor=L.+A.+Colina-Vegasauthor=J.+Ellenaauthor=A.+A.+Batistaauthor=M.+R.+Cominetti&title=Cytotoxicity+and+anti-tumor+effects+of+new+ruthenium+complexes+on+triple+negative+breast+cancer+cells&doi=10.1371%2Fjournal.pone.0183275"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0183275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0183275%26sid%3Dliteratum%253Aachs%26aulast%3DPopolin%26aufirst%3DC.%2BP.%26aulast%3DReis%26aufirst%3DJ.%2BP.%2BB.%26aulast%3DBecceneri%26aufirst%3DA.%2BB.%26aulast%3DGraminha%26aufirst%3DA.%2BE.%26aulast%3DAlmeida%26aufirst%3DM.%2BA.%2BP.%26aulast%3DCorr%25C3%25AAa%26aufirst%3DR.%2BS.%26aulast%3DColina-Vegas%26aufirst%3DL.%2BA.%26aulast%3DEllena%26aufirst%3DJ.%26aulast%3DBatista%26aufirst%3DA.%2BA.%26aulast%3DCominetti%26aufirst%3DM.%2BR.%26atitle%3DCytotoxicity%2520and%2520anti-tumor%2520effects%2520of%2520new%2520ruthenium%2520complexes%2520on%2520triple%2520negative%2520breast%2520cancer%2520cells%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0183275%26doi%3D10.1371%2Fjournal.pone.0183275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grozav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balacescu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balacescu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheminel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berindan-Neagoe, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, B.</span></span> <span> </span><span class="NLM_article-title">Synthesis, anticancer activity, and genome profiling of thiazolo arene ruthenium complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8475</span>– <span class="NLM_lpage">8490</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00855</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00855" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8475-8490&author=A.+Grozavauthor=O.+Balacescuauthor=L.+Balacescuauthor=T.+Cheminelauthor=I.+Berindan-Neagoeauthor=B.+Therrien&title=Synthesis%2C+anticancer+activity%2C+and+genome+profiling+of+thiazolo+arene+ruthenium+complexes&doi=10.1021%2Facs.jmedchem.5b00855"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00855%26sid%3Dliteratum%253Aachs%26aulast%3DGrozav%26aufirst%3DA.%26aulast%3DBalacescu%26aufirst%3DO.%26aulast%3DBalacescu%26aufirst%3DL.%26aulast%3DCheminel%26aufirst%3DT.%26aulast%3DBerindan-Neagoe%26aufirst%3DI.%26aulast%3DTherrien%26aufirst%3DB.%26atitle%3DSynthesis%252C%2520anticancer%2520activity%252C%2520and%2520genome%2520profiling%2520of%2520thiazolo%2520arene%2520ruthenium%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8475%26epage%3D8490%26doi%3D10.1021%2Facs.jmedchem.5b00855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaveera, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span> <span> </span><span class="NLM_article-title">Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexes</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.3109/14756360903357577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.3109%2F14756360903357577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=20128638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotlSmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=513-519&author=S.+Thotaauthor=S.+S.+Karkiauthor=K.+N.+Jayaveeraauthor=J.+Balzariniauthor=E.+De+Clercq&title=Synthesis%2C+antineoplastic+and+cytotoxic+activities+of+some+mononuclear+Ru%28II%29+complexes&doi=10.3109%2F14756360903357577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexes</span></div><div class="casAuthors">Thota, Sreekanth; Karki, Subhas S.; Jayaveera, K. N.; Balzarini, Jan; De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">513-519</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A series of mononuclear Ru(II) complexes of the type [Ru(S)2(K)]2+, where S = 1,10-phenanthroline/2,2'-bipyridine and K = 4-OH-btsz, 4-CH3-btsz, 3,4-di-OCH3-btsz, 4-OH-binh, 4-CH3-binh, 3,4-di-OCH3-binh (btsz/binh = benzaldehyde thiosemicarbazone/isonicotinyl hydrazone), were prepd. and characterized by elemental anal., FTIR, 1H-NMR, and mass spectroscopy.  The complexes displayed metal-ligand charge transfer (MLCT) transitions in the visible region.  These ligands formed bidentate octahedral ruthenium complexes.  The title complexes were evaluated for their in vivo anticancer activity against a transplantable murine tumor cell line, Ehrlich's ascites carcinoma (EAC), and in vitro cytotoxic activity against human cancer cell lines Molt 4/C8 and CEM and murine tumor cell line L1210.  The ruthenium complexes showed promising biol. activity esp. in decreasing tumor vol. and viable ascites cell counts.  Treatment with these complexes prolonged the life span of mice bearing EAC tumors by 10-52%.  In vitro evaluation of these ruthenium complexes revealed cytotoxic activity from 0.21 to 24 μM against Molt 4/C8, 0.16 to 19 μM against CEM, and 0.75 to 32 μM against L1210.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfjIM2peX8cLVg90H21EOLACvtfcHk0ljh_ZaWfJsRtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotlSmsbk%253D&md5=ec0a391d97808f590d089d4b7d7535d2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.3109%2F14756360903357577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756360903357577%26sid%3Dliteratum%253Aachs%26aulast%3DThota%26aufirst%3DS.%26aulast%3DKarki%26aufirst%3DS.%2BS.%26aulast%3DJayaveera%26aufirst%3DK.%2BN.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DSynthesis%252C%2520antineoplastic%2520and%2520cytotoxic%2520activities%2520of%2520some%2520mononuclear%2520Ru%2528II%2529%2520complexes%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2010%26volume%3D25%26spage%3D513%26epage%3D519%26doi%3D10.3109%2F14756360903357577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1038/nrd3428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2Fnrd3428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=21455236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=261-275&author=S.+Balasubramanianauthor=L.+H.+Hurleyauthor=S.+Neidle&title=Targeting+G-quadruplexes+in+gene+promoters%3A+a+novel+anticancer+strategy%3F&doi=10.1038%2Fnrd3428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?</span></div><div class="casAuthors">Balasubramanian, Shankar; Hurley, Laurence H.; Neidle, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">261-275</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  G-quadruplexes are four-stranded DNA structures that are over-represented in gene promoter regions and are viewed as emerging therapeutic targets in oncol., as transcriptional repression of oncogenes through stabilization of these structures could be a novel anticancer strategy.  Many gene promoter G-quadruplexes have physicochem. properties and structural characteristics that might make them druggable, and their structural diversity suggests that a high degree of selectivity might be possible.  Here, we describe the evidence for G-quadruplexes in gene promoters and discuss their potential as therapeutic targets, as well as progress in the development of strategies to harness this potential through intervention with small-mol. ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk0ePjfQEBk7Vg90H21EOLACvtfcHk0ljh_ZaWfJsRtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmtbw%253D&md5=b3ea27635da9d1ff72d60228f1ef6d76</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1038%2Fnrd3428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3428%26sid%3Dliteratum%253Aachs%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DHurley%26aufirst%3DL.%2BH.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DTargeting%2520G-quadruplexes%2520in%2520gene%2520promoters%253A%2520a%2520novel%2520anticancer%2520strategy%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D261%26epage%3D275%26doi%3D10.1038%2Fnrd3428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagawa, K.</span></span> <span> </span><span class="NLM_article-title">Targeting DNA damage response in cancer therapy</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">370</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1111/cas.12366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1111%2Fcas.12366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=24484288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvFWitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2014&pages=370-388&author=N.+Hosoyaauthor=K.+Miyagawa&title=Targeting+DNA+damage+response+in+cancer+therapy&doi=10.1111%2Fcas.12366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting DNA damage response in cancer therapy</span></div><div class="casAuthors">Hosoya, Noriko; Miyagawa, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">370-388</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Cancer chemotherapy and radiotherapy are designed to kill cancer cells mostly by inducing DNA damage.  DNA damage is normally recognized and repaired by the intrinsic DNA damage response machinery.  If the damaged lesions are successfully repaired, the cells will survive.  In order to specifically and effectively kill cancer cells by therapies that induce DNA damage, it is important to take advantage of specific abnormalities in the DNA damage response machinery that are present in cancer cells but not in normal cells.  Such properties of cancer cells can provide biomarkers or targets for sensitization.  For example, defects or upregulation of the specific pathways that recognize or repair specific types of DNA damage can serve as biomarkers of favorable or poor response to therapies that induce such types of DNA damage.  Inhibition of a DNA damage response pathway may enhance the therapeutic effects in combination with the DNA-damaging agents.  Moreover, it may also be useful as a monotherapy when it achieves synthetic lethality, in which inhibition of a complementary DNA damage response pathway selectively kills cancer cells that have a defect in a particular DNA repair pathway.  The most striking application of this strategy is the treatment of cancers deficient in homologous recombination by poly(ADP-ribose) polymerase inhibitors.  In this review, we describe the impact of targeting the cancer-specific aberrations in the DNA damage response by explaining how these treatment strategies are currently being evaluated in preclin. or clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNrms7_IuKabVg90H21EOLACvtfcHk0ljh_ZaWfJsRtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvFWitb0%253D&md5=e5484fa4a619052a621c999349ec9b83</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1111%2Fcas.12366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.12366%26sid%3Dliteratum%253Aachs%26aulast%3DHosoya%26aufirst%3DN.%26aulast%3DMiyagawa%26aufirst%3DK.%26atitle%3DTargeting%2520DNA%2520damage%2520response%2520in%2520cancer%2520therapy%26jtitle%3DCancer%2520Sci.%26date%3D2014%26volume%3D105%26spage%3D370%26epage%3D388%26doi%3D10.1111%2Fcas.12366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patra, A. K.</span></span> <span> </span><span class="NLM_article-title">Ruthenium(II) complexes of saccharin with dipyridoquinoxaline and dipyridophenazine: Structures, biological interactions and photoinduced DNA damage activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ejmech.2017.04.076" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=52-62&author=P.+Kumarauthor=S.+Dasariauthor=A.+K.+Patra&title=Ruthenium%28II%29+complexes+of+saccharin+with+dipyridoquinoxaline+and+dipyridophenazine%3A+Structures%2C+biological+interactions+and+photoinduced+DNA+damage+activity&doi=10.1016%2Fj.ejmech.2017.04.076"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.076%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DDasari%26aufirst%3DS.%26aulast%3DPatra%26aufirst%3DA.%2BK.%26atitle%3DRuthenium%2528II%2529%2520complexes%2520of%2520saccharin%2520with%2520dipyridoquinoxaline%2520and%2520dipyridophenazine%253A%2520Structures%252C%2520biological%2520interactions%2520and%2520photoinduced%2520DNA%2520damage%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D136%26spage%3D52%26epage%3D62%26doi%3D10.1016%2Fj.ejmech.2017.04.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sathyaraj, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weyhermüller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, B. U.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization and DNA binding studies of new ruthenium(II)bisterpyridine complexes</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2009.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ejmech.2009.10.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=284-291&author=G.+Sathyarajauthor=T.+Weyherm%C3%BCllerauthor=B.+U.+Nair&title=Synthesis%2C+characterization+and+DNA+binding+studies+of+new+ruthenium%28II%29bisterpyridine+complexes&doi=10.1016%2Fj.ejmech.2009.10.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DSathyaraj%26aufirst%3DG.%26aulast%3DWeyherm%25C3%25BCller%26aufirst%3DT.%26aulast%3DNair%26aufirst%3DB.%2BU.%26atitle%3DSynthesis%252C%2520characterization%2520and%2520DNA%2520binding%2520studies%2520of%2520new%2520ruthenium%2528II%2529bisterpyridine%2520complexes%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D284%26epage%3D291%26doi%3D10.1016%2Fj.ejmech.2009.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arockiasamy, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radhika, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parthasarathi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, B. U.</span></span> <span> </span><span class="NLM_article-title">Synthesis and DNA-binding studies of two ruthenium(II) complexes of an intercalating ligand</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">2044</span>– <span class="NLM_lpage">2051</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2008.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ejmech.2008.10.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=2044-2051&author=D.+L.+Arockiasamyauthor=S.+Radhikaauthor=R.+Parthasarathiauthor=B.+U.+Nair&title=Synthesis+and+DNA-binding+studies+of+two+ruthenium%28II%29+complexes+of+an+intercalating+ligand&doi=10.1016%2Fj.ejmech.2008.10.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2008.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2008.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DArockiasamy%26aufirst%3DD.%2BL.%26aulast%3DRadhika%26aufirst%3DS.%26aulast%3DParthasarathi%26aufirst%3DR.%26aulast%3DNair%26aufirst%3DB.%2BU.%26atitle%3DSynthesis%2520and%2520DNA-binding%2520studies%2520of%2520two%2520ruthenium%2528II%2529%2520complexes%2520of%2520an%2520intercalating%2520ligand%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D2044%26epage%3D2051%26doi%3D10.1016%2Fj.ejmech.2008.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, and anticancer activity of a series of ketone-N(4)-substituted thiosemicarbazones and their ruthenium(II) arene complexes</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">12440</span>– <span class="NLM_lpage">12449</span>, <span class="refDoi"> DOI: 10.1021/ic401362s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic401362s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=12440-12449&author=W.+Suauthor=Q.+Qianauthor=P.+Liauthor=X.+Leiauthor=Q.+Xiaoauthor=S.+Huangauthor=C.+Huangauthor=J.+Cui&title=Synthesis%2C+characterization%2C+and+anticancer+activity+of+a+series+of+ketone-N%284%29-substituted+thiosemicarbazones+and+their+ruthenium%28II%29+arene+complexes&doi=10.1021%2Fic401362s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fic401362s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic401362s%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DW.%26aulast%3DQian%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DCui%26aufirst%3DJ.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520anticancer%2520activity%2520of%2520a%2520series%2520of%2520ketone-N%25284%2529-substituted%2520thiosemicarbazones%2520and%2520their%2520ruthenium%2528II%2529%2520arene%2520complexes%26jtitle%3DInorg.%2520Chem.%26date%3D2013%26volume%3D52%26spage%3D12440%26epage%3D12449%26doi%3D10.1021%2Fic401362s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamatchi, T.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitrapriya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fronczek, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natarajan, K.</span></span> <span> </span><span class="NLM_article-title">Influence of carboxylic acid functionalities in ruthenium (II) polypyridyl complexes on DNA binding, cytotoxicity and antioxidant activity: synthesis, structure and <i>in vitro</i> anticancer activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.11.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ejmech.2012.11.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2013&pages=253-264&author=T.%0AS.+Kamatchiauthor=N.+Chitrapriyaauthor=S.+K.+Kimauthor=F.+R.+Fronczekauthor=K.+Natarajan&title=Influence+of+carboxylic+acid+functionalities+in+ruthenium+%28II%29+polypyridyl+complexes+on+DNA+binding%2C+cytotoxicity+and+antioxidant+activity%3A+synthesis%2C+structure+and+in+vitro+anticancer+activity&doi=10.1016%2Fj.ejmech.2012.11.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.11.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.11.024%26sid%3Dliteratum%253Aachs%26aulast%3DKamatchi%26aufirst%3DT.%2BS.%26aulast%3DChitrapriya%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DS.%2BK.%26aulast%3DFronczek%26aufirst%3DF.%2BR.%26aulast%3DNatarajan%26aufirst%3DK.%26atitle%3DInfluence%2520of%2520carboxylic%2520acid%2520functionalities%2520in%2520ruthenium%2520%2528II%2529%2520polypyridyl%2520complexes%2520on%2520DNA%2520binding%252C%2520cytotoxicity%2520and%2520antioxidant%2520activity%253A%2520synthesis%252C%2520structure%2520and%2520in%2520vitro%2520anticancer%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D59%26spage%3D253%26epage%3D264%26doi%3D10.1016%2Fj.ejmech.2012.11.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Busto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valladolid, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alonso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozano, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalon, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzano, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrion, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biver, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García, B.</span></span> <span> </span><span class="NLM_article-title">Anticancer activity and DNA binding of a bifunctional Ru(II) arene aqua-complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">9962</span>– <span class="NLM_lpage">9974</span>, <span class="refDoi"> DOI: 10.1021/ic401197a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic401197a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=9962-9974&author=N.+Bustoauthor=J.+Valladolidauthor=M.+Martinez-Alonsoauthor=H.+J.+Lozanoauthor=F.+A.+Jalonauthor=B.+R.+Manzanoauthor=A.+M.+Rodriguezauthor=M.+C.+Carrionauthor=T.+Biverauthor=J.+M.+Lealauthor=G.+Espinoauthor=B.+Garc%C3%ADa&title=Anticancer+activity+and+DNA+binding+of+a+bifunctional+Ru%28II%29+arene+aqua-complex+with+the+2%2C4-diamino-6-%282-pyridyl%29-1%2C3%2C5-triazine+ligand&doi=10.1021%2Fic401197a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fic401197a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic401197a%26sid%3Dliteratum%253Aachs%26aulast%3DBusto%26aufirst%3DN.%26aulast%3DValladolid%26aufirst%3DJ.%26aulast%3DMartinez-Alonso%26aufirst%3DM.%26aulast%3DLozano%26aufirst%3DH.%2BJ.%26aulast%3DJalon%26aufirst%3DF.%2BA.%26aulast%3DManzano%26aufirst%3DB.%2BR.%26aulast%3DRodriguez%26aufirst%3DA.%2BM.%26aulast%3DCarrion%26aufirst%3DM.%2BC.%26aulast%3DBiver%26aufirst%3DT.%26aulast%3DLeal%26aufirst%3DJ.%2BM.%26aulast%3DEspino%26aufirst%3DG.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DB.%26atitle%3DAnticancer%2520activity%2520and%2520DNA%2520binding%2520of%2520a%2520bifunctional%2520Ru%2528II%2529%2520arene%2520aqua-complex%2520with%2520the%25202%252C4-diamino-6-%25282-pyridyl%2529-1%252C3%252C5-triazine%2520ligand%26jtitle%3DInorg.%2520Chem.%26date%3D2013%26volume%3D52%26spage%3D9962%26epage%3D9974%26doi%3D10.1021%2Fic401197a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lincoln, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordén, B.</span></span> <span> </span><span class="NLM_article-title">DNA binding geometries of ruthenium(II) complexes with 1,10-phenanthroline and 2,2′-bipyridine ligands studied with linear dichroism spectroscopy. Borderline cases of intercalation</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">9583</span>– <span class="NLM_lpage">9594</span>, <span class="refDoi"> DOI: 10.1021/jp9824914</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp9824914" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=9583-9594&author=P.+Lincolnauthor=B.+Nord%C3%A9n&title=DNA+binding+geometries+of+ruthenium%28II%29+complexes+with+1%2C10-phenanthroline+and+2%2C2%E2%80%B2-bipyridine+ligands+studied+with+linear+dichroism+spectroscopy.+Borderline+cases+of+intercalation&doi=10.1021%2Fjp9824914"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjp9824914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp9824914%26sid%3Dliteratum%253Aachs%26aulast%3DLincoln%26aufirst%3DP.%26aulast%3DNord%25C3%25A9n%26aufirst%3DB.%26atitle%3DDNA%2520binding%2520geometries%2520of%2520ruthenium%2528II%2529%2520complexes%2520with%25201%252C10-phenanthroline%2520and%25202%252C2%25E2%2580%25B2-bipyridine%2520ligands%2520studied%2520with%2520linear%2520dichroism%2520spectroscopy.%2520Borderline%2520cases%2520of%2520intercalation%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D1998%26volume%3D102%26spage%3D9583%26epage%3D9594%26doi%3D10.1021%2Fjp9824914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1021/ja027719m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja027719m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFCnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=173-186&author=H.+Chenauthor=J.+A.+Parkinsonauthor=R.+E.+Morrisauthor=P.+J.+Sadler&title=Highly+selective+binding+of+organometallic+ruthenium+ethylenediamine+complexes+to+nucleic+acids%3A+novel+recognition+mechanisms&doi=10.1021%2Fja027719m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Selective Binding of Organometallic Ruthenium Ethylenediamine Complexes to Nucleic Acids: Novel Recognition Mechanisms</span></div><div class="casAuthors">Chen, Haimei; Parkinson, John A.; Morris, Robert E.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">173-186</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recognition of nucleic acid derivs. by organometallic ruthenium(II) arene anticancer complexes of the type [(η6-arene)Ru(II)(en)X] (en = ethylenediamine, arene = biphenyl (Bip), tetrahydroanthracene (THA), dihydroanthracene (DHA), p-cymene (Cym) or benzene (Ben), X = Cl- or H2O) was studied using 1H, 31P and 15N (15N-en) NMR spectroscopy.  For mononucleosides, [(η6-Bip)Ru(en)]2+ binds only to N7 of guanosine, to N7 and N1 of inosine, and to N3 of thymidine.  Binding to N3 of cytidine was weak, and almost no binding to adenosine was obsd.  The reactivity of the various binding sites of nucleobases toward Ru at neutral pH decreased in the order G(N7) > I(N7) > I(N1), T(N3) > C(N3) > A(N7), A(N1).  Therefore, pseudo-octahedral diamino Ru(II) arene complexes are much more highly discriminatory between G and A bases than square-planar Pt(II) complexes.  Such site-selectivity appears to be controlled by the en NH2 groups, which H-bond with exocyclic oxygens but are nonbonding and repulsive toward exocyclic amino groups of the nucleobases.  For reactions with mononucleotides, the same pattern of site selectivity was obsd., but, in addn., significant amts. of the 5'-phosphate-bound species (40-60%) were present at equil. for 5'-TMP, 5'-CMP and 5'-AMP.  In contrast, no binding to the phosphodiester groups of 3', 5'-cyclic-GMP (cGMP) or cAMP was detected.  Reactions with nucleotides proceeded via aquation of [(η6-arene)Ru(en)Cl]+, followed by rapid binding to the 5'-phosphate, and then rearrangement to give N7, N1, or N3-bound products.  Small amts. of the dinuclear species, e.g., Ru-O(PO3)GMPN7-Ru, Ru-O(PO3)IMPN1-Ru, Ru-O(PO3)TMPN3-Ru, Ru-N7IMPN1-Ru, and Ru-N7InoN1-Ru were also detected.  In competitive binding expts. for [(η6-Bip)Ru(en)Cl]+ with 5'-GMP vs. 5'-AMP or 5'-CMP or 5'-TMP, the only final adduct was [(η6-Bip)Ru(en)(N7-GMP)]. Ru-H2O species were more reactive than Ru-OH species.  The presence of Cl- or phosphate in neutral soln. significantly decreased the rates of Ru-N7 binding through competitive coordination to Ru.  In kinetic studies (pH 7.0, 298 K, 100 mM NaClO4), the rates of reaction of cGMP with {(η6-arene)Ru(II)(en)X}n+ (X = Cl- or H2O) decreased in the order: THA > Bip > DHA >> Cym > Ben, suggesting that N7-binding is promoted by favorable arene-purine hydrophobic interactions in the associative transition state.  These findings have revealed that the diamine NH2 groups, the hydrophobic arene, and the chloride leaving group have important roles in the novel mechanism of recognition of nucleic acids by Ru arene complexes, and will aid the design of more effective anticancer complexes, as well as new site-specific DNA reagents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrarvfTzPmCsLVg90H21EOLACvtfcHk0li32ue_agIhXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFCnsLg%253D&md5=0eeb6544ba9d89d997369cbfebc7a3cd</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fja027719m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja027719m%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DParkinson%26aufirst%3DJ.%2BA.%26aulast%3DMorris%26aufirst%3DR.%2BE.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DHighly%2520selective%2520binding%2520of%2520organometallic%2520ruthenium%2520ethylenediamine%2520complexes%2520to%2520nucleic%2520acids%253A%2520novel%2520recognition%2520mechanisms%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D173%26epage%3D186%26doi%3D10.1021%2Fja027719m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bešker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coletti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Re, N.</span></span> <span> </span><span class="NLM_article-title">Binding of antitumor ruthenium complexes to DNA and proteins: A theoretical approach</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">9955</span>– <span class="NLM_lpage">9964</span>, <span class="refDoi"> DOI: 10.1021/jp072182q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp072182q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2007&pages=9955-9964&author=N.+Be%C5%A1kerauthor=C.+Colettiauthor=A.+Marroneauthor=N.+Re&title=Binding+of+antitumor+ruthenium+complexes+to+DNA+and+proteins%3A+A+theoretical+approach&doi=10.1021%2Fjp072182q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjp072182q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp072182q%26sid%3Dliteratum%253Aachs%26aulast%3DBe%25C5%25A1ker%26aufirst%3DN.%26aulast%3DColetti%26aufirst%3DC.%26aulast%3DMarrone%26aufirst%3DA.%26aulast%3DRe%26aufirst%3DN.%26atitle%3DBinding%2520of%2520antitumor%2520ruthenium%2520complexes%2520to%2520DNA%2520and%2520proteins%253A%2520A%2520theoretical%2520approach%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2007%26volume%3D111%26spage%3D9955%26epage%3D9964%26doi%3D10.1021%2Fjp072182q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caruso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gariboldi, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettinari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettinari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, and antitumor activity of water-soluble (arene)ruthenium(II) derivatives of 1,3-dimethyl-4-acylpyrazolon-5-ato ligands. First example of Ru(arene)(ligand) antitumor species involving simultaneous Ru-N7(guanine) bonding and ligand intercalation to DNA</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3668</span>– <span class="NLM_lpage">3677</span>, <span class="refDoi"> DOI: 10.1021/ic403170y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic403170y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=3668-3677&author=F.+Carusoauthor=E.+Montiauthor=J.+Matthewsauthor=M.+Rossiauthor=M.+B.+Gariboldiauthor=C.+Pettinariauthor=R.+Pettinariauthor=F.+Marchetti&title=Synthesis%2C+characterization%2C+and+antitumor+activity+of+water-soluble+%28arene%29ruthenium%28II%29+derivatives+of+1%2C3-dimethyl-4-acylpyrazolon-5-ato+ligands.+First+example+of+Ru%28arene%29%28ligand%29+antitumor+species+involving+simultaneous+Ru-N7%28guanine%29+bonding+and+ligand+intercalation+to+DNA&doi=10.1021%2Fic403170y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fic403170y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic403170y%26sid%3Dliteratum%253Aachs%26aulast%3DCaruso%26aufirst%3DF.%26aulast%3DMonti%26aufirst%3DE.%26aulast%3DMatthews%26aufirst%3DJ.%26aulast%3DRossi%26aufirst%3DM.%26aulast%3DGariboldi%26aufirst%3DM.%2BB.%26aulast%3DPettinari%26aufirst%3DC.%26aulast%3DPettinari%26aufirst%3DR.%26aulast%3DMarchetti%26aufirst%3DF.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520antitumor%2520activity%2520of%2520water-soluble%2520%2528arene%2529ruthenium%2528II%2529%2520derivatives%2520of%25201%252C3-dimethyl-4-acylpyrazolon-5-ato%2520ligands.%2520First%2520example%2520of%2520Ru%2528arene%2529%2528ligand%2529%2520antitumor%2520species%2520involving%2520simultaneous%2520Ru-N7%2528guanine%2529%2520bonding%2520and%2520ligand%2520intercalation%2520to%2520DNA%26jtitle%3DInorg.%2520Chem.%26date%3D2014%26volume%3D53%26spage%3D3668%26epage%3D3677%26doi%3D10.1021%2Fic403170y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foxon, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wragg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, A. J. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, and DNA binding properties of ruthenium(II) complexes containing the redox active ligand benzo[<i>i</i>]dipyrido[3,2-<i>a</i>:2′,3′-<i>c</i>]phenazine-11,16-quinone</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.1021/ic201914h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic201914h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=463-471&author=S.+P.+Foxonauthor=C.+Greenauthor=M.+G.+Walkerauthor=A.+Wraggauthor=H.+Adamsauthor=J.+A.+Weinsteinauthor=S.+C.+Parkerauthor=A.+J.+H.+M.+Meijerauthor=J.+A.+Thomas&title=Synthesis%2C+characterization%2C+and+DNA+binding+properties+of+ruthenium%28II%29+complexes+containing+the+redox+active+ligand+benzo%5Bi%5Ddipyrido%5B3%2C2-a%3A2%E2%80%B2%2C3%E2%80%B2-c%5Dphenazine-11%2C16-quinone&doi=10.1021%2Fic201914h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fic201914h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic201914h%26sid%3Dliteratum%253Aachs%26aulast%3DFoxon%26aufirst%3DS.%2BP.%26aulast%3DGreen%26aufirst%3DC.%26aulast%3DWalker%26aufirst%3DM.%2BG.%26aulast%3DWragg%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DH.%26aulast%3DWeinstein%26aufirst%3DJ.%2BA.%26aulast%3DParker%26aufirst%3DS.%2BC.%26aulast%3DMeijer%26aufirst%3DA.%2BJ.%2BH.%2BM.%26aulast%3DThomas%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520DNA%2520binding%2520properties%2520of%2520ruthenium%2528II%2529%2520complexes%2520containing%2520the%2520redox%2520active%2520ligand%2520benzo%255Bi%255Ddipyrido%255B3%252C2-a%253A2%25E2%2580%25B2%252C3%25E2%2580%25B2-c%255Dphenazine-11%252C16-quinone%26jtitle%3DInorg.%2520Chem.%26date%3D2012%26volume%3D51%26spage%3D463%26epage%3D471%26doi%3D10.1021%2Fic201914h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elie, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalo, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez
de Mingo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Delgado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadhukha, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contel, M.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo evaluation of water-soluble iminophosphorane ruthenium(II) compounds. A potential chemotherapeutic agent for triple negative breast cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">9995</span>– <span class="NLM_lpage">10012</span>, <span class="refDoi"> DOI: 10.1021/jm5012337</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012337" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKqur3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9995-10012&author=M.+Frikauthor=A.+Martinezauthor=B.+T.+Elieauthor=O.+Gonzaloauthor=D.+Ramirez%0Ade+Mingoauthor=M.+Sanauauthor=R.+Sanchez-Delgadoauthor=T.+Sadhukhaauthor=S.+Prabhaauthor=J.+W.+Ramosauthor=I.+Marzoauthor=M.+Contel&title=In+vitro+and+in+vivo+evaluation+of+water-soluble+iminophosphorane+ruthenium%28II%29+compounds.+A+potential+chemotherapeutic+agent+for+triple+negative+breast+cancer&doi=10.1021%2Fjm5012337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Breast Cancer</span></div><div class="casAuthors">Frik, Malgorzata; Martinez, Alberto; Elie, Benelita T.; Gonzalo, Oscar; Ramirez de Mingo, Daniel; Sanau, Mercedes; Sanchez-Delgado, Roberto; Sadhukha, Tanmoy; Prabha, Swayam; Ramos, Joe W.; Marzo, Isabel; Contel, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9995-10012</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of organometallic ruthenium(II) complexes contg. iminophosphorane ligands have been synthesized and characterized.  Cationic compds. with chloride as counterion are sol. in water (70-100 mg/mL).  Most compds. (esp. highly water-sol. I) are more cytotoxic to a no. of human cancer cell lines than cisplatin.  Initial mechanistic studies indicate that the cell death type for these compds. is mainly through canonical or caspase-dependent apoptosis, nondependent on p53, and that the compds. do not interact with DNA or inhibit protease cathepsin B.  In vivo expts. of I on MDA-MB-231 xenografts in NOD.CB17-Prkdc SCID/J mice showed an impressive tumor redn. (shrinkage) of 56% after 28 days of treatment (14 doses of 5 mg/kg every other day) with low systemic toxicity.  Pharmacokinetic studies showed a quick absorption of I in plasma with preferential accumulation in the breast tumor tissues when compared to kidney and liver, which may explain its high efficacy in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsRq4axNxQnbVg90H21EOLACvtfcHk0li32ue_agIhXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKqur3M&md5=6f5f53172aeae72fe6f7c73646c3b878</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm5012337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012337%26sid%3Dliteratum%253Aachs%26aulast%3DFrik%26aufirst%3DM.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DElie%26aufirst%3DB.%2BT.%26aulast%3DGonzalo%26aufirst%3DO.%26aulast%3DRamirez%2Bde%2BMingo%26aufirst%3DD.%26aulast%3DSanau%26aufirst%3DM.%26aulast%3DSanchez-Delgado%26aufirst%3DR.%26aulast%3DSadhukha%26aufirst%3DT.%26aulast%3DPrabha%26aufirst%3DS.%26aulast%3DRamos%26aufirst%3DJ.%2BW.%26aulast%3DMarzo%26aufirst%3DI.%26aulast%3DContel%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520evaluation%2520of%2520water-soluble%2520iminophosphorane%2520ruthenium%2528II%2529%2520compounds.%2520A%2520potential%2520chemotherapeutic%2520agent%2520for%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9995%26epage%3D10012%26doi%3D10.1021%2Fjm5012337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, X. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L. N.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, DNA-binding and DNA-photocleavage studies of [Ru(bpy)<sub>2</sub>(pmip)]<sup>2+</sup> and [Ru(phen)<sub>2</sub>(pmip)]<sup>2+</sup> (pmip = 2-(2′-pyrimidyl)imidazo[4,5-<i>f</i> ][1,10]phenanthroline</span>. <i>Polyhedron</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">1361</span>, <span class="refDoi"> DOI: 10.1016/j.poly.2009.02.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.poly.2009.02.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=1355-1361&author=S.+Shiauthor=T.+Xieauthor=T.+M.+Yaoauthor=C.+R.+Wangauthor=X.+T.+Gengauthor=D.+J.+Yangauthor=L.+J.+Hanauthor=L.+N.+Ji&title=Synthesis%2C+characterization%2C+DNA-binding+and+DNA-photocleavage+studies+of+%5BRu%28bpy%292%28pmip%29%5D2%2B+and+%5BRu%28phen%292%28pmip%29%5D2%2B+%28pmip+%3D+2-%282%E2%80%B2-pyrimidyl%29imidazo%5B4%2C5-f+%5D%5B1%2C10%5Dphenanthroline&doi=10.1016%2Fj.poly.2009.02.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.poly.2009.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.poly.2009.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DT.%26aulast%3DYao%26aufirst%3DT.%2BM.%26aulast%3DWang%26aufirst%3DC.%2BR.%26aulast%3DGeng%26aufirst%3DX.%2BT.%26aulast%3DYang%26aufirst%3DD.%2BJ.%26aulast%3DHan%26aufirst%3DL.%2BJ.%26aulast%3DJi%26aufirst%3DL.%2BN.%26atitle%3DSynthesis%252C%2520characterization%252C%2520DNA-binding%2520and%2520DNA-photocleavage%2520studies%2520of%2520%255BRu%2528bpy%25292%2528pmip%2529%255D2%252B%2520and%2520%255BRu%2528phen%25292%2528pmip%2529%255D2%252B%2520%2528pmip%2520%253D%25202-%25282%25E2%2580%25B2-pyrimidyl%2529imidazo%255B4%252C5-f%2520%255D%255B1%252C10%255Dphenanthroline%26jtitle%3DPolyhedron%26date%3D2009%26volume%3D28%26spage%3D1355%26epage%3D1361%26doi%3D10.1016%2Fj.poly.2009.02.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span> <span> </span><span class="NLM_article-title">Targeting nucleus DNA with a cyclometalated dipyridophenazine ruthenium(II) complex</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8971</span>– <span class="NLM_lpage">8983</span>, <span class="refDoi"> DOI: 10.1021/jm501095r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501095r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8971-8983&author=H.+Huangauthor=P.+Zhangauthor=B.+Yuauthor=Y.+Chenauthor=J.+Wangauthor=L.+Jiauthor=H.+Chao&title=Targeting+nucleus+DNA+with+a+cyclometalated+dipyridophenazine+ruthenium%28II%29+complex&doi=10.1021%2Fjm501095r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm501095r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501095r%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26atitle%3DTargeting%2520nucleus%2520DNA%2520with%2520a%2520cyclometalated%2520dipyridophenazine%2520ruthenium%2528II%2529%2520complex%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8971%26epage%3D8983%26doi%3D10.1021%2Fjm501095r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. J.</span></span> <span> </span><span class="NLM_article-title">Protein binding and anticancer activity studies of ruthenium(II) polypyridyl complexes toward BEL-7402 cells</span>. <i>J. Photochem. Photobiol., B</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2016.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jphotobiol.2016.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=26945645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1yhu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2016&pages=39-48&author=S.+H.+Laiauthor=W.+Liauthor=J.+H.+Yaoauthor=B.+J.+Hanauthor=G.+B.+Jiangauthor=C.+Zhangauthor=C.+C.+Zengauthor=Y.+J.+Liu&title=Protein+binding+and+anticancer+activity+studies+of+ruthenium%28II%29+polypyridyl+complexes+toward+BEL-7402+cells&doi=10.1016%2Fj.jphotobiol.2016.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Protein binding and anticancer activity studies of ruthenium(II) polypyridyl complexes toward BEL-7402 cells</span></div><div class="casAuthors">Lai, Shang-Hai; Li, Wei; Yao, Jun-Hua; Han, Bing-Jie; Jiang, Guang-Bin; Zhang, Cheng; Zeng, Chuan-Chuan; Liu, Yun-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39-48</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Four new ruthenium(II) polypyridyl complexes [Ru(dmb)2(dqtbt)](ClO4)2 (1) (dqtbt = 12-(2,3-diphenyl-quinoxalin-6-yl)-4,5,10,13-tetraazabenzo[b]triphenylene, dmb = 4,4'-dimethyl-2,2'-bipyridine), [Ru(bpy)2(dqtbt)](ClO4)2 (2) (bpy = 2,2'-bipyridine), [Ru(phen)2(dqtbt)](ClO4)2 (3) (phen = 1,10-phenanthroline) and [Ru(dmp)2(dqtbt)](ClO4)2 (4) (dmp = 2,9-dimethyl-1,10-phenanthroline) were synthesized and characterized.  The cytotoxicity in vitro of the complexes was evaluated against human BEL-7402, A549, HeLa, HepG-2 and MG-63 cancer cell lines.  These complexes are sensitive to BEL-7402 cells, the IC50 values are 4.9 ± 0.5, 4.6 ± 0.4, 7.7 ± 1.8 and 1.9 ± 0.3 μM toward BEL-7402 cells.  The complexes can increase the levels of reactive oxygen species and induce the decrease of mitochondrial membrane potential.  Morphol. and comet assay studies show that the complexes can effectively induce apoptosis in BEL-7402 cells.  Complexes 1-4 inhibit the cell growth at G0/G1 phase in BEL-7402 cell line.  The complexes can downregulate the expression of Bcl-2 and Bcl-x proteins and upregulate the levels of Bid protein in BEL-7402 cells.  The results show that the complexes induce BEL-7402 cell apoptosis through a ROS-mediated mitochondrial dysfunction pathway.  In addn., the complexes show strong protein-binding affinities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTeunpIXY6O7Vg90H21EOLACvtfcHk0lgS9gbyut595A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1yhu7o%253D&md5=16ee8ad22ec41491a82f3c9b606b5866</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2016.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2016.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DS.%2BH.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DYao%26aufirst%3DJ.%2BH.%26aulast%3DHan%26aufirst%3DB.%2BJ.%26aulast%3DJiang%26aufirst%3DG.%2BB.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZeng%26aufirst%3DC.%2BC.%26aulast%3DLiu%26aufirst%3DY.%2BJ.%26atitle%3DProtein%2520binding%2520and%2520anticancer%2520activity%2520studies%2520of%2520ruthenium%2528II%2529%2520polypyridyl%2520complexes%2520toward%2520BEL-7402%2520cells%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%252C%2520B%26date%3D2016%26volume%3D158%26spage%3D39%26epage%3D48%26doi%3D10.1016%2Fj.jphotobiol.2016.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Čanović, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simović, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radisavljević, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bratsos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demitri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitrović, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bugarčić, Z. D.</span></span> <span> </span><span class="NLM_article-title">Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1007</span>– <span class="NLM_lpage">1028</span>, <span class="refDoi"> DOI: 10.1007/s00775-017-1479-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1007%2Fs00775-017-1479-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28695374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFCrt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1007-1028&author=P.+%C4%8Canovi%C4%87author=A.+R.+Simovi%C4%87author=S.+Radisavljevi%C4%87author=I.+Bratsosauthor=N.+Demitriauthor=M.+Mitrovi%C4%87author=I.+Zelenauthor=Z.+D.+Bugar%C4%8Di%C4%87&title=Impact+of+aromaticity+on+anticancer+activity+of+polypyridyl+ruthenium%28II%29+complexes%3A+synthesis%2C+structure%2C+DNA%2Fprotein+binding%2C+lipophilicity+and+anticancer+activity&doi=10.1007%2Fs00775-017-1479-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity</span></div><div class="casAuthors">Canovic, Petar; Simovic, Ana Rilak; Radisavljevic, Snezana; Bratsos, Ioannis; Demitri, Nicola; Mitrovic, Marina; Zelen, Ivanka; Bugarcic, Zivadin D.</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1028</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Abstr.: With the aim of assessing how the aromaticity of the inert chelating ligand can influence the activity of ruthenium(II) polypyridyl complexes, two new monofunctional ruthenium(II) complexes, [Ru(Cl-Ph-tpy)(phen)Cl]Cl (1) and [Ru(Cl-Ph-tpy)(o-bqdi)Cl]Cl (2) (where Cl-Ph-tpy = 4'-(4-chlorophenyl)-2,2':6',2''-terpyridine, phen = 1,10-phenanthroline, o-bqdi = o-benzoquinonediimine), were synthesized.  All complexes were fully characterized by elemental anal. and spectroscopic techniques (IR, UV-Vis, 1D and 2D NMR, XRD).  Their chem. behavior in aq. soln. was studied by UV-Vis and NMR spectroscopy showing that both compds. are relatively labile leading to the formation of the corresponding aqua species 1a and 2a. 1H NMR spectroscopy studies performed on complexes 1 and 2 demonstrated that after the hydrolysis of the Cl ligand, they are capable to interact with guanine derivs. (i.e., 9-methylguanine (9MeG) and 5'-GMP) through the N7, forming monofunctional adduct.  The kinetics and the mechanism of the reaction of complexes 1 and 2 with the biol. more relevant 5'-GMP ligand were studied by UV-Vis spectroscopy.  DNA/protein interactions of the complexes have been examd. by photophys. studies, which demonstrated a bifunctional binding mode of the complexes with DNA and the complexes strongly quench the fluorescence intensity of bovine serum albumin (BSA) through the mechanism of both static and dynamic quenching.  Complexes 1 and 2 strongly induced apoptosis of treated cancer cells with high percentages of apoptotic cells and negligible percentage of necrotic cells.  In addn., both ruthenium complexes decreased Bcl-2/Bax ratio causing cytochrome c mitochondrial release, the activation of caspase-3 and induction of apoptosis.  Graphical Abstr.: [Figure not available: see fulltext.].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLs52nvOspf7Vg90H21EOLACvtfcHk0lgS9gbyut595A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFCrt77J&md5=0744e0901c1da0af41f8a8c9804cf32c</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs00775-017-1479-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-017-1479-7%26sid%3Dliteratum%253Aachs%26aulast%3D%25C4%258Canovi%25C4%2587%26aufirst%3DP.%26aulast%3DSimovi%25C4%2587%26aufirst%3DA.%2BR.%26aulast%3DRadisavljevi%25C4%2587%26aufirst%3DS.%26aulast%3DBratsos%26aufirst%3DI.%26aulast%3DDemitri%26aufirst%3DN.%26aulast%3DMitrovi%25C4%2587%26aufirst%3DM.%26aulast%3DZelen%26aufirst%3DI.%26aulast%3DBugar%25C4%258Di%25C4%2587%26aufirst%3DZ.%2BD.%26atitle%3DImpact%2520of%2520aromaticity%2520on%2520anticancer%2520activity%2520of%2520polypyridyl%2520ruthenium%2528II%2529%2520complexes%253A%2520synthesis%252C%2520structure%252C%2520DNA%252Fprotein%2520binding%252C%2520lipophilicity%2520and%2520anticancer%2520activity%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2017%26volume%3D22%26spage%3D1007%26epage%3D1028%26doi%3D10.1007%2Fs00775-017-1479-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heffeter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atil, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reza Hoda, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Körner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jungwirth, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micksche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koellensperger, G.</span></span> <span> </span><span class="NLM_article-title">Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1007/s00775-010-0642-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1007%2Fs00775-010-0642-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=20221888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVWrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=737-748&author=P.+Heffeterauthor=K.+B%C3%B6ckauthor=B.+Atilauthor=M.+A.+Reza+Hodaauthor=W.+K%C3%B6rnerauthor=C.+Bartelauthor=U.+Jungwirthauthor=B.+K.+Kepplerauthor=M.+Mickscheauthor=W.+Bergerauthor=G.+Koellensperger&title=Intracellular+protein+binding+patterns+of+the+anticancer+ruthenium+drugs+KP1019+and+KP1339&doi=10.1007%2Fs00775-010-0642-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339</span></div><div class="casAuthors">Heffeter, Petra; Boeck, Katharina; Atil, Bihter; Hoda, Mir Ali Reza; Koerner, Wilfried; Bartel, Caroline; Jungwirth, Ute; Keppler, Bernhard K.; Micksche, Michael; Berger, Walter; Koellensperger, Gunda</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">737-748</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The ruthenium compd. KP1019 has demonstrated promising anticancer activity in a pilot clin. trial.  This study aims to evaluate the intracellular uptake/binding patterns of KP1019 and its sodium salt KP1339, which is currently in a phase I-IIa study.  Although KP1339 tended to be moderately less cytotoxic than KP1019, IC50 values in several cancer cell models revealed significant correlation of the cytotoxicity profiles, suggesting similar targets for the two drugs.  Accordingly, both drugs activated apoptosis, indicated by caspase activation via comparable pathways.  Drug uptake detd. by inductively coupled plasma mass spectrometry (ICP-MS) was completed after 1 h, corresponding to full cytotoxicity as early as after 3 h of drug exposure.  Surprisingly, the total cellular drug uptake did not correlate with cytotoxicity.  However, distinct differences in intracellular distribution patterns suggested that the major targets for the two ruthenium drugs are cytosolic rather than nuclear.  Consequently, drug-protein binding in cytosolic fractions of drug-treated cells was analyzed by native size-exclusion chromatog. (SEC) coupled online with ICP-MS.  Ruthenium-protein binding of KP1019- and KP1339-treated cells distinctly differed from the platinum binding pattern obsd. after cisplatin treatment.  An adapted SEC-SEC-ICP-MS system identified large protein complexes/aggregates above 700 kDa as initial major binding partners in the cytosol, followed by ruthenium redistribution to the sol. protein wt. fraction below 40 kDa.  Taken together, our data indicate that KP1019 and KP1339 rapidly enter tumor cells, followed by binding to larger protein complexes/organelles.  The different protein binding patterns as compared with those for cisplatin suggest specific protein targets and consequently a unique mode of action for the ruthenium drugs investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEoJ1NMqGFDbVg90H21EOLACvtfcHk0lieYRy0HU6V2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVWrtr4%253D&md5=7ac9cd4c320cb6a888eedccfabd2bbc2</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1007%2Fs00775-010-0642-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-010-0642-1%26sid%3Dliteratum%253Aachs%26aulast%3DHeffeter%26aufirst%3DP.%26aulast%3DB%25C3%25B6ck%26aufirst%3DK.%26aulast%3DAtil%26aufirst%3DB.%26aulast%3DReza%2BHoda%26aufirst%3DM.%2BA.%26aulast%3DK%25C3%25B6rner%26aufirst%3DW.%26aulast%3DBartel%26aufirst%3DC.%26aulast%3DJungwirth%26aufirst%3DU.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26aulast%3DMicksche%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DKoellensperger%26aufirst%3DG.%26atitle%3DIntracellular%2520protein%2520binding%2520patterns%2520of%2520the%2520anticancer%2520ruthenium%2520drugs%2520KP1019%2520and%2520KP1339%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2010%26volume%3D15%26spage%3D737%26epage%3D748%26doi%3D10.1007%2Fs00775-010-0642-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabbiani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorrentino, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigobello, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bindoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geldbach, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Re, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartinger, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messori, L.</span></span> <span> </span><span class="NLM_article-title">Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">6773</span>– <span class="NLM_lpage">6781</span>, <span class="refDoi"> DOI: 10.1021/jm8006678</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8006678" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SjtrnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6773-6781&author=A.+Casiniauthor=C.+Gabbianiauthor=F.+Sorrentinoauthor=M.+P.+Rigobelloauthor=A.+Bindoliauthor=T.+J.+Geldbachauthor=A.+Marroneauthor=N.+Reauthor=C.+G.+Hartingerauthor=P.+J.+Dysonauthor=L.+Messori&title=Emerging+protein+targets+for+anticancer+metallodrugs%3A+inhibition+of+thioredoxin+reductase+and+cathepsin+B+by+antitumor+ruthenium%28II%29-arene+compounds&doi=10.1021%2Fjm8006678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging Protein Targets for Anticancer Metallodrugs: Inhibition of Thioredoxin Reductase and Cathepsin B by Antitumor Ruthenium(II)-Arene Compounds</span></div><div class="casAuthors">Casini, Angela; Gabbiani, Chiara; Sorrentino, Francesca; Rigobello, Maria Pia; Bindoli, Alberto; Geldbach, Tilmann J.; Marrone, Alessandro; Re, Nazzareno; Hartinger, Christian G.; Dyson, Paul J.; Messori, Luigi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6773-6781</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of ruthenium(II)-arene (RAPTA) compds. were evaluated for their ability to inhibit thioredoxin reductase (either cytosolic or mitochondrial) and cathepsin B, two possible targets for anticancer metallodrugs.  In general, inhibition of the thioredoxin reductases was lower than that of cathepsin B, although selected compds. were excellent inhibitors of both classes of enzymes in comparison to other metal-based drugs.  Some initial structure-activity relationships could be established.  On the basis of the obtained data, different mechanisms of binding/inhibition appear to be operative; remarkably the selectivity of the ruthenium compds. toward solid metastatic tumors also correlates to the obsd. trends.  Notably, docking studies of the interactions of representative RAPTA compds. with cathepsin B were performed that provided realistic structures for the resulting protein-metallodrug adducts.  Good agreement was generally found between the inhibiting potency of the RAPTA compds. and the computed stability of the corresponding cat B/RAPTA adducts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp31mwpgTGSJrVg90H21EOLACvtfcHk0lieYRy0HU6V2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SjtrnP&md5=b0476c1489528084f704025bd416dbc3</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm8006678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8006678%26sid%3Dliteratum%253Aachs%26aulast%3DCasini%26aufirst%3DA.%26aulast%3DGabbiani%26aufirst%3DC.%26aulast%3DSorrentino%26aufirst%3DF.%26aulast%3DRigobello%26aufirst%3DM.%2BP.%26aulast%3DBindoli%26aufirst%3DA.%26aulast%3DGeldbach%26aufirst%3DT.%2BJ.%26aulast%3DMarrone%26aufirst%3DA.%26aulast%3DRe%26aufirst%3DN.%26aulast%3DHartinger%26aufirst%3DC.%2BG.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DMessori%26aufirst%3DL.%26atitle%3DEmerging%2520protein%2520targets%2520for%2520anticancer%2520metallodrugs%253A%2520inhibition%2520of%2520thioredoxin%2520reductase%2520and%2520cathepsin%2520B%2520by%2520antitumor%2520ruthenium%2528II%2529-arene%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6773%26epage%3D6781%26doi%3D10.1021%2Fjm8006678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghobrial, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witzig, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adjei, A. A.</span></span> <span> </span><span class="NLM_article-title">Targeting apoptosis pathways in cancer therapy</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">178</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.3322/canjclin.55.3.178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.3322%2Fcanjclin.55.3.178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=15890640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A280%3ADC%252BD2M3ltFSrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=178-194&author=I.+M.+Ghobrialauthor=T.+E.+Witzigauthor=A.+A.+Adjei&title=Targeting+apoptosis+pathways+in+cancer+therapy&doi=10.3322%2Fcanjclin.55.3.178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting apoptosis pathways in cancer therapy</span></div><div class="casAuthors">Ghobrial Irene M; Witzig Thomas E; Adjei Alex A</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">178-94</span>
        ISSN:<span class="NLM_cas:issn">0007-9235</span>.
    </div><div class="casAbstract">Apoptosis, or programmed cell death, is a mechanism by which cells undergo death to control cell proliferation or in response to DNA damage.  The understanding of apoptosis has provided the basis for novel targeted therapies that can induce death in cancer cells or sensitize them to established cytotoxic agents and radiation therapy.  These novel agents include those targeting the extrinsic pathway such as tumor necrosis factor-related apoptosis-inducing ligand receptor 1, and those targeting the intrinsic Bcl-2 family pathway such as antisense bcl-2 oligonucleotides.  Many pathways and proteins control the apoptosis machinery.  Examples include p53, the nuclear factor kappa B, the phosphatidylinositol 3 kinase pathway, and the ubiquitin/proteosome pathway.  These can be targeted by specific modulators such as bortezomib, and mammalian target of rapamycin inhibitors such as CCI-779 and RAD 001.  Because these pathways may be preferentially altered in tumor cells, there is potential for a selective effect in tumors sparing normal tissue.  This article reviews the current understanding of the apoptotic pathways, including the extrinsic (cytoplasmic) and intrinsic (mitochondrial) pathways, and the agents being developed to target these pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLw6UbhfjAnfcsfMJQC1ZdfW6udTcc2ebT65l_wykWO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M3ltFSrsw%253D%253D&md5=4d3abeedf409e92fdd2c39ba33c79252</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.3322%2Fcanjclin.55.3.178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcanjclin.55.3.178%26sid%3Dliteratum%253Aachs%26aulast%3DGhobrial%26aufirst%3DI.%2BM.%26aulast%3DWitzig%26aufirst%3DT.%2BE.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26atitle%3DTargeting%2520apoptosis%2520pathways%2520in%2520cancer%2520therapy%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2005%26volume%3D55%26spage%3D178%26epage%3D194%26doi%3D10.3322%2Fcanjclin.55.3.178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S.</span></span> <span> </span><span class="NLM_article-title">Apoptosis: A review of programmed cell death</span>. <i>Toxicol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1080/01926230701320337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1080%2F01926230701320337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=17562483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtlWmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=495-516&author=S.+Elmore&title=Apoptosis%3A+A+review+of+programmed+cell+death&doi=10.1080%2F01926230701320337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis: A Review of Programmed Cell Death</span></div><div class="casAuthors">Elmore, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">495-516</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The process of programmed cell death, or apoptosis, is generally characterized by distinct morphol. characteristics and energy-dependent biochem. mechanisms.  Apoptosis is considered a vital component of various processes including normal cell turnover, proper development and functioning of the immune system, hormone-dependent atrophy, embryonic development and chem.-induced cell death.  Inappropriate apoptosis (either too little or too much) is a factor in many human conditions including neurodegenerative diseases, ischemic damage, autoimmune disorders and many types of cancer.  The ability to modulate the life or death of a cell is recognized for its immense therapeutic potential.  Therefore, research continues to focus on the elucidation and anal. of the cell cycle machinery and signaling pathways that control cell cycle arrest and apoptosis.  To that end, the field of apoptosis research has been moving forward at an alarmingly rapid rate.  Although many of the key apoptotic proteins have been identified, the mol. mechanisms of action or inaction of these proteins remain to be elucidated.  The goal of this review is to provide a general overview of current knowledge on the process of apoptosis including morphol., biochem., the role of apoptosis in health and disease, detection methods, as well as a discussion of potential alternative forms of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOnYsGFlMYFbVg90H21EOLACvtfcHk0ljsjvHuy__XaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtlWmtb4%253D&md5=0f5e4a0a17cbfae1c7b3246eb1245e52</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1080%2F01926230701320337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F01926230701320337%26sid%3Dliteratum%253Aachs%26aulast%3DElmore%26aufirst%3DS.%26atitle%3DApoptosis%253A%2520A%2520review%2520of%2520programmed%2520cell%2520death%26jtitle%3DToxicol.%2520Pathol.%26date%3D2007%26volume%3D35%26spage%3D495%26epage%3D516%26doi%3D10.1080%2F01926230701320337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, W.</span></span> <span> </span><span class="NLM_article-title">Ruthenium(II) complexes as potential apoptosis inducers in chemotherapy</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.2174/1871520616666160622085441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2174%2F1871520616666160622085441" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=29-39&author=K.+Zhengauthor=Q.+Wuauthor=C.+Wangauthor=W.+Tanauthor=W.+Mei&title=Ruthenium%28II%29+complexes+as+potential+apoptosis+inducers+in+chemotherapy&doi=10.2174%2F1871520616666160622085441"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.2174%2F1871520616666160622085441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871520616666160622085441%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DMei%26aufirst%3DW.%26atitle%3DRuthenium%2528II%2529%2520complexes%2520as%2520potential%2520apoptosis%2520inducers%2520in%2520chemotherapy%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2017%26volume%3D17%26spage%3D29%26epage%3D39%26doi%3D10.2174%2F1871520616666160622085441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and anticancer properties of ruthenium (II) complexes as potent apoptosis inducers through mitochondrial disruption</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.07.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ejmech.2017.07.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28800456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSls7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=180-190&author=D.+Wanauthor=B.+Tangauthor=Y.+J.+Wangauthor=B.+H.+Guoauthor=H.+Yinauthor=Q.+Y.+Yiauthor=Y.+J.+Liu&title=Synthesis+and+anticancer+properties+of+ruthenium+%28II%29+complexes+as+potent+apoptosis+inducers+through+mitochondrial+disruption&doi=10.1016%2Fj.ejmech.2017.07.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and anticancer properties of ruthenium (II) complexes as potent apoptosis inducers through mitochondrial disruption</span></div><div class="casAuthors">Wan, Dan; Tang, Bing; Wang, Yang-Jie; Guo, Bo-Hong; Yin, Hui; Yi, Qiao-Yan; Liu, Yun-Jun</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">180-190</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A new ligand MHPIP (MHPIP = 2-(1-methyl-1H-pyrazol-4-yl)-1H-imidazo[4,5-f][1,10]phenanthroline) and its three ruthenium (II) complexes [Ru(N-N)2(MHPIP)](ClO4)2 (N-N = phen: 1,10-phenanthroline 1; dmp = 2,9-dimethyl-1,10-phenanthroline 2; ttbpy = 4,4'-ditertiarybutyl-2,2'-bipyridine 3) were synthesized and characterized.  The cytotoxic activity in vitro was studied by MTT method.  The complexes 1-3 show moderate cytotoxic effects on the cell growth in HepG2 cells with an IC50 value of 25.5 ± 3.5, 35.6 ± 1.9 and 27.4 ± 2.3 μM, resp.  The apoptosis was investigated with AO/EB and Annex V/PI staining methods and comet assay.  The reactive oxygen species, mitochondrial membrane potential were investigated under a fluorescent microscope.  Autophagy assay shows that the complexes can cause autophagy and up-regulate the expression of Beclin-1 protein.  Addnl., the complexes inhibit the cell growth in HepG2 cells at G0/G1 phase, and the complexes can regulate the expression of caspase-3 and Bcl-2 family proteins.  The complexes induce apoptosis in HepG2 cells through DNA damage and ROS-mediated mitochondrial dysfunction pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBFjnmKY3YzrVg90H21EOLACvtfcHk0ljsjvHuy__XaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSls7fK&md5=4480f3a3257d2e3b6b6333ea35990724</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.07.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.07.066%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%2BJ.%26aulast%3DGuo%26aufirst%3DB.%2BH.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DYi%26aufirst%3DQ.%2BY.%26aulast%3DLiu%26aufirst%3DY.%2BJ.%26atitle%3DSynthesis%2520and%2520anticancer%2520properties%2520of%2520ruthenium%2520%2528II%2529%2520complexes%2520as%2520potent%2520apoptosis%2520inducers%2520through%2520mitochondrial%2520disruption%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D139%26spage%3D180%26epage%3D190%26doi%3D10.1016%2Fj.ejmech.2017.07.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. S.</span></span> <span> </span><span class="NLM_article-title">Ruthenium polypyridyl complexes that induce mitochondria-mediated apoptosis in cancer cells</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6366</span>– <span class="NLM_lpage">6368</span>, <span class="refDoi"> DOI: 10.1021/ic100277w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic100277w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFyqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6366-6368&author=T.+Chenauthor=Y.+Liuauthor=W.+J.+Zhengauthor=J.+Liuauthor=Y.+S.+Wong&title=Ruthenium+polypyridyl+complexes+that+induce+mitochondria-mediated+apoptosis+in+cancer+cells&doi=10.1021%2Fic100277w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium Polypyridyl Complexes That Induce Mitochondria-Mediated Apoptosis in Cancer Cells</span></div><div class="casAuthors">Chen, Tianfeng; Liu, Yanan; Zheng, Wen-Jie; Liu, Jie; Wong, Yum-Shing</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6366-6368</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The limitations of cisplatin-based chemotherapy, including high toxicity, undesirable side effects, and drug resistance, have motivated extensive investigations into alternative metal-based cancer therapies.  Ruthenium (Ru) possesses several favorable properties suited to rational anticancer drug design and biol. applications.  In the present study, we synthesized a series of ruthenium polypyridyl complexes contg. N,N-chelating ligands, examd. their anticancer activities, and elucidated the mol. mechanisms through which they caused the cancer cell death.  The results demonstrated that [Ru(phen)2-p-MOPIP](PF6)2·2H2O (RuPOP), a complex with potent antiproliferative activity, is able to induce mitochondria-mediated and caspase-dependent apoptosis in human cancer cells.  On the basis of these results, we suggest that RuPOP may be a candidate for further evaluation as a chemopreventive and chemotherapeutic agent for human cancers, esp. for melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK3CCg7D3hOLVg90H21EOLACvtfcHk0lji-RqwOcd8iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFyqsL8%253D&md5=5b73dac8b2f844d4c31d6bd081a7f5f0</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fic100277w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic100277w%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DW.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DY.%2BS.%26atitle%3DRuthenium%2520polypyridyl%2520complexes%2520that%2520induce%2520mitochondria-mediated%2520apoptosis%2520in%2520cancer%2520cells%26jtitle%3DInorg.%2520Chem.%26date%3D2010%26volume%3D49%26spage%3D6366%26epage%3D6368%26doi%3D10.1021%2Fic100277w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. J.</span></span> <span> </span><span class="NLM_article-title">Ruthenium(II) complexes: DNA-binding, cytotoxicity, apoptosis, cellular localization, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential and western blot analysis</span>. <i>J. Photochem. Photobiol., B</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2014.07.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jphotobiol.2014.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=25108205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Kqsr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2014&pages=94-104&author=W.+Liauthor=G.+W.+Jiangauthor=J.+H.+Yaoauthor=X.+Z.+Wangauthor=J.+Wangauthor=B.+J.+Hanauthor=Y.+Y.+Xieauthor=G.+J.+Linauthor=H.+L.+Huangauthor=Y.+J.+Liu&title=Ruthenium%28II%29+complexes%3A+DNA-binding%2C+cytotoxicity%2C+apoptosis%2C+cellular+localization%2C+cell+cycle+arrest%2C+reactive+oxygen+species%2C+mitochondrial+membrane+potential+and+western+blot+analysis&doi=10.1016%2Fj.jphotobiol.2014.07.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium(II) complexes: DNA-binding, cytotoxicity, apoptosis, cellular localization, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential and western blot analysis</span></div><div class="casAuthors">Li, Wei; Jiang, Guang-Bin; Yao, Jun-Hua; Wang, Xiu-Zhen; Wang, Ji; Han, Bing-Jie; Xie, Yang-Yin; Lin, Gan-Jian; Huang, Hong-Liang; Liu, Yun-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">94-104</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The aim of our study was to investigate DNA-binding and cytotoxic activity of the four new Ru(II) polypyridyl complexes [Ru(dmb)2(HMHPIP)](ClO4)2 (1), [Ru(bpy)2(HMHPIP)](ClO4)2 (2), [Ru(phen)2(HMHPIP)](ClO4)2 (3) and [Ru(dmp)2(HMHPIP)](ClO4)2 (4).  The complexes interact with DNA through intercalative mode and show relatively high cytotoxic activity against A549 cells, no cytotoxicity toward MG-63 cells.  Complexes 1-4 can enhance the levels of ROS in A549 cells and induce the decrease of the mitochondrial membrane potential.  These complexes inhibit the cell growth in A549 cells at G0/G1 or S phase.  Complex 3 activated caspase 7, and down-regulated the expression of the anti-apoptotic protein Bcl-2.  Complexes 1-4 induce apoptosis in A549 cells through ROS-mediated mitochondrial dysfunction pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmiX4GYtV-pbVg90H21EOLACvtfcHk0lji-RqwOcd8iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Kqsr7J&md5=de43b46ff2feae8af918450a6ba09287</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2014.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2014.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DG.%2BW.%26aulast%3DYao%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DX.%2BZ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DB.%2BJ.%26aulast%3DXie%26aufirst%3DY.%2BY.%26aulast%3DLin%26aufirst%3DG.%2BJ.%26aulast%3DHuang%26aufirst%3DH.%2BL.%26aulast%3DLiu%26aufirst%3DY.%2BJ.%26atitle%3DRuthenium%2528II%2529%2520complexes%253A%2520DNA-binding%252C%2520cytotoxicity%252C%2520apoptosis%252C%2520cellular%2520localization%252C%2520cell%2520cycle%2520arrest%252C%2520reactive%2520oxygen%2520species%252C%2520mitochondrial%2520membrane%2520potential%2520and%2520western%2520blot%2520analysis%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%252C%2520B%26date%3D2014%26volume%3D140%26spage%3D94%26epage%3D104%26doi%3D10.1016%2Fj.jphotobiol.2014.07.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castonguay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doucet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juhas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maysinger, D.</span></span> <span> </span><span class="NLM_article-title">New ruthenium(II)–letrozole complexes as anticancer therapeutics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8799</span>– <span class="NLM_lpage">8806</span>, <span class="refDoi"> DOI: 10.1021/jm301103y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301103y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8799-8806&author=A.+Castonguayauthor=C.+Doucetauthor=M.+Juhasauthor=D.+Maysinger&title=New+ruthenium%28II%29%E2%80%93letrozole+complexes+as+anticancer+therapeutics&doi=10.1021%2Fjm301103y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fjm301103y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301103y%26sid%3Dliteratum%253Aachs%26aulast%3DCastonguay%26aufirst%3DA.%26aulast%3DDoucet%26aufirst%3DC.%26aulast%3DJuhas%26aufirst%3DM.%26aulast%3DMaysinger%26aufirst%3DD.%26atitle%3DNew%2520ruthenium%2528II%2529%25E2%2580%2593letrozole%2520complexes%2520as%2520anticancer%2520therapeutics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8799%26epage%3D8806%26doi%3D10.1021%2Fjm301103y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span> <span> </span><span class="NLM_article-title">Nuclear permeable ruthenium(II) β-carboline complexes induce autophagy to antagonize mitochondrial-mediated apoptosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7613</span>– <span class="NLM_lpage">7624</span>, <span class="refDoi"> DOI: 10.1021/jm1009296</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1009296" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSntbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7613-7624&author=C.+Tanauthor=S.+Laiauthor=S.+Wuauthor=S.+Huauthor=L.+Zhouauthor=Y.+Chenauthor=M.+Wangauthor=Y.+Zhuauthor=W.+Lianauthor=W.+Pengauthor=L.+Jiauthor=A.+Xu&title=Nuclear+permeable+ruthenium%28II%29+%CE%B2-carboline+complexes+induce+autophagy+to+antagonize+mitochondrial-mediated+apoptosis&doi=10.1021%2Fjm1009296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear Permeable Ruthenium(II) β-Carboline Complexes Induce Autophagy To Antagonize Mitochondrial-Mediated Apoptosis</span></div><div class="casAuthors">Tan, Caiping; Lai, Sensen; Wu, Shouhai; Hu, Sheng; Zhou, Lingjun; Chen, Yu; Wang, Minxu; Zhu, Yiping; Lian, Wu; Peng, Wenlie; Ji, Liangnian; Xu, Anlong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7613-7624</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The role of autophagy in cancer development and response to cancer therapy has been a subject of debate.  Here we demonstrate that a series of ruthenium(II) complexes contg. a β-carboline alkaloid as ligand can simultaneously induce autophagy and apoptosis in tumor cells.  These Ru(II) complexes are nuclear permeable and highly active against a panel of human cancer cell lines, with complex 3 displaying activities greater than those of cisplatin.  The antiproliferative potentialities of 1-3 are in accordance with their relative lipophilicities, cell membrane penetration abilities, and in vitro DNA binding affinities.  Complexes 1-3 trigger release of reactive oxygen species (ROS) and attenuation of ROS by scavengers reduced the sub-G1 population, suggesting ROS-dependent apoptosis.  Inhibition of ROS generation also reduces autophagy, indicating that ROS triggers autophagy.  Further studies show that suppression of autophagy using pharmacol. inhibitors (3-methyladenine and chloroquine) enhances apoptotic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfI94bSBZCQLVg90H21EOLACvtfcHk0lji-RqwOcd8iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSntbjN&md5=8c2e1e1037d4a28e485e4776ddef930c</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjm1009296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1009296%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DC.%26aulast%3DLai%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLian%26aufirst%3DW.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DA.%26atitle%3DNuclear%2520permeable%2520ruthenium%2528II%2529%2520%25CE%25B2-carboline%2520complexes%2520induce%2520autophagy%2520to%2520antagonize%2520mitochondrial-mediated%2520apoptosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7613%26epage%3D7624%26doi%3D10.1021%2Fjm1009296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngai, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1480</span>– <span class="NLM_lpage">1490</span>, <span class="refDoi"> DOI: 10.1039/C4MT00044G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC4MT00044G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=24823440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtF2rsrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1480-1490&author=Z.+Luoauthor=L.+Yuauthor=F.+Yangauthor=Z.+Zhaoauthor=B.+Yuauthor=H.+Laiauthor=K.+H.+Wongauthor=S.+M.+Ngaiauthor=W.+Zhengauthor=T.+Chen&title=Ruthenium+polypyridyl+complexes+as+inducer+of+ROS-mediated+apoptosis+in+cancer+cells+by+targeting+thioredoxin+reductase&doi=10.1039%2FC4MT00044G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase</span></div><div class="casAuthors">Luo, Zuandi; Yu, Lianling; Yang, Fang; Zhao, Zhennan; Yu, Bo; Lai, Haoqiang; Wong, Ka-Hing; Ngai, Sai-Ming; Zheng, Wenjie; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1480-1490</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">TrxR is an NADPH-dependent selenoenzyme upregulated in a no. of cancers.  It plays a pivotal role in cancer progression and represents an increasingly attractive target for anticancer drugs.  The limitations of cisplatin in cancer treatment have motivated the extensive investigation to other metal complexes, esp. ruthenium (Ru) complexes.  In this study, we present the in vitro biol. evaluation of four Ru(II) polypridyl complexes with diimine ligands, namely, [Ru(bpy)3]2+ (1), [Ru(phen)3]2+ (2), [Ru(i.p.)3]2+ (3), [Ru(pip)3]2+ (4) (bpy = 2,2'-bipyridine, phen = 1,10-phenanthroline, i.p. = imidazole[4,5-f][1,10]phenanthroline, pip = 2-phenylimidazo[4,5-f][1,10]phenanthroline), and demonstrate that they exhibit antiproliferative activities against A375 human melanoma cells through inhibition of TrxR.  As the planarity of the structure increases, their TrxR-inhibitory effects and in vitro anticancer activities were enhanced.  Among them, complex 4 exhibited higher antiproliferative activity than cisplatin, and the TrxR-inhibitory potency of 4 was more effective than auranofin, a pos. TrxR inhibitor.  Complex 4 suppressed the cancer cell growth through induction of apoptosis as evidenced by accumulation of sub-G1 cell population, DNA fragmentation and nuclear condensation.  Moreover, complex 4 was able to localize in mitochondria and therein induced ROS-dependent apoptosis by inhibition of TrxR activity.  Activation of MAPKs, AKT, DNA damage-mediated p53 phosphorylation and inhibition of VEGFR signaling were also triggered in cells exposed to complex 4.  On the basis of this evidence, we suggest that Ru polypyridyl complexes could be developed as TrxR-targeted agents that demonstrate application potentials for treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeZZCCQveR-rVg90H21EOLACvtfcHk0lh9RN9Rqwdb6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtF2rsrrK&md5=9e74cca7a8be3d1fbbc36a986d333e2e</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1039%2FC4MT00044G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MT00044G%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DLai%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DK.%2BH.%26aulast%3DNgai%26aufirst%3DS.%2BM.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DRuthenium%2520polypyridyl%2520complexes%2520as%2520inducer%2520of%2520ROS-mediated%2520apoptosis%2520in%2520cancer%2520cells%2520by%2520targeting%2520thioredoxin%2520reductase%26jtitle%3DMetallomics%26date%3D2014%26volume%3D6%26spage%3D1480%26epage%3D1490%26doi%3D10.1039%2FC4MT00044G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Q. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span> <span> </span><span class="NLM_article-title">Water-soluble ruthenium(II) complexes with chiral 4-(2,3-dihydroxypropyl)-formamide oxoaporphine (FOA): In vitro and in vivo anticancer activity by stabilization of G-quadruplex DNA, inhibition of telomerase activity, and induction of tumor cell apoptosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4771</span>– <span class="NLM_lpage">4789</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00444</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00444" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFaktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4771-4789&author=Z.+F.+Chenauthor=Q.+P.+Qinauthor=J.+L.+Qinauthor=J.+Zhouauthor=Y.+L.+Liauthor=N.+Liauthor=Y.+C.+Liuauthor=H.+Liang&title=Water-soluble+ruthenium%28II%29+complexes+with+chiral+4-%282%2C3-dihydroxypropyl%29-formamide+oxoaporphine+%28FOA%29%3A+In+vitro+and+in+vivo+anticancer+activity+by+stabilization+of+G-quadruplex+DNA%2C+inhibition+of+telomerase+activity%2C+and+induction+of+tumor+cell+apoptosis&doi=10.1021%2Facs.jmedchem.5b00444"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Water-Soluble Ruthenium(II) Complexes with Chiral 4-(2,3-Dihydroxypropyl)-formamide Oxoaporphine (FOA): In Vitro and in Vivo Anticancer Activity by Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity, and Induction of Tumor Cell Apoptosis</span></div><div class="casAuthors">Chen, Zhen-Feng; Qin, Qi-Pin; Qin, Jiao-Lan; Zhou, Jie; Li, Yu-Lan; Li, Nan; Liu, Yan-Cheng; Liang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4771-4789</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Three water-sol. ruthenium(II) complexes with chiral 4-(2,3-dihydroxypropyl)-formamide oxoaporphine (FOA) were synthesized and characterized.  It was found that these ruthenium(II) complexes exhibited considerable in vitro anticancer activities and that they were the effective stabilizers of telomeric and G-quadruplex-DNA (G4-DNA) in promoter of c-myc, which acted as a telomerase inhibitor targeting G4-DNA and induced cell senescence and apoptosis.  Interestingly, the in vitro anticancer activity of 6 (LC-003) was higher than those of 4 (LC-001) and 5 (LC-002), more selective for BEL-7404 cells than for normal HL-7702 cells, and preferred to activate caspases-3/9.  The different biol. behaviors of the ruthenium complexes could be correlated with the chiral nature of 4-(2,3-dihydroxypropyl)-formamide oxoaporphine.  More significantly, 6 exhibited effective inhibitory on tumor growth in BEL-7402 xenograft mouse model and higher in vivo safety than cisplatin.  These mechanistic insights indicate that 6 displays low toxicity and can be a novel anticancer drug candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJKydKSiDEKLVg90H21EOLACvtfcHk0lh9RN9Rqwdb6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFaktb0%253D&md5=3cd16ac3e5f3ad27f46be1ccea91be60</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00444%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%2BF.%26aulast%3DQin%26aufirst%3DQ.%2BP.%26aulast%3DQin%26aufirst%3DJ.%2BL.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DY.%2BC.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3DWater-soluble%2520ruthenium%2528II%2529%2520complexes%2520with%2520chiral%25204-%25282%252C3-dihydroxypropyl%2529-formamide%2520oxoaporphine%2520%2528FOA%2529%253A%2520In%2520vitro%2520and%2520in%2520vivo%2520anticancer%2520activity%2520by%2520stabilization%2520of%2520G-quadruplex%2520DNA%252C%2520inhibition%2520of%2520telomerase%2520activity%252C%2520and%2520induction%2520of%2520tumor%2520cell%2520apoptosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4771%26epage%3D4789%26doi%3D10.1021%2Facs.jmedchem.5b00444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettinari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettinari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skelton, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonfili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuccioloni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozzicafreddo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecarini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeletti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eleuteri, A. M.</span></span> <span> </span><span class="NLM_article-title">Arene-ruthenium(II) acylpyrazolonato complexes: apoptosis-promoting effects on human cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4532</span>– <span class="NLM_lpage">4542</span>, <span class="refDoi"> DOI: 10.1021/jm500458c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500458c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntlKns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4532-4542&author=R.+Pettinariauthor=C.+Pettinariauthor=F.+Marchettiauthor=B.+W.+Skeltonauthor=A.+H.+Whiteauthor=L.+Bonfiliauthor=M.+Cuccioloniauthor=M.+Mozzicafreddoauthor=V.+Cecariniauthor=M.+Angelettiauthor=M.+Nabissiauthor=A.+M.+Eleuteri&title=Arene-ruthenium%28II%29+acylpyrazolonato+complexes%3A+apoptosis-promoting+effects+on+human+cancer+cells&doi=10.1021%2Fjm500458c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Arene-Ruthenium(II) Acylpyrazolonato Complexes: Apoptosis-Promoting Effects on Human Cancer Cells</span></div><div class="casAuthors">Pettinari, Riccardo; Pettinari, Claudio; Marchetti, Fabio; Skelton, Brian W.; White, Allan H.; Bonfili, Laura; Cuccioloni, Massimiliano; Mozzicafreddo, Matteo; Cecarini, Valentina; Angeletti, Mauro; Nabissi, Massimo; Eleuteri, Anna Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4532-4542</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of ruthenium(II) arene complexes with the 4-(biphenyl-4-carbonyl)-3-methyl-1-phenyl-5-pyrazolonate ligand, and related 1,3,5-triaza-7-phosphaadamantane (PTA) derivs., has been synthesized.  The compds. have been characterized by NMR and IR spectroscopy, ESI mass spectrometry, elemental anal., and X-ray crystallog.  Antiproliferative activity in four human cancer cell lines was detd. by MTT assay, yielding dose- and cancer cell line-dependent IC50 values of 9-34 μM for three hexamethylbenzene-ruthenium complexes, whereas the other metal complexes were much less active.  Apoptosis was the mechanism involved in the anticancer activity of such compds.  In fact, the hexamethylbenzene-ruthenium complexes activated caspase activity, with consequent DNA fragmentation, accumulation of pro-apoptotic proteins (p27, p53, p89 PARP fragments), and the concomitant down-regulation of antiapoptotic protein Bcl-2.  Biosensor-based binding studies indicated that the ancillary ligands were crit. in detg. the DNA binding affinities, and competition binding expts. further characterized the nature of the interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFYkJ_DKvP4LVg90H21EOLACvtfcHk0lh9RN9Rqwdb6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntlKns7c%253D&md5=7b7494a51759b407387713df02331c9a</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fjm500458c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500458c%26sid%3Dliteratum%253Aachs%26aulast%3DPettinari%26aufirst%3DR.%26aulast%3DPettinari%26aufirst%3DC.%26aulast%3DMarchetti%26aufirst%3DF.%26aulast%3DSkelton%26aufirst%3DB.%2BW.%26aulast%3DWhite%26aufirst%3DA.%2BH.%26aulast%3DBonfili%26aufirst%3DL.%26aulast%3DCuccioloni%26aufirst%3DM.%26aulast%3DMozzicafreddo%26aufirst%3DM.%26aulast%3DCecarini%26aufirst%3DV.%26aulast%3DAngeletti%26aufirst%3DM.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DEleuteri%26aufirst%3DA.%2BM.%26atitle%3DArene-ruthenium%2528II%2529%2520acylpyrazolonato%2520complexes%253A%2520apoptosis-promoting%2520effects%2520on%2520human%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4532%26epage%3D4542%26doi%3D10.1021%2Fjm500458c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yerra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, E. J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, characterization, cytotoxic and structure activity relationships of novel Ru(II) complexes</span>. <i>Chin. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">721</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1016/j.cclet.2015.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.cclet.2015.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltlKgsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=721-726&author=S.+Thotaauthor=S.+Vallalaauthor=R.+Yerraauthor=E.+J.+Barreiro&title=Design%2C+synthesis%2C+characterization%2C+cytotoxic+and+structure+activity+relationships+of+novel+Ru%28II%29+complexes&doi=10.1016%2Fj.cclet.2015.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, characterization, cytotoxic and structure activity relationships of novel Ru(II) complexes</span></div><div class="casAuthors">Thota, Sreekanth; Vallala, Srujana; Yerra, Rajeshwar; Barreiro, Eliezer J.</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Chemical Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">721-726</span>CODEN:
                <span class="NLM_cas:coden">CCLEE7</span>;
        ISSN:<span class="NLM_cas:issn">1001-8417</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Platinum contg. compds. showed antineoplastic potential, but their clin. applications have been limited by high toxicity.  Ruthenium contg. complexes have long been known to be well suited for biol. applications, and have long been used as replacements to popular platinum based-drugs.  Here, the authors report a novel series of ruthenium(II) arene compds. ([Ru(N-N)2L] where N-N = 1,10-phenanthroline or 2,2'-bipyridine and L = thiosemicarbazone or isonicotinylhydrazone ligands) bearing thiosemicarbazone and isonicotinylhydrazone ligands with potent anticancer activity their structure activity relations and apoptosis was studied.  The cytotoxic activity of the new ruthenium(II) arene compds. has been evaluated in several cell lines (Molt 4/C8, L1210, CEM, HL60 and BEL7402).  Among them, ten complexes are excellent in vitro growth inhibitory activity against various cell lines with IC50 in the sub-micromolar range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAymQ-dzQlj7Vg90H21EOLACvtfcHk0lgkikOCFdXRaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltlKgsr4%253D&md5=f431961ac7548e424c007a2d49ca530a</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.cclet.2015.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cclet.2015.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DThota%26aufirst%3DS.%26aulast%3DVallala%26aufirst%3DS.%26aulast%3DYerra%26aufirst%3DR.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520characterization%252C%2520cytotoxic%2520and%2520structure%2520activity%2520relationships%2520of%2520novel%2520Ru%2528II%2529%2520complexes%26jtitle%3DChin.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D26%26spage%3D721%26epage%3D726%26doi%3D10.1016%2Fj.cclet.2015.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cloonan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmes, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bright, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poynton, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunnlaugsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. C.</span></span> <span> </span><span class="NLM_article-title">Detailed biological profiling of a photoactivated and apoptosis inducing pdppz ruthenium(II) polypyridyl complex in cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4494</span>– <span class="NLM_lpage">4505</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00451</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00451" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXot1SqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4494-4505&author=S.+M.+Cloonanauthor=R.+B.+Elmesauthor=M.+Erbyauthor=S.+A.+Brightauthor=F.+E.+Poyntonauthor=D.+E.+Nolanauthor=S.+J.+Quinnauthor=T.+Gunnlaugssonauthor=D.+C.+Williams&title=Detailed+biological+profiling+of+a+photoactivated+and+apoptosis+inducing+pdppz+ruthenium%28II%29+polypyridyl+complex+in+cancer+cells&doi=10.1021%2Facs.jmedchem.5b00451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Detailed Biological Profiling of a Photoactivated and Apoptosis Inducing pdppz Ruthenium(II) Polypyridyl Complex in Cancer Cells</span></div><div class="casAuthors">Cloonan, Suzanne M.; Elmes, Robert B. P.; Erby, MariaLuisa; Bright, Sandra A.; Poynton, Fergus E.; Nolan, Derek E.; Quinn, Susan J.; Gunnlaugsson, Thorfinnur; Williams, D. Clive</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4494-4505</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ruthenium polypyridyl complexes show great promise as new photodynamic therapy (PDT) agents.  However, a lack of detailed understanding of their mode of action in cells poses a challenge to their development.  We have designed a new Ru(II) PDT candidate that efficiently enters cells by incorporation of the lipophilic arom. pdppz ([2,3-h]dipyrido[3,2-a:2',3'-c]phenazine) ligand and exhibits photoactivity through incorporation of 1,4,5,8-tetraazaphenanthrene ancillary ligands.  Its photoreactivity toward biomols. was studied in vitro, where light activation caused DNA cleavage.  Cellular internalization occurred via an energy dependent mechanism.  Confocal and transmission electron microscopy revealed that the complex localizes in various organelles, including the mitochondria.  The complex is nontoxic in the dark, with cellular clearance within 96 h; however, upon visible light activation it induces caspase-dependent and reactive-oxygen-species-dependent apoptosis, with low micromolar IC50 values.  This investigation greatly increases our understanding of such systems in cellulo, aiding development and realization of their application in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou-7ftJg3jLLVg90H21EOLACvtfcHk0lgkikOCFdXRaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXot1SqsLk%253D&md5=973d63ff055f258aaf2a7af8cf975468</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00451%26sid%3Dliteratum%253Aachs%26aulast%3DCloonan%26aufirst%3DS.%2BM.%26aulast%3DElmes%26aufirst%3DR.%2BB.%26aulast%3DErby%26aufirst%3DM.%26aulast%3DBright%26aufirst%3DS.%2BA.%26aulast%3DPoynton%26aufirst%3DF.%2BE.%26aulast%3DNolan%26aufirst%3DD.%2BE.%26aulast%3DQuinn%26aufirst%3DS.%2BJ.%26aulast%3DGunnlaugsson%26aufirst%3DT.%26aulast%3DWilliams%26aufirst%3DD.%2BC.%26atitle%3DDetailed%2520biological%2520profiling%2520of%2520a%2520photoactivated%2520and%2520apoptosis%2520inducing%2520pdppz%2520ruthenium%2528II%2529%2520polypyridyl%2520complex%2520in%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4494%26epage%3D4505%26doi%3D10.1021%2Facs.jmedchem.5b00451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liany, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corrêa, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deflon, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cominetti, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista, A. A.</span></span> <span> </span><span class="NLM_article-title">Selective Ru(II)/lawsone complexes inhibiting tumor cell growth by apoptosis</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2017.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jinorgbio.2017.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28865744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOjtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2017&pages=66-76&author=K.+M.+Oliveiraauthor=L.+D.+Lianyauthor=R.+S.+Corr%C3%AAaauthor=V.+M.+Deflonauthor=M.+R.+Cominettiauthor=A.+A.+Batista&title=Selective+Ru%28II%29%2Flawsone+complexes+inhibiting+tumor+cell+growth+by+apoptosis&doi=10.1016%2Fj.jinorgbio.2017.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Ru(II)/lawsone complexes inhibiting tumor cell growth by apoptosis</span></div><div class="casAuthors">Oliveira, Katia M.; Liany, Luna-Dulcey; Correa, Rodrigo S.; Deflon, Victor M.; Cominetti, Marcia R.; Batista, Alzir A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">66-76</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">New Ru(II) complexes with lawsone (law) characterized as trans-[Ru(law)(PPh3)2(N-N)]PF6, where PPh3 means triphenylphosphine and N-N is 2,2'-bipyridine (1), 4,4'-dimethyl-2,2'-bipyridine (2), 4,4'-dimethoxy-2,2'-bipyridine (3), 1,10-phenanthroline (4) or 4,7-diphenyl-1,10-phenanthroline (5), induce apoptosis in tumor cells.  Cytotoxicity of the complexes against the tumor cell lines DU-145 (prostate cancer cells), MCF-7 (breast cancer cells), A549 (lung cancer cells) and lung non-tumor cell line MRC-5 demonstrated promising IC50 values, lower than those found for the cisplatin, a drug used as a ref.  Due to the high cytotoxic activity and selectivity against A549 cells line, complex was selected for detailed assays.  The complex inhibits cells migration in concns. in a nanomolar range, inducing tumor cell death by apoptosis, as confirmed by flow cytometry expts.  Furthermore, the antiproliferative activity of complex on A549 tumor cells is attributed to a cell cycle arrest at the Sub G1 phase, followed by a decrease in the no. of cells at the S phase.  In addn., the interaction of the complexes (1-5) with CT-DNA was evaluated by CD, in which no changes in the secondary structure of DNA were obsd., suggesting a weak interaction of the complexes with the biomol.  Complexes (1-5) showed a higher interaction with human serum albumin (HSA) by non-covalent van der Waals forces and hydrogen bonding, resulting in static quenching.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWVjOT08uTD7Vg90H21EOLACvtfcHk0lgkikOCFdXRaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOjtr3J&md5=5d1be17905dc0bcfb5e7caa42d5faa06</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2017.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2017.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DOliveira%26aufirst%3DK.%2BM.%26aulast%3DLiany%26aufirst%3DL.%2BD.%26aulast%3DCorr%25C3%25AAa%26aufirst%3DR.%2BS.%26aulast%3DDeflon%26aufirst%3DV.%2BM.%26aulast%3DCominetti%26aufirst%3DM.%2BR.%26aulast%3DBatista%26aufirst%3DA.%2BA.%26atitle%3DSelective%2520Ru%2528II%2529%252Flawsone%2520complexes%2520inhibiting%2520tumor%2520cell%2520growth%2520by%2520apoptosis%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2017%26volume%3D176%26spage%3D66%26epage%3D76%26doi%3D10.1016%2Fj.jinorgbio.2017.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span> <span> </span><span class="NLM_article-title">Protein kinase biochemistry and drug discovery</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2011.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.bioorg.2011.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=21872901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GqsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=192-210&author=P.+A.+Schwartzauthor=B.+W.+Murray&title=Protein+kinase+biochemistry+and+drug+discovery&doi=10.1016%2Fj.bioorg.2011.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinase biochemistry and drug discovery</span></div><div class="casAuthors">Schwartz, Phillip A.; Murray, Brion W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">192-210</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein kinases are fascinating biol. catalysts with a rapidly expanding knowledge base, a growing appreciation in cell regulatory control, and an ascendant role in successful therapeutic intervention.  To better understand protein kinases, the mol. underpinnings of phosphoryl group transfer, protein phosphorylation, and inhibitor interactions are examd.  This anal. begins with a survey of phosphate group and phosphoprotein properties which provide context to the evolutionary selection of phosphorylation as a central mechanism for biol. regulation of most cellular processes.  Next, the kinetic and catalytic mechanisms of protein kinases are examd. with respect to model aq. systems to define the elements of catalysis.  A brief structural biol. overview further delves into the mol. basis of catalysis and regulation of catalytic activity.  Concomitant with a prominent role in normal physiol., protein kinases have important roles in the disease state.  To facilitate effective kinase drug discovery, classic and emerging approaches for characterizing kinase inhibitors are evaluated including biochem. assay design, inhibitor mechanism of action anal., and proper kinetic treatment of irreversible inhibitors.  As the resulting protein kinase inhibitors can modulate intended and unintended targets, profiling methods are discussed which can illuminate a more complete range of an inhibitor's biol. activities to enable more meaningful cellular studies and more effective clin. studies.  Taken as a whole, a wealth of protein kinase biochem. knowledge is available, yet it is clear that a substantial extent of our understanding in this field remains to be discovered which should yield many new opportunities for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx9JNgQhbDT7Vg90H21EOLACvtfcHk0lgmLB4zo15Olg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GqsrfE&md5=3c85386861ef6effbd7ef95d638df0a2</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2011.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2011.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DP.%2BA.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26atitle%3DProtein%2520kinase%2520biochemistry%2520and%2520drug%2520discovery%26jtitle%3DBioorg.%2520Chem.%26date%3D2011%26volume%3D39%26spage%3D192%26epage%3D210%26doi%3D10.1016%2Fj.bioorg.2011.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Organometallic compounds: an opportunity for chemical biology?</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1232</span>– <span class="NLM_lpage">1252</span>, <span class="refDoi"> DOI: 10.1002/cbic.201200159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fcbic.201200159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=22619182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Kktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=1232-1252&author=M.+Patraauthor=G.+Gasser&title=Organometallic+compounds%3A+an+opportunity+for+chemical+biology%3F&doi=10.1002%2Fcbic.201200159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic Compounds: An Opportunity for Chemical Biology?</span></div><div class="casAuthors">Patra, Malay; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1232-1252</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Organometallic compds. are renowned for their remarkable applications in the field of catalysis, but much less is known about their potential in chem. biol.  Indeed, such compds. have long been considered to be either unstable under physiol. conditions or cytotoxic.  As a consequence, little attention has been paid to their possible utilization for biol. purposes.  Because of their outstanding physicochem. properties, which include chem. stability, structural diversity and unique photo- and electrochem. properties, however, organometallic compds. have the ability to play a leading role in the field of chem. biol.  Indeed, remarkable examples of the use of such compds.-notably as enzyme inhibitors and as luminescent agents-have recently been reported.  Here we summarise recent advances in the use of organometallic compds. for chem. biol. purposes, an area that we define as "organometallic chem. biol.".  We also demonstrate that these recent discoveries are only a beginning and that many other organometallic complexes are likely to be found useful in this field of research in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPNf0UB7MS87Vg90H21EOLACvtfcHk0lgmLB4zo15Olg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Kktrw%253D&md5=45260dcd1168ae3b7311dad351669eda</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201200159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201200159%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DM.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DOrganometallic%2520compounds%253A%2520an%2520opportunity%2520for%2520chemical%2520biology%253F%26jtitle%3DChemBioChem%26date%3D2012%26volume%3D13%26spage%3D1232%26epage%3D1252%26doi%3D10.1002%2Fcbic.201200159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meggers, E.</span></span> <span> </span><span class="NLM_article-title">Exploring biologically relevant chemical space with metal complexes</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2007.05.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.cbpa.2007.05.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=17548234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvVOnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=287-292&author=E.+Meggers&title=Exploring+biologically+relevant+chemical+space+with+metal+complexes&doi=10.1016%2Fj.cbpa.2007.05.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring biologically relevant chemical space with metal complexes</span></div><div class="casAuthors">Meggers, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">287-292</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Altering biol. processes with small synthetic mols. is a general approach for the design of drugs and mol. probes.  Medicinal chem. and chem. biol. are focused predominately on the design of org. mols., whereas inorg. compds. find applications mainly for their reactivity (e.g. cisplatin as a DNA-reactive therapeutic) or imaging properties (e.g. gadolinium complexes as MRI diagnostics).  In such inorg. pharmaceuticals or probes, coordination chem. in the biol. environment or at the target site lies at the heart of their modes of action.  However, past and very recent results suggest that it is also worth exploring a different aspect of metal complexes: their ability to form structures with unique and defined shapes for the design of org.-like' small-mol. probes and drugs.  In such metal-org. compds., the metal has the main purpose to organize the org. ligands in three-dimensional space.  It is likely that such an approach will complement the mol. diversity of org. chem. in the quest for the discovery of compds. with superior biol. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY2uFY9Nc-ybVg90H21EOLACvtfcHk0lgmLB4zo15Olg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvVOnsr8%253D&md5=e6966e955608408cc652f3433c9c600a</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2007.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2007.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DMeggers%26aufirst%3DE.%26atitle%3DExploring%2520biologically%2520relevant%2520chemical%2520space%2520with%2520metal%2520complexes%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D11%26spage%3D287%26epage%3D292%26doi%3D10.1016%2Fj.cbpa.2007.05.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggers, E.</span></span> <span> </span><span class="NLM_article-title">Rapid access to unexplored chemical space by ligand scanning around a ruthenium center: discovery of potent and selective protein kinase inhibitors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">884</span>, <span class="refDoi"> DOI: 10.1021/ja055523r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja055523r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=877-884&author=H.+Bregmanauthor=P.+J.+Carrollauthor=E.+Meggers&title=Rapid+access+to+unexplored+chemical+space+by+ligand+scanning+around+a+ruthenium+center%3A+discovery+of+potent+and+selective+protein+kinase+inhibitors&doi=10.1021%2Fja055523r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1021%2Fja055523r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja055523r%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DCarroll%26aufirst%3DP.%2BJ.%26aulast%3DMeggers%26aufirst%3DE.%26atitle%3DRapid%2520access%2520to%2520unexplored%2520chemical%2520space%2520by%2520ligand%2520scanning%2520around%2520a%2520ruthenium%2520center%253A%2520discovery%2520of%2520potent%2520and%2520selective%2520protein%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D877%26epage%3D884%26doi%3D10.1021%2Fja055523r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maksimoska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kissil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marmorstein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meggers, E.</span></span> <span> </span><span class="NLM_article-title">Targeting large kinase active site with rigid, bulky octahedral ruthenium complexes</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">15764</span>– <span class="NLM_lpage">15765</span>, <span class="refDoi"> DOI: 10.1021/ja805555a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja805555a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=15764-15765&author=J.+Maksimoskaauthor=L.+Fengauthor=K.+Harmsauthor=C.+Yiauthor=J.+Kissilauthor=R.+Marmorsteinauthor=E.+Meggers&title=Targeting+large+kinase+active+site+with+rigid%2C+bulky+octahedral+ruthenium+complexes&doi=10.1021%2Fja805555a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fja805555a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja805555a%26sid%3Dliteratum%253Aachs%26aulast%3DMaksimoska%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DHarms%26aufirst%3DK.%26aulast%3DYi%26aufirst%3DC.%26aulast%3DKissil%26aufirst%3DJ.%26aulast%3DMarmorstein%26aufirst%3DR.%26aulast%3DMeggers%26aufirst%3DE.%26atitle%3DTargeting%2520large%2520kinase%2520active%2520site%2520with%2520rigid%252C%2520bulky%2520octahedral%2520ruthenium%2520complexes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D15764%26epage%3D15765%26doi%3D10.1021%2Fja805555a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biersack, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoldakova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Effenberger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schobert, R.</span></span> <span> </span><span class="NLM_article-title">Arene)Ru(II) complexes of epidermal growth factor receptor inhibiting tyrphostins with enhanced selectivity and cytotoxicity in cancer cells</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1972</span>– <span class="NLM_lpage">1975</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2010.01.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ejmech.2010.01.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=1972-1975&author=B.+Biersackauthor=M.+Zoldakovaauthor=K.+Effenbergerauthor=R.+Schobert&title=Arene%29Ru%28II%29+complexes+of+epidermal+growth+factor+receptor+inhibiting+tyrphostins+with+enhanced+selectivity+and+cytotoxicity+in+cancer+cells&doi=10.1016%2Fj.ejmech.2010.01.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.01.040%26sid%3Dliteratum%253Aachs%26aulast%3DBiersack%26aufirst%3DB.%26aulast%3DZoldakova%26aufirst%3DM.%26aulast%3DEffenberger%26aufirst%3DK.%26aulast%3DSchobert%26aufirst%3DR.%26atitle%3DArene%2529Ru%2528II%2529%2520complexes%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520inhibiting%2520tyrphostins%2520with%2520enhanced%2520selectivity%2520and%2520cytotoxicity%2520in%2520cancer%2520cells%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D1972%26epage%3D1975%26doi%3D10.1016%2Fj.ejmech.2010.01.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seršen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kljun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kryeziu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panchuk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Körner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffeter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turel, I.</span></span> <span> </span><span class="NLM_article-title">Structure-related mode-of-action differences of anticancer organoruthenium complexes with β–Diketonates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3984</span>– <span class="NLM_lpage">3996</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00288</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00288" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3984-3996&author=S.+Ser%C5%A1enauthor=J.+Kljunauthor=K.+Kryeziuauthor=R.+Panchukauthor=B.+Alteauthor=W.+K%C3%B6rnerauthor=P.+Heffeterauthor=W.+Bergerauthor=I.+Turel&title=Structure-related+mode-of-action+differences+of+anticancer+organoruthenium+complexes+with+%CE%B2%E2%80%93Diketonates&doi=10.1021%2Facs.jmedchem.5b00288"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00288%26sid%3Dliteratum%253Aachs%26aulast%3DSer%25C5%25A1en%26aufirst%3DS.%26aulast%3DKljun%26aufirst%3DJ.%26aulast%3DKryeziu%26aufirst%3DK.%26aulast%3DPanchuk%26aufirst%3DR.%26aulast%3DAlte%26aufirst%3DB.%26aulast%3DK%25C3%25B6rner%26aufirst%3DW.%26aulast%3DHeffeter%26aufirst%3DP.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DTurel%26aufirst%3DI.%26atitle%3DStructure-related%2520mode-of-action%2520differences%2520of%2520anticancer%2520organoruthenium%2520complexes%2520with%2520%25CE%25B2%25E2%2580%2593Diketonates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3984%26epage%3D3996%26doi%3D10.1021%2Facs.jmedchem.5b00288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mello-Andrade, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Costa, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pires, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lino-Junior, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irusta, V. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carneiro, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Melo-Reis, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silveira-Lacerda, E. P.</span></span> <span> </span><span class="NLM_article-title">Antitumor effectiveness and mechanism of action of Ru(II)/amino acid/diphosphine complexes in the peritoneal carcinomatosis progression</span>. <i>Tumor Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1177/1010428317695933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1177%2F1010428317695933" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2017&pages=1-18&author=F.+Mello-Andradeauthor=W.+L.+da+Costaauthor=W.+C.+Piresauthor=F.+C.+Pereiraauthor=C.+G.+Cardosoauthor=R.+S.+Lino-Juniorauthor=V.+R.+C.+Irustaauthor=C.+C.+Carneiroauthor=P.+R.+de+Melo-Reisauthor=C.+H.+Castroauthor=M.+A.+P.+Almeidaauthor=A.+A.+Batistaauthor=E.+P.+Silveira-Lacerda&title=Antitumor+effectiveness+and+mechanism+of+action+of+Ru%28II%29%2Famino+acid%2Fdiphosphine+complexes+in+the+peritoneal+carcinomatosis+progression&doi=10.1177%2F1010428317695933"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1177%2F1010428317695933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1010428317695933%26sid%3Dliteratum%253Aachs%26aulast%3DMello-Andrade%26aufirst%3DF.%26aulast%3Dda%2BCosta%26aufirst%3DW.%2BL.%26aulast%3DPires%26aufirst%3DW.%2BC.%26aulast%3DPereira%26aufirst%3DF.%2BC.%26aulast%3DCardoso%26aufirst%3DC.%2BG.%26aulast%3DLino-Junior%26aufirst%3DR.%2BS.%26aulast%3DIrusta%26aufirst%3DV.%2BR.%2BC.%26aulast%3DCarneiro%26aufirst%3DC.%2BC.%26aulast%3Dde%2BMelo-Reis%26aufirst%3DP.%2BR.%26aulast%3DCastro%26aufirst%3DC.%2BH.%26aulast%3DAlmeida%26aufirst%3DM.%2BA.%2BP.%26aulast%3DBatista%26aufirst%3DA.%2BA.%26aulast%3DSilveira-Lacerda%26aufirst%3DE.%2BP.%26atitle%3DAntitumor%2520effectiveness%2520and%2520mechanism%2520of%2520action%2520of%2520Ru%2528II%2529%252Famino%2520acid%252Fdiphosphine%2520complexes%2520in%2520the%2520peritoneal%2520carcinomatosis%2520progression%26jtitle%3DTumor%2520Biol.%26date%3D2017%26volume%3D39%26spage%3D1%26epage%3D18%26doi%3D10.1177%2F1010428317695933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Süss-Fink, G.</span></span> <span> </span><span class="NLM_article-title">Arene ruthenium complexes as anticancer agents</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1673</span>– <span class="NLM_lpage">1688</span>, <span class="refDoi"> DOI: 10.1039/B916860P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FB916860P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=20449402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=1673-1688&author=G.+S%C3%BCss-Fink&title=Arene+ruthenium+complexes+as+anticancer+agents&doi=10.1039%2FB916860P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Arene ruthenium complexes as anticancer agents</span></div><div class="casAuthors">Suess-Fink, Georg</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1673-1688</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Neutral or cationic arene ruthenium complexes providing both hydrophilic as well as hydrophobic properties due to the robustness of the ruthenium-arene unit hold a high potential for the development of metal-based anticancer drugs.  Mononuclear arene ruthenium complexes contg. P- or N-donor ligands or N,N-, N,O- or O,O-chelating ligands, dinuclear arene ruthenium systems with adjustable org. linkers, trinuclear arene ruthenium clusters contg. an oxo cap, tetranuclear arene ruthenium porphyrin derivs. that are photoactive, as well as hexanuclear ruthenium cages that are either empty or filled with other mols. have been shown to be active against a variety of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1IE2hoGlyPrVg90H21EOLACvtfcHk0ljNP6J-cobMzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqtr4%253D&md5=2758ad6804f77d33612401411fe7c116</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1039%2FB916860P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB916860P%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25BCss-Fink%26aufirst%3DG.%26atitle%3DArene%2520ruthenium%2520complexes%2520as%2520anticancer%2520agents%26jtitle%3DDalton%2520Trans.%26date%3D2010%26volume%3D39%26spage%3D1673%26epage%3D1688%26doi%3D10.1039%2FB916860P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lima, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida, M. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mello, F. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pires, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delella, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felisbino, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Paula
Silveira-Lacerda, E.</span></span> <span> </span><span class="NLM_article-title">Cytoxicity and apoptotic mechanism of ruthenium(II) amino acid complexes in sarcoma-180 tumor cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e105865</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0105865</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1371%2Fjournal.pone.0105865" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e105865&author=A.+P.+Limaauthor=F.+C.+Pereiraauthor=M.+A.+P.+Almeidaauthor=F.+M.+S.+Melloauthor=W.+C.+Piresauthor=T.+M.+Pintoauthor=F.+K.+Delellaauthor=S.+L.+Felisbinoauthor=V.+Morenoauthor=A.+A.+Batistaauthor=E.+de+Paula%0ASilveira-Lacerda&title=Cytoxicity+and+apoptotic+mechanism+of+ruthenium%28II%29+amino+acid+complexes+in+sarcoma-180+tumor+cells&doi=10.1371%2Fjournal.pone.0105865"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0105865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0105865%26sid%3Dliteratum%253Aachs%26aulast%3DLima%26aufirst%3DA.%2BP.%26aulast%3DPereira%26aufirst%3DF.%2BC.%26aulast%3DAlmeida%26aufirst%3DM.%2BA.%2BP.%26aulast%3DMello%26aufirst%3DF.%2BM.%2BS.%26aulast%3DPires%26aufirst%3DW.%2BC.%26aulast%3DPinto%26aufirst%3DT.%2BM.%26aulast%3DDelella%26aufirst%3DF.%2BK.%26aulast%3DFelisbino%26aufirst%3DS.%2BL.%26aulast%3DMoreno%26aufirst%3DV.%26aulast%3DBatista%26aufirst%3DA.%2BA.%26aulast%3Dde%2BPaula%2BSilveira-Lacerda%26aufirst%3DE.%26atitle%3DCytoxicity%2520and%2520apoptotic%2520mechanism%2520of%2520ruthenium%2528II%2529%2520amino%2520acid%2520complexes%2520in%2520sarcoma-180%2520tumor%2520cells%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De105865%26doi%3D10.1371%2Fjournal.pone.0105865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Irace, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuozzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccolo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caraglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paduano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montesarchio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santamaria, R.</span></span> <span> </span><span class="NLM_article-title">Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer <i>in vitro</i>: insights into their mode of action</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">45236</span>, <span class="refDoi"> DOI: 10.1038/srep45236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2Fsrep45236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28349991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1KisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=45236&author=C.+Iraceauthor=G.+Missoauthor=A.+Capuozzoauthor=M.+Piccoloauthor=C.+Riccardiauthor=A.+Luchiniauthor=M.+Caragliaauthor=L.+Paduanoauthor=D.+Montesarchioauthor=R.+Santamaria&title=Antiproliferative+effects+of+ruthenium-based+nucleolipidic+nanoaggregates+in+human+models+of+breast+cancer+in+vitro%3A+insights+into+their+mode+of+action&doi=10.1038%2Fsrep45236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action</span></div><div class="casAuthors">Irace, Carlo; Misso, Gabriella; Capuozzo, Antonella; Piccolo, Marialuisa; Riccardi, Claudia; Luchini, Alessandra; Caraglia, Michele; Paduano, Luigi; Montesarchio, Daniela; Santamaria, Rita</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45236</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Looking for new metal-based anticancer treatments, in recent years many ruthenium complexes have been proposed as effective and safe potential drugs.  In this context we have recently developed a novel approach for the in vivo delivery of Ru(III) complexes, prepg. stable ruthenium-based nucleolipidic nanoaggregates endowed with significant antiproliferative activity.  Herein we describe the cellular response to our ruthenium-contg. formulations in selected models of human breast cancer.  By in vitro bioscreens in the context of preclin. studies, we have focused on their ability to inhibit breast cancer cell proliferation by the activation of the intrinsic apoptotic pathway, possibly via mitochondrial perturbations involving Bcl-2 family members and predisposing to programmed cell death.  In addn., the most efficient ruthenium-contg. cationic nanoaggregates we have hitherto developed are able to elicit both extrinsic and intrinsic apoptosis, as well as autophagy.  To limit chemoresistance and counteract uncontrolled proliferation, multiple cell death pathways activation by metal-based chemotherapeutics is a challenging, yet very promising strategy for targeted therapy development in aggressive cancer diseases, such as triple-neg. breast cancer with limited treatment options.  These outcomes provide valuable, original knowledge on ruthenium-based candidate drugs and new insights for future optimized cancer treatment protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXTcZAcU_G8rVg90H21EOLACvtfcHk0lhlDmRsR7sPSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1KisLs%253D&md5=2171f837866f8ddcb74bd3ea0fa871f2</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1038%2Fsrep45236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep45236%26sid%3Dliteratum%253Aachs%26aulast%3DIrace%26aufirst%3DC.%26aulast%3DMisso%26aufirst%3DG.%26aulast%3DCapuozzo%26aufirst%3DA.%26aulast%3DPiccolo%26aufirst%3DM.%26aulast%3DRiccardi%26aufirst%3DC.%26aulast%3DLuchini%26aufirst%3DA.%26aulast%3DCaraglia%26aufirst%3DM.%26aulast%3DPaduano%26aufirst%3DL.%26aulast%3DMontesarchio%26aufirst%3DD.%26aulast%3DSantamaria%26aufirst%3DR.%26atitle%3DAntiproliferative%2520effects%2520of%2520ruthenium-based%2520nucleolipidic%2520nanoaggregates%2520in%2520human%2520models%2520of%2520breast%2520cancer%2520in%2520vitro%253A%2520insights%2520into%2520their%2520mode%2520of%2520action%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D45236%26doi%3D10.1038%2Fsrep45236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span>; <span class="NLM_string-name">Crans, D.
C.</span></span> <i>Metal Nanoparticles: Synthesis and Applications in Pharmaceutical Sciences</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thota, S.</span>, <span class="NLM_string-name">Crans, D.
C.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Germany</span>, <span class="NLM_year">2018</span>; pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">312</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2F9783527807093" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=1-312&author=S.+Thota&author=D.%0AC.+Cransauthor=S.+Thota&author=D.%0AC.+Crans&title=Metal+Nanoparticles%3A+Synthesis+and+Applications+in+Pharmaceutical+Sciences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1002%2F9783527807093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527807093%26sid%3Dliteratum%253Aachs%26aulast%3DThota%26aufirst%3DS.%26btitle%3DMetal%2520Nanoparticles%253A%2520Synthesis%2520and%2520Applications%2520in%2520Pharmaceutical%2520Sciences%26aulast%3DThota%26aufirst%3DS.%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2018%26spage%3D1%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astruc, D.</span></span> <span> </span><span class="NLM_article-title">Docetaxel nanotechnology in anticancer therapy</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">952</span>– <span class="NLM_lpage">972</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fcmdc.201200052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=952-972&author=P.+Zhaoauthor=D.+Astruc&title=Docetaxel+nanotechnology+in+anticancer+therapy&doi=10.1002%2Fcmdc.201200052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200052%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DAstruc%26aufirst%3DD.%26atitle%3DDocetaxel%2520nanotechnology%2520in%2520anticancer%2520therapy%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D952%26epage%3D972%26doi%3D10.1002%2Fcmdc.201200052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of tumor growth and vasculature and fluorescence imaging using functionalized ruthenium-thiol protected selenium nanoparticles</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1572</span>– <span class="NLM_lpage">1583</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2013.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.biomaterials.2013.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=24268198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVShu7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=1572-1583&author=D.+Sunauthor=Y.+Liuauthor=Q.+Yuauthor=X.+Qinauthor=L.+Yangauthor=Y.+Zhouauthor=L.+Chenauthor=J.+Liu&title=Inhibition+of+tumor+growth+and+vasculature+and+fluorescence+imaging+using+functionalized+ruthenium-thiol+protected+selenium+nanoparticles&doi=10.1016%2Fj.biomaterials.2013.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tumor growth and vasculature and fluorescence imaging using functionalized ruthenium-thiol protected selenium nanoparticles</span></div><div class="casAuthors">Sun, Dongdong; Liu, Yanan; Yu, Qianqian; Qin, Xiuying; Yang, Licong; Zhou, Yanhui; Chen, Lanmei; Liu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1572-1583</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Here we reported the high tumor targeting efficacy of luminescent Ru(II)-thiols protected selenium nanoparticles (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="95c7e0b8d8c0d4d5c6f0">[email protected]</a>).  We have shown that a dual-target inhibitor <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="affdda82e2faeeeffcca">[email protected]</a> directly suppress the tumor growth but also block blood-vessel growth.  We also detd. that the nanoparticles entered the cells via clathrin-mediated endocytosis pathway.  In a xenograft HepG2 tumor model, we found that <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="beeccb93f3ebfffeeddb">[email protected]</a> effectively inhibited tumor angiogenesis and suppressed tumor growth with low side effects using metronomic chemotherapy with <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="c99bbce4849c88899aace7">[email protected]</a>  In vivo investigation of nanoparticles on nude mice bearing HepG2 cancer xenografts confirmed that <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="b8eacd95f5edf9f8ebdd">[email protected]</a> nanoparticles possessed high tumor-targeted fluorescence imaging, exhibited enhanced antitumor efficacy and decreased systemic toxicity.  Moreover, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="0c5e792141594d4c5f69">[email protected]</a> not only significantly induced dose-dependent disruption of mitochondrial membrane potential in HepG2 cells after 24 h treatment, but it also enhanced reactive oxygen species (ROS) generation.  Our results suggest that the potential application of these <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="5e0c2b73130b1f1e0d3b">[email protected]</a> nanoparticles in targeting cancer imaging and chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp87jzmAWwlCrVg90H21EOLACvtfcHk0lhlDmRsR7sPSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVShu7vP&md5=251af033e93a1d0ebf4ce86fe690b9f1</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2013.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2013.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520tumor%2520growth%2520and%2520vasculature%2520and%2520fluorescence%2520imaging%2520using%2520functionalized%2520ruthenium-thiol%2520protected%2520selenium%2520nanoparticles%26jtitle%3DBiomaterials%26date%3D2014%26volume%3D35%26spage%3D1572%26epage%3D1583%26doi%3D10.1016%2Fj.biomaterials.2013.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2012.09.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.biomaterials.2012.09.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=23059005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVOgt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=171-180&author=D.+Sunauthor=Y.+Liuauthor=Q.+Yuauthor=Y.+Zhouauthor=R.+Zhangauthor=X.+Chenauthor=A.+Hongauthor=J.+Liu&title=The+effects+of+luminescent+ruthenium%28II%29+polypyridyl+functionalized+selenium+nanoparticles+on+bFGF-induced+angiogenesis+and+AKT%2FERK+signaling&doi=10.1016%2Fj.biomaterials.2012.09.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling</span></div><div class="casAuthors">Sun, Dongdong; Liu, Yanan; Yu, Qianqian; Zhou, Yanhui; Zhang, Rong; Chen, Xiaojia; Hong, An; Liu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">171-180</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Anti-angiogenesis is an effective strategy for cancer treatment because uncontrolled tumor growth depends on tumor angiogenesis and sufficient blood supply.  Thus, blocking angiogenesis could be a strategy to arrest tumor growth.  The function and mechanism of luminescent ruthenium-modified selenium nanoparticles (Ru-SeNPs) in angiogenesis have not been elucidated to date.  Here, we found that Ru-SeNPs significantly inhibited human umbilical vascular endothelial cell (HUVEC) proliferation, migration and tube formation.  Ru-SeNPs was also tested in vivo in the chicken chorioallantoic membrane (CAM) assay and found to inhibit bFGF-treated CAMs development like suramin.  Moreover, we showed that Ru-SeNPs inhibited the activations of FGFR1 and its downstream protein kinases, such ErK and AKT.  Furthermore, by using fluorescence confocal microscopy and TEM imaging studies, we have demonstrated their cellular uptake and localization within the cytoplasm of HepG2 and HUVEC cells.  These findings indicate that Ru-SeNPs inhibits angiogenesis and may be a viable drug candidate in anti-angiogenesis and anticancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxnG8kCEmuBLVg90H21EOLACvtfcHk0lig-g57kpp-FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVOgt7zJ&md5=f1ac1941e25fc3089b9cca828f86e02b</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2012.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2012.09.031%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHong%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DThe%2520effects%2520of%2520luminescent%2520ruthenium%2528II%2529%2520polypyridyl%2520functionalized%2520selenium%2520nanoparticles%2520on%2520bFGF-induced%2520angiogenesis%2520and%2520AKT%252FERK%2520signaling%26jtitle%3DBiomaterials%26date%3D2013%26volume%3D34%26spage%3D171%26epage%3D180%26doi%3D10.1016%2Fj.biomaterials.2012.09.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Rational design of cancer-targeted selenium nanoparticles to antagonize multidrug resistance in cancer cells</span>. <i>Nanomedicine</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">947</span>– <span class="NLM_lpage">958</span>, <span class="refDoi"> DOI: 10.1016/j.nano.2015.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.nano.2015.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=25680543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisl2ru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=947-958&author=T.+Liuauthor=L.+Zengauthor=W.+Jiangauthor=Y.+Fuauthor=W.+Zhengauthor=T.+Chen&title=Rational+design+of+cancer-targeted+selenium+nanoparticles+to+antagonize+multidrug+resistance+in+cancer+cells&doi=10.1016%2Fj.nano.2015.01.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of cancer-targeted selenium nanoparticles to antagonize multidrug resistance in cancer cells</span></div><div class="casAuthors">Liu, Ting; Zeng, Lilan; Jiang, Wenting; Fu, Yuanting; Zheng, Wenjie; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">947-958</span>CODEN:
                <span class="NLM_cas:coden">NANOBF</span>;
        ISSN:<span class="NLM_cas:issn">1549-9634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Multidrug resistance is one of the greatest challenges in cancer therapy.  Herein we described the synthesis of folate (FA)-conjugated selenium nanoparticles (SeNPs) as cancer-targeted nano-drug delivery system for ruthenium polypyridyl (RuPOP) exhibits strong fluorescence, which allows the direct imaging of the cellular trafficking of the nanosystem.  This nanosystem could effectively antagonize against multidrug resistance in liver cancer.  FA surface conjugation significantly enhanced the cellular uptake of SeNPs by FA receptor-mediated endocytosis through nystain-dependent lipid raft-mediated and clathrin-mediated pathways.  The nanomaterials overcame the multidrug resistance in R-HepG2 cells through inhibition of ABC family proteins expression.  Internalized nanoparticles triggered ROS overprodn. and induced apoptosis by activating p53 and MAPKs pathways.  Moreover, FA-SeNPs exhibited low in vivo acute toxicity, which verified the safety and application potential of FA-SeNPs as nanodrugs.  This study provides an effective strategy for the design of cancer-targeted nanodrugs against multidrug resistant cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4SBRYhbZLXbVg90H21EOLACvtfcHk0lig-g57kpp-FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisl2ru7w%253D&md5=e28985eb3878313d3b214ecaec3994fd</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.nano.2015.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nano.2015.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DRational%2520design%2520of%2520cancer-targeted%2520selenium%2520nanoparticles%2520to%2520antagonize%2520multidrug%2520resistance%2520in%2520cancer%2520cells%26jtitle%3DNanomedicine%26date%3D2015%26volume%3D11%26spage%3D947%26epage%3D958%26doi%3D10.1016%2Fj.nano.2015.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">An upconversion nanoparticle/Ru(II) polypyridyl complex assembly for NIR-activated release of a DNA covalent-binding agent</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">23804</span>– <span class="NLM_lpage">23808</span>, <span class="refDoi"> DOI: 10.1039/C6RA03396B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC6RA03396B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFCrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=23804-23808&author=Y.+Chenauthor=G.+Jiangauthor=Q.+Zhouauthor=Y.+Zhangauthor=K.+Liauthor=Y.+Zhengauthor=B.+Zhangauthor=X.+Wang&title=An+upconversion+nanoparticle%2FRu%28II%29+polypyridyl+complex+assembly+for+NIR-activated+release+of+a+DNA+covalent-binding+agent&doi=10.1039%2FC6RA03396B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">An upconversion nanoparticle/Ru(II) polypyridyl complex assembly for NIR-activated release of a DNA covalent-binding agent</span></div><div class="casAuthors">Chen, Yumeng; Jiang, Guoyu; Zhou, Qianxiong; Zhang, Yangyang; Li, Ke; Zheng, Yue; Zhang, Baowen; Wang, Xuesong</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">23804-23808</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Photoactivated anticancer chemotherapy distinguishes itself by its high selectivity by virtue of the spatiotemporal control of irradn.  However, short photoactivation wavelengths limit its application.  Herein, an amphiphilic Ru(II) complex, cis-[Ru(bpy)2(C18H37CN)2]2+ (bpy = 2,2'-bipyridine), was embedded along with a poly(ethylene glycol, PEG)-modified lipid onto the surfaces of oleate-capped lanthanide-doped upconversion nanoparticles (UCNPs).  The resultant core-shell hybrid system is water-dispersible, stable in the dark, and releases a DNA covalent-binding agent of [Ru(bpy)2(H2O)2]2+ upon 980 nm laser irradn., providing guidelines for developing near-IR (NIR) light triggered chemotherapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTU2opfKYcirVg90H21EOLACvtfcHk0lig-g57kpp-FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFCrsrk%253D&md5=b1ce76f4cc5336695bdf8257070dd67d</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1039%2FC6RA03396B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6RA03396B%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DAn%2520upconversion%2520nanoparticle%252FRu%2528II%2529%2520polypyridyl%2520complex%2520assembly%2520for%2520NIR-activated%2520release%2520of%2520a%2520DNA%2520covalent-binding%2520agent%26jtitle%3DRSC%2520Adv.%26date%3D2016%26volume%3D6%26spage%3D23804%26epage%3D23808%26doi%3D10.1039%2FC6RA03396B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfram, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guevara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span> <span> </span><span class="NLM_article-title">A liposome encapsulated ruthenium polypyridine complex as a theranostic platform for triple-negative breast cancer</span>. <i>Nano Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2913</span>– <span class="NLM_lpage">2920</span>, <span class="refDoi"> DOI: 10.1021/acs.nanolett.7b00132</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.nanolett.7b00132" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmt12lsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=2913-2920&author=J.+Shenauthor=H.+C.+Kimauthor=J.+Wolframauthor=C.+Muauthor=W.+Zhangauthor=H.+Liuauthor=Y.+Xieauthor=J.+Maiauthor=H.+Zhangauthor=Z.+Liauthor=M.+Guevaraauthor=Z.+W.+Maoauthor=H.+Shen&title=A+liposome+encapsulated+ruthenium+polypyridine+complex+as+a+theranostic+platform+for+triple-negative+breast+cancer&doi=10.1021%2Facs.nanolett.7b00132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer</span></div><div class="casAuthors">Shen, Jianliang; Kim, Han-Cheon; Wolfram, Joy; Mu, Chaofeng; Zhang, Wei; Liu, Haoran; Xie, Yan; Mai, Junhua; Zhang, Hang; Li, Zhi; Guevara, Maria; Mao, Zong-Wan; Shen, Haifa</div><div class="citationInfo"><span class="NLM_cas:title">Nano Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2913-2920</span>CODEN:
                <span class="NLM_cas:coden">NALEFD</span>;
        ISSN:<span class="NLM_cas:issn">1530-6984</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ruthenium coordination complexes have the potential to serve as novel theranostic agents for cancer.  However, a major limitation in their clin. implementation is effective tumor accumulation.  In this study, the authors have developed a liposome-based theranostic nanodelivery system for [Ru(phen)2dppz](ClO4)2 (Lipo-Ru).  This ruthenium polypyridine complex emits a strong fluorescent signal when incorporated in the hydrophobic lipid bilayer of the delivery vehicle or in the DNA helix, enabling visualization of the therapeutic agent in tumor tissues.  Incubation of MDA-MB-231 breast cancer cells with Lipo-Ru induced double-strand DNA breaks and triggers apoptosis.  In a mouse model of triple-neg. breast cancer, treatment with Lipo-Ru dramatically reduced tumor growth.  Biodistribution studies of Lipo-Ru revealed that more than 20% of the injected dose accumulated in the tumor.  These results suggest that Lipo-Ru could serve as a promising theranostic platform for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2FW6TrBmR1bVg90H21EOLACvtfcHk0ljvjFVX62SxDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmt12lsbg%253D&md5=4c3097a926d8fc33d2f07cfb002453b9</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Facs.nanolett.7b00132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.nanolett.7b00132%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%2BC.%26aulast%3DWolfram%26aufirst%3DJ.%26aulast%3DMu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DMai%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGuevara%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DZ.%2BW.%26aulast%3DShen%26aufirst%3DH.%26atitle%3DA%2520liposome%2520encapsulated%2520ruthenium%2520polypyridine%2520complex%2520as%2520a%2520theranostic%2520platform%2520for%2520triple-negative%2520breast%2520cancer%26jtitle%3DNano%2520Lett.%26date%3D2017%26volume%3D17%26spage%3D2913%26epage%3D2920%26doi%3D10.1021%2Facs.nanolett.7b00132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Functionalized multiwalled carbon nanotubes as carriers of ruthenium complexes to antagonize cancer multidrug resistance and radioresistance</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">14933</span>– <span class="NLM_lpage">14945</span>, <span class="refDoi"> DOI: 10.1021/acsami.5b03739</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.5b03739" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKit7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=14933-14945&author=N.+Wangauthor=Y.+Fengauthor=L.+Zengauthor=Z.+Zhaoauthor=T.+Chen&title=Functionalized+multiwalled+carbon+nanotubes+as+carriers+of+ruthenium+complexes+to+antagonize+cancer+multidrug+resistance+and+radioresistance&doi=10.1021%2Facsami.5b03739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Functionalized Multiwalled Carbon Nanotubes as Carriers of Ruthenium Complexes to Antagonize Cancer Multidrug Resistance and Radioresistance</span></div><div class="casAuthors">Wang, Ni; Feng, Yanxian; Zeng, Lilan; Zhao, Zhennan; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">14933-14945</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multidrug resistance and radioresistance are major obstacles for successful cancer therapy.  Due to the unique characteristics of high surface area, improved cellular uptake, and the possibility to be easily bound with therapeutics, carbon nanotubes (CNTs) have attracted increasing attention as potential nanodrug delivery systems.  In this study, a CNT-based radiosensitive nanodrug delivery system was rationally designed to antagonize the multidrug resistance in hepatocellular carcinoma.  The nanosystem was loaded with a potent anticancer ruthenium polypyridyl complex (RuPOP) via π-π interaction and formation of a hydrogen bond.  The functionalized nanosystem (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="99cbecc9d6c9d9d4cedad7cdea">[email protected]</a>) enhanced the cellular uptake of RuPOP in liver cancer cells, esp. drug-resistant R-HepG2 cells, through endocytosis.  Consistently, the selective cellular uptake endowed the nanosystem amplified anticancer efficacy against R-HepG2 cells but not in normal cells.  Interestingly, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="ca98bf9a859a8a879d89849eb9">[email protected]</a> significantly enhanced the anticancer efficacy of clin. used X-ray against R-HepG2 cells through induction of apoptosis and G0/G1 cell cycle arrest, with the involvement of ROS overprodn., which activated several downstream signaling pathways, including DNA damage-mediated p53 phosphorylation, activation of p38, and inactivation of AKT and ERK.  Moreover, the nanosystem also effectively reduces the toxic side effects of loaded drugs and prolongs the blood circulation in vivo.  Taken together, the results demonstrate the rational design of functionalized carbon nanotubes and their application as effective nanomedicine to overcome cancer multidrug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8cjbcIKuLxLVg90H21EOLACvtfcHk0ljvjFVX62SxDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKit7fI&md5=992f09a410b8776359a0a0f87994ae8b</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Facsami.5b03739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.5b03739%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DN.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DFunctionalized%2520multiwalled%2520carbon%2520nanotubes%2520as%2520carriers%2520of%2520ruthenium%2520complexes%2520to%2520antagonize%2520cancer%2520multidrug%2520resistance%2520and%2520radioresistance%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2015%26volume%3D7%26spage%3D14933%26epage%3D14945%26doi%3D10.1021%2Facsami.5b03739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span> <span> </span><span class="NLM_article-title">Noncovalent ruthenium(II) complexes-single-walled carbon nanotube composites for bimodal photothermal and photodynamic therapy with near-infrared irradiation</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">23278</span>– <span class="NLM_lpage">23290</span>, <span class="refDoi"> DOI: 10.1021/acsami.5b07510</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.5b07510" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1SisLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=23278-23290&author=P.+Zhangauthor=H.+Huangauthor=J.+Huangauthor=H.+Chenauthor=J.+Wangauthor=K.+Qiuauthor=D.+Zhaoauthor=L.+Jiauthor=H.+Chao&title=Noncovalent+ruthenium%28II%29+complexes-single-walled+carbon+nanotube+composites+for+bimodal+photothermal+and+photodynamic+therapy+with+near-infrared+irradiation&doi=10.1021%2Facsami.5b07510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Noncovalent Ruthenium(II) Complexes-Single-Walled Carbon Nanotube Composites for Bimodal Photothermal and Photodynamic Therapy with Near-Infrared Irradiation</span></div><div class="casAuthors">Zhang, Pingyu; Huang, Huaiyi; Huang, Juanjuan; Chen, Hongmin; Wang, Jinquan; Qiu, Kangqiang; Zhao, Donglei; Ji, Liangnian; Chao, Hui</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">23278-23290</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To enhance the efficacy and optimize the treatment of cancers, the integration of multimodal treatment strategies leading to synergistic effects is a promising approach.  The coassembly of multifunctional agents for systematic therapies has received considerable interest in cancer treatment.  Herein, Ru(II) complex-functionalized single-walled carbon nanotubes (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="f7a582b7a4a0b4b9a384">[email protected]</a>) are developed as nanotemplates for bimodal photothermal and two-photon photodynamic therapy (PTT-TPPDT).  SWCNTs have the ability to load a great amt. of Ru(II) complexes (Ru1 or Ru2) via noncovalent π-π interactions.  The loaded Ru(II) complexes are efficiently released by the photothermal effect of irradn. from an 808 nm diode laser (0.25 W/cm2).  The released Ru(II) complexes produce singlet oxygen species (1O2) upon two-photon laser irradn. (808 nm, 0.25 W/cm2) and can be used as a two-photon photodynamic therapy (TPPDT) agent.  Based on the combination of photothermal therapy and two-photon photodynamic therapy, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="bfedcaffece8fcf1ebcc">[email protected]</a> have greater anticancer efficacies than either PDT using Ru(II) complexes or PTT using SWCNTs in two-dimensional (2D) cancer cell and three-dimensional (3D) multicellular tumor spheroid (MCTS) models.  Furthermore, in vivo tumor ablation is achieved with excellent treatment efficacy under a diode laser (808 nm) irradn. at the power d. of 0.25 W/cm2 for 5 min.  This study examines an efficacious bimodal PTT and TPPDT nanoplatform for the development of cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq83C2yDWwiqrVg90H21EOLACvtfcHk0ljvjFVX62SxDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1SisLbP&md5=cd55dec6607f67ce7e1743c74fdb5e82</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Facsami.5b07510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.5b07510%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26atitle%3DNoncovalent%2520ruthenium%2528II%2529%2520complexes-single-walled%2520carbon%2520nanotube%2520composites%2520for%2520bimodal%2520photothermal%2520and%2520photodynamic%2520therapy%2520with%2520near-infrared%2520irradiation%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2015%26volume%3D7%26spage%3D23278%26epage%3D23290%26doi%3D10.1021%2Facsami.5b07510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farabi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zikeli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Styles, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodges, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikramenou, Z.</span></span> <span> </span><span class="NLM_article-title">High coating of Ru(II) complexes on gold nanoparticles for single particle luminescence imaging in cells</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1039/C3CC47606E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC3CC47606E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=24281162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2rt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=617-619&author=N.+J.+Rogersauthor=S.+Claireauthor=R.+M.+Harrisauthor=S.+Farabiauthor=G.+Zikeliauthor=I.+B.+Stylesauthor=N.+J.+Hodgesauthor=Z.+Pikramenou&title=High+coating+of+Ru%28II%29+complexes+on+gold+nanoparticles+for+single+particle+luminescence+imaging+in+cells&doi=10.1039%2FC3CC47606E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">High coating of Ru(II) complexes on gold nanoparticles for single particle luminescence imaging in cells</span></div><div class="casAuthors">Rogers, Nicola J.; Claire, Sunil; Harris, Robert M.; Farabi, Shiva; Zikeli, Gerald; Styles, Iain B.; Hodges, Nikolas J.; Pikramenou, Zoe</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">617-619</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Gold nanoparticles are efficiently labeled with a luminescent ruthenium complex, producing 13 and 100 nm diam., monodisperse red-emissive imaging probes with luminescence lifetimes prolonged over the mol. unit.  Single, 100 nm particles are obsd. in whole cell luminescence imaging which reveals their biomol. assocn. with chromatin in the nucleus of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZHNUWV-v2YLVg90H21EOLACvtfcHk0lgQ66oSZSta8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2rt7%252FK&md5=96ac312118bcd5b7729be4ad9f984742</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1039%2FC3CC47606E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CC47606E%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DN.%2BJ.%26aulast%3DClaire%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DR.%2BM.%26aulast%3DFarabi%26aufirst%3DS.%26aulast%3DZikeli%26aufirst%3DG.%26aulast%3DStyles%26aufirst%3DI.%2BB.%26aulast%3DHodges%26aufirst%3DN.%2BJ.%26aulast%3DPikramenou%26aufirst%3DZ.%26atitle%3DHigh%2520coating%2520of%2520Ru%2528II%2529%2520complexes%2520on%2520gold%2520nanoparticles%2520for%2520single%2520particle%2520luminescence%2520imaging%2520in%2520cells%26jtitle%3DChem.%2520Commun.%26date%3D2014%26volume%3D50%26spage%3D617%26epage%3D619%26doi%3D10.1039%2FC3CC47606E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">Effective PDT/PTT dual-modal phototherapeutic killing of pathogenic bacteria by using ruthenium nanoparticles</span>. <i>J. Mater. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">6258</span>– <span class="NLM_lpage">6270</span>, <span class="refDoi"> DOI: 10.1039/C6TB01122E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC6TB01122E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=32263638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKru73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=6258-6270&author=X.+Huangauthor=G.+Chenauthor=J.+Panauthor=X.+Chenauthor=N.+Huangauthor=X.+Wangauthor=J.+Liu&title=Effective+PDT%2FPTT+dual-modal+phototherapeutic+killing+of+pathogenic+bacteria+by+using+ruthenium+nanoparticles&doi=10.1039%2FC6TB01122E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Effective PDT/PTT dual-modal phototherapeutic killing of pathogenic bacteria by using ruthenium nanoparticles</span></div><div class="casAuthors">Huang, Xiaoquan; Chen, Gengjia; Pan, Jiali; Chen, Xu; Huang, Na; Wang, Xin; Liu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry B: Materials for Biology and Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">6258-6270</span>CODEN:
                <span class="NLM_cas:coden">JMCBDV</span>;
        ISSN:<span class="NLM_cas:issn">2050-7518</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A s.c. abscess is a local infection caused by pathogenic bacteria.  Due to the emergence of multidrug-resistant (MDR) pathogenic bacteria, there is an urgent need for the development of new approaches to treat s.c. abscesses.  In recent studies, we detd. that ruthenium nanoparticles have high photothermal conversion efficiency and can transfer energy to surrounding oxygen mols. to generate cytotoxic singlet oxygen (ROS).  Acetylcholine (Ach) was modified and added to the surface of the ruthenium nanoparticles to form composite nanoparticles (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="e3a2808ba3b196adb390">[email protected]</a>).  Acetylcholine played a role in targeting the nanoparticles on bacteria, and promoting their entry into the bacterial cells as detd. by bacterial plate assays.  Expts. using a mouse s.c. abscess model also showed that <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="d091b3b89082a59e80a3">[email protected]</a> were targeted on bacteria.  Upon irradn. with an 808 nm laser, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="abeac8c3ebf9dee5fbd8">[email protected]</a> could function as both a photodynamic therapeutic (PDT) and a photothermal therapeutic (PTT) agent to kill pathogenic bacteria, and repair infected wounds without leaving residual implanted materials.  The use of <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="bafbd9d2fae8cff4eac9">[email protected]</a> represents an attractive potential treatment approach for s.c. abscesses due to their high efficacy and minimal invasiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTUM0HmAW9abVg90H21EOLACvtfcHk0lgQ66oSZSta8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKru73J&md5=8978e64a1b5be47ce64f9d88905a96ab</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1039%2FC6TB01122E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6TB01122E%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DEffective%2520PDT%252FPTT%2520dual-modal%2520phototherapeutic%2520killing%2520of%2520pathogenic%2520bacteria%2520by%2520using%2520ruthenium%2520nanoparticles%26jtitle%3DJ.%2520Mater.%2520Chem.%2520B%26date%3D2016%26volume%3D4%26spage%3D6258%26epage%3D6270%26doi%3D10.1039%2FC6TB01122E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jori, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korbelik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Q.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">889</span>– <span class="NLM_lpage">905</span>, <span class="refDoi"> DOI: 10.1093/jnci/90.12.889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1093%2Fjnci%2F90.12.889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=9637138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADyaK1cXktFOqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1998&pages=889-905&author=T.+J.+Doughertyauthor=C.+J.+Gomerauthor=B.+W.+Hendersonauthor=G.+Joriauthor=D.+Kesselauthor=M.+Korbelikauthor=J.+Moanauthor=Q.+Peng&title=Photodynamic+therapy&doi=10.1093%2Fjnci%2F90.12.889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy</span></div><div class="casAuthors">Dougherty, Thomas J.; Gomer, Charles J.; Henderson, Barbara W.; Jori, Giulio; Kessel, David; Korbelik, Mladen; Moan, Johan; Peng, Qian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">889-905</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 221 refs.  Photodynamic therapy involves administration of a tumor-localizing photosensitizing agent, which may require metabolic synthesis (i.e., a prodrug), followed by activation of the agent by light of a specific wavelength.  This therapy results in a sequence of photochem. and photobiol. processes that cause irreversible photodamage to tumor tissues.  Results from preclin. and clin. studies conducted world-wide over a 25-yr period have established photodynamic therapy as a useful treatment approach for some cancers.  Since 1993, regulatory approval for photodynamic therapy involving use of a partially purified, com. available hematoporphyrin deriv. compd. (Photofrin) in patients with early and advanced stage cancer of the lung, digestive tract, and genitourinary tract has been obtained in Canada, The Netherlands, France, Germany, Japan, and the United States.  We have attempted to conduct and present a comprehensive review of this rapidly expanding field.  Mechanisms of subcellular and tumor localization of photosensitizing agents, as well as of mol., cellular, and tumor responses assocd. with photodynamic therapy, are discussed.  Tech. issues regarding light dosimetry are also considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCG5-ldyzkdbVg90H21EOLACvtfcHk0lgQ66oSZSta8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktFOqsLY%253D&md5=f78d7eece516f3e15cee527ffe97779e</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F90.12.889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F90.12.889%26sid%3Dliteratum%253Aachs%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26aulast%3DGomer%26aufirst%3DC.%2BJ.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DJori%26aufirst%3DG.%26aulast%3DKessel%26aufirst%3DD.%26aulast%3DKorbelik%26aufirst%3DM.%26aulast%3DMoan%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DQ.%26atitle%3DPhotodynamic%2520therapy%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1998%26volume%3D90%26spage%3D889%26epage%3D905%26doi%3D10.1093%2Fjnci%2F90.12.889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubbiani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubafard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacque, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anstaett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felgentrager, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maisch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiccia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization, and biological evaluation of new Ru(II) polypyridyl photosensitizers for photodynamic therapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7280</span>– <span class="NLM_lpage">7292</span>, <span class="refDoi"> DOI: 10.1021/jm500566f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500566f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKlu73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7280-7292&author=A.+Freiauthor=R.+Rubbianiauthor=S.+Tubafardauthor=O.+Blacqueauthor=P.+Anstaettauthor=A.+Felgentragerauthor=T.+Maischauthor=L.+Spicciaauthor=G.+Gasser&title=Synthesis%2C+characterization%2C+and+biological+evaluation+of+new+Ru%28II%29+polypyridyl+photosensitizers+for+photodynamic+therapy&doi=10.1021%2Fjm500566f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Characterization, and Biological Evaluation of New Ru(II) Polypyridyl Photosensitizers for Photodynamic Therapy</span></div><div class="casAuthors">Frei, Angelo; Rubbiani, Riccardo; Tubafard, Solmaz; Blacque, Olivier; Anstaett, Philipp; Felgentrager, Ariane; Maisch, Tim; Spiccia, Leone; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7280-7292</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two Ru(II) polypyridyl complexes, Ru(DIP)2(bdt) (1) and [Ru(dqpCO2Me)(ptpy)]2+ (2) (DIP = 4,7-diphenyl-1,10-phenanthroline, bdt = 1,2-benzenedithiolate, dqpCO2Me = 4-methylcarboxy-2,6-di(quinolin-8-yl)pyridine), ptpy = 4'-phenyl-2,2':6',2''-terpyridine) have been investigated as photosensitizers (PSs) for photodynamic therapy (PDT).  In our exptl. settings, the phototoxicity and phototoxic index (PI) of 2 (IC50(light): 25.3 μM, 420 nm, 6.95 J/cm2; PI >4) and particularly of 1 (IC50(light): 0.62 μM, 420 nm, 6.95 J/cm2; PI: 80) are considerably superior compared to the two clin. approved PSs porfimer sodium and 5-aminolevulinic acid.  Cellular uptake and distribution of these complexes was investigated by confocal microscopy (1) and by inductively coupled plasma mass spectrometry (1 and 2).  Their phototoxicity was also detd. against the Gram-(+) Staphylococcus aureus and Gram-(-) Escherichia coli for potential antimicrobial PDT (aPDT) applications.  Both complexes showed significant aPDT activity (420 nm, 8 J/cm2) against Gram-(+) (S. aureus; >6 log10 CFU redn.) and, for 2, also against Gram-(-) E. coli (>4 log10 CFU redn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1QENinj0EILVg90H21EOLACvtfcHk0liyPvCT7kzStA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKlu73M&md5=95f232e052cf5ad756557e861e9086e5</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjm500566f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500566f%26sid%3Dliteratum%253Aachs%26aulast%3DFrei%26aufirst%3DA.%26aulast%3DRubbiani%26aufirst%3DR.%26aulast%3DTubafard%26aufirst%3DS.%26aulast%3DBlacque%26aufirst%3DO.%26aulast%3DAnstaett%26aufirst%3DP.%26aulast%3DFelgentrager%26aufirst%3DA.%26aulast%3DMaisch%26aufirst%3DT.%26aulast%3DSpiccia%26aufirst%3DL.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520biological%2520evaluation%2520of%2520new%2520Ru%2528II%2529%2520polypyridyl%2520photosensitizers%2520for%2520photodynamic%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7280%26epage%3D7292%26doi%3D10.1021%2Fjm500566f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hess, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierroz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacque, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the medicinal potential of two ruthenium(II) polypyridine complexes as one- and two-photon photodynamic therapy photosensitizers</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">9888</span>– <span class="NLM_lpage">9896</span>, <span class="refDoi"> DOI: 10.1002/chem.201701392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fchem.201701392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28509422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2gs77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=9888-9896&author=J.+Hessauthor=H.+Huangauthor=A.+Kaiserauthor=V.+Pierrozauthor=O.+Blacqueauthor=H.+Chaoauthor=G.+Gasser&title=Evaluation+of+the+medicinal+potential+of+two+ruthenium%28II%29+polypyridine+complexes+as+one-+and+two-photon+photodynamic+therapy+photosensitizers&doi=10.1002%2Fchem.201701392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers</span></div><div class="casAuthors">Hess, Jeannine; Huang, Huaiyi; Kaiser, Adrian; Pierroz, Vanessa; Blacque, Olivier; Chao, Hui; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">9888-9896</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Two [Ru(phen)2dppz]2+ derivs. (phen=1,10-phenantroline, dppz=dipyrido[3,2-a:2',3'-c]phenazine) with different functional groups on the dppz ligand [dppz-7,8-(OMe)2 (1), dppz-7,8-(OH)2 (2)] have been synthesized, characterized and investigated as photosensitizers (PSs) for photodynamic therapy (PDT) against cancer.  Both complexes showed intense red phosphorescence and promising singlet oxygen (1O2) quantum yields of 75 % (1) and 54 % (2) in acetonitrile.  Complex 1 (logPo/w=-0.52, 2.4 nmol Ru per mg protein) was found to be more lipophilic, having also a higher cellular uptake efficiency compared to 2 (logPo/w=-0.20, 0.9 nmol Ru per mg protein).  Complex 1 localized evenly in HeLa cells whereas 2, was mainly visualized in the cell membrane by confocal microscopy.  In the dark, complex 1 (IC50=36.5 μm) was found to be more toxic than complex 2 (IC50 >100 μm) on a HeLa cells monolayer.  Importantly, in view of PDT applications, both complexes were found to be non-toxic in the dark towards multicellular HeLa spheroids (IC50>100 μM).  Upon one-photon irradn. (420 nm, 9.27 J cm-2), 1 exhibited higher phototoxicity (IC50=3.1 μm) than 2 (IC50=16.7 μm) on HeLa cell monolayers.  When two-photon irradn. (800 nm, 9.90 J cm-2) was applied, only 1 (IC50=9.5 μm) was found to be active toward HeLa spheroids.  This study demonstrates that the functional group on the intercalative ligand has a strong influence on the cellular localization and anticancer activity of RuII polypyridyl complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpALsMHxl67W7Vg90H21EOLACvtfcHk0liyPvCT7kzStA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2gs77K&md5=5f4b0fb8ecd4d2cd980344015aaec947</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1002%2Fchem.201701392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201701392%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DPierroz%26aufirst%3DV.%26aulast%3DBlacque%26aufirst%3DO.%26aulast%3DChao%26aufirst%3DH.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DEvaluation%2520of%2520the%2520medicinal%2520potential%2520of%2520two%2520ruthenium%2528II%2529%2520polypyridine%2520complexes%2520as%2520one-%2520and%2520two-photon%2520photodynamic%2520therapy%2520photosensitizers%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D9888%26epage%3D9896%26doi%3D10.1002%2Fchem.201701392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heinemann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karges, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Critical Overview of the Use of Ru(II) Polypyridyl complexes as photosensitizers in one-photon and two-photon photodynamic therapy</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2727</span>– <span class="NLM_lpage">2736</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.7b00180</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.7b00180" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yqs7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2017&pages=2727-2736&author=F.+Heinemannauthor=J.+Kargesauthor=G.+Gasser&title=Critical+Overview+of+the+Use+of+Ru%28II%29+Polypyridyl+complexes+as+photosensitizers+in+one-photon+and+two-photon+photodynamic+therapy&doi=10.1021%2Facs.accounts.7b00180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy</span></div><div class="casAuthors">Heinemann, Franz; Karges, Johannes; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2727-2736</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photodynamic Therapy (PDT) is an emerging technique to treat certain types of cancer, bacterial, fungal, and viral infections, and skin diseases.  In past years, different research groups developed new ruthenium-contg. photosensitizers (PSs) with tuned photophys. and biol. properties to better fit the requirements of PDT.  In this Account, we report and discuss the latest results in this research area, emphasizing particularly our own research.  For example, inspired by the DNA intercalating complex [Ru(bpy)2(dppz)]2+ bpy = 2,2'-bipyridine; dppz = (dipyrido[3,2-a:2',3'-c]phenazine), a series of ruthenium complexes bearing differently functionalized dppz ligands were synthesized to target DNA.  The introduction of the substituents on the dppz ligand did not reduce much the affinity of the complexes to DNA but highly affected their cellular uptake.  The most effective complex in this series, [Ru(bpy)2(dppz-7-OMe)]2+, showed IC50 values in the low micromolar range against several types of cancer cells upon light irradn. and, importantly, a high phototoxic index (PI) of >150.  This value is comparable to or even better than several PSs used in clinics under comparable exptl. conditions.  This compd. was found to localize in the nucleus and to induce DNA damage in HeLa cells upon light irradn.  Interestingly, cells in the mitotic phase were found to be more affected and to have a different mechanism of cell death (apoptosis) upon light irradn. than those in the interphase (paraptosis).  To take advantage of that, the PS was combined with a cell cycle inhibitor to synchronize cells in the mitotic phase, further improving the phototoxicity by a factor of 3.6.  In addn., our group recently demonstrated that [Ru(bphen)2(benzene-1,2-dislufinate)] (bphen = 4,7-diphenyl-1,10-phenanthroline) localizes in mitochondria and has an IC50 value of 0.62 μM with a PI of over 80 in HeLa cells upon light irradn. at 420 nm.  Interestingly, this complex was also found to efficiently kill Gram-pos. Staphylococcus aureus under light irradn.  Antimicrobial PDT (aPDT) is another field of research where Ru(II) polypyridyl complexes can play an interesting role to fight antibiotics resistance. [Ru(dqpCO2Me)(ptpy)]2+ (dqpCO2Me = 4-methylcarboxy-2,6-di(quinolin-8-yl)pyridine), ptpy = 4'-phenyl-2,2':6',2''-terpyridine is addnl. efficient against Gram-neg. Escherichia coli.  The efficacy of pos. charged Ru(II) PSs is related to their affinity to the neg. charged membrane of Gram-neg. bacteria.A drawback of many Ru(II) polypyridyl PSs is their low absorption in the biol. optical window (600-900 nm) where light penetration depth into tissue is the highest.  The lowest energy transition in the UV/Vis spectra of Ru(II) polypyridyl complexes is usually a metal-to-ligand charge-transfer band.  To shift the absorption into this range, tuning of the ligand system, for example, by extending π-systems, has been described in the literature.  Another approach to make excitation in the optical biol. window possible is Two-Photon Absorption (2PA).  High photon d. is needed and usually confocal laser beams are used for excitation.  In collaboration with the Chao group, a series of homoleptic Ru(II) complexes bearing tertiary alkyl ammonium substituted bipyridine ligands with two photon cross sections between 185 and 250 GM at around 800 nm was tested in vitro.  They showed IC50 values in the micromolar range and PIs between 103 and 313.  The highly pos.-charged complexes were found to enter the cell via endocytosis and to target lysosomes.  Studies on 3D tumor cell spheroids, a model closer to real tumors than commonly used 2D cell monolayers, were also performed.  It could be demonstrated that 2P-PDT treatment with 800 nm laser irradn. was significantly more effective than that with 450 nm laser irradn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcr8TypCe_ALVg90H21EOLACvtfcHk0liyPvCT7kzStA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yqs7zL&md5=d14969ed7afc004cd5bf16c208ddfcd2</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.7b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.7b00180%26sid%3Dliteratum%253Aachs%26aulast%3DHeinemann%26aufirst%3DF.%26aulast%3DKarges%26aufirst%3DJ.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DCritical%2520Overview%2520of%2520the%2520Use%2520of%2520Ru%2528II%2529%2520Polypyridyl%2520complexes%2520as%2520photosensitizers%2520in%2520one-photon%2520and%2520two-photon%2520photodynamic%2520therapy%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2017%26volume%3D50%26spage%3D2727%26epage%3D2736%26doi%3D10.1021%2Facs.accounts.7b00180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierroz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Combination of Ru(ii) complexes and light: new frontiers in cancer therapy</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2660</span>– <span class="NLM_lpage">2686</span>, <span class="refDoi"> DOI: 10.1039/C4SC03759F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC4SC03759F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=29308166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVGqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=2660-2686&author=C.+Mariauthor=V.+Pierrozauthor=S.+Ferrariauthor=G.+Gasser&title=Combination+of+Ru%28ii%29+complexes+and+light%3A+new+frontiers+in+cancer+therapy&doi=10.1039%2FC4SC03759F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of Ru(II) complexes and light: new frontiers in cancer therapy</span></div><div class="casAuthors">Mari, Cristina; Pierroz, Vanessa; Ferrari, Stefano; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2660-2686</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The synergistic action of light, oxygen and a photosensitizer (PS) has found applications for decades in medicine under the name of photodynamic therapy (PDT) for the treatment of skin diseases and, more recently, for the treatment of cancer.  However, of the thirteen PSs currently approved for the treatment of cancer over more than 10 countries, only two contain a metal ion.  This fact is rather surprising considering that nowadays around 50% of conventional chemotherapies involve the use of cisplatin and other platinum-contg. drugs.  In this perspective article, we review the opportunities brought by the use of Ru(II) complexes as PSs in PDT.  In addn., we also present the recent achievements in the application of Ru(II) complexes in photoactivated chemotherapy (PACT).  In this strategy, the presence of oxygen is not required to achieve cell toxicity.  This is of significance since tumors are generally hypoxic.  Importantly, this perspective article focuses particularly on the Ru(II) complexes for which an in vitro biol. evaluation has been performed and the mechanism of action (partially) unveiled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_bEsxUQdijbVg90H21EOLACvtfcHk0lin6-yPg6byAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVGqsA%253D%253D&md5=6df3d5f614a2cd6f951189a3340a2590</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1039%2FC4SC03759F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4SC03759F%26sid%3Dliteratum%253Aachs%26aulast%3DMari%26aufirst%3DC.%26aulast%3DPierroz%26aufirst%3DV.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DCombination%2520of%2520Ru%2528ii%2529%2520complexes%2520and%2520light%253A%2520new%2520frontiers%2520in%2520cancer%2520therapy%26jtitle%3DChem.%2520Sci.%26date%3D2015%26volume%3D6%26spage%3D2660%26epage%3D2686%26doi%3D10.1039%2FC4SC03759F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span> <span> </span><span class="NLM_article-title">Highly charged ruthenium(II) polypyridyl complexes as lysosome-localized photosensitizers for two-photon photodynamic therapy</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">14049</span>– <span class="NLM_lpage">14052</span>, <span class="refDoi"> DOI: 10.1002/anie.201507800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fanie.201507800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1elsL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=14049-14052&author=H.+Huangauthor=B.+Yuauthor=P.+Zhangauthor=J.+Huangauthor=Y.+Chenauthor=G.+Gasserauthor=L.+Jiauthor=H.+Chao&title=Highly+charged+ruthenium%28II%29+polypyridyl+complexes+as+lysosome-localized+photosensitizers+for+two-photon+photodynamic+therapy&doi=10.1002%2Fanie.201507800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Charged Ruthenium(II) Polypyridyl Complexes as Lysosome-Localized Photosensitizers for Two-Photon Photodynamic Therapy</span></div><div class="casAuthors">Huang, Huaiyi; Yu, Bole; Zhang, Pingyu; Huang, Juanjuan; Chen, Yu; Gasser, Gilles; Ji, Liangnian; Chao, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">14049-14052</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is a noninvasive medical technique that has received increasing attention over the last years and been applied for the treatment of certain types of cancer.  However, the currently clin. used PDT agents have several limitations, such as low water soly., poor photostability, and limited selectivity towards cancer cells, aside from having very low two-photon cross-sections around 800 nm, which limits their potential use in TP-PDT.  To tackle these drawbacks, three highly pos. charged ruthenium(II) polypyridyl complexes were synthesized.  These complexes selectively localize in the lysosomes, an ideal localization for PDT purposes.  One of these complexes showed an impressive phototoxicity index upon irradn. at 800 nm in 3D HeLa multicellular tumor spheroids and thus holds great promise for applications in two-photon photodynamic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcb9izqx5Zk7Vg90H21EOLACvtfcHk0lin6-yPg6byAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1elsL%252FN&md5=fad2f74f12a45ffcc49ac2e56fb287ae</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1002%2Fanie.201507800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201507800%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGasser%26aufirst%3DG.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26atitle%3DHighly%2520charged%2520ruthenium%2528II%2529%2520polypyridyl%2520complexes%2520as%2520lysosome-localized%2520photosensitizers%2520for%2520two-photon%2520photodynamic%2520therapy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D14049%26epage%3D14052%26doi%3D10.1002%2Fanie.201507800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span> <span> </span><span class="NLM_article-title">Direct imaging of biological sulfur dioxide derivatives in vivo using a two-photon phosphorescent probe</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2015.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.biomaterials.2015.06.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2015&pages=128-136&author=G.+Liauthor=Y.+Chenauthor=J.+Wangauthor=J.+Wuauthor=G.+Gasserauthor=L.+Jiauthor=H.+Chao&title=Direct+imaging+of+biological+sulfur+dioxide+derivatives+in+vivo+using+a+two-photon+phosphorescent+probe&doi=10.1016%2Fj.biomaterials.2015.06.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2015.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2015.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DGasser%26aufirst%3DG.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26atitle%3DDirect%2520imaging%2520of%2520biological%2520sulfur%2520dioxide%2520derivatives%2520in%2520vivo%2520using%2520a%2520two-photon%2520phosphorescent%2520probe%26jtitle%3DBiomaterials%26date%3D2015%26volume%3D63%26spage%3D128%26epage%3D136%26doi%3D10.1016%2Fj.biomaterials.2015.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennigar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colpitts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasimova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeCoste, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamberlain, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, S. A.</span></span> <span> </span><span class="NLM_article-title">Ru(II) dyads derived from α-oligothiophenes: A new class of potent and versatile photosensitizers for PDT</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>282–283</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2014.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ccr.2014.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Gns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282%E2%80%93283&publication_year=2015&pages=127-138&author=G.+Shiauthor=S.+Monroauthor=R.+Hennigarauthor=J.+Colpittsauthor=J.+Fongauthor=K.+Kasimovaauthor=H.+Yinauthor=R.+DeCosteauthor=C.+Spencerauthor=L.+Chamberlainauthor=A.+Mandelauthor=L.+Lilgeauthor=S.+A.+McFarland&title=Ru%28II%29+dyads+derived+from+%CE%B1-oligothiophenes%3A+A+new+class+of+potent+and+versatile+photosensitizers+for+PDT&doi=10.1016%2Fj.ccr.2014.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Ru(II) dyads derived from α-oligothiophenes: A new class of potent and versatile photosensitizers for PDT</span></div><div class="casAuthors">Shi, Ge; Monro, Susan; Hennigar, Robie; Colpitts, Julie; Fong, Jamie; Kasimova, Kamola; Yin, Huimin; DeCoste, Ryan; Spencer, Colin; Chamberlain, Lance; Mandel, Arkady; Lilge, Lothar; McFarland, Sherri A.</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">282-283</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-138</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Ru(II) dyads derived from org. units that impart low-lying 3IL excited states combine the most attractive features of org. photosensitizers with those of coordination complexes.  The result is a bichromophoric system with excited-state lifetimes that are significantly longer than those assocd. with traditional 3MLCT states.  Incorporation of α-oligothiophenes as the org. chromophore leads to systems that act as dual Type I/II photosensitizers, opening up the possibility of treating hypoxic tumors with photodynamic therapy (PDT) and overcoming problems with in vivo dosimetry.  These photosensitizers, particularly those that consist of three thiophene units and higher, are remarkable DNA binders and photocleavers when exposed to light, exhibiting no interference with DNA structural integrity in the absence of a light-trigger.  Such light-responsive agents localize in the nuclei of cells without the need for a carrier and produce a potent PDT response with minimal dark toxicity.  This phototherapeutic effect translates directly to animals and is superior to the clin. agent Photofrin in this model.  These Ru(II) dyads can be activated with light in the PDT window, despite very low molar absorptivities in this region, and this phenomenon can be attributed to the efficiency with which these agents operate.  The ability to activate these prodrugs with UV to near-IR light marks an unprecedented versatility that can be exploited to match treatment depth to tumor invasion depth without compromising potency, giving rise to photosensitizers for multiwavelength PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNfTsxLAyC7rVg90H21EOLACvtfcHk0li6vGBdGLXByw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Gns78%253D&md5=148232f59b51e383d97a9d94d5e576cc</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DG.%26aulast%3DMonro%26aufirst%3DS.%26aulast%3DHennigar%26aufirst%3DR.%26aulast%3DColpitts%26aufirst%3DJ.%26aulast%3DFong%26aufirst%3DJ.%26aulast%3DKasimova%26aufirst%3DK.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DDeCoste%26aufirst%3DR.%26aulast%3DSpencer%26aufirst%3DC.%26aulast%3DChamberlain%26aufirst%3DL.%26aulast%3DMandel%26aufirst%3DA.%26aulast%3DLilge%26aufirst%3DL.%26aulast%3DMcFarland%26aufirst%3DS.%2BA.%26atitle%3DRu%2528II%2529%2520dyads%2520derived%2520from%2520%25CE%25B1-oligothiophenes%253A%2520A%2520new%2520class%2520of%2520potent%2520and%2520versatile%2520photosensitizers%2520for%2520PDT%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2015%26volume%3D282%25E2%2580%2593283%26spage%3D127%26epage%3D138%26doi%3D10.1016%2Fj.ccr.2014.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boca, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Four, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Sanden, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astilean, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldeck, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemercier, G.</span></span> <span> </span><span class="NLM_article-title">An ethylene-glycol decorated ruthenium(II) complex for two-photon photodynamic therapy</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_fpage">4590</span>– <span class="NLM_lpage">4592</span>, <span class="refDoi"> DOI: 10.1039/b907143a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2Fb907143a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=19617993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD1MXoslClsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=4590-4592&author=S.+C.+Bocaauthor=M.+Fourauthor=A.+Bonneauthor=B.+van+der%0ASandenauthor=S.+Astileanauthor=P.+L.+Baldeckauthor=G.+Lemercier&title=An+ethylene-glycol+decorated+ruthenium%28II%29+complex+for+two-photon+photodynamic+therapy&doi=10.1039%2Fb907143a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">An ethylene-glycol decorated ruthenium(II) complex for two-photon photodynamic therapy</span></div><div class="casAuthors">Boca, Sanda C.; Four, Mickael; Bonne, Adeline; van der Sanden, Boudewijn; Astilean, Simion; Baldeck, Patrice L.; Lemercier, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">4590-4592</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel water-sol. ethylene-glycol decorated terpyridine Ru(II) complex was prepd., which represents a promising new class of selective two-photon sensitizers for use in photodynamic therapy within a confined space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwj5EPJCOgiLVg90H21EOLACvtfcHk0li6vGBdGLXByw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXoslClsr8%253D&md5=3bdf65a4e3b748f1c29be0a444316724</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1039%2Fb907143a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb907143a%26sid%3Dliteratum%253Aachs%26aulast%3DBoca%26aufirst%3DS.%2BC.%26aulast%3DFour%26aufirst%3DM.%26aulast%3DBonne%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BSanden%26aufirst%3DB.%26aulast%3DAstilean%26aufirst%3DS.%26aulast%3DBaldeck%26aufirst%3DP.%2BL.%26aulast%3DLemercier%26aufirst%3DG.%26atitle%3DAn%2520ethylene-glycol%2520decorated%2520ruthenium%2528II%2529%2520complex%2520for%2520two-photon%2520photodynamic%2520therapy%26jtitle%3DChem.%2520Commun.%26date%3D2009%26spage%3D4590%26epage%3D4592%26doi%3D10.1039%2Fb907143a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lemercier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Four, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson-Daku, L. M.</span></span> <span> </span><span class="NLM_article-title"><sup>3</sup>MLCT excited states in Ru(II) complexes: Reactivity and related two-photon absorption applications in the near-infrared spectral range</span>. <i>C. R. Chim.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">709</span>– <span class="NLM_lpage">715</span>, <span class="refDoi"> DOI: 10.1016/j.crci.2007.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.crci.2007.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1yktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=709-715&author=G.+Lemercierauthor=A.+Bonneauthor=M.+Fourauthor=L.+M.+Lawson-Daku&title=3MLCT+excited+states+in+Ru%28II%29+complexes%3A+Reactivity+and+related+two-photon+absorption+applications+in+the+near-infrared+spectral+range&doi=10.1016%2Fj.crci.2007.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">3MLCT excited states in Ru(II) complexes: Reactivity and related two-photon absorption applications in the near-infrared spectral range</span></div><div class="casAuthors">Lemercier, Gilles; Bonne, Adeline; Four, Mickael; Lawson-Daku, Latevi M.</div><div class="citationInfo"><span class="NLM_cas:title">Comptes Rendus Chimie</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">709-715</span>CODEN:
                <span class="NLM_cas:coden">CRCOCR</span>;
        ISSN:<span class="NLM_cas:issn">1631-0748</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">This short review provides a concise summary of the current state of research on the population by two-photon absorption of the triplet metal-to-ligand 3MLCT excited state of ruthenium(II) complexes.  Several effective and potential applications of this nonlinear optics phenomenon (optical power limiting in the near IR, biol. imagery and photodynamic therapy, PDT) and related linear effects will also be presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBULVF_PgSJbVg90H21EOLACvtfcHk0li6vGBdGLXByw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1yktro%253D&md5=92668f550849c632960a6a429f2f68cf</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2Fj.crci.2007.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.crci.2007.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DLemercier%26aufirst%3DG.%26aulast%3DBonne%26aufirst%3DA.%26aulast%3DFour%26aufirst%3DM.%26aulast%3DLawson-Daku%26aufirst%3DL.%2BM.%26atitle%3D3MLCT%2520excited%2520states%2520in%2520Ru%2528II%2529%2520complexes%253A%2520Reactivity%2520and%2520related%2520two-photon%2520absorption%2520applications%2520in%2520the%2520near-infrared%2520spectral%2520range%26jtitle%3DC.%2520R.%2520Chim.%26date%3D2008%26volume%3D11%26spage%3D709%26epage%3D715%26doi%3D10.1016%2Fj.crci.2007.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westhorpe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallevo, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bark, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menezes, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. A.</span></span> <span> </span><span class="NLM_article-title">Radiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">20596</span>, <span class="refDoi"> DOI: 10.1038/srep20596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2Fsrep20596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=26867983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFSksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=20596&author=R.+Carterauthor=A.+Westhorpeauthor=M.+J.+Romeroauthor=A.+Habtemariamauthor=C.+R.+Gallevoauthor=Y.+Barkauthor=N.+Menezesauthor=P.+J.+Sadlerauthor=R.+A.+Sharma&title=Radiosensitisation+of+human+colorectal+cancer+cells+by+ruthenium%28II%29+arene+anticancer+complexes&doi=10.1038%2Fsrep20596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes</span></div><div class="casAuthors">Carter, R.; Westhorpe, A.; Romero, Mj; Habtemariam, A.; Gallevo, Cr; Bark, Y.; Menezes, N.; Sadler, Pj; Sharma, Ra</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">20596</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Some of the largest improvements in clin. outcomes for patients with solid cancers obsd. over the past 3 decades have been from concurrent treatment with chemotherapy and radiotherapy (RT).  The lethal effects of RT on cancer cells arise primarily from damage to DNA.  Ruthenium (Ru) is a transition metal of the platinum group, with potentially less toxicity than platinum drugs.  We postulated that ruthenium-arene complexes are radiosensitizers when used in combination with RT.  We screened 14 ruthenium-arene complexes and identified AH54 and AH63 as supra-additive radiosensitizers by clonogenic survival assays and isobologram analyses.  Both complexes displayed facial chirality.  At clin. relevant doses of RT, radiosensitization of cancer cells by AH54 and AH63 was p53-dependent.  Radiation enhancement ratios for 5-10 micromolar drug concns. ranged from 1.19 to 1.82.  In p53-wildtype cells, both drugs induced significant G2 cell cycle arrest and apoptosis.  Colorectal cancer cells deficient in DNA damage repair proteins, EME1 and MUS81, were significantly more sensitive to both agents.  Both drugs were active in cancer cell lines displaying acquired resistance to oxaliplatin or cisplatin.  Our findings broaden the potential scope for these drugs for use in cancer therapy, including combination with radiotherapy to treat colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVMH20t7IG0rVg90H21EOLACvtfcHk0liQTdTp1_Q_WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFSksbw%253D&md5=0e95ec3f1b55cdad044af8d17fcb4217</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1038%2Fsrep20596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep20596%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DR.%26aulast%3DWesthorpe%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DM.%2BJ.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DGallevo%26aufirst%3DC.%2BR.%26aulast%3DBark%26aufirst%3DY.%26aulast%3DMenezes%26aufirst%3DN.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26aulast%3DSharma%26aufirst%3DR.%2BA.%26atitle%3DRadiosensitisation%2520of%2520human%2520colorectal%2520cancer%2520cells%2520by%2520ruthenium%2528II%2529%2520arene%2520anticancer%2520complexes%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D20596%26doi%3D10.1038%2Fsrep20596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span> <span> </span><span class="NLM_article-title">Hypoxia--a key regulatory factor in tumour growth</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1038/nrc704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1038%2Fnrc704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=11902584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=38-47&author=A.+L.+Harris&title=Hypoxia%2D%2Da+key+regulatory+factor+in+tumour+growth&doi=10.1038%2Fnrc704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia - a key regulatory factor in tumor growth</span></div><div class="casAuthors">Harris, Adrian L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-47</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cells undergo a variety of biol. responses when placed in hypoxic conditions, including activation of signaling pathways that regulate proliferation, angiogenesis and death.  Cancer cells have adapted these pathways, allowing tumors to survive and even grow under hypoxic conditions, and tumor hypoxia is assocd. with poor prognosis and resistance to radiation therapy.  Many elements of the hypoxia-response pathway are therefore good candidates for therapeutic targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO3m4smDSP37Vg90H21EOLACvtfcHk0liQTdTp1_Q_WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL4%253D&md5=e3f65ce80422e4743d49905e1796fe5c</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1038%2Fnrc704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc704%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DHypoxia--a%2520key%2520regulatory%2520factor%2520in%2520tumour%2520growth%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D38%26epage%3D47%26doi%3D10.1038%2Fnrc704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span> <span> </span><span class="NLM_article-title">Lightening up ruthenium complexes to fight cancer?</span>. <i>Chimia</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.2533/chimia.2015.176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.2533%2Fchimia.2015.176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=26668934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2MXoslyntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2015&pages=176-181&author=C.+Mariauthor=G.+Gasser&title=Lightening+up+ruthenium+complexes+to+fight+cancer%3F&doi=10.2533%2Fchimia.2015.176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Lightening up ruthenium complexes to fight cancer?</span></div><div class="casAuthors">Mari, Cristina; Gasser, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Chimia</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">176-181</span>CODEN:
                <span class="NLM_cas:coden">CHIMAD</span>;
        ISSN:<span class="NLM_cas:issn">0009-4293</span>.
    
            (<span class="NLM_cas:orgname">Swiss Chemical Society</span>)
        </div><div class="casAbstract">A review.  In medicine, light is used in a medical treatment called photodynamic therapy (PDT) to treat some types of cancer and skin diseases.  This technique generally allows for reduced side effects compared to traditional chemotherapy.  However, PDT is not fully effective on hypoxic tumors (i.e. lacking oxygen).  To overcome this important drawback, photoactivated chemotherapy (PACT) agents have been designed to obtain light-mediated cancer cell death via an oxygen-independent mechanism.  Ruthenium complexes have already been and are currently deeply explored as traditional anticancer agents.  However, as reported in this short review article, such compds. can also bring novel opportunities in the field of light-mediated cancer treatment.  Herein, we report on our findings in the optimization of Ru(ii) polypyridyl complexes as PDT and PACT agents for the potential treatment of cancer and, interestingly, also of bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLTvt-SxlhXbVg90H21EOLACvtfcHk0liQTdTp1_Q_WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXoslyntLY%253D&md5=54b50c6f699710bb9afbefd7dbde6599</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.2533%2Fchimia.2015.176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2533%252Fchimia.2015.176%26sid%3Dliteratum%253Aachs%26aulast%3DMari%26aufirst%3DC.%26aulast%3DGasser%26aufirst%3DG.%26atitle%3DLightening%2520up%2520ruthenium%2520complexes%2520to%2520fight%2520cancer%253F%26jtitle%3DChimia%26date%3D2015%26volume%3D69%26spage%3D176%26epage%3D181%26doi%3D10.2533%2Fchimia.2015.176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farrer, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salassa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine</span>. <i>Dalton trans.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>0</i></span>,  <span class="NLM_fpage">10690</span>– <span class="NLM_lpage">10701</span>, <span class="refDoi"> DOI: 10.1039/b917753a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2Fb917753a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFSgt7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=0&publication_year=2009&pages=10690-10701&author=N.+J.+Farrerauthor=L.+Salassaauthor=P.+J.+Sadler&title=Photoactivated+chemotherapy+%28PACT%29%3A+the+potential+of+excited-state+d-block+metals+in+medicine&doi=10.1039%2Fb917753a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine</span></div><div class="casAuthors">Farrer, Nicola J.; Salassa, Luca; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">10690-10701</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The fields of phototherapy and of inorg. chemotherapy both have long histories.  Inorg. photoactivated chemotherapy (PACT) offers both temporal and spatial control over drug activation and has remarkable potential for the treatment of cancer.  Following photoexcitation, a no. of different decay pathways (both photophys. and photochem.) are available to a metal complex.  These pathways can result in radiative energy release, loss of ligands or transfer of energy to another species, such as triplet oxygen.  We discuss the features which need to be considered when developing a metal-based anticancer drug, and the common mechanisms by which the current complexes are believed to operate.  We then provide a comprehensive overview of PACT developments for complexes of the different d-block metals for the treatment of cancer, detailing the more established areas concerning Ti, V, Cr, Mn, Re, Fe, Ru, Os, Co, Rh, Pt, and Cu and also highlighting areas where there is potential for greater exploration.  Nanoparticles (Ag, Au) and quantum dots (Cd) are also discussed for their photothermal destructive potential.  We also discuss the potential held in particular by mixed-metal systems and Ru complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaW_paG_wgTrVg90H21EOLACvtfcHk0ljlipXQLEzvWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFSgt7%252FP&md5=c505a936782c60488c0809227baf711a</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1039%2Fb917753a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb917753a%26sid%3Dliteratum%253Aachs%26aulast%3DFarrer%26aufirst%3DN.%2BJ.%26aulast%3DSalassa%26aufirst%3DL.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DPhotoactivated%2520chemotherapy%2520%2528PACT%2529%253A%2520the%2520potential%2520of%2520excited-state%2520d-block%2520metals%2520in%2520medicine%26jtitle%3DDalton%2520trans.%26date%3D2009%26volume%3D0%26spage%3D10690%26epage%3D10701%26doi%3D10.1039%2Fb917753a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kohler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nease, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garofolo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidary, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thummel, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glazer, E. C.</span></span> <span> </span><span class="NLM_article-title">Photochemical and photobiological activity of ru(II) homoleptic and heteroleptic complexes containing methylated bipyridyl-type ligands</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">12214</span>– <span class="NLM_lpage">12223</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.7b01642</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.7b01642" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGjsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=12214-12223&author=L.+Kohlerauthor=L.+Neaseauthor=P.+Voauthor=J.+Garofoloauthor=D.+K.+Heidaryauthor=R.+P.+Thummelauthor=E.+C.+Glazer&title=Photochemical+and+photobiological+activity+of+ru%28II%29+homoleptic+and+heteroleptic+complexes+containing+methylated+bipyridyl-type+ligands&doi=10.1021%2Facs.inorgchem.7b01642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Photochemical and photobiological activity of Ru(II) homoleptic and heteroleptic complexes containing methylated bipyridyl-type ligands</span></div><div class="casAuthors">Kohler, Lars; Nease, Leona; Vo, Pascal; Garofolo, Jenna; Heidary, David K.; Thummel, Randolph P.; Glazer, Edith C.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">12214-12223</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Light-activated compds. are powerful tools and potential agents for medical applications, as biol. effects can be controlled in space and time.  Ruthenium polypyridyl complexes can induce cytotoxic effects through multiple mechanisms, including acting as photosensitizers for singlet oxygen (1O2) prodn., generating other reactive oxygen species (ROS), releasing biol. active ligands, and creating reactive intermediates that form covalent bonds to biol. mols.  A structure-activity relationship (SAR) study was performed on a series of Ru(II) complexes contg. isomeric tetramethyl-substituted bipyridyl-type ligands.  Three of the ligand systems studied contained strain-inducing Me groups and created photolabile metal complexes, which can form covalent bonds to biomols. upon light activation, while the fourth was unstrained and resulted in photostable complexes, which can generate 1O2.  The compds. studied included both bis-heteroleptic complexes contg. two bipyridine ligands and a third, substituted ligand and tris-homoleptic complexes contg. only the substituted ligand.  The photophysics, electrochem., photochem., and photobiol. were assessed.  Strained heteroleptic complexes were found to be more photoactive and cytotoxic then tris-homoleptic complexes, and bipyridine ligands were superior to bipyrimidine.  However, the homoleptic complexes exhibited an enhanced ability to inhibit protein prodn. in live cells.  Specific methylation patterns were assocd. with improved activation with red light, and photolabile complexes were generally more potent cytotoxic agents than the photostable 1O2-generating compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMF1WUOUEWnbVg90H21EOLACvtfcHk0ljlipXQLEzvWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGjsLrL&md5=d0fd85043d710c2a1e56d1d9b82be06e</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.7b01642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.7b01642%26sid%3Dliteratum%253Aachs%26aulast%3DKohler%26aufirst%3DL.%26aulast%3DNease%26aufirst%3DL.%26aulast%3DVo%26aufirst%3DP.%26aulast%3DGarofolo%26aufirst%3DJ.%26aulast%3DHeidary%26aufirst%3DD.%2BK.%26aulast%3DThummel%26aufirst%3DR.%2BP.%26aulast%3DGlazer%26aufirst%3DE.%2BC.%26atitle%3DPhotochemical%2520and%2520photobiological%2520activity%2520of%2520ru%2528II%2529%2520homoleptic%2520and%2520heteroleptic%2520complexes%2520containing%2520methylated%2520bipyridyl-type%2520ligands%26jtitle%3DInorg.%2520Chem.%26date%3D2017%26volume%3D56%26spage%3D12214%26epage%3D12223%26doi%3D10.1021%2Facs.inorgchem.7b01642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Havrylyuk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidary, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nease, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glazer, E. C.</span></span> <span> </span><span class="NLM_article-title">Photochemical properties and structure-activity relationships of Ru(II) complexes with pyridylbenzazole ligands as promising anticancer agents</span>. <i>Eur. J. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">1687</span>– <span class="NLM_lpage">1694</span>, <span class="refDoi"> DOI: 10.1002/ejic.201601450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fejic.201601450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=29200939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislOit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=1687-1694&author=D.+Havrylyukauthor=D.+K.+Heidaryauthor=L.+Neaseauthor=S.+Parkinauthor=E.+C.+Glazer&title=Photochemical+properties+and+structure-activity+relationships+of+Ru%28II%29+complexes+with+pyridylbenzazole+ligands+as+promising+anticancer+agents&doi=10.1002%2Fejic.201601450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Photochemical Properties and Structure-Activity Relationships of RuII Complexes with Pyridylbenzazole Ligands as Promising Anticancer Agents</span></div><div class="casAuthors">Havrylyuk, Dmytro; Heidary, David K.; Nease, Leona; Parkin, Sean; Glazer, Edith C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1687-1694</span>CODEN:
                <span class="NLM_cas:coden">EJICFO</span>;
        ISSN:<span class="NLM_cas:issn">1434-1948</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Ruthenium complexes capable of light-triggered cytotoxicity are appealing potential prodrugs for photodynamic therapy (PDT) and photoactivated chemotherapy (PACT).  Two groups of (polypyridyl)RuII complexes with 2-(2-pyridyl)benzazole ligands were synthesized and investigated for their photochem. properties and anticancer activity to compare strained and unstrained systems that are likely to have different biol. mechanisms of action.  The structure-activity relationship was focused on the benzazole-core bioisosterism and replacement of coligands in RuII complexes.  Strained compds. rapidly ejected the 2-(2-pyridyl)benzazole ligand after light irradn., and possessed strong toxicity in the HL-60 cell line both under dark and light conditions.  In contrast, unstrained RuII complexes were nontoxic in the absence of light, induced cytotoxicity at nanomolar concns. after light irradn., and were capable of light-induced DNA damage.  The 90-220-fold difference in light and dark IC50 values provides a large potential therapeutic window to allow for selective targeting of cells by exposure to light.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh2vmg-ypKLbVg90H21EOLACvtfcHk0ljlipXQLEzvWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislOit7o%253D&md5=6ea0044d8943685afa5e60daf66b47d4</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1002%2Fejic.201601450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejic.201601450%26sid%3Dliteratum%253Aachs%26aulast%3DHavrylyuk%26aufirst%3DD.%26aulast%3DHeidary%26aufirst%3DD.%2BK.%26aulast%3DNease%26aufirst%3DL.%26aulast%3DParkin%26aufirst%3DS.%26aulast%3DGlazer%26aufirst%3DE.%2BC.%26atitle%3DPhotochemical%2520properties%2520and%2520structure-activity%2520relationships%2520of%2520Ru%2528II%2529%2520complexes%2520with%2520pyridylbenzazole%2520ligands%2520as%2520promising%2520anticancer%2520agents%26jtitle%3DEur.%2520J.%2520Inorg.%2520Chem.%26date%3D2017%26volume%3D2017%26spage%3D1687%26epage%3D1694%26doi%3D10.1002%2Fejic.201601450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Rixel, V. H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moolenaar, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegler, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messori, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, S.</span></span> <span> </span><span class="NLM_article-title">Controlling with light the interaction between trans-tetrapyridyl ruthenium complexes and an oligonucleotide</span>. <i>Dalton trans.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1039/C7DT03613B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC7DT03613B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=29230469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVGmt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=507-516&author=V.+H.+S.+Van+Rixelauthor=G.+F.+Moolenaarauthor=M.+A.+Sieglerauthor=L.+Messoriauthor=S.+Bonnet&title=Controlling+with+light+the+interaction+between+trans-tetrapyridyl+ruthenium+complexes+and+an+oligonucleotide&doi=10.1039%2FC7DT03613B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Controlling with light the interaction between trans-tetrapyridyl ruthenium complexes and an oligonucleotide</span></div><div class="casAuthors">van Rixel, Vincent H. S.; Moolenaar, Geri F.; Siegler, Maxime A.; Messori, Luigi; Bonnet, Sylvestre</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">507-516</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Three new trans-Ru(II) complexes coordinated to tetrapyridyl ligands, [Ru(bapbpy)(DMSO)Cl]Cl ([2]Cl), [Ru(bapbpy)(Hmte)2](PF6)2 ([3](PF6)2), and [Ru(biqbpy)(Hmte)2](PF6)2 ([4](PF6)2), (biqbpy = 6,6'-bis[N-(isoquinolyl)-1-amino]-2,2'-bipyridine, bapbpy = 6,6'-bis[N-(pyridyl)-1-amino]-2,2'-bipyridine, Hmte = 2-(Methylthio)ethanol) were prepd. as analogs of [Ru(biqbpy)(DMSO)Cl]Cl ([1]Cl), a recently described photoactivated chemotherapy agent.  The new complexes were characterized, and their crystal structures showed the distorted coordination octahedron typical of this family of complexes.  Their photoreactivity in soln. was analyzed by spectrophotometry and mass spectrometry, which showed that the S ligand was substituted upon blue light irradn.  The binding of the Ru complexes to a ref. single-stranded oligonucleotide (s(5'CTACGGTTTCAC3')) was explored both in the dark and under light irradn. by gel electrophoresis and high-resoln. mass spectrometry.  While adduct formation in the dark was negligible for the four complexes, light irradn. gave adducts with one or two Ru centers per oligonucleotide.  The absence of interactions in the dark and the presence of complex-oligonucleotide adducts demonstrate that visible light controls the interaction of these Ru complexes with nucleic acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGBFMW6lG1d7Vg90H21EOLACvtfcHk0ljxcWkTGuYYZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVGmt77L&md5=60dda0e64c593ecea874acf8f9d61469</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1039%2FC7DT03613B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7DT03613B%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BRixel%26aufirst%3DV.%2BH.%2BS.%26aulast%3DMoolenaar%26aufirst%3DG.%2BF.%26aulast%3DSiegler%26aufirst%3DM.%2BA.%26aulast%3DMessori%26aufirst%3DL.%26aulast%3DBonnet%26aufirst%3DS.%26atitle%3DControlling%2520with%2520light%2520the%2520interaction%2520between%2520trans-tetrapyridyl%2520ruthenium%2520complexes%2520and%2520an%2520oligonucleotide%26jtitle%3DDalton%2520trans.%26date%3D2018%26volume%3D47%26spage%3D507%26epage%3D516%26doi%3D10.1039%2FC7DT03613B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lameijer, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Askes, S. H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Devedec, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, S.</span></span> <span> </span><span class="NLM_article-title">A red-light-activated ruthenium-caged NAMPT inhibitor remains phototoxic in hypoxic cancer cells</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">11549</span>– <span class="NLM_lpage">11553</span>, <span class="refDoi"> DOI: 10.1002/anie.201703890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1002%2Fanie.201703890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSmu77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=11549-11553&author=L.+N.+Lameijerauthor=D.+Ernstauthor=S.+L.+Hopkinsauthor=M.+S.+Meijerauthor=S.+H.+C.+Askesauthor=S.+E.+Le+Devedecauthor=S.+Bonnet&title=A+red-light-activated+ruthenium-caged+NAMPT+inhibitor+remains+phototoxic+in+hypoxic+cancer+cells&doi=10.1002%2Fanie.201703890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">A Red-Light-Activated Ruthenium-Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells</span></div><div class="casAuthors">Lameijer, Lucien N.; Ernst, Daniel; Hopkins, Samantha L.; Meijer, Michael S.; Askes, Sven H. C.; Le Devedec, Sylvia E.; Bonnet, Sylvestre</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">11549-11553</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We describe two water-sol. ruthenium complexes, [1]Cl2 and [2]Cl2, that photodissociate to release a cytotoxic nicotinamide phosphoribosyltransferase (NAMPT) inhibitor with a low dose (21 J cm-2) of red light in an oxygen-independent manner.  Using a specific NAMPT activity assay, up to an 18-fold increase in inhibition potency was measured upon red-light activation of [2]Cl2, while [1]Cl2 was thermally unstable.  For the first time, the dark and red-light-induced cytotoxicity of these photocaged compds. could be tested under hypoxia (1 % O2).  In skin (A431) and lung (A549) cancer cells, a 3- to 4-fold increase in cytotoxicity was found upon red-light irradn. for [2]Cl2, whether the cells were cultured and irradiated with 1 % or 21 % O2.  These results demonstrate the potential of photoactivated chemotherapy for hypoxic cancer cells, in which classical photodynamic therapy, which relies on oxygen activation, is poorly efficient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPvyLLGQboPLVg90H21EOLACvtfcHk0ljxcWkTGuYYZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSmu77L&md5=b5ab704916712872f33ed4d67838e380</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1002%2Fanie.201703890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201703890%26sid%3Dliteratum%253Aachs%26aulast%3DLameijer%26aufirst%3DL.%2BN.%26aulast%3DErnst%26aufirst%3DD.%26aulast%3DHopkins%26aufirst%3DS.%2BL.%26aulast%3DMeijer%26aufirst%3DM.%2BS.%26aulast%3DAskes%26aufirst%3DS.%2BH.%2BC.%26aulast%3DLe%2BDevedec%26aufirst%3DS.%2BE.%26aulast%3DBonnet%26aufirst%3DS.%26atitle%3DA%2520red-light-activated%2520ruthenium-caged%2520NAMPT%2520inhibitor%2520remains%2520phototoxic%2520in%2520hypoxic%2520cancer%2520cells%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D11549%26epage%3D11553%26doi%3D10.1002%2Fanie.201703890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herroon, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podgorski, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodanko, J. J.</span></span> <span> </span><span class="NLM_article-title">Illuminating cytochrome P450 binding: Ru(ii)-caged inhibitors of CYP17A1</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3673</span>– <span class="NLM_lpage">3676</span>, <span class="refDoi"> DOI: 10.1039/C7CC01459G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC7CC01459G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28304025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktVShu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=3673-3676&author=A.+Liauthor=R.+Yadavauthor=J.+K.+Whiteauthor=M.+K.+Herroonauthor=B.+P.+Callahanauthor=I.+Podgorskiauthor=C.+Turroauthor=E.+E.+Scottauthor=J.+J.+Kodanko&title=Illuminating+cytochrome+P450+binding%3A+Ru%28ii%29-caged+inhibitors+of+CYP17A1&doi=10.1039%2FC7CC01459G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Illuminating cytochrome P450 binding: Ru(II)-caged inhibitors of CYP17A1</span></div><div class="casAuthors">Li, Ao; Yadav, Rahul; White, Jessica K.; Herroon, Mackenzie K.; Callahan, Brian P.; Podgorski, Izabela; Turro, Claudia; Scott, Emily E.; Kodanko, Jeremy J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">3673-3676</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">New Ru(II)-caged abiraterone (ABI) complexes were synthesized that exhibit strong absorption in the visible region and release the steroidal CYP17A1 inhibitor abiraterone upon exposure to low energy visible light in buffer and prostate cancer cells.  Photoinduced release results in abiraterone binding to its CYP17A1 target in an inhibitory mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraOhsrARVNiLVg90H21EOLACvtfcHk0ljxcWkTGuYYZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktVShu7k%253D&md5=042870f352c3f09a7352d072edfe54c2</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1039%2FC7CC01459G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC01459G%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DA.%26aulast%3DYadav%26aufirst%3DR.%26aulast%3DWhite%26aufirst%3DJ.%2BK.%26aulast%3DHerroon%26aufirst%3DM.%2BK.%26aulast%3DCallahan%26aufirst%3DB.%2BP.%26aulast%3DPodgorski%26aufirst%3DI.%26aulast%3DTurro%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DE.%2BE.%26aulast%3DKodanko%26aufirst%3DJ.%2BJ.%26atitle%3DIlluminating%2520cytochrome%2520P450%2520binding%253A%2520Ru%2528ii%2529-caged%2520inhibitors%2520of%2520CYP17A1%26jtitle%3DChem.%2520Commun.%26date%3D2017%26volume%3D53%26spage%3D3673%26epage%3D3676%26doi%3D10.1039%2FC7CC01459G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renfrew, A. K.</span></span> <span> </span><span class="NLM_article-title">Photolabile ruthenium complexes to cage and release a highly cytotoxic anticancer agent</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>179</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2017.11.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jinorgbio.2017.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=29180165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOiu7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2018&pages=146-153&author=J.+Weiauthor=A.+K.+Renfrew&title=Photolabile+ruthenium+complexes+to+cage+and+release+a+highly+cytotoxic+anticancer+agent&doi=10.1016%2Fj.jinorgbio.2017.11.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Photolabile ruthenium complexes to cage and release a highly cytotoxic anticancer agent</span></div><div class="casAuthors">Wei, Jianhua; Renfrew, Anna K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">146-153</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">CHS-828 (N-(6-(4-chlorophenoxy)hexyl)-N'-cyano-N''-4-pyridyl guanidine) is an anticancer agent with low bioavailability and high systemic toxicity.  Here the authors present an approach to improve the therapeutic profile of the drug using photolabile ruthenium complexes to generate light-activated prodrugs of CHS-828.  Both prodrug complexes are stable in the dark but release CHS-828 when irradiated with visible light.  The complexes are water-sol. and accumulate in tumor cells in very high concns., predominantly in the mitochondria.  Both prodrug complexes are significantly less cytotoxic than free CHS-828 in the dark but their toxicity increases up to 10-fold in combination with visible light.  The cellular responses to light treatment are consistent with release of the cytotoxic CHS-828 ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4QFiFHaHZbrVg90H21EOLACvtfcHk0lgsFpXSBDZmww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOiu7bO&md5=bbbd0b7a2197150e2665a8fd2afe677e</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2017.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2017.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DRenfrew%26aufirst%3DA.%2BK.%26atitle%3DPhotolabile%2520ruthenium%2520complexes%2520to%2520cage%2520and%2520release%2520a%2520highly%2520cytotoxic%2520anticancer%2520agent%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2018%26volume%3D179%26spage%3D146%26epage%3D153%26doi%3D10.1016%2Fj.jinorgbio.2017.11.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zamora, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denning, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidary, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wachter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nease, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glazer, E. C.</span></span> <span> </span><span class="NLM_article-title">Ruthenium-containing P450 inhibitors for dual enzyme inhibition and DNA damage</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2165</span>– <span class="NLM_lpage">2173</span>, <span class="refDoi"> DOI: 10.1039/C6DT04405K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC6DT04405K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=28121322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=2165-2173&author=A.+Zamoraauthor=C.+A.+Denningauthor=D.+K.+Heidaryauthor=E.+Wachterauthor=L.+A.+Neaseauthor=J.+Ruizauthor=E.+C.+Glazer&title=Ruthenium-containing+P450+inhibitors+for+dual+enzyme+inhibition+and+DNA+damage&doi=10.1039%2FC6DT04405K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium-containing P450 inhibitors for dual enzyme inhibition and DNA damage</span></div><div class="casAuthors">Zamora, Ana; Denning, Catherine A.; Heidary, David K.; Wachter, Erin; Nease, Leona A.; Ruiz, Jose; Glazer, Edith C.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2165-2173</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cytochrome P450s are key players in drug metab., and overexpression in tumors is assocd. with significant resistance to many medicinal agents.  Consequently, inhibition of P450s could serve as a strategy to restore drug efficacy.  However, the widespread expression of P450s throughout the human body and the crit. roles they play in various biosynthetic pathways motivates the development of P 450 inhibitors capable of controlled local administration.  Ruthenium complexes contg. P 450 inhibitors as ligands were synthesized in order to develop pro-drugs that can be triggered to release the inhibitors in a spatially and temporally controlled fashion.  Upon light activation the compds. release ligands that directly bind and inhibit P 450 enzymes, while the ruthenium center is able to directly damage DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoThP9A_DHfxrVg90H21EOLACvtfcHk0lgsFpXSBDZmww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCrsLc%253D&md5=181eacdc16d10e3af5f3d539cd98147c</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1039%2FC6DT04405K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6DT04405K%26sid%3Dliteratum%253Aachs%26aulast%3DZamora%26aufirst%3DA.%26aulast%3DDenning%26aufirst%3DC.%2BA.%26aulast%3DHeidary%26aufirst%3DD.%2BK.%26aulast%3DWachter%26aufirst%3DE.%26aulast%3DNease%26aufirst%3DL.%2BA.%26aulast%3DRuiz%26aufirst%3DJ.%26aulast%3DGlazer%26aufirst%3DE.%2BC.%26atitle%3DRuthenium-containing%2520P450%2520inhibitors%2520for%2520dual%2520enzyme%2520inhibition%2520and%2520DNA%2520damage%26jtitle%3DDalton%2520Trans.%26date%3D2017%26volume%3D46%26spage%3D2165%26epage%3D2173%26doi%3D10.1039%2FC6DT04405K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pracharova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepankova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span> <span> </span><span class="NLM_article-title">Photo-induced DNA cleavage and cytotoxicity of a ruthenium(II) arene anticancer complex</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2015.12.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jinorgbio.2015.12.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2016&pages=149-155&author=V.+Brabecauthor=J.+Pracharovaauthor=J.+Stepankovaauthor=P.+J.+Sadlerauthor=J.+Kasparkova&title=Photo-induced+DNA+cleavage+and+cytotoxicity+of+a+ruthenium%28II%29+arene+anticancer+complex&doi=10.1016%2Fj.jinorgbio.2015.12.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2015.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2015.12.029%26sid%3Dliteratum%253Aachs%26aulast%3DBrabec%26aufirst%3DV.%26aulast%3DPracharova%26aufirst%3DJ.%26aulast%3DStepankova%26aufirst%3DJ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26aulast%3DKasparkova%26aufirst%3DJ.%26atitle%3DPhoto-induced%2520DNA%2520cleavage%2520and%2520cytotoxicity%2520of%2520a%2520ruthenium%2528II%2529%2520arene%2520anticancer%2520complex%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2016%26volume%3D160%26spage%3D149%26epage%3D155%26doi%3D10.1016%2Fj.jinorgbio.2015.12.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Fusion of photodynamic therapy and photoactivated chemotherapy: a novel Ru(II) arene complex with dual activities of photo binding and photocleavage toward DNA</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">15375</span>– <span class="NLM_lpage">15384</span>, <span class="refDoi"> DOI: 10.1039/C4DT01755B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1039%2FC4DT01755B" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=15375-15384&author=Y.+Chenauthor=W.+Leiauthor=G.+Jiangauthor=Y.+Houauthor=C.+Liauthor=B.+Zhangauthor=Q.+Zhouauthor=X.+Wang&title=Fusion+of+photodynamic+therapy+and+photoactivated+chemotherapy%3A+a+novel+Ru%28II%29+arene+complex+with+dual+activities+of+photo+binding+and+photocleavage+toward+DNA&doi=10.1039%2FC4DT01755B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1039%2FC4DT01755B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4DT01755B%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLei%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DFusion%2520of%2520photodynamic%2520therapy%2520and%2520photoactivated%2520chemotherapy%253A%2520a%2520novel%2520Ru%2528II%2529%2520arene%2520complex%2520with%2520dual%2520activities%2520of%2520photo%2520binding%2520and%2520photocleavage%2520toward%2520DNA%26jtitle%3DDalton%2520Trans.%26date%3D2014%26volume%3D43%26spage%3D15375%26epage%3D15384%26doi%3D10.1039%2FC4DT01755B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leijen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgers, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pluim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tibben, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Werkhoven, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sava, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beijnen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schellens, J. H.</span></span> <span> </span><span class="NLM_article-title">Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1007/s10637-014-0179-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1007%2Fs10637-014-0179-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=25344453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFShsLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=201-214&author=S.+Leijenauthor=S.+A.+Burgersauthor=P.+Baasauthor=D.+Pluimauthor=M.+Tibbenauthor=E.+van+Werkhovenauthor=E.+Alessioauthor=G.+Savaauthor=J.+H.+Beijnenauthor=J.+H.+Schellens&title=Phase+I%2FII+study+with+ruthenium+compound+NAMI-A+and+gemcitabine+in+patients+with+non-small+cell+lung+cancer+after+first+line+therapy&doi=10.1007%2Fs10637-014-0179-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy</span></div><div class="casAuthors">Leijen, Suzanne; Burgers, Sjaak A.; Baas, Paul; Pluim, Dick; Tibben, Matthijs; van Werkhoven, Erik; Alessio, Enzo; Sava, Gianni; Beijnen, Jos H.; Schellens, Jan H. M.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">201-214</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">This phase I/II study detd. the maximal tolerable dose, dose limiting toxicities, antitumor activity, the pharmacokinetics and pharmacodynamics of ruthenium compd. NAMI-A in combination with gemcitabine in Non-Small Cell Lung Cancer patients after first line treatment.  Initial dose escalation of NAMI-A was performed in a 28 day cycle: NAMI-A as a 3 h infusion through a port-a-cath at a starting dose of 300 mg/m2 at day 1, 8 and 15, in combination with gemcitabine 1,000 mg/m2 at days 2, 9 and 16.  Subsequently, dose escalation of NAMI-A in a 21 day schedule was explored.  At the maximal tolerable dose level of this schedule an expansion group was enrolled of which 15 patients were evaluable for response.  Due to frequent neutropenic dose interruptions in the third week, the 28 day schedule was amended into a 21 day schedule.  The maximal tolerable dose was 300 and 450 mg/m2 of NAMI-A (21 day schedule).  Main adverse events consisted of neutropenia, anemia, elevated liver enzymes, transient creatinine elevation, nausea, vomiting, constipation, diarrhea, fatigue, and renal toxicity.  NAMI-A administered in combination with gemcitabine is only moderately tolerated and less active in NSCLC patients after first line treatment than gemcitabine alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcT3vG0pRk3LVg90H21EOLACvtfcHk0lip5vSrBSJ0ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFShsLvI&md5=7e39b259bf03bd8990fdcfde165c5412</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1007%2Fs10637-014-0179-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-014-0179-1%26sid%3Dliteratum%253Aachs%26aulast%3DLeijen%26aufirst%3DS.%26aulast%3DBurgers%26aufirst%3DS.%2BA.%26aulast%3DBaas%26aufirst%3DP.%26aulast%3DPluim%26aufirst%3DD.%26aulast%3DTibben%26aufirst%3DM.%26aulast%3Dvan%2BWerkhoven%26aufirst%3DE.%26aulast%3DAlessio%26aufirst%3DE.%26aulast%3DSava%26aufirst%3DG.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%26atitle%3DPhase%2520I%252FII%2520study%2520with%2520ruthenium%2520compound%2520NAMI-A%2520and%2520gemcitabine%2520in%2520patients%2520with%2520non-small%2520cell%2520lung%2520cancer%2520after%2520first%2520line%2520therapy%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2015%26volume%3D33%26spage%3D201%26epage%3D214%26doi%3D10.1007%2Fs10637-014-0179-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heffeter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atil, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kryeziu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groza, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koellensperger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Körner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jungwirth, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, W.</span></span> <span> </span><span class="NLM_article-title">The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3366</span>– <span class="NLM_lpage">3375</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2013.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ejca.2013.05.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=3366-3375&author=P.+Heffeterauthor=B.+Atilauthor=K.+Kryeziuauthor=D.+Grozaauthor=G.+Koellenspergerauthor=W.+K%C3%B6rnerauthor=U.+Jungwirthauthor=T.+Mohrauthor=B.+K.+Kepplerauthor=W.+Berger&title=The+ruthenium+compound+KP1339+potentiates+the+anticancer+activity+of+sorafenib+in+vitro+and+in+vivo&doi=10.1016%2Fj.ejca.2013.05.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2013.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2013.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DHeffeter%26aufirst%3DP.%26aulast%3DAtil%26aufirst%3DB.%26aulast%3DKryeziu%26aufirst%3DK.%26aulast%3DGroza%26aufirst%3DD.%26aulast%3DKoellensperger%26aufirst%3DG.%26aulast%3DK%25C3%25B6rner%26aufirst%3DW.%26aulast%3DJungwirth%26aufirst%3DU.%26aulast%3DMohr%26aufirst%3DT.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26aulast%3DBerger%26aufirst%3DW.%26atitle%3DThe%2520ruthenium%2520compound%2520KP1339%2520potentiates%2520the%2520anticancer%2520activity%2520of%2520sorafenib%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2013%26volume%3D49%26spage%3D3366%26epage%3D3375%26doi%3D10.1016%2Fj.ejca.2013.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crans, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lay, P. A.</span></span> <span> </span><span class="NLM_article-title">Speciation of metal drugs, supplements and toxins in media and bodily fluids controls <i>in vitro</i> activities</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">498</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2017.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.ccr.2017.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlGgtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2017&pages=473-498&author=A.+Levinaauthor=D.+C.+Cransauthor=P.+A.+Lay&title=Speciation+of+metal+drugs%2C+supplements+and+toxins+in+media+and+bodily+fluids+controls+in+vitro+activities&doi=10.1016%2Fj.ccr.2017.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Speciation of metal drugs, supplements and toxins in media and bodily fluids controls in vitro activities</span></div><div class="casAuthors">Levina, Aviva; Crans, Debbie C.; Lay, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">473-498</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Studies of metal uptake, metab. and excretion by single bacterial, yeast, plant and animal cells is a widespread area of research, yet little is known about the reactivity and speciation of metal ions in the corresponding cell culture media, which dictates in vitro activities.  This review discusses: (i) compn. requirements for the culture of different types of cells; (ii) the main anal. techniques used in metal speciation studies, including sepn. techniques, spectroscopies (electronic, magnetic resonance and X-ray absorption), biol. assays and computational techniques; (iii) speciation of essential or toxic metal ions added to the media as inorg. salts; (iv) speciation of typical metal-based drugs in mammalian cell test systems; (v) factors such as the time-dependence of speciation, which will differ depending on whether or not the species was pre-incubated in the medium; and (vi) whether assays where performed in media that are in contact with other extracellular components that were more reminiscent of the in vivo extracellular environment than std. assays.  Reactions with cell culture media often lead to complete changes in metal speciation and to alterations of biol. activities that may often differ significantly from in vivo activities, or between different in vitro assays, often leading to conflicting evidence of activities.  In particular, the main cellular uptake pathways of metal compds., including passive diffusion, active uptake through transport channels and endocytosis-mediated uptake, provide a link between chem. forms of the metal species in the medium and their biol. activities.  Particular care is required for the complexes with strong chelating ligands, such as 1,10-phenanthroline and its derivs.  The release of such ligands and their binding to essential trace elements in the media may elicit strong biol. effects of their own through the interference with both extracellular and intracellular essential metal metab. that may have nothing to do with the parent drug.  The role of serum proteins, in particular albumin and transferrin, in the speciation and reactivity of metal complexes in cell culture media is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnpw2zoRSm-bVg90H21EOLACvtfcHk0lip5vSrBSJ0ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlGgtb0%253D&md5=4e7b34c5a269dfa959fb08fb77309791</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2017.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2017.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DLevina%26aufirst%3DA.%26aulast%3DCrans%26aufirst%3DD.%2BC.%26aulast%3DLay%26aufirst%3DP.%2BA.%26atitle%3DSpeciation%2520of%2520metal%2520drugs%252C%2520supplements%2520and%2520toxins%2520in%2520media%2520and%2520bodily%2520fluids%2520controls%2520in%2520vitro%2520activities%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2017%26volume%3D352%26spage%3D473%26epage%3D498%26doi%3D10.1016%2Fj.ccr.2017.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doucette, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassell, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crans, D. C.</span></span> <span> </span><span class="NLM_article-title">Selective speciation improves efficacy and lowers toxicity of platinum anticancer and vanadium antidiabetic drugs</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2016.09.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=10.1016%2Fj.jinorgbio.2016.09.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=27751591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslSiu7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2016&pages=56-70&author=K.+A.+Doucetteauthor=K.+N.+Hassellauthor=D.+C.+Crans&title=Selective+speciation+improves+efficacy+and+lowers+toxicity+of+platinum+anticancer+and+vanadium+antidiabetic+drugs&doi=10.1016%2Fj.jinorgbio.2016.09.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Selective speciation improves efficacy and lowers toxicity of platinum anticancer and vanadium antidiabetic drugs</span></div><div class="casAuthors">Doucette, Kaitlin A.; Hassell, Kelly N.; Crans, Debbie C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">56-70</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Improving efficacy and lowering resistance to metal-based drugs can be addressed by consideration of the coordination complex speciation and key reactions important to vanadium antidiabetic drugs or platinum anticancer drugs under biol. conditions.  The methods of analyses vary depending on the specific metal ion chem.  The vanadium compds. interconvert readily, whereas the reactions of the platinum compds. are much slower and thus much easier to study.  However, the vanadium species are readily differentiated due to vanadium complexes differing in color.  For both vanadium and platinum systems, understanding the processes as the compds., Lipoplatin and Satraplatin, enter cells is needed to better combat the disease; there are many cellular metabolites, which may affect processing and thus the efficacy of the drugs.  Examples of two formulations of platinum compds. illustrate how changing the chem. of the platinum will result in less toxic and better tolerated drugs.  The consequence of the much lower toxicity of the drug, can be readily realized because cisplatin administration requires hospital stay whereas Lipoplatin can be done in an outpatient manner.  Similarly, the properties of Satraplatin allow for development of an oral drug.  These forms of platinum demonstrate that the direct consequence of more selective speciation is lower side effects and cheaper administration of the anticancer agent.  Therefore we urge that as the community goes forward in development of new drugs, control of speciation chem. will be considered as one of the key strategies in the future development of anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbmUDjquH_lLVg90H21EOLACvtfcHk0liPEDTcLHXXeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslSiu7jO&md5=e44a3b89c54e51d203396d402a62f95d</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2016.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2016.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DDoucette%26aufirst%3DK.%2BA.%26aulast%3DHassell%26aufirst%3DK.%2BN.%26aulast%3DCrans%26aufirst%3DD.%2BC.%26atitle%3DSelective%2520speciation%2520improves%2520efficacy%2520and%2520lowers%2520toxicity%2520of%2520platinum%2520anticancer%2520and%2520vanadium%2520antidiabetic%2520drugs%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2016%26volume%3D165%26spage%3D56%26epage%3D70%26doi%3D10.1016%2Fj.jinorgbio.2016.09.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YHS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YHS','PDB','1YHS'); return false;">PDB: 1YHS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BZI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BZI','PDB','2BZI'); return false;">PDB: 2BZI</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01689&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01689%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01689" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a5077fceb3d00","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
